data_2f3i_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2f3i _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 13.3 tp . . . . . 0 CA--C 1.545 0.765 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -148.14 147.47 29.52 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.868 1.213 . . . . 0.0 112.152 -177.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -159.43 137.79 10.56 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 128.174 2.59 . . . . 0.0 107.177 -175.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -158.46 154.86 27.5 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 119.336 0.971 . . . . 0.0 110.638 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.1 mp -99.16 159.6 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 126.392 1.877 . . . . 0.0 107.652 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -137.21 168.94 18.65 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.493 1.117 . . . . 0.0 110.549 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -134.1 128.76 34.85 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.641 1.576 . . . . 0.0 106.956 165.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 74.6 t -66.61 133.59 31.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 175.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -103.63 -34.32 8.67 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.616 1.167 . . . . 0.0 110.479 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -158.16 161.26 37.86 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.702 0.801 . . . . 0.0 110.146 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.8 mp -134.44 137.3 51.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 126.827 2.051 . . . . 0.0 105.728 -177.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -140.77 79.0 19.74 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 123.27 0.628 . . . . 0.0 111.453 -167.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -67.48 30.88 0.13 Allowed 'Trans proline' 0 CA--C 1.553 1.432 1 C-N-CA 126.089 4.526 . . . . 0.0 117.849 -172.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -50.13 -46.0 53.46 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 120.985 1.721 . . . . 0.0 115.449 -161.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -129.73 82.05 0.33 Allowed Glycine 0 C--N 1.336 0.572 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -160.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.425 ' HE2' ' HA ' ' A' ' 20' ' ' LYS . 9.5 mmpt? -74.44 62.91 1.02 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.26 1.424 . . . . 0.0 111.124 -176.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -55.92 -39.14 71.2 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.428 -0.795 . . . . 0.0 108.941 163.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -136.14 135.92 39.64 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 104.694 -2.336 . . . . 0.0 104.694 170.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -61.51 -33.29 73.54 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.271 0.487 . . . . 0.0 111.23 -177.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 -75.94 5.87 5.94 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.9 t -121.53 133.52 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 121.841 2.11 . . . . 0.0 107.858 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.7 m -148.38 158.97 44.43 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.352 1.061 . . . . 0.0 110.063 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 27.7 ttp180 -73.4 148.58 43.19 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 163.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 74.1 mt -134.18 162.66 31.52 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 126.153 1.781 . . . . 0.0 108.082 175.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -137.0 130.74 31.9 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 174.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 64.2 m -141.21 164.85 29.15 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.115 1.366 . . . . 0.0 109.525 -170.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -141.15 136.1 31.52 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.4 p -81.39 157.89 24.83 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.29 0.495 . . . . 0.0 111.194 -177.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -100.65 -50.78 3.77 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.581 0.752 . . . . 0.0 111.768 -168.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.0 m -73.57 -24.12 60.04 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 118.844 0.747 . . . . 0.0 111.292 -175.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.455 ' HB3' HD22 ' A' ' 131' ' ' ASN . 19.1 m-85 -126.01 -134.08 0.25 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.921 1.289 . . . . 0.0 108.767 -177.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -143.61 13.54 1.74 Allowed 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.879 1.218 . . . . 0.0 113.689 -165.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 65.7 mtm -68.94 152.0 45.83 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 118.857 0.753 . . . . 0.0 110.685 -172.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -121.5 125.23 46.33 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 126.759 2.024 . . . . 0.0 106.516 176.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 67.9 tp -137.16 148.8 46.84 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.718 0.771 . . . . 0.0 110.264 -163.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.3 mm -130.88 144.9 36.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 128.704 2.801 . . . . 0.0 104.296 170.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.5 mp -134.79 162.51 32.15 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 173.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -132.39 109.16 9.65 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 104.692 -2.336 . . . . 0.0 104.692 158.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.4 p -153.42 158.66 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -154.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -62.16 125.2 23.06 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 169.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 pp -105.39 -1.13 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.253 1.021 . . . . 0.0 112.965 -177.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -66.75 -11.73 55.92 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 120.567 1.53 . . . . 0.0 112.357 177.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.9 mt -63.21 -40.2 88.14 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.75 1.22 . . . . 0.0 108.731 171.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -72.55 155.42 91.11 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 124.152 0.981 . . . . 0.0 109.155 174.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -63.37 -53.08 1.59 Allowed 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 121.766 1.644 . . . . 0.0 111.683 -174.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.8 m -152.67 -143.77 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 126.073 1.749 . . . . 0.0 107.604 -177.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -54.38 -30.42 51.84 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 127.805 2.442 . . . . 0.0 115.143 -173.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 27.9 tp -86.17 -18.92 30.93 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 -147.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.18 173.29 41.36 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -165.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -163.95 178.14 7.97 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.312 1.845 . . . . 0.0 107.912 -175.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -93.58 125.77 38.37 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 121.3 -0.875 . . . . 0.0 109.875 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -106.44 170.76 7.74 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.494 1.518 . . . . 0.0 109.544 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.3 ttp180 -127.54 104.52 7.93 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 126.172 1.789 . . . . 0.0 106.188 165.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.9 152.04 28.3 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 171.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 95.4 t -141.72 134.96 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 -175.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.0 pt -121.25 25.63 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 163.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.345 0.407 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 152.245 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.446 -0.644 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -39.03 -33.23 0.11 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 127.11 2.164 . . . . 0.0 114.591 -175.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -149.5 157.77 43.58 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 173.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.5 p -163.7 138.39 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 40.2 tpp -163.16 166.8 22.97 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.051 0.54 . . . . 0.0 110.387 -166.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -111.94 163.09 14.63 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.707 1.603 . . . . 0.0 109.589 172.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -165.16 -159.67 11.68 Favored Glycine 0 CA--C 1.521 0.419 0 O-C-N 121.648 -0.658 . . . . 0.0 113.022 -175.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 11.1 ttmm -141.73 126.84 18.43 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 177.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.2 t -89.94 143.29 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 171.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -127.41 111.85 14.32 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 177.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.25 144.9 16.15 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 -177.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.451 HG13 ' H ' ' A' ' 101' ' ' GLY . 3.2 pt -75.56 -171.82 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 127.587 2.355 . . . . 0.0 109.663 169.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -64.59 -6.38 7.52 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.462 1.505 . . . . 0.0 114.384 176.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.451 ' H ' HG13 ' A' ' 99' ' ' ILE . . . . . . . . 0 C--N 1.336 0.529 0 C-N-CA 126.698 2.094 . . . . 0.0 110.255 -177.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.8 p . . . . . 0 CA--C 1.536 0.429 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -108.48 115.3 29.85 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 165.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 34.5 tp -56.02 131.8 48.35 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 160.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 14.7 m -87.34 171.62 10.46 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 171.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -152.0 146.92 25.94 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 124.62 1.168 . . . . 0.0 108.237 161.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 2.9 m-30 -122.81 139.51 53.93 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 104.001 -2.592 . . . . 0.0 104.001 170.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.2 t -139.42 137.46 40.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 -174.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.1 m -116.92 132.09 56.79 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 166.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -149.43 109.77 4.19 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.089 0.859 . . . . 0.0 109.703 -170.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 58.19 22.94 51.47 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 123.797 0.713 . . . . 0.0 114.334 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.1 -14.11 65.0 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-N 118.42 1.11 . . . . 0.0 112.98 -176.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -83.05 171.87 13.33 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.643 1.177 . . . . 0.0 109.012 170.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 10.1 tp -140.07 153.74 46.85 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.242 1.017 . . . . 0.0 110.192 -173.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 42.6 mtt -138.75 158.31 44.47 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.684 1.194 . . . . 0.0 110.281 164.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.6 ttt-85 -143.97 122.34 12.35 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 104.357 -2.461 . . . . 0.0 104.357 176.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 33.8 tp -142.93 151.54 41.07 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.183 0.901 . . . . 0.0 109.342 -158.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -141.47 145.26 35.02 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.174 1.39 . . . . 0.0 109.817 167.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -172.76 166.81 39.54 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 125.989 1.757 . . . . 0.0 109.883 171.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -51.58 146.75 7.13 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.019 1.41 . . . . 0.0 111.09 176.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.77 -47.53 82.26 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -169.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -65.17 -43.71 90.85 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 122.678 0.391 . . . . 0.0 110.069 174.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.455 HD22 ' HB3' ' A' ' 35' ' ' PHE . 49.8 t30 -65.21 -40.73 94.54 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.416 1.086 . . . . 0.0 112.765 -172.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.2 tt -63.83 -22.17 66.79 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.522 1.129 . . . . 0.0 111.285 176.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 53.08 39.01 28.82 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.998 1.719 . . . . 0.0 112.556 170.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -157.5 50.8 0.42 Allowed Glycine 0 C--N 1.338 0.656 0 C-N-CA 124.067 0.842 . . . . 0.0 111.03 -169.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -58.36 -35.48 72.02 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.294 0.637 . . . . 0.0 110.406 170.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -83.63 155.0 23.43 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.535 1.534 . . . . 0.0 110.326 -170.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.1 m -73.28 -3.46 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 C-N-CA 123.68 0.792 . . . . 0.0 112.208 168.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -133.56 6.41 3.77 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.616 1.166 . . . . 0.0 112.877 -164.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 72.2 m -87.84 -69.3 0.7 Allowed 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.085 -1.01 . . . . 0.0 109.902 173.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.276 12.7 ptm180 -82.05 11.74 4.87 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 120.605 -1.309 . . . . 0.0 114.147 -170.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 24.6 m -62.87 -31.8 53.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 O-C-N 121.992 -0.442 . . . . 0.0 110.305 157.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -73.21 113.47 10.31 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 170.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.3 tt -145.95 137.57 24.97 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 118.342 0.519 . . . . 0.0 110.282 -167.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.3 tt -150.66 150.64 31.38 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.784 1.634 . . . . 0.0 107.088 -168.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 60.3 mtt -142.19 157.42 44.88 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 120.624 -1.298 . . . . 0.0 108.802 -176.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 15.5 ptmt -155.42 173.58 16.46 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 125.002 1.321 . . . . 0.0 109.718 163.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -57.93 163.5 2.69 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 164.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.09 159.82 5.46 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.281 163.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -132.17 106.59 8.06 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 175.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.252 1.196 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 -168.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.5 tm? . . . . . 0 C--O 1.232 0.157 0 CA-C-O 118.948 -0.549 . . . . 0.0 110.054 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -154.71 151.68 29.02 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -151.78 141.87 22.21 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 126.508 1.923 . . . . 0.0 107.642 -173.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -151.57 150.71 30.63 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 168.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 mp -72.42 148.52 9.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 172.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -135.94 156.82 48.17 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.325 1.85 . . . . 0.0 107.455 175.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -129.21 144.98 51.41 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.901 1.28 . . . . 0.0 108.355 176.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.8 p -73.83 146.22 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 C-N-CA 124.283 1.033 . . . . 0.0 108.767 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -125.59 -28.94 3.23 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 126.558 1.943 . . . . 0.0 109.479 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -157.68 166.62 32.34 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.028 0.831 . . . . 0.0 110.67 170.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.6 mp -143.57 138.15 25.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 127.26 2.224 . . . . 0.0 106.58 -174.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -151.66 101.25 2.91 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 123.202 0.601 . . . . 0.0 109.721 169.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -57.79 146.18 86.95 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.917 2.411 . . . . 0.0 111.292 172.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -127.66 13.64 6.96 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.227 0.611 . . . . 0.0 112.207 -172.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 174.72 79.86 0.05 OUTLIER Glycine 0 C--N 1.338 0.689 0 O-C-N 121.199 -0.938 . . . . 0.0 111.511 -170.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.9 mmtt -57.46 -18.4 18.15 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -72.47 -14.37 61.66 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.8 0.727 . . . . 0.0 111.111 175.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -136.32 52.33 1.97 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 127.149 2.18 . . . . 0.0 106.108 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -50.05 -28.06 6.52 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.806 1.643 . . . . 0.0 114.783 -169.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -68.64 2.17 2.66 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 117.668 -1.158 . . . . 0.0 113.707 173.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.3 t -125.52 121.89 61.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 121.138 1.79 . . . . 0.0 107.596 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.3 m -147.15 158.25 43.88 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.888 0.875 . . . . 0.0 110.759 -173.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.5 ttp-105 -83.02 148.28 27.65 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 170.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.0 mt -139.41 154.12 47.74 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.7 2.0 . . . . 0.0 107.273 177.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -126.69 132.52 51.15 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 103.926 -2.62 . . . . 0.0 103.926 171.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 64.0 m -145.21 167.24 23.28 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.956 1.302 . . . . 0.0 111.154 -169.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -140.71 142.5 34.84 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.463 1.905 . . . . 0.0 108.081 -176.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 31.9 p -72.72 151.78 42.0 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 118.125 0.421 . . . . 0.0 111.092 177.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -83.55 -37.32 23.14 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 118.757 -0.64 . . . . 0.0 111.495 176.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.6 m -101.76 -17.61 16.17 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 -168.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -124.2 -102.16 0.38 Allowed 'General case' 0 C--N 1.342 0.252 0 CA-C-N 120.545 1.52 . . . . 0.0 110.542 -170.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -168.19 10.8 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.204 1.002 . . . . 0.0 113.003 -169.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 59.6 mtm -70.56 146.7 49.96 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.342 0.591 . . . . 0.0 110.158 -173.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -118.58 128.78 54.87 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 172.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.4 tp -133.34 139.18 46.69 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 123.598 0.759 . . . . 0.0 110.46 -169.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 14.8 mm -125.6 148.25 30.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 103.776 -2.675 . . . . 0.0 103.776 169.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.5 mt -150.21 144.68 25.77 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 126.346 1.858 . . . . 0.0 107.057 -171.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -131.58 94.62 3.56 Favored 'General case' 0 C--N 1.32 -0.694 1 N-CA-C 99.754 -4.165 . . . . 0.0 99.754 168.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.7 p -136.24 161.65 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-O 122.07 0.938 . . . . 0.0 112.536 -166.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.2 t30 -68.48 90.71 0.38 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.039 2.135 . . . . 0.0 109.057 169.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.6 pp -69.65 3.88 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -169.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -65.98 -11.68 49.46 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 120.854 1.661 . . . . 0.0 111.957 176.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 55.7 mt -59.51 -34.08 53.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 169.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -92.32 155.04 42.88 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 124.923 1.289 . . . . 0.0 108.426 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.04 -23.82 33.64 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.196 1.931 . . . . 0.0 112.526 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.0 t -145.81 153.97 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 -178.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -53.93 -28.94 40.13 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.445 1.098 . . . . 0.0 112.306 169.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 39.5 tp -56.64 -17.0 7.24 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.456 1.502 . . . . 0.0 112.903 173.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.88 173.67 49.71 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 124.011 0.815 . . . . 0.0 111.359 177.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -164.11 175.07 10.56 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.901 2.08 . . . . 0.0 106.497 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -67.43 147.25 53.12 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 169.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -150.03 -173.44 4.43 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.063 1.345 . . . . 0.0 107.711 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -132.95 148.08 52.28 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 119.136 0.88 . . . . 0.0 109.338 170.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.1 tt -118.88 143.21 47.11 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.5 t -139.34 155.46 26.04 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 C-N-CA 124.666 1.187 . . . . 0.0 109.694 -168.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.1 tt -129.72 148.35 33.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 127.725 2.41 . . . . 0.0 106.24 170.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.397 0 C-N-CA 124.939 1.295 . . . . 0.0 109.155 -173.536 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 . . . . . 0 CA--C 1.535 0.376 0 N-CA-C 107.4 -1.334 . . . . 0.0 107.4 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -82.83 -31.29 28.15 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.703 0.683 . . . . 0.0 110.127 169.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -147.54 150.31 34.26 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.187 0.595 . . . . 0.0 109.663 177.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.2 t -143.62 138.88 25.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.08 169.56 23.24 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.894 0.855 . . . . 0.0 110.571 175.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -134.22 93.57 3.1 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 -171.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -92.62 -164.31 37.99 Favored Glycine 0 C--N 1.332 0.357 0 CA-C-O 121.682 0.601 . . . . 0.0 112.732 -169.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -134.04 111.93 10.78 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 169.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.7 t -69.84 149.0 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 169.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -143.34 58.59 1.39 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.556 0.742 . . . . 0.0 110.935 174.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -143.59 160.86 39.88 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.964 1.306 . . . . 0.0 109.878 174.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -83.5 -177.2 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 125.432 1.493 . . . . 0.0 109.723 169.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -64.08 -6.99 7.38 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.612 1.565 . . . . 0.0 114.847 -177.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.406 0 N-CA-C 107.0 -2.44 . . . . 0.0 107.0 -172.961 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 32.8 p . . . . . 0 N--CA 1.469 0.517 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -128.46 144.05 51.08 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 173.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 7.8 tt -92.83 149.08 21.51 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 168.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 10.7 p -116.0 146.0 42.5 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -139.42 100.18 3.92 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -95.66 128.19 42.32 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 101.65 -3.463 . . . . 0.0 101.65 169.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.7 t -140.02 137.7 38.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -169.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.7 t -117.45 137.82 52.26 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 170.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -150.15 105.63 3.39 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.609 0.764 . . . . 0.0 109.536 -171.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 61.27 22.44 60.94 Favored Glycine 0 CA--C 1.534 1.264 0 O-C-N 121.546 -0.721 . . . . 0.0 113.927 175.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.49 -13.58 65.34 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.499 1.047 . . . . 0.0 112.934 -177.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -85.59 164.13 17.93 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 169.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 7.8 tt -146.21 155.92 43.03 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 121.695 -0.628 . . . . 0.0 109.956 -171.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 23.4 ptm -150.42 161.01 43.34 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.394 1.077 . . . . 0.0 108.906 172.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 58.7 ttt-85 -135.96 127.44 28.65 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 104.978 -2.231 . . . . 0.0 104.978 172.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 25.5 tp -141.97 140.69 32.8 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -170.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -132.54 145.79 51.41 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 169.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -171.74 178.18 44.15 Favored Glycine 0 C--N 1.331 0.298 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 174.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.08 140.66 48.56 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 118.158 0.979 . . . . 0.0 109.221 172.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -52.27 -62.18 1.8 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.604 0.761 . . . . 0.0 112.613 -175.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.31 -24.08 66.48 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.117 0.871 . . . . 0.0 113.032 -174.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.37 -35.5 77.81 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 126.16 1.784 . . . . 0.0 109.774 174.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 16.9 tp -94.81 -19.2 20.53 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.713 0.805 . . . . 0.0 110.252 -175.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 42.58 42.2 2.7 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.669 1.988 . . . . 0.0 112.041 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -105.71 20.17 37.22 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.029 0.823 . . . . 0.0 112.458 -172.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -74.16 8.8 1.91 Allowed 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.25 1.025 . . . . 0.0 113.497 -178.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -131.79 131.11 42.64 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 169.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.9 p -57.65 -10.15 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 125.124 1.37 . . . . 0.0 110.857 169.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -123.56 12.71 9.33 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 126.002 1.721 . . . . 0.0 112.978 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 3.4 m -89.12 -58.98 2.35 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 167.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.6 tpm_? -75.55 2.07 12.66 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 115.466 -0.788 . . . . 0.0 113.031 -169.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 29.2 m -60.25 -37.98 75.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 124.422 1.089 . . . . 0.0 110.14 169.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -71.95 118.47 14.85 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 63.3 tp -138.88 120.65 15.32 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 -172.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.59 149.34 45.16 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -174.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 61.6 mtt -143.11 144.59 32.29 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -172.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -152.3 160.78 43.28 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -64.02 157.19 25.81 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 168.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.3 pp -67.21 165.36 16.27 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.242 0.544 . . . . 0.0 110.172 170.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -142.14 140.08 32.34 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 170.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 . . . . . 0 C--O 1.25 1.102 0 C-N-CA 126.392 1.877 . . . . 0.0 110.413 -176.312 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.3 tm? . . . . . 0 CA--C 1.532 0.278 0 CA-C-O 121.006 0.432 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -153.36 134.34 13.97 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 172.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -144.76 147.7 33.25 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.28 1.432 . . . . 0.0 108.08 -169.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -150.31 155.7 40.16 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.187 0.595 . . . . 0.0 109.434 169.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.3 mp -85.82 144.7 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 169.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -113.04 143.59 44.06 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.035 1.334 . . . . 0.0 107.68 171.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -117.06 122.83 45.29 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.878 1.671 . . . . 0.0 106.832 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.7 t -71.7 121.43 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -176.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.5 mmmt -96.61 -29.86 13.6 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.194 177.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -155.33 165.08 37.75 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.408 1.003 . . . . 0.0 111.459 175.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.4 mp -142.55 135.61 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 127.85 2.46 . . . . 0.0 105.756 -177.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -147.87 93.04 4.58 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 118.301 0.501 . . . . 0.0 111.155 178.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -61.16 144.77 99.18 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.911 2.407 . . . . 0.0 109.954 169.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -131.79 9.4 4.58 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -174.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.84 46.61 10.68 Favored Glycine 0 C--N 1.343 0.918 0 O-C-N 121.478 -0.764 . . . . 0.0 111.202 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.0 mmmm -73.03 25.97 0.06 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.289 1.436 . . . . 0.0 112.772 -171.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp 68.02 -59.84 0.42 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 128.497 2.719 . . . . 0.0 108.569 -168.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 4.8 m-30 -81.26 87.18 6.13 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 103.633 -2.729 . . . . 0.0 103.633 168.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -62.68 -17.58 60.85 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.285 -0.884 . . . . 0.0 112.656 -174.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 -66.54 -14.49 62.38 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 118.028 -0.987 . . . . 0.0 112.51 169.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 77.2 t -88.78 134.15 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 169.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.6 m -151.04 159.44 44.54 Favored 'General case' 0 C--O 1.239 0.542 0 O-C-N 120.928 -1.108 . . . . 0.0 109.981 -176.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.6 tpp85 -72.66 150.44 42.98 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 172.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.6 mt -138.14 157.19 46.81 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.923 1.689 . . . . 0.0 107.247 172.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -135.46 133.57 38.69 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 169.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 33.7 m -141.11 166.11 25.68 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.242 1.417 . . . . 0.0 110.087 -174.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -134.87 143.47 47.0 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 172.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.1 p -83.85 145.47 28.62 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 118.762 0.71 . . . . 0.0 110.255 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -80.57 -32.05 36.7 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -169.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.9 m -102.62 -34.21 9.16 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.138 0.881 . . . . 0.0 111.75 -171.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -121.71 10.28 10.29 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.669 1.187 . . . . 0.0 112.712 -170.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.315 0.0 OUTLIER 43.11 39.19 1.78 Allowed 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.915 2.086 . . . . 0.0 114.371 174.637 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 62.5 mtm -63.64 154.08 34.02 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 169.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -112.46 127.77 56.13 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 176.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 59.3 tp -137.81 144.9 41.74 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.78 0.8 . . . . 0.0 110.437 -169.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 35.6 mm -127.83 149.12 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 128.479 2.712 . . . . 0.0 103.737 169.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 123' ' ' MET . 2.0 mp -143.63 161.08 39.46 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 126.201 1.801 . . . . 0.0 108.254 176.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -138.48 94.59 2.87 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 102.312 -3.218 . . . . 0.0 102.312 168.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.7 m -144.15 168.74 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 124.36 1.064 . . . . 0.0 111.295 -168.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -60.03 134.2 56.81 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.041 0.936 . . . . 0.0 110.149 170.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 pp -116.51 2.14 7.88 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.445 0 C-N-CA 125.372 1.469 . . . . 0.0 112.966 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -64.77 -12.24 45.37 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 121.367 1.894 . . . . 0.0 113.248 -172.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 66.2 mt -58.95 -22.53 21.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 125.891 1.676 . . . . 0.0 108.816 169.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -127.38 167.05 19.19 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 128.531 2.733 . . . . 0.0 109.426 -178.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -52.17 157.27 6.59 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.664 2.242 . . . . 0.0 111.875 169.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.7 m -59.57 -10.77 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 N-CA-C 115.573 1.694 . . . . 0.0 115.573 -169.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -139.9 27.5 2.2 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.761 1.224 . . . . 0.0 110.55 -177.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 25.7 tp -140.89 163.16 33.7 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.235 -0.916 . . . . 0.0 110.753 -173.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -165.37 167.81 39.08 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 128.068 2.747 . . . . 0.0 106.405 171.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -141.77 -64.06 0.44 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 118.705 1.252 . . . . 0.0 111.788 -178.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -148.32 162.7 38.99 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.419 1.009 . . . . 0.0 111.159 178.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -145.27 171.34 14.71 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.54 1.936 . . . . 0.0 107.415 170.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -136.02 123.47 22.07 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.5 mp -125.15 146.44 49.49 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -169.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -157.01 128.25 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 121.839 0.828 . . . . 0.0 108.775 -169.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.0 tp -69.16 -32.46 54.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 123.508 0.723 . . . . 0.0 109.945 174.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.565 0 C-N-CA 126.845 2.058 . . . . 0.0 112.787 -172.002 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 . . . . . 0 CA--C 1.542 0.638 0 CA-C-O 120.304 0.097 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -164.29 124.93 2.12 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.494 1.117 . . . . 0.0 109.114 172.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -148.69 154.17 39.27 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 168.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.7 m -137.18 151.93 27.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 O-C-N 121.538 -0.726 . . . . 0.0 110.215 -171.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 37.5 ttm -152.84 161.92 41.94 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.597 1.559 . . . . 0.0 107.353 176.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -136.85 151.72 49.44 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -173.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.18 -157.51 8.58 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 120.908 -0.663 . . . . 0.0 114.366 -169.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -144.82 123.72 12.71 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.772 1.629 . . . . 0.0 107.146 176.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.9 t -77.89 141.89 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 169.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -140.09 64.89 1.43 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.857 1.263 . . . . 0.0 110.057 177.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -154.17 167.52 29.58 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.245 -1.535 . . . . 0.0 112.415 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.9 pt -83.4 -177.12 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 127.249 2.22 . . . . 0.0 112.21 -170.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -74.5 -3.15 29.09 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.742 1.617 . . . . 0.0 114.115 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.23 0 C-N-CA 124.338 0.97 . . . . 0.0 112.537 -178.462 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 72.7 p . . . . . 0 C--O 1.235 0.332 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? 58.87 120.28 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 127.799 2.44 . . . . 0.0 111.652 -173.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 55.3 tp -57.98 144.28 40.11 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 170.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.6 p -123.65 149.03 45.91 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.473 1.109 . . . . 0.0 109.8 -173.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -148.38 108.15 4.01 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.575 1.15 . . . . 0.0 108.373 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 7.6 m-30 -91.57 122.63 34.32 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 102.379 -3.193 . . . . 0.0 102.379 168.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.0 t -129.71 112.75 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -169.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.2 p -88.24 128.77 35.47 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 104.767 -2.308 . . . . 0.0 104.767 169.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.39 134.35 20.27 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 118.711 0.687 . . . . 0.0 109.631 -172.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 47.21 33.19 7.34 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 124.646 1.117 . . . . 0.0 115.188 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 76.51 17.07 80.23 Favored Glycine 0 CA--C 1.536 1.399 0 CA-C-N 118.716 1.258 . . . . 0.0 113.682 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 93.8 mt -129.2 178.65 6.28 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 128.284 2.633 . . . . 0.0 107.283 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 58.3 tp -139.13 154.15 48.08 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 120.837 -1.164 . . . . 0.0 111.539 -171.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' MET . . . . . 0.409 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 76.5 mtm -143.43 156.16 44.58 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.777 2.031 . . . . 0.0 107.901 169.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -137.54 117.93 13.73 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 169.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 51.3 tp -125.59 148.95 48.76 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 125.943 1.697 . . . . 0.0 109.789 -168.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -139.74 148.81 42.81 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.222 1.409 . . . . 0.0 108.448 169.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -165.59 165.17 37.77 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 173.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -71.87 86.7 0.98 Allowed 'General case' 0 N--CA 1.463 0.205 0 O-C-N 122.059 -0.671 . . . . 0.0 110.301 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . 22.85 -77.45 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 130.436 3.494 . . . . 0.0 115.242 -170.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -13.13 16.3 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 11.3 m-20 -85.74 -36.16 20.33 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.972 1.709 . . . . 0.0 109.323 176.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 9.2 tt -72.64 -29.97 63.91 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 170.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 1.8 t60 54.99 45.52 26.24 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.606 1.962 . . . . 0.0 112.069 169.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -152.04 68.49 0.32 Allowed Glycine 0 C--N 1.335 0.484 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 -175.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -73.4 3.55 5.83 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.233 1.013 . . . . 0.0 113.728 -174.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.422 ' C ' ' H ' ' A' ' 138' ' ' ASP . 51.1 mt-10 -129.13 145.35 51.32 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.366 1.866 . . . . 0.0 108.513 172.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 7.8 m -66.32 -1.04 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.098 168.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.422 ' H ' ' C ' ' A' ' 136' ' ' GLU . 28.7 t70 -123.16 15.36 9.84 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 127.746 2.419 . . . . 0.0 111.447 177.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 75.3 m -80.95 -70.5 0.53 Allowed 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.463 -0.773 . . . . 0.0 109.366 168.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.316 1.8 ptp180 -81.56 15.14 2.21 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -169.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 30.3 m -70.97 -12.24 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 167.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -109.27 120.77 43.52 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 103.232 -2.877 . . . . 0.0 103.232 168.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -136.75 130.5 32.07 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -172.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 7.5 tt -117.83 139.47 51.06 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 176.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 19.6 ptt? -144.83 162.11 37.61 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 121.327 -0.858 . . . . 0.0 109.733 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 78.8 mttt -152.86 166.64 31.66 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.759 1.623 . . . . 0.0 108.635 -169.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -71.17 167.69 18.82 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 167.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.34 157.26 8.84 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.173 0.511 . . . . 0.0 110.81 169.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -147.76 123.37 10.47 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 171.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 . . . . . 0 C--O 1.248 0.982 0 C-N-CA 125.995 1.718 . . . . 0.0 107.162 178.092 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.2 tm? . . . . . 0 C--O 1.232 0.15 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -142.87 163.58 32.41 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.006 1.322 . . . . 0.0 107.682 169.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -139.31 124.14 18.63 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 103.878 -2.638 . . . . 0.0 103.878 174.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -142.35 131.97 23.95 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.418 0.687 . . . . 0.0 109.357 -171.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.8 mp -81.79 129.15 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 177.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -96.69 153.03 18.1 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.651 1.581 . . . . 0.0 108.065 175.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -132.27 114.99 15.09 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 126.083 1.753 . . . . 0.0 106.999 172.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 68.9 t -71.47 122.19 23.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 177.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.0 mmmt -85.21 -41.35 15.7 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 173.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -158.6 166.56 31.79 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.305 0.502 . . . . 0.0 111.73 -173.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.4 mp -137.05 141.21 41.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 127.756 2.422 . . . . 0.0 106.481 -175.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -145.59 89.2 6.31 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 124.45 1.1 . . . . 0.0 110.485 -171.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -66.32 142.23 65.52 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.92 3.08 . . . . 0.0 111.352 170.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -78.37 -38.39 41.94 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.942 -0.474 . . . . 0.0 111.597 177.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 147.38 47.48 0.03 OUTLIER Glycine 0 CA--C 1.527 0.829 0 N-CA-C 104.932 -3.267 . . . . 0.0 104.932 -169.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -63.15 120.49 11.59 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.213 1.405 . . . . 0.0 113.468 -167.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.413 ' HA ' ' HE3' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -64.97 -46.93 79.44 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.164 168.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -80.63 -19.21 45.89 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.08 0.552 . . . . 0.0 112.351 -174.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.7 t70 47.12 39.08 7.52 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.99 2.116 . . . . 0.0 113.956 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -142.64 8.25 1.73 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 176.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.7 t -139.24 133.4 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 73.1 m -156.43 168.17 28.18 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 120.786 1.63 . . . . 0.0 110.48 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.1 ttm105 -72.19 149.3 44.76 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 169.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.88 158.09 45.25 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 125.786 1.634 . . . . 0.0 107.755 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -133.31 125.48 29.32 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 174.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 58.5 m -141.89 169.59 17.3 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.947 1.299 . . . . 0.0 111.004 -169.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.1 tt0 -143.78 145.0 32.05 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 125.267 1.427 . . . . 0.0 108.118 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.3 m -75.68 131.48 39.92 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 123.285 0.634 . . . . 0.0 109.939 169.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -80.28 -19.6 46.34 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.557 0.743 . . . . 0.0 111.011 170.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.23 -36.07 3.03 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -169.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -115.38 21.53 14.0 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.527 1.131 . . . . 0.0 112.243 -177.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt 42.96 18.03 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 118.685 2.846 . . . . 0.0 118.685 172.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 68.7 mtm -67.72 151.08 47.82 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.868 1.213 . . . . 0.0 108.534 174.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -112.35 127.69 56.08 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 104.613 -2.365 . . . . 0.0 104.613 171.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.5 mp -136.21 150.89 49.19 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 119.094 0.861 . . . . 0.0 112.614 -168.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 46.2 mm -123.1 144.5 32.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 102.812 -3.033 . . . . 0.0 102.812 168.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.8 mp -143.32 160.66 40.1 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 127.347 2.259 . . . . 0.0 107.455 -169.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -140.2 102.68 4.42 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 102.487 -3.153 . . . . 0.0 102.487 168.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.4 m -144.52 169.35 9.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 C-N-CA 124.203 1.001 . . . . 0.0 111.567 -168.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -65.43 136.06 56.01 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 169.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.8 pp -112.33 7.66 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 124.507 1.123 . . . . 0.0 112.686 -175.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -59.72 -23.14 62.93 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 121.541 -0.725 . . . . 0.0 110.675 169.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.1 mt -68.89 -26.83 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 126.127 1.771 . . . . 0.0 109.839 173.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -127.92 68.16 74.99 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 126.01 1.724 . . . . 0.0 109.02 -170.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -73.41 6.4 2.71 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.676 2.917 . . . . 0.0 114.464 -169.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.6 m -136.87 148.89 26.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 C-N-CA 124.934 1.293 . . . . 0.0 108.862 -174.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -60.57 -25.97 66.58 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.613 1.165 . . . . 0.0 112.349 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 52.7 tp -60.95 -23.92 65.68 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.652 1.181 . . . . 0.0 112.314 174.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.42 -168.08 46.22 Favored Glycine 0 CA--C 1.532 1.123 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -169.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -153.07 173.59 15.26 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.332 1.053 . . . . 0.0 108.281 176.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -94.46 152.46 18.57 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.566 0.746 . . . . 0.0 109.016 169.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -151.92 -177.0 5.88 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.246 1.418 . . . . 0.0 107.911 -173.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 10.7 ttp180 -136.65 146.29 45.81 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 120.929 -1.107 . . . . 0.0 108.661 177.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.0 tt -127.65 145.59 50.83 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.662 1.585 . . . . 0.0 107.883 176.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -145.59 166.91 9.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 127.342 2.257 . . . . 0.0 105.921 -174.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 46.4 pt -129.09 27.1 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 O-C-N 121.297 -0.877 . . . . 0.0 111.389 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.694 0 C-N-CA 124.882 1.273 . . . . 0.0 113.773 -174.471 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 52.8 p90 . . . . . 0 CA--C 1.532 0.268 0 CA-C-O 121.091 0.472 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -120.05 -33.57 3.91 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 169.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -144.75 144.87 31.41 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.198 1.799 . . . . 0.0 106.209 169.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.7 p -148.72 141.27 18.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -178.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 31.9 tpp -159.34 173.63 15.98 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.51 1.124 . . . . 0.0 110.457 -171.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -134.82 147.78 50.02 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 127.265 2.226 . . . . 0.0 106.924 -173.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -158.38 -157.2 8.35 Favored Glycine 0 C--N 1.338 0.692 0 CA-C-N 119.171 0.896 . . . . 0.0 113.857 -171.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -133.39 125.8 29.88 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 125.665 1.586 . . . . 0.0 106.767 173.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 84.3 t -93.19 150.64 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 175.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -134.94 154.46 51.69 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 126.625 1.97 . . . . 0.0 105.984 175.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.76 162.03 39.77 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.632 1.105 . . . . 0.0 111.423 171.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 24.5 pt -80.35 177.67 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 O-C-N 123.973 0.796 . . . . 0.0 108.937 169.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -76.95 -3.27 38.0 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.72 1.208 . . . . 0.0 113.683 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.725 0 CA-C-O 119.328 -0.707 . . . . 0.0 112.614 -176.972 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.4 p . . . . . 0 C--O 1.234 0.247 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -136.44 144.64 44.55 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.797 1.239 . . . . 0.0 108.773 169.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.1 tp -88.82 152.96 21.44 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 167.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 14.3 m -126.46 145.16 50.6 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 118.294 0.497 . . . . 0.0 109.822 177.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -146.46 160.04 42.61 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.748 1.219 . . . . 0.0 110.213 -172.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -130.38 158.56 39.51 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 169.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.0 p -149.27 136.2 13.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 169.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.9 t -123.75 129.16 50.64 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 178.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -150.42 122.67 8.36 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 123.859 0.863 . . . . 0.0 109.381 -169.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 54.28 21.64 19.83 Favored Glycine 0 CA--C 1.538 1.527 0 CA-C-O 119.158 -0.801 . . . . 0.0 114.899 178.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 92.7 -4.52 75.93 Favored Glycine 0 CA--C 1.536 1.347 0 CA-C-N 118.735 1.267 . . . . 0.0 113.797 -177.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -95.15 164.13 13.0 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 118.975 1.387 . . . . 0.0 108.229 171.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 39.9 tp -143.85 155.45 44.12 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 122.939 0.495 . . . . 0.0 110.693 -169.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 15.3 mtt -144.04 152.11 40.56 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.891 1.676 . . . . 0.0 106.649 168.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 74.5 mtm180 -137.91 135.26 35.93 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 104.948 -2.241 . . . . 0.0 104.948 169.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -155.49 167.37 30.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 119.335 0.971 . . . . 0.0 112.975 -169.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -134.42 159.72 40.2 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.118 1.367 . . . . 0.0 107.562 168.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -172.06 164.18 36.66 Favored Glycine 0 CA--C 1.516 0.148 0 N-CA-C 108.213 -1.955 . . . . 0.0 108.213 171.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.19 137.66 51.42 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 172.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -45.13 -60.26 2.19 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -169.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.18 -4.98 36.29 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -178.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -92.62 -21.46 20.03 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 125.386 1.475 . . . . 0.0 110.756 170.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.8 tt -68.13 -23.85 64.94 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 119.53 1.059 . . . . 0.0 109.204 171.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 1.4 t60 44.1 34.47 0.98 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 128.348 2.659 . . . . 0.0 114.54 168.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 179.97 42.55 0.08 OUTLIER Glycine 0 C--N 1.336 0.574 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 -171.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -65.76 -14.81 62.07 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 117.618 0.709 . . . . 0.0 112.535 172.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -61.68 103.81 0.37 Allowed 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 127.418 2.287 . . . . 0.0 108.24 169.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 13.8 m -53.98 -9.86 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 126.969 2.107 . . . . 0.0 113.307 173.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -133.35 23.15 4.07 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.344 1.058 . . . . 0.0 113.402 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 24.7 m -106.58 -58.15 1.96 Allowed 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 119.004 -0.522 . . . . 0.0 110.402 168.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.396 16.0 ptm180 -75.88 11.88 1.27 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.223 0.919 . . . . 0.0 113.24 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 16.9 m -63.0 -39.15 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 167.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -70.09 119.39 14.23 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 170.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.3 tt -136.37 134.6 38.01 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -177.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.6 tt -143.97 140.43 29.64 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 -173.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 25.3 ptp -140.92 154.21 46.01 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 119.229 0.922 . . . . 0.0 110.619 173.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -159.24 160.63 35.53 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 126.352 1.861 . . . . 0.0 107.656 -176.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -54.49 159.0 2.22 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 118.847 0.749 . . . . 0.0 110.581 169.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.57 166.04 19.81 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.819 0.342 . . . . 0.0 110.58 169.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -142.73 36.31 1.44 Allowed 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.611 1.165 . . . . 0.0 110.299 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 43.1 t80 . . . . . 0 C--O 1.249 1.054 0 C-N-CA 124.62 1.168 . . . . 0.0 108.166 -174.335 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.9 tt . . . . . 0 N--CA 1.464 0.227 0 CA-C-O 120.823 0.344 . . . . 0.0 110.329 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -143.34 143.89 31.86 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 126.837 2.055 . . . . 0.0 106.002 169.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -150.6 134.82 17.0 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.195 1.398 . . . . 0.0 107.36 172.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -154.94 151.64 28.77 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.673 0.67 . . . . 0.0 109.943 169.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.1 mp -81.92 156.73 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 170.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -139.7 151.52 45.95 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.064 0.946 . . . . 0.0 108.745 169.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -117.2 126.33 52.6 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 125.518 1.527 . . . . 0.0 107.603 -176.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -70.64 128.22 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 176.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.6 mmmt -95.8 -35.71 11.41 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.476 1.111 . . . . 0.0 109.403 173.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -158.02 167.72 29.11 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 118.983 0.811 . . . . 0.0 111.307 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.9 mp -138.85 144.43 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 127.036 2.134 . . . . 0.0 107.244 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -145.29 92.58 5.6 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 126.814 2.046 . . . . 0.0 108.276 -176.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -55.26 156.05 18.02 Favored 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 124.081 3.187 . . . . 0.0 114.162 -178.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -77.81 45.78 0.53 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.425 1.49 . . . . 0.0 112.093 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.92 35.71 64.53 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 124.471 1.034 . . . . 0.0 113.54 169.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt 47.44 19.73 0.15 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.027 2.131 . . . . 0.0 114.167 -171.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.17 -34.88 56.31 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 121.084 -1.01 . . . . 0.0 109.813 170.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -138.09 87.23 2.23 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 -177.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -55.06 -36.94 66.12 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.072 0.949 . . . . 0.0 113.341 -169.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -90.1 14.55 12.15 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 117.962 -1.018 . . . . 0.0 112.967 -178.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.7 t -127.34 140.93 47.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-N 120.821 1.646 . . . . 0.0 107.522 -176.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.6 m -151.87 151.67 31.6 Favored 'General case' 0 C--O 1.239 0.518 0 O-C-N 121.33 -0.856 . . . . 0.0 111.05 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 36.6 ttp180 -80.66 145.81 31.44 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 104.554 -2.387 . . . . 0.0 104.554 168.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.1 mp -134.09 158.44 43.6 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 125.923 1.689 . . . . 0.0 106.453 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -125.86 130.59 51.66 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 169.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 58.3 m -141.94 173.27 11.67 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.06 1.344 . . . . 0.0 109.796 -170.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -140.69 131.23 25.44 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 171.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.1 m -71.73 134.63 46.37 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 175.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -71.11 -35.23 71.7 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.62 1.168 . . . . 0.0 113.62 -169.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.72 -16.85 6.57 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -169.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -121.11 48.22 1.69 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.854 0.862 . . . . 0.0 112.168 -169.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt 30.34 64.37 0.16 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.582 1.953 . . . . 0.0 113.328 168.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 20.6 mtm -137.45 117.6 13.49 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 118.355 0.525 . . . . 0.0 110.474 -176.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -82.95 133.23 35.12 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 168.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -134.67 148.1 50.27 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.989 0.899 . . . . 0.0 113.045 -168.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 38.3 mm -130.14 141.97 44.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 101.237 -3.616 . . . . 0.0 101.237 168.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 53.0 tp -146.91 152.72 39.14 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 126.799 2.04 . . . . 0.0 107.096 -168.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -146.43 109.64 4.72 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 173.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.8 m -150.01 169.79 2.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 122.032 0.92 . . . . 0.0 112.13 -169.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 43.1 t-20 -64.5 130.51 44.0 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.15 1.38 . . . . 0.0 107.966 169.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.3 pp -105.68 0.94 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 124.48 1.112 . . . . 0.0 112.982 -177.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -68.43 -16.37 63.88 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 120.249 1.386 . . . . 0.0 111.064 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.7 mt -62.39 -34.16 62.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 125.275 1.43 . . . . 0.0 109.337 171.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -91.32 159.11 39.97 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 124.754 1.222 . . . . 0.0 110.868 -169.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.71 179.25 3.25 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.462 2.774 . . . . 0.0 111.537 175.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.4 m -59.75 -16.52 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.84 1.256 . . . . 0.0 113.742 -177.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -67.69 -7.35 26.27 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.752 0.821 . . . . 0.0 112.476 170.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.5 tp 72.36 7.5 5.67 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 128.232 2.613 . . . . 0.0 113.389 174.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -167.23 164.47 37.91 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 108.289 -1.925 . . . . 0.0 108.289 174.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -161.34 168.61 23.61 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.769 1.627 . . . . 0.0 107.132 174.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -64.71 138.25 58.28 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 169.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -140.9 176.31 8.91 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -177.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.7 ttp180 -135.56 142.51 45.36 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -173.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 tt -121.09 140.43 51.97 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 126.149 1.78 . . . . 0.0 107.02 -176.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.0 t -143.05 166.81 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 126.995 2.118 . . . . 0.0 106.051 -178.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 30.0 pt -119.59 13.45 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 123.568 0.747 . . . . 0.0 112.27 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.733 0 C-N-CA 125.081 1.353 . . . . 0.0 113.182 -175.765 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 47.2 p90 . . . . . 0 N--CA 1.451 -0.384 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -122.36 -23.46 5.25 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.105 0.562 . . . . 0.0 110.729 172.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -145.66 149.45 34.49 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.804 1.242 . . . . 0.0 107.701 169.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.2 m -143.4 148.2 19.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 C-N-CA 125.621 1.568 . . . . 0.0 107.365 172.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 23.1 tpp -159.45 168.05 27.21 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.872 0.869 . . . . 0.0 109.207 176.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 84.7 t80 -128.5 150.52 50.13 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.809 1.643 . . . . 0.0 106.806 172.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -152.92 -160.06 9.43 Favored Glycine 0 C--N 1.336 0.569 0 CA-C-N 118.636 0.653 . . . . 0.0 113.672 -171.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -145.69 132.43 20.01 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.995 1.318 . . . . 0.0 108.771 172.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 42.2 t -77.14 145.57 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 168.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -144.87 74.94 1.43 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.057 1.743 . . . . 0.0 108.894 175.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -152.72 157.77 41.35 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.223 -0.923 . . . . 0.0 109.588 176.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 25.2 pt -76.99 -170.27 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 125.804 1.642 . . . . 0.0 111.356 177.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.63 -9.79 1.31 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 127.406 2.282 . . . . 0.0 115.47 -178.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.569 0 N-CA-C 107.525 -2.23 . . . . 0.0 107.525 -174.762 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.467 0.415 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -137.43 139.81 40.89 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 169.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 46.2 tp -75.96 159.5 30.81 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 168.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 16.6 m -134.98 150.65 50.39 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 175.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -142.13 128.79 20.36 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -112.52 129.76 56.24 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 168.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.6 p -146.72 144.91 19.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -169.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.3 t -134.53 144.01 47.75 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -136.9 82.62 1.95 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.282 1.833 . . . . 0.0 107.676 -170.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 58.57 19.67 42.79 Favored Glycine 0 CA--C 1.538 1.494 0 CA-C-O 118.977 -0.902 . . . . 0.0 114.629 174.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 124.32 -26.99 5.66 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.953 1.264 . . . . 0.0 112.723 -177.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 9.9 mp -75.31 150.06 38.59 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 169.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 7.0 tt -145.52 157.28 44.02 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.493 1.042 . . . . 0.0 110.689 -175.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 56.6 mtt -147.61 159.08 44.17 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.016 1.326 . . . . 0.0 108.861 170.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 85.4 mtp180 -141.25 130.22 23.2 Favored 'General case' 0 C--N 1.334 -0.1 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 169.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -152.59 160.09 43.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 119.059 0.845 . . . . 0.0 111.079 -170.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -137.17 149.65 47.4 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 124.315 1.046 . . . . 0.0 108.575 169.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -178.08 168.44 39.76 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -177.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -57.93 132.79 54.48 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -178.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -43.81 -73.7 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 -168.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -67.11 -26.18 66.58 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 122.404 1.097 . . . . 0.0 111.93 -172.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.95 -31.36 72.56 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 128.164 2.586 . . . . 0.0 111.203 175.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 5.4 tt -76.38 -13.47 60.13 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.28 1.032 . . . . 0.0 111.307 -176.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 32.3 t-80 52.81 40.51 30.75 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.721 1.208 . . . . 0.0 111.937 177.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -123.86 33.04 4.03 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 125.247 1.403 . . . . 0.0 110.642 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -76.48 -3.95 40.01 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.07 0.948 . . . . 0.0 113.34 -175.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -129.43 143.02 50.67 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 127.534 2.334 . . . . 0.0 106.142 169.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 8.2 p -59.21 -11.85 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.994 169.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -124.06 21.72 8.88 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 126.001 1.72 . . . . 0.0 113.492 176.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 57.9 m -72.83 -78.36 0.09 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.962 0.887 . . . . 0.0 109.779 168.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -82.58 12.62 4.41 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -169.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 33.9 m -67.27 -28.42 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-O 118.816 -0.612 . . . . 0.0 110.016 170.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -77.86 107.6 10.5 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 177.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 45.3 tp -112.66 131.38 55.67 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.459 1.104 . . . . 0.0 108.283 -176.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.5 tt -138.33 135.85 35.82 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 104.418 -2.438 . . . . 0.0 104.418 169.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -142.14 152.72 43.49 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 118.817 0.735 . . . . 0.0 111.484 176.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 39.6 pttt -165.01 172.97 12.05 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 126.224 1.81 . . . . 0.0 109.171 -174.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -55.1 156.69 3.82 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.422 0.689 . . . . 0.0 111.732 171.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.41 169.04 9.65 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.399 169.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -134.79 122.92 22.78 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 173.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 9.9 t80 . . . . . 0 C--O 1.246 0.902 0 C-N-CA 124.484 1.113 . . . . 0.0 108.276 176.66 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.2 tm? . . . . . 0 CA--C 1.532 0.273 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -151.47 158.16 43.28 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.902 1.281 . . . . 0.0 108.668 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -145.81 140.96 27.48 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.798 1.639 . . . . 0.0 108.371 -176.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -152.67 146.49 25.19 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.346 1.459 . . . . 0.0 110.54 -170.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.6 mp -112.59 137.74 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 105.847 -1.908 . . . . 0.0 105.847 171.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -145.64 161.89 38.78 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.758 1.223 . . . . 0.0 110.489 -174.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -140.86 144.79 35.51 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.598 0.759 . . . . 0.0 110.049 -174.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 39.0 t -70.08 122.56 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 125.078 1.351 . . . . 0.0 107.834 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -96.03 -32.0 12.77 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 124.508 1.123 . . . . 0.0 110.126 176.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -157.14 167.66 29.74 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.284 0.947 . . . . 0.0 110.718 175.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.7 mp -133.05 140.88 46.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 127.138 2.175 . . . . 0.0 106.296 -175.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -143.78 89.82 7.21 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 124.069 0.947 . . . . 0.0 110.011 -171.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -65.09 9.4 0.17 Allowed 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 124.121 3.214 . . . . 0.0 116.774 -178.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -78.82 55.88 1.8 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.079 1.351 . . . . 0.0 109.914 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -170.08 35.66 0.18 Allowed Glycine 0 CA--C 1.527 0.803 0 C-N-CA 124.89 1.233 . . . . 0.0 111.454 -172.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.2 mmpt? -65.97 64.58 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.61 1.564 . . . . 0.0 113.392 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -60.49 -38.4 84.16 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 168.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -144.37 165.5 27.75 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 129.468 3.107 . . . . 0.0 104.218 169.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.29 -40.86 83.05 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.28 -0.887 . . . . 0.0 110.737 175.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 49.0 ptt85 -70.4 7.72 0.98 Allowed 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 126.508 1.923 . . . . 0.0 114.806 175.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 77.7 t -120.48 132.09 70.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 121.497 1.953 . . . . 0.0 107.487 178.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 37.0 m -149.06 163.65 36.92 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.93 0.892 . . . . 0.0 109.789 176.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.1 ttm105 -85.45 154.28 21.92 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 169.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.0 mt -143.16 156.75 44.85 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 127.114 2.166 . . . . 0.0 107.199 -177.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -131.56 131.65 43.51 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 105.335 -2.098 . . . . 0.0 105.335 174.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 55.1 m -143.77 164.71 29.72 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.771 1.228 . . . . 0.0 110.201 -170.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -140.79 140.06 34.68 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 38.2 p -70.45 136.29 49.39 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 173.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -75.75 -35.68 60.11 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 168.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.6 m -69.56 -38.19 77.31 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -170.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -135.11 -102.26 0.22 Allowed 'General case' 0 C--N 1.345 0.38 0 CA-C-N 119.818 1.19 . . . . 0.0 110.34 -171.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -166.51 19.02 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.332 1.453 . . . . 0.0 112.559 -169.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 85.4 mtp -62.94 122.68 16.61 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.995 0.918 . . . . 0.0 108.68 176.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -98.08 112.45 24.4 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 169.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 49.0 tp -122.62 138.41 54.6 Favored 'General case' 0 N--CA 1.461 0.089 0 C-N-CA 123.455 0.702 . . . . 0.0 110.528 -169.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 33.1 mm -124.71 146.34 30.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 103.634 -2.728 . . . . 0.0 103.634 169.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 123' ' ' MET . 2.3 pt? -154.17 154.85 34.25 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.723 1.209 . . . . 0.0 109.547 176.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -121.59 120.68 35.52 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 102.992 -2.966 . . . . 0.0 102.992 170.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.2 p -151.09 163.18 2.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 121.707 0.765 . . . . 0.0 110.876 -168.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -69.02 90.23 0.44 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.907 1.683 . . . . 0.0 109.208 169.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.0 pp -65.84 -7.26 4.73 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -170.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -64.14 -18.61 64.6 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 120.161 1.346 . . . . 0.0 111.115 173.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.3 tt -55.34 -41.95 64.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.728 1.211 . . . . 0.0 110.629 169.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -88.02 139.37 30.74 Favored Pre-proline 0 CA--C 1.538 0.508 0 C-N-CA 125.88 1.672 . . . . 0.0 109.636 -173.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.45 132.74 30.11 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.272 1.981 . . . . 0.0 111.101 -177.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.8 t 50.34 31.06 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 126.567 1.947 . . . . 0.0 112.588 171.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.1 t70 62.42 -35.54 0.12 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 128.168 2.587 . . . . 0.0 115.203 -175.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 60.1 tp -59.36 -34.19 72.09 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.369 1.468 . . . . 0.0 111.405 177.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.37 -178.83 52.71 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-O 121.904 0.725 . . . . 0.0 112.262 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -157.96 174.16 15.67 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 126.662 1.985 . . . . 0.0 106.983 -174.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -58.92 134.22 56.74 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 173.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -128.91 168.66 15.65 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 125.908 1.683 . . . . 0.0 107.626 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -132.38 147.69 52.39 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.6 tt -137.88 144.0 41.16 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 -169.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.5 m -135.31 154.43 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 169.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 35.2 pt -121.15 147.84 24.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 104.287 -2.486 . . . . 0.0 104.287 168.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.442 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.198 -168.26 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 40.7 p90 . . . . . 0 N--CA 1.451 -0.393 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -123.58 -23.06 4.84 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.446 1.498 . . . . 0.0 109.476 169.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -142.81 155.03 44.74 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.378 1.471 . . . . 0.0 108.214 172.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.0 t -141.78 144.62 25.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 124.89 1.276 . . . . 0.0 107.83 -169.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 16.3 mtm -147.8 152.35 37.54 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.551 1.541 . . . . 0.0 110.308 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -138.46 144.49 40.12 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 127.587 2.355 . . . . 0.0 105.158 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.44 -151.3 6.73 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-N 120.641 1.564 . . . . 0.0 115.396 -169.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -144.71 133.39 22.25 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 126.098 1.759 . . . . 0.0 107.186 172.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.9 p -101.54 133.85 43.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 169.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -142.09 88.52 2.11 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.528 1.131 . . . . 0.0 108.874 -170.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -156.98 162.98 39.6 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.654 -1.279 . . . . 0.0 110.713 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.27 178.07 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 124.327 1.051 . . . . 0.0 110.543 178.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -64.42 4.85 0.33 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.9 2.08 . . . . 0.0 114.467 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.356 0 C-N-CA 125.49 1.519 . . . . 0.0 109.5 175.566 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.8 p . . . . . 0 C--O 1.235 0.308 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? -115.09 141.64 47.73 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.019 0.927 . . . . 0.0 108.95 176.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.0 tp -88.78 154.97 19.85 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 167.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 10.8 m -130.57 149.76 52.09 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 -174.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -144.12 143.76 31.27 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -127.05 125.8 41.98 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 101.052 -3.684 . . . . 0.0 101.052 169.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.2 t -135.13 130.1 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -170.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 50.1 m -115.99 136.02 53.43 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 176.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -136.35 158.99 43.11 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.427 1.091 . . . . 0.0 109.961 -169.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -71.87 65.88 1.15 Allowed Glycine 0 CA--C 1.531 1.056 0 N-CA-C 108.204 -1.958 . . . . 0.0 108.204 168.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 171.16 -17.22 0.06 OUTLIER Glycine 0 CA--C 1.534 1.268 0 CA-C-O 117.194 -1.892 . . . . 0.0 112.194 -169.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . 0.435 43.4 mt 133.17 -136.14 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 130.514 3.526 . . . . 0.0 111.453 168.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 5.2 tt -139.48 157.74 45.33 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 121.661 2.028 . . . . 0.0 113.516 -168.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' MET . . . . . 0.416 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 35.7 mtt -145.25 157.89 43.96 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.135 1.774 . . . . 0.0 109.961 177.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 62.9 mtt180 -136.11 137.73 41.34 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 104.651 -2.351 . . . . 0.0 104.651 169.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 27.6 tp -148.71 146.38 28.08 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 119.054 0.843 . . . . 0.0 110.463 -168.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -137.3 153.05 50.37 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.661 1.184 . . . . 0.0 108.314 168.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 176.17 -177.1 47.81 Favored Glycine 0 CA--C 1.519 0.336 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 170.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -53.1 139.86 27.27 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 118.291 1.046 . . . . 0.0 109.681 175.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -53.04 -56.25 17.57 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 123.593 0.558 . . . . 0.0 112.167 -174.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -54.81 -40.55 69.64 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-O 121.437 0.637 . . . . 0.0 111.471 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.5 -30.98 71.82 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 127.193 2.197 . . . . 0.0 110.39 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.37 -25.28 65.9 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 118.475 -0.774 . . . . 0.0 109.447 -178.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 72.2 m80 40.94 44.46 1.98 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.48 1.512 . . . . 0.0 111.76 -177.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -137.22 64.01 0.57 Allowed Glycine 0 C--N 1.338 0.648 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 -169.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -103.37 12.88 34.82 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.729 0.812 . . . . 0.0 112.055 -173.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.473 ' C ' ' H ' ' A' ' 138' ' ' ASP . 7.4 tp10 -140.61 146.3 37.79 Favored 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 126.122 1.769 . . . . 0.0 108.002 173.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.5 m -56.51 -9.06 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 124.512 1.125 . . . . 0.0 111.346 169.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.473 ' H ' ' C ' ' A' ' 136' ' ' GLU . 31.9 t70 -134.35 15.03 3.78 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 127.548 2.339 . . . . 0.0 112.245 -172.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 68.6 m -73.37 -81.8 0.06 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 122.309 1.052 . . . . 0.0 109.642 168.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -80.0 14.34 1.87 Allowed 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -169.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 20.1 m -68.18 -29.73 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 169.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -82.56 106.18 14.21 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 175.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 24.7 tp -129.79 137.18 50.36 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 124.617 1.167 . . . . 0.0 108.133 -173.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.9 mp -139.63 151.43 45.97 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 172.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 60.4 mtm -138.85 154.18 48.4 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.616 0.767 . . . . 0.0 109.581 -176.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 34.0 pttt -165.0 175.18 9.71 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.205 1.402 . . . . 0.0 110.964 -169.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 23.0 ptmt -63.31 157.17 23.57 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 122.406 0.283 . . . . 0.0 110.239 169.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.33 154.6 31.26 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.691 0.758 . . . . 0.0 111.512 172.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -135.86 112.72 10.24 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 169.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 . . . . . 0 C--O 1.247 0.939 0 CA-C-O 118.546 -0.74 . . . . 0.0 109.962 -177.247 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 44.3 tp . . . . . 0 C--O 1.232 0.137 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -161.04 166.65 27.83 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.485 1.114 . . . . 0.0 109.559 173.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -140.63 132.89 28.2 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.925 2.09 . . . . 0.0 106.313 176.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -149.86 153.75 37.24 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 171.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.0 mp -75.52 146.0 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 173.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -129.65 153.9 47.66 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.478 1.511 . . . . 0.0 107.389 170.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -131.74 129.59 40.82 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.664 1.586 . . . . 0.0 108.278 -174.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 51.8 t -72.51 118.03 16.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 124.448 1.099 . . . . 0.0 108.197 -177.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.2 mmpt? -78.25 -43.33 28.51 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 124.489 1.116 . . . . 0.0 109.59 169.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -159.11 170.65 21.54 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 118.824 0.738 . . . . 0.0 111.038 -175.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.2 mp -138.6 142.56 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 127.104 2.162 . . . . 0.0 106.825 -173.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -147.39 93.99 4.56 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 124.195 0.998 . . . . 0.0 111.205 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -73.14 90.84 0.85 Allowed 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 123.306 2.671 . . . . 0.0 107.765 168.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -57.87 -33.56 68.83 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -169.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 155.81 42.5 0.02 OUTLIER Glycine 0 CA--C 1.527 0.79 0 N-CA-C 106.248 -2.741 . . . . 0.0 106.248 -169.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 22.1 mmtt -72.42 95.96 1.84 Allowed 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.443 1.497 . . . . 0.0 109.66 -168.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -47.7 -43.31 26.56 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.232 1.013 . . . . 0.0 112.025 175.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.5 m-30 -81.08 -18.58 46.11 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 122.741 0.416 . . . . 0.0 112.071 -174.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.7 t70 62.75 -36.13 0.13 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 130.064 3.345 . . . . 0.0 115.688 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -72.64 11.0 0.71 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.316 1.446 . . . . 0.0 113.124 170.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 53.7 t -126.53 140.46 48.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 104.029 -2.582 . . . . 0.0 104.029 174.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 55.7 m -156.21 160.82 40.17 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 119.637 1.108 . . . . 0.0 110.417 174.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 15.1 ttm180 -83.81 150.38 25.8 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 170.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 66.0 mt -137.76 155.17 49.34 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.744 2.018 . . . . 0.0 106.141 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -121.58 127.35 50.82 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 102.804 -3.036 . . . . 0.0 102.804 169.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 74.5 m -141.27 162.63 35.01 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.182 0.993 . . . . 0.0 110.864 -169.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -138.75 134.2 33.2 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.556 1.542 . . . . 0.0 107.607 -176.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.5 p -67.18 148.3 51.97 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.014 0.926 . . . . 0.0 110.697 173.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -77.78 -30.41 51.34 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 118.756 -0.64 . . . . 0.0 111.013 172.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -132.49 -31.45 1.39 Allowed 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 115.234 1.568 . . . . 0.0 115.234 -169.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 23.3 m-30 -108.35 30.9 6.01 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -168.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 49.5 pttt 40.11 53.73 2.75 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.564 1.546 . . . . 0.0 114.282 169.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 47.6 mtt -114.52 110.82 20.42 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.388 1.875 . . . . 0.0 107.972 177.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -82.74 125.06 30.83 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 169.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 51.9 tp -132.85 142.09 48.77 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 118.733 0.697 . . . . 0.0 112.305 -168.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 40.8 mm -120.03 136.98 55.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 101.635 -3.468 . . . . 0.0 101.635 169.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 22.3 tp -152.7 105.21 2.95 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.062 0.945 . . . . 0.0 109.316 -168.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.422 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 16.1 t70 -100.87 105.54 16.82 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 126.212 1.805 . . . . 0.0 107.246 173.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.7 m -150.51 172.03 1.34 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-O 121.662 0.744 . . . . 0.0 110.515 -169.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -59.9 128.14 35.41 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.175 1.39 . . . . 0.0 109.264 169.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.1 pp -114.67 0.88 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 124.597 1.159 . . . . 0.0 113.812 -174.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.68 -4.92 25.97 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 120.42 1.463 . . . . 0.0 111.255 177.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.8 mt -62.83 -38.79 82.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 168.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -78.21 148.15 74.03 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 123.505 0.722 . . . . 0.0 110.138 -171.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.93 -25.33 19.92 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 122.592 2.195 . . . . 0.0 112.669 -177.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.8 m -145.42 160.82 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 125.611 1.564 . . . . 0.0 108.352 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -60.25 -27.82 67.53 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.313 1.045 . . . . 0.0 112.463 178.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 42.7 tp -62.65 -15.17 50.71 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.761 1.224 . . . . 0.0 112.456 174.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.1 -176.46 51.48 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -172.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -155.71 166.1 34.53 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.436 1.494 . . . . 0.0 107.344 177.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -66.95 131.69 46.39 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 173.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -139.69 146.16 39.28 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -172.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 61.5 mtm180 -79.67 134.08 36.41 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 170.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -106.04 134.44 49.17 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 104.355 -2.461 . . . . 0.0 104.355 169.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 80.1 t -134.29 138.65 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 -176.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.1 mm -106.78 135.18 46.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 104.832 -2.285 . . . . 0.0 104.832 169.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.515 0 C-N-CA 124.708 1.203 . . . . 0.0 110.127 -169.469 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.7 p90 . . . . . 0 C--O 1.236 0.357 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -116.15 -23.31 8.51 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.669 0.787 . . . . 0.0 110.353 175.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -149.86 150.32 31.77 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.247 1.019 . . . . 0.0 109.218 171.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.4 p -148.42 142.99 19.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 174.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 10.3 tpt -159.94 166.93 29.15 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.938 0.895 . . . . 0.0 109.596 176.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -121.06 146.8 46.34 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.107 1.363 . . . . 0.0 108.138 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -141.65 -160.43 8.32 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-N 118.637 0.653 . . . . 0.0 112.328 -175.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -142.02 128.84 20.54 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.862 1.265 . . . . 0.0 107.824 169.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 39.3 t -79.68 144.03 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 171.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -143.46 75.47 1.48 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.931 1.293 . . . . 0.0 109.529 177.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -157.09 163.58 38.82 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 120.764 -1.21 . . . . 0.0 110.954 170.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.53 -172.49 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 125.691 1.596 . . . . 0.0 110.935 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.22 -13.93 3.67 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.91 2.084 . . . . 0.0 115.437 -178.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.435 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.329 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.4 p . . . . . 0 CA--C 1.533 0.3 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? 60.32 131.98 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 127.804 2.442 . . . . 0.0 111.611 -168.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 9.1 tt -79.55 135.87 36.73 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 103.15 -2.907 . . . . 0.0 103.15 167.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 41.8 m -109.47 136.77 48.34 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 105.477 -2.046 . . . . 0.0 105.477 173.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -128.22 152.02 48.57 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.121 1.369 . . . . 0.0 108.091 -174.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -132.56 137.71 47.21 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 102.834 -3.025 . . . . 0.0 102.834 169.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.8 t -132.38 147.13 32.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 177.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.0 m -127.31 157.68 39.23 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 102.513 -3.143 . . . . 0.0 102.513 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . 0.333 98.4 m-85 58.76 -148.79 0.47 Allowed 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -167.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 61.15 13.57 35.74 Favored Glycine 0 CA--C 1.535 1.325 0 CA-C-N 120.186 1.357 . . . . 0.0 113.17 -176.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 138.21 -50.31 0.81 Allowed Glycine 0 CA--C 1.528 0.848 0 C-N-CA 126.066 1.793 . . . . 0.0 109.601 -171.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.65 -68.63 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.458 1.503 . . . . 0.0 109.0 169.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 11.3 tp -157.79 148.21 20.71 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 124.561 1.144 . . . . 0.0 109.065 -178.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.58 156.34 41.77 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 170.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 70.2 ttt-85 -127.61 142.57 51.32 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 169.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 15.3 tp -149.74 148.89 29.77 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -169.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -144.39 143.42 30.93 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 168.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -175.93 178.05 47.49 Favored Glycine 0 CA--C 1.52 0.361 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -52.42 137.24 29.98 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 118.305 1.053 . . . . 0.0 110.622 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -56.91 -55.98 27.53 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -169.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -57.03 -43.95 82.39 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 122.349 1.071 . . . . 0.0 111.403 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 27.0 t30 -60.99 -28.09 68.77 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 126.292 1.837 . . . . 0.0 111.935 177.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.11 -29.38 54.81 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 123.911 0.884 . . . . 0.0 110.145 178.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 49.21 21.56 0.54 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.925 1.69 . . . . 0.0 113.191 -169.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.02 -10.86 84.17 Favored Glycine 0 CA--C 1.528 0.865 0 O-C-N 121.059 -1.026 . . . . 0.0 113.955 -169.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -59.12 -30.64 68.27 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 118.476 1.138 . . . . 0.0 111.693 172.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -87.35 87.82 7.52 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 126.743 2.017 . . . . 0.0 106.212 169.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.5 m -59.59 -7.12 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 124.49 1.116 . . . . 0.0 113.407 176.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -123.4 18.74 9.75 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 126.11 1.764 . . . . 0.0 113.17 176.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.9 m -83.84 -68.93 0.67 Allowed 'General case' 0 C--O 1.232 0.147 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 167.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.292 10.6 ptm85 -78.31 11.67 2.29 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 -169.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 29.7 m -67.58 -34.86 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-O 118.645 -0.693 . . . . 0.0 109.337 168.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -82.82 104.35 12.99 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 10.3 tt -117.2 134.72 54.44 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -170.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -140.51 135.92 32.39 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 -171.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 78.4 mtm -137.85 149.4 46.26 Favored 'General case' 0 C--O 1.237 0.426 0 O-C-N 121.267 -0.896 . . . . 0.0 109.944 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -154.62 172.51 17.75 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.305 1.042 . . . . 0.0 109.761 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -53.51 160.46 1.23 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.298 0.639 . . . . 0.0 111.857 175.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.25 166.3 0.86 Allowed 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.394 0.616 . . . . 0.0 111.981 169.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -87.09 86.59 7.31 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 175.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 19.2 t80 . . . . . 0 C--O 1.248 0.995 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 172.632 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 23.1 tp . . . . . 0 CA--C 1.538 0.509 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -147.33 134.04 19.99 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -148.5 138.4 22.29 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 169.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -151.17 150.62 30.85 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.026 0.83 . . . . 0.0 110.869 172.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.6 mp -75.16 152.65 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 169.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -132.59 146.66 52.07 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.651 1.58 . . . . 0.0 107.788 174.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -123.75 119.74 30.63 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 127.225 2.21 . . . . 0.0 106.641 -175.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.7 t -78.39 123.92 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -177.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.5 mmmt -88.7 -40.0 13.58 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.952 0.901 . . . . 0.0 109.687 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -157.93 170.91 21.27 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 118.386 0.539 . . . . 0.0 112.318 -169.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.1 mp -141.9 147.54 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 127.881 2.472 . . . . 0.0 106.786 -175.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -143.86 110.58 5.2 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 169.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -64.62 7.35 0.25 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.605 2.87 . . . . 0.0 117.454 -177.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 46.14 39.93 6.62 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.731 2.012 . . . . 0.0 112.294 -174.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.29 37.71 41.26 Favored Glycine 0 CA--C 1.531 1.065 0 O-C-N 121.528 -0.732 . . . . 0.0 111.447 -177.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? 45.55 57.64 4.81 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 126.661 1.984 . . . . 0.0 109.642 -169.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -54.63 -36.76 64.86 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.921 0.888 . . . . 0.0 110.645 -178.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -140.17 160.99 38.73 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 169.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -64.64 -25.55 68.01 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -177.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -136.57 16.47 3.13 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 117.639 -1.172 . . . . 0.0 113.579 -173.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.8 t -131.61 129.14 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 121.005 1.73 . . . . 0.0 107.364 -178.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 39.6 m -148.34 159.55 43.89 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 124.387 1.075 . . . . 0.0 110.396 -170.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 -69.01 146.46 52.7 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 169.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.2 mp -127.86 158.09 38.72 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 127.018 2.127 . . . . 0.0 106.521 170.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -136.08 132.01 35.59 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 171.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.3 m -142.85 173.02 11.92 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.318 1.447 . . . . 0.0 110.609 -169.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -140.99 143.66 34.59 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.59 1.956 . . . . 0.0 106.858 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.3 p -88.09 147.68 24.83 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.109 0.868 . . . . 0.0 110.033 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -77.58 -41.79 37.48 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.497 1.119 . . . . 0.0 112.811 -169.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.28 -26.74 9.0 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.831 0.852 . . . . 0.0 112.775 -169.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -121.35 23.78 10.26 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.957 1.303 . . . . 0.0 112.188 -170.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.9 pttt 43.6 27.37 0.15 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 127.097 2.159 . . . . 0.0 116.247 168.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 53.8 mtt -70.53 149.29 47.3 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 119.813 1.188 . . . . 0.0 108.366 175.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -112.29 131.07 55.71 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 173.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 48.7 tp -133.56 141.88 47.9 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.667 0.746 . . . . 0.0 111.154 -169.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 42.6 mm -123.05 142.4 39.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 101.161 -3.644 . . . . 0.0 101.161 168.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 51.3 tp -148.92 154.73 39.84 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 126.221 1.808 . . . . 0.0 106.929 -168.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -137.18 114.14 10.59 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 103.478 -2.786 . . . . 0.0 103.478 169.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.0 p -151.46 167.29 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 O-C-N 124.373 1.046 . . . . 0.0 111.026 -168.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -60.61 137.08 58.22 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.943 1.297 . . . . 0.0 109.413 169.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.6 pp -119.14 8.0 6.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 124.935 1.294 . . . . 0.0 113.417 -177.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -65.41 -19.57 66.0 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 120.367 1.44 . . . . 0.0 110.96 173.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.4 mt -63.65 -33.92 64.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 126.238 1.815 . . . . 0.0 110.291 172.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -65.75 138.73 96.68 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 123.757 0.823 . . . . 0.0 112.916 -167.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -72.91 177.43 7.7 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.418 2.745 . . . . 0.0 110.974 172.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.6 m -70.87 -22.93 23.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 O-C-N 121.766 -0.583 . . . . 0.0 111.62 171.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -69.16 153.19 44.11 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.755 0.822 . . . . 0.0 110.733 177.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 53.9 tp -63.8 -29.68 70.85 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.512 0.725 . . . . 0.0 112.625 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.21 160.51 13.78 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-N 119.091 0.859 . . . . 0.0 111.679 -175.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -157.69 164.81 36.77 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 126.097 1.759 . . . . 0.0 107.433 174.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -138.43 150.87 46.92 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.681 0.792 . . . . 0.0 109.339 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -151.59 -175.32 5.15 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 124.989 1.316 . . . . 0.0 107.598 173.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.7 ttp180 -136.12 147.85 47.97 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 125.233 1.413 . . . . 0.0 107.716 -177.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.1 tp -134.91 151.0 50.5 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.132 0.973 . . . . 0.0 109.755 -169.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 55.7 t -136.46 137.11 48.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 105.472 -2.048 . . . . 0.0 105.472 173.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 pp -137.45 3.5 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 123.808 0.843 . . . . 0.0 113.077 -176.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.295 0 O-C-N 121.446 -0.784 . . . . 0.0 112.462 -170.905 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 30.4 p90 . . . . . 0 CA--C 1.538 0.519 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -97.8 -49.71 4.72 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.212 0.914 . . . . 0.0 110.209 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -157.4 165.97 34.3 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.18 0.9 . . . . 0.0 110.994 172.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.7 p -141.47 142.87 28.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 170.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.8 tpt -152.91 162.06 41.77 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.779 1.232 . . . . 0.0 109.164 -175.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -114.6 116.59 29.01 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 170.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.75 -167.08 32.09 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 -174.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.42 111.04 10.42 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 169.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 87.2 t -72.22 155.97 7.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 174.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -128.39 106.81 9.25 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 104.632 -2.359 . . . . 0.0 104.632 169.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -75.48 138.69 41.76 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -174.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.4 pt -128.31 179.46 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.149 0.98 . . . . 0.0 108.808 169.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -74.18 -1.46 20.52 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.609 1.564 . . . . 0.0 114.607 -173.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.583 0 O-C-N 121.841 -0.537 . . . . 0.0 112.696 -176.92 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.1 p . . . . . 0 CA--C 1.533 0.317 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -124.04 131.94 53.62 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.294 1.838 . . . . 0.0 106.562 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 34.9 tp -70.8 153.63 42.57 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 170.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -126.88 161.46 28.21 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.206 1.002 . . . . 0.0 108.838 -172.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -147.97 161.22 41.78 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.752 1.221 . . . . 0.0 108.974 171.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -124.48 147.7 48.18 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 169.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.8 t -144.54 143.16 23.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 29.6 m -120.48 136.4 54.77 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 169.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -146.58 114.99 6.71 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -178.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 57.19 23.33 46.95 Favored Glycine 0 CA--C 1.539 1.588 0 CA-C-O 119.311 -0.716 . . . . 0.0 114.456 174.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.57 -8.42 64.04 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 124.763 1.173 . . . . 0.0 113.633 -178.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -95.26 170.2 9.55 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.777 1.631 . . . . 0.0 108.814 175.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.0 tp -139.19 160.63 39.36 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 118.741 0.7 . . . . 0.0 111.587 -169.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 71.4 mtm -153.97 161.56 41.88 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.56 1.544 . . . . 0.0 110.253 169.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -141.49 133.61 27.77 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 103.825 -2.657 . . . . 0.0 103.825 167.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.8 tt -140.92 151.1 43.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 119.259 0.936 . . . . 0.0 108.866 -171.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -132.93 153.42 51.42 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.644 1.177 . . . . 0.0 109.409 170.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -168.66 169.26 41.59 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 170.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -51.13 136.98 22.88 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.224 1.012 . . . . 0.0 109.005 172.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -42.73 -53.65 4.44 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -172.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -60.83 -41.35 95.62 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 123.174 1.464 . . . . 0.0 111.511 -177.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -71.63 -18.92 62.17 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 127.099 2.16 . . . . 0.0 111.386 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -67.87 -25.2 65.4 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 119.168 0.895 . . . . 0.0 109.184 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 25.2 t-80 53.28 40.42 31.26 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.88 1.272 . . . . 0.0 111.064 171.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -165.92 50.65 0.27 Allowed Glycine 0 C--N 1.338 0.655 0 O-C-N 121.366 -0.834 . . . . 0.0 112.609 -169.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -74.7 8.35 2.45 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.085 0.954 . . . . 0.0 112.18 171.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.414 ' C ' ' H ' ' A' ' 138' ' ' ASP . 20.4 tt0 -135.17 130.24 35.05 Favored 'General case' 0 CA--C 1.508 -0.649 0 C-N-CA 126.005 1.722 . . . . 0.0 106.909 -178.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.9 p -59.01 -4.68 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 126.14 1.776 . . . . 0.0 111.348 170.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.414 ' H ' ' C ' ' A' ' 136' ' ' GLU . 28.3 t70 -131.93 15.2 4.76 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.288 1.435 . . . . 0.0 113.075 178.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 6.8 m -87.14 -66.52 0.9 Allowed 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 167.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.32 0.0 OUTLIER -81.41 14.92 2.23 Favored 'General case' 0 C--N 1.345 0.38 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -169.521 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 16.3 m -64.23 -32.28 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 167.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -65.23 127.41 31.6 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 175.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 63.4 tp -143.07 130.95 21.57 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -177.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.3 tt -139.93 144.47 37.12 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 172.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 57.4 ttm -131.36 144.71 51.43 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 174.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 50.4 pttt -153.55 174.36 14.53 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.18 1.392 . . . . 0.0 109.524 178.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -64.26 157.95 24.57 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 122.533 0.333 . . . . 0.0 111.012 172.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.88 166.55 15.35 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.767 0.427 . . . . 0.0 110.961 169.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -141.61 134.29 28.55 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 172.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 . . . . . 0 C--O 1.25 1.094 0 C-N-CA 127.009 2.124 . . . . 0.0 110.937 -177.586 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 56.1 tp . . . . . 0 C--O 1.233 0.211 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -147.84 151.04 35.27 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 126.527 1.931 . . . . 0.0 106.744 169.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -149.54 138.09 20.86 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.239 1.415 . . . . 0.0 107.581 -175.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -153.79 140.91 19.41 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.823 1.249 . . . . 0.0 109.251 -178.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.4 mp -107.46 139.16 30.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -134.99 158.07 45.3 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.438 1.095 . . . . 0.0 110.363 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -125.21 135.13 52.27 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 126.055 1.742 . . . . 0.0 107.514 -177.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.5 p -69.01 146.51 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 122.203 1.002 . . . . 0.0 109.358 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -125.11 -28.78 3.38 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 126.837 2.055 . . . . 0.0 109.116 -176.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -157.61 164.29 37.4 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 118.946 0.794 . . . . 0.0 110.913 170.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.8 mp -141.64 138.03 31.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 127.423 2.289 . . . . 0.0 106.032 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -146.61 97.8 4.26 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 125.351 1.46 . . . . 0.0 108.773 -176.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -60.67 26.1 0.04 OUTLIER 'Trans proline' 0 CA--C 1.543 0.952 1 C-N-CA 125.831 4.354 . . . . 0.0 118.554 -175.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -63.2 -9.05 9.61 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.214 -1.554 . . . . 0.0 113.628 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.72 10.63 12.48 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.442 1.496 . . . . 0.0 112.695 172.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.8 tppt? -44.15 -12.89 0.01 OUTLIER 'General case' 0 C--N 1.345 0.373 0 C-N-CA 129.536 3.134 . . . . 0.0 116.749 -176.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.2 tppt? -55.38 -31.35 61.73 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.224 0.92 . . . . 0.0 110.054 169.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -136.84 110.17 7.88 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 104.125 -2.546 . . . . 0.0 104.125 169.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -56.99 -28.3 62.27 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -169.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.2 ptt180 -72.02 4.7 3.22 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 117.453 -1.26 . . . . 0.0 113.759 174.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.0 t -120.85 134.95 62.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 121.363 1.892 . . . . 0.0 107.311 -178.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.8 m -145.78 151.73 38.41 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.694 0.797 . . . . 0.0 110.145 -177.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.5 ttp180 -73.25 143.12 47.2 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 168.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -136.46 155.61 49.76 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 125.547 1.539 . . . . 0.0 107.289 -174.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -131.92 135.06 46.34 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 105.218 -2.141 . . . . 0.0 105.218 169.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 65.7 m -141.18 167.02 23.17 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.536 1.534 . . . . 0.0 109.305 -176.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -135.94 130.47 33.77 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 178.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.3 m -76.62 131.01 38.64 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.218 0.607 . . . . 0.0 110.16 178.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -80.21 -36.5 34.76 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.91 0.884 . . . . 0.0 110.844 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.07 -29.5 69.3 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.506 0.722 . . . . 0.0 112.918 -169.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -132.92 -99.1 0.28 Allowed 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -167.08 13.82 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.449 1.1 . . . . 0.0 112.959 -172.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 72.2 mtm -71.18 141.14 50.69 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.174 0.512 . . . . 0.0 111.234 -169.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -88.73 135.97 33.24 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 169.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 64.1 tp -136.96 141.5 42.61 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 119.212 0.914 . . . . 0.0 109.426 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 36.3 mm -128.85 147.76 33.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 104.057 -2.571 . . . . 0.0 104.057 169.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 mp -144.17 166.28 25.48 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 125.639 1.575 . . . . 0.0 108.995 177.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -136.84 96.21 3.27 Favored 'General case' 0 C--N 1.324 -0.539 1 N-CA-C 99.038 -4.43 . . . . 0.0 99.038 167.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.7 p -139.45 161.18 27.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-O 121.353 0.596 . . . . 0.0 112.013 -167.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 62.5 t-20 -62.46 128.12 34.54 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.854 1.262 . . . . 0.0 109.273 170.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.5 pp -105.54 0.71 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 124.998 1.319 . . . . 0.0 112.93 -178.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -68.27 -17.51 64.31 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 120.347 1.431 . . . . 0.0 110.977 -177.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.4 mt -67.05 -34.97 73.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 124.501 1.12 . . . . 0.0 109.1 174.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -69.02 149.73 97.73 Favored Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -77.76 30.75 0.43 Allowed 'Trans proline' 0 CA--C 1.546 1.109 0 C-N-CA 124.445 3.43 . . . . 0.0 113.384 -172.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . 0.268 29.9 m 42.9 51.2 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 126.7 2.0 . . . . 0.0 111.937 -176.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -139.4 172.87 12.19 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.137 1.775 . . . . 0.0 108.343 -177.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 53.1 tp -52.14 -33.7 41.3 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.534 1.533 . . . . 0.0 113.417 -171.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -174.92 170.54 43.67 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 118.554 0.615 . . . . 0.0 111.611 172.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -158.84 172.34 18.4 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 126.431 1.892 . . . . 0.0 107.41 174.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -112.5 148.95 33.36 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.316 1.046 . . . . 0.0 109.916 -178.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -141.48 173.62 11.32 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.76 1.224 . . . . 0.0 108.367 -178.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -130.24 129.24 43.08 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 124.669 1.188 . . . . 0.0 107.911 -170.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.9 tp -91.53 141.12 29.07 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 169.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 55.1 t -134.7 146.72 30.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 172.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.4 mt -135.05 127.74 48.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 104.391 -2.448 . . . . 0.0 104.391 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.379 0 N-CA-C 105.083 -2.191 . . . . 0.0 105.083 175.161 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -75.39 -19.62 59.44 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.945 0.498 . . . . 0.0 111.889 -169.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -140.92 143.39 34.57 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.167 0.987 . . . . 0.0 108.968 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.7 p -145.5 140.77 22.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 174.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 40.7 tpp -154.96 163.02 40.9 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.591 1.156 . . . . 0.0 108.779 -177.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -121.63 152.28 39.49 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 175.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -152.24 -143.0 3.6 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.119 -169.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -151.52 142.91 23.45 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 127.69 2.396 . . . . 0.0 105.001 169.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.3 p -116.05 140.48 37.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 172.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -132.96 54.69 1.94 Allowed 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.04 163.34 22.58 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.074 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 15.8 pt -103.17 175.25 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 123.238 0.615 . . . . 0.0 110.161 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -72.77 -5.26 36.73 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.017 1.327 . . . . 0.0 113.253 178.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.758 0 C-N-CA 124.417 1.008 . . . . 0.0 112.585 -179.196 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.47 0.572 0 CA-C-O 121.295 0.569 . . . . 0.0 111.428 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -132.49 144.04 50.18 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 169.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 45.1 tp -80.35 143.62 33.4 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 168.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 13.4 m -135.75 143.4 45.27 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -169.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -138.89 156.27 47.42 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.881 0.873 . . . . 0.0 111.182 -169.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -133.74 139.42 46.35 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 171.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.3 t -137.8 144.05 32.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -177.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 65.6 m -126.31 121.75 33.5 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 174.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -145.47 116.11 7.67 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 119.396 0.998 . . . . 0.0 109.354 -170.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 56.92 21.3 36.98 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-O 119.377 -0.679 . . . . 0.0 114.513 -178.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 91.06 -8.49 79.62 Favored Glycine 0 CA--C 1.535 1.335 0 CA-C-N 118.553 1.176 . . . . 0.0 113.296 -175.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -85.91 168.12 14.49 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 118.719 1.26 . . . . 0.0 107.992 169.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.8 tp -139.59 157.75 45.28 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.457 0.703 . . . . 0.0 110.09 -173.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 14.6 ptp -155.64 159.26 39.45 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.141 0.976 . . . . 0.0 109.578 168.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 29.7 ttp85 -135.63 141.05 45.0 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 169.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 5.8 tt -143.38 154.5 43.78 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 118.801 0.728 . . . . 0.0 109.829 -176.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -135.13 148.48 49.77 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 169.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -169.2 166.41 39.67 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 170.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -70.9 103.57 2.68 Favored 'General case' 0 N--CA 1.462 0.126 0 O-C-N 121.728 -0.866 . . . . 0.0 109.825 179.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . 10.7 -67.57 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 130.987 3.715 . . . . 0.0 117.786 -171.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -61.47 -13.5 21.27 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 120.76 1.618 . . . . 0.0 114.077 178.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -62.8 -43.77 97.93 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 126.608 1.963 . . . . 0.0 109.781 171.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.47 -38.3 77.3 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.737 1.215 . . . . 0.0 109.977 -176.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 42.79 35.72 0.75 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.431 2.693 . . . . 0.0 113.599 175.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 173.86 58.82 0.05 OUTLIER Glycine 0 C--N 1.333 0.412 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -170.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -95.38 -0.65 52.38 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.761 0.824 . . . . 0.0 112.469 -170.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.504 ' C ' ' H ' ' A' ' 138' ' ' ASP . 7.0 tp10 -72.22 146.09 47.55 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 170.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 1.8 p -62.15 0.48 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 124.734 1.214 . . . . 0.0 110.988 169.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.504 ' H ' ' C ' ' A' ' 136' ' ' GLU . 36.8 t70 -137.97 9.51 2.8 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.471 1.909 . . . . 0.0 113.28 179.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 58.5 m -68.4 -73.1 0.15 Allowed 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.46 -0.775 . . . . 0.0 111.081 169.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.341 10.3 ptm180 -89.03 25.96 1.69 Allowed 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 122.364 1.078 . . . . 0.0 112.755 -169.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . 0.255 60.9 t -83.01 -4.93 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 C-N-CA 127.446 2.299 . . . . 0.0 107.708 168.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -126.45 120.12 28.94 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 102.654 -3.091 . . . . 0.0 102.654 169.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 10.4 tt -141.68 141.76 33.35 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -168.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 mp -138.65 157.33 46.33 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.379 1.072 . . . . 0.0 108.463 -174.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 78.1 mtm -143.03 158.94 43.14 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.887 -0.508 . . . . 0.0 110.795 173.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -152.26 169.47 22.4 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.985 1.714 . . . . 0.0 108.567 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -61.55 168.83 2.64 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.233 -0.917 . . . . 0.0 110.952 169.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.41 168.35 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.966 1.706 . . . . 0.0 114.551 175.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -142.45 21.26 2.04 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.692 1.197 . . . . 0.0 112.597 171.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 . . . . . 0 C--O 1.247 0.963 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -178.561 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 42.0 tp . . . . . 0 CA--C 1.536 0.414 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -154.3 164.64 38.26 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.742 1.217 . . . . 0.0 109.225 174.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -148.69 151.45 34.93 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 126.621 1.969 . . . . 0.0 105.948 172.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -147.1 148.06 31.22 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 123.381 0.672 . . . . 0.0 110.633 176.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.8 mp -115.84 137.17 50.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 104.529 -2.397 . . . . 0.0 104.529 169.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -137.84 168.62 19.32 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.318 0.647 . . . . 0.0 110.933 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -131.17 121.33 24.67 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.964 2.106 . . . . 0.0 107.697 -175.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 96.3 t -63.81 127.51 24.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 176.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.2 mmmt -105.83 -30.52 9.34 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 124.204 1.001 . . . . 0.0 109.87 176.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -156.27 167.33 30.76 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.833 0.742 . . . . 0.0 111.45 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.4 mp -139.53 140.41 37.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 127.758 2.423 . . . . 0.0 105.845 -176.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -146.67 93.19 4.93 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 123.35 0.66 . . . . 0.0 110.025 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.73 149.16 51.3 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.196 2.597 . . . . 0.0 112.234 173.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -82.51 -3.05 55.24 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -176.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.09 52.1 0.39 Allowed Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.981 -1.247 . . . . 0.0 109.981 -174.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? 40.3 42.33 1.2 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.865 2.066 . . . . 0.0 112.434 -169.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -79.02 79.79 5.4 Favored 'General case' 0 C--N 1.338 0.108 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 170.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 65.62 114.88 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 128.733 2.813 . . . . 0.0 108.704 -169.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -56.74 -33.89 66.99 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -169.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 51.6 ptt85 -81.89 0.53 39.31 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-O 116.558 -1.687 . . . . 0.0 113.708 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.5 t -121.77 113.78 40.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 121.686 2.039 . . . . 0.0 107.521 -174.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.4 m -147.84 163.21 37.48 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 123.206 0.603 . . . . 0.0 110.565 -172.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.9 ttm-85 -73.52 154.2 39.97 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 172.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.3 mt -135.13 155.01 51.45 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 125.749 1.62 . . . . 0.0 107.315 170.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -131.0 130.11 42.94 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 169.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 30.2 m -140.65 153.71 46.12 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.047 1.339 . . . . 0.0 110.571 -169.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -112.07 124.69 52.96 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 177.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 69.8 m -77.67 140.88 39.64 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 174.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -94.43 -26.73 16.37 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.456 1.102 . . . . 0.0 111.411 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.5 m -62.87 -46.52 87.5 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -169.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -141.68 -95.58 0.13 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.596 0.634 . . . . 0.0 110.413 -172.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 43.5 mtmt -145.29 21.09 1.55 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.7 1.6 . . . . 0.0 110.868 -168.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 56.5 mtm -88.64 159.44 17.85 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.402 0.681 . . . . 0.0 111.62 -169.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -138.98 127.67 23.32 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 127.62 2.368 . . . . 0.0 106.635 -177.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 56.6 tp -129.48 138.68 51.54 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.623 1.101 . . . . 0.0 110.769 -169.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.7 mm -124.41 146.94 29.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 169.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.1 mp -140.88 163.95 31.56 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.995 1.718 . . . . 0.0 108.142 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -138.49 96.29 3.14 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 100.374 -3.936 . . . . 0.0 100.374 168.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.3 p -140.95 171.18 13.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 123.26 0.624 . . . . 0.0 111.389 -167.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -68.17 93.13 0.43 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.194 1.398 . . . . 0.0 109.624 170.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.6 pp -74.14 -1.33 2.83 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -171.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 60.9 mm-40 -65.75 -13.87 60.21 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 120.357 1.435 . . . . 0.0 111.503 175.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 82.7 mt -58.25 -29.79 38.38 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 C-N-CA 124.314 1.046 . . . . 0.0 108.921 168.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -115.61 145.42 34.48 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 124.663 1.185 . . . . 0.0 113.002 -168.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -78.93 77.65 4.01 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.531 2.82 . . . . 0.0 107.152 169.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.7 m -57.53 -9.93 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -171.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -57.67 -31.42 66.32 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.732 0.813 . . . . 0.0 111.999 169.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -147.03 -7.42 0.48 Allowed 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.811 1.412 . . . . 0.0 114.811 178.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.82 174.88 45.51 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-N 119.349 0.977 . . . . 0.0 111.827 -178.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -155.52 174.27 15.5 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.882 1.273 . . . . 0.0 108.713 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -93.61 153.21 18.52 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.169 0.988 . . . . 0.0 109.772 174.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -148.66 173.6 13.04 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.622 1.169 . . . . 0.0 109.458 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 50.6 ttt180 -131.18 146.23 52.25 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 125.839 1.656 . . . . 0.0 107.569 -175.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.1 tt -141.25 138.17 33.06 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 125.5 1.52 . . . . 0.0 107.474 -171.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.4 t -147.75 154.35 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -173.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 tt -81.71 -52.12 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 168.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.483 0 C-N-CA 128.544 2.738 . . . . 0.0 114.168 -175.33 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 . . . . . 0 N--CA 1.454 -0.248 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -80.52 -30.78 37.22 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 122.022 -0.424 . . . . 0.0 109.965 178.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -153.85 147.69 25.41 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.111 0.964 . . . . 0.0 108.972 171.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.4 p -151.93 142.39 15.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 169.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.7 tpt -158.28 168.43 27.03 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.006 1.323 . . . . 0.0 109.144 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -119.5 146.13 45.71 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 172.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -150.14 -158.33 8.15 Favored Glycine 0 C--N 1.336 0.558 0 CA-C-N 118.775 0.716 . . . . 0.0 112.014 -171.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -125.91 136.22 52.79 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 174.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 47.1 t -98.03 150.09 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 176.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -135.21 157.96 45.57 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 169.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.07 153.47 29.45 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 120.754 -1.216 . . . . 0.0 109.234 172.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.56 -177.85 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 O-C-N 123.671 0.607 . . . . 0.0 109.618 176.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -68.48 -6.57 25.78 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.053 1.341 . . . . 0.0 114.054 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.682 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 -175.194 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.5 p . . . . . 0 C--O 1.233 0.198 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -127.69 132.23 49.69 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 126.707 2.003 . . . . 0.0 105.605 175.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 66.1 tp -65.9 147.05 53.98 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 169.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -115.77 133.01 56.47 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 169.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -122.36 157.23 32.26 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 173.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -126.68 149.32 49.61 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.9 t -134.43 132.62 55.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 18.5 m -124.22 119.58 29.77 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -144.22 117.37 8.94 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.282 1.033 . . . . 0.0 109.192 -169.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 56.79 27.21 55.52 Favored Glycine 0 CA--C 1.535 1.294 0 O-C-N 121.724 -0.61 . . . . 0.0 114.221 176.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 84.13 -3.1 86.82 Favored Glycine 0 CA--C 1.536 1.346 0 CA-C-N 118.25 1.025 . . . . 0.0 113.543 -177.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 78.8 mt -95.7 163.52 13.15 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.1 1.36 . . . . 0.0 107.483 169.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.8 tt -148.88 157.67 43.6 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 121.712 -0.618 . . . . 0.0 111.068 -169.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 24.6 ptp -151.63 162.44 40.98 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.655 1.182 . . . . 0.0 109.311 169.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 43.6 ttt-85 -132.03 127.24 35.78 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 171.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 54.6 tp -127.37 119.38 26.08 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 -178.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -94.38 149.42 21.25 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 168.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -169.09 171.03 42.84 Favored Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 171.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -53.66 133.05 41.74 Favored 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 169.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -43.24 -59.28 2.14 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -172.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -58.43 -43.66 88.84 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 122.288 1.042 . . . . 0.0 111.429 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -61.73 -26.25 67.94 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 113.58 -1.646 . . . . 0.0 111.31 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 32.8 tp -81.23 -22.74 38.54 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 118.765 -0.636 . . . . 0.0 110.668 -176.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 37.6 49.49 1.04 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.292 1.037 . . . . 0.0 111.997 -170.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -118.08 0.42 17.01 Favored Glycine 0 C--N 1.341 0.845 0 CA-C-O 118.536 -1.147 . . . . 0.0 113.425 -173.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -67.06 -32.09 73.04 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.477 1.638 . . . . 0.0 108.211 168.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -65.14 71.19 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.678 1 C-N-CA 131.8 4.04 . . . . 0.0 108.936 169.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.9 m -59.82 -4.21 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 125.351 1.46 . . . . 0.0 113.954 176.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -125.6 18.39 8.08 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 125.711 1.605 . . . . 0.0 112.128 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.2 m -103.03 -59.1 1.76 Allowed 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 168.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.379 9.9 ptm85 -75.44 11.65 1.2 Allowed 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -175.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 16.6 m -62.35 -40.11 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 167.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -81.19 129.49 34.61 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 176.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -141.65 122.82 14.72 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 -169.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.7 tt -137.44 138.32 39.67 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -172.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 90.5 mtp -139.8 142.64 36.66 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 123.769 0.828 . . . . 0.0 109.229 -177.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -155.92 168.43 27.24 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.226 1.411 . . . . 0.0 107.875 -175.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -60.14 159.03 10.21 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.54 -0.725 . . . . 0.0 109.217 169.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.6 pp -68.91 165.22 20.4 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 120.684 0.278 . . . . 0.0 110.788 169.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -130.75 63.17 1.59 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.285 1.034 . . . . 0.0 109.288 -173.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 . . . . . 0 C--O 1.251 1.159 0 C-N-CA 125.947 1.699 . . . . 0.0 107.646 178.295 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 CA--C 1.534 0.363 0 CA-C-O 121.015 0.435 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -161.7 148.87 14.39 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.645 1.978 . . . . 0.0 106.061 169.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -154.16 138.96 17.09 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.382 1.073 . . . . 0.0 109.035 -172.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -151.12 145.07 25.2 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 168.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.7 mp -85.78 145.1 8.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 106.233 -1.765 . . . . 0.0 106.233 178.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -132.97 148.08 52.27 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.634 1.174 . . . . 0.0 108.654 177.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -117.64 130.55 56.44 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.268 1.427 . . . . 0.0 108.349 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 84.0 t -70.08 113.22 5.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -84.48 -35.18 23.14 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.804 1.241 . . . . 0.0 110.157 175.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -155.99 170.18 22.75 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.316 0.962 . . . . 0.0 111.19 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.8 mp -137.76 132.37 44.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 126.873 2.069 . . . . 0.0 105.905 -178.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -129.25 103.63 18.19 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 124.607 1.163 . . . . 0.0 109.08 176.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -104.31 11.69 0.26 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.925 3.084 . . . . 0.0 113.63 175.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -76.33 74.99 3.12 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.828 1.251 . . . . 0.0 111.346 -169.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 144.0 -9.68 2.03 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.812 1.672 . . . . 0.0 111.76 -178.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -71.33 86.17 0.81 Allowed 'General case' 0 C--N 1.339 0.144 0 C-N-CA 125.195 1.398 . . . . 0.0 110.78 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -54.66 -42.9 71.86 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 169.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -78.25 82.13 4.57 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 169.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -56.95 -24.62 54.15 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.881 1.273 . . . . 0.0 114.419 -169.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -73.9 3.82 6.18 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 174.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.7 t -115.15 147.77 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 176.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.7 m -150.25 158.02 43.71 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 120.995 -1.066 . . . . 0.0 110.439 169.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 19.6 ttp180 -85.89 89.41 7.77 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 171.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 82.2 mt -66.03 152.26 45.02 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 169.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -126.32 133.29 51.42 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 104.306 -2.479 . . . . 0.0 104.306 172.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.9 m -144.13 165.75 26.95 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.103 0.865 . . . . 0.0 112.733 -169.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -135.76 138.21 42.42 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.445 1.498 . . . . 0.0 109.543 -176.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 29.5 t -60.11 135.23 57.65 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.005 1.722 . . . . 0.0 110.326 174.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -81.92 -41.99 20.11 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 119.157 -0.449 . . . . 0.0 110.326 171.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.2 m -92.04 -26.82 18.16 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 115.654 1.724 . . . . 0.0 115.654 -168.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -129.89 -107.84 0.28 Allowed 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 120.359 1.436 . . . . 0.0 109.933 -169.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -149.7 0.44 0.48 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.748 1.619 . . . . 0.0 112.931 -169.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 68.3 mtm -67.03 145.78 55.03 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.36 0.6 . . . . 0.0 109.54 -172.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -123.11 138.28 54.7 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 177.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.1 mt -136.31 152.59 50.85 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.729 0.776 . . . . 0.0 112.221 -169.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 31.6 mm -137.32 140.82 41.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 129.248 3.019 . . . . 0.0 102.97 169.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 8.2 mt -148.82 100.59 3.1 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 126.495 1.918 . . . . 0.0 106.575 -169.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -84.55 92.8 8.21 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 169.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.1 m -143.53 167.64 12.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 124.016 0.926 . . . . 0.0 111.995 -169.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -55.58 138.47 46.8 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.289 1.436 . . . . 0.0 110.889 170.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 pp -120.77 1.39 7.06 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 C-N-CA 124.8 1.24 . . . . 0.0 113.374 178.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -67.69 -9.52 44.25 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 121.209 1.822 . . . . 0.0 112.543 -175.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 28.8 mt -61.41 -24.02 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 C-N-CA 125.507 1.523 . . . . 0.0 108.315 169.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -127.22 169.32 12.47 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 127.785 2.434 . . . . 0.0 109.501 -169.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -53.17 156.3 10.47 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.422 2.081 . . . . 0.0 111.982 169.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.4 p -56.49 -21.74 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 125.543 1.537 . . . . 0.0 114.53 -169.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -133.29 29.49 3.98 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.535 1.134 . . . . 0.0 110.594 -173.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 21.6 tp -144.42 168.3 20.43 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.154 0.982 . . . . 0.0 110.18 -173.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -150.57 164.2 29.78 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 107.122 -2.391 . . . . 0.0 107.122 169.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -141.81 166.45 24.7 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.928 0.891 . . . . 0.0 109.66 -172.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -57.73 140.66 50.91 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.223 1.009 . . . . 0.0 110.615 -173.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -148.49 -179.68 7.14 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.595 1.558 . . . . 0.0 108.466 -178.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -129.34 150.26 50.78 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 121.38 -0.825 . . . . 0.0 109.142 173.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 61.4 tp -110.55 141.29 43.92 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.925 1.69 . . . . 0.0 107.026 174.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 55.6 t -141.91 157.76 20.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 128.248 2.619 . . . . 0.0 105.534 -177.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.2 pt -133.14 30.51 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 123.899 0.88 . . . . 0.0 110.772 -175.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.552 0 C-N-CA 124.899 1.279 . . . . 0.0 113.599 -169.958 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 7.8 p90 . . . . . 0 CA--C 1.537 0.465 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -124.66 -37.8 2.45 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.303 0.641 . . . . 0.0 110.619 172.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -152.2 158.53 43.0 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.386 0.994 . . . . 0.0 110.746 174.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.4 m -145.26 146.93 19.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 126.367 1.867 . . . . 0.0 107.877 174.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.31 175.63 10.69 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.835 0.826 . . . . 0.0 112.684 173.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -133.55 154.31 50.95 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 128.092 2.557 . . . . 0.0 106.883 172.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.88 -152.35 6.87 Favored Glycine 0 C--N 1.337 0.6 0 CA-C-N 119.602 1.092 . . . . 0.0 113.342 -171.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 43.9 tttp -141.46 139.03 33.27 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.215 1.406 . . . . 0.0 108.397 173.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 38.9 t -83.54 149.87 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.868 1.267 . . . . 0.0 108.932 169.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -133.31 48.3 2.4 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.196 1.798 . . . . 0.0 109.354 -177.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.5 mmt180 -149.45 163.18 38.5 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.595 1.158 . . . . 0.0 110.044 -177.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 25.5 pt -72.12 171.43 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 124.698 1.199 . . . . 0.0 111.207 174.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -74.42 4.77 5.42 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 127.114 2.166 . . . . 0.0 114.471 -177.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.674 0 C-N-CA 124.458 1.028 . . . . 0.0 113.769 -176.889 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 37.1 p . . . . . 0 C--O 1.236 0.362 0 CA-C-O 121.845 0.831 . . . . 0.0 111.718 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -62.62 138.13 58.42 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 168.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.4 125.32 26.68 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 103.162 -2.903 . . . . 0.0 103.162 167.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 13.6 m -105.1 144.05 32.43 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 173.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -135.49 85.33 2.16 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 125.592 1.557 . . . . 0.0 107.367 -169.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 5.9 m-30 -85.28 126.35 33.64 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 103.03 -2.952 . . . . 0.0 103.03 169.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.1 t -141.23 143.59 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 119.971 1.26 . . . . 0.0 108.306 -171.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.0 t -130.38 139.4 50.64 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 171.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -149.65 106.44 3.55 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.339 1.455 . . . . 0.0 108.525 -169.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 58.45 24.34 55.95 Favored Glycine 0 CA--C 1.535 1.313 0 CA-C-O 119.362 -0.688 . . . . 0.0 114.248 175.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.04 -8.95 65.41 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-N 118.295 1.048 . . . . 0.0 113.47 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 11.2 mp -95.21 158.08 15.62 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 106.924 -1.509 . . . . 0.0 106.924 169.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.3 tt -144.1 154.14 42.89 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.915 -0.491 . . . . 0.0 110.109 -170.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 23.3 ptt? -142.11 161.24 38.5 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 169.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 25.6 ttm180 -138.27 115.27 10.86 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 104.464 -2.421 . . . . 0.0 104.464 171.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 11.2 tp -126.15 149.15 49.18 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 126.389 1.876 . . . . 0.0 107.086 -169.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -140.95 150.97 43.8 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 168.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -173.58 177.03 46.1 Favored Glycine 0 C--N 1.331 0.279 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 169.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -57.04 139.53 51.98 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 118.51 1.155 . . . . 0.0 109.183 172.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -50.86 -55.16 18.34 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -176.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.69 -11.4 60.61 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 121.467 -0.771 . . . . 0.0 112.507 -177.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -81.4 -29.12 34.05 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.603 1.161 . . . . 0.0 110.366 172.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.9 mp -80.36 -29.52 37.9 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 169.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 2.1 t60 59.92 25.35 14.49 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.278 1.831 . . . . 0.0 114.44 171.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -168.84 95.06 0.11 Allowed Glycine 0 C--N 1.335 0.49 0 N-CA-C 107.142 -2.383 . . . . 0.0 107.142 177.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -96.0 9.94 39.08 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.388 1.075 . . . . 0.0 113.544 -175.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -74.75 146.56 42.07 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.593 0.711 . . . . 0.0 109.142 173.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.6 m -64.53 -5.19 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.273 168.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -122.09 17.34 10.81 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 127.368 2.267 . . . . 0.0 111.787 176.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 57.5 m -88.2 -57.16 3.03 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 121.272 -0.892 . . . . 0.0 109.096 167.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 4.9 mmm180 -74.58 -5.24 41.75 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -169.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 30.2 m -62.09 -40.9 89.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.408 177.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -74.68 117.4 16.47 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.2 tt -132.56 135.72 46.12 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 -174.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 10.2 tt -143.19 142.03 31.31 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 173.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 80.5 mtp -135.82 152.24 50.88 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 174.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 51.7 mttt -144.09 176.43 9.31 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.108 0.963 . . . . 0.0 109.315 177.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -57.3 165.98 1.3 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.212 0.605 . . . . 0.0 109.47 168.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.57 166.58 0.88 Allowed 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.662 -0.649 . . . . 0.0 111.831 169.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.8 77.72 4.81 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.672 0.789 . . . . 0.0 109.084 176.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 15.5 t80 . . . . . 0 C--O 1.25 1.123 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 175.527 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.53 0.211 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -151.98 140.81 20.98 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.293 0.637 . . . . 0.0 110.909 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -158.11 138.27 12.47 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.84 2.456 . . . . 0.0 106.756 171.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -159.55 157.47 29.95 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.955 0.798 . . . . 0.0 110.265 168.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.35 153.41 4.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 105.588 -2.004 . . . . 0.0 105.588 169.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -134.21 151.12 51.16 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.569 1.547 . . . . 0.0 107.857 175.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -120.07 122.43 41.07 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 126.598 1.959 . . . . 0.0 107.786 -176.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.8 t -71.63 116.43 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -90.88 -32.7 15.93 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 124.878 1.271 . . . . 0.0 110.245 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -157.02 167.37 30.68 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 119.308 0.958 . . . . 0.0 111.181 176.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.4 mp -141.54 146.53 23.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 127.212 2.205 . . . . 0.0 107.358 -175.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -136.31 109.31 9.62 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 125.819 1.648 . . . . 0.0 108.294 170.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -118.13 26.77 0.02 OUTLIER 'Trans proline' 0 CA--C 1.548 1.181 1 C-N-CA 125.744 4.296 . . . . 0.0 110.203 169.675 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -61.53 -19.75 62.47 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 116.161 1.912 . . . . 0.0 116.161 -167.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -178.63 35.15 0.08 OUTLIER Glycine 0 C--N 1.336 0.554 0 N-CA-C 107.827 -2.109 . . . . 0.0 107.827 177.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.47 117.99 9.47 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 -177.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -41.85 -38.17 1.45 Allowed 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.498 1.919 . . . . 0.0 112.98 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -117.79 104.1 10.63 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 104.386 -2.45 . . . . 0.0 104.386 170.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -63.5 -25.22 68.16 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -169.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -66.18 -16.89 64.36 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.611 171.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 20.6 t -98.1 137.3 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 173.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 40.5 m -138.28 149.91 46.14 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 21.8 ttp180 -79.18 143.67 35.18 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 104.797 -2.298 . . . . 0.0 104.797 168.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.0 mt -135.28 158.7 43.7 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -130.85 130.78 44.05 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 104.222 -2.51 . . . . 0.0 104.222 169.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 58.3 m -138.46 168.68 19.26 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.577 1.151 . . . . 0.0 109.866 -175.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -136.19 135.89 39.5 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 174.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.1 p -66.52 149.52 50.33 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 174.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -67.08 -34.46 77.7 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.893 -0.504 . . . . 0.0 111.008 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.3 m -136.7 -32.74 0.81 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -173.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -83.12 17.44 2.0 Allowed 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -171.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 31.6 pttt 43.75 26.55 0.13 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.554 1.942 . . . . 0.0 114.98 175.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 64.3 mtt -80.13 115.79 19.89 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 124.927 1.291 . . . . 0.0 108.208 176.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -78.99 127.51 32.07 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 104.02 -2.585 . . . . 0.0 104.02 168.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.5 tp -133.11 144.06 49.71 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 119.949 1.249 . . . . 0.0 110.745 -169.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 34.1 mm -130.13 146.51 33.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 128.209 2.604 . . . . 0.0 104.216 169.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 mp -143.09 162.54 35.25 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 126.398 1.879 . . . . 0.0 108.7 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -137.03 95.41 3.1 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 101.163 -3.643 . . . . 0.0 101.163 168.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.1 p -142.6 158.87 19.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 123.357 0.663 . . . . 0.0 111.297 -167.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 36.8 t30 -60.69 140.16 57.6 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.378 1.071 . . . . 0.0 109.969 171.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.6 pp -117.47 -2.7 10.06 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 C-N-CA 125.299 1.44 . . . . 0.0 112.698 176.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -67.67 -11.71 58.87 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 120.19 1.359 . . . . 0.0 111.177 171.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.5 mt -60.11 -39.48 80.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 C-N-CA 124.633 1.173 . . . . 0.0 107.867 168.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -76.38 130.24 77.77 Favored Pre-proline 0 CA--C 1.538 0.503 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.05 -25.13 12.08 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.488 2.125 . . . . 0.0 112.746 -175.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.8 m -143.59 162.22 16.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 C-N-CA 125.681 1.593 . . . . 0.0 108.277 -178.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.3 t70 50.24 -148.97 0.29 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.062 1.345 . . . . 0.0 110.597 -174.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 87.0 mt -123.44 -8.58 8.05 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.427 1.491 . . . . 0.0 110.983 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 179.45 164.05 31.3 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 174.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -156.01 -89.69 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 173.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 35.7 mtmt -140.64 151.75 44.85 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.589 1.156 . . . . 0.0 108.241 170.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -151.04 170.65 18.86 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.517 1.127 . . . . 0.0 110.477 -179.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 65.5 ttp85 -115.64 119.51 36.34 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.52 1.528 . . . . 0.0 107.131 -177.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -106.72 139.12 41.66 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 177.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.0 p -158.25 149.79 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-O 121.389 0.614 . . . . 0.0 110.458 -169.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.7 pt -129.77 -19.38 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.491 1.117 . . . . 0.0 109.609 169.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.345 0.389 0 C-N-CA 125.767 1.627 . . . . 0.0 113.583 179.366 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.305 0 CA-C-O 121.842 0.829 . . . . 0.0 111.854 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.8 pm0 -56.98 125.14 21.28 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 114.561 -1.2 . . . . 0.0 112.052 -176.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -68.32 160.21 29.88 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 169.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.6 p -132.06 144.63 36.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 124.254 1.021 . . . . 0.0 109.542 -169.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 34.1 tpp -145.07 168.09 21.14 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 125.608 1.563 . . . . 0.0 107.935 171.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -130.65 147.02 52.27 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.404 1.482 . . . . 0.0 107.027 -173.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -156.62 -162.7 11.67 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 118.729 0.695 . . . . 0.0 113.638 -171.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -133.32 123.35 25.29 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.578 1.551 . . . . 0.0 106.828 174.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.4 t -84.14 147.28 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 173.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -139.66 129.74 25.06 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 173.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.88 157.54 43.28 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 120.706 1.594 . . . . 0.0 111.369 -178.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.2 pt -77.24 179.02 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 O-C-N 124.126 0.891 . . . . 0.0 110.42 -177.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -74.33 -3.52 30.76 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.918 1.287 . . . . 0.0 113.537 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.731 0 CA-C-O 119.251 -0.749 . . . . 0.0 113.045 -177.975 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 23.1 p . . . . . 0 N--CA 1.468 0.448 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -136.45 141.16 43.53 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.374 1.069 . . . . 0.0 108.97 178.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 55.6 tp -83.28 155.61 23.53 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 167.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.1 m -130.8 135.61 47.91 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 177.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -143.26 160.75 39.91 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.393 1.077 . . . . 0.0 110.79 -169.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -136.56 156.56 48.41 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.473 1.909 . . . . 0.0 107.485 176.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.0 p -150.69 139.94 15.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 169.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.5 m -121.07 123.41 42.28 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 -178.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 26.7 p90 -140.96 119.32 12.18 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 124.532 1.133 . . . . 0.0 109.437 -169.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 53.59 28.12 36.52 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 123.677 0.656 . . . . 0.0 114.464 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 84.55 -3.43 86.58 Favored Glycine 0 CA--C 1.535 1.342 0 CA-C-N 118.479 1.139 . . . . 0.0 113.782 -177.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 84.7 mt -95.5 166.24 11.95 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 125.282 1.433 . . . . 0.0 107.352 169.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 7.4 tt -148.63 155.66 41.37 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 121.306 -0.871 . . . . 0.0 110.99 -169.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 14.2 ptt? -153.29 157.92 40.84 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.944 0.898 . . . . 0.0 109.087 169.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -140.63 139.41 34.86 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 126.006 1.722 . . . . 0.0 106.829 -175.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -153.6 160.12 42.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 118.584 0.629 . . . . 0.0 112.221 -170.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -133.46 157.48 45.5 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.799 0.84 . . . . 0.0 109.029 169.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 178.42 173.77 44.09 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 171.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -52.52 134.38 35.12 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.651 1.225 . . . . 0.0 109.157 174.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -43.86 -66.09 0.43 Allowed 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 -169.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -57.88 -43.82 86.28 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 122.36 1.076 . . . . 0.0 111.665 -177.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -60.89 -26.38 67.4 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 126.797 2.039 . . . . 0.0 111.656 179.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 16.4 tp -73.45 -18.73 61.1 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 119.153 0.888 . . . . 0.0 110.186 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 41.89 44.65 2.98 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.689 1.596 . . . . 0.0 112.038 -178.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -142.78 2.66 1.7 Allowed Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.042 0.829 . . . . 0.0 113.557 -172.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -62.76 -27.0 68.98 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.507 1.154 . . . . 0.0 111.043 169.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -70.35 91.6 0.75 Allowed 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 129.083 2.953 . . . . 0.0 108.735 169.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 63.0 t -48.59 -21.39 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 126.996 2.119 . . . . 0.0 112.021 172.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -133.35 21.91 4.03 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -172.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 14.3 m -94.87 -64.02 1.11 Allowed 'General case' 0 C--O 1.232 0.179 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 167.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.329 9.3 ptm85 -77.89 12.95 1.52 Allowed 'General case' 0 C--N 1.344 0.356 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -172.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 15.7 m -61.44 -39.63 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 167.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -76.6 124.28 27.38 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 104.759 -2.311 . . . . 0.0 104.759 169.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 10.0 tt -137.96 128.15 25.99 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 -174.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 mp -134.66 151.01 50.71 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -175.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -156.13 153.34 29.16 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 174.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -144.53 164.44 30.89 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 169.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -56.07 164.04 1.37 Allowed 'General case' 0 CA--C 1.538 0.505 0 O-C-N 120.644 -1.285 . . . . 0.0 109.521 168.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.17 163.1 21.01 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.634 -0.666 . . . . 0.0 110.873 172.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -141.11 39.07 1.77 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.611 1.165 . . . . 0.0 110.065 -178.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 . . . . . 0 C--O 1.248 0.98 0 C-N-CA 125.578 1.551 . . . . 0.0 108.012 -174.884 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 61.6 tp . . . . . 0 C--O 1.233 0.234 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -151.93 137.6 17.87 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 178.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -157.0 130.6 8.1 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 169.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -158.46 152.52 23.89 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 118.474 0.579 . . . . 0.0 110.539 169.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 mp -86.54 142.87 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 172.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -126.04 148.87 49.21 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 125.576 1.55 . . . . 0.0 107.866 178.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -126.42 123.24 37.45 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 126.251 1.82 . . . . 0.0 107.615 -169.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 66.1 t -68.93 127.89 31.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 -173.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.9 mmpt? -89.97 -39.42 12.99 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.768 1.227 . . . . 0.0 109.338 169.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -159.62 166.99 29.52 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.083 0.856 . . . . 0.0 111.793 -177.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.4 mp -137.11 139.47 44.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 127.426 2.29 . . . . 0.0 106.124 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -147.41 95.18 4.36 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 124.902 1.281 . . . . 0.0 109.282 -171.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -63.51 9.72 0.12 Allowed 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 123.778 2.985 . . . . 0.0 116.921 -177.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -78.26 58.18 2.02 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.151 1.38 . . . . 0.0 109.631 175.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -166.94 35.59 0.23 Allowed Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.901 1.239 . . . . 0.0 111.277 -173.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.0 mmpt? -68.13 66.16 0.1 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.779 1.232 . . . . 0.0 113.295 -177.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -59.9 -38.0 81.03 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 168.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -143.66 167.69 21.66 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 130.002 3.321 . . . . 0.0 104.25 169.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -56.66 -41.17 76.78 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.415 -0.803 . . . . 0.0 110.644 171.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -71.73 7.41 1.52 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.201 1.4 . . . . 0.0 114.594 178.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 74.8 t -122.33 137.33 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 122.057 2.208 . . . . 0.0 107.783 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 67.4 m -147.25 161.7 40.41 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.329 1.052 . . . . 0.0 109.799 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 -83.42 149.81 26.45 Favored 'General case' 0 C--N 1.342 0.246 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 170.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.6 mp -145.08 164.82 30.05 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.83 2.052 . . . . 0.0 107.495 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -134.89 133.15 39.35 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 172.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 43.8 m -140.0 171.79 13.68 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.144 1.378 . . . . 0.0 110.081 -176.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -142.47 145.26 33.55 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.163 1.785 . . . . 0.0 107.152 -176.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.8 p -64.52 134.28 54.11 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 118.792 0.723 . . . . 0.0 109.946 174.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.4 tp10 -71.64 -30.18 65.46 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 119.177 -0.44 . . . . 0.0 110.609 172.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.1 m -100.32 -17.46 17.26 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 -169.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -129.71 -105.31 0.29 Allowed 'General case' 0 C--N 1.344 0.336 0 CA-C-N 120.594 1.543 . . . . 0.0 110.754 -169.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -168.64 5.67 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.271 1.428 . . . . 0.0 113.713 -169.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 7.7 ptt? -82.85 152.52 25.58 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.686 0.755 . . . . 0.0 110.009 -173.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -121.56 128.14 51.68 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.401 1.881 . . . . 0.0 107.497 -169.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.86 136.36 52.99 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.444 1.097 . . . . 0.0 108.401 -169.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.1 mm -127.02 137.77 56.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 102.634 -3.098 . . . . 0.0 102.634 169.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -154.2 159.46 41.38 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.111 0.964 . . . . 0.0 111.302 -177.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -126.8 112.32 15.24 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 102.967 -2.975 . . . . 0.0 102.967 172.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.2 p -146.22 160.38 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 121.411 0.624 . . . . 0.0 111.339 -168.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -64.61 125.43 24.7 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.866 1.266 . . . . 0.0 109.226 170.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.3 pp -95.21 -4.07 10.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 123.962 0.905 . . . . 0.0 113.178 -177.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -68.72 -15.15 63.43 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 120.684 1.584 . . . . 0.0 111.299 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 26.1 mt -64.66 -35.79 75.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 124.876 1.27 . . . . 0.0 108.533 171.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -78.97 150.86 75.6 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 123.253 0.621 . . . . 0.0 109.412 -175.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.73 -22.87 23.34 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.501 2.134 . . . . 0.0 112.925 -177.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.4 p -156.07 154.27 6.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -177.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -60.55 -27.59 67.78 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.315 1.046 . . . . 0.0 112.528 178.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 38.1 tp -63.31 -14.64 51.92 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.718 1.207 . . . . 0.0 112.269 174.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.0 170.38 46.55 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.467 1.032 . . . . 0.0 111.812 178.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -162.76 170.65 18.0 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.221 2.208 . . . . 0.0 106.472 177.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 11.9 mttp -60.5 151.73 27.7 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 118.896 0.771 . . . . 0.0 109.708 171.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -146.07 177.27 9.09 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.174 0.989 . . . . 0.0 108.402 172.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -132.73 138.41 47.21 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -172.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.2 mp -108.13 144.69 35.18 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 169.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.4 p -150.01 150.31 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 123.941 0.897 . . . . 0.0 108.662 -178.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.2 mt -142.74 127.28 15.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 174.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.239 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 172.135 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 19.3 p90 . . . . . 0 N--CA 1.455 -0.182 0 CA-C-O 121.666 0.746 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -59.45 88.59 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.966 2.506 . . . . 0.0 112.468 -175.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -68.94 152.15 45.63 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 168.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.8 p -115.77 152.37 17.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 118.995 0.816 . . . . 0.0 111.327 -169.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 45.9 tpp -149.89 155.3 39.78 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 126.552 1.941 . . . . 0.0 108.369 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -136.35 142.96 43.84 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 126.185 1.794 . . . . 0.0 106.811 -172.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -156.52 -159.48 9.46 Favored Glycine 0 C--N 1.339 0.708 0 CA-C-N 119.452 1.023 . . . . 0.0 114.789 -170.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 3.8 tmtp? -142.86 116.67 9.3 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 172.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 62.1 t -84.54 148.59 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 176.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -136.47 151.44 49.47 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 128.556 2.742 . . . . 0.0 105.276 176.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.69 167.71 29.64 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 120.241 -1.537 . . . . 0.0 112.085 -175.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.5 pt -120.65 177.47 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 124.222 1.009 . . . . 0.0 108.579 169.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -67.61 -5.08 13.89 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.316 1.446 . . . . 0.0 114.139 -175.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.624 0 N-CA-C 107.446 -2.262 . . . . 0.0 107.446 -173.952 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.6 p . . . . . 0 C--O 1.234 0.271 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -87.2 152.95 21.88 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 169.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 54.6 tp -100.22 141.73 32.66 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 103.638 -2.726 . . . . 0.0 103.638 167.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 17.9 m -131.7 139.34 49.0 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -176.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -136.4 149.28 48.22 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 124.415 1.086 . . . . 0.0 108.646 -178.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -111.14 142.94 42.65 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 103.868 -2.642 . . . . 0.0 103.868 169.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.1 p -144.78 126.66 9.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 38.1 m -100.37 139.76 35.58 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -135.49 78.88 1.75 Allowed 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.629 1.172 . . . . 0.0 109.114 -169.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 61.16 21.33 59.3 Favored Glycine 0 CA--C 1.537 1.435 0 CA-C-O 119.269 -0.74 . . . . 0.0 114.244 171.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 119.41 -24.29 8.17 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 125.268 1.413 . . . . 0.0 112.111 -176.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -82.84 167.9 17.63 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 169.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 31.7 tp -148.45 155.23 40.93 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.398 -0.814 . . . . 0.0 110.167 -174.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 34.6 mtt -147.38 161.11 41.68 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.888 1.275 . . . . 0.0 108.561 169.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -137.17 123.04 20.08 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 103.721 -2.696 . . . . 0.0 103.721 169.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -132.28 131.39 41.98 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 -175.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -125.07 140.26 53.06 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 171.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -164.13 178.24 39.56 Favored Glycine 0 N--CA 1.452 -0.243 0 N-CA-C 108.616 -1.793 . . . . 0.0 108.616 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -55.91 141.47 39.18 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.257 1.028 . . . . 0.0 108.879 170.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -41.82 -62.35 0.92 Allowed 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.39 -11.57 61.0 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.179 -0.95 . . . . 0.0 113.507 -176.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -83.71 -28.45 28.28 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.771 1.228 . . . . 0.0 110.137 173.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.34 -38.2 60.28 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 170.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 49.81 11.98 0.07 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 127.33 2.252 . . . . 0.0 116.105 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -73.99 -56.36 5.35 Favored Glycine 0 CA--C 1.522 0.53 0 O-C-N 121.008 -1.058 . . . . 0.0 110.835 -169.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 44.06 24.42 0.08 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 128.58 2.752 . . . . 0.0 115.01 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -162.87 133.15 4.54 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 125.659 1.584 . . . . 0.0 107.813 -169.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.5 m -67.66 -13.34 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.91 169.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -135.39 16.68 3.41 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -169.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 11.6 m -89.28 -66.35 0.93 Allowed 'General case' 0 N--CA 1.462 0.166 0 O-C-N 121.609 -0.682 . . . . 0.0 109.253 168.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.318 13.2 ptm180 -80.23 14.04 2.09 Favored 'General case' 0 C--N 1.344 0.339 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -170.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 19.4 m -60.79 -34.61 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 167.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -79.27 119.83 22.88 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 170.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -140.42 140.23 35.41 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -178.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.0 mp -129.54 156.48 44.1 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 174.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 23.6 ptp -148.44 152.86 37.67 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 121.854 -0.529 . . . . 0.0 111.342 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -158.03 -177.66 6.72 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.355 1.462 . . . . 0.0 110.408 -178.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -53.06 161.41 0.82 Allowed 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.688 1.595 . . . . 0.0 112.591 170.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.53 166.77 0.59 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.022 0.929 . . . . 0.0 111.473 169.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -88.82 89.52 8.02 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 173.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 17.1 t80 . . . . . 0 C--O 1.249 1.07 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 171.872 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.0 tm? . . . . . 0 C--O 1.233 0.207 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -147.23 150.97 35.91 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 126.076 1.75 . . . . 0.0 106.641 172.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -152.96 142.4 21.71 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.149 0.98 . . . . 0.0 109.094 178.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -158.58 158.91 34.82 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.53 0.732 . . . . 0.0 110.174 169.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 mp -76.2 150.4 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 168.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -131.85 154.21 49.39 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.885 1.274 . . . . 0.0 107.959 175.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -128.9 122.95 31.4 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -173.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.8 t -75.81 105.77 5.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -72.8 -37.78 67.44 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.192 0.997 . . . . 0.0 109.89 177.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -159.58 167.65 28.01 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.326 0.967 . . . . 0.0 111.486 176.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.5 mp -133.17 140.24 47.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 127.333 2.253 . . . . 0.0 106.211 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -146.17 92.95 5.17 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 124.494 1.118 . . . . 0.0 109.908 -170.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -64.26 13.59 0.09 OUTLIER 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 124.129 3.219 . . . . 0.0 116.696 -178.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -79.07 53.13 1.38 Allowed 'General case' 0 CA--C 1.544 0.712 0 O-C-N 120.648 -1.283 . . . . 0.0 109.338 172.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -174.89 41.44 0.12 Allowed Glycine 0 CA--C 1.525 0.682 0 C-N-CA 124.677 1.132 . . . . 0.0 111.052 -170.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -74.71 69.37 1.78 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.123 0.961 . . . . 0.0 110.496 -177.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -55.16 -38.65 68.55 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 169.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -146.73 169.48 18.97 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 129.256 3.022 . . . . 0.0 104.677 169.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -62.07 -33.23 74.02 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 120.985 -1.072 . . . . 0.0 111.744 178.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -83.82 9.45 11.96 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-O 116.919 -1.515 . . . . 0.0 113.105 175.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.0 t -119.32 142.74 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 121.84 2.109 . . . . 0.0 107.809 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 57.3 m -148.59 174.41 12.15 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.018 0.927 . . . . 0.0 108.913 175.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 45.5 ttp180 -84.5 149.33 26.01 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 106.754 -1.572 . . . . 0.0 106.754 168.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -139.44 153.57 47.6 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 126.806 2.042 . . . . 0.0 106.634 -172.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -130.93 126.66 36.68 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 173.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 85.0 m -142.96 166.77 23.71 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.202 1.401 . . . . 0.0 110.161 -170.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 55.8 tt0 -144.78 139.8 28.06 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.339 1.056 . . . . 0.0 108.636 177.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.21 137.31 46.77 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 174.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -68.13 -32.52 72.87 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.869 0.868 . . . . 0.0 111.424 -176.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 m -117.15 -30.6 5.59 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.108 0.963 . . . . 0.0 111.887 -171.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -113.22 13.33 19.18 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -171.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt 45.71 20.87 0.07 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 118.224 2.676 . . . . 0.0 118.224 169.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 52.3 mtm -64.74 125.85 26.07 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 120.858 1.663 . . . . 0.0 107.806 176.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -77.65 118.62 20.22 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 104.921 -2.252 . . . . 0.0 104.921 169.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 49.8 tp -129.05 130.32 46.41 Favored 'General case' 0 N--CA 1.457 -0.081 0 C-N-CA 123.183 0.593 . . . . 0.0 110.303 -169.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 49.6 mm -118.04 142.41 32.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 103.272 -2.862 . . . . 0.0 103.272 168.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 123' ' ' MET . 2.5 pt? -155.67 163.0 40.48 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.21 1.004 . . . . 0.0 110.761 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -124.96 105.73 9.44 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 102.642 -3.095 . . . . 0.0 102.642 178.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -150.5 166.11 2.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 O-C-N 124.267 0.979 . . . . 0.0 111.366 -168.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -55.82 133.22 51.01 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.731 1.612 . . . . 0.0 110.504 170.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.5 pp -108.28 0.03 9.78 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 C-N-CA 125.045 1.338 . . . . 0.0 114.183 -177.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -67.29 -14.24 62.73 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 120.913 1.688 . . . . 0.0 111.623 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.1 mt -62.66 -27.35 42.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 125.505 1.522 . . . . 0.0 109.643 169.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -116.57 158.48 43.27 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 124.681 1.192 . . . . 0.0 112.182 -168.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -78.49 -15.72 13.79 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.251 2.634 . . . . 0.0 112.766 174.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . 0.283 17.7 m 53.96 -19.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 130.694 3.597 . . . . 0.0 117.243 -175.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -66.7 -23.72 66.16 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.668 1.122 . . . . 0.0 111.872 173.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.0 tp -151.76 163.41 39.22 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.449 1.9 . . . . 0.0 107.513 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.19 163.62 20.87 Favored Glycine 0 CA--C 1.534 1.263 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 169.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -156.02 176.21 12.95 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.22 1.408 . . . . 0.0 108.417 -173.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -126.92 150.64 49.22 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.4 1.08 . . . . 0.0 109.618 -175.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -152.58 178.31 9.72 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 125.411 1.484 . . . . 0.0 108.17 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 -129.11 144.7 51.29 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.5 tt -134.24 139.42 45.76 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 -170.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.3 t -140.78 139.57 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 125.247 1.419 . . . . 0.0 107.6 -169.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 38.3 mm -88.12 66.87 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 170.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.625 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -169.673 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 31.2 p90 . . . . . 0 CA--C 1.538 0.483 0 CA-C-O 121.34 0.59 . . . . 0.0 111.872 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -125.24 -9.68 7.01 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.12 1.368 . . . . 0.0 110.816 169.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 36.9 t80 62.24 -149.55 0.37 Allowed 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 116.993 -1.48 . . . . 0.0 108.604 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . 0.456 20.7 t 154.92 -90.1 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 130.308 3.443 . . . . 0.0 110.405 169.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.45 -173.09 2.12 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 122.183 2.265 . . . . 0.0 115.83 -167.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -125.77 154.93 41.82 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 129.562 3.145 . . . . 0.0 105.692 169.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -157.46 -151.42 6.02 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-N 119.835 1.198 . . . . 0.0 113.147 -174.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -140.73 147.76 39.68 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.972 1.709 . . . . 0.0 107.007 169.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.9 p -125.42 135.12 64.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 124.392 1.077 . . . . 0.0 108.33 177.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -146.3 106.75 4.06 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.09 0.956 . . . . 0.0 111.235 -170.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -156.71 167.58 30.01 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.089 1.356 . . . . 0.0 109.821 169.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -62.67 168.95 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 125.466 1.506 . . . . 0.0 112.028 174.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -61.45 3.83 0.11 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 129.171 2.988 . . . . 0.0 116.026 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.937 0 CA-C-N 119.405 1.002 . . . . 0.0 111.988 -175.712 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 81.2 p . . . . . 0 N--CA 1.47 0.54 0 CA-C-O 122.069 0.938 . . . . 0.0 113.31 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -129.79 138.88 51.29 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 174.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.1 tp -84.87 152.45 23.57 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 169.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 11.8 m -122.55 150.79 42.11 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -176.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -148.14 140.43 24.27 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.685 0.794 . . . . 0.0 108.981 178.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 -120.76 134.27 55.29 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 103.11 -2.922 . . . . 0.0 103.11 169.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.3 t -125.11 142.6 41.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 -175.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 45.6 m -133.35 122.83 24.38 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 -178.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -147.79 105.21 3.66 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 122.809 0.444 . . . . 0.0 110.173 -169.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 58.48 27.85 61.47 Favored Glycine 0 CA--C 1.536 1.361 0 O-C-N 121.53 -0.731 . . . . 0.0 113.878 174.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 90.92 -2.87 80.38 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 118.312 1.056 . . . . 0.0 113.528 -178.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 88.0 mt -95.39 164.22 12.91 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 125.439 1.496 . . . . 0.0 107.878 171.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 7.9 tp -142.96 161.91 36.88 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -168.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' MET . . . . . 0.404 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 27.6 mtt -147.04 155.38 42.17 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 126.391 1.877 . . . . 0.0 108.671 169.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 36.9 mtp-105 -142.4 126.07 16.94 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 104.849 -2.278 . . . . 0.0 104.849 169.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -152.28 163.6 39.11 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 119.179 0.899 . . . . 0.0 112.339 -172.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -138.78 155.91 47.78 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.856 1.263 . . . . 0.0 108.78 169.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -169.63 175.8 43.71 Favored Glycine 0 CA--C 1.52 0.381 0 N-CA-C 108.52 -1.832 . . . . 0.0 108.52 169.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -56.77 142.16 41.58 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 118.467 1.134 . . . . 0.0 108.493 170.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -47.09 -48.73 22.62 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.131 0.878 . . . . 0.0 112.035 177.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -56.34 -36.63 68.98 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 122.214 1.007 . . . . 0.0 112.174 178.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -79.0 -19.32 51.89 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 113.58 -1.646 . . . . 0.0 111.004 -174.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 14.7 tp -70.39 -28.15 64.85 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 119.826 1.194 . . . . 0.0 109.309 169.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 1.9 t60 44.44 34.36 1.06 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.504 2.322 . . . . 0.0 114.623 171.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 167.38 73.37 0.03 OUTLIER Glycine 0 C--N 1.334 0.446 0 N-CA-C 108.482 -1.847 . . . . 0.0 108.482 -169.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -101.98 3.84 39.35 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -169.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.434 ' C ' ' H ' ' A' ' 138' ' ' ASP . 9.7 mm-40 -71.85 149.68 44.99 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 169.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 16.5 m -57.79 -7.43 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 124.713 1.205 . . . . 0.0 110.941 168.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.434 ' H ' ' C ' ' A' ' 136' ' ' GLU . 34.1 t70 -135.85 15.6 3.33 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 126.825 2.05 . . . . 0.0 112.692 -178.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 58.6 m -80.77 -76.25 0.24 Allowed 'General case' 0 C--N 1.338 0.079 0 O-C-N 121.412 -0.805 . . . . 0.0 109.06 168.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 11.5 ptm85 -81.23 16.61 1.52 Allowed 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -169.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 30.2 m -68.19 -30.37 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 CA-C-O 118.732 -0.652 . . . . 0.0 109.348 168.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -72.36 124.13 24.49 Favored 'General case' 0 C--N 1.341 0.212 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 175.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 60.0 tp -138.17 103.44 4.94 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.511 0.725 . . . . 0.0 109.231 -173.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 15.9 tp -114.83 135.0 54.67 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 174.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 61.5 mtt -118.96 155.41 31.4 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.961 1.304 . . . . 0.0 107.51 171.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -146.85 161.84 39.86 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 126.36 1.864 . . . . 0.0 107.684 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -67.4 -176.07 0.55 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.351 0.596 . . . . 0.0 110.161 169.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 66.6 mt -57.19 119.8 7.01 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 121.773 0.797 . . . . 0.0 110.273 169.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -142.34 144.85 33.39 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 102.171 -3.27 . . . . 0.0 102.171 169.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 . . . . . 0 C--O 1.249 1.077 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -174.313 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 66.5 tp . . . . . 0 N--CA 1.468 0.438 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -145.2 143.53 30.35 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 169.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -151.83 139.59 19.85 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.429 1.491 . . . . 0.0 107.871 -177.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -154.26 115.71 4.13 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.408 0.683 . . . . 0.0 109.897 -171.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 mp -71.32 143.89 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -143.61 158.94 43.29 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 123.503 0.721 . . . . 0.0 111.431 175.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -135.35 129.27 33.17 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 126.385 1.874 . . . . 0.0 108.286 -174.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.7 t -66.13 126.86 26.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 175.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.1 mmmt -108.01 -25.46 11.15 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 124.312 1.045 . . . . 0.0 110.663 178.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -154.36 166.58 32.76 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.556 1.071 . . . . 0.0 110.672 172.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.4 mp -144.42 141.62 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 126.947 2.099 . . . . 0.0 106.975 -170.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -147.92 100.91 3.67 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 124.213 1.005 . . . . 0.0 109.02 171.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -65.07 -2.1 5.21 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 122.578 2.185 . . . . 0.0 115.937 176.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 36.9 45.41 0.43 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 128.756 2.822 . . . . 0.0 113.76 -176.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.19 11.95 37.78 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.094 0.854 . . . . 0.0 113.077 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? 45.82 67.86 0.68 Allowed 'General case' 0 C--N 1.343 0.307 0 C-N-CA 126.736 2.014 . . . . 0.0 109.895 -170.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -48.93 -41.16 32.91 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.451 1.1 . . . . 0.0 111.435 -177.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -140.74 156.56 46.16 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 169.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -62.5 -4.45 1.93 Allowed 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -172.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -147.24 26.75 1.06 Allowed 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 125.132 1.373 . . . . 0.0 112.229 -176.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.5 t -133.21 126.45 52.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.4 m -148.12 155.64 41.67 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.916 0.886 . . . . 0.0 110.271 -171.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 54.5 ttm-85 -83.41 149.72 26.5 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 169.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 85.9 mt -140.33 159.72 41.56 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 125.788 1.635 . . . . 0.0 107.815 -178.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -133.92 136.87 44.54 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 169.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.9 m -140.82 166.17 25.49 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.384 1.073 . . . . 0.0 109.845 -173.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -129.73 149.39 51.5 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 171.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.6 m -117.46 117.6 29.89 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -169.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -65.84 -44.22 86.17 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.241 1.416 . . . . 0.0 111.437 -169.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.2 m -74.94 -41.32 59.87 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 119.229 -0.415 . . . . 0.0 111.733 -169.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -131.66 29.36 4.5 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -172.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.292 0.0 OUTLIER 44.94 35.14 1.41 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 127.138 2.175 . . . . 0.0 114.702 169.814 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 11.8 tmm? -87.34 114.35 23.87 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.365 1.066 . . . . 0.0 109.003 -175.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -71.87 132.08 43.91 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 171.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 45.8 tp -135.81 143.37 45.13 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.474 0.71 . . . . 0.0 110.739 -169.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 41.4 mm -127.58 147.87 32.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 103.187 -2.894 . . . . 0.0 103.187 169.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.2 mt -150.88 146.44 26.32 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 126.577 1.951 . . . . 0.0 107.557 -169.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -135.3 101.74 4.93 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 102.056 -3.313 . . . . 0.0 102.056 169.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.3 p -146.34 163.51 9.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 122.483 1.135 . . . . 0.0 113.202 -167.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -67.01 123.92 21.57 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 126.072 1.749 . . . . 0.0 106.43 168.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 pp -105.44 4.64 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -174.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -69.36 -10.51 58.23 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 120.069 1.304 . . . . 0.0 111.146 176.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.3 mt -59.75 -42.11 87.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 169.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -79.57 155.4 76.15 Favored Pre-proline 0 C--O 1.236 0.39 0 C-N-CA 123.639 0.775 . . . . 0.0 109.467 -175.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -67.14 -21.1 49.18 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.315 2.01 . . . . 0.0 112.357 176.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.9 p -158.15 155.37 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.782 1.633 . . . . 0.0 106.938 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -55.66 -25.84 41.55 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.376 1.471 . . . . 0.0 113.126 178.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 58.5 tp -57.97 -22.46 49.36 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.281 1.432 . . . . 0.0 112.58 173.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.92 178.58 47.6 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 123.741 0.686 . . . . 0.0 112.219 177.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -157.75 168.57 26.83 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.534 1.933 . . . . 0.0 107.625 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -73.73 136.09 43.66 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 174.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 7.3 m-30 -138.59 178.88 6.82 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.977 1.711 . . . . 0.0 107.012 176.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.93 141.15 49.24 Favored 'General case' 0 CA--C 1.515 -0.383 0 O-C-N 121.127 -0.983 . . . . 0.0 109.129 169.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 12.9 tp -96.24 152.05 18.93 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 177.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 53.7 t -140.01 142.26 32.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 177.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.9 pt -132.64 21.02 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 122.94 0.496 . . . . 0.0 112.104 -178.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.324 0 O-C-N 121.506 -0.746 . . . . 0.0 109.302 172.25 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.1 p90 . . . . . 0 N--CA 1.446 -0.667 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -88.96 -32.82 17.48 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 118.966 -0.54 . . . . 0.0 110.261 175.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -155.67 153.57 30.2 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 118.819 0.736 . . . . 0.0 110.054 177.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.4 m -143.6 145.89 21.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 125.462 1.505 . . . . 0.0 107.464 169.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 5.8 tpt -162.13 174.27 13.17 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.029 0.932 . . . . 0.0 109.452 174.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -137.84 155.8 48.6 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 126.613 1.965 . . . . 0.0 106.212 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -167.08 -157.92 10.98 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 118.689 0.677 . . . . 0.0 113.147 -169.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.4 tttm -141.78 130.18 22.44 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 117.848 0.824 . . . . 0.0 109.152 174.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.3 t -75.11 148.35 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 124.656 1.182 . . . . 0.0 108.779 169.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -144.31 70.67 1.29 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.916 0.887 . . . . 0.0 110.798 175.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -144.01 163.67 32.84 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.376 1.07 . . . . 0.0 110.635 174.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 26.3 pt -76.47 -170.08 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 125.124 1.369 . . . . 0.0 110.269 174.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -60.64 -0.29 0.26 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.965 2.106 . . . . 0.0 115.186 178.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.48 0 C-N-CA 125.231 1.396 . . . . 0.0 111.511 174.047 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.8 p . . . . . 0 N--CA 1.466 0.363 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -118.77 151.9 37.17 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 172.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.18 139.98 33.16 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 169.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.6 p -101.73 147.26 26.68 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 174.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -146.33 144.0 29.5 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 176.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 15.3 m-30 -122.85 137.27 54.98 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 102.485 -3.154 . . . . 0.0 102.485 169.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.4 p -142.47 144.36 24.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 24.0 p -116.97 130.23 56.55 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 172.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -144.51 116.05 8.12 Favored 'General case' 0 N--CA 1.458 -0.073 0 C-N-CA 123.878 0.871 . . . . 0.0 109.581 -169.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 55.78 21.75 30.83 Favored Glycine 0 CA--C 1.537 1.423 0 CA-C-O 119.234 -0.759 . . . . 0.0 114.534 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 92.19 -5.04 78.15 Favored Glycine 0 CA--C 1.535 1.3 0 CA-C-N 118.648 1.224 . . . . 0.0 113.477 -176.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -95.09 170.92 9.07 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.956 1.302 . . . . 0.0 107.809 170.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.5 tt -149.3 151.45 34.19 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 121.522 -0.736 . . . . 0.0 110.545 -170.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 13.0 ptp -148.37 158.08 43.88 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 169.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 -140.51 138.53 34.65 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 178.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -154.2 162.12 41.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 118.855 0.752 . . . . 0.0 112.937 -169.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -134.44 118.43 17.38 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 104.109 -2.552 . . . . 0.0 104.109 168.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -151.05 175.56 29.94 Favored Glycine 0 N--CA 1.452 -0.256 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 -175.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -58.21 148.45 26.98 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 122.332 -0.511 . . . . 0.0 111.177 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -46.49 -42.15 15.13 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 175.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.77 -12.61 60.44 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.996 1.271 . . . . 0.0 113.191 178.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -66.57 -19.06 65.69 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 168.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -100.0 19.19 16.72 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 117.067 -1.444 . . . . 0.0 110.634 174.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -30.2 108.0 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 120.32 1.418 . . . . 0.0 112.021 169.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 122.84 -13.97 8.55 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 125.077 1.322 . . . . 0.0 112.134 -169.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . 0.26 30.9 m-85 44.11 56.6 4.7 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 129.527 3.131 . . . . 0.0 114.165 177.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.436 ' C ' ' H ' ' A' ' 138' ' ' ASP . 2.1 mp0 70.97 164.53 0.28 Allowed 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 129.499 3.12 . . . . 0.0 113.488 170.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 60.1 t 59.23 -9.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 127.091 2.156 . . . . 0.0 113.686 -172.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.436 ' H ' ' C ' ' A' ' 136' ' ' GLU . 32.6 t70 -154.02 -11.99 0.14 Allowed 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 119.84 1.2 . . . . 0.0 114.007 -172.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 16.0 m -54.68 -63.47 1.14 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.963 0.887 . . . . 0.0 112.652 169.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 8.6 mmm180 -88.67 11.19 18.18 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.43 -169.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 98.2 t -87.9 -5.73 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 C-N-CA 124.838 1.255 . . . . 0.0 108.861 -177.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -128.2 114.71 17.33 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 103.383 -2.821 . . . . 0.0 103.383 168.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.7 tt -133.69 126.23 30.32 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 -171.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.0 tt -134.68 147.97 50.23 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 106.768 -1.568 . . . . 0.0 106.768 178.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 56.5 ttm -139.56 138.32 36.14 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.221 -1.399 . . . . 0.0 107.221 -178.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -147.01 162.84 37.97 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -57.06 156.36 7.1 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 118.532 0.605 . . . . 0.0 109.7 169.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.0 pp -67.4 160.04 28.19 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 169.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -148.09 125.93 11.94 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 177.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 . . . . . 0 C--O 1.251 1.162 0 C-N-CA 126.289 1.836 . . . . 0.0 107.186 175.753 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.4 tt . . . . . 0 CA--C 1.53 0.193 0 CA-C-O 118.62 -0.705 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -161.48 150.69 16.26 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 119.17 0.895 . . . . 0.0 109.627 174.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -157.87 132.12 8.2 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.053 1.341 . . . . 0.0 108.434 169.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -161.06 155.01 22.5 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.471 0.708 . . . . 0.0 109.879 168.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 mp -74.5 151.33 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 169.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -129.13 150.71 50.41 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 172.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -133.97 129.21 35.88 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.054 1.342 . . . . 0.0 108.004 -169.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.6 p -63.82 147.97 11.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-O 122.078 0.942 . . . . 0.0 110.153 -177.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -125.09 -29.01 3.36 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 126.73 2.012 . . . . 0.0 109.373 178.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -160.25 166.6 29.27 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.348 0.977 . . . . 0.0 111.062 170.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.1 mp -133.01 135.06 57.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 127.292 2.237 . . . . 0.0 105.372 178.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -146.45 89.85 5.76 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 124.03 0.932 . . . . 0.0 110.301 -169.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -64.27 16.92 0.07 OUTLIER 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 124.26 3.307 . . . . 0.0 116.594 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -79.98 53.98 1.8 Allowed 'General case' 0 CA--C 1.542 0.66 0 O-C-N 120.256 -1.527 . . . . 0.0 109.778 176.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -172.88 38.67 0.15 Allowed Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.231 0.92 . . . . 0.0 111.577 -171.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.6 mmmt -74.31 66.71 1.34 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 118.152 0.976 . . . . 0.0 111.445 -175.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -57.09 -36.63 70.84 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 169.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -143.85 167.77 21.52 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 128.194 2.598 . . . . 0.0 105.027 169.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -62.13 -31.59 72.09 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.355 -0.84 . . . . 0.0 111.243 177.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -82.68 11.07 6.27 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-O 116.738 -1.601 . . . . 0.0 113.559 175.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 93.5 t -123.05 138.54 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 122.391 2.36 . . . . 0.0 108.302 -179.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.7 m -149.66 170.44 18.68 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.876 1.27 . . . . 0.0 109.472 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -91.22 149.7 21.66 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 169.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -141.33 158.16 44.24 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 126.83 2.052 . . . . 0.0 106.713 -172.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -133.14 134.91 44.81 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 172.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 64.3 m -141.24 175.94 9.24 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.953 1.701 . . . . 0.0 109.68 -177.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -141.85 144.94 34.12 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.798 1.639 . . . . 0.0 107.836 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 64.6 p -67.82 130.29 42.53 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 175.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -69.36 -31.3 69.63 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 122.869 0.468 . . . . 0.0 111.785 -174.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 m -113.48 -5.48 13.48 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 114.587 1.328 . . . . 0.0 114.587 -169.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -123.77 -106.86 0.35 Allowed 'General case' 0 C--N 1.341 0.23 0 CA-C-N 119.892 1.223 . . . . 0.0 108.874 -176.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -169.61 3.74 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -169.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 5.3 mpp? -77.69 137.0 38.26 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 123.6 0.76 . . . . 0.0 110.9 -169.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -81.64 137.59 35.43 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 168.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 38.8 tp -133.16 138.75 46.72 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 174.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 35.9 mm -126.75 145.7 33.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 102.801 -3.037 . . . . 0.0 102.801 169.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -157.51 156.52 32.16 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.499 1.12 . . . . 0.0 109.952 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -126.67 107.12 9.89 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 178.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.0 m -148.21 171.44 2.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 O-C-N 124.656 1.222 . . . . 0.0 112.234 -168.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -59.79 141.06 56.0 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.612 1.565 . . . . 0.0 110.415 169.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.6 pp -117.08 1.08 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 125.982 1.713 . . . . 0.0 113.045 177.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -62.05 -22.54 65.83 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 120.48 1.491 . . . . 0.0 110.669 169.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 12.7 mt -53.62 -38.92 35.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 126.179 1.792 . . . . 0.0 109.857 169.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -68.42 129.02 92.98 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -172.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -72.28 -31.6 11.48 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.473 2.116 . . . . 0.0 111.402 178.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.7 m -145.79 154.96 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 126.124 1.77 . . . . 0.0 107.415 177.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -61.7 -25.09 67.19 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.349 0.66 . . . . 0.0 112.061 177.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.2 tp -57.79 -36.26 71.95 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.496 1.118 . . . . 0.0 112.261 -178.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 164.14 177.24 36.72 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-N 118.91 0.777 . . . . 0.0 112.851 178.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -156.99 169.44 24.82 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.487 1.515 . . . . 0.0 109.002 177.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -135.84 158.86 43.36 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.752 1.621 . . . . 0.0 107.974 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -142.47 169.85 16.8 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 123.921 0.888 . . . . 0.0 109.331 -169.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 -133.81 107.2 7.74 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 169.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 68.3 tp -93.98 132.74 38.15 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.0 p -153.6 155.91 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-O 121.943 0.877 . . . . 0.0 109.369 -170.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 tp -147.1 112.1 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 104.146 -2.538 . . . . 0.0 104.146 169.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.507 0 C-N-CA 125.966 1.706 . . . . 0.0 109.229 -175.05 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 . . . . . 0 N--CA 1.465 0.321 0 CA-C-O 118.709 -0.662 . . . . 0.0 112.751 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -140.05 31.84 1.97 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 119.301 0.955 . . . . 0.0 113.291 -168.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -78.41 59.88 2.47 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 120.614 1.552 . . . . 0.0 109.504 174.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.1 p -78.73 147.72 6.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 125.363 1.465 . . . . 0.0 108.414 178.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 3.2 ttm -158.68 174.3 15.26 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.243 1.017 . . . . 0.0 108.904 170.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -126.06 154.19 43.38 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 169.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -152.01 -162.24 10.7 Favored Glycine 0 C--N 1.333 0.369 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -173.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -140.83 112.54 7.57 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 172.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.8 p -69.17 149.91 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 C-N-CA 124.613 1.165 . . . . 0.0 109.347 168.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -139.44 122.65 16.95 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 102.296 -3.224 . . . . 0.0 102.296 172.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.04 142.38 31.55 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 120.065 1.302 . . . . 0.0 109.965 -168.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.9 pt -74.95 174.46 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 123.961 0.905 . . . . 0.0 110.917 -177.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -69.52 -2.99 12.81 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.292 1.437 . . . . 0.0 113.525 177.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.719 0 C-N-CA 124.748 1.166 . . . . 0.0 112.879 -176.313 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.8 p . . . . . 0 N--CA 1.465 0.284 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -126.07 141.29 52.01 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.627 1.171 . . . . 0.0 108.676 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.2 tp -102.81 152.09 21.66 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.122 1.769 . . . . 0.0 107.316 169.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.6 m -132.88 146.4 51.78 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 176.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -139.78 158.17 44.53 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 125.179 1.391 . . . . 0.0 108.872 -177.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -124.5 152.88 42.86 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 169.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.0 t -140.97 141.03 32.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 174.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 72.8 p -118.87 135.72 54.41 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 169.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -151.84 116.6 5.14 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -173.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 54.12 29.14 43.72 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 123.757 0.694 . . . . 0.0 113.97 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 85.48 -2.04 88.16 Favored Glycine 0 CA--C 1.535 1.316 0 CA-C-N 118.159 0.98 . . . . 0.0 113.879 -178.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 49.0 mt -95.22 168.21 10.88 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.281 1.432 . . . . 0.0 108.363 172.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 10.7 tp -139.12 158.1 44.78 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.868 -0.52 . . . . 0.0 111.062 -169.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 43.8 mtt -148.77 159.67 43.93 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.921 1.688 . . . . 0.0 109.408 169.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.7 ttp85 -140.17 131.0 25.93 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 168.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.7 tt -138.42 131.26 29.55 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 -169.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -136.6 144.63 44.2 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -178.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 177.63 -175.21 47.45 Favored Glycine 0 CA--C 1.518 0.245 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 177.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.01 141.93 32.17 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.04 0.92 . . . . 0.0 108.782 169.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -50.46 -53.3 30.77 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -175.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -61.77 -36.55 81.38 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.619 0.723 . . . . 0.0 112.112 179.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -65.64 -23.23 66.75 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 125.032 1.333 . . . . 0.0 111.871 176.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.52 -8.62 55.08 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 120.126 1.33 . . . . 0.0 110.524 172.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 77.2 m80 44.04 43.54 5.57 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 129.413 3.085 . . . . 0.0 111.088 -176.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 173.25 112.1 0.28 Allowed Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 107.267 -2.333 . . . . 0.0 107.267 179.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -65.79 -8.68 22.78 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-O 121.507 0.67 . . . . 0.0 110.93 167.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 50.83 152.13 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.179 1 C-N-CA 135.389 5.476 . . . . 0.0 121.128 168.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER 171.6 -27.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.555 1 C-N-CA 133.438 4.695 . . . . 0.0 107.63 169.41 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -167.24 40.44 0.04 OUTLIER 'General case' 0 C--N 1.349 0.569 0 CA-C-N 119.085 0.857 . . . . 0.0 113.11 -172.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 26.9 m -118.66 -38.41 3.12 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 123.353 0.661 . . . . 0.0 110.617 169.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -11.78 18.77 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.999 0.904 . . . . 0.0 113.084 174.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 18.6 m -77.7 -4.14 6.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 C-N-CA 126.216 1.806 . . . . 0.0 112.689 -174.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -122.19 118.38 28.47 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 104.036 -2.579 . . . . 0.0 104.036 170.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -149.56 147.1 27.76 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.846 0.748 . . . . 0.0 111.131 -172.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 15.7 tp -140.74 139.88 34.74 Favored 'General case' 0 CA--C 1.523 -0.094 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -177.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 16.7 tmm? -125.39 144.28 50.59 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 173.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -149.98 172.55 15.03 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.328 1.451 . . . . 0.0 109.426 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -62.64 157.11 21.57 Favored 'General case' 0 C--O 1.235 0.297 0 O-C-N 122.1 -0.375 . . . . 0.0 110.438 172.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.2 pp -67.61 161.42 25.77 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.121 0.486 . . . . 0.0 110.671 169.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -146.88 129.83 16.32 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 173.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 . . . . . 0 C--O 1.248 1.019 0 C-N-CA 126.466 1.906 . . . . 0.0 106.995 174.04 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.4 tt . . . . . 0 N--CA 1.468 0.437 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -149.36 136.3 19.69 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 173.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -148.87 144.79 27.13 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.339 1.456 . . . . 0.0 108.262 -172.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -157.68 159.91 37.43 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 122.879 0.472 . . . . 0.0 110.585 169.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.1 mp -79.8 153.29 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 105.45 -2.056 . . . . 0.0 105.45 169.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -135.15 138.47 43.74 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.909 1.284 . . . . 0.0 107.644 178.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -105.57 122.96 47.1 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.073 1.349 . . . . 0.0 108.245 -178.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 44.8 t -71.09 116.92 13.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.6 mmmt -80.62 -40.99 24.69 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.729 0.811 . . . . 0.0 109.417 173.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -156.98 169.22 25.3 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 118.518 0.599 . . . . 0.0 111.458 -175.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.6 mp -135.18 144.96 32.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 127.245 2.218 . . . . 0.0 106.503 -178.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -141.91 89.12 9.05 Favored Pre-proline 0 CA--C 1.539 0.558 0 C-N-CA 126.552 1.941 . . . . 0.0 108.737 -176.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -81.21 100.88 1.2 Allowed 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 123.542 2.828 . . . . 0.0 107.674 169.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -61.77 -35.5 78.31 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.486 1.114 . . . . 0.0 112.705 -169.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 141.52 47.04 0.05 OUTLIER Glycine 0 CA--C 1.527 0.808 0 N-CA-C 103.595 -3.802 . . . . 0.0 103.595 -169.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.6 mmmt -61.49 115.97 4.33 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.542 1.537 . . . . 0.0 110.445 -167.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -55.47 -33.29 63.53 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.994 0.918 . . . . 0.0 110.884 170.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -127.22 96.61 4.64 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 176.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.98 -15.03 58.36 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.954 0.902 . . . . 0.0 113.411 -172.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -68.61 -0.2 4.91 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 118.789 -0.624 . . . . 0.0 112.546 169.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.8 t -120.62 138.52 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 104.929 -2.249 . . . . 0.0 104.929 169.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 61.0 m -155.34 160.67 40.9 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.634 1.107 . . . . 0.0 110.061 173.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 41.7 ttm105 -83.35 144.09 29.9 Favored 'General case' 0 C--N 1.342 0.272 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 173.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.1 mp -129.3 157.22 42.49 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 128.075 2.55 . . . . 0.0 105.958 177.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -130.47 130.68 44.54 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 170.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 22.1 m -141.79 168.48 19.67 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.716 1.206 . . . . 0.0 110.998 -171.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -134.3 155.97 49.27 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.447 1.099 . . . . 0.0 108.589 169.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.6 p -69.34 143.82 53.65 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.165 0.586 . . . . 0.0 110.375 176.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -71.77 -36.92 70.53 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.426 0.69 . . . . 0.0 111.247 175.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.1 m -110.92 -10.86 14.39 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -168.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -125.99 -105.97 0.33 Allowed 'General case' 0 C--N 1.343 0.303 0 CA-C-N 120.733 1.606 . . . . 0.0 111.3 -169.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -169.16 14.48 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.749 1.22 . . . . 0.0 114.16 -169.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -65.92 150.52 48.48 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 121.571 -0.706 . . . . 0.0 110.329 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -124.87 113.93 18.52 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 104.18 -2.526 . . . . 0.0 104.18 169.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.1 tp -124.66 145.28 49.74 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.237 1.015 . . . . 0.0 111.243 -168.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 33.2 mm -131.29 142.28 43.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 128.536 2.734 . . . . 0.0 103.741 169.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 123' ' ' MET . 2.1 pt? -156.62 133.05 10.0 Favored 'General case' 0 C--O 1.224 -0.265 0 C-N-CA 124.543 1.137 . . . . 0.0 111.133 175.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -97.02 103.92 15.89 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 102.815 -3.032 . . . . 0.0 102.815 168.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.9 p -128.51 154.34 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 124.344 1.058 . . . . 0.0 111.309 -167.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -68.66 96.05 0.7 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.779 2.032 . . . . 0.0 108.404 169.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.0 pp -75.58 0.35 2.27 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.362 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -169.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -68.15 -4.65 14.49 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 121.425 1.92 . . . . 0.0 112.045 178.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.5 mt -62.16 -34.11 62.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 168.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -77.86 127.54 81.69 Favored Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 174.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.1 -51.23 0.28 Allowed 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.031 1.82 . . . . 0.0 113.052 -169.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.6 m -144.84 -12.94 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -169.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -155.12 152.48 29.54 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.133 0.973 . . . . 0.0 108.785 -175.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.3 mt -111.05 -3.18 15.61 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.437 1.095 . . . . 0.0 112.727 -170.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.09 51.1 4.23 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 176.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -144.4 166.61 24.61 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.676 1.59 . . . . 0.0 108.615 -172.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -93.4 165.39 12.79 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.139 0.976 . . . . 0.0 109.573 -177.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -139.74 -179.17 5.77 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 124.256 1.022 . . . . 0.0 108.767 174.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -136.46 142.25 43.59 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -173.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.3 tt -138.98 144.04 38.78 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.374 1.069 . . . . 0.0 108.605 -169.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.1 t -140.79 152.91 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 126.46 1.904 . . . . 0.0 106.937 -177.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.0 pt -128.85 25.15 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.381 1.073 . . . . 0.0 111.433 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.254 0 C-N-CA 123.38 0.672 . . . . 0.0 110.922 179.287 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.5 p90 . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -159.63 59.61 0.38 Allowed 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.494 -0.754 . . . . 0.0 109.633 -176.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -74.65 72.42 1.96 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 169.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.3 p -85.3 145.87 7.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 124.569 1.148 . . . . 0.0 109.002 -176.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.76 166.99 31.7 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.903 1.681 . . . . 0.0 109.74 -169.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -137.99 142.32 40.45 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.959 1.304 . . . . 0.0 108.911 -177.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -152.73 -157.27 7.93 Favored Glycine 0 C--N 1.336 0.582 0 CA-C-N 118.672 0.669 . . . . 0.0 113.225 -175.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -134.49 130.01 36.02 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 172.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 44.4 t -95.7 150.49 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -132.81 162.34 31.77 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 127.184 2.194 . . . . 0.0 106.883 174.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.93 169.66 19.34 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.12 -0.987 . . . . 0.0 110.67 177.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.64 171.31 18.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 125.121 1.368 . . . . 0.0 107.313 168.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -65.78 -6.99 13.52 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.0 1.72 . . . . 0.0 115.022 -170.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.225 0 C-N-CA 124.975 1.274 . . . . 0.0 112.868 -175.694 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.7 p . . . . . 0 C--O 1.238 0.448 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? 61.75 163.0 0.08 Allowed 'General case' 0 C--N 1.345 0.378 0 C-N-CA 126.593 1.957 . . . . 0.0 110.885 -169.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 52.9 tp -101.04 135.91 41.74 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 103.448 -2.797 . . . . 0.0 103.448 168.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 16.1 m -128.18 134.17 49.01 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -171.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -137.67 162.36 34.05 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.65 1.58 . . . . 0.0 109.405 -169.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -130.3 156.6 44.39 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 172.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.6 t -138.5 139.78 40.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.7 m -125.71 121.42 33.4 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 105.069 -2.196 . . . . 0.0 105.069 174.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -142.38 103.61 4.29 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.333 0.653 . . . . 0.0 109.848 -169.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 59.59 26.5 62.38 Favored Glycine 0 CA--C 1.534 1.269 0 O-C-N 121.68 -0.638 . . . . 0.0 113.628 178.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 93.23 -12.93 68.8 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.409 1.004 . . . . 0.0 113.128 -177.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 84.3 mt -80.91 162.78 23.77 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 118.553 1.176 . . . . 0.0 107.885 169.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 10.7 tp -140.16 153.94 46.8 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 121.808 -0.558 . . . . 0.0 110.3 -170.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' MET . . . . . 0.401 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 29.4 mtm -144.88 156.56 44.07 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.098 1.359 . . . . 0.0 108.494 169.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -136.71 133.44 36.12 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 104.126 -2.546 . . . . 0.0 104.126 169.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 32.5 tp -148.37 145.59 28.14 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.194 0.598 . . . . 0.0 110.374 -168.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -136.01 153.49 51.35 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 167.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -170.25 172.86 44.14 Favored Glycine 0 CA--C 1.521 0.424 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 172.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -55.22 139.61 41.63 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.007 1.404 . . . . 0.0 108.869 173.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -41.06 -54.93 2.71 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -63.4 -37.71 88.34 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 122.564 1.173 . . . . 0.0 111.716 -176.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -69.22 -20.24 63.96 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 113.337 -1.756 . . . . 0.0 111.798 178.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 24.6 tp -69.67 -22.79 63.41 Favored 'General case' 0 C--N 1.346 0.439 0 CA-C-N 120.158 1.344 . . . . 0.0 110.092 174.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 45.71 34.22 1.72 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.675 1.99 . . . . 0.0 114.13 171.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -159.21 57.07 0.33 Allowed Glycine 0 C--N 1.335 0.496 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 -171.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -65.65 -10.0 32.28 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -169.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.412 ' C ' ' H ' ' A' ' 138' ' ' ASP . 38.7 mt-10 -107.27 145.51 32.63 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 125.153 1.381 . . . . 0.0 109.93 179.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 7.7 m -60.69 -7.94 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.233 168.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.412 ' H ' ' C ' ' A' ' 136' ' ' GLU . 32.8 t70 -124.16 14.8 9.1 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 127.58 2.352 . . . . 0.0 112.035 -179.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 70.2 m -81.6 -71.08 0.49 Allowed 'General case' 0 CA--C 1.529 0.151 0 O-C-N 121.589 -0.695 . . . . 0.0 109.491 168.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.299 13.1 ptm180 -85.27 18.26 2.71 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -169.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 18.7 m -62.12 -35.26 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 167.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -79.69 122.8 27.01 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 174.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 56.3 tp -142.82 140.7 31.41 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -169.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.8 tt -145.53 137.43 25.4 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -178.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 58.6 mtt -131.01 157.44 42.98 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.989 0.916 . . . . 0.0 109.457 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 39.8 pttt -164.7 169.95 16.22 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.146 1.378 . . . . 0.0 109.26 178.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.89 162.47 11.1 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.224 0.61 . . . . 0.0 111.363 172.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.44 164.71 2.43 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.57 1.148 . . . . 0.0 113.699 -177.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.72 60.3 5.21 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.063 1.345 . . . . 0.0 111.174 178.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 22.0 t80 . . . . . 0 C--O 1.25 1.105 0 C-N-CA 124.356 1.062 . . . . 0.0 108.371 176.107 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 65.7 tp . . . . . 0 N--CA 1.466 0.366 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -143.3 144.52 32.15 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 169.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -147.46 140.57 25.12 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 -171.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -147.78 144.25 28.09 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 124.262 1.025 . . . . 0.0 109.42 -178.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.77 141.13 25.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -138.08 158.84 43.51 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 122.786 0.435 . . . . 0.0 110.651 174.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -135.08 148.26 49.79 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.802 1.241 . . . . 0.0 109.386 -172.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.1 t -59.86 141.4 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 125.54 1.536 . . . . 0.0 109.847 -178.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -123.35 -29.75 3.78 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 126.377 1.871 . . . . 0.0 108.912 169.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -158.99 169.79 23.52 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.886 0.874 . . . . 0.0 109.669 169.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.6 mp -131.67 141.21 46.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -140.26 76.07 27.05 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 124.319 1.048 . . . . 0.0 108.286 -178.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -81.59 10.27 3.54 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.015 2.477 . . . . 0.0 113.92 -169.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -79.45 54.99 1.84 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.682 1.593 . . . . 0.0 110.199 176.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -150.19 38.4 0.9 Allowed Glycine 0 CA--C 1.528 0.851 0 C-N-CA 126.14 1.829 . . . . 0.0 110.002 -175.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.47 ' HE2' ' HA ' ' A' ' 20' ' ' LYS . 5.3 mmpt? -68.89 65.09 0.13 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.41 1.884 . . . . 0.0 114.083 -169.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -60.43 -38.74 85.04 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 168.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -144.05 162.79 35.33 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 129.161 2.984 . . . . 0.0 104.268 169.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -60.29 -33.68 72.7 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.328 -0.857 . . . . 0.0 111.764 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -75.77 -6.9 52.85 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 117.096 -1.431 . . . . 0.0 114.133 178.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 72.9 t -101.41 123.85 54.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 120.886 1.676 . . . . 0.0 107.162 -174.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.3 m -147.19 152.56 38.59 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.911 0.884 . . . . 0.0 109.561 -176.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 64.9 mtm-85 -83.36 150.61 25.99 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 169.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -129.69 155.16 46.33 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 127.092 2.157 . . . . 0.0 105.8 175.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -127.69 128.62 45.74 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 103.485 -2.783 . . . . 0.0 103.485 170.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 71.3 m -142.61 169.09 18.23 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.396 1.078 . . . . 0.0 111.481 -169.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -135.49 134.86 39.96 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.716 1.606 . . . . 0.0 106.957 176.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.0 m -75.05 142.38 43.75 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 121.392 0.615 . . . . 0.0 110.767 176.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -93.97 -34.93 12.87 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.634 1.174 . . . . 0.0 110.694 -175.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -69.89 -41.98 74.01 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.607 0.763 . . . . 0.0 112.949 -169.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -136.49 -95.22 0.23 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.596 0.758 . . . . 0.0 109.17 -175.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -165.91 110.96 0.85 Allowed 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.06 1.344 . . . . 0.0 108.379 -175.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.8 mtt -158.58 142.01 15.04 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 174.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -112.89 129.31 56.51 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 104.802 -2.296 . . . . 0.0 104.802 169.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.3 tp -136.63 139.46 42.09 Favored 'General case' 0 C--O 1.227 -0.112 0 C-N-CA 123.52 0.728 . . . . 0.0 111.987 -168.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 35.3 mm -121.72 140.96 44.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 102.261 -3.237 . . . . 0.0 102.261 168.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 123' ' ' MET . 2.3 pt? -154.66 158.25 39.37 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 123.704 0.802 . . . . 0.0 110.586 177.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -127.09 111.53 14.13 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.6 m -145.6 166.89 9.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 O-C-N 124.224 0.953 . . . . 0.0 113.195 -168.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -72.65 126.87 30.92 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.945 1.298 . . . . 0.0 107.659 169.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 pp -105.6 -1.05 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -67.23 -16.92 64.58 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 120.775 1.625 . . . . 0.0 111.644 177.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.3 mt -58.57 -27.44 33.89 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 124.23 1.012 . . . . 0.0 109.187 169.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -122.42 158.68 55.4 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 125.093 1.357 . . . . 0.0 113.49 -168.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -75.01 75.13 3.8 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 124.012 3.142 . . . . 0.0 109.55 171.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.5 p -53.98 -23.81 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 124.972 1.309 . . . . 0.0 113.328 -174.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -59.25 -22.43 61.11 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.438 1.095 . . . . 0.0 113.024 174.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 59.1 tp -129.79 -30.19 2.07 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.192 1.397 . . . . 0.0 111.713 -177.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.82 164.95 36.37 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 -169.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -159.2 166.2 31.94 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.71 1.204 . . . . 0.0 108.525 -178.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -74.63 163.97 27.11 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 172.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -128.25 164.92 21.51 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.754 1.622 . . . . 0.0 107.159 177.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.8 ttm180 -127.1 141.14 51.84 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 125.914 1.686 . . . . 0.0 106.581 170.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 39.9 tp -123.72 141.44 52.02 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 127.057 2.143 . . . . 0.0 106.653 178.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.1 t -134.83 142.06 41.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 172.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.7 pt -128.96 19.51 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.329 1.052 . . . . 0.0 110.759 -173.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.216 0 C-N-CA 124.24 1.016 . . . . 0.0 110.57 175.174 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 . . . . . 0 CA--C 1.536 0.426 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -61.08 -31.26 70.93 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 114.09 1.145 . . . . 0.0 114.09 -168.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -144.01 142.23 30.58 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 118.799 0.727 . . . . 0.0 109.154 172.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.2 m -143.06 139.15 27.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 C-N-CA 126.143 1.777 . . . . 0.0 106.707 177.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 37.5 tpp -161.02 166.04 28.84 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.325 1.05 . . . . 0.0 109.078 -177.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -124.54 145.31 49.65 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 170.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -153.15 -170.16 19.08 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-N 118.768 0.713 . . . . 0.0 111.766 -172.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -117.84 134.79 54.58 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.0 t -112.21 134.79 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 175.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -151.23 148.21 27.94 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.739 1.216 . . . . 0.0 108.233 -174.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.15 175.46 1.52 Allowed 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.427 1.491 . . . . 0.0 109.476 170.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 33.8 pt -70.06 -175.44 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 123.861 0.864 . . . . 0.0 110.304 169.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -63.81 -6.38 5.7 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.5 1.92 . . . . 0.0 115.687 -171.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.66 0 CA-C-O 118.851 -0.972 . . . . 0.0 112.812 178.003 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.6 p . . . . . 0 N--CA 1.47 0.546 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.4 mpt_? -132.72 128.69 37.46 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 126.077 1.751 . . . . 0.0 106.497 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.5 tp -73.91 139.0 44.65 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 174.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 7.8 p -90.75 154.95 19.16 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 122.045 -0.409 . . . . 0.0 110.34 176.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -147.77 137.78 22.8 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.132 0.973 . . . . 0.0 108.641 170.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 10.6 m-30 -114.96 146.53 41.09 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 103.45 -2.796 . . . . 0.0 103.45 168.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.2 t -135.33 143.56 36.6 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -173.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.3 t -134.85 123.94 24.29 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 105.496 -2.038 . . . . 0.0 105.496 169.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -146.98 107.94 4.19 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.408 0.683 . . . . 0.0 109.359 -169.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 57.17 24.15 50.03 Favored Glycine 0 CA--C 1.536 1.389 0 O-C-N 121.595 -0.691 . . . . 0.0 113.855 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 93.96 -11.33 71.03 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 124.629 1.109 . . . . 0.0 113.435 -178.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.5 mp -82.34 160.67 22.79 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 170.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 7.0 tp -139.5 159.71 41.53 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.817 -0.552 . . . . 0.0 111.036 -169.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' MET . . . . . 0.401 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 26.1 mtt -149.25 156.38 42.03 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 125.295 1.438 . . . . 0.0 109.092 169.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 39.0 mtm105 -143.47 126.31 16.17 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 105.019 -2.215 . . . . 0.0 105.019 169.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -155.81 166.4 33.61 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 119.667 1.122 . . . . 0.0 112.902 -169.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -134.82 141.33 46.37 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 168.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -156.53 168.85 33.82 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.32 132.19 33.91 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 170.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -45.82 -43.33 13.24 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 175.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.6 -22.86 65.34 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 120.989 -1.069 . . . . 0.0 113.601 177.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -75.65 -19.61 59.05 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 125.527 1.531 . . . . 0.0 110.808 172.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -85.84 3.6 40.9 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 119.467 1.03 . . . . 0.0 109.365 168.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 1.5 t60 38.33 30.04 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.513 1 C-N-CA 131.789 4.036 . . . . 0.0 118.107 169.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 163.27 28.69 0.02 OUTLIER Glycine 0 CA--C 1.525 0.698 0 CA-C-O 119.243 -0.754 . . . . 0.0 111.947 178.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 45.79 40.05 5.99 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.82 1.648 . . . . 0.0 111.95 -169.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . 0.369 2.7 pp20? 43.57 -148.53 0.05 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.932 2.093 . . . . 0.0 114.623 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.7 t 67.9 -34.49 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 127.6 2.36 . . . . 0.0 111.879 -168.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -154.37 18.05 0.48 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.416 1.087 . . . . 0.0 112.433 -170.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 48.8 m -87.04 -77.02 0.34 Allowed 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 169.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.277 9.8 ptm180 -79.35 14.53 1.51 Allowed 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.482 1.113 . . . . 0.0 113.186 -172.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 20.8 m -63.72 -38.67 82.91 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 167.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -82.67 129.22 34.92 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 169.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 7.4 tt -142.12 127.25 18.52 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 118.637 0.653 . . . . 0.0 109.306 -174.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 7.3 tt -132.94 134.06 44.03 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 178.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 60.2 ttm -137.78 140.07 40.39 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -176.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -158.94 -176.28 5.77 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.152 0.981 . . . . 0.0 109.786 178.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -52.93 158.63 1.35 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.992 1.317 . . . . 0.0 112.283 169.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.34 169.68 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.69 2.396 . . . . 0.0 114.205 174.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -125.85 0.43 7.35 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 179.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 14.2 p90 . . . . . 0 C--O 1.249 1.033 0 C-N-CA 127.955 2.502 . . . . 0.0 106.826 -179.482 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tt . . . . . 0 CA--C 1.536 0.441 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -151.69 148.12 27.54 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.101 1.36 . . . . 0.0 108.184 171.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -148.64 143.15 26.33 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 126.431 1.892 . . . . 0.0 107.529 -173.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -151.81 124.9 8.66 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.224 1.009 . . . . 0.0 108.785 172.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.6 mp -79.44 142.14 14.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 104.385 -2.45 . . . . 0.0 104.385 169.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -130.44 158.4 39.99 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.391 0.615 . . . . 0.0 109.807 171.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -119.1 132.98 56.05 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.477 1.511 . . . . 0.0 107.194 178.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.4 p -69.99 135.04 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.9 mmmm -113.06 -25.17 9.07 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.303 1.441 . . . . 0.0 109.977 -177.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -156.07 163.34 39.79 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.098 0.863 . . . . 0.0 110.672 169.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.9 mp -139.09 137.27 42.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 127.264 2.225 . . . . 0.0 105.414 179.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -142.89 97.24 5.87 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 124.589 1.156 . . . . 0.0 108.985 -173.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -61.02 1.28 0.62 Allowed 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 124.326 3.351 . . . . 0.0 117.541 -175.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -77.28 46.73 0.52 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.726 2.01 . . . . 0.0 110.973 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -153.74 35.72 0.74 Allowed Glycine 0 CA--C 1.528 0.859 0 C-N-CA 126.995 2.236 . . . . 0.0 108.928 178.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.423 ' HA ' ' CE ' ' A' ' 20' ' ' LYS . 0.1 OUTLIER -71.68 55.41 0.26 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.567 1.947 . . . . 0.0 113.648 -169.812 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -54.44 -39.76 67.71 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 121.35 -0.843 . . . . 0.0 109.647 170.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -142.64 163.97 31.37 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 128.037 2.535 . . . . 0.0 104.569 169.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -57.48 -34.63 69.23 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.55 -0.719 . . . . 0.0 111.485 176.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 -79.03 4.23 15.03 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-O 117.101 -1.428 . . . . 0.0 114.535 178.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 81.3 t -118.04 132.17 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 121.736 2.062 . . . . 0.0 107.519 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 65.1 m -145.79 159.84 42.61 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.637 0.775 . . . . 0.0 109.709 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -76.69 148.91 36.52 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 169.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -142.56 153.99 44.05 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.712 1.605 . . . . 0.0 107.521 -169.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -134.3 136.58 43.61 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 171.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 67.7 m -145.35 165.38 28.63 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.277 1.031 . . . . 0.0 110.945 -171.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -139.54 136.01 34.03 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.273 1.429 . . . . 0.0 108.496 178.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.2 m -60.67 139.87 57.69 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.842 0.857 . . . . 0.0 112.185 173.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -94.41 -44.44 7.9 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 168.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.0 m -73.13 -38.16 66.39 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 118.643 -0.694 . . . . 0.0 112.029 -172.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -121.14 -106.84 0.37 Allowed 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -166.3 8.96 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 -169.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.8 mpp? -69.04 148.55 49.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.75 0.786 . . . . 0.0 109.145 -174.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -103.93 138.69 40.13 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 169.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.8 mt -135.86 144.71 45.75 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.287 0.635 . . . . 0.0 110.17 -169.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.8 mm -130.19 143.19 41.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 103.157 -2.905 . . . . 0.0 103.157 169.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.8 mp -144.61 159.84 42.15 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.622 1.569 . . . . 0.0 108.166 -177.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -136.04 95.1 3.14 Favored 'General case' 0 C--N 1.32 -0.693 1 N-CA-C 99.758 -4.164 . . . . 0.0 99.758 169.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.1 p -147.11 167.45 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 121.285 0.564 . . . . 0.0 112.392 -167.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -58.27 140.31 53.49 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.883 1.273 . . . . 0.0 109.31 169.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 pp -119.55 -1.38 8.56 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.669 0 CA-C-O 116.972 -1.49 . . . . 0.0 113.263 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -63.64 -15.57 58.65 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 121.773 2.079 . . . . 0.0 114.212 -169.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.519 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.6 OUTLIER -65.69 -28.39 44.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 127.388 2.275 . . . . 0.0 111.093 173.803 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -52.57 155.17 3.99 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 124.534 1.134 . . . . 0.0 111.979 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -73.87 50.57 2.15 Favored 'Trans proline' 0 CA--C 1.547 1.162 0 C-N-CA 124.698 3.599 . . . . 0.0 112.959 175.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . 0.27 20.3 m 52.65 -9.94 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 131.13 3.772 . . . . 0.0 119.229 169.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -143.2 -12.5 0.72 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 120.358 1.435 . . . . 0.0 112.625 -173.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -156.36 169.16 25.23 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 126.239 1.815 . . . . 0.0 108.259 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.16 175.22 54.71 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 176.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -152.18 171.08 18.48 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.732 1.213 . . . . 0.0 109.142 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -79.17 155.39 28.68 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.51 1.124 . . . . 0.0 109.698 175.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -129.74 162.25 28.83 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.975 1.31 . . . . 0.0 108.808 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 42.0 ttt180 -115.07 134.14 55.43 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 173.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 57.7 tp -127.78 132.86 49.47 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 177.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.6 m -137.99 163.99 28.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 124.551 1.14 . . . . 0.0 108.093 177.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.0 pt -127.41 13.07 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 123.514 0.726 . . . . 0.0 110.53 177.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.436 0 C-N-CA 124.548 1.139 . . . . 0.0 113.574 -175.7 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 . . . . . 0 CA--C 1.538 0.518 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -146.04 -40.85 0.21 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.175 0.59 . . . . 0.0 109.421 169.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -143.94 144.73 31.83 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 123.909 0.884 . . . . 0.0 108.698 175.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.1 p -142.58 142.29 26.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 5.2 tmm? -158.89 160.75 36.48 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.455 0.645 . . . . 0.0 111.28 -168.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -129.91 104.92 7.65 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 104.721 -2.326 . . . . 0.0 104.721 173.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -94.93 -173.11 37.62 Favored Glycine 0 C--N 1.332 0.361 0 CA-C-O 121.288 0.382 . . . . 0.0 112.585 -169.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -120.61 100.56 7.2 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 169.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -70.42 142.13 16.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 170.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -136.37 127.22 27.48 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 103.075 -2.935 . . . . 0.0 103.075 169.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -146.29 169.18 19.33 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 120.028 1.285 . . . . 0.0 112.881 -169.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.1 pt -134.63 165.77 30.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 C-N-CA 126.533 1.933 . . . . 0.0 108.325 -169.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -66.53 -3.96 7.46 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.964 1.706 . . . . 0.0 112.77 175.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.934 0 N-CA-C 104.855 -3.298 . . . . 0.0 104.855 -169.851 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.469 0.492 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -138.27 140.14 39.49 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 103.948 -2.612 . . . . 0.0 103.948 169.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 22.3 tp -75.96 157.77 32.74 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 169.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 2.2 m -139.96 146.09 38.7 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -177.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -147.84 160.17 43.05 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.019 0.928 . . . . 0.0 109.157 178.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -124.76 149.78 46.97 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 173.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.9 t -141.24 116.07 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 17.2 m -86.34 124.56 32.84 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 105.469 -2.048 . . . . 0.0 105.469 169.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.4 m-30 -86.89 163.43 17.17 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 169.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -56.96 67.02 0.01 OUTLIER Glycine 0 CA--C 1.539 1.538 0 C-N-CA 126.521 2.01 . . . . 0.0 114.512 170.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 119.24 -7.24 12.72 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 127.137 2.303 . . . . 0.0 113.407 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -139.24 -179.81 6.09 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 119.885 1.842 . . . . 0.0 108.369 -169.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.7 tt -154.77 160.46 41.32 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 121.346 1.885 . . . . 0.0 112.3 -177.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -149.74 161.52 42.06 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.7 1.6 . . . . 0.0 109.426 169.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 92.0 mtt-85 -137.54 139.91 40.75 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 174.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 8.0 tt -143.89 147.93 34.71 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 123.13 0.572 . . . . 0.0 110.441 -169.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -129.07 151.47 49.72 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 168.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -173.55 173.07 45.65 Favored Glycine 0 C--N 1.329 0.146 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 170.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.93 139.98 38.75 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 169.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -39.94 -60.43 1.02 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -178.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -60.45 -37.52 81.22 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.874 0.845 . . . . 0.0 112.46 -178.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -66.9 -23.38 65.99 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 125.307 1.443 . . . . 0.0 111.249 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.7 tt -69.58 -26.78 64.63 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.481 1.037 . . . . 0.0 110.195 177.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 43.39 40.05 2.46 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 127.798 2.439 . . . . 0.0 113.472 175.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -165.62 42.71 0.28 Allowed Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 -169.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -76.17 9.41 2.55 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.546 1.138 . . . . 0.0 112.273 -173.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -130.15 135.95 48.75 Favored 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 125.212 1.405 . . . . 0.0 108.643 -172.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.6 m -57.1 -5.07 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 126.626 1.97 . . . . 0.0 112.31 169.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -134.38 16.83 3.7 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 173.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.7 m -102.78 -51.97 3.18 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 167.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 5.2 tpm_? -75.71 0.45 17.73 Favored 'General case' 0 C--N 1.342 0.271 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -172.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 35.7 m -62.55 -41.57 92.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 124.18 0.992 . . . . 0.0 110.83 169.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -71.28 130.95 42.69 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -170.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 7.7 tt -150.67 134.09 16.34 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 117.939 0.336 . . . . 0.0 110.292 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.8 tt -144.56 135.35 24.85 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 106.492 -1.669 . . . . 0.0 106.492 169.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 14.6 ptp -142.38 159.08 42.94 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 118.501 0.592 . . . . 0.0 111.663 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -157.01 -173.77 4.61 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 126.084 1.754 . . . . 0.0 108.756 171.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -60.95 169.69 1.85 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.889 0.768 . . . . 0.0 109.669 169.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -44.2 155.63 0.09 Allowed 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 179.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.86 63.5 7.0 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.776 1.23 . . . . 0.0 110.054 177.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 19.8 t80 . . . . . 0 C--O 1.249 1.042 0 C-N-CA 123.944 0.897 . . . . 0.0 108.81 178.495 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 22.1 tp . . . . . 0 CA--C 1.542 0.664 0 CA-C-O 120.95 0.405 . . . . 0.0 109.909 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -150.69 125.61 9.82 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.416 1.086 . . . . 0.0 109.095 -177.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -155.87 140.59 17.05 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 178.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -148.41 148.59 30.5 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.13 0.877 . . . . 0.0 110.368 169.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 mp -77.54 154.46 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 173.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -145.76 160.45 41.72 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.971 0.909 . . . . 0.0 110.241 171.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -135.13 129.58 34.11 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.194 1.798 . . . . 0.0 108.194 -169.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.8 p -68.36 123.51 21.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 121.825 0.822 . . . . 0.0 109.058 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -82.14 -42.06 19.6 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 124.537 1.135 . . . . 0.0 109.294 170.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -159.76 167.98 26.98 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 118.831 0.742 . . . . 0.0 111.638 -175.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.3 mp -138.82 138.27 42.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 127.769 2.428 . . . . 0.0 105.55 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -146.0 97.76 4.48 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 118.787 0.721 . . . . 0.0 110.966 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -58.07 59.82 0.05 OUTLIER 'Trans proline' 0 CA--C 1.548 1.214 1 C-N-CA 126.921 5.081 . . . . 0.0 116.595 174.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -123.91 43.67 2.92 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.688 1.595 . . . . 0.0 109.789 178.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -168.1 44.45 0.24 Allowed Glycine 0 C--N 1.336 0.554 0 C-N-CA 124.182 0.896 . . . . 0.0 110.994 -175.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.9 mmmm -76.0 68.07 2.43 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.13 0.965 . . . . 0.0 111.149 -169.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.21 -36.61 68.63 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 169.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -139.68 167.44 22.09 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 128.651 2.78 . . . . 0.0 104.551 169.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -68.72 -25.34 64.71 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.079 -1.013 . . . . 0.0 111.351 -173.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -82.0 -6.35 59.07 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-O 116.536 -1.697 . . . . 0.0 113.553 175.016 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 70.0 t -101.35 128.75 53.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 121.664 2.029 . . . . 0.0 107.728 -175.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.2 m -148.19 167.97 23.7 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.787 1.235 . . . . 0.0 109.304 -177.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.0 tpp85 -70.58 153.98 42.33 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 170.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.8 mt -138.19 156.13 48.01 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.296 1.838 . . . . 0.0 106.904 170.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -133.39 133.68 42.72 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 170.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 65.0 m -143.0 163.65 32.2 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.719 1.208 . . . . 0.0 110.352 -171.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -134.7 137.73 43.79 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.861 1.664 . . . . 0.0 107.051 177.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.8 m -93.65 142.62 27.15 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.058 0.456 . . . . 0.0 110.169 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -69.75 -54.93 11.42 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.788 1.635 . . . . 0.0 113.122 -168.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.6 m -89.35 -35.47 16.07 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 123.114 0.566 . . . . 0.0 111.747 -169.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -108.03 6.56 27.16 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -169.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.287 0.0 OUTLIER 45.99 28.58 0.64 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.179 1.792 . . . . 0.0 114.467 178.678 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 78.8 mtm -61.52 152.48 30.11 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 169.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -123.73 124.12 42.01 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.6 tt -130.67 150.63 51.77 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.864 0.84 . . . . 0.0 111.818 -168.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 16.8 mm -129.15 147.46 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 128.75 2.82 . . . . 0.0 103.729 169.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -147.5 155.42 41.87 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 127.626 2.37 . . . . 0.0 105.89 -171.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -142.49 103.01 4.18 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 104.701 -2.333 . . . . 0.0 104.701 170.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.9 p -163.43 179.59 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 124.044 0.938 . . . . 0.0 109.765 -169.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -52.53 130.49 31.99 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.84 1.656 . . . . 0.0 111.646 172.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.6 pp -110.33 -1.98 10.07 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 C-N-CA 124.946 1.299 . . . . 0.0 113.134 177.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -70.24 -9.54 56.22 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 120.028 1.285 . . . . 0.0 111.395 177.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.2 mt -61.65 -36.53 74.05 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 168.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -91.05 156.14 44.32 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 125.36 1.464 . . . . 0.0 110.526 -177.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.28 169.63 17.87 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.567 2.178 . . . . 0.0 109.921 169.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.0 m -63.71 -23.9 34.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 -169.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -153.23 -35.34 0.11 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.248 0.931 . . . . 0.0 113.497 -175.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 54.6 tp -62.65 -27.69 69.4 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -172.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.98 177.65 36.6 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 -169.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -158.35 175.2 14.02 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.134 0.974 . . . . 0.0 108.768 -178.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -125.39 135.57 52.54 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.003 1.321 . . . . 0.0 107.695 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -131.53 -173.39 3.11 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -129.85 151.48 50.37 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.846 1.258 . . . . 0.0 108.246 177.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 62.1 tp -124.39 138.87 54.32 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 127.005 2.122 . . . . 0.0 107.328 -174.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 41.0 t -144.77 152.64 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 126.626 1.97 . . . . 0.0 106.048 -175.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.5 pt -133.0 55.24 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.477 1.111 . . . . 0.0 108.925 176.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.145 0 C-N-CA 124.752 1.221 . . . . 0.0 110.662 -176.485 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 . . . . . 0 CA--C 1.535 0.386 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -78.11 -33.62 50.5 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.691 -0.631 . . . . 0.0 109.485 174.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -160.19 158.67 30.49 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.492 0.717 . . . . 0.0 109.791 169.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.2 m -139.53 145.07 27.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 C-N-CA 125.25 1.42 . . . . 0.0 107.177 172.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 15.8 ttt -151.83 143.39 23.53 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.915 0.886 . . . . 0.0 109.073 -169.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -135.74 75.67 1.57 Allowed 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 175.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -93.57 -163.94 36.8 Favored Glycine 0 C--N 1.337 0.589 0 N-CA-C 115.26 0.864 . . . . 0.0 115.26 -167.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -131.31 128.84 40.58 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 170.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -74.55 148.84 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 124.946 1.299 . . . . 0.0 108.642 169.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -142.09 64.83 1.38 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.653 1.581 . . . . 0.0 109.131 178.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -156.3 178.96 9.71 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 120.772 -1.205 . . . . 0.0 110.913 -178.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.53 -179.69 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 126.643 1.977 . . . . 0.0 109.5 -173.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -59.99 -6.69 1.42 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.849 2.06 . . . . 0.0 116.481 -169.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.47 0 N-CA-C 108.236 -1.946 . . . . 0.0 108.236 171.126 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.9 p . . . . . 0 N--CA 1.468 0.431 0 CA-C-O 122.024 0.916 . . . . 0.0 112.916 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -135.34 145.42 47.39 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 171.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 40.6 tp -76.49 150.11 36.68 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 105.453 -2.055 . . . . 0.0 105.453 168.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 14.9 m -128.24 150.19 50.14 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -174.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -143.67 149.13 36.8 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.286 1.034 . . . . 0.0 108.365 176.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -134.54 135.2 42.15 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 101.412 -3.551 . . . . 0.0 101.412 169.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.4 t -142.35 144.23 25.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -170.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.4 m -134.46 143.2 47.38 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -159.92 134.15 7.48 Favored 'General case' 0 C--O 1.226 -0.151 0 C-N-CA 123.524 0.73 . . . . 0.0 109.957 171.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 54.61 27.41 42.17 Favored Glycine 0 CA--C 1.537 1.461 0 N-CA-C 114.935 0.734 . . . . 0.0 114.935 169.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 85.73 1.13 87.49 Favored Glycine 0 CA--C 1.535 1.312 0 CA-C-N 118.488 1.144 . . . . 0.0 113.866 -177.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.12 153.19 17.77 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.821 1.648 . . . . 0.0 107.995 173.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 22.8 tp -133.38 156.57 47.43 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.109 0.964 . . . . 0.0 109.477 -176.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 60.6 mtt -144.04 156.48 44.4 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.789 1.636 . . . . 0.0 108.44 171.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.6 129.96 23.84 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 104.377 -2.453 . . . . 0.0 104.377 169.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 18.8 tp -144.7 147.61 33.22 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 119.511 1.05 . . . . 0.0 109.72 -168.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -139.19 153.78 47.95 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.989 0.916 . . . . 0.0 108.753 169.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -172.78 171.13 44.18 Favored Glycine 0 CA--C 1.519 0.333 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 169.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -54.71 141.18 33.22 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 118.804 1.302 . . . . 0.0 107.52 169.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -40.47 -59.44 1.33 Allowed 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -178.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.15 -13.71 62.32 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.345 -0.847 . . . . 0.0 113.134 -174.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -89.31 -27.23 20.67 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 126.175 1.79 . . . . 0.0 109.808 177.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 5.8 tt -78.02 -26.48 48.5 Favored 'General case' 0 C--N 1.344 0.33 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 169.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 3.1 t60 51.95 32.24 9.73 Favored 'General case' 0 C--N 1.344 0.355 0 C-N-CA 126.885 2.074 . . . . 0.0 113.155 168.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -154.97 86.66 0.13 Allowed Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 -169.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -50.66 125.78 13.96 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 169.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.49 175.37 2.3 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -168.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.4 t 70.12 -25.18 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 127.602 2.361 . . . . 0.0 111.768 -170.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -163.53 59.26 0.17 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 120.351 1.432 . . . . 0.0 112.285 -170.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 36.3 m -145.79 -53.9 0.27 Allowed 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 113.64 -1.618 . . . . 0.0 108.841 168.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -75.35 4.59 6.93 Favored 'General case' 0 C--N 1.343 0.299 0 O-C-N 121.867 -0.521 . . . . 0.0 112.285 177.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 11.1 m -81.93 -3.63 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 C-N-CA 123.872 0.869 . . . . 0.0 111.696 178.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -136.57 116.12 12.87 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 169.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 10.4 tt -143.28 142.97 31.53 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.154 0.582 . . . . 0.0 109.527 -169.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 15.6 tp -140.53 141.75 35.26 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 125.815 1.646 . . . . 0.0 107.477 -172.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 38.6 ttm -131.35 132.37 44.4 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -148.35 147.72 29.57 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -178.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -54.55 155.96 3.73 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.663 1.12 . . . . 0.0 111.597 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.6 pp -67.38 158.92 30.52 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 169.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -149.38 96.89 2.57 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.298 0.639 . . . . 0.0 110.058 -177.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 24.3 p90 . . . . . 0 C--O 1.252 1.185 0 C-N-CA 126.096 1.758 . . . . 0.0 107.471 169.675 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 60.9 tp . . . . . 0 CA--C 1.531 0.22 0 CA-C-O 120.924 0.392 . . . . 0.0 110.599 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -157.97 145.36 18.25 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 104.096 -2.557 . . . . 0.0 104.096 169.244 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -147.72 144.8 28.56 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.443 1.497 . . . . 0.0 107.786 -175.01 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -154.27 167.64 29.26 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.233 1.813 . . . . 0.0 108.548 178.464 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.2 mp -124.72 114.34 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 103.646 -2.724 . . . . 0.0 103.646 169.828 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -94.23 152.2 18.88 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.486 0.66 . . . . 0.0 109.705 -179.863 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -135.1 133.85 39.68 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 126.408 1.883 . . . . 0.0 108.257 -173.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 40.3 t -68.71 143.88 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 123.997 0.919 . . . . 0.0 109.392 -178.057 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -124.24 -28.22 3.71 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 126.785 2.034 . . . . 0.0 109.341 177.542 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -159.06 168.23 27.21 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.481 1.037 . . . . 0.0 111.136 171.066 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.4 mp -135.2 139.05 47.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 127.443 2.297 . . . . 0.0 105.927 179.603 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -147.06 91.98 5.04 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 123.301 0.64 . . . . 0.0 112.27 -173.519 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -68.5 97.12 0.51 Allowed 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 123.059 2.506 . . . . 0.0 108.477 168.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -59.37 -36.32 75.53 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.966 0.906 . . . . 0.0 112.84 -169.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.35 44.65 0.03 OUTLIER Glycine 0 CA--C 1.525 0.703 0 N-CA-C 103.749 -3.741 . . . . 0.0 103.749 -170.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.4 mmmt -65.47 132.37 48.77 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.37 1.068 . . . . 0.0 111.811 -167.394 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -60.47 -33.59 72.81 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 113.798 -1.546 . . . . 0.0 110.087 169.3 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -132.47 102.4 5.71 Favored 'General case' 0 N--CA 1.458 -0.068 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 178.212 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -55.04 -33.09 62.39 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.468 1.107 . . . . 0.0 113.514 -169.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -65.54 -5.69 8.75 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 117.446 -1.264 . . . . 0.0 113.586 178.475 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.5 t -121.52 111.82 32.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 174.677 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 74.0 m -140.11 169.2 18.13 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 124.383 1.073 . . . . 0.0 111.013 -173.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -74.59 150.48 39.67 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 175.083 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 71.5 mt -134.12 158.16 44.34 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 127.051 2.14 . . . . 0.0 106.81 173.816 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -128.67 134.57 48.55 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 169.478 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 72.2 m -142.95 169.04 18.32 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.451 1.5 . . . . 0.0 110.352 -171.516 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -136.41 144.5 44.54 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.802 2.041 . . . . 0.0 107.863 -177.707 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.2 p -74.98 158.65 32.91 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.431 1.093 . . . . 0.0 110.992 174.203 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -72.59 -41.55 65.51 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.558 -0.714 . . . . 0.0 110.748 177.656 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.4 m -136.45 6.64 3.02 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -169.052 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -121.32 14.97 11.31 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -169.174 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.264 0.0 OUTLIER 41.45 31.66 0.19 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.95 2.1 . . . . 0.0 114.739 178.295 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 57.3 mtt -74.38 153.95 39.04 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.452 1.101 . . . . 0.0 110.381 -179.104 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -114.34 104.31 11.94 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 169.459 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 62.3 tp -112.18 144.26 41.88 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -171.707 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 31.2 mm -134.0 147.05 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 104.088 -2.56 . . . . 0.0 104.088 174.131 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 123' ' ' MET . 3.2 mp -144.13 158.11 43.91 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 126.155 1.782 . . . . 0.0 107.961 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -133.35 100.86 4.96 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 101.971 -3.344 . . . . 0.0 101.971 168.239 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.8 m -146.23 175.57 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 124.867 1.267 . . . . 0.0 111.126 -167.552 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -58.54 128.5 37.48 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.823 0.849 . . . . 0.0 109.254 169.654 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 pp -115.44 6.0 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 125.101 1.361 . . . . 0.0 112.875 -179.005 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -66.81 -15.0 63.3 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 120.693 1.588 . . . . 0.0 112.069 -176.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.6 mt -65.14 -24.52 35.45 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 C-N-CA 125.293 1.437 . . . . 0.0 109.581 169.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -123.22 71.88 45.92 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 126.931 2.092 . . . . 0.0 109.275 -172.682 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -68.32 -12.34 34.67 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.651 2.234 . . . . 0.0 111.933 173.323 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.5 p -147.32 175.2 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 128.728 2.811 . . . . 0.0 104.917 173.351 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -69.78 69.98 0.31 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.967 0.907 . . . . 0.0 110.123 169.849 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 50.3 tp -64.96 -25.85 68.05 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.729 1.612 . . . . 0.0 111.96 -175.084 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 67.35 26.54 73.52 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-O 119.659 -0.523 . . . . 0.0 112.108 -177.279 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -70.75 157.66 37.66 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 118.024 0.912 . . . . 0.0 108.736 169.853 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -135.97 152.83 51.36 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.188 0.995 . . . . 0.0 109.819 -169.323 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -132.9 127.24 33.93 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -174.456 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -71.45 134.79 46.84 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 169.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 tt -134.79 139.69 45.31 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 -179.67 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 t -139.19 158.04 28.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 -178.176 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 36.0 pt -121.62 14.87 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 123.389 0.675 . . . . 0.0 111.11 176.652 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.481 0 C-N-CA 124.453 1.101 . . . . 0.0 113.444 -175.521 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 . . . . . 0 CA--C 1.533 0.289 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -78.86 -24.83 44.05 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 122.954 0.502 . . . . 0.0 111.741 -171.067 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -147.67 148.22 30.82 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.683 0.793 . . . . 0.0 109.686 -175.53 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.4 p -146.14 143.64 21.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 175.365 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 31.4 tpp -157.81 170.47 22.27 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.592 0.757 . . . . 0.0 110.424 -175.288 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -136.07 154.47 51.01 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.486 2.315 . . . . 0.0 106.116 -175.252 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -161.89 -153.0 6.91 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-N 119.365 0.984 . . . . 0.0 113.838 -169.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -147.57 124.61 11.38 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.339 1.456 . . . . 0.0 108.243 176.823 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 46.1 t -77.61 133.72 29.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 168.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -141.24 70.72 1.35 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.99 0.916 . . . . 0.0 110.524 -169.093 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -155.5 173.01 17.29 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.873 -1.142 . . . . 0.0 111.556 175.079 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 19.7 pt -74.02 -177.63 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 126.128 1.771 . . . . 0.0 112.255 -172.575 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -65.81 -13.59 59.78 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.256 1.822 . . . . 0.0 114.893 -173.621 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.68 0 C-N-CA 124.514 1.054 . . . . 0.0 111.483 178.663 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.3 p . . . . . 0 C--O 1.233 0.212 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? -126.91 141.07 51.9 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 172.133 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.3 tp -73.13 144.48 46.92 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 104.339 -2.467 . . . . 0.0 104.339 167.7 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 7.9 p -110.25 141.92 42.56 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 169.749 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -142.65 152.61 42.63 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 125.29 1.436 . . . . 0.0 107.207 -175.643 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -134.63 143.46 47.31 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 102.332 -3.21 . . . . 0.0 102.332 169.092 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 13.8 t -133.07 116.59 26.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 105.658 -1.979 . . . . 0.0 105.658 -179.155 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.5 p -96.76 129.96 44.09 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 170.042 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -152.05 123.62 7.86 Favored 'General case' 0 C--N 1.334 -0.103 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -171.051 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 52.9 27.66 29.82 Favored Glycine 0 CA--C 1.538 1.492 0 CA-C-O 119.455 -0.636 . . . . 0.0 114.234 -178.801 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 82.28 -0.39 88.95 Favored Glycine 0 CA--C 1.536 1.384 0 CA-C-N 118.448 1.124 . . . . 0.0 114.007 -177.815 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 63.5 mt -99.16 170.94 8.33 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.449 1.5 . . . . 0.0 108.3 171.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 45.4 tp -139.46 157.65 45.47 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 118.628 0.649 . . . . 0.0 111.301 -170.494 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' MET . . . . . 0.414 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 54.5 mtt -143.57 160.3 40.88 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 126.258 1.823 . . . . 0.0 109.055 169.389 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 41.5 ttt180 -135.04 137.28 42.78 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 102.972 -2.973 . . . . 0.0 102.972 168.532 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 25.4 tp -147.91 137.29 22.32 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -169.743 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -128.45 144.3 51.12 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 170.41 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -177.79 170.23 42.49 Favored Glycine 0 CA--C 1.519 0.288 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 175.341 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -52.59 134.55 35.45 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 118.5 1.15 . . . . 0.0 108.685 172.868 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -46.69 -58.74 3.57 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -172.767 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -57.97 -45.26 86.99 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 122.322 1.058 . . . . 0.0 111.277 -177.55 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -61.13 -27.29 68.28 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 126.438 1.895 . . . . 0.0 111.793 178.381 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 tt -81.05 -24.19 38.02 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.917 0.887 . . . . 0.0 109.236 -179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 54.27 30.25 12.11 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.212 1.005 . . . . 0.0 111.234 -170.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -104.25 9.74 50.16 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.662 1.125 . . . . 0.0 112.544 -176.447 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -72.13 7.95 1.48 Allowed 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.555 1.542 . . . . 0.0 112.643 178.233 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -145.18 106.55 4.21 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 127.76 2.424 . . . . 0.0 105.21 -178.221 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 14.6 m -63.02 -7.99 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 113.973 -1.467 . . . . 0.0 112.478 -177.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -122.05 18.89 10.85 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.364 1.065 . . . . 0.0 113.761 175.291 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 3.7 m -88.97 -70.26 0.66 Allowed 'General case' 0 N--CA 1.453 -0.296 0 O-C-N 121.639 -0.663 . . . . 0.0 110.683 168.516 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.28 2.0 ptp180 -75.64 11.48 1.31 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -173.006 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.3 m -65.61 -37.09 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 167.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -78.08 130.47 36.47 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 177.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.2 tt -141.2 141.96 34.03 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -172.492 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 49.2 tp -146.14 127.76 15.17 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 -174.564 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 48.9 ttp -143.8 146.06 32.81 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 119.829 1.195 . . . . 0.0 111.955 -169.443 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -151.57 166.05 32.37 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.904 2.081 . . . . 0.0 107.543 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -54.48 169.0 0.21 Allowed 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.464 1.029 . . . . 0.0 111.038 169.15 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.95 158.82 0.3 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 122.231 1.015 . . . . 0.0 113.333 173.938 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -143.61 130.15 20.11 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 174.112 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 54.3 p90 . . . . . 0 C--O 1.252 1.19 0 C-N-CA 126.169 1.787 . . . . 0.0 108.13 177.269 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 120.891 0.377 . . . . 0.0 110.712 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -124.7 38.31 4.22 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.468 2.307 . . . . 0.0 108.144 166.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -89.07 56.4 4.02 Favored Glycine 0 C--N 1.34 0.762 0 C-N-CA 125.508 1.528 . . . . 0.0 112.3 -161.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . 2.436 0.2 OUTLIER 67.46 -157.19 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 123.753 0.821 . . . . 0.0 108.871 -175.106 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 13.3 tp -149.33 15.59 0.9 Allowed 'General case' 0 CA--C 1.545 0.765 0 O-C-N 119.669 -1.895 . . . . 0.0 113.241 19.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -148.14 147.47 29.52 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.868 1.213 . . . . 0.0 112.152 -177.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -159.43 137.79 10.56 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 128.174 2.59 . . . . 0.0 107.177 -175.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -158.46 154.86 27.5 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 119.336 0.971 . . . . 0.0 110.638 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.1 mp -99.16 159.6 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 126.392 1.877 . . . . 0.0 107.652 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -137.21 168.94 18.65 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.493 1.117 . . . . 0.0 110.549 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -134.1 128.76 34.85 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.641 1.576 . . . . 0.0 106.956 165.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 74.6 t -66.61 133.59 31.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 175.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -103.63 -34.32 8.67 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.616 1.167 . . . . 0.0 110.479 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -158.16 161.26 37.86 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.702 0.801 . . . . 0.0 110.146 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.8 mp -134.44 137.3 51.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 126.827 2.051 . . . . 0.0 105.728 -177.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -140.77 79.0 19.74 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 123.27 0.628 . . . . 0.0 111.453 -167.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -67.48 30.88 0.13 Allowed 'Trans proline' 0 CA--C 1.553 1.432 1 C-N-CA 126.089 4.526 . . . . 0.0 117.849 -172.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -50.13 -46.0 53.46 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 120.985 1.721 . . . . 0.0 115.449 -161.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -129.73 82.05 0.33 Allowed Glycine 0 C--N 1.336 0.572 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -160.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.425 ' HE2' ' HA ' ' A' ' 20' ' ' LYS . 9.5 mmpt? -74.44 62.91 1.02 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.26 1.424 . . . . 0.0 111.124 -176.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -55.92 -39.14 71.2 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.428 -0.795 . . . . 0.0 108.941 163.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -136.14 135.92 39.64 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 104.694 -2.336 . . . . 0.0 104.694 170.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -61.51 -33.29 73.54 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.271 0.487 . . . . 0.0 111.23 -177.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 -75.94 5.87 5.94 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.9 t -121.53 133.52 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 121.841 2.11 . . . . 0.0 107.858 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.7 m -148.38 158.97 44.43 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.352 1.061 . . . . 0.0 110.063 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 27.7 ttp180 -73.4 148.58 43.19 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 163.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 74.1 mt -134.18 162.66 31.52 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 126.153 1.781 . . . . 0.0 108.082 175.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -137.0 130.74 31.9 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 174.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 64.2 m -141.21 164.85 29.15 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.115 1.366 . . . . 0.0 109.525 -170.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -141.15 136.1 31.52 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.4 p -81.39 157.89 24.83 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.29 0.495 . . . . 0.0 111.194 -177.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -100.65 -50.78 3.77 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.581 0.752 . . . . 0.0 111.768 -168.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.0 m -73.57 -24.12 60.04 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 118.844 0.747 . . . . 0.0 111.292 -175.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.455 ' HB3' HD22 ' A' ' 131' ' ' ASN . 19.1 m-85 -126.01 -134.08 0.25 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.921 1.289 . . . . 0.0 108.767 -177.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -143.61 13.54 1.74 Allowed 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.879 1.218 . . . . 0.0 113.689 -165.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 65.7 mtm -68.94 152.0 45.83 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 118.857 0.753 . . . . 0.0 110.685 -172.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -121.5 125.23 46.33 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 126.759 2.024 . . . . 0.0 106.516 176.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 67.9 tp -137.16 148.8 46.84 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.718 0.771 . . . . 0.0 110.264 -163.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.3 mm -130.88 144.9 36.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 128.704 2.801 . . . . 0.0 104.296 170.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.5 mp -134.79 162.51 32.15 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 173.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -132.39 109.16 9.65 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 104.692 -2.336 . . . . 0.0 104.692 158.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.4 p -153.42 158.66 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -154.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -62.16 125.2 23.06 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 169.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 pp -105.39 -1.13 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.253 1.021 . . . . 0.0 112.965 -177.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -66.75 -11.73 55.92 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 120.567 1.53 . . . . 0.0 112.357 177.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.9 mt -63.21 -40.2 88.14 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.75 1.22 . . . . 0.0 108.731 171.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -72.55 155.42 91.11 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 124.152 0.981 . . . . 0.0 109.155 174.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -63.37 -53.08 1.59 Allowed 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 121.766 1.644 . . . . 0.0 111.683 -174.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.8 m -152.67 -143.77 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 126.073 1.749 . . . . 0.0 107.604 -177.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -54.38 -30.42 51.84 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 127.805 2.442 . . . . 0.0 115.143 -173.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 27.9 tp -86.17 -18.92 30.93 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 -147.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.18 173.29 41.36 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -165.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -163.95 178.14 7.97 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.312 1.845 . . . . 0.0 107.912 -175.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -93.58 125.77 38.37 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 121.3 -0.875 . . . . 0.0 109.875 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -106.44 170.76 7.74 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.494 1.518 . . . . 0.0 109.544 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.3 ttp180 -127.54 104.52 7.93 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 126.172 1.789 . . . . 0.0 106.188 165.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.9 152.04 28.3 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 171.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 95.4 t -141.72 134.96 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 -175.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.0 pt -121.25 25.63 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 163.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -48.89 114.8 1.07 Allowed 'General case' 0 C--N 1.345 0.407 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 152.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 72.3 m -63.2 155.55 27.93 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 123.744 0.653 . . . . 0.0 109.494 -171.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.282 6.6 t -94.47 -89.67 0.22 Allowed 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -151.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.4 tt -153.45 -37.87 0.1 Allowed 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 110.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . 0.268 0.3 OUTLIER -125.79 46.77 2.34 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 120.443 -1.411 . . . . 0.0 109.241 -71.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -69.07 -19.72 64.08 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.532 1.133 . . . . 0.0 112.796 170.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -120.2 -78.51 0.59 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -149.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 168.85 27.6 0.02 OUTLIER Glycine 0 CA--C 1.528 0.905 0 C-N-CA 120.104 -1.046 . . . . 0.0 114.731 -159.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 91.0 m -82.92 -17.27 44.25 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 118.935 1.368 . . . . 0.0 109.831 160.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.69 -42.54 0.92 Allowed 'General case' 0 C--N 1.344 0.361 0 C-N-CA 124.341 1.057 . . . . 0.0 111.159 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -60.37 -12.93 10.58 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 118.869 0.759 . . . . 0.0 112.236 174.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -44.54 -33.63 1.82 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.588 1.955 . . . . 0.0 113.287 163.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -5.51 0.35 Allowed Glycine 0 CA--C 1.531 1.067 0 CA-C-O 118.869 -0.962 . . . . 0.0 114.053 173.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.427 ' C ' ' H ' ' A' ' 76' ' ' ASN . 16.1 tt0 -95.72 -143.87 0.27 Allowed 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 118.904 1.352 . . . . 0.0 108.294 179.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . 0.253 26.1 t80 62.84 -7.42 0.14 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 126.029 1.731 . . . . 0.0 114.912 -177.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.427 ' H ' ' C ' ' A' ' 74' ' ' GLU . 0.4 OUTLIER -65.11 -25.76 1.55 Allowed Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 116.956 2.206 . . . . 0.0 116.956 158.38 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.403 ' C ' ' H ' ' A' ' 79' ' ' ASP . 2.6 Cg_endo -87.29 -157.43 0.07 OUTLIER 'Trans proline' 0 C--N 1.358 1.032 0 CA-C-N 123.601 2.322 . . . . 0.0 109.893 -161.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 73.5 p -30.54 1.62 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.628 1 C-N-CA 135.588 5.555 . . . . 0.0 118.063 154.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.403 ' H ' ' C ' ' A' ' 77' ' ' PRO . 25.5 t70 -74.06 -17.46 60.96 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 119.399 -2.063 . . . . 0.0 110.155 154.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -143.89 -142.59 0.13 Allowed 'General case' 0 CA--C 1.553 1.083 1 C-N-CA 132.197 4.199 . . . . 0.0 105.926 176.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . 0.337 70.7 mtm-85 53.19 -109.42 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.901 0 CA-C-O 115.042 -2.409 . . . . 0.0 112.0 -169.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.26 -36.25 3.36 Favored 'Trans proline' 0 C--N 1.36 1.153 0 CA-C-N 124.835 2.762 . . . . 0.0 110.395 177.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.0 m -70.95 177.07 3.87 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.303 1.041 . . . . 0.0 108.863 164.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 13.2 mmt85 -154.51 -179.92 8.42 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 -171.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -55.88 80.01 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 131.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -154.69 -41.8 0.09 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 128.739 2.816 . . . . 0.0 108.141 175.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -56.44 -13.78 2.53 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.613 0.765 . . . . 0.0 110.917 154.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -167.39 73.22 0.12 Allowed 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 129.253 3.021 . . . . 0.0 105.879 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -39.03 -33.23 0.11 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 127.11 2.164 . . . . 0.0 114.591 -175.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -149.5 157.77 43.58 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 173.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.5 p -163.7 138.39 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 40.2 tpp -163.16 166.8 22.97 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.051 0.54 . . . . 0.0 110.387 -166.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -111.94 163.09 14.63 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.707 1.603 . . . . 0.0 109.589 172.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -165.16 -159.67 11.68 Favored Glycine 0 CA--C 1.521 0.419 0 O-C-N 121.648 -0.658 . . . . 0.0 113.022 -175.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 11.1 ttmm -141.73 126.84 18.43 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 177.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.2 t -89.94 143.29 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 171.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -127.41 111.85 14.32 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 177.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.25 144.9 16.15 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 -177.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.451 HG13 ' H ' ' A' ' 101' ' ' GLY . 3.2 pt -75.56 -171.82 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 127.587 2.355 . . . . 0.0 109.663 169.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -64.59 -6.38 7.52 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.462 1.505 . . . . 0.0 114.384 176.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.451 ' H ' HG13 ' A' ' 99' ' ' ILE . . . 107.36 -46.51 1.16 Allowed Glycine 0 C--N 1.336 0.529 0 C-N-CA 126.698 2.094 . . . . 0.0 110.255 -177.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -68.72 137.69 54.3 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 117.163 0.482 . . . . 0.0 111.549 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -143.43 15.25 1.82 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.424 1.09 . . . . 0.0 109.934 162.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 70.2 p -81.98 -39.34 23.78 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.252 -0.905 . . . . 0.0 110.825 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 74.7 m 117.77 -36.58 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.47 1 C-N-CA 132.162 4.185 . . . . 0.0 109.902 -176.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.1 p -151.1 -29.55 0.19 Allowed 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -159.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -74.31 -7.87 54.29 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 118.923 0.783 . . . . 0.0 110.289 174.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 50.92 51.25 17.42 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.72 2.008 . . . . 0.0 110.515 177.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -1.28 103.05 0.01 OUTLIER 'General case' 0 C--N 1.348 0.539 0 C-N-CA 129.363 3.065 . . . . 0.0 113.304 -163.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.8 p -56.24 -21.05 21.12 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.496 1.118 . . . . 0.0 112.704 -174.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -108.48 115.3 29.85 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 165.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 34.5 tp -56.02 131.8 48.35 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 160.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 14.7 m -87.34 171.62 10.46 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 171.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -152.0 146.92 25.94 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 124.62 1.168 . . . . 0.0 108.237 161.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 2.9 m-30 -122.81 139.51 53.93 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 104.001 -2.592 . . . . 0.0 104.001 170.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.2 t -139.42 137.46 40.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 -174.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.1 m -116.92 132.09 56.79 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 166.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -149.43 109.77 4.19 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.089 0.859 . . . . 0.0 109.703 -170.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 58.19 22.94 51.47 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 123.797 0.713 . . . . 0.0 114.334 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.1 -14.11 65.0 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-N 118.42 1.11 . . . . 0.0 112.98 -176.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -83.05 171.87 13.33 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.643 1.177 . . . . 0.0 109.012 170.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 10.1 tp -140.07 153.74 46.85 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.242 1.017 . . . . 0.0 110.192 -173.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 42.6 mtt -138.75 158.31 44.47 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.684 1.194 . . . . 0.0 110.281 164.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.6 ttt-85 -143.97 122.34 12.35 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 104.357 -2.461 . . . . 0.0 104.357 176.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 33.8 tp -142.93 151.54 41.07 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.183 0.901 . . . . 0.0 109.342 -158.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -141.47 145.26 35.02 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.174 1.39 . . . . 0.0 109.817 167.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -172.76 166.81 39.54 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 125.989 1.757 . . . . 0.0 109.883 171.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -51.58 146.75 7.13 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.019 1.41 . . . . 0.0 111.09 176.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.77 -47.53 82.26 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -169.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -65.17 -43.71 90.85 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 122.678 0.391 . . . . 0.0 110.069 174.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.455 HD22 ' HB3' ' A' ' 35' ' ' PHE . 49.8 t30 -65.21 -40.73 94.54 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.416 1.086 . . . . 0.0 112.765 -172.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.2 tt -63.83 -22.17 66.79 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.522 1.129 . . . . 0.0 111.285 176.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 53.08 39.01 28.82 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.998 1.719 . . . . 0.0 112.556 170.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -157.5 50.8 0.42 Allowed Glycine 0 C--N 1.338 0.656 0 C-N-CA 124.067 0.842 . . . . 0.0 111.03 -169.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -58.36 -35.48 72.02 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.294 0.637 . . . . 0.0 110.406 170.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -83.63 155.0 23.43 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.535 1.534 . . . . 0.0 110.326 -170.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.1 m -73.28 -3.46 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 C-N-CA 123.68 0.792 . . . . 0.0 112.208 168.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -133.56 6.41 3.77 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.616 1.166 . . . . 0.0 112.877 -164.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 72.2 m -87.84 -69.3 0.7 Allowed 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.085 -1.01 . . . . 0.0 109.902 173.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.276 12.7 ptm180 -82.05 11.74 4.87 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 120.605 -1.309 . . . . 0.0 114.147 -170.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 24.6 m -62.87 -31.8 53.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 O-C-N 121.992 -0.442 . . . . 0.0 110.305 157.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -73.21 113.47 10.31 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 170.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.3 tt -145.95 137.57 24.97 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 118.342 0.519 . . . . 0.0 110.282 -167.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.3 tt -150.66 150.64 31.38 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.784 1.634 . . . . 0.0 107.088 -168.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 60.3 mtt -142.19 157.42 44.88 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 120.624 -1.298 . . . . 0.0 108.802 -176.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 15.5 ptmt -155.42 173.58 16.46 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 125.002 1.321 . . . . 0.0 109.718 163.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -57.93 163.5 2.69 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 164.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.09 159.82 5.46 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.281 163.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -132.17 106.59 8.06 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 175.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.252 1.196 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 -168.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.0 ptt? . . . . . 0 N--CA 1.479 1.016 0 CA-C-O 119.587 -0.244 . . . . 0.0 110.591 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.26 -35.04 68.66 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 119.443 -0.313 . . . . 0.0 111.067 169.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 60.88 56.67 22.87 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.161 -1.175 . . . . 0.0 110.161 -176.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.5 tt -51.48 139.83 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 124.424 1.09 . . . . 0.0 110.206 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -120.38 -48.1 2.32 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.697 0.799 . . . . 0.0 110.054 -169.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -154.71 151.68 29.02 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -151.78 141.87 22.21 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 126.508 1.923 . . . . 0.0 107.642 -173.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -151.57 150.71 30.63 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 168.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 mp -72.42 148.52 9.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 172.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -135.94 156.82 48.17 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.325 1.85 . . . . 0.0 107.455 175.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -129.21 144.98 51.41 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.901 1.28 . . . . 0.0 108.355 176.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.8 p -73.83 146.22 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 C-N-CA 124.283 1.033 . . . . 0.0 108.767 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -125.59 -28.94 3.23 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 126.558 1.943 . . . . 0.0 109.479 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -157.68 166.62 32.34 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.028 0.831 . . . . 0.0 110.67 170.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.6 mp -143.57 138.15 25.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 127.26 2.224 . . . . 0.0 106.58 -174.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -151.66 101.25 2.91 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 123.202 0.601 . . . . 0.0 109.721 169.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -57.79 146.18 86.95 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.917 2.411 . . . . 0.0 111.292 172.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -127.66 13.64 6.96 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.227 0.611 . . . . 0.0 112.207 -172.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 174.72 79.86 0.05 OUTLIER Glycine 0 C--N 1.338 0.689 0 O-C-N 121.199 -0.938 . . . . 0.0 111.511 -170.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.9 mmtt -57.46 -18.4 18.15 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -72.47 -14.37 61.66 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.8 0.727 . . . . 0.0 111.111 175.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -136.32 52.33 1.97 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 127.149 2.18 . . . . 0.0 106.108 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -50.05 -28.06 6.52 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.806 1.643 . . . . 0.0 114.783 -169.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -68.64 2.17 2.66 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 117.668 -1.158 . . . . 0.0 113.707 173.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.3 t -125.52 121.89 61.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 121.138 1.79 . . . . 0.0 107.596 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.3 m -147.15 158.25 43.88 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.888 0.875 . . . . 0.0 110.759 -173.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.5 ttp-105 -83.02 148.28 27.65 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 170.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.0 mt -139.41 154.12 47.74 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.7 2.0 . . . . 0.0 107.273 177.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -126.69 132.52 51.15 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 103.926 -2.62 . . . . 0.0 103.926 171.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 64.0 m -145.21 167.24 23.28 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.956 1.302 . . . . 0.0 111.154 -169.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -140.71 142.5 34.84 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.463 1.905 . . . . 0.0 108.081 -176.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 31.9 p -72.72 151.78 42.0 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 118.125 0.421 . . . . 0.0 111.092 177.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -83.55 -37.32 23.14 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 118.757 -0.64 . . . . 0.0 111.495 176.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.6 m -101.76 -17.61 16.17 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 -168.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -124.2 -102.16 0.38 Allowed 'General case' 0 C--N 1.342 0.252 0 CA-C-N 120.545 1.52 . . . . 0.0 110.542 -170.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -168.19 10.8 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.204 1.002 . . . . 0.0 113.003 -169.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 59.6 mtm -70.56 146.7 49.96 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.342 0.591 . . . . 0.0 110.158 -173.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -118.58 128.78 54.87 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 172.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.4 tp -133.34 139.18 46.69 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 123.598 0.759 . . . . 0.0 110.46 -169.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 14.8 mm -125.6 148.25 30.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 103.776 -2.675 . . . . 0.0 103.776 169.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.5 mt -150.21 144.68 25.77 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 126.346 1.858 . . . . 0.0 107.057 -171.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -131.58 94.62 3.56 Favored 'General case' 0 C--N 1.32 -0.694 1 N-CA-C 99.754 -4.165 . . . . 0.0 99.754 168.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.7 p -136.24 161.65 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-O 122.07 0.938 . . . . 0.0 112.536 -166.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.2 t30 -68.48 90.71 0.38 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.039 2.135 . . . . 0.0 109.057 169.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.6 pp -69.65 3.88 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -169.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -65.98 -11.68 49.46 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 120.854 1.661 . . . . 0.0 111.957 176.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 55.7 mt -59.51 -34.08 53.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 169.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -92.32 155.04 42.88 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 124.923 1.289 . . . . 0.0 108.426 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.04 -23.82 33.64 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.196 1.931 . . . . 0.0 112.526 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.0 t -145.81 153.97 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 -178.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -53.93 -28.94 40.13 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.445 1.098 . . . . 0.0 112.306 169.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 39.5 tp -56.64 -17.0 7.24 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.456 1.502 . . . . 0.0 112.903 173.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.88 173.67 49.71 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 124.011 0.815 . . . . 0.0 111.359 177.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -164.11 175.07 10.56 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.901 2.08 . . . . 0.0 106.497 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -67.43 147.25 53.12 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 169.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -150.03 -173.44 4.43 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.063 1.345 . . . . 0.0 107.711 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -132.95 148.08 52.28 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 119.136 0.88 . . . . 0.0 109.338 170.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.1 tt -118.88 143.21 47.11 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.5 t -139.34 155.46 26.04 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 C-N-CA 124.666 1.187 . . . . 0.0 109.694 -168.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.1 tt -129.72 148.35 33.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 127.725 2.41 . . . . 0.0 106.24 170.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -149.04 -168.16 3.03 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.939 1.295 . . . . 0.0 109.155 -173.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 37.1 m -145.05 51.85 1.22 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.51 1.524 . . . . 0.0 108.275 -174.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.2 m -43.87 105.29 0.05 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.569 1.947 . . . . 0.0 114.349 -169.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 19.6 tp -77.6 -13.53 59.89 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.45 1.1 . . . . 0.0 111.017 174.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -57.86 -24.62 58.36 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.016 -1.053 . . . . 0.0 111.786 174.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -68.94 -34.65 75.71 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.035 0.834 . . . . 0.0 111.333 174.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -72.63 -32.79 66.17 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 118.216 0.462 . . . . 0.0 110.331 174.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 124.6 41.79 0.37 Allowed Glycine 0 C--N 1.34 0.754 0 CA-C-O 118.4 -1.222 . . . . 0.0 113.65 169.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.84 -35.62 69.05 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 120.126 1.963 . . . . 0.0 111.734 -176.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.3 pp -76.03 -13.27 60.23 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -91.07 -30.11 16.94 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.966 0.803 . . . . 0.0 109.369 169.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -70.18 -22.56 62.94 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.081 0.952 . . . . 0.0 113.443 176.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 154.27 -15.51 0.58 Allowed Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.515 1.055 . . . . 0.0 115.237 169.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -80.6 40.96 0.53 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 119.471 1.636 . . . . 0.0 111.423 -173.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -74.74 75.28 2.07 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 120.86 -1.15 . . . . 0.0 109.189 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -59.3 127.41 84.23 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-O 118.088 -0.958 . . . . 0.0 109.388 -174.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -52.54 -31.37 48.72 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.216 2.61 . . . . 0.0 114.678 -177.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.99 -12.19 60.3 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.726 1.21 . . . . 0.0 111.784 -178.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -64.53 -19.84 65.86 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 120.585 -1.322 . . . . 0.0 111.814 175.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -135.76 4.24 3.04 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.201 1.0 . . . . 0.0 112.763 -176.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 67.5 mtt85 -127.1 128.24 24.18 Favored Pre-proline 0 N--CA 1.468 0.434 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER 23.36 58.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.683 1 C-N-CA 125.702 4.268 . . . . 0.0 113.665 -169.218 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.2 p -65.77 22.49 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 128.719 2.808 . . . . 0.0 116.787 -168.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.61 147.15 46.67 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 168.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.43 160.93 6.23 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.519 0.676 . . . . 0.0 110.125 174.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -159.45 -32.55 0.06 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.82 1.248 . . . . 0.0 111.038 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -53.01 -49.41 66.27 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.584 1.954 . . . . 0.0 109.127 169.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -146.8 167.81 22.96 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 127.6 2.36 . . . . 0.0 107.4 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -82.83 -31.29 28.15 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.703 0.683 . . . . 0.0 110.127 169.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -147.54 150.31 34.26 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.187 0.595 . . . . 0.0 109.663 177.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.2 t -143.62 138.88 25.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.08 169.56 23.24 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.894 0.855 . . . . 0.0 110.571 175.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -134.22 93.57 3.1 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 -171.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -92.62 -164.31 37.99 Favored Glycine 0 C--N 1.332 0.357 0 CA-C-O 121.682 0.601 . . . . 0.0 112.732 -169.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -134.04 111.93 10.78 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 169.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.7 t -69.84 149.0 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 169.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -143.34 58.59 1.39 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.556 0.742 . . . . 0.0 110.935 174.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -143.59 160.86 39.88 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.964 1.306 . . . . 0.0 109.878 174.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -83.5 -177.2 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 125.432 1.493 . . . . 0.0 109.723 169.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -64.08 -6.99 7.38 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.612 1.565 . . . . 0.0 114.847 -177.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 138.3 -61.81 0.58 Allowed Glycine 0 CA--C 1.52 0.406 0 N-CA-C 107.0 -2.44 . . . . 0.0 107.0 -172.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -147.49 -97.77 0.09 Allowed 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 125.045 1.338 . . . . 0.0 107.734 169.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -167.85 74.6 0.12 Allowed 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 124.295 1.038 . . . . 0.0 109.566 -170.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.2 t -150.15 -159.79 1.08 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 123.013 1.387 . . . . 0.0 111.756 -169.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.0 m -125.26 9.46 7.95 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 128.876 2.871 . . . . 0.0 109.481 169.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . 0.279 3.9 m 109.77 38.41 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 130.27 3.428 . . . . 0.0 108.232 170.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -139.91 -2.15 1.54 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.731 1.612 . . . . 0.0 112.278 -176.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -109.58 -46.29 3.55 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 169.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -111.61 149.21 31.81 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 111.991 -2.368 . . . . 0.0 107.676 167.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 32.8 p -128.64 -3.78 5.33 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -177.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -128.46 144.05 51.08 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 173.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 7.8 tt -92.83 149.08 21.51 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 168.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 10.7 p -116.0 146.0 42.5 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -139.42 100.18 3.92 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -95.66 128.19 42.32 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 101.65 -3.463 . . . . 0.0 101.65 169.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.7 t -140.02 137.7 38.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -169.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.7 t -117.45 137.82 52.26 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 170.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -150.15 105.63 3.39 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.609 0.764 . . . . 0.0 109.536 -171.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 61.27 22.44 60.94 Favored Glycine 0 CA--C 1.534 1.264 0 O-C-N 121.546 -0.721 . . . . 0.0 113.927 175.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.49 -13.58 65.34 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.499 1.047 . . . . 0.0 112.934 -177.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -85.59 164.13 17.93 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 169.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 7.8 tt -146.21 155.92 43.03 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 121.695 -0.628 . . . . 0.0 109.956 -171.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 23.4 ptm -150.42 161.01 43.34 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.394 1.077 . . . . 0.0 108.906 172.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 58.7 ttt-85 -135.96 127.44 28.65 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 104.978 -2.231 . . . . 0.0 104.978 172.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 25.5 tp -141.97 140.69 32.8 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -170.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -132.54 145.79 51.41 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 169.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -171.74 178.18 44.15 Favored Glycine 0 C--N 1.331 0.298 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 174.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.08 140.66 48.56 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 118.158 0.979 . . . . 0.0 109.221 172.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -52.27 -62.18 1.8 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.604 0.761 . . . . 0.0 112.613 -175.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.31 -24.08 66.48 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.117 0.871 . . . . 0.0 113.032 -174.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.37 -35.5 77.81 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 126.16 1.784 . . . . 0.0 109.774 174.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 16.9 tp -94.81 -19.2 20.53 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.713 0.805 . . . . 0.0 110.252 -175.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 42.58 42.2 2.7 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.669 1.988 . . . . 0.0 112.041 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -105.71 20.17 37.22 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.029 0.823 . . . . 0.0 112.458 -172.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -74.16 8.8 1.91 Allowed 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.25 1.025 . . . . 0.0 113.497 -178.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -131.79 131.11 42.64 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 169.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.9 p -57.65 -10.15 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 125.124 1.37 . . . . 0.0 110.857 169.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -123.56 12.71 9.33 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 126.002 1.721 . . . . 0.0 112.978 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 3.4 m -89.12 -58.98 2.35 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 167.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.6 tpm_? -75.55 2.07 12.66 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 115.466 -0.788 . . . . 0.0 113.031 -169.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 29.2 m -60.25 -37.98 75.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 124.422 1.089 . . . . 0.0 110.14 169.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -71.95 118.47 14.85 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 63.3 tp -138.88 120.65 15.32 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 -172.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.59 149.34 45.16 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -174.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 61.6 mtt -143.11 144.59 32.29 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -172.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -152.3 160.78 43.28 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -64.02 157.19 25.81 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 168.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.3 pp -67.21 165.36 16.27 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.242 0.544 . . . . 0.0 110.172 170.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -142.14 140.08 32.34 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 170.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 . . . . . 0 C--O 1.25 1.102 0 C-N-CA 126.392 1.877 . . . . 0.0 110.413 -176.312 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.4 mmm . . . . . 0 N--CA 1.474 0.757 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -56.28 145.46 26.74 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.241 0.616 . . . . 0.0 111.386 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -88.97 -162.64 38.69 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.747 1.165 . . . . 0.0 111.124 175.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.7 mm -135.92 144.61 32.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 171.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -49.85 116.34 1.76 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.613 1.165 . . . . 0.0 111.003 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -153.36 134.34 13.97 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 172.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -144.76 147.7 33.25 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.28 1.432 . . . . 0.0 108.08 -169.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -150.31 155.7 40.16 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.187 0.595 . . . . 0.0 109.434 169.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.3 mp -85.82 144.7 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 169.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -113.04 143.59 44.06 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.035 1.334 . . . . 0.0 107.68 171.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -117.06 122.83 45.29 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.878 1.671 . . . . 0.0 106.832 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.7 t -71.7 121.43 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -176.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.5 mmmt -96.61 -29.86 13.6 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.194 177.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -155.33 165.08 37.75 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.408 1.003 . . . . 0.0 111.459 175.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.4 mp -142.55 135.61 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 127.85 2.46 . . . . 0.0 105.756 -177.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -147.87 93.04 4.58 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 118.301 0.501 . . . . 0.0 111.155 178.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -61.16 144.77 99.18 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.911 2.407 . . . . 0.0 109.954 169.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -131.79 9.4 4.58 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -174.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.84 46.61 10.68 Favored Glycine 0 C--N 1.343 0.918 0 O-C-N 121.478 -0.764 . . . . 0.0 111.202 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.0 mmmm -73.03 25.97 0.06 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.289 1.436 . . . . 0.0 112.772 -171.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp 68.02 -59.84 0.42 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 128.497 2.719 . . . . 0.0 108.569 -168.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 4.8 m-30 -81.26 87.18 6.13 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 103.633 -2.729 . . . . 0.0 103.633 168.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -62.68 -17.58 60.85 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.285 -0.884 . . . . 0.0 112.656 -174.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 -66.54 -14.49 62.38 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 118.028 -0.987 . . . . 0.0 112.51 169.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 77.2 t -88.78 134.15 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 169.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.6 m -151.04 159.44 44.54 Favored 'General case' 0 C--O 1.239 0.542 0 O-C-N 120.928 -1.108 . . . . 0.0 109.981 -176.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.6 tpp85 -72.66 150.44 42.98 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 172.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.6 mt -138.14 157.19 46.81 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.923 1.689 . . . . 0.0 107.247 172.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -135.46 133.57 38.69 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 169.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 33.7 m -141.11 166.11 25.68 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.242 1.417 . . . . 0.0 110.087 -174.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -134.87 143.47 47.0 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 172.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.1 p -83.85 145.47 28.62 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 118.762 0.71 . . . . 0.0 110.255 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -80.57 -32.05 36.7 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -169.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.9 m -102.62 -34.21 9.16 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.138 0.881 . . . . 0.0 111.75 -171.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -121.71 10.28 10.29 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.669 1.187 . . . . 0.0 112.712 -170.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.315 0.0 OUTLIER 43.11 39.19 1.78 Allowed 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.915 2.086 . . . . 0.0 114.371 174.637 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 62.5 mtm -63.64 154.08 34.02 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 169.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -112.46 127.77 56.13 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 176.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 59.3 tp -137.81 144.9 41.74 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.78 0.8 . . . . 0.0 110.437 -169.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 35.6 mm -127.83 149.12 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 128.479 2.712 . . . . 0.0 103.737 169.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 123' ' ' MET . 2.0 mp -143.63 161.08 39.46 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 126.201 1.801 . . . . 0.0 108.254 176.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -138.48 94.59 2.87 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 102.312 -3.218 . . . . 0.0 102.312 168.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.7 m -144.15 168.74 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 124.36 1.064 . . . . 0.0 111.295 -168.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -60.03 134.2 56.81 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.041 0.936 . . . . 0.0 110.149 170.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 pp -116.51 2.14 7.88 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.445 0 C-N-CA 125.372 1.469 . . . . 0.0 112.966 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -64.77 -12.24 45.37 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 121.367 1.894 . . . . 0.0 113.248 -172.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 66.2 mt -58.95 -22.53 21.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 125.891 1.676 . . . . 0.0 108.816 169.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -127.38 167.05 19.19 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 128.531 2.733 . . . . 0.0 109.426 -178.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -52.17 157.27 6.59 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.664 2.242 . . . . 0.0 111.875 169.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.7 m -59.57 -10.77 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 N-CA-C 115.573 1.694 . . . . 0.0 115.573 -169.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -139.9 27.5 2.2 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.761 1.224 . . . . 0.0 110.55 -177.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 25.7 tp -140.89 163.16 33.7 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.235 -0.916 . . . . 0.0 110.753 -173.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -165.37 167.81 39.08 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 128.068 2.747 . . . . 0.0 106.405 171.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -141.77 -64.06 0.44 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 118.705 1.252 . . . . 0.0 111.788 -178.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -148.32 162.7 38.99 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.419 1.009 . . . . 0.0 111.159 178.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -145.27 171.34 14.71 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.54 1.936 . . . . 0.0 107.415 170.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -136.02 123.47 22.07 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.5 mp -125.15 146.44 49.49 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -169.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -157.01 128.25 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 121.839 0.828 . . . . 0.0 108.775 -169.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.0 tp -69.16 -32.46 54.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 123.508 0.723 . . . . 0.0 109.945 174.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 57.55 175.43 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.845 2.058 . . . . 0.0 112.787 -172.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.6 m -81.67 5.66 17.62 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.654 -0.654 . . . . 0.0 112.231 172.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.9 m 62.66 -179.18 0.14 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.45 1.5 . . . . 0.0 110.782 -177.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -126.83 11.15 7.15 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.514 1.126 . . . . 0.0 113.505 -170.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 42.5 56.21 3.87 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.284 1.834 . . . . 0.0 113.554 171.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -59.92 -20.7 58.85 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.022 0.929 . . . . 0.0 111.748 176.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -61.86 -25.61 67.64 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.301 1.04 . . . . 0.0 111.893 176.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 151.11 -28.24 1.0 Allowed Glycine 0 C--N 1.34 0.765 0 CA-C-O 119.121 -0.822 . . . . 0.0 113.623 169.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -58.78 -27.97 65.5 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.454 1.127 . . . . 0.0 113.923 -168.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 98.3 mt -121.5 -19.27 6.98 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.201 0.91 . . . . 0.0 112.421 171.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -60.46 -27.65 67.7 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 119.277 0.944 . . . . 0.0 111.043 172.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -64.83 -9.81 23.55 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.24 1.416 . . . . 0.0 114.612 177.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -136.76 -0.54 2.85 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 125.362 1.458 . . . . 0.0 113.193 178.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 45.33 41.51 6.39 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.067 1.747 . . . . 0.0 111.23 -173.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -63.24 118.03 7.4 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -156.04 103.91 2.09 Favored Pre-proline 0 N--CA 1.452 -0.346 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -173.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -54.3 -23.09 28.9 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.292 2.661 . . . . 0.0 114.633 177.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.5 m 50.26 36.63 13.1 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.9 1.68 . . . . 0.0 110.851 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -77.83 64.76 3.14 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.282 1.433 . . . . 0.0 111.452 -169.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -152.25 -49.05 0.11 Allowed 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 125.992 1.717 . . . . 0.0 109.002 174.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -66.09 -45.26 62.36 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-O 117.12 -1.419 . . . . 0.0 113.401 -177.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -89.34 18.34 1.45 Allowed 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.149 2.566 . . . . 0.0 111.71 176.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.7 m -135.69 -168.55 2.23 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.125 1.77 . . . . 0.0 108.656 -169.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -64.37 109.54 1.95 Allowed 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 169.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.05 24.11 0.1 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.887 1.275 . . . . 0.0 112.468 -176.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -82.32 35.26 0.44 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.362 1.465 . . . . 0.0 111.462 -174.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 41.94 53.55 4.14 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 129.38 3.072 . . . . 0.0 114.066 175.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -75.35 38.27 0.14 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.35 1.46 . . . . 0.0 110.846 169.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -164.29 124.93 2.12 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.494 1.117 . . . . 0.0 109.114 172.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -148.69 154.17 39.27 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 168.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.7 m -137.18 151.93 27.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 O-C-N 121.538 -0.726 . . . . 0.0 110.215 -171.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 37.5 ttm -152.84 161.92 41.94 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.597 1.559 . . . . 0.0 107.353 176.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -136.85 151.72 49.44 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -173.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.18 -157.51 8.58 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 120.908 -0.663 . . . . 0.0 114.366 -169.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -144.82 123.72 12.71 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.772 1.629 . . . . 0.0 107.146 176.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.9 t -77.89 141.89 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 169.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -140.09 64.89 1.43 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.857 1.263 . . . . 0.0 110.057 177.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -154.17 167.52 29.58 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.245 -1.535 . . . . 0.0 112.415 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.9 pt -83.4 -177.12 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 127.249 2.22 . . . . 0.0 112.21 -170.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -74.5 -3.15 29.09 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.742 1.617 . . . . 0.0 114.115 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 56.44 42.2 89.21 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.338 0.97 . . . . 0.0 112.537 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -143.42 65.5 1.32 Allowed 'General case' 0 C--O 1.233 0.214 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 172.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -143.64 95.27 2.72 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.513 1.125 . . . . 0.0 108.768 -171.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -65.17 146.39 55.03 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 168.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 84.3 p 121.46 -15.41 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 130.99 3.716 . . . . 0.0 109.707 169.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.6 29.95 3.2 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.331 0.653 . . . . 0.0 109.684 169.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 47.27 43.84 15.32 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.103 1.761 . . . . 0.0 111.702 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -114.78 39.54 2.82 Favored 'General case' 0 C--N 1.342 0.261 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -102.85 -2.98 26.95 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -168.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 72.7 p -134.85 158.27 44.66 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 125.382 1.473 . . . . 0.0 108.537 169.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? 58.87 120.28 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 127.799 2.44 . . . . 0.0 111.652 -173.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 55.3 tp -57.98 144.28 40.11 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 170.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.6 p -123.65 149.03 45.91 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.473 1.109 . . . . 0.0 109.8 -173.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -148.38 108.15 4.01 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.575 1.15 . . . . 0.0 108.373 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 7.6 m-30 -91.57 122.63 34.32 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 102.379 -3.193 . . . . 0.0 102.379 168.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.0 t -129.71 112.75 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -169.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.2 p -88.24 128.77 35.47 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 104.767 -2.308 . . . . 0.0 104.767 169.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.39 134.35 20.27 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 118.711 0.687 . . . . 0.0 109.631 -172.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 47.21 33.19 7.34 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 124.646 1.117 . . . . 0.0 115.188 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 76.51 17.07 80.23 Favored Glycine 0 CA--C 1.536 1.399 0 CA-C-N 118.716 1.258 . . . . 0.0 113.682 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 93.8 mt -129.2 178.65 6.28 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 128.284 2.633 . . . . 0.0 107.283 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 58.3 tp -139.13 154.15 48.08 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 120.837 -1.164 . . . . 0.0 111.539 -171.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' MET . . . . . 0.409 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 76.5 mtm -143.43 156.16 44.58 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.777 2.031 . . . . 0.0 107.901 169.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -137.54 117.93 13.73 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 169.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 51.3 tp -125.59 148.95 48.76 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 125.943 1.697 . . . . 0.0 109.789 -168.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -139.74 148.81 42.81 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.222 1.409 . . . . 0.0 108.448 169.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -165.59 165.17 37.77 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 173.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -71.87 86.7 0.98 Allowed 'General case' 0 N--CA 1.463 0.205 0 O-C-N 122.059 -0.671 . . . . 0.0 110.301 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . 22.85 -77.45 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 130.436 3.494 . . . . 0.0 115.242 -170.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -13.13 16.3 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 11.3 m-20 -85.74 -36.16 20.33 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.972 1.709 . . . . 0.0 109.323 176.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 9.2 tt -72.64 -29.97 63.91 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 170.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 1.8 t60 54.99 45.52 26.24 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.606 1.962 . . . . 0.0 112.069 169.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -152.04 68.49 0.32 Allowed Glycine 0 C--N 1.335 0.484 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 -175.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -73.4 3.55 5.83 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.233 1.013 . . . . 0.0 113.728 -174.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.422 ' C ' ' H ' ' A' ' 138' ' ' ASP . 51.1 mt-10 -129.13 145.35 51.32 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.366 1.866 . . . . 0.0 108.513 172.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 7.8 m -66.32 -1.04 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.098 168.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.422 ' H ' ' C ' ' A' ' 136' ' ' GLU . 28.7 t70 -123.16 15.36 9.84 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 127.746 2.419 . . . . 0.0 111.447 177.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 75.3 m -80.95 -70.5 0.53 Allowed 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.463 -0.773 . . . . 0.0 109.366 168.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.316 1.8 ptp180 -81.56 15.14 2.21 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -169.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 30.3 m -70.97 -12.24 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 167.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -109.27 120.77 43.52 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 103.232 -2.877 . . . . 0.0 103.232 168.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -136.75 130.5 32.07 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -172.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 7.5 tt -117.83 139.47 51.06 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 176.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 19.6 ptt? -144.83 162.11 37.61 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 121.327 -0.858 . . . . 0.0 109.733 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 78.8 mttt -152.86 166.64 31.66 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.759 1.623 . . . . 0.0 108.635 -169.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -71.17 167.69 18.82 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 167.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.34 157.26 8.84 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.173 0.511 . . . . 0.0 110.81 169.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -147.76 123.37 10.47 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 171.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 . . . . . 0 C--O 1.248 0.982 0 C-N-CA 125.995 1.718 . . . . 0.0 107.162 178.092 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 ttt . . . . . 0 N--CA 1.485 1.317 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -48.22 148.79 1.7 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.928 0.891 . . . . 0.0 111.195 170.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -63.63 -26.06 69.45 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 123.646 0.641 . . . . 0.0 113.461 -171.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.2 tp -143.08 169.02 12.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 125.772 1.629 . . . . 0.0 107.127 171.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -144.6 136.14 25.58 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -177.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -142.87 163.58 32.41 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.006 1.322 . . . . 0.0 107.682 169.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -139.31 124.14 18.63 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 103.878 -2.638 . . . . 0.0 103.878 174.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -142.35 131.97 23.95 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.418 0.687 . . . . 0.0 109.357 -171.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.8 mp -81.79 129.15 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 177.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -96.69 153.03 18.1 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.651 1.581 . . . . 0.0 108.065 175.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -132.27 114.99 15.09 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 126.083 1.753 . . . . 0.0 106.999 172.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 68.9 t -71.47 122.19 23.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 177.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.0 mmmt -85.21 -41.35 15.7 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 173.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -158.6 166.56 31.79 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.305 0.502 . . . . 0.0 111.73 -173.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.4 mp -137.05 141.21 41.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 127.756 2.422 . . . . 0.0 106.481 -175.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -145.59 89.2 6.31 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 124.45 1.1 . . . . 0.0 110.485 -171.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -66.32 142.23 65.52 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.92 3.08 . . . . 0.0 111.352 170.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -78.37 -38.39 41.94 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.942 -0.474 . . . . 0.0 111.597 177.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 147.38 47.48 0.03 OUTLIER Glycine 0 CA--C 1.527 0.829 0 N-CA-C 104.932 -3.267 . . . . 0.0 104.932 -169.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -63.15 120.49 11.59 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.213 1.405 . . . . 0.0 113.468 -167.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.413 ' HA ' ' HE3' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -64.97 -46.93 79.44 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.164 168.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -80.63 -19.21 45.89 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.08 0.552 . . . . 0.0 112.351 -174.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.7 t70 47.12 39.08 7.52 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.99 2.116 . . . . 0.0 113.956 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -142.64 8.25 1.73 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 176.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.7 t -139.24 133.4 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 73.1 m -156.43 168.17 28.18 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 120.786 1.63 . . . . 0.0 110.48 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.1 ttm105 -72.19 149.3 44.76 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 169.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.88 158.09 45.25 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 125.786 1.634 . . . . 0.0 107.755 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -133.31 125.48 29.32 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 174.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 58.5 m -141.89 169.59 17.3 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.947 1.299 . . . . 0.0 111.004 -169.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.1 tt0 -143.78 145.0 32.05 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 125.267 1.427 . . . . 0.0 108.118 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.3 m -75.68 131.48 39.92 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 123.285 0.634 . . . . 0.0 109.939 169.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -80.28 -19.6 46.34 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.557 0.743 . . . . 0.0 111.011 170.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.23 -36.07 3.03 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -169.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -115.38 21.53 14.0 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.527 1.131 . . . . 0.0 112.243 -177.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt 42.96 18.03 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 118.685 2.846 . . . . 0.0 118.685 172.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 68.7 mtm -67.72 151.08 47.82 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.868 1.213 . . . . 0.0 108.534 174.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -112.35 127.69 56.08 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 104.613 -2.365 . . . . 0.0 104.613 171.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.5 mp -136.21 150.89 49.19 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 119.094 0.861 . . . . 0.0 112.614 -168.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 46.2 mm -123.1 144.5 32.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 102.812 -3.033 . . . . 0.0 102.812 168.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.8 mp -143.32 160.66 40.1 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 127.347 2.259 . . . . 0.0 107.455 -169.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -140.2 102.68 4.42 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 102.487 -3.153 . . . . 0.0 102.487 168.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.4 m -144.52 169.35 9.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 C-N-CA 124.203 1.001 . . . . 0.0 111.567 -168.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -65.43 136.06 56.01 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 169.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.8 pp -112.33 7.66 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 124.507 1.123 . . . . 0.0 112.686 -175.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -59.72 -23.14 62.93 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 121.541 -0.725 . . . . 0.0 110.675 169.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.1 mt -68.89 -26.83 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 126.127 1.771 . . . . 0.0 109.839 173.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -127.92 68.16 74.99 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 126.01 1.724 . . . . 0.0 109.02 -170.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -73.41 6.4 2.71 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.676 2.917 . . . . 0.0 114.464 -169.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.6 m -136.87 148.89 26.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 C-N-CA 124.934 1.293 . . . . 0.0 108.862 -174.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -60.57 -25.97 66.58 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.613 1.165 . . . . 0.0 112.349 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 52.7 tp -60.95 -23.92 65.68 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.652 1.181 . . . . 0.0 112.314 174.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.42 -168.08 46.22 Favored Glycine 0 CA--C 1.532 1.123 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -169.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -153.07 173.59 15.26 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.332 1.053 . . . . 0.0 108.281 176.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -94.46 152.46 18.57 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.566 0.746 . . . . 0.0 109.016 169.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -151.92 -177.0 5.88 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.246 1.418 . . . . 0.0 107.911 -173.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 10.7 ttp180 -136.65 146.29 45.81 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 120.929 -1.107 . . . . 0.0 108.661 177.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.0 tt -127.65 145.59 50.83 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.662 1.585 . . . . 0.0 107.883 176.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -145.59 166.91 9.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 127.342 2.257 . . . . 0.0 105.921 -174.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 46.4 pt -129.09 27.1 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 O-C-N 121.297 -0.877 . . . . 0.0 111.389 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -83.58 13.18 4.78 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.882 1.273 . . . . 0.0 113.773 -174.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.1 m -64.06 6.8 0.16 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 116.589 2.07 . . . . 0.0 116.589 -169.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.37 35.07 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 56.1 tp -60.4 -24.42 65.12 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 120.82 -1.175 . . . . 0.0 108.635 168.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 39.2 t80 76.05 166.32 0.26 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 128.814 2.845 . . . . 0.0 111.837 169.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -75.65 41.69 0.21 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.245 1.818 . . . . 0.0 110.222 170.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -62.13 -22.35 65.77 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.812 1.645 . . . . 0.0 113.635 -169.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -66.33 -2.67 15.5 Favored Glycine 0 CA--C 1.532 1.128 0 CA-C-O 119.069 -0.85 . . . . 0.0 113.698 170.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 57.9 m -64.15 -30.19 71.27 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.158 1.479 . . . . 0.0 108.834 169.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 73.8 mt -71.44 131.7 43.72 Favored 'General case' 0 C--N 1.343 0.302 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 169.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -75.42 60.82 1.19 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.222 1.409 . . . . 0.0 113.575 -169.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -145.15 13.51 1.43 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.403 1.081 . . . . 0.0 111.006 169.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.17 -32.6 3.01 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 126.502 2.001 . . . . 0.0 111.593 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -168.57 155.97 7.73 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 128.98 2.912 . . . . 0.0 105.225 177.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -139.87 23.09 2.45 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.452 1.101 . . . . 0.0 110.608 -175.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -130.17 81.03 69.6 Favored Pre-proline 0 C--O 1.233 0.219 0 C-N-CA 125.331 1.452 . . . . 0.0 107.64 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -62.64 -17.11 56.98 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.194 1.929 . . . . 0.0 111.856 176.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.5 m -55.05 -21.91 14.02 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.723 1.609 . . . . 0.0 112.509 171.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -67.21 -16.68 64.44 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 119.575 1.08 . . . . 0.0 112.776 172.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -124.79 -30.78 3.25 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.044 1.337 . . . . 0.0 112.567 -175.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 -58.69 123.18 66.4 Favored Pre-proline 0 N--CA 1.467 0.408 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 171.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER 23.86 45.94 0.0 OUTLIER 'Trans proline' 0 CA--C 1.539 0.748 1 C-N-CA 126.711 4.941 . . . . 0.0 116.72 -168.904 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.6 m -149.79 160.32 43.65 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.138 1.775 . . . . 0.0 108.645 -175.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 85.4 mtt85 -145.92 172.52 13.24 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.632 1.173 . . . . 0.0 108.671 -177.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.88 -13.22 22.61 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 171.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -49.82 -16.66 0.28 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.033 2.133 . . . . 0.0 113.891 172.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -50.19 -27.67 6.26 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.318 1.047 . . . . 0.0 112.441 169.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -146.3 171.72 14.55 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.493 1.517 . . . . 0.0 110.893 -178.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -120.05 -33.57 3.91 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 169.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -144.75 144.87 31.41 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.198 1.799 . . . . 0.0 106.209 169.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.7 p -148.72 141.27 18.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -178.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 31.9 tpp -159.34 173.63 15.98 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.51 1.124 . . . . 0.0 110.457 -171.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -134.82 147.78 50.02 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 127.265 2.226 . . . . 0.0 106.924 -173.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -158.38 -157.2 8.35 Favored Glycine 0 C--N 1.338 0.692 0 CA-C-N 119.171 0.896 . . . . 0.0 113.857 -171.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -133.39 125.8 29.88 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 125.665 1.586 . . . . 0.0 106.767 173.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 84.3 t -93.19 150.64 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 175.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -134.94 154.46 51.69 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 126.625 1.97 . . . . 0.0 105.984 175.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.76 162.03 39.77 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.632 1.105 . . . . 0.0 111.423 171.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 24.5 pt -80.35 177.67 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 O-C-N 123.973 0.796 . . . . 0.0 108.937 169.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -76.95 -3.27 38.0 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.72 1.208 . . . . 0.0 113.683 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 89.4 3.84 74.63 Favored Glycine 0 C--N 1.339 0.725 0 CA-C-O 119.328 -0.707 . . . . 0.0 112.614 -176.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -123.78 125.44 44.71 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 118.651 1.225 . . . . 0.0 108.683 169.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -138.82 42.64 2.12 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 169.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -138.12 -46.01 0.52 Allowed 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.25 1.02 . . . . 0.0 109.624 -169.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.3 p -177.2 -58.17 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.082 1.353 . . . . 0.0 109.372 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 175.08 -22.39 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 130.659 3.583 . . . . 0.0 107.8 -169.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -63.25 -20.12 65.16 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.158 0.983 . . . . 0.0 113.536 -174.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 84.98 113.55 0.05 Allowed 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 129.731 3.212 . . . . 0.0 106.589 -178.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.87 162.17 19.58 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.753 -170.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.4 p -71.29 -6.21 38.11 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -177.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -136.44 144.64 44.55 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.797 1.239 . . . . 0.0 108.773 169.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.1 tp -88.82 152.96 21.44 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 167.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 14.3 m -126.46 145.16 50.6 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 118.294 0.497 . . . . 0.0 109.822 177.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -146.46 160.04 42.61 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.748 1.219 . . . . 0.0 110.213 -172.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -130.38 158.56 39.51 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 169.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.0 p -149.27 136.2 13.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 169.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.9 t -123.75 129.16 50.64 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 178.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -150.42 122.67 8.36 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 123.859 0.863 . . . . 0.0 109.381 -169.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 54.28 21.64 19.83 Favored Glycine 0 CA--C 1.538 1.527 0 CA-C-O 119.158 -0.801 . . . . 0.0 114.899 178.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 92.7 -4.52 75.93 Favored Glycine 0 CA--C 1.536 1.347 0 CA-C-N 118.735 1.267 . . . . 0.0 113.797 -177.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -95.15 164.13 13.0 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 118.975 1.387 . . . . 0.0 108.229 171.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 39.9 tp -143.85 155.45 44.12 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 122.939 0.495 . . . . 0.0 110.693 -169.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 15.3 mtt -144.04 152.11 40.56 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.891 1.676 . . . . 0.0 106.649 168.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 74.5 mtm180 -137.91 135.26 35.93 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 104.948 -2.241 . . . . 0.0 104.948 169.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -155.49 167.37 30.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 119.335 0.971 . . . . 0.0 112.975 -169.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -134.42 159.72 40.2 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.118 1.367 . . . . 0.0 107.562 168.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -172.06 164.18 36.66 Favored Glycine 0 CA--C 1.516 0.148 0 N-CA-C 108.213 -1.955 . . . . 0.0 108.213 171.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.19 137.66 51.42 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 172.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -45.13 -60.26 2.19 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -169.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.18 -4.98 36.29 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -178.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -92.62 -21.46 20.03 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 125.386 1.475 . . . . 0.0 110.756 170.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.8 tt -68.13 -23.85 64.94 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 119.53 1.059 . . . . 0.0 109.204 171.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 1.4 t60 44.1 34.47 0.98 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 128.348 2.659 . . . . 0.0 114.54 168.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 179.97 42.55 0.08 OUTLIER Glycine 0 C--N 1.336 0.574 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 -171.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -65.76 -14.81 62.07 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 117.618 0.709 . . . . 0.0 112.535 172.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -61.68 103.81 0.37 Allowed 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 127.418 2.287 . . . . 0.0 108.24 169.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 13.8 m -53.98 -9.86 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 126.969 2.107 . . . . 0.0 113.307 173.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -133.35 23.15 4.07 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.344 1.058 . . . . 0.0 113.402 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 24.7 m -106.58 -58.15 1.96 Allowed 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 119.004 -0.522 . . . . 0.0 110.402 168.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.396 16.0 ptm180 -75.88 11.88 1.27 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.223 0.919 . . . . 0.0 113.24 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 16.9 m -63.0 -39.15 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 167.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -70.09 119.39 14.23 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 170.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.3 tt -136.37 134.6 38.01 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -177.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.6 tt -143.97 140.43 29.64 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 -173.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 25.3 ptp -140.92 154.21 46.01 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 119.229 0.922 . . . . 0.0 110.619 173.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -159.24 160.63 35.53 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 126.352 1.861 . . . . 0.0 107.656 -176.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -54.49 159.0 2.22 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 118.847 0.749 . . . . 0.0 110.581 169.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.57 166.04 19.81 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.819 0.342 . . . . 0.0 110.58 169.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -142.73 36.31 1.44 Allowed 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.611 1.165 . . . . 0.0 110.299 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 43.1 t80 . . . . . 0 C--O 1.249 1.054 0 C-N-CA 124.62 1.168 . . . . 0.0 108.166 -174.335 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 ttt . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.18 150.55 42.64 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.135 0.493 . . . . 0.0 111.29 177.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -154.58 8.45 0.37 Allowed Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.55 1.071 . . . . 0.0 112.967 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.02 170.13 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 126.899 2.08 . . . . 0.0 107.328 -178.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.9 tt -118.7 148.41 42.8 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 124.376 1.07 . . . . 0.0 110.329 -172.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -143.34 143.89 31.86 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 126.837 2.055 . . . . 0.0 106.002 169.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -150.6 134.82 17.0 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.195 1.398 . . . . 0.0 107.36 172.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -154.94 151.64 28.77 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.673 0.67 . . . . 0.0 109.943 169.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.1 mp -81.92 156.73 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 170.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -139.7 151.52 45.95 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.064 0.946 . . . . 0.0 108.745 169.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -117.2 126.33 52.6 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 125.518 1.527 . . . . 0.0 107.603 -176.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -70.64 128.22 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 176.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.6 mmmt -95.8 -35.71 11.41 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.476 1.111 . . . . 0.0 109.403 173.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -158.02 167.72 29.11 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 118.983 0.811 . . . . 0.0 111.307 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.9 mp -138.85 144.43 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 127.036 2.134 . . . . 0.0 107.244 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -145.29 92.58 5.6 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 126.814 2.046 . . . . 0.0 108.276 -176.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -55.26 156.05 18.02 Favored 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 124.081 3.187 . . . . 0.0 114.162 -178.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -77.81 45.78 0.53 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.425 1.49 . . . . 0.0 112.093 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.92 35.71 64.53 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 124.471 1.034 . . . . 0.0 113.54 169.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt 47.44 19.73 0.15 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.027 2.131 . . . . 0.0 114.167 -171.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.17 -34.88 56.31 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 121.084 -1.01 . . . . 0.0 109.813 170.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -138.09 87.23 2.23 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 -177.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -55.06 -36.94 66.12 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.072 0.949 . . . . 0.0 113.341 -169.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -90.1 14.55 12.15 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 117.962 -1.018 . . . . 0.0 112.967 -178.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.7 t -127.34 140.93 47.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-N 120.821 1.646 . . . . 0.0 107.522 -176.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.6 m -151.87 151.67 31.6 Favored 'General case' 0 C--O 1.239 0.518 0 O-C-N 121.33 -0.856 . . . . 0.0 111.05 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 36.6 ttp180 -80.66 145.81 31.44 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 104.554 -2.387 . . . . 0.0 104.554 168.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.1 mp -134.09 158.44 43.6 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 125.923 1.689 . . . . 0.0 106.453 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -125.86 130.59 51.66 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 169.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 58.3 m -141.94 173.27 11.67 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.06 1.344 . . . . 0.0 109.796 -170.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -140.69 131.23 25.44 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 171.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.1 m -71.73 134.63 46.37 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 175.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -71.11 -35.23 71.7 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.62 1.168 . . . . 0.0 113.62 -169.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.72 -16.85 6.57 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -169.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -121.11 48.22 1.69 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.854 0.862 . . . . 0.0 112.168 -169.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt 30.34 64.37 0.16 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.582 1.953 . . . . 0.0 113.328 168.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 20.6 mtm -137.45 117.6 13.49 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 118.355 0.525 . . . . 0.0 110.474 -176.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -82.95 133.23 35.12 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 168.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -134.67 148.1 50.27 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.989 0.899 . . . . 0.0 113.045 -168.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 38.3 mm -130.14 141.97 44.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 101.237 -3.616 . . . . 0.0 101.237 168.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 53.0 tp -146.91 152.72 39.14 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 126.799 2.04 . . . . 0.0 107.096 -168.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -146.43 109.64 4.72 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 173.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.8 m -150.01 169.79 2.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 122.032 0.92 . . . . 0.0 112.13 -169.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 43.1 t-20 -64.5 130.51 44.0 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.15 1.38 . . . . 0.0 107.966 169.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.3 pp -105.68 0.94 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 124.48 1.112 . . . . 0.0 112.982 -177.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -68.43 -16.37 63.88 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 120.249 1.386 . . . . 0.0 111.064 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.7 mt -62.39 -34.16 62.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 125.275 1.43 . . . . 0.0 109.337 171.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -91.32 159.11 39.97 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 124.754 1.222 . . . . 0.0 110.868 -169.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.71 179.25 3.25 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.462 2.774 . . . . 0.0 111.537 175.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.4 m -59.75 -16.52 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.84 1.256 . . . . 0.0 113.742 -177.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -67.69 -7.35 26.27 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.752 0.821 . . . . 0.0 112.476 170.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.5 tp 72.36 7.5 5.67 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 128.232 2.613 . . . . 0.0 113.389 174.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -167.23 164.47 37.91 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 108.289 -1.925 . . . . 0.0 108.289 174.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -161.34 168.61 23.61 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.769 1.627 . . . . 0.0 107.132 174.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -64.71 138.25 58.28 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 169.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -140.9 176.31 8.91 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -177.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.7 ttp180 -135.56 142.51 45.36 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -173.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 tt -121.09 140.43 51.97 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 126.149 1.78 . . . . 0.0 107.02 -176.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.0 t -143.05 166.81 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 126.995 2.118 . . . . 0.0 106.051 -178.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 30.0 pt -119.59 13.45 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 123.568 0.747 . . . . 0.0 112.27 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.24 25.36 0.13 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.081 1.353 . . . . 0.0 113.182 -175.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.2 m -67.57 -9.77 45.77 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.628 1.571 . . . . 0.0 113.808 -173.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.0 t -146.61 169.88 18.07 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.862 0.865 . . . . 0.0 109.353 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 29.6 tp -63.51 111.05 2.18 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.444 1.097 . . . . 0.0 108.213 171.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -59.1 137.69 57.85 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 169.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -69.06 -13.82 62.66 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 177.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -71.46 141.88 50.22 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.144 0.978 . . . . 0.0 110.857 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -49.83 -23.5 5.25 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.66 1.6 . . . . 0.0 114.945 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 32.4 m -56.01 -27.46 53.08 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.483 1.641 . . . . 0.0 111.452 177.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 88.9 mt -122.98 -36.3 2.89 Favored 'General case' 0 C--N 1.343 0.291 0 C-N-CA 123.548 0.739 . . . . 0.0 111.056 171.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -67.31 -19.73 65.51 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 118.862 0.756 . . . . 0.0 112.524 -177.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -128.95 31.53 4.9 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.115 1.766 . . . . 0.0 108.399 170.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.03 28.8 2.23 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 126.396 1.95 . . . . 0.0 110.702 -175.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 59.89 12.95 3.32 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.191 1.796 . . . . 0.0 113.671 169.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER 52.39 25.37 3.45 Favored 'General case' 0 CA--C 1.55 0.961 0 O-C-N 121.28 -0.888 . . . . 0.0 110.082 -168.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -156.09 78.27 4.31 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 125.122 1.369 . . . . 0.0 109.54 -169.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -79.49 54.68 5.3 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 124.02 3.147 . . . . 0.0 108.421 169.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . 0.251 33.1 p 64.82 11.61 7.05 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.476 2.31 . . . . 0.0 112.829 -169.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -63.05 -34.0 76.65 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 124.839 1.256 . . . . 0.0 112.358 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -135.16 5.98 3.31 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.457 1.103 . . . . 0.0 112.514 -169.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.15 139.09 65.39 Favored Pre-proline 0 N--CA 1.468 0.427 0 CA-C-O 117.592 -1.194 . . . . 0.0 108.357 176.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . 0.282 0.1 OUTLIER 3.19 69.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.555 1 C-N-CA 127.892 5.728 . . . . 0.0 117.291 -169.141 . . . . . . . . 4 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.5 m -145.52 154.15 41.89 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.313 1.845 . . . . 0.0 108.429 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -71.07 149.34 46.62 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 169.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.41 108.8 2.08 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -145.89 1.45 0.88 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.704 1.602 . . . . 0.0 111.519 -174.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -72.0 0.36 9.58 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.134 1.374 . . . . 0.0 113.22 -175.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -146.47 161.44 40.41 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 126.463 1.905 . . . . 0.0 108.541 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -122.36 -23.46 5.25 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.105 0.562 . . . . 0.0 110.729 172.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -145.66 149.45 34.49 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.804 1.242 . . . . 0.0 107.701 169.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.2 m -143.4 148.2 19.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 C-N-CA 125.621 1.568 . . . . 0.0 107.365 172.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 23.1 tpp -159.45 168.05 27.21 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.872 0.869 . . . . 0.0 109.207 176.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 84.7 t80 -128.5 150.52 50.13 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.809 1.643 . . . . 0.0 106.806 172.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -152.92 -160.06 9.43 Favored Glycine 0 C--N 1.336 0.569 0 CA-C-N 118.636 0.653 . . . . 0.0 113.672 -171.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -145.69 132.43 20.01 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.995 1.318 . . . . 0.0 108.771 172.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 42.2 t -77.14 145.57 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 168.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -144.87 74.94 1.43 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.057 1.743 . . . . 0.0 108.894 175.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -152.72 157.77 41.35 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.223 -0.923 . . . . 0.0 109.588 176.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 25.2 pt -76.99 -170.27 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 125.804 1.642 . . . . 0.0 111.356 177.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.63 -9.79 1.31 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 127.406 2.282 . . . . 0.0 115.47 -178.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 155.3 -91.7 0.12 Allowed Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 107.525 -2.23 . . . . 0.0 107.525 -174.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -149.68 28.59 0.78 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.454 1.101 . . . . 0.0 111.381 175.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 72.75 76.12 0.15 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 127.697 2.399 . . . . 0.0 111.447 176.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.288 0.0 OUTLIER 64.84 163.4 0.14 Allowed 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 117.996 2.591 . . . . 0.0 117.996 169.626 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.3 p -153.51 -43.49 0.09 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.805 2.442 . . . . 0.0 106.663 169.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 21.1 p -128.69 -55.24 1.23 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.917 1.287 . . . . 0.0 109.962 173.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -145.94 -16.27 0.46 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.371 1.068 . . . . 0.0 112.877 -174.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -159.29 156.99 29.7 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 131.481 3.912 . . . . 0.0 101.353 170.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.47 148.3 46.11 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 120.09 1.314 . . . . 0.0 108.644 174.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.21 -6.82 25.56 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -169.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -137.43 139.81 40.89 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 169.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 46.2 tp -75.96 159.5 30.81 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 168.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 16.6 m -134.98 150.65 50.39 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 175.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -142.13 128.79 20.36 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -112.52 129.76 56.24 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 168.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.6 p -146.72 144.91 19.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -169.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.3 t -134.53 144.01 47.75 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -136.9 82.62 1.95 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.282 1.833 . . . . 0.0 107.676 -170.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 58.57 19.67 42.79 Favored Glycine 0 CA--C 1.538 1.494 0 CA-C-O 118.977 -0.902 . . . . 0.0 114.629 174.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 124.32 -26.99 5.66 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.953 1.264 . . . . 0.0 112.723 -177.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 9.9 mp -75.31 150.06 38.59 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 169.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 7.0 tt -145.52 157.28 44.02 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.493 1.042 . . . . 0.0 110.689 -175.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 56.6 mtt -147.61 159.08 44.17 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.016 1.326 . . . . 0.0 108.861 170.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 85.4 mtp180 -141.25 130.22 23.2 Favored 'General case' 0 C--N 1.334 -0.1 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 169.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -152.59 160.09 43.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 119.059 0.845 . . . . 0.0 111.079 -170.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -137.17 149.65 47.4 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 124.315 1.046 . . . . 0.0 108.575 169.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -178.08 168.44 39.76 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -177.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -57.93 132.79 54.48 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -178.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -43.81 -73.7 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 -168.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -67.11 -26.18 66.58 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 122.404 1.097 . . . . 0.0 111.93 -172.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.95 -31.36 72.56 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 128.164 2.586 . . . . 0.0 111.203 175.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 5.4 tt -76.38 -13.47 60.13 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.28 1.032 . . . . 0.0 111.307 -176.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 32.3 t-80 52.81 40.51 30.75 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.721 1.208 . . . . 0.0 111.937 177.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -123.86 33.04 4.03 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 125.247 1.403 . . . . 0.0 110.642 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -76.48 -3.95 40.01 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.07 0.948 . . . . 0.0 113.34 -175.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -129.43 143.02 50.67 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 127.534 2.334 . . . . 0.0 106.142 169.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 8.2 p -59.21 -11.85 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.994 169.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -124.06 21.72 8.88 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 126.001 1.72 . . . . 0.0 113.492 176.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 57.9 m -72.83 -78.36 0.09 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.962 0.887 . . . . 0.0 109.779 168.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -82.58 12.62 4.41 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -169.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 33.9 m -67.27 -28.42 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-O 118.816 -0.612 . . . . 0.0 110.016 170.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -77.86 107.6 10.5 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 177.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 45.3 tp -112.66 131.38 55.67 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.459 1.104 . . . . 0.0 108.283 -176.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.5 tt -138.33 135.85 35.82 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 104.418 -2.438 . . . . 0.0 104.418 169.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -142.14 152.72 43.49 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 118.817 0.735 . . . . 0.0 111.484 176.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 39.6 pttt -165.01 172.97 12.05 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 126.224 1.81 . . . . 0.0 109.171 -174.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -55.1 156.69 3.82 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.422 0.689 . . . . 0.0 111.732 171.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.41 169.04 9.65 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.399 169.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -134.79 122.92 22.78 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 173.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 9.9 t80 . . . . . 0 C--O 1.246 0.902 0 C-N-CA 124.484 1.113 . . . . 0.0 108.276 176.66 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 mmt . . . . . 0 N--CA 1.486 1.34 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.79 163.18 0.1 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.492 2.317 . . . . 0.0 113.666 -175.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 69.28 178.39 19.44 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.373 0.987 . . . . 0.0 112.351 -175.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 40.0 pt -77.94 168.83 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 O-C-N 122.345 -0.503 . . . . 0.0 109.844 173.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -123.08 -36.08 2.9 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.24 1.416 . . . . 0.0 109.976 -176.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -151.47 158.16 43.28 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.902 1.281 . . . . 0.0 108.668 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -145.81 140.96 27.48 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.798 1.639 . . . . 0.0 108.371 -176.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -152.67 146.49 25.19 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.346 1.459 . . . . 0.0 110.54 -170.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.6 mp -112.59 137.74 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 105.847 -1.908 . . . . 0.0 105.847 171.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -145.64 161.89 38.78 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.758 1.223 . . . . 0.0 110.489 -174.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -140.86 144.79 35.51 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.598 0.759 . . . . 0.0 110.049 -174.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 39.0 t -70.08 122.56 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 125.078 1.351 . . . . 0.0 107.834 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -96.03 -32.0 12.77 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 124.508 1.123 . . . . 0.0 110.126 176.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -157.14 167.66 29.74 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.284 0.947 . . . . 0.0 110.718 175.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.7 mp -133.05 140.88 46.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 127.138 2.175 . . . . 0.0 106.296 -175.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -143.78 89.82 7.21 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 124.069 0.947 . . . . 0.0 110.011 -171.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -65.09 9.4 0.17 Allowed 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 124.121 3.214 . . . . 0.0 116.774 -178.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -78.82 55.88 1.8 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.079 1.351 . . . . 0.0 109.914 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -170.08 35.66 0.18 Allowed Glycine 0 CA--C 1.527 0.803 0 C-N-CA 124.89 1.233 . . . . 0.0 111.454 -172.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.2 mmpt? -65.97 64.58 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.61 1.564 . . . . 0.0 113.392 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -60.49 -38.4 84.16 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 168.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -144.37 165.5 27.75 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 129.468 3.107 . . . . 0.0 104.218 169.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.29 -40.86 83.05 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.28 -0.887 . . . . 0.0 110.737 175.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 49.0 ptt85 -70.4 7.72 0.98 Allowed 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 126.508 1.923 . . . . 0.0 114.806 175.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 77.7 t -120.48 132.09 70.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 121.497 1.953 . . . . 0.0 107.487 178.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 37.0 m -149.06 163.65 36.92 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.93 0.892 . . . . 0.0 109.789 176.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.1 ttm105 -85.45 154.28 21.92 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 169.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.0 mt -143.16 156.75 44.85 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 127.114 2.166 . . . . 0.0 107.199 -177.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -131.56 131.65 43.51 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 105.335 -2.098 . . . . 0.0 105.335 174.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 55.1 m -143.77 164.71 29.72 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.771 1.228 . . . . 0.0 110.201 -170.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -140.79 140.06 34.68 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 38.2 p -70.45 136.29 49.39 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 173.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -75.75 -35.68 60.11 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 168.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.6 m -69.56 -38.19 77.31 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -170.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -135.11 -102.26 0.22 Allowed 'General case' 0 C--N 1.345 0.38 0 CA-C-N 119.818 1.19 . . . . 0.0 110.34 -171.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -166.51 19.02 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.332 1.453 . . . . 0.0 112.559 -169.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 85.4 mtp -62.94 122.68 16.61 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.995 0.918 . . . . 0.0 108.68 176.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -98.08 112.45 24.4 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 169.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 49.0 tp -122.62 138.41 54.6 Favored 'General case' 0 N--CA 1.461 0.089 0 C-N-CA 123.455 0.702 . . . . 0.0 110.528 -169.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 33.1 mm -124.71 146.34 30.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 103.634 -2.728 . . . . 0.0 103.634 169.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 123' ' ' MET . 2.3 pt? -154.17 154.85 34.25 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.723 1.209 . . . . 0.0 109.547 176.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -121.59 120.68 35.52 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 102.992 -2.966 . . . . 0.0 102.992 170.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.2 p -151.09 163.18 2.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 121.707 0.765 . . . . 0.0 110.876 -168.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -69.02 90.23 0.44 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.907 1.683 . . . . 0.0 109.208 169.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.0 pp -65.84 -7.26 4.73 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -170.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -64.14 -18.61 64.6 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 120.161 1.346 . . . . 0.0 111.115 173.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.3 tt -55.34 -41.95 64.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.728 1.211 . . . . 0.0 110.629 169.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -88.02 139.37 30.74 Favored Pre-proline 0 CA--C 1.538 0.508 0 C-N-CA 125.88 1.672 . . . . 0.0 109.636 -173.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.45 132.74 30.11 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.272 1.981 . . . . 0.0 111.101 -177.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.8 t 50.34 31.06 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 126.567 1.947 . . . . 0.0 112.588 171.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.1 t70 62.42 -35.54 0.12 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 128.168 2.587 . . . . 0.0 115.203 -175.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 60.1 tp -59.36 -34.19 72.09 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.369 1.468 . . . . 0.0 111.405 177.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.37 -178.83 52.71 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-O 121.904 0.725 . . . . 0.0 112.262 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -157.96 174.16 15.67 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 126.662 1.985 . . . . 0.0 106.983 -174.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -58.92 134.22 56.74 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 173.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -128.91 168.66 15.65 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 125.908 1.683 . . . . 0.0 107.626 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -132.38 147.69 52.39 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.6 tt -137.88 144.0 41.16 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 -169.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.5 m -135.31 154.43 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 169.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 35.2 pt -121.15 147.84 24.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 104.287 -2.486 . . . . 0.0 104.287 168.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -138.55 54.2 1.77 Allowed 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.198 -168.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.9 m -42.9 116.51 0.9 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.563 1.545 . . . . 0.0 109.854 175.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 11.2 t -159.56 -170.52 2.96 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.34 0.656 . . . . 0.0 109.88 -169.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 25.8 tp -143.9 44.66 1.47 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.271 1.828 . . . . 0.0 108.086 173.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -58.11 151.32 19.15 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.41 0.624 . . . . 0.0 110.499 176.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -141.62 175.02 10.02 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 127.444 2.298 . . . . 0.0 108.708 173.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -62.6 -18.6 62.51 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.052 0.941 . . . . 0.0 113.491 -173.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -141.66 50.65 0.72 Allowed Glycine 0 CA--C 1.524 0.656 0 C-N-CA 125.45 1.5 . . . . 0.0 110.192 -178.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.4 m -62.61 159.0 16.85 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 117.651 0.725 . . . . 0.0 109.442 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 54.8 mt 45.43 26.81 0.32 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.592 1.957 . . . . 0.0 112.897 -169.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.9 t70 45.72 31.0 0.9 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 127.106 2.162 . . . . 0.0 113.658 -171.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -148.84 6.18 0.7 Allowed 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 177.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.48 38.28 90.64 Favored Glycine 0 CA--C 1.533 1.199 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -171.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 70.32 131.4 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 128.176 2.59 . . . . 0.0 111.928 -172.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -75.37 66.67 1.84 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.059 1.344 . . . . 0.0 109.472 175.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 57.4 t-20 -134.21 66.1 70.39 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 123.617 0.767 . . . . 0.0 112.189 -169.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -69.18 -18.76 39.59 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 122.373 2.048 . . . . 0.0 110.961 169.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -60.62 -5.11 1.1 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.814 2.446 . . . . 0.0 113.511 172.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.04 -23.53 1.21 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 120.038 1.29 . . . . 0.0 113.047 169.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -114.48 14.5 17.82 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 -169.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 19.2 ptt180 -77.0 -155.56 0.0 OUTLIER Pre-proline 0 CA--C 1.557 1.249 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 167.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -50.4 -11.53 0.37 Allowed 'Trans proline' 0 CA--C 1.543 0.957 0 CA-C-N 123.044 2.123 . . . . 0.0 116.215 169.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.3 m -52.17 -25.36 8.84 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 128.462 2.705 . . . . 0.0 114.459 168.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.5 tpm_? -30.78 -51.21 0.15 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.816 1.646 . . . . 0.0 113.626 -168.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -140.44 11.58 2.33 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.146 0.43 . . . . 0.0 112.118 168.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -73.96 -11.91 60.49 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.142 -0.973 . . . . 0.0 110.642 169.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -60.6 -59.53 5.25 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.634 0.773 . . . . 0.0 109.237 169.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -162.39 161.54 27.37 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 126.136 1.774 . . . . 0.0 110.218 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -123.58 -23.06 4.84 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.446 1.498 . . . . 0.0 109.476 169.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -142.81 155.03 44.74 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.378 1.471 . . . . 0.0 108.214 172.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.0 t -141.78 144.62 25.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 124.89 1.276 . . . . 0.0 107.83 -169.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 16.3 mtm -147.8 152.35 37.54 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.551 1.541 . . . . 0.0 110.308 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -138.46 144.49 40.12 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 127.587 2.355 . . . . 0.0 105.158 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.44 -151.3 6.73 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-N 120.641 1.564 . . . . 0.0 115.396 -169.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -144.71 133.39 22.25 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 126.098 1.759 . . . . 0.0 107.186 172.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.9 p -101.54 133.85 43.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 169.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -142.09 88.52 2.11 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.528 1.131 . . . . 0.0 108.874 -170.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -156.98 162.98 39.6 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.654 -1.279 . . . . 0.0 110.713 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.27 178.07 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 124.327 1.051 . . . . 0.0 110.543 178.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -64.42 4.85 0.33 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.9 2.08 . . . . 0.0 114.467 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.19 -52.93 1.6 Allowed Glycine 0 C--N 1.332 0.356 0 C-N-CA 125.49 1.519 . . . . 0.0 109.5 175.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -67.08 124.12 22.15 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.324 0.583 . . . . 0.0 109.704 169.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -132.68 16.64 4.33 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.023 1.329 . . . . 0.0 110.45 169.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 44.4 p -87.75 -161.95 0.76 Allowed 'General case' 0 C--O 1.236 0.353 0 CA-C-O 122.084 0.945 . . . . 0.0 109.984 178.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 21.8 m -157.22 16.82 0.28 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.5 2.32 . . . . 0.0 107.238 -176.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.0 p -151.91 -59.72 0.16 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.144 1.377 . . . . 0.0 109.142 -168.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -77.96 -35.87 49.78 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.095 0.558 . . . . 0.0 111.398 -170.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 56.29 74.66 0.38 Allowed 'General case' 0 C--N 1.343 0.322 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 -169.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.21 135.87 16.13 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 114.302 -1.317 . . . . 0.0 112.423 -167.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.8 p -92.92 4.21 54.34 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 -169.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? -115.09 141.64 47.73 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.019 0.927 . . . . 0.0 108.95 176.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.0 tp -88.78 154.97 19.85 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 167.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 10.8 m -130.57 149.76 52.09 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 -174.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -144.12 143.76 31.27 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -127.05 125.8 41.98 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 101.052 -3.684 . . . . 0.0 101.052 169.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.2 t -135.13 130.1 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -170.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 50.1 m -115.99 136.02 53.43 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 176.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -136.35 158.99 43.11 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.427 1.091 . . . . 0.0 109.961 -169.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -71.87 65.88 1.15 Allowed Glycine 0 CA--C 1.531 1.056 0 N-CA-C 108.204 -1.958 . . . . 0.0 108.204 168.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 171.16 -17.22 0.06 OUTLIER Glycine 0 CA--C 1.534 1.268 0 CA-C-O 117.194 -1.892 . . . . 0.0 112.194 -169.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . 0.435 43.4 mt 133.17 -136.14 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 130.514 3.526 . . . . 0.0 111.453 168.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 5.2 tt -139.48 157.74 45.33 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 121.661 2.028 . . . . 0.0 113.516 -168.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' MET . . . . . 0.416 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 35.7 mtt -145.25 157.89 43.96 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.135 1.774 . . . . 0.0 109.961 177.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 62.9 mtt180 -136.11 137.73 41.34 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 104.651 -2.351 . . . . 0.0 104.651 169.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 27.6 tp -148.71 146.38 28.08 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 119.054 0.843 . . . . 0.0 110.463 -168.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -137.3 153.05 50.37 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.661 1.184 . . . . 0.0 108.314 168.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 176.17 -177.1 47.81 Favored Glycine 0 CA--C 1.519 0.336 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 170.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -53.1 139.86 27.27 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 118.291 1.046 . . . . 0.0 109.681 175.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -53.04 -56.25 17.57 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 123.593 0.558 . . . . 0.0 112.167 -174.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -54.81 -40.55 69.64 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-O 121.437 0.637 . . . . 0.0 111.471 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.5 -30.98 71.82 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 127.193 2.197 . . . . 0.0 110.39 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.37 -25.28 65.9 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 118.475 -0.774 . . . . 0.0 109.447 -178.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 72.2 m80 40.94 44.46 1.98 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.48 1.512 . . . . 0.0 111.76 -177.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -137.22 64.01 0.57 Allowed Glycine 0 C--N 1.338 0.648 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 -169.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -103.37 12.88 34.82 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.729 0.812 . . . . 0.0 112.055 -173.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.473 ' C ' ' H ' ' A' ' 138' ' ' ASP . 7.4 tp10 -140.61 146.3 37.79 Favored 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 126.122 1.769 . . . . 0.0 108.002 173.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.5 m -56.51 -9.06 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 124.512 1.125 . . . . 0.0 111.346 169.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.473 ' H ' ' C ' ' A' ' 136' ' ' GLU . 31.9 t70 -134.35 15.03 3.78 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 127.548 2.339 . . . . 0.0 112.245 -172.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 68.6 m -73.37 -81.8 0.06 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 122.309 1.052 . . . . 0.0 109.642 168.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -80.0 14.34 1.87 Allowed 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -169.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 20.1 m -68.18 -29.73 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 169.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -82.56 106.18 14.21 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 175.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 24.7 tp -129.79 137.18 50.36 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 124.617 1.167 . . . . 0.0 108.133 -173.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.9 mp -139.63 151.43 45.97 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 172.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 60.4 mtm -138.85 154.18 48.4 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.616 0.767 . . . . 0.0 109.581 -176.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 34.0 pttt -165.0 175.18 9.71 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.205 1.402 . . . . 0.0 110.964 -169.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 23.0 ptmt -63.31 157.17 23.57 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 122.406 0.283 . . . . 0.0 110.239 169.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.33 154.6 31.26 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.691 0.758 . . . . 0.0 111.512 172.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -135.86 112.72 10.24 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 169.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 . . . . . 0 C--O 1.247 0.939 0 CA-C-O 118.546 -0.74 . . . . 0.0 109.962 -177.247 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 119.881 -0.104 . . . . 0.0 110.846 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.36 6.7 3.3 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.394 1.078 . . . . 0.0 112.852 -175.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -172.83 171.6 44.5 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.476 -1.049 . . . . 0.0 110.476 178.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.0 tt -138.9 145.32 27.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 125.318 1.447 . . . . 0.0 108.53 -174.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 44.3 tp -109.57 -48.93 3.16 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 124.408 1.083 . . . . 0.0 109.668 178.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -161.04 166.65 27.83 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.485 1.114 . . . . 0.0 109.559 173.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -140.63 132.89 28.2 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.925 2.09 . . . . 0.0 106.313 176.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -149.86 153.75 37.24 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 171.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.0 mp -75.52 146.0 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 173.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -129.65 153.9 47.66 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.478 1.511 . . . . 0.0 107.389 170.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -131.74 129.59 40.82 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.664 1.586 . . . . 0.0 108.278 -174.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 51.8 t -72.51 118.03 16.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 124.448 1.099 . . . . 0.0 108.197 -177.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.2 mmpt? -78.25 -43.33 28.51 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 124.489 1.116 . . . . 0.0 109.59 169.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -159.11 170.65 21.54 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 118.824 0.738 . . . . 0.0 111.038 -175.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.2 mp -138.6 142.56 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 127.104 2.162 . . . . 0.0 106.825 -173.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -147.39 93.99 4.56 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 124.195 0.998 . . . . 0.0 111.205 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -73.14 90.84 0.85 Allowed 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 123.306 2.671 . . . . 0.0 107.765 168.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -57.87 -33.56 68.83 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -169.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 155.81 42.5 0.02 OUTLIER Glycine 0 CA--C 1.527 0.79 0 N-CA-C 106.248 -2.741 . . . . 0.0 106.248 -169.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 22.1 mmtt -72.42 95.96 1.84 Allowed 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.443 1.497 . . . . 0.0 109.66 -168.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -47.7 -43.31 26.56 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.232 1.013 . . . . 0.0 112.025 175.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.5 m-30 -81.08 -18.58 46.11 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 122.741 0.416 . . . . 0.0 112.071 -174.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.7 t70 62.75 -36.13 0.13 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 130.064 3.345 . . . . 0.0 115.688 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -72.64 11.0 0.71 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.316 1.446 . . . . 0.0 113.124 170.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 53.7 t -126.53 140.46 48.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 104.029 -2.582 . . . . 0.0 104.029 174.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 55.7 m -156.21 160.82 40.17 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 119.637 1.108 . . . . 0.0 110.417 174.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 15.1 ttm180 -83.81 150.38 25.8 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 170.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 66.0 mt -137.76 155.17 49.34 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.744 2.018 . . . . 0.0 106.141 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -121.58 127.35 50.82 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 102.804 -3.036 . . . . 0.0 102.804 169.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 74.5 m -141.27 162.63 35.01 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.182 0.993 . . . . 0.0 110.864 -169.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -138.75 134.2 33.2 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.556 1.542 . . . . 0.0 107.607 -176.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.5 p -67.18 148.3 51.97 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.014 0.926 . . . . 0.0 110.697 173.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -77.78 -30.41 51.34 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 118.756 -0.64 . . . . 0.0 111.013 172.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -132.49 -31.45 1.39 Allowed 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 115.234 1.568 . . . . 0.0 115.234 -169.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 23.3 m-30 -108.35 30.9 6.01 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -168.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 49.5 pttt 40.11 53.73 2.75 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.564 1.546 . . . . 0.0 114.282 169.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 47.6 mtt -114.52 110.82 20.42 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.388 1.875 . . . . 0.0 107.972 177.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -82.74 125.06 30.83 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 169.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 51.9 tp -132.85 142.09 48.77 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 118.733 0.697 . . . . 0.0 112.305 -168.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 40.8 mm -120.03 136.98 55.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 101.635 -3.468 . . . . 0.0 101.635 169.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 22.3 tp -152.7 105.21 2.95 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.062 0.945 . . . . 0.0 109.316 -168.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.422 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 16.1 t70 -100.87 105.54 16.82 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 126.212 1.805 . . . . 0.0 107.246 173.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.7 m -150.51 172.03 1.34 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-O 121.662 0.744 . . . . 0.0 110.515 -169.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -59.9 128.14 35.41 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.175 1.39 . . . . 0.0 109.264 169.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.1 pp -114.67 0.88 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 124.597 1.159 . . . . 0.0 113.812 -174.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.68 -4.92 25.97 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 120.42 1.463 . . . . 0.0 111.255 177.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.8 mt -62.83 -38.79 82.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 168.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -78.21 148.15 74.03 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 123.505 0.722 . . . . 0.0 110.138 -171.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.93 -25.33 19.92 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 122.592 2.195 . . . . 0.0 112.669 -177.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.8 m -145.42 160.82 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 125.611 1.564 . . . . 0.0 108.352 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -60.25 -27.82 67.53 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.313 1.045 . . . . 0.0 112.463 178.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 42.7 tp -62.65 -15.17 50.71 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.761 1.224 . . . . 0.0 112.456 174.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.1 -176.46 51.48 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -172.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -155.71 166.1 34.53 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.436 1.494 . . . . 0.0 107.344 177.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -66.95 131.69 46.39 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 173.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -139.69 146.16 39.28 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -172.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 61.5 mtm180 -79.67 134.08 36.41 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 170.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -106.04 134.44 49.17 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 104.355 -2.461 . . . . 0.0 104.355 169.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 80.1 t -134.29 138.65 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 -176.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.1 mm -106.78 135.18 46.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 104.832 -2.285 . . . . 0.0 104.832 169.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -120.02 -167.87 1.51 Allowed 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.708 1.203 . . . . 0.0 110.127 -169.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 69.7 m -152.48 145.05 24.17 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 169.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 26.5 m -145.94 133.07 20.4 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 42.7 tp -80.01 61.83 4.01 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 169.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -61.27 -23.36 65.61 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.613 -0.679 . . . . 0.0 112.753 -169.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -58.93 -22.5 60.01 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.112 0.965 . . . . 0.0 112.294 175.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -68.85 -22.76 64.2 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.593 0.757 . . . . 0.0 112.238 175.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.31 34.54 90.19 Favored Glycine 0 CA--C 1.534 1.233 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -173.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.92 -25.26 66.63 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 118.624 1.212 . . . . 0.0 110.216 173.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 75.5 mt -128.78 46.48 2.61 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 127.31 2.244 . . . . 0.0 106.706 171.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -50.21 119.69 3.88 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 124.084 0.954 . . . . 0.0 109.002 -177.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -51.42 96.63 0.01 OUTLIER 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.157 1.783 . . . . 0.0 111.033 -175.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 146.67 -30.97 1.52 Allowed Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.619 1.104 . . . . 0.0 110.657 -169.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -140.14 48.22 1.78 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 128.963 2.905 . . . . 0.0 106.183 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -70.35 86.61 0.6 Allowed 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 176.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -56.63 147.45 51.05 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 125.208 1.403 . . . . 0.0 110.569 -174.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -55.33 -12.47 5.74 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.544 2.829 . . . . 0.0 115.869 176.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.6 m 55.95 35.61 25.82 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.953 1.701 . . . . 0.0 110.751 -173.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -128.64 28.23 5.42 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 127.319 2.248 . . . . 0.0 106.767 169.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -152.35 -62.72 0.16 Allowed 'General case' 0 C--O 1.231 0.13 0 C-N-CA 127.791 2.436 . . . . 0.0 104.771 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 84.9 mtt180 -74.65 144.15 79.94 Favored Pre-proline 0 N--CA 1.469 0.486 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 167.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER 10.85 64.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.833 1 C-N-CA 127.383 5.389 . . . . 0.0 115.828 -169.664 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.7 p -59.4 -18.7 41.19 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.951 1.7 . . . . 0.0 114.921 -169.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -58.72 -23.87 60.47 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 121.272 -0.893 . . . . 0.0 111.875 172.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -74.6 -3.12 29.23 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 118.125 -0.94 . . . . 0.0 112.994 177.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -73.0 60.15 0.53 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 120.552 1.524 . . . . 0.0 112.19 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -139.84 -13.74 1.08 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.634 1.974 . . . . 0.0 111.215 -176.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -79.85 162.43 25.06 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 118.505 0.593 . . . . 0.0 110.269 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -116.15 -23.31 8.51 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.669 0.787 . . . . 0.0 110.353 175.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -149.86 150.32 31.77 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.247 1.019 . . . . 0.0 109.218 171.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.4 p -148.42 142.99 19.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 174.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 10.3 tpt -159.94 166.93 29.15 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.938 0.895 . . . . 0.0 109.596 176.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -121.06 146.8 46.34 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.107 1.363 . . . . 0.0 108.138 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -141.65 -160.43 8.32 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-N 118.637 0.653 . . . . 0.0 112.328 -175.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -142.02 128.84 20.54 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.862 1.265 . . . . 0.0 107.824 169.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 39.3 t -79.68 144.03 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 171.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -143.46 75.47 1.48 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.931 1.293 . . . . 0.0 109.529 177.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -157.09 163.58 38.82 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 120.764 -1.21 . . . . 0.0 110.954 170.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.53 -172.49 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 125.691 1.596 . . . . 0.0 110.935 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.22 -13.93 3.67 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.91 2.084 . . . . 0.0 115.437 -178.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 152.55 -67.04 0.33 Allowed Glycine 0 C--N 1.334 0.435 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -146.68 12.08 1.13 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.373 1.069 . . . . 0.0 112.906 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 58.47 71.12 0.6 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.751 2.021 . . . . 0.0 111.719 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 32.1 p -56.3 -57.38 12.48 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.675 0.79 . . . . 0.0 109.35 169.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 17.4 m 157.34 -37.4 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.441 1 C-N-CA 132.006 4.123 . . . . 0.0 107.915 -176.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.89 -25.92 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.686 0.794 . . . . 0.0 111.376 -169.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -64.87 -28.55 69.62 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.324 0.65 . . . . 0.0 111.599 -174.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 75.32 115.4 0.06 Allowed 'General case' 0 C--O 1.237 0.401 0 C-N-CA 128.638 2.775 . . . . 0.0 107.181 -172.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.05 165.44 5.61 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.809 -169.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.4 p -56.87 116.46 3.2 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 173.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? 60.32 131.98 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 127.804 2.442 . . . . 0.0 111.611 -168.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 9.1 tt -79.55 135.87 36.73 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 103.15 -2.907 . . . . 0.0 103.15 167.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 41.8 m -109.47 136.77 48.34 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 105.477 -2.046 . . . . 0.0 105.477 173.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -128.22 152.02 48.57 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.121 1.369 . . . . 0.0 108.091 -174.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -132.56 137.71 47.21 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 102.834 -3.025 . . . . 0.0 102.834 169.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.8 t -132.38 147.13 32.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 177.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.0 m -127.31 157.68 39.23 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 102.513 -3.143 . . . . 0.0 102.513 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . 0.333 98.4 m-85 58.76 -148.79 0.47 Allowed 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -167.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 61.15 13.57 35.74 Favored Glycine 0 CA--C 1.535 1.325 0 CA-C-N 120.186 1.357 . . . . 0.0 113.17 -176.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 138.21 -50.31 0.81 Allowed Glycine 0 CA--C 1.528 0.848 0 C-N-CA 126.066 1.793 . . . . 0.0 109.601 -171.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.65 -68.63 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.458 1.503 . . . . 0.0 109.0 169.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 11.3 tp -157.79 148.21 20.71 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 124.561 1.144 . . . . 0.0 109.065 -178.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.58 156.34 41.77 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 170.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 70.2 ttt-85 -127.61 142.57 51.32 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 169.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 15.3 tp -149.74 148.89 29.77 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -169.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -144.39 143.42 30.93 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 168.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -175.93 178.05 47.49 Favored Glycine 0 CA--C 1.52 0.361 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -52.42 137.24 29.98 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 118.305 1.053 . . . . 0.0 110.622 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -56.91 -55.98 27.53 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -169.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -57.03 -43.95 82.39 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 122.349 1.071 . . . . 0.0 111.403 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 27.0 t30 -60.99 -28.09 68.77 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 126.292 1.837 . . . . 0.0 111.935 177.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.11 -29.38 54.81 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 123.911 0.884 . . . . 0.0 110.145 178.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 49.21 21.56 0.54 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.925 1.69 . . . . 0.0 113.191 -169.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.02 -10.86 84.17 Favored Glycine 0 CA--C 1.528 0.865 0 O-C-N 121.059 -1.026 . . . . 0.0 113.955 -169.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -59.12 -30.64 68.27 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 118.476 1.138 . . . . 0.0 111.693 172.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -87.35 87.82 7.52 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 126.743 2.017 . . . . 0.0 106.212 169.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.5 m -59.59 -7.12 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 124.49 1.116 . . . . 0.0 113.407 176.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -123.4 18.74 9.75 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 126.11 1.764 . . . . 0.0 113.17 176.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.9 m -83.84 -68.93 0.67 Allowed 'General case' 0 C--O 1.232 0.147 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 167.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.292 10.6 ptm85 -78.31 11.67 2.29 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 -169.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 29.7 m -67.58 -34.86 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-O 118.645 -0.693 . . . . 0.0 109.337 168.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -82.82 104.35 12.99 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 10.3 tt -117.2 134.72 54.44 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -170.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -140.51 135.92 32.39 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 -171.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 78.4 mtm -137.85 149.4 46.26 Favored 'General case' 0 C--O 1.237 0.426 0 O-C-N 121.267 -0.896 . . . . 0.0 109.944 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -154.62 172.51 17.75 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.305 1.042 . . . . 0.0 109.761 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -53.51 160.46 1.23 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.298 0.639 . . . . 0.0 111.857 175.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.25 166.3 0.86 Allowed 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.394 0.616 . . . . 0.0 111.981 169.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -87.09 86.59 7.31 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 175.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 19.2 t80 . . . . . 0 C--O 1.248 0.995 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 172.632 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.3 mmt . . . . . 0 N--CA 1.483 1.217 0 N-CA-C 109.254 -0.646 . . . . 0.0 109.254 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.26 142.67 57.6 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 122.953 0.501 . . . . 0.0 110.528 -177.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 174.29 177.63 43.59 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 170.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.6 tp -150.96 138.6 13.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 169.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 23.1 tp -153.37 -13.79 0.15 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.055 0.942 . . . . 0.0 112.088 175.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -147.33 134.04 19.99 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -148.5 138.4 22.29 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 169.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -151.17 150.62 30.85 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.026 0.83 . . . . 0.0 110.869 172.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.6 mp -75.16 152.65 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 169.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -132.59 146.66 52.07 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.651 1.58 . . . . 0.0 107.788 174.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -123.75 119.74 30.63 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 127.225 2.21 . . . . 0.0 106.641 -175.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.7 t -78.39 123.92 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -177.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.5 mmmt -88.7 -40.0 13.58 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.952 0.901 . . . . 0.0 109.687 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -157.93 170.91 21.27 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 118.386 0.539 . . . . 0.0 112.318 -169.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.1 mp -141.9 147.54 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 127.881 2.472 . . . . 0.0 106.786 -175.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -143.86 110.58 5.2 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 169.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -64.62 7.35 0.25 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.605 2.87 . . . . 0.0 117.454 -177.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 46.14 39.93 6.62 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.731 2.012 . . . . 0.0 112.294 -174.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.29 37.71 41.26 Favored Glycine 0 CA--C 1.531 1.065 0 O-C-N 121.528 -0.732 . . . . 0.0 111.447 -177.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? 45.55 57.64 4.81 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 126.661 1.984 . . . . 0.0 109.642 -169.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -54.63 -36.76 64.86 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.921 0.888 . . . . 0.0 110.645 -178.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -140.17 160.99 38.73 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 169.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -64.64 -25.55 68.01 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -177.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -136.57 16.47 3.13 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 117.639 -1.172 . . . . 0.0 113.579 -173.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.8 t -131.61 129.14 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 121.005 1.73 . . . . 0.0 107.364 -178.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 39.6 m -148.34 159.55 43.89 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 124.387 1.075 . . . . 0.0 110.396 -170.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 -69.01 146.46 52.7 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 169.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.2 mp -127.86 158.09 38.72 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 127.018 2.127 . . . . 0.0 106.521 170.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -136.08 132.01 35.59 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 171.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.3 m -142.85 173.02 11.92 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.318 1.447 . . . . 0.0 110.609 -169.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -140.99 143.66 34.59 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.59 1.956 . . . . 0.0 106.858 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.3 p -88.09 147.68 24.83 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.109 0.868 . . . . 0.0 110.033 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -77.58 -41.79 37.48 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.497 1.119 . . . . 0.0 112.811 -169.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.28 -26.74 9.0 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.831 0.852 . . . . 0.0 112.775 -169.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -121.35 23.78 10.26 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.957 1.303 . . . . 0.0 112.188 -170.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.9 pttt 43.6 27.37 0.15 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 127.097 2.159 . . . . 0.0 116.247 168.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 53.8 mtt -70.53 149.29 47.3 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 119.813 1.188 . . . . 0.0 108.366 175.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -112.29 131.07 55.71 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 173.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 48.7 tp -133.56 141.88 47.9 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.667 0.746 . . . . 0.0 111.154 -169.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 42.6 mm -123.05 142.4 39.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 101.161 -3.644 . . . . 0.0 101.161 168.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 51.3 tp -148.92 154.73 39.84 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 126.221 1.808 . . . . 0.0 106.929 -168.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -137.18 114.14 10.59 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 103.478 -2.786 . . . . 0.0 103.478 169.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.0 p -151.46 167.29 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 O-C-N 124.373 1.046 . . . . 0.0 111.026 -168.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -60.61 137.08 58.22 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.943 1.297 . . . . 0.0 109.413 169.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.6 pp -119.14 8.0 6.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 124.935 1.294 . . . . 0.0 113.417 -177.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -65.41 -19.57 66.0 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 120.367 1.44 . . . . 0.0 110.96 173.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.4 mt -63.65 -33.92 64.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 126.238 1.815 . . . . 0.0 110.291 172.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -65.75 138.73 96.68 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 123.757 0.823 . . . . 0.0 112.916 -167.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -72.91 177.43 7.7 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.418 2.745 . . . . 0.0 110.974 172.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.6 m -70.87 -22.93 23.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 O-C-N 121.766 -0.583 . . . . 0.0 111.62 171.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -69.16 153.19 44.11 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.755 0.822 . . . . 0.0 110.733 177.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 53.9 tp -63.8 -29.68 70.85 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.512 0.725 . . . . 0.0 112.625 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.21 160.51 13.78 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-N 119.091 0.859 . . . . 0.0 111.679 -175.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -157.69 164.81 36.77 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 126.097 1.759 . . . . 0.0 107.433 174.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -138.43 150.87 46.92 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.681 0.792 . . . . 0.0 109.339 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -151.59 -175.32 5.15 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 124.989 1.316 . . . . 0.0 107.598 173.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.7 ttp180 -136.12 147.85 47.97 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 125.233 1.413 . . . . 0.0 107.716 -177.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.1 tp -134.91 151.0 50.5 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.132 0.973 . . . . 0.0 109.755 -169.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 55.7 t -136.46 137.11 48.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 105.472 -2.048 . . . . 0.0 105.472 173.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 pp -137.45 3.5 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 123.808 0.843 . . . . 0.0 113.077 -176.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.16 -46.66 17.51 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.446 -0.784 . . . . 0.0 112.462 -170.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.1 m -157.55 173.08 17.41 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.595 1.558 . . . . 0.0 108.306 -169.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.456 HG22 ' H ' ' A' ' 65' ' ' TYR . 1.8 m -66.94 151.82 46.88 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 168.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 24.0 tp -77.06 -17.18 58.94 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.309 -0.869 . . . . 0.0 111.329 170.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.456 ' H ' HG22 ' A' ' 63' ' ' THR . 12.4 m-85 -143.56 159.75 41.87 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.349 1.06 . . . . 0.0 112.032 -172.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -150.25 -174.09 4.64 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.76 2.024 . . . . 0.0 108.408 169.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -57.3 -21.37 34.42 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.494 1.518 . . . . 0.0 114.492 -171.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -109.4 -5.44 30.04 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-O 118.873 -0.96 . . . . 0.0 113.721 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.03 173.21 11.55 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.258 1.529 . . . . 0.0 108.667 170.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 52.6 mt 48.87 -121.2 1.47 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -177.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -136.27 120.51 17.87 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 104.3 -2.481 . . . . 0.0 104.3 168.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.2 t70 54.99 25.88 7.38 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.121 1.368 . . . . 0.0 112.917 -173.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 66.84 25.01 73.08 Favored Glycine 0 CA--C 1.527 0.825 0 O-C-N 121.344 -0.847 . . . . 0.0 112.714 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -132.0 149.58 52.39 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.735 1.214 . . . . 0.0 107.894 -175.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -72.46 16.44 0.14 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.754 1.221 . . . . 0.0 113.507 -176.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -69.76 -16.79 0.34 Allowed Pre-proline 0 CA--C 1.542 0.643 0 CA-C-O 115.261 -2.304 . . . . 0.0 116.198 -175.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -79.98 47.36 2.51 Favored 'Trans proline' 0 C--N 1.358 1.068 0 CA-C-N 124.544 2.658 . . . . 0.0 109.848 169.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . 0.25 23.6 p 44.06 38.38 2.25 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 128.276 2.63 . . . . 0.0 113.083 -172.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -78.33 -19.3 53.78 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 121.359 -0.838 . . . . 0.0 111.657 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -149.38 -39.79 0.15 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.272 1.829 . . . . 0.0 109.36 171.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -60.65 135.47 92.24 Favored Pre-proline 0 CA--C 1.533 0.289 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . 0.279 2.4 Cg_exo 32.03 44.71 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.715 1 C-N-CA 125.439 4.093 . . . . 0.0 116.541 -169.243 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.9 m -139.52 -179.4 5.88 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.657 1.983 . . . . 0.0 108.97 173.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 26.6 mmt85 -63.78 172.85 2.0 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.279 0.632 . . . . 0.0 110.201 171.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -129.39 28.11 5.24 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.479 1.512 . . . . 0.0 109.855 176.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -80.72 -21.23 41.38 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.455 1.502 . . . . 0.0 111.573 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.91 -45.13 91.05 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.41 1.884 . . . . 0.0 112.656 -169.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -146.85 158.93 44.04 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.571 1.548 . . . . 0.0 108.178 178.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -97.8 -49.71 4.72 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.212 0.914 . . . . 0.0 110.209 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -157.4 165.97 34.3 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.18 0.9 . . . . 0.0 110.994 172.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.7 p -141.47 142.87 28.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 170.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.8 tpt -152.91 162.06 41.77 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.779 1.232 . . . . 0.0 109.164 -175.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -114.6 116.59 29.01 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 170.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.75 -167.08 32.09 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 -174.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.42 111.04 10.42 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 169.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 87.2 t -72.22 155.97 7.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 174.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -128.39 106.81 9.25 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 104.632 -2.359 . . . . 0.0 104.632 169.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -75.48 138.69 41.76 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -174.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.4 pt -128.31 179.46 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.149 0.98 . . . . 0.0 108.808 169.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -74.18 -1.46 20.52 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.609 1.564 . . . . 0.0 114.607 -173.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.1 37.68 91.82 Favored Glycine 0 C--N 1.336 0.583 0 O-C-N 121.841 -0.537 . . . . 0.0 112.696 -176.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -145.67 127.15 15.03 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 168.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -131.81 16.42 4.76 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 123.971 0.794 . . . . 0.0 111.617 169.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 43.1 p -68.44 -63.14 1.12 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.7 m 152.36 -38.69 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 131.02 3.728 . . . . 0.0 108.402 -175.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.04 -19.22 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.113 0.565 . . . . 0.0 112.231 -169.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -66.03 -23.82 66.63 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.134 0.879 . . . . 0.0 110.489 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 68.45 86.03 0.13 Allowed 'General case' 0 C--N 1.344 0.352 0 C-N-CA 127.449 2.3 . . . . 0.0 107.388 175.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.56 144.49 7.83 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 114.004 -1.453 . . . . 0.0 112.774 -168.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.1 p -84.5 4.1 33.37 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.56 1.144 . . . . 0.0 114.055 -176.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -124.04 131.94 53.62 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.294 1.838 . . . . 0.0 106.562 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 34.9 tp -70.8 153.63 42.57 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 170.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -126.88 161.46 28.21 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.206 1.002 . . . . 0.0 108.838 -172.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -147.97 161.22 41.78 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.752 1.221 . . . . 0.0 108.974 171.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -124.48 147.7 48.18 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 169.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.8 t -144.54 143.16 23.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 29.6 m -120.48 136.4 54.77 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 169.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -146.58 114.99 6.71 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -178.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 57.19 23.33 46.95 Favored Glycine 0 CA--C 1.539 1.588 0 CA-C-O 119.311 -0.716 . . . . 0.0 114.456 174.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.57 -8.42 64.04 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 124.763 1.173 . . . . 0.0 113.633 -178.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -95.26 170.2 9.55 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.777 1.631 . . . . 0.0 108.814 175.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.0 tp -139.19 160.63 39.36 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 118.741 0.7 . . . . 0.0 111.587 -169.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 71.4 mtm -153.97 161.56 41.88 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.56 1.544 . . . . 0.0 110.253 169.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -141.49 133.61 27.77 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 103.825 -2.657 . . . . 0.0 103.825 167.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.8 tt -140.92 151.1 43.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 119.259 0.936 . . . . 0.0 108.866 -171.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -132.93 153.42 51.42 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.644 1.177 . . . . 0.0 109.409 170.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -168.66 169.26 41.59 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 170.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -51.13 136.98 22.88 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.224 1.012 . . . . 0.0 109.005 172.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -42.73 -53.65 4.44 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -172.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -60.83 -41.35 95.62 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 123.174 1.464 . . . . 0.0 111.511 -177.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -71.63 -18.92 62.17 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 127.099 2.16 . . . . 0.0 111.386 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -67.87 -25.2 65.4 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 119.168 0.895 . . . . 0.0 109.184 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 25.2 t-80 53.28 40.42 31.26 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.88 1.272 . . . . 0.0 111.064 171.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -165.92 50.65 0.27 Allowed Glycine 0 C--N 1.338 0.655 0 O-C-N 121.366 -0.834 . . . . 0.0 112.609 -169.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -74.7 8.35 2.45 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.085 0.954 . . . . 0.0 112.18 171.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.414 ' C ' ' H ' ' A' ' 138' ' ' ASP . 20.4 tt0 -135.17 130.24 35.05 Favored 'General case' 0 CA--C 1.508 -0.649 0 C-N-CA 126.005 1.722 . . . . 0.0 106.909 -178.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.9 p -59.01 -4.68 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 126.14 1.776 . . . . 0.0 111.348 170.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.414 ' H ' ' C ' ' A' ' 136' ' ' GLU . 28.3 t70 -131.93 15.2 4.76 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.288 1.435 . . . . 0.0 113.075 178.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 6.8 m -87.14 -66.52 0.9 Allowed 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 167.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.32 0.0 OUTLIER -81.41 14.92 2.23 Favored 'General case' 0 C--N 1.345 0.38 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -169.521 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 16.3 m -64.23 -32.28 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 167.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -65.23 127.41 31.6 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 175.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 63.4 tp -143.07 130.95 21.57 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -177.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.3 tt -139.93 144.47 37.12 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 172.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 57.4 ttm -131.36 144.71 51.43 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 174.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 50.4 pttt -153.55 174.36 14.53 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.18 1.392 . . . . 0.0 109.524 178.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -64.26 157.95 24.57 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 122.533 0.333 . . . . 0.0 111.012 172.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.88 166.55 15.35 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.767 0.427 . . . . 0.0 110.961 169.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -141.61 134.29 28.55 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 172.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 . . . . . 0 C--O 1.25 1.094 0 C-N-CA 127.009 2.124 . . . . 0.0 110.937 -177.586 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 mpp? . . . . . 0 N--CA 1.482 1.16 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.6 173.3 15.7 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.596 1.158 . . . . 0.0 109.275 174.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -147.58 162.22 28.64 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 169.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.1 mm 62.63 155.72 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 125.893 1.677 . . . . 0.0 110.444 -169.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 56.1 tp -153.45 142.64 21.43 Favored 'General case' 0 C--O 1.233 0.211 0 O-C-N 120.918 -1.114 . . . . 0.0 109.039 174.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -147.84 151.04 35.27 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 126.527 1.931 . . . . 0.0 106.744 169.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -149.54 138.09 20.86 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.239 1.415 . . . . 0.0 107.581 -175.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -153.79 140.91 19.41 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.823 1.249 . . . . 0.0 109.251 -178.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.4 mp -107.46 139.16 30.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -134.99 158.07 45.3 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.438 1.095 . . . . 0.0 110.363 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -125.21 135.13 52.27 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 126.055 1.742 . . . . 0.0 107.514 -177.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.5 p -69.01 146.51 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 122.203 1.002 . . . . 0.0 109.358 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -125.11 -28.78 3.38 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 126.837 2.055 . . . . 0.0 109.116 -176.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -157.61 164.29 37.4 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 118.946 0.794 . . . . 0.0 110.913 170.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.8 mp -141.64 138.03 31.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 127.423 2.289 . . . . 0.0 106.032 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -146.61 97.8 4.26 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 125.351 1.46 . . . . 0.0 108.773 -176.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -60.67 26.1 0.04 OUTLIER 'Trans proline' 0 CA--C 1.543 0.952 1 C-N-CA 125.831 4.354 . . . . 0.0 118.554 -175.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -63.2 -9.05 9.61 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.214 -1.554 . . . . 0.0 113.628 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.72 10.63 12.48 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.442 1.496 . . . . 0.0 112.695 172.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.8 tppt? -44.15 -12.89 0.01 OUTLIER 'General case' 0 C--N 1.345 0.373 0 C-N-CA 129.536 3.134 . . . . 0.0 116.749 -176.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.2 tppt? -55.38 -31.35 61.73 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.224 0.92 . . . . 0.0 110.054 169.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -136.84 110.17 7.88 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 104.125 -2.546 . . . . 0.0 104.125 169.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -56.99 -28.3 62.27 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -169.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.2 ptt180 -72.02 4.7 3.22 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 117.453 -1.26 . . . . 0.0 113.759 174.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.0 t -120.85 134.95 62.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 121.363 1.892 . . . . 0.0 107.311 -178.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.8 m -145.78 151.73 38.41 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.694 0.797 . . . . 0.0 110.145 -177.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.5 ttp180 -73.25 143.12 47.2 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 168.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -136.46 155.61 49.76 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 125.547 1.539 . . . . 0.0 107.289 -174.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -131.92 135.06 46.34 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 105.218 -2.141 . . . . 0.0 105.218 169.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 65.7 m -141.18 167.02 23.17 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.536 1.534 . . . . 0.0 109.305 -176.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -135.94 130.47 33.77 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 178.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.3 m -76.62 131.01 38.64 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.218 0.607 . . . . 0.0 110.16 178.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -80.21 -36.5 34.76 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.91 0.884 . . . . 0.0 110.844 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.07 -29.5 69.3 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.506 0.722 . . . . 0.0 112.918 -169.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -132.92 -99.1 0.28 Allowed 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -167.08 13.82 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.449 1.1 . . . . 0.0 112.959 -172.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 72.2 mtm -71.18 141.14 50.69 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.174 0.512 . . . . 0.0 111.234 -169.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -88.73 135.97 33.24 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 169.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 64.1 tp -136.96 141.5 42.61 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 119.212 0.914 . . . . 0.0 109.426 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 36.3 mm -128.85 147.76 33.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 104.057 -2.571 . . . . 0.0 104.057 169.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 mp -144.17 166.28 25.48 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 125.639 1.575 . . . . 0.0 108.995 177.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -136.84 96.21 3.27 Favored 'General case' 0 C--N 1.324 -0.539 1 N-CA-C 99.038 -4.43 . . . . 0.0 99.038 167.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.7 p -139.45 161.18 27.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-O 121.353 0.596 . . . . 0.0 112.013 -167.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 62.5 t-20 -62.46 128.12 34.54 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.854 1.262 . . . . 0.0 109.273 170.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.5 pp -105.54 0.71 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 124.998 1.319 . . . . 0.0 112.93 -178.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -68.27 -17.51 64.31 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 120.347 1.431 . . . . 0.0 110.977 -177.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.4 mt -67.05 -34.97 73.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 124.501 1.12 . . . . 0.0 109.1 174.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -69.02 149.73 97.73 Favored Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -77.76 30.75 0.43 Allowed 'Trans proline' 0 CA--C 1.546 1.109 0 C-N-CA 124.445 3.43 . . . . 0.0 113.384 -172.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . 0.268 29.9 m 42.9 51.2 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 126.7 2.0 . . . . 0.0 111.937 -176.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -139.4 172.87 12.19 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.137 1.775 . . . . 0.0 108.343 -177.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 53.1 tp -52.14 -33.7 41.3 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.534 1.533 . . . . 0.0 113.417 -171.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -174.92 170.54 43.67 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 118.554 0.615 . . . . 0.0 111.611 172.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -158.84 172.34 18.4 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 126.431 1.892 . . . . 0.0 107.41 174.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -112.5 148.95 33.36 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.316 1.046 . . . . 0.0 109.916 -178.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -141.48 173.62 11.32 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.76 1.224 . . . . 0.0 108.367 -178.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -130.24 129.24 43.08 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 124.669 1.188 . . . . 0.0 107.911 -170.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.9 tp -91.53 141.12 29.07 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 169.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 55.1 t -134.7 146.72 30.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 172.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.4 mt -135.05 127.74 48.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 104.391 -2.448 . . . . 0.0 104.391 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -153.3 131.31 11.78 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 105.083 -2.191 . . . . 0.0 105.083 175.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.1 m -77.32 90.27 3.77 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 -176.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.2 m -61.99 -28.56 69.65 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.691 0.797 . . . . 0.0 111.375 176.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 71.7 mt 52.7 26.21 4.3 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.331 1.452 . . . . 0.0 112.23 -175.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -75.85 156.19 34.63 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.826 0.85 . . . . 0.0 110.158 -175.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -140.55 159.44 42.18 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.416 1.486 . . . . 0.0 108.672 169.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -60.37 -24.23 64.93 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -173.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -106.38 26.85 18.86 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.181 1.372 . . . . 0.0 112.688 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 46.7 m -60.96 -26.99 67.93 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 119.126 1.463 . . . . 0.0 110.316 172.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 38.7 mt -132.58 160.75 35.68 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 126.545 1.938 . . . . 0.0 106.813 174.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -80.96 44.94 0.78 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.245 1.018 . . . . 0.0 111.314 -178.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -164.12 -50.24 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.185 1.394 . . . . 0.0 110.742 175.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 126.19 -37.58 2.42 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 127.163 2.316 . . . . 0.0 110.878 -175.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -144.5 42.61 1.37 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.403 1.481 . . . . 0.0 108.896 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -57.26 125.12 21.34 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 169.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -140.41 79.29 20.98 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -168.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.48 -15.29 30.96 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.225 2.617 . . . . 0.0 112.835 -174.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 47.2 m -153.51 152.85 31.43 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 104.055 -2.572 . . . . 0.0 104.055 172.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -47.8 -45.41 29.49 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -169.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.83 -3.93 57.01 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -174.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -78.1 132.01 68.1 Favored Pre-proline 0 C--O 1.234 0.242 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -176.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . 0.262 0.1 OUTLIER 17.55 51.63 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.638 1 C-N-CA 127.609 5.539 . . . . 0.0 116.381 -169.216 . . . . . . . . 4 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.8 p -83.44 -176.08 6.13 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.035 1.734 . . . . 0.0 111.44 -176.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -62.78 167.49 4.56 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.793 0.837 . . . . 0.0 109.313 169.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -53.75 -44.45 69.98 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 118.44 -0.79 . . . . 0.0 111.73 -176.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.7 t70 61.44 -34.99 0.1 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 129.711 3.204 . . . . 0.0 115.931 177.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -64.22 -18.24 64.33 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.586 2.355 . . . . 0.0 111.509 174.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -133.57 146.08 50.66 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 126.168 1.787 . . . . 0.0 106.485 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -75.39 -19.62 59.44 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.945 0.498 . . . . 0.0 111.889 -169.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -140.92 143.39 34.57 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.167 0.987 . . . . 0.0 108.968 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.7 p -145.5 140.77 22.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 174.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 40.7 tpp -154.96 163.02 40.9 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.591 1.156 . . . . 0.0 108.779 -177.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -121.63 152.28 39.49 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 175.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -152.24 -143.0 3.6 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.119 -169.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -151.52 142.91 23.45 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 127.69 2.396 . . . . 0.0 105.001 169.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.3 p -116.05 140.48 37.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 172.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -132.96 54.69 1.94 Allowed 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.04 163.34 22.58 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.074 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 15.8 pt -103.17 175.25 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 123.238 0.615 . . . . 0.0 110.161 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -72.77 -5.26 36.73 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.017 1.327 . . . . 0.0 113.253 178.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.67 17.22 57.16 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.417 1.008 . . . . 0.0 112.585 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -139.63 119.45 13.34 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 169.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -130.05 25.74 5.23 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.291 1.836 . . . . 0.0 108.054 175.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 33.3 p -127.54 -174.0 3.06 Favored 'General case' 0 C--O 1.237 0.413 0 O-C-N 120.921 -1.112 . . . . 0.0 111.884 -168.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 71.0 m -143.0 -27.71 0.57 Allowed 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.048 0.939 . . . . 0.0 110.378 -169.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -147.37 -27.46 0.37 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.967 0.507 . . . . 0.0 111.008 177.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -57.18 -41.55 79.49 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.017 1.727 . . . . 0.0 109.077 171.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 54.99 73.84 0.39 Allowed 'General case' 0 C--N 1.343 0.321 0 C-N-CA 127.575 2.35 . . . . 0.0 107.223 177.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.72 150.79 2.67 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 113.465 -1.698 . . . . 0.0 113.315 -168.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.1 m -128.52 22.49 5.96 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.523 0.729 . . . . 0.0 111.428 -170.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -132.49 144.04 50.18 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 169.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 45.1 tp -80.35 143.62 33.4 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 168.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 13.4 m -135.75 143.4 45.27 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -169.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -138.89 156.27 47.42 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.881 0.873 . . . . 0.0 111.182 -169.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -133.74 139.42 46.35 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 171.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.3 t -137.8 144.05 32.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -177.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 65.6 m -126.31 121.75 33.5 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 174.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -145.47 116.11 7.67 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 119.396 0.998 . . . . 0.0 109.354 -170.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 56.92 21.3 36.98 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-O 119.377 -0.679 . . . . 0.0 114.513 -178.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 91.06 -8.49 79.62 Favored Glycine 0 CA--C 1.535 1.335 0 CA-C-N 118.553 1.176 . . . . 0.0 113.296 -175.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -85.91 168.12 14.49 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 118.719 1.26 . . . . 0.0 107.992 169.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.8 tp -139.59 157.75 45.28 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.457 0.703 . . . . 0.0 110.09 -173.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 14.6 ptp -155.64 159.26 39.45 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.141 0.976 . . . . 0.0 109.578 168.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 29.7 ttp85 -135.63 141.05 45.0 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 169.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 5.8 tt -143.38 154.5 43.78 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 118.801 0.728 . . . . 0.0 109.829 -176.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -135.13 148.48 49.77 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 169.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -169.2 166.41 39.67 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 170.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -70.9 103.57 2.68 Favored 'General case' 0 N--CA 1.462 0.126 0 O-C-N 121.728 -0.866 . . . . 0.0 109.825 179.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . 10.7 -67.57 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 130.987 3.715 . . . . 0.0 117.786 -171.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -61.47 -13.5 21.27 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 120.76 1.618 . . . . 0.0 114.077 178.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -62.8 -43.77 97.93 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 126.608 1.963 . . . . 0.0 109.781 171.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.47 -38.3 77.3 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.737 1.215 . . . . 0.0 109.977 -176.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 42.79 35.72 0.75 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.431 2.693 . . . . 0.0 113.599 175.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 173.86 58.82 0.05 OUTLIER Glycine 0 C--N 1.333 0.412 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -170.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -95.38 -0.65 52.38 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.761 0.824 . . . . 0.0 112.469 -170.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.504 ' C ' ' H ' ' A' ' 138' ' ' ASP . 7.0 tp10 -72.22 146.09 47.55 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 170.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 1.8 p -62.15 0.48 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 124.734 1.214 . . . . 0.0 110.988 169.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.504 ' H ' ' C ' ' A' ' 136' ' ' GLU . 36.8 t70 -137.97 9.51 2.8 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.471 1.909 . . . . 0.0 113.28 179.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 58.5 m -68.4 -73.1 0.15 Allowed 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.46 -0.775 . . . . 0.0 111.081 169.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.341 10.3 ptm180 -89.03 25.96 1.69 Allowed 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 122.364 1.078 . . . . 0.0 112.755 -169.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . 0.255 60.9 t -83.01 -4.93 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 C-N-CA 127.446 2.299 . . . . 0.0 107.708 168.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -126.45 120.12 28.94 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 102.654 -3.091 . . . . 0.0 102.654 169.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 10.4 tt -141.68 141.76 33.35 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -168.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 mp -138.65 157.33 46.33 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.379 1.072 . . . . 0.0 108.463 -174.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 78.1 mtm -143.03 158.94 43.14 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.887 -0.508 . . . . 0.0 110.795 173.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -152.26 169.47 22.4 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.985 1.714 . . . . 0.0 108.567 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -61.55 168.83 2.64 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.233 -0.917 . . . . 0.0 110.952 169.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.41 168.35 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.966 1.706 . . . . 0.0 114.551 175.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -142.45 21.26 2.04 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.692 1.197 . . . . 0.0 112.597 171.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 . . . . . 0 C--O 1.247 0.963 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -178.561 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.6 tpt . . . . . 0 N--CA 1.478 0.935 0 CA-C-O 121.34 0.591 . . . . 0.0 109.727 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.38 166.17 23.7 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.941 1.296 . . . . 0.0 111.813 -176.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 155.01 173.98 24.4 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 110.461 -1.055 . . . . 0.0 110.461 169.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 35.7 pt -78.6 43.78 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 O-C-N 121.554 -0.968 . . . . 0.0 110.168 170.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 42.0 tp -63.62 -30.08 71.23 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.603 1.161 . . . . 0.0 112.347 -169.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -154.3 164.64 38.26 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.742 1.217 . . . . 0.0 109.225 174.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -148.69 151.45 34.93 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 126.621 1.969 . . . . 0.0 105.948 172.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -147.1 148.06 31.22 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 123.381 0.672 . . . . 0.0 110.633 176.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.8 mp -115.84 137.17 50.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 104.529 -2.397 . . . . 0.0 104.529 169.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -137.84 168.62 19.32 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.318 0.647 . . . . 0.0 110.933 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -131.17 121.33 24.67 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.964 2.106 . . . . 0.0 107.697 -175.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 96.3 t -63.81 127.51 24.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 176.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.2 mmmt -105.83 -30.52 9.34 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 124.204 1.001 . . . . 0.0 109.87 176.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -156.27 167.33 30.76 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.833 0.742 . . . . 0.0 111.45 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.4 mp -139.53 140.41 37.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 127.758 2.423 . . . . 0.0 105.845 -176.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -146.67 93.19 4.93 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 123.35 0.66 . . . . 0.0 110.025 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.73 149.16 51.3 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.196 2.597 . . . . 0.0 112.234 173.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -82.51 -3.05 55.24 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -176.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.09 52.1 0.39 Allowed Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.981 -1.247 . . . . 0.0 109.981 -174.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? 40.3 42.33 1.2 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.865 2.066 . . . . 0.0 112.434 -169.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -79.02 79.79 5.4 Favored 'General case' 0 C--N 1.338 0.108 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 170.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 65.62 114.88 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 128.733 2.813 . . . . 0.0 108.704 -169.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -56.74 -33.89 66.99 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -169.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 51.6 ptt85 -81.89 0.53 39.31 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-O 116.558 -1.687 . . . . 0.0 113.708 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.5 t -121.77 113.78 40.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 121.686 2.039 . . . . 0.0 107.521 -174.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.4 m -147.84 163.21 37.48 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 123.206 0.603 . . . . 0.0 110.565 -172.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.9 ttm-85 -73.52 154.2 39.97 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 172.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.3 mt -135.13 155.01 51.45 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 125.749 1.62 . . . . 0.0 107.315 170.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -131.0 130.11 42.94 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 169.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 30.2 m -140.65 153.71 46.12 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.047 1.339 . . . . 0.0 110.571 -169.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -112.07 124.69 52.96 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 177.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 69.8 m -77.67 140.88 39.64 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 174.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -94.43 -26.73 16.37 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.456 1.102 . . . . 0.0 111.411 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.5 m -62.87 -46.52 87.5 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -169.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -141.68 -95.58 0.13 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.596 0.634 . . . . 0.0 110.413 -172.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 43.5 mtmt -145.29 21.09 1.55 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.7 1.6 . . . . 0.0 110.868 -168.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 56.5 mtm -88.64 159.44 17.85 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.402 0.681 . . . . 0.0 111.62 -169.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -138.98 127.67 23.32 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 127.62 2.368 . . . . 0.0 106.635 -177.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 56.6 tp -129.48 138.68 51.54 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.623 1.101 . . . . 0.0 110.769 -169.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.7 mm -124.41 146.94 29.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 169.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.1 mp -140.88 163.95 31.56 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.995 1.718 . . . . 0.0 108.142 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -138.49 96.29 3.14 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 100.374 -3.936 . . . . 0.0 100.374 168.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.3 p -140.95 171.18 13.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 123.26 0.624 . . . . 0.0 111.389 -167.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -68.17 93.13 0.43 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.194 1.398 . . . . 0.0 109.624 170.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.6 pp -74.14 -1.33 2.83 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -171.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 60.9 mm-40 -65.75 -13.87 60.21 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 120.357 1.435 . . . . 0.0 111.503 175.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 82.7 mt -58.25 -29.79 38.38 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 C-N-CA 124.314 1.046 . . . . 0.0 108.921 168.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -115.61 145.42 34.48 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 124.663 1.185 . . . . 0.0 113.002 -168.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -78.93 77.65 4.01 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.531 2.82 . . . . 0.0 107.152 169.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.7 m -57.53 -9.93 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -171.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -57.67 -31.42 66.32 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.732 0.813 . . . . 0.0 111.999 169.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -147.03 -7.42 0.48 Allowed 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.811 1.412 . . . . 0.0 114.811 178.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.82 174.88 45.51 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-N 119.349 0.977 . . . . 0.0 111.827 -178.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -155.52 174.27 15.5 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.882 1.273 . . . . 0.0 108.713 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -93.61 153.21 18.52 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.169 0.988 . . . . 0.0 109.772 174.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -148.66 173.6 13.04 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.622 1.169 . . . . 0.0 109.458 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 50.6 ttt180 -131.18 146.23 52.25 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 125.839 1.656 . . . . 0.0 107.569 -175.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.1 tt -141.25 138.17 33.06 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 125.5 1.52 . . . . 0.0 107.474 -171.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.4 t -147.75 154.35 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -173.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 tt -81.71 -52.12 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 168.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 61.06 161.32 0.06 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 128.544 2.738 . . . . 0.0 114.168 -175.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.5 m -62.4 151.57 36.62 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.966 173.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.0 m -159.25 89.96 0.94 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 -177.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.1 tt -58.38 -23.93 58.44 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.558 0.743 . . . . 0.0 111.221 173.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -55.16 -17.05 3.64 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.381 1.472 . . . . 0.0 113.547 176.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -62.3 -21.36 65.18 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.236 0.926 . . . . 0.0 112.51 173.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -130.62 -35.85 1.45 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.593 1.157 . . . . 0.0 111.54 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -90.48 44.94 2.92 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 169.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.53 173.68 0.9 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.092 1.357 . . . . 0.0 108.76 169.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.0 pp -55.4 -23.92 27.31 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.107 -0.996 . . . . 0.0 113.41 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -61.04 -20.65 62.8 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.442 1.097 . . . . 0.0 112.799 175.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -73.73 2.26 8.61 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.153 0.981 . . . . 0.0 113.375 175.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.14 30.47 31.05 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.584 1.088 . . . . 0.0 112.222 172.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -138.23 116.38 11.78 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 177.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -154.04 143.86 21.8 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.827 1.251 . . . . 0.0 107.997 178.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -141.84 147.21 44.15 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 126.106 1.762 . . . . 0.0 107.396 169.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.82 -27.23 14.91 Favored 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 122.233 1.955 . . . . 0.0 113.043 -170.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -39.11 93.4 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.498 1.119 . . . . 0.0 110.944 177.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.2 t70 55.5 -51.98 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 130.846 3.658 . . . . 0.0 115.591 -178.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -138.85 -24.89 0.9 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.691 1.997 . . . . 0.0 111.923 174.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -62.06 131.69 93.46 Favored Pre-proline 0 C--N 1.343 0.298 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -178.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . 0.259 0.9 OUTLIER 28.14 38.95 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.654 1 C-N-CA 126.17 4.58 . . . . 0.0 116.985 -169.203 . . . . . . . . 4 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.8 m -99.27 11.51 38.86 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.807 1.243 . . . . 0.0 111.354 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 56.45 28.11 13.18 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.182 1.793 . . . . 0.0 112.431 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -137.22 2.02 2.49 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.35 1.06 . . . . 0.0 112.799 176.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.434 ' C ' ' H ' ' A' ' 88' ' ' PHE . 23.9 t0 -81.56 55.23 2.58 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 169.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -78.53 22.13 0.36 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.263 1.425 . . . . 0.0 111.122 -175.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.434 ' H ' ' C ' ' A' ' 86' ' ' ASP . 17.5 m-85 -133.75 159.83 39.4 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 126.93 2.092 . . . . 0.0 108.806 -168.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -80.52 -30.78 37.22 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 122.022 -0.424 . . . . 0.0 109.965 178.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -153.85 147.69 25.41 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.111 0.964 . . . . 0.0 108.972 171.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.4 p -151.93 142.39 15.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 169.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.7 tpt -158.28 168.43 27.03 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.006 1.323 . . . . 0.0 109.144 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -119.5 146.13 45.71 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 172.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -150.14 -158.33 8.15 Favored Glycine 0 C--N 1.336 0.558 0 CA-C-N 118.775 0.716 . . . . 0.0 112.014 -171.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -125.91 136.22 52.79 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 174.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 47.1 t -98.03 150.09 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 176.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -135.21 157.96 45.57 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 169.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.07 153.47 29.45 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 120.754 -1.216 . . . . 0.0 109.234 172.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.56 -177.85 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 O-C-N 123.671 0.607 . . . . 0.0 109.618 176.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -68.48 -6.57 25.78 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.053 1.341 . . . . 0.0 114.054 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 121.58 -60.45 0.55 Allowed Glycine 0 C--N 1.338 0.682 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 -175.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -66.96 125.48 26.08 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 175.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -127.79 15.5 6.94 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.65 0.78 . . . . 0.0 111.169 174.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 38.7 p -139.67 -60.71 0.55 Allowed 'General case' 0 C--O 1.233 0.203 0 O-C-N 120.862 -1.149 . . . . 0.0 112.438 -169.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.3 m 156.6 -41.65 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.422 1 C-N-CA 133.678 4.791 . . . . 0.0 106.184 -173.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -178.24 -39.45 0.01 OUTLIER 'General case' 0 C--N 1.346 0.445 0 C-N-CA 125.817 1.647 . . . . 0.0 108.891 -174.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -58.87 -22.23 58.77 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 -169.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -139.17 15.89 2.61 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.927 1.239 . . . . 0.0 111.791 169.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.88 -9.39 20.6 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 177.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.5 p -75.39 -7.25 53.54 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 127.303 2.241 . . . . 0.0 113.59 -174.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -127.69 132.23 49.69 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 126.707 2.003 . . . . 0.0 105.605 175.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 66.1 tp -65.9 147.05 53.98 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 169.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -115.77 133.01 56.47 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 169.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -122.36 157.23 32.26 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 173.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -126.68 149.32 49.61 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.9 t -134.43 132.62 55.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 18.5 m -124.22 119.58 29.77 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -144.22 117.37 8.94 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.282 1.033 . . . . 0.0 109.192 -169.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 56.79 27.21 55.52 Favored Glycine 0 CA--C 1.535 1.294 0 O-C-N 121.724 -0.61 . . . . 0.0 114.221 176.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 84.13 -3.1 86.82 Favored Glycine 0 CA--C 1.536 1.346 0 CA-C-N 118.25 1.025 . . . . 0.0 113.543 -177.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 78.8 mt -95.7 163.52 13.15 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.1 1.36 . . . . 0.0 107.483 169.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.8 tt -148.88 157.67 43.6 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 121.712 -0.618 . . . . 0.0 111.068 -169.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 24.6 ptp -151.63 162.44 40.98 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.655 1.182 . . . . 0.0 109.311 169.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 43.6 ttt-85 -132.03 127.24 35.78 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 171.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 54.6 tp -127.37 119.38 26.08 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 -178.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -94.38 149.42 21.25 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 168.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -169.09 171.03 42.84 Favored Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 171.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -53.66 133.05 41.74 Favored 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 169.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -43.24 -59.28 2.14 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -172.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -58.43 -43.66 88.84 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 122.288 1.042 . . . . 0.0 111.429 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -61.73 -26.25 67.94 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 113.58 -1.646 . . . . 0.0 111.31 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 32.8 tp -81.23 -22.74 38.54 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 118.765 -0.636 . . . . 0.0 110.668 -176.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 37.6 49.49 1.04 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.292 1.037 . . . . 0.0 111.997 -170.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -118.08 0.42 17.01 Favored Glycine 0 C--N 1.341 0.845 0 CA-C-O 118.536 -1.147 . . . . 0.0 113.425 -173.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -67.06 -32.09 73.04 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.477 1.638 . . . . 0.0 108.211 168.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -65.14 71.19 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.678 1 C-N-CA 131.8 4.04 . . . . 0.0 108.936 169.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.9 m -59.82 -4.21 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 125.351 1.46 . . . . 0.0 113.954 176.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -125.6 18.39 8.08 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 125.711 1.605 . . . . 0.0 112.128 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.2 m -103.03 -59.1 1.76 Allowed 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 168.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.379 9.9 ptm85 -75.44 11.65 1.2 Allowed 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -175.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 16.6 m -62.35 -40.11 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 167.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -81.19 129.49 34.61 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 176.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -141.65 122.82 14.72 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 -169.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.7 tt -137.44 138.32 39.67 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -172.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 90.5 mtp -139.8 142.64 36.66 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 123.769 0.828 . . . . 0.0 109.229 -177.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -155.92 168.43 27.24 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.226 1.411 . . . . 0.0 107.875 -175.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -60.14 159.03 10.21 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.54 -0.725 . . . . 0.0 109.217 169.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.6 pp -68.91 165.22 20.4 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 120.684 0.278 . . . . 0.0 110.788 169.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -130.75 63.17 1.59 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.285 1.034 . . . . 0.0 109.288 -173.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 . . . . . 0 C--O 1.251 1.159 0 C-N-CA 125.947 1.699 . . . . 0.0 107.646 178.295 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 mmt . . . . . 0 N--CA 1.484 1.243 0 N-CA-C 110.035 -0.358 . . . . 0.0 110.035 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.25 170.91 18.87 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.129 1.372 . . . . 0.0 109.049 178.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -67.21 -178.39 10.86 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.624 1.107 . . . . 0.0 113.111 174.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 40.1 pt -134.36 153.39 35.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 125.39 1.476 . . . . 0.0 109.424 -175.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -71.21 113.57 8.39 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.015 0.435 . . . . 0.0 110.223 177.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -161.7 148.87 14.39 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.645 1.978 . . . . 0.0 106.061 169.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -154.16 138.96 17.09 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.382 1.073 . . . . 0.0 109.035 -172.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -151.12 145.07 25.2 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 168.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.7 mp -85.78 145.1 8.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 106.233 -1.765 . . . . 0.0 106.233 178.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -132.97 148.08 52.27 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.634 1.174 . . . . 0.0 108.654 177.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -117.64 130.55 56.44 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.268 1.427 . . . . 0.0 108.349 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 84.0 t -70.08 113.22 5.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -84.48 -35.18 23.14 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.804 1.241 . . . . 0.0 110.157 175.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -155.99 170.18 22.75 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.316 0.962 . . . . 0.0 111.19 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.8 mp -137.76 132.37 44.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 126.873 2.069 . . . . 0.0 105.905 -178.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -129.25 103.63 18.19 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 124.607 1.163 . . . . 0.0 109.08 176.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -104.31 11.69 0.26 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.925 3.084 . . . . 0.0 113.63 175.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -76.33 74.99 3.12 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.828 1.251 . . . . 0.0 111.346 -169.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 144.0 -9.68 2.03 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.812 1.672 . . . . 0.0 111.76 -178.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -71.33 86.17 0.81 Allowed 'General case' 0 C--N 1.339 0.144 0 C-N-CA 125.195 1.398 . . . . 0.0 110.78 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -54.66 -42.9 71.86 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 169.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -78.25 82.13 4.57 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 169.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -56.95 -24.62 54.15 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.881 1.273 . . . . 0.0 114.419 -169.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -73.9 3.82 6.18 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 174.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.7 t -115.15 147.77 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 176.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.7 m -150.25 158.02 43.71 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 120.995 -1.066 . . . . 0.0 110.439 169.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 19.6 ttp180 -85.89 89.41 7.77 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 171.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 82.2 mt -66.03 152.26 45.02 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 169.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -126.32 133.29 51.42 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 104.306 -2.479 . . . . 0.0 104.306 172.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.9 m -144.13 165.75 26.95 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.103 0.865 . . . . 0.0 112.733 -169.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -135.76 138.21 42.42 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.445 1.498 . . . . 0.0 109.543 -176.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 29.5 t -60.11 135.23 57.65 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.005 1.722 . . . . 0.0 110.326 174.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -81.92 -41.99 20.11 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 119.157 -0.449 . . . . 0.0 110.326 171.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.2 m -92.04 -26.82 18.16 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 115.654 1.724 . . . . 0.0 115.654 -168.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -129.89 -107.84 0.28 Allowed 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 120.359 1.436 . . . . 0.0 109.933 -169.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -149.7 0.44 0.48 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.748 1.619 . . . . 0.0 112.931 -169.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 68.3 mtm -67.03 145.78 55.03 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.36 0.6 . . . . 0.0 109.54 -172.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -123.11 138.28 54.7 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 177.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.1 mt -136.31 152.59 50.85 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.729 0.776 . . . . 0.0 112.221 -169.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 31.6 mm -137.32 140.82 41.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 129.248 3.019 . . . . 0.0 102.97 169.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 8.2 mt -148.82 100.59 3.1 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 126.495 1.918 . . . . 0.0 106.575 -169.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -84.55 92.8 8.21 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 169.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.1 m -143.53 167.64 12.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 124.016 0.926 . . . . 0.0 111.995 -169.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -55.58 138.47 46.8 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.289 1.436 . . . . 0.0 110.889 170.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 pp -120.77 1.39 7.06 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 C-N-CA 124.8 1.24 . . . . 0.0 113.374 178.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -67.69 -9.52 44.25 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 121.209 1.822 . . . . 0.0 112.543 -175.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 28.8 mt -61.41 -24.02 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 C-N-CA 125.507 1.523 . . . . 0.0 108.315 169.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -127.22 169.32 12.47 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 127.785 2.434 . . . . 0.0 109.501 -169.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -53.17 156.3 10.47 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.422 2.081 . . . . 0.0 111.982 169.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.4 p -56.49 -21.74 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 125.543 1.537 . . . . 0.0 114.53 -169.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -133.29 29.49 3.98 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.535 1.134 . . . . 0.0 110.594 -173.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 21.6 tp -144.42 168.3 20.43 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.154 0.982 . . . . 0.0 110.18 -173.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -150.57 164.2 29.78 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 107.122 -2.391 . . . . 0.0 107.122 169.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -141.81 166.45 24.7 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.928 0.891 . . . . 0.0 109.66 -172.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -57.73 140.66 50.91 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.223 1.009 . . . . 0.0 110.615 -173.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -148.49 -179.68 7.14 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.595 1.558 . . . . 0.0 108.466 -178.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -129.34 150.26 50.78 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 121.38 -0.825 . . . . 0.0 109.142 173.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 61.4 tp -110.55 141.29 43.92 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.925 1.69 . . . . 0.0 107.026 174.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 55.6 t -141.91 157.76 20.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 128.248 2.619 . . . . 0.0 105.534 -177.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.2 pt -133.14 30.51 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 123.899 0.88 . . . . 0.0 110.772 -175.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -100.73 -0.69 36.78 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.899 1.279 . . . . 0.0 113.599 -169.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.9 p -70.21 177.89 3.08 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.901 1.28 . . . . 0.0 111.987 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.9 m -137.06 167.66 21.1 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 170.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 65.6 tp -62.44 -34.32 76.55 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.342 -0.849 . . . . 0.0 110.941 171.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 64.72 165.22 0.15 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 127.752 2.421 . . . . 0.0 112.953 -175.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -138.09 -157.31 0.76 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 128.391 2.676 . . . . 0.0 107.669 170.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -59.76 -23.89 63.61 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 -169.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -154.39 25.9 0.68 Allowed Glycine 0 C--N 1.341 0.825 0 CA-C-O 118.898 -0.945 . . . . 0.0 114.832 -171.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.8 m -61.24 -27.5 68.49 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.352 1.576 . . . . 0.0 112.245 -177.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 90.2 mt -75.63 -11.41 60.0 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 118.64 -0.695 . . . . 0.0 111.958 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.6 t0 40.06 54.69 2.7 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.39 1.876 . . . . 0.0 111.268 -169.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -147.63 -61.53 0.27 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.084 -169.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 66.62 1.3 10.72 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 126.72 2.105 . . . . 0.0 114.919 175.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -83.45 -38.18 22.21 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.166 1.483 . . . . 0.0 108.554 173.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -57.64 117.99 4.78 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.433 1.093 . . . . 0.0 108.398 169.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -148.53 161.07 34.74 Favored Pre-proline 0 CA--C 1.534 0.333 0 C-N-CA 125.731 1.613 . . . . 0.0 107.445 -178.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -52.96 -26.51 31.94 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 123.345 2.696 . . . . 0.0 114.85 176.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.1 p -60.59 -11.35 6.93 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.055 1.742 . . . . 0.0 113.243 174.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -66.87 -19.77 65.79 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.845 0.858 . . . . 0.0 112.023 170.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -132.07 -33.66 1.32 Allowed 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 45.8 mtm180 -60.68 128.28 88.31 Favored Pre-proline 0 N--CA 1.468 0.474 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 169.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . 0.27 1.1 Cg_exo 32.94 41.09 0.0 OUTLIER 'Trans proline' 0 CA--C 1.541 0.872 1 C-N-CA 125.392 4.061 . . . . 0.0 116.056 -168.805 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.8 m -152.08 -158.76 0.93 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 128.565 2.746 . . . . 0.0 106.407 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? -152.63 114.75 4.41 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 120.886 -1.134 . . . . 0.0 109.591 172.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.3 146.13 54.43 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 169.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -140.4 -29.55 0.69 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.471 1.108 . . . . 0.0 111.68 174.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.21 -30.04 64.23 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.774 1.63 . . . . 0.0 111.291 173.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -148.67 174.1 12.51 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.664 2.385 . . . . 0.0 107.378 176.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -124.66 -37.8 2.45 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.303 0.641 . . . . 0.0 110.619 172.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -152.2 158.53 43.0 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.386 0.994 . . . . 0.0 110.746 174.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.4 m -145.26 146.93 19.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 126.367 1.867 . . . . 0.0 107.877 174.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.31 175.63 10.69 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.835 0.826 . . . . 0.0 112.684 173.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -133.55 154.31 50.95 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 128.092 2.557 . . . . 0.0 106.883 172.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.88 -152.35 6.87 Favored Glycine 0 C--N 1.337 0.6 0 CA-C-N 119.602 1.092 . . . . 0.0 113.342 -171.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 43.9 tttp -141.46 139.03 33.27 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.215 1.406 . . . . 0.0 108.397 173.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 38.9 t -83.54 149.87 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.868 1.267 . . . . 0.0 108.932 169.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -133.31 48.3 2.4 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.196 1.798 . . . . 0.0 109.354 -177.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.5 mmt180 -149.45 163.18 38.5 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.595 1.158 . . . . 0.0 110.044 -177.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 25.5 pt -72.12 171.43 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 124.698 1.199 . . . . 0.0 111.207 174.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -74.42 4.77 5.42 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 127.114 2.166 . . . . 0.0 114.471 -177.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.61 29.01 70.73 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 124.458 1.028 . . . . 0.0 113.769 -176.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -129.05 120.24 25.63 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 169.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.431 ' H ' ' HA ' ' A' ' 109' ' ' ALA . 8.6 tp10 -112.9 -21.18 11.27 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 124.006 0.816 . . . . 0.0 111.628 -178.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.263 0.0 OUTLIER 44.03 169.85 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 131.092 3.757 . . . . 0.0 117.55 177.681 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 34.7 m -176.35 -50.02 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 129.765 3.226 . . . . 0.0 104.834 175.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.0 p -147.56 -58.4 0.26 Allowed 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 169.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -146.93 64.65 1.17 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.176 2.19 . . . . 0.0 106.371 177.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -124.75 24.25 7.77 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.867 0.867 . . . . 0.0 110.573 -173.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.431 ' HA ' ' H ' ' A' ' 103' ' ' GLU . . . -61.02 165.94 3.85 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 123.174 0.59 . . . . 0.0 109.935 169.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 37.1 p -130.46 -172.66 2.86 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 121.319 -0.863 . . . . 0.0 111.718 -169.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -62.62 138.13 58.42 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 168.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.4 125.32 26.68 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 103.162 -2.903 . . . . 0.0 103.162 167.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 13.6 m -105.1 144.05 32.43 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 173.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -135.49 85.33 2.16 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 125.592 1.557 . . . . 0.0 107.367 -169.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 5.9 m-30 -85.28 126.35 33.64 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 103.03 -2.952 . . . . 0.0 103.03 169.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.1 t -141.23 143.59 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 119.971 1.26 . . . . 0.0 108.306 -171.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.0 t -130.38 139.4 50.64 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 171.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -149.65 106.44 3.55 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.339 1.455 . . . . 0.0 108.525 -169.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 58.45 24.34 55.95 Favored Glycine 0 CA--C 1.535 1.313 0 CA-C-O 119.362 -0.688 . . . . 0.0 114.248 175.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.04 -8.95 65.41 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-N 118.295 1.048 . . . . 0.0 113.47 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 11.2 mp -95.21 158.08 15.62 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 106.924 -1.509 . . . . 0.0 106.924 169.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.3 tt -144.1 154.14 42.89 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.915 -0.491 . . . . 0.0 110.109 -170.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 23.3 ptt? -142.11 161.24 38.5 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 169.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 25.6 ttm180 -138.27 115.27 10.86 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 104.464 -2.421 . . . . 0.0 104.464 171.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 11.2 tp -126.15 149.15 49.18 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 126.389 1.876 . . . . 0.0 107.086 -169.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -140.95 150.97 43.8 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 168.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -173.58 177.03 46.1 Favored Glycine 0 C--N 1.331 0.279 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 169.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -57.04 139.53 51.98 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 118.51 1.155 . . . . 0.0 109.183 172.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -50.86 -55.16 18.34 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -176.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.69 -11.4 60.61 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 121.467 -0.771 . . . . 0.0 112.507 -177.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -81.4 -29.12 34.05 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.603 1.161 . . . . 0.0 110.366 172.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.9 mp -80.36 -29.52 37.9 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 169.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 2.1 t60 59.92 25.35 14.49 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.278 1.831 . . . . 0.0 114.44 171.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -168.84 95.06 0.11 Allowed Glycine 0 C--N 1.335 0.49 0 N-CA-C 107.142 -2.383 . . . . 0.0 107.142 177.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -96.0 9.94 39.08 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.388 1.075 . . . . 0.0 113.544 -175.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -74.75 146.56 42.07 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.593 0.711 . . . . 0.0 109.142 173.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.6 m -64.53 -5.19 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.273 168.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -122.09 17.34 10.81 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 127.368 2.267 . . . . 0.0 111.787 176.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 57.5 m -88.2 -57.16 3.03 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 121.272 -0.892 . . . . 0.0 109.096 167.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 4.9 mmm180 -74.58 -5.24 41.75 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -169.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 30.2 m -62.09 -40.9 89.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.408 177.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -74.68 117.4 16.47 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.2 tt -132.56 135.72 46.12 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 -174.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 10.2 tt -143.19 142.03 31.31 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 173.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 80.5 mtp -135.82 152.24 50.88 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 174.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 51.7 mttt -144.09 176.43 9.31 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.108 0.963 . . . . 0.0 109.315 177.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -57.3 165.98 1.3 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.212 0.605 . . . . 0.0 109.47 168.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.57 166.58 0.88 Allowed 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.662 -0.649 . . . . 0.0 111.831 169.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.8 77.72 4.81 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.672 0.789 . . . . 0.0 109.084 176.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 15.5 t80 . . . . . 0 C--O 1.25 1.123 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 175.527 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ptp . . . . . 0 N--CA 1.482 1.143 0 CA-C-O 120.417 0.151 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.67 162.93 20.09 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 122.879 0.471 . . . . 0.0 109.802 169.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.14 -163.78 37.06 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 -177.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.0 tp -52.49 126.92 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 123.844 0.857 . . . . 0.0 109.261 175.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.56 -61.7 0.16 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.625 0.77 . . . . 0.0 109.182 -175.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -151.98 140.81 20.98 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.293 0.637 . . . . 0.0 110.909 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -158.11 138.27 12.47 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.84 2.456 . . . . 0.0 106.756 171.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -159.55 157.47 29.95 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.955 0.798 . . . . 0.0 110.265 168.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.35 153.41 4.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 105.588 -2.004 . . . . 0.0 105.588 169.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -134.21 151.12 51.16 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.569 1.547 . . . . 0.0 107.857 175.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -120.07 122.43 41.07 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 126.598 1.959 . . . . 0.0 107.786 -176.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.8 t -71.63 116.43 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -90.88 -32.7 15.93 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 124.878 1.271 . . . . 0.0 110.245 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -157.02 167.37 30.68 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 119.308 0.958 . . . . 0.0 111.181 176.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.4 mp -141.54 146.53 23.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 127.212 2.205 . . . . 0.0 107.358 -175.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -136.31 109.31 9.62 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 125.819 1.648 . . . . 0.0 108.294 170.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -118.13 26.77 0.02 OUTLIER 'Trans proline' 0 CA--C 1.548 1.181 1 C-N-CA 125.744 4.296 . . . . 0.0 110.203 169.675 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -61.53 -19.75 62.47 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 116.161 1.912 . . . . 0.0 116.161 -167.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -178.63 35.15 0.08 OUTLIER Glycine 0 C--N 1.336 0.554 0 N-CA-C 107.827 -2.109 . . . . 0.0 107.827 177.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.47 117.99 9.47 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 -177.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -41.85 -38.17 1.45 Allowed 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.498 1.919 . . . . 0.0 112.98 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -117.79 104.1 10.63 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 104.386 -2.45 . . . . 0.0 104.386 170.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -63.5 -25.22 68.16 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -169.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -66.18 -16.89 64.36 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.611 171.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 20.6 t -98.1 137.3 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 173.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 40.5 m -138.28 149.91 46.14 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 21.8 ttp180 -79.18 143.67 35.18 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 104.797 -2.298 . . . . 0.0 104.797 168.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.0 mt -135.28 158.7 43.7 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -130.85 130.78 44.05 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 104.222 -2.51 . . . . 0.0 104.222 169.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 58.3 m -138.46 168.68 19.26 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.577 1.151 . . . . 0.0 109.866 -175.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -136.19 135.89 39.5 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 174.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.1 p -66.52 149.52 50.33 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 174.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -67.08 -34.46 77.7 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.893 -0.504 . . . . 0.0 111.008 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.3 m -136.7 -32.74 0.81 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -173.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -83.12 17.44 2.0 Allowed 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -171.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 31.6 pttt 43.75 26.55 0.13 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.554 1.942 . . . . 0.0 114.98 175.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 64.3 mtt -80.13 115.79 19.89 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 124.927 1.291 . . . . 0.0 108.208 176.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -78.99 127.51 32.07 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 104.02 -2.585 . . . . 0.0 104.02 168.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.5 tp -133.11 144.06 49.71 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 119.949 1.249 . . . . 0.0 110.745 -169.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 34.1 mm -130.13 146.51 33.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 128.209 2.604 . . . . 0.0 104.216 169.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 mp -143.09 162.54 35.25 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 126.398 1.879 . . . . 0.0 108.7 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -137.03 95.41 3.1 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 101.163 -3.643 . . . . 0.0 101.163 168.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.1 p -142.6 158.87 19.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 123.357 0.663 . . . . 0.0 111.297 -167.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 36.8 t30 -60.69 140.16 57.6 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.378 1.071 . . . . 0.0 109.969 171.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.6 pp -117.47 -2.7 10.06 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 C-N-CA 125.299 1.44 . . . . 0.0 112.698 176.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -67.67 -11.71 58.87 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 120.19 1.359 . . . . 0.0 111.177 171.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.5 mt -60.11 -39.48 80.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 C-N-CA 124.633 1.173 . . . . 0.0 107.867 168.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -76.38 130.24 77.77 Favored Pre-proline 0 CA--C 1.538 0.503 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.05 -25.13 12.08 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.488 2.125 . . . . 0.0 112.746 -175.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.8 m -143.59 162.22 16.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 C-N-CA 125.681 1.593 . . . . 0.0 108.277 -178.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.3 t70 50.24 -148.97 0.29 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.062 1.345 . . . . 0.0 110.597 -174.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 87.0 mt -123.44 -8.58 8.05 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.427 1.491 . . . . 0.0 110.983 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 179.45 164.05 31.3 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 174.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -156.01 -89.69 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 173.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 35.7 mtmt -140.64 151.75 44.85 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.589 1.156 . . . . 0.0 108.241 170.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -151.04 170.65 18.86 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.517 1.127 . . . . 0.0 110.477 -179.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 65.5 ttp85 -115.64 119.51 36.34 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.52 1.528 . . . . 0.0 107.131 -177.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -106.72 139.12 41.66 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 177.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.0 p -158.25 149.79 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-O 121.389 0.614 . . . . 0.0 110.458 -169.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.7 pt -129.77 -19.38 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.491 1.117 . . . . 0.0 109.609 169.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -52.27 -33.78 43.43 Favored 'General case' 0 C--N 1.345 0.389 0 C-N-CA 125.767 1.627 . . . . 0.0 113.583 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.3 m -70.44 -9.24 55.92 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.046 0.938 . . . . 0.0 112.931 -178.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.3 m -67.06 130.57 43.54 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 119.281 0.946 . . . . 0.0 109.124 175.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 23.8 tp -151.03 48.64 0.85 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 169.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -55.68 -32.24 63.08 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.856 0.863 . . . . 0.0 112.746 -169.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.19 -13.91 61.66 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.148 0.979 . . . . 0.0 112.869 -178.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -68.98 -20.33 64.17 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.284 0.947 . . . . 0.0 110.98 169.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.98 33.36 65.57 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 -177.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.0 m -60.83 -21.46 63.2 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.039 1.336 . . . . 0.0 112.428 -174.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.6 20.31 6.65 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.077 1.751 . . . . 0.0 111.096 175.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.8 t70 37.67 34.47 0.05 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 129.822 3.249 . . . . 0.0 115.042 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.2 t70 44.88 31.03 0.62 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.405 1.882 . . . . 0.0 113.239 -174.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 169.67 -11.91 0.05 OUTLIER Glycine 0 CA--C 1.531 1.047 0 CA-C-O 118.631 -1.094 . . . . 0.0 115.49 -174.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -67.91 -25.97 65.75 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.695 1.748 . . . . 0.0 110.03 169.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -55.83 108.76 0.48 Allowed 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.441 1.096 . . . . 0.0 108.939 170.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -152.15 166.12 15.98 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 124.605 1.162 . . . . 0.0 108.801 -174.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -54.84 -13.98 7.1 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 124.001 3.134 . . . . 0.0 117.933 -171.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 34.7 p -59.91 -19.7 53.11 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 121.255 1.843 . . . . 0.0 112.452 174.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -99.29 -2.49 36.35 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.193 0.997 . . . . 0.0 111.96 178.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -126.77 -30.9 2.73 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.668 1.187 . . . . 0.0 113.08 -169.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -65.38 -48.04 68.27 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-O 117.534 -1.222 . . . . 0.0 110.503 171.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -84.13 5.2 6.46 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.274 1.982 . . . . 0.0 111.645 169.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . 0.288 8.9 p 37.56 43.5 0.44 Allowed 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 128.826 2.851 . . . . 0.0 114.516 -175.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -60.0 -20.63 58.78 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 118.729 -0.653 . . . . 0.0 111.351 172.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -53.81 -29.08 39.06 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.32 0.963 . . . . 0.0 112.349 171.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -60.81 -13.68 16.89 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.608 1.163 . . . . 0.0 113.175 -178.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -52.29 -32.33 37.02 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 121.355 -0.84 . . . . 0.0 112.435 171.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -148.96 -177.55 5.87 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.125 1.37 . . . . 0.0 111.854 -172.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.8 pm0 -56.98 125.14 21.28 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 114.561 -1.2 . . . . 0.0 112.052 -176.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -68.32 160.21 29.88 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 169.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.6 p -132.06 144.63 36.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 124.254 1.021 . . . . 0.0 109.542 -169.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 34.1 tpp -145.07 168.09 21.14 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 125.608 1.563 . . . . 0.0 107.935 171.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -130.65 147.02 52.27 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.404 1.482 . . . . 0.0 107.027 -173.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -156.62 -162.7 11.67 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 118.729 0.695 . . . . 0.0 113.638 -171.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -133.32 123.35 25.29 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.578 1.551 . . . . 0.0 106.828 174.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.4 t -84.14 147.28 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 173.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -139.66 129.74 25.06 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 173.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.88 157.54 43.28 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 120.706 1.594 . . . . 0.0 111.369 -178.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.2 pt -77.24 179.02 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 O-C-N 124.126 0.891 . . . . 0.0 110.42 -177.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -74.33 -3.52 30.76 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.918 1.287 . . . . 0.0 113.537 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.8 15.29 59.82 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-O 119.251 -0.749 . . . . 0.0 113.045 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -140.07 127.28 21.13 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 168.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -133.89 36.56 3.28 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.175 170.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.52 -44.01 1.56 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.653 1.181 . . . . 0.0 109.885 -169.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.2 p -164.03 -66.15 0.04 OUTLIER 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.5 p -151.95 -41.83 0.11 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.64 1.176 . . . . 0.0 110.211 -178.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -161.9 22.69 0.11 Allowed 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -169.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -120.34 7.73 10.74 Favored 'General case' 0 C--O 1.234 0.259 0 O-C-N 121.71 -0.619 . . . . 0.0 112.17 -170.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.84 165.66 8.3 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 169.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 23.1 p -121.89 -3.79 9.14 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -136.45 141.16 43.53 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.374 1.069 . . . . 0.0 108.97 178.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 55.6 tp -83.28 155.61 23.53 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 167.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.1 m -130.8 135.61 47.91 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 177.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -143.26 160.75 39.91 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.393 1.077 . . . . 0.0 110.79 -169.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -136.56 156.56 48.41 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.473 1.909 . . . . 0.0 107.485 176.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.0 p -150.69 139.94 15.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 169.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.5 m -121.07 123.41 42.28 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 -178.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 26.7 p90 -140.96 119.32 12.18 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 124.532 1.133 . . . . 0.0 109.437 -169.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 53.59 28.12 36.52 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 123.677 0.656 . . . . 0.0 114.464 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 84.55 -3.43 86.58 Favored Glycine 0 CA--C 1.535 1.342 0 CA-C-N 118.479 1.139 . . . . 0.0 113.782 -177.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 84.7 mt -95.5 166.24 11.95 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 125.282 1.433 . . . . 0.0 107.352 169.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 7.4 tt -148.63 155.66 41.37 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 121.306 -0.871 . . . . 0.0 110.99 -169.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 14.2 ptt? -153.29 157.92 40.84 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.944 0.898 . . . . 0.0 109.087 169.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -140.63 139.41 34.86 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 126.006 1.722 . . . . 0.0 106.829 -175.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -153.6 160.12 42.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 118.584 0.629 . . . . 0.0 112.221 -170.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -133.46 157.48 45.5 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.799 0.84 . . . . 0.0 109.029 169.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 178.42 173.77 44.09 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 171.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -52.52 134.38 35.12 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.651 1.225 . . . . 0.0 109.157 174.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -43.86 -66.09 0.43 Allowed 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 -169.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -57.88 -43.82 86.28 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 122.36 1.076 . . . . 0.0 111.665 -177.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -60.89 -26.38 67.4 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 126.797 2.039 . . . . 0.0 111.656 179.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 16.4 tp -73.45 -18.73 61.1 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 119.153 0.888 . . . . 0.0 110.186 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 41.89 44.65 2.98 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.689 1.596 . . . . 0.0 112.038 -178.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -142.78 2.66 1.7 Allowed Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.042 0.829 . . . . 0.0 113.557 -172.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -62.76 -27.0 68.98 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.507 1.154 . . . . 0.0 111.043 169.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -70.35 91.6 0.75 Allowed 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 129.083 2.953 . . . . 0.0 108.735 169.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 63.0 t -48.59 -21.39 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 126.996 2.119 . . . . 0.0 112.021 172.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -133.35 21.91 4.03 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -172.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 14.3 m -94.87 -64.02 1.11 Allowed 'General case' 0 C--O 1.232 0.179 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 167.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.329 9.3 ptm85 -77.89 12.95 1.52 Allowed 'General case' 0 C--N 1.344 0.356 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -172.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 15.7 m -61.44 -39.63 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 167.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -76.6 124.28 27.38 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 104.759 -2.311 . . . . 0.0 104.759 169.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 10.0 tt -137.96 128.15 25.99 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 -174.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 mp -134.66 151.01 50.71 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -175.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -156.13 153.34 29.16 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 174.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -144.53 164.44 30.89 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 169.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -56.07 164.04 1.37 Allowed 'General case' 0 CA--C 1.538 0.505 0 O-C-N 120.644 -1.285 . . . . 0.0 109.521 168.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.17 163.1 21.01 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.634 -0.666 . . . . 0.0 110.873 172.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -141.11 39.07 1.77 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.611 1.165 . . . . 0.0 110.065 -178.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 . . . . . 0 C--O 1.248 0.98 0 C-N-CA 125.578 1.551 . . . . 0.0 108.012 -174.884 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.0 mtm . . . . . 0 N--CA 1.484 1.251 0 CA-C-O 120.766 0.317 . . . . 0.0 110.419 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.99 -22.07 56.25 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.106 0.963 . . . . 0.0 112.177 178.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -161.39 -167.6 22.08 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -177.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -62.49 148.37 10.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 175.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 61.6 tp -66.83 128.67 37.18 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 169.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -151.93 137.6 17.87 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 178.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -157.0 130.6 8.1 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 169.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -158.46 152.52 23.89 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 118.474 0.579 . . . . 0.0 110.539 169.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 mp -86.54 142.87 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 172.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -126.04 148.87 49.21 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 125.576 1.55 . . . . 0.0 107.866 178.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -126.42 123.24 37.45 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 126.251 1.82 . . . . 0.0 107.615 -169.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 66.1 t -68.93 127.89 31.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 -173.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.9 mmpt? -89.97 -39.42 12.99 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.768 1.227 . . . . 0.0 109.338 169.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -159.62 166.99 29.52 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.083 0.856 . . . . 0.0 111.793 -177.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.4 mp -137.11 139.47 44.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 127.426 2.29 . . . . 0.0 106.124 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -147.41 95.18 4.36 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 124.902 1.281 . . . . 0.0 109.282 -171.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -63.51 9.72 0.12 Allowed 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 123.778 2.985 . . . . 0.0 116.921 -177.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -78.26 58.18 2.02 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.151 1.38 . . . . 0.0 109.631 175.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -166.94 35.59 0.23 Allowed Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.901 1.239 . . . . 0.0 111.277 -173.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.0 mmpt? -68.13 66.16 0.1 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.779 1.232 . . . . 0.0 113.295 -177.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -59.9 -38.0 81.03 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 168.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -143.66 167.69 21.66 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 130.002 3.321 . . . . 0.0 104.25 169.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -56.66 -41.17 76.78 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.415 -0.803 . . . . 0.0 110.644 171.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -71.73 7.41 1.52 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.201 1.4 . . . . 0.0 114.594 178.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 74.8 t -122.33 137.33 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 122.057 2.208 . . . . 0.0 107.783 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 67.4 m -147.25 161.7 40.41 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.329 1.052 . . . . 0.0 109.799 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 -83.42 149.81 26.45 Favored 'General case' 0 C--N 1.342 0.246 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 170.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.6 mp -145.08 164.82 30.05 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.83 2.052 . . . . 0.0 107.495 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -134.89 133.15 39.35 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 172.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 43.8 m -140.0 171.79 13.68 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.144 1.378 . . . . 0.0 110.081 -176.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -142.47 145.26 33.55 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.163 1.785 . . . . 0.0 107.152 -176.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.8 p -64.52 134.28 54.11 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 118.792 0.723 . . . . 0.0 109.946 174.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.4 tp10 -71.64 -30.18 65.46 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 119.177 -0.44 . . . . 0.0 110.609 172.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.1 m -100.32 -17.46 17.26 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 -169.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -129.71 -105.31 0.29 Allowed 'General case' 0 C--N 1.344 0.336 0 CA-C-N 120.594 1.543 . . . . 0.0 110.754 -169.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -168.64 5.67 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.271 1.428 . . . . 0.0 113.713 -169.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 7.7 ptt? -82.85 152.52 25.58 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.686 0.755 . . . . 0.0 110.009 -173.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -121.56 128.14 51.68 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.401 1.881 . . . . 0.0 107.497 -169.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.86 136.36 52.99 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.444 1.097 . . . . 0.0 108.401 -169.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.1 mm -127.02 137.77 56.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 102.634 -3.098 . . . . 0.0 102.634 169.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -154.2 159.46 41.38 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.111 0.964 . . . . 0.0 111.302 -177.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -126.8 112.32 15.24 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 102.967 -2.975 . . . . 0.0 102.967 172.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.2 p -146.22 160.38 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 121.411 0.624 . . . . 0.0 111.339 -168.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -64.61 125.43 24.7 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.866 1.266 . . . . 0.0 109.226 170.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.3 pp -95.21 -4.07 10.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 123.962 0.905 . . . . 0.0 113.178 -177.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -68.72 -15.15 63.43 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 120.684 1.584 . . . . 0.0 111.299 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 26.1 mt -64.66 -35.79 75.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 124.876 1.27 . . . . 0.0 108.533 171.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -78.97 150.86 75.6 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 123.253 0.621 . . . . 0.0 109.412 -175.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.73 -22.87 23.34 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.501 2.134 . . . . 0.0 112.925 -177.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.4 p -156.07 154.27 6.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -177.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -60.55 -27.59 67.78 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.315 1.046 . . . . 0.0 112.528 178.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 38.1 tp -63.31 -14.64 51.92 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.718 1.207 . . . . 0.0 112.269 174.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.0 170.38 46.55 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.467 1.032 . . . . 0.0 111.812 178.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -162.76 170.65 18.0 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.221 2.208 . . . . 0.0 106.472 177.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 11.9 mttp -60.5 151.73 27.7 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 118.896 0.771 . . . . 0.0 109.708 171.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -146.07 177.27 9.09 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.174 0.989 . . . . 0.0 108.402 172.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -132.73 138.41 47.21 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -172.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.2 mp -108.13 144.69 35.18 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 169.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.4 p -150.01 150.31 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 123.941 0.897 . . . . 0.0 108.662 -178.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.2 mt -142.74 127.28 15.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 174.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -153.24 -69.98 0.15 Allowed 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 172.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 70.0 m -142.52 150.69 40.78 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.256 1.023 . . . . 0.0 108.663 177.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -66.92 142.26 57.34 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.089 1.356 . . . . 0.0 110.952 -177.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.0 tp -72.58 -29.81 63.85 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.258 0.623 . . . . 0.0 109.933 169.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 62.18 174.63 0.13 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.709 2.004 . . . . 0.0 111.144 -169.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -141.22 15.25 2.23 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.217 1.007 . . . . 0.0 111.739 -175.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -124.02 14.7 9.18 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.104 1.362 . . . . 0.0 111.768 -176.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.76 31.03 77.16 Favored Glycine 0 CA--C 1.531 1.04 0 O-C-N 121.071 -1.018 . . . . 0.0 111.671 -175.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.6 m -61.45 -36.3 80.02 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.749 0.82 . . . . 0.0 109.032 170.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 60.0 mt -86.46 148.25 25.63 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 168.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -70.59 10.95 0.41 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.938 1.295 . . . . 0.0 114.071 -169.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -164.99 -43.53 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 126.102 1.761 . . . . 0.0 109.902 174.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.25 21.59 75.84 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-N 113.447 -1.706 . . . . 0.0 114.516 169.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -140.64 -47.58 0.42 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.206 1.503 . . . . 0.0 109.794 178.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 49.73 32.25 5.06 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.156 1.782 . . . . 0.0 113.129 174.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.454 HD22 ' NE2' ' A' ' 87' ' ' GLN . 41.1 t30 -141.71 72.63 24.42 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 124.299 1.04 . . . . 0.0 110.134 -177.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -54.15 -30.73 62.19 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.6 2.2 . . . . 0.0 112.353 171.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.23 7.71 1.21 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 127.625 2.37 . . . . 0.0 113.776 177.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -44.49 -47.02 10.02 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.901 1.28 . . . . 0.0 111.91 173.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -67.64 -16.52 64.2 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.259 1.423 . . . . 0.0 114.126 -174.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 32.1 mtp-105 -65.48 -63.28 3.55 Favored Pre-proline 0 N--CA 1.471 0.598 0 CA-C-N 119.895 1.225 . . . . 0.0 110.307 -175.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -79.49 -8.64 14.92 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.332 1.355 . . . . 0.0 111.145 168.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.4 t 52.92 49.52 20.04 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.726 2.01 . . . . 0.0 109.027 -169.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 45.9 mtm-85 -149.37 153.18 37.01 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 126.327 1.851 . . . . 0.0 107.939 177.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -101.85 -2.17 30.56 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.244 0.617 . . . . 0.0 112.658 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -59.11 -11.97 4.39 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.796 1.239 . . . . 0.0 113.278 177.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.454 ' NE2' HD22 ' A' ' 76' ' ' ASN . 51.7 mt-30 -53.36 -26.9 20.98 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.336 1.454 . . . . 0.0 112.166 170.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -139.32 167.13 22.76 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.481 1.112 . . . . 0.0 110.378 -179.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -59.45 88.59 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.966 2.506 . . . . 0.0 112.468 -175.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -68.94 152.15 45.63 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 168.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.8 p -115.77 152.37 17.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 118.995 0.816 . . . . 0.0 111.327 -169.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 45.9 tpp -149.89 155.3 39.78 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 126.552 1.941 . . . . 0.0 108.369 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -136.35 142.96 43.84 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 126.185 1.794 . . . . 0.0 106.811 -172.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -156.52 -159.48 9.46 Favored Glycine 0 C--N 1.339 0.708 0 CA-C-N 119.452 1.023 . . . . 0.0 114.789 -170.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 3.8 tmtp? -142.86 116.67 9.3 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 172.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 62.1 t -84.54 148.59 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 176.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -136.47 151.44 49.47 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 128.556 2.742 . . . . 0.0 105.276 176.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.69 167.71 29.64 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 120.241 -1.537 . . . . 0.0 112.085 -175.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.5 pt -120.65 177.47 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 124.222 1.009 . . . . 0.0 108.579 169.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -67.61 -5.08 13.89 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.316 1.446 . . . . 0.0 114.139 -175.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -179.82 -129.94 1.41 Allowed Glycine 0 CA--C 1.524 0.624 0 N-CA-C 107.446 -2.262 . . . . 0.0 107.446 -173.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -122.0 -21.21 6.06 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.235 1.414 . . . . 0.0 113.045 169.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 46.38 60.37 3.31 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.126 2.17 . . . . 0.0 112.441 169.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 22.5 p -61.21 -56.47 20.25 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 168.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 65.1 m -166.77 -41.14 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.616 1 C-N-CA 134.23 5.012 . . . . 0.0 104.833 172.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -176.3 -45.49 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.505 2.322 . . . . 0.0 106.548 -171.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -49.25 -27.72 4.01 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 127.158 2.183 . . . . 0.0 116.505 -169.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -140.0 15.5 2.46 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.735 1.152 . . . . 0.0 112.297 171.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.06 -5.04 4.04 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 114.336 1.235 . . . . 0.0 114.336 176.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.6 p -67.71 -20.67 65.3 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 128.778 2.831 . . . . 0.0 114.056 171.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -87.2 152.95 21.88 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 169.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 54.6 tp -100.22 141.73 32.66 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 103.638 -2.726 . . . . 0.0 103.638 167.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 17.9 m -131.7 139.34 49.0 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -176.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -136.4 149.28 48.22 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 124.415 1.086 . . . . 0.0 108.646 -178.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -111.14 142.94 42.65 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 103.868 -2.642 . . . . 0.0 103.868 169.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.1 p -144.78 126.66 9.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 38.1 m -100.37 139.76 35.58 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -135.49 78.88 1.75 Allowed 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.629 1.172 . . . . 0.0 109.114 -169.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 61.16 21.33 59.3 Favored Glycine 0 CA--C 1.537 1.435 0 CA-C-O 119.269 -0.74 . . . . 0.0 114.244 171.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 119.41 -24.29 8.17 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 125.268 1.413 . . . . 0.0 112.111 -176.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -82.84 167.9 17.63 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 169.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 31.7 tp -148.45 155.23 40.93 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.398 -0.814 . . . . 0.0 110.167 -174.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 34.6 mtt -147.38 161.11 41.68 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.888 1.275 . . . . 0.0 108.561 169.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -137.17 123.04 20.08 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 103.721 -2.696 . . . . 0.0 103.721 169.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -132.28 131.39 41.98 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 -175.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -125.07 140.26 53.06 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 171.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -164.13 178.24 39.56 Favored Glycine 0 N--CA 1.452 -0.243 0 N-CA-C 108.616 -1.793 . . . . 0.0 108.616 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -55.91 141.47 39.18 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.257 1.028 . . . . 0.0 108.879 170.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -41.82 -62.35 0.92 Allowed 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.39 -11.57 61.0 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.179 -0.95 . . . . 0.0 113.507 -176.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -83.71 -28.45 28.28 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.771 1.228 . . . . 0.0 110.137 173.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.34 -38.2 60.28 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 170.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 49.81 11.98 0.07 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 127.33 2.252 . . . . 0.0 116.105 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -73.99 -56.36 5.35 Favored Glycine 0 CA--C 1.522 0.53 0 O-C-N 121.008 -1.058 . . . . 0.0 110.835 -169.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 44.06 24.42 0.08 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 128.58 2.752 . . . . 0.0 115.01 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -162.87 133.15 4.54 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 125.659 1.584 . . . . 0.0 107.813 -169.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.5 m -67.66 -13.34 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.91 169.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -135.39 16.68 3.41 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -169.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 11.6 m -89.28 -66.35 0.93 Allowed 'General case' 0 N--CA 1.462 0.166 0 O-C-N 121.609 -0.682 . . . . 0.0 109.253 168.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.318 13.2 ptm180 -80.23 14.04 2.09 Favored 'General case' 0 C--N 1.344 0.339 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -170.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 19.4 m -60.79 -34.61 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 167.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -79.27 119.83 22.88 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 170.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -140.42 140.23 35.41 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -178.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.0 mp -129.54 156.48 44.1 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 174.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 23.6 ptp -148.44 152.86 37.67 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 121.854 -0.529 . . . . 0.0 111.342 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -158.03 -177.66 6.72 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.355 1.462 . . . . 0.0 110.408 -178.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -53.06 161.41 0.82 Allowed 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.688 1.595 . . . . 0.0 112.591 170.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.53 166.77 0.59 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.022 0.929 . . . . 0.0 111.473 169.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -88.82 89.52 8.02 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 173.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 17.1 t80 . . . . . 0 C--O 1.249 1.07 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 171.872 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.484 1.253 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.1 39.85 0.32 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.704 1.201 . . . . 0.0 111.928 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 177.93 -175.81 47.7 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.828 1.68 . . . . 0.0 109.398 -175.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.9 tt -63.39 156.34 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 174.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -133.41 135.7 44.79 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -175.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -147.23 150.97 35.91 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 126.076 1.75 . . . . 0.0 106.641 172.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -152.96 142.4 21.71 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.149 0.98 . . . . 0.0 109.094 178.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -158.58 158.91 34.82 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.53 0.732 . . . . 0.0 110.174 169.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 mp -76.2 150.4 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 168.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -131.85 154.21 49.39 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.885 1.274 . . . . 0.0 107.959 175.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -128.9 122.95 31.4 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -173.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.8 t -75.81 105.77 5.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -72.8 -37.78 67.44 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.192 0.997 . . . . 0.0 109.89 177.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -159.58 167.65 28.01 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.326 0.967 . . . . 0.0 111.486 176.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.5 mp -133.17 140.24 47.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 127.333 2.253 . . . . 0.0 106.211 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -146.17 92.95 5.17 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 124.494 1.118 . . . . 0.0 109.908 -170.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -64.26 13.59 0.09 OUTLIER 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 124.129 3.219 . . . . 0.0 116.696 -178.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -79.07 53.13 1.38 Allowed 'General case' 0 CA--C 1.544 0.712 0 O-C-N 120.648 -1.283 . . . . 0.0 109.338 172.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -174.89 41.44 0.12 Allowed Glycine 0 CA--C 1.525 0.682 0 C-N-CA 124.677 1.132 . . . . 0.0 111.052 -170.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -74.71 69.37 1.78 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.123 0.961 . . . . 0.0 110.496 -177.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -55.16 -38.65 68.55 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 169.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -146.73 169.48 18.97 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 129.256 3.022 . . . . 0.0 104.677 169.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -62.07 -33.23 74.02 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 120.985 -1.072 . . . . 0.0 111.744 178.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -83.82 9.45 11.96 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-O 116.919 -1.515 . . . . 0.0 113.105 175.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.0 t -119.32 142.74 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 121.84 2.109 . . . . 0.0 107.809 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 57.3 m -148.59 174.41 12.15 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.018 0.927 . . . . 0.0 108.913 175.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 45.5 ttp180 -84.5 149.33 26.01 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 106.754 -1.572 . . . . 0.0 106.754 168.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -139.44 153.57 47.6 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 126.806 2.042 . . . . 0.0 106.634 -172.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -130.93 126.66 36.68 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 173.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 85.0 m -142.96 166.77 23.71 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.202 1.401 . . . . 0.0 110.161 -170.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 55.8 tt0 -144.78 139.8 28.06 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.339 1.056 . . . . 0.0 108.636 177.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.21 137.31 46.77 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 174.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -68.13 -32.52 72.87 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.869 0.868 . . . . 0.0 111.424 -176.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 m -117.15 -30.6 5.59 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.108 0.963 . . . . 0.0 111.887 -171.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -113.22 13.33 19.18 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -171.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt 45.71 20.87 0.07 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 118.224 2.676 . . . . 0.0 118.224 169.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 52.3 mtm -64.74 125.85 26.07 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 120.858 1.663 . . . . 0.0 107.806 176.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -77.65 118.62 20.22 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 104.921 -2.252 . . . . 0.0 104.921 169.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 49.8 tp -129.05 130.32 46.41 Favored 'General case' 0 N--CA 1.457 -0.081 0 C-N-CA 123.183 0.593 . . . . 0.0 110.303 -169.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 49.6 mm -118.04 142.41 32.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 103.272 -2.862 . . . . 0.0 103.272 168.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 123' ' ' MET . 2.5 pt? -155.67 163.0 40.48 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.21 1.004 . . . . 0.0 110.761 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -124.96 105.73 9.44 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 102.642 -3.095 . . . . 0.0 102.642 178.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -150.5 166.11 2.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 O-C-N 124.267 0.979 . . . . 0.0 111.366 -168.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -55.82 133.22 51.01 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.731 1.612 . . . . 0.0 110.504 170.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.5 pp -108.28 0.03 9.78 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 C-N-CA 125.045 1.338 . . . . 0.0 114.183 -177.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -67.29 -14.24 62.73 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 120.913 1.688 . . . . 0.0 111.623 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.1 mt -62.66 -27.35 42.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 125.505 1.522 . . . . 0.0 109.643 169.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -116.57 158.48 43.27 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 124.681 1.192 . . . . 0.0 112.182 -168.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -78.49 -15.72 13.79 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.251 2.634 . . . . 0.0 112.766 174.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . 0.283 17.7 m 53.96 -19.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 130.694 3.597 . . . . 0.0 117.243 -175.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -66.7 -23.72 66.16 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.668 1.122 . . . . 0.0 111.872 173.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.0 tp -151.76 163.41 39.22 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.449 1.9 . . . . 0.0 107.513 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.19 163.62 20.87 Favored Glycine 0 CA--C 1.534 1.263 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 169.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -156.02 176.21 12.95 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.22 1.408 . . . . 0.0 108.417 -173.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -126.92 150.64 49.22 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.4 1.08 . . . . 0.0 109.618 -175.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -152.58 178.31 9.72 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 125.411 1.484 . . . . 0.0 108.17 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 -129.11 144.7 51.29 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.5 tt -134.24 139.42 45.76 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 -170.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.3 t -140.78 139.57 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 125.247 1.419 . . . . 0.0 107.6 -169.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 38.3 mm -88.12 66.87 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 170.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -155.77 30.79 0.36 Allowed 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -169.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.8 p -66.83 -7.14 19.45 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 120.003 1.274 . . . . 0.0 112.618 170.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -46.82 145.54 1.94 Allowed 'General case' 0 C--O 1.237 0.422 0 C-N-CA 127.4 2.28 . . . . 0.0 111.927 -179.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.6 tt -134.24 126.5 29.96 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 175.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -72.02 70.82 0.79 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.725 1.21 . . . . 0.0 109.207 177.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -62.17 -16.52 53.46 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.882 1.273 . . . . 0.0 112.719 -177.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -62.29 -20.52 64.39 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.24 1.416 . . . . 0.0 111.866 169.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.12 18.21 56.17 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 124.574 1.083 . . . . 0.0 111.732 -177.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -61.33 -31.57 71.43 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.334 1.067 . . . . 0.0 111.706 -170.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 92.6 mt -92.81 -37.15 12.47 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 123.384 0.673 . . . . 0.0 110.441 174.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -60.42 -21.55 62.39 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.888 0.875 . . . . 0.0 112.585 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -63.24 -7.86 7.04 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.375 1.47 . . . . 0.0 114.177 172.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -127.86 -77.49 0.23 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 107.751 -2.14 . . . . 0.0 107.751 169.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -156.55 144.34 19.35 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 126.026 1.73 . . . . 0.0 107.105 169.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -112.3 23.29 13.81 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.389 1.076 . . . . 0.0 108.801 169.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -143.63 28.92 0.08 OUTLIER Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 127.096 2.158 . . . . 0.0 113.757 -172.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -58.28 -53.49 4.09 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.267 1.978 . . . . 0.0 112.325 -169.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.6 p -135.96 -0.84 2.49 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.413 1.885 . . . . 0.0 110.779 -176.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -66.88 -27.56 67.62 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.075 0.95 . . . . 0.0 111.662 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -128.32 -32.58 2.21 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.393 1.077 . . . . 0.0 112.454 -174.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 78.4 mtt85 -61.4 130.35 91.75 Favored Pre-proline 0 N--CA 1.468 0.445 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 170.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . 0.263 0.1 OUTLIER 18.29 57.12 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.693 1 C-N-CA 127.163 5.242 . . . . 0.0 116.92 -169.551 . . . . . . . . 4 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.3 m -146.95 166.01 28.08 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.056 2.143 . . . . 0.0 108.138 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 95.5 mtm-85 -139.62 166.62 24.11 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.602 1.161 . . . . 0.0 108.729 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.27 -13.87 43.12 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -51.05 -20.85 1.55 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.923 1.689 . . . . 0.0 113.295 172.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -51.13 -31.03 18.2 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.705 1.202 . . . . 0.0 113.367 170.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -146.22 174.72 11.08 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.259 1.024 . . . . 0.0 111.872 -169.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -125.24 -9.68 7.01 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.12 1.368 . . . . 0.0 110.816 169.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 36.9 t80 62.24 -149.55 0.37 Allowed 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 116.993 -1.48 . . . . 0.0 108.604 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . 0.456 20.7 t 154.92 -90.1 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 130.308 3.443 . . . . 0.0 110.405 169.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.45 -173.09 2.12 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 122.183 2.265 . . . . 0.0 115.83 -167.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -125.77 154.93 41.82 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 129.562 3.145 . . . . 0.0 105.692 169.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -157.46 -151.42 6.02 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-N 119.835 1.198 . . . . 0.0 113.147 -174.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -140.73 147.76 39.68 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.972 1.709 . . . . 0.0 107.007 169.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.9 p -125.42 135.12 64.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 124.392 1.077 . . . . 0.0 108.33 177.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -146.3 106.75 4.06 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.09 0.956 . . . . 0.0 111.235 -170.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -156.71 167.58 30.01 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.089 1.356 . . . . 0.0 109.821 169.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -62.67 168.95 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 125.466 1.506 . . . . 0.0 112.028 174.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -61.45 3.83 0.11 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 129.171 2.988 . . . . 0.0 116.026 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 58.05 43.82 94.93 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-N 119.405 1.002 . . . . 0.0 111.988 -175.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -143.76 80.03 1.65 Allowed 'General case' 0 C--O 1.232 0.144 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 170.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -130.92 14.73 5.27 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.573 0.702 . . . . 0.0 112.108 -169.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.0 t -170.67 -132.5 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 -174.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.1 m -144.05 -8.67 0.7 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.205 2.202 . . . . 0.0 108.923 -178.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 21.9 p -142.75 -90.12 0.13 Allowed 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 118.907 0.776 . . . . 0.0 110.276 -176.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -55.88 -17.57 6.74 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 116.933 2.197 . . . . 0.0 116.933 -168.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -145.53 27.49 1.23 Allowed 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 119.823 1.192 . . . . 0.0 108.403 175.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -126.42 -2.03 6.86 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.24 1.416 . . . . 0.0 114.565 169.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 81.2 p -124.64 -9.82 7.34 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.715 1.606 . . . . 0.0 113.31 176.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -129.79 138.88 51.29 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 174.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.1 tp -84.87 152.45 23.57 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 169.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 11.8 m -122.55 150.79 42.11 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -176.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -148.14 140.43 24.27 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.685 0.794 . . . . 0.0 108.981 178.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 -120.76 134.27 55.29 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 103.11 -2.922 . . . . 0.0 103.11 169.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.3 t -125.11 142.6 41.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 -175.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 45.6 m -133.35 122.83 24.38 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 -178.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -147.79 105.21 3.66 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 122.809 0.444 . . . . 0.0 110.173 -169.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 58.48 27.85 61.47 Favored Glycine 0 CA--C 1.536 1.361 0 O-C-N 121.53 -0.731 . . . . 0.0 113.878 174.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 90.92 -2.87 80.38 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 118.312 1.056 . . . . 0.0 113.528 -178.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 88.0 mt -95.39 164.22 12.91 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 125.439 1.496 . . . . 0.0 107.878 171.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 7.9 tp -142.96 161.91 36.88 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -168.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' MET . . . . . 0.404 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 27.6 mtt -147.04 155.38 42.17 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 126.391 1.877 . . . . 0.0 108.671 169.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 36.9 mtp-105 -142.4 126.07 16.94 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 104.849 -2.278 . . . . 0.0 104.849 169.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -152.28 163.6 39.11 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 119.179 0.899 . . . . 0.0 112.339 -172.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -138.78 155.91 47.78 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.856 1.263 . . . . 0.0 108.78 169.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -169.63 175.8 43.71 Favored Glycine 0 CA--C 1.52 0.381 0 N-CA-C 108.52 -1.832 . . . . 0.0 108.52 169.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -56.77 142.16 41.58 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 118.467 1.134 . . . . 0.0 108.493 170.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -47.09 -48.73 22.62 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.131 0.878 . . . . 0.0 112.035 177.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -56.34 -36.63 68.98 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 122.214 1.007 . . . . 0.0 112.174 178.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -79.0 -19.32 51.89 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 113.58 -1.646 . . . . 0.0 111.004 -174.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 14.7 tp -70.39 -28.15 64.85 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 119.826 1.194 . . . . 0.0 109.309 169.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 1.9 t60 44.44 34.36 1.06 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.504 2.322 . . . . 0.0 114.623 171.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 167.38 73.37 0.03 OUTLIER Glycine 0 C--N 1.334 0.446 0 N-CA-C 108.482 -1.847 . . . . 0.0 108.482 -169.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -101.98 3.84 39.35 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -169.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.434 ' C ' ' H ' ' A' ' 138' ' ' ASP . 9.7 mm-40 -71.85 149.68 44.99 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 169.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 16.5 m -57.79 -7.43 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 124.713 1.205 . . . . 0.0 110.941 168.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.434 ' H ' ' C ' ' A' ' 136' ' ' GLU . 34.1 t70 -135.85 15.6 3.33 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 126.825 2.05 . . . . 0.0 112.692 -178.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 58.6 m -80.77 -76.25 0.24 Allowed 'General case' 0 C--N 1.338 0.079 0 O-C-N 121.412 -0.805 . . . . 0.0 109.06 168.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 11.5 ptm85 -81.23 16.61 1.52 Allowed 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -169.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 30.2 m -68.19 -30.37 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 CA-C-O 118.732 -0.652 . . . . 0.0 109.348 168.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -72.36 124.13 24.49 Favored 'General case' 0 C--N 1.341 0.212 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 175.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 60.0 tp -138.17 103.44 4.94 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.511 0.725 . . . . 0.0 109.231 -173.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 15.9 tp -114.83 135.0 54.67 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 174.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 61.5 mtt -118.96 155.41 31.4 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.961 1.304 . . . . 0.0 107.51 171.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -146.85 161.84 39.86 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 126.36 1.864 . . . . 0.0 107.684 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -67.4 -176.07 0.55 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.351 0.596 . . . . 0.0 110.161 169.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 66.6 mt -57.19 119.8 7.01 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 121.773 0.797 . . . . 0.0 110.273 169.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -142.34 144.85 33.39 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 102.171 -3.27 . . . . 0.0 102.171 169.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 . . . . . 0 C--O 1.249 1.077 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -174.313 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.0 ptt? . . . . . 0 N--CA 1.486 1.328 0 N-CA-C 110.664 -0.124 . . . . 0.0 110.664 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 51.89 -146.21 0.5 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.403 1.481 . . . . 0.0 111.296 -178.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 75.52 29.03 60.39 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-O 119.057 -0.857 . . . . 0.0 112.855 176.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 41.3 pt 36.68 57.53 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 127.036 2.134 . . . . 0.0 113.19 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 66.5 tp -48.79 -37.28 18.69 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.097 1.359 . . . . 0.0 111.917 176.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -145.2 143.53 30.35 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 169.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -151.83 139.59 19.85 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.429 1.491 . . . . 0.0 107.871 -177.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -154.26 115.71 4.13 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.408 0.683 . . . . 0.0 109.897 -171.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 mp -71.32 143.89 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -143.61 158.94 43.29 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 123.503 0.721 . . . . 0.0 111.431 175.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -135.35 129.27 33.17 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 126.385 1.874 . . . . 0.0 108.286 -174.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.7 t -66.13 126.86 26.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 175.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.1 mmmt -108.01 -25.46 11.15 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 124.312 1.045 . . . . 0.0 110.663 178.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -154.36 166.58 32.76 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.556 1.071 . . . . 0.0 110.672 172.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.4 mp -144.42 141.62 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 126.947 2.099 . . . . 0.0 106.975 -170.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -147.92 100.91 3.67 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 124.213 1.005 . . . . 0.0 109.02 171.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -65.07 -2.1 5.21 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 122.578 2.185 . . . . 0.0 115.937 176.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 36.9 45.41 0.43 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 128.756 2.822 . . . . 0.0 113.76 -176.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.19 11.95 37.78 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.094 0.854 . . . . 0.0 113.077 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? 45.82 67.86 0.68 Allowed 'General case' 0 C--N 1.343 0.307 0 C-N-CA 126.736 2.014 . . . . 0.0 109.895 -170.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -48.93 -41.16 32.91 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.451 1.1 . . . . 0.0 111.435 -177.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -140.74 156.56 46.16 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 169.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -62.5 -4.45 1.93 Allowed 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -172.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -147.24 26.75 1.06 Allowed 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 125.132 1.373 . . . . 0.0 112.229 -176.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.5 t -133.21 126.45 52.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.4 m -148.12 155.64 41.67 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.916 0.886 . . . . 0.0 110.271 -171.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 54.5 ttm-85 -83.41 149.72 26.5 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 169.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 85.9 mt -140.33 159.72 41.56 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 125.788 1.635 . . . . 0.0 107.815 -178.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -133.92 136.87 44.54 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 169.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.9 m -140.82 166.17 25.49 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.384 1.073 . . . . 0.0 109.845 -173.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -129.73 149.39 51.5 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 171.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.6 m -117.46 117.6 29.89 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -169.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -65.84 -44.22 86.17 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.241 1.416 . . . . 0.0 111.437 -169.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.2 m -74.94 -41.32 59.87 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 119.229 -0.415 . . . . 0.0 111.733 -169.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -131.66 29.36 4.5 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -172.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.292 0.0 OUTLIER 44.94 35.14 1.41 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 127.138 2.175 . . . . 0.0 114.702 169.814 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 11.8 tmm? -87.34 114.35 23.87 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.365 1.066 . . . . 0.0 109.003 -175.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -71.87 132.08 43.91 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 171.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 45.8 tp -135.81 143.37 45.13 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.474 0.71 . . . . 0.0 110.739 -169.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 41.4 mm -127.58 147.87 32.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 103.187 -2.894 . . . . 0.0 103.187 169.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.2 mt -150.88 146.44 26.32 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 126.577 1.951 . . . . 0.0 107.557 -169.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -135.3 101.74 4.93 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 102.056 -3.313 . . . . 0.0 102.056 169.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.3 p -146.34 163.51 9.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 122.483 1.135 . . . . 0.0 113.202 -167.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -67.01 123.92 21.57 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 126.072 1.749 . . . . 0.0 106.43 168.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 pp -105.44 4.64 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -174.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -69.36 -10.51 58.23 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 120.069 1.304 . . . . 0.0 111.146 176.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.3 mt -59.75 -42.11 87.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 169.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -79.57 155.4 76.15 Favored Pre-proline 0 C--O 1.236 0.39 0 C-N-CA 123.639 0.775 . . . . 0.0 109.467 -175.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -67.14 -21.1 49.18 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.315 2.01 . . . . 0.0 112.357 176.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.9 p -158.15 155.37 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.782 1.633 . . . . 0.0 106.938 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -55.66 -25.84 41.55 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.376 1.471 . . . . 0.0 113.126 178.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 58.5 tp -57.97 -22.46 49.36 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.281 1.432 . . . . 0.0 112.58 173.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.92 178.58 47.6 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 123.741 0.686 . . . . 0.0 112.219 177.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -157.75 168.57 26.83 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.534 1.933 . . . . 0.0 107.625 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -73.73 136.09 43.66 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 174.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 7.3 m-30 -138.59 178.88 6.82 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.977 1.711 . . . . 0.0 107.012 176.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.93 141.15 49.24 Favored 'General case' 0 CA--C 1.515 -0.383 0 O-C-N 121.127 -0.983 . . . . 0.0 109.129 169.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 12.9 tp -96.24 152.05 18.93 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 177.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 53.7 t -140.01 142.26 32.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 177.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.9 pt -132.64 21.02 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 122.94 0.496 . . . . 0.0 112.104 -178.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.94 138.47 57.41 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 121.506 -0.746 . . . . 0.0 109.302 172.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.0 t -59.14 130.02 44.94 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 169.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.4 t -165.04 167.87 17.94 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.875 0.845 . . . . 0.0 110.846 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.3 tp -139.48 11.83 2.53 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.66 2.384 . . . . 0.0 108.159 168.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . 0.321 47.5 p90 42.83 24.75 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 129.673 3.189 . . . . 0.0 116.194 -173.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -63.56 -20.72 65.88 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.4 1.08 . . . . 0.0 111.106 169.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -67.1 -23.04 65.79 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.127 1.371 . . . . 0.0 112.805 -177.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -163.27 36.6 0.32 Allowed Glycine 0 C--N 1.338 0.69 0 CA-C-N 118.284 0.493 . . . . 0.0 112.366 -172.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.82 159.21 11.5 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.194 0.998 . . . . 0.0 110.261 -177.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 72.7 mt 43.94 46.93 7.0 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.962 1.705 . . . . 0.0 110.761 -177.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.3 t0 42.3 69.28 0.39 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.919 2.088 . . . . 0.0 112.398 -169.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.4 t0 48.5 37.75 9.62 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.884 1.674 . . . . 0.0 112.634 -174.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.32 3.5 70.79 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.122 1.344 . . . . 0.0 113.916 177.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -70.27 -27.54 64.5 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.43 1.615 . . . . 0.0 110.617 175.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 25.0 t80 44.75 59.51 3.35 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 126.285 1.834 . . . . 0.0 110.59 -170.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -58.15 137.59 84.38 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 113.919 -1.491 . . . . 0.0 111.409 -169.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -50.08 -29.61 22.52 Favored 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 123.937 3.091 . . . . 0.0 115.374 176.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.2 m -65.31 -21.74 66.75 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 120.079 1.308 . . . . 0.0 111.422 178.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -96.89 -44.77 6.9 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.543 1.137 . . . . 0.0 109.205 176.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -71.37 -40.06 70.86 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.282 1.433 . . . . 0.0 114.621 -176.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 71.6 mmt-85 -69.36 -43.19 22.99 Favored Pre-proline 0 N--CA 1.466 0.337 0 CA-C-N 120.444 1.475 . . . . 0.0 111.466 -172.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -82.58 2.41 8.52 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 121.628 1.552 . . . . 0.0 111.667 168.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . 0.294 9.3 p 31.0 55.9 0.22 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 129.973 3.309 . . . . 0.0 113.393 -173.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -151.06 158.22 43.8 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 125.49 1.516 . . . . 0.0 107.713 176.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -56.73 129.82 42.84 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 123.537 0.523 . . . . 0.0 111.063 -172.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -125.74 -21.12 4.49 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.5 1.92 . . . . 0.0 110.23 170.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -52.78 -38.37 61.0 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.954 1.301 . . . . 0.0 110.688 169.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -146.36 161.39 40.46 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 129.428 3.091 . . . . 0.0 106.136 176.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -88.96 -32.82 17.48 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 118.966 -0.54 . . . . 0.0 110.261 175.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -155.67 153.57 30.2 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 118.819 0.736 . . . . 0.0 110.054 177.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.4 m -143.6 145.89 21.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 125.462 1.505 . . . . 0.0 107.464 169.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 5.8 tpt -162.13 174.27 13.17 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.029 0.932 . . . . 0.0 109.452 174.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -137.84 155.8 48.6 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 126.613 1.965 . . . . 0.0 106.212 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -167.08 -157.92 10.98 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 118.689 0.677 . . . . 0.0 113.147 -169.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.4 tttm -141.78 130.18 22.44 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 117.848 0.824 . . . . 0.0 109.152 174.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.3 t -75.11 148.35 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 124.656 1.182 . . . . 0.0 108.779 169.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -144.31 70.67 1.29 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.916 0.887 . . . . 0.0 110.798 175.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -144.01 163.67 32.84 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.376 1.07 . . . . 0.0 110.635 174.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 26.3 pt -76.47 -170.08 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 125.124 1.369 . . . . 0.0 110.269 174.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -60.64 -0.29 0.26 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.965 2.106 . . . . 0.0 115.186 178.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.38 -47.7 1.58 Allowed Glycine 0 C--N 1.335 0.48 0 C-N-CA 125.231 1.396 . . . . 0.0 111.511 174.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -73.65 118.78 17.0 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -135.52 35.27 2.95 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.891 1.276 . . . . 0.0 109.197 -175.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.8 t -141.35 179.68 6.64 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.099 1.36 . . . . 0.0 109.085 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.7 m -151.22 7.2 0.51 Allowed 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 128.132 2.573 . . . . 0.0 108.91 -172.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.3 p -128.38 4.62 5.7 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.745 0.818 . . . . 0.0 111.481 -169.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -157.5 -31.73 0.08 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.371 1.468 . . . . 0.0 110.106 173.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 63.79 97.88 0.04 OUTLIER 'General case' 0 C--N 1.35 0.602 0 C-N-CA 126.923 2.089 . . . . 0.0 106.2 -169.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.84 136.42 51.36 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.984 -1.007 . . . . 0.0 112.499 -167.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.8 p -96.84 4.32 51.75 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.036 1.335 . . . . 0.0 113.482 -178.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -118.77 151.9 37.17 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 172.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.18 139.98 33.16 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 169.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.6 p -101.73 147.26 26.68 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 174.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -146.33 144.0 29.5 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 176.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 15.3 m-30 -122.85 137.27 54.98 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 102.485 -3.154 . . . . 0.0 102.485 169.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.4 p -142.47 144.36 24.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 24.0 p -116.97 130.23 56.55 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 172.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -144.51 116.05 8.12 Favored 'General case' 0 N--CA 1.458 -0.073 0 C-N-CA 123.878 0.871 . . . . 0.0 109.581 -169.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 55.78 21.75 30.83 Favored Glycine 0 CA--C 1.537 1.423 0 CA-C-O 119.234 -0.759 . . . . 0.0 114.534 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 92.19 -5.04 78.15 Favored Glycine 0 CA--C 1.535 1.3 0 CA-C-N 118.648 1.224 . . . . 0.0 113.477 -176.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -95.09 170.92 9.07 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.956 1.302 . . . . 0.0 107.809 170.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.5 tt -149.3 151.45 34.19 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 121.522 -0.736 . . . . 0.0 110.545 -170.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 13.0 ptp -148.37 158.08 43.88 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 169.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 -140.51 138.53 34.65 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 178.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -154.2 162.12 41.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 118.855 0.752 . . . . 0.0 112.937 -169.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -134.44 118.43 17.38 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 104.109 -2.552 . . . . 0.0 104.109 168.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -151.05 175.56 29.94 Favored Glycine 0 N--CA 1.452 -0.256 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 -175.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -58.21 148.45 26.98 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 122.332 -0.511 . . . . 0.0 111.177 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -46.49 -42.15 15.13 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 175.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.77 -12.61 60.44 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.996 1.271 . . . . 0.0 113.191 178.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -66.57 -19.06 65.69 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 168.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -100.0 19.19 16.72 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 117.067 -1.444 . . . . 0.0 110.634 174.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -30.2 108.0 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 120.32 1.418 . . . . 0.0 112.021 169.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 122.84 -13.97 8.55 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 125.077 1.322 . . . . 0.0 112.134 -169.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . 0.26 30.9 m-85 44.11 56.6 4.7 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 129.527 3.131 . . . . 0.0 114.165 177.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.436 ' C ' ' H ' ' A' ' 138' ' ' ASP . 2.1 mp0 70.97 164.53 0.28 Allowed 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 129.499 3.12 . . . . 0.0 113.488 170.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 60.1 t 59.23 -9.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 127.091 2.156 . . . . 0.0 113.686 -172.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.436 ' H ' ' C ' ' A' ' 136' ' ' GLU . 32.6 t70 -154.02 -11.99 0.14 Allowed 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 119.84 1.2 . . . . 0.0 114.007 -172.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 16.0 m -54.68 -63.47 1.14 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.963 0.887 . . . . 0.0 112.652 169.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 8.6 mmm180 -88.67 11.19 18.18 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.43 -169.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 98.2 t -87.9 -5.73 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 C-N-CA 124.838 1.255 . . . . 0.0 108.861 -177.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -128.2 114.71 17.33 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 103.383 -2.821 . . . . 0.0 103.383 168.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.7 tt -133.69 126.23 30.32 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 -171.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.0 tt -134.68 147.97 50.23 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 106.768 -1.568 . . . . 0.0 106.768 178.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 56.5 ttm -139.56 138.32 36.14 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.221 -1.399 . . . . 0.0 107.221 -178.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -147.01 162.84 37.97 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -57.06 156.36 7.1 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 118.532 0.605 . . . . 0.0 109.7 169.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.0 pp -67.4 160.04 28.19 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 169.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -148.09 125.93 11.94 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 177.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 . . . . . 0 C--O 1.251 1.162 0 C-N-CA 126.289 1.836 . . . . 0.0 107.186 175.753 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.8 mmm . . . . . 0 N--CA 1.484 1.27 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.32 173.84 5.37 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.314 0.646 . . . . 0.0 110.08 169.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -150.01 171.31 30.01 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 108.348 -1.901 . . . . 0.0 108.348 171.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.6 tp -59.87 119.75 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 118.029 0.915 . . . . 0.0 108.695 175.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.4 tt -137.75 -37.19 0.61 Allowed 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 118.62 -0.705 . . . . 0.0 110.95 -170.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -161.48 150.69 16.26 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 119.17 0.895 . . . . 0.0 109.627 174.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -157.87 132.12 8.2 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.053 1.341 . . . . 0.0 108.434 169.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -161.06 155.01 22.5 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.471 0.708 . . . . 0.0 109.879 168.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 mp -74.5 151.33 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 169.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -129.13 150.71 50.41 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 172.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -133.97 129.21 35.88 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.054 1.342 . . . . 0.0 108.004 -169.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.6 p -63.82 147.97 11.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-O 122.078 0.942 . . . . 0.0 110.153 -177.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -125.09 -29.01 3.36 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 126.73 2.012 . . . . 0.0 109.373 178.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -160.25 166.6 29.27 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.348 0.977 . . . . 0.0 111.062 170.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.1 mp -133.01 135.06 57.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 127.292 2.237 . . . . 0.0 105.372 178.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -146.45 89.85 5.76 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 124.03 0.932 . . . . 0.0 110.301 -169.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -64.27 16.92 0.07 OUTLIER 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 124.26 3.307 . . . . 0.0 116.594 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -79.98 53.98 1.8 Allowed 'General case' 0 CA--C 1.542 0.66 0 O-C-N 120.256 -1.527 . . . . 0.0 109.778 176.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -172.88 38.67 0.15 Allowed Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.231 0.92 . . . . 0.0 111.577 -171.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.6 mmmt -74.31 66.71 1.34 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 118.152 0.976 . . . . 0.0 111.445 -175.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -57.09 -36.63 70.84 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 169.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -143.85 167.77 21.52 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 128.194 2.598 . . . . 0.0 105.027 169.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -62.13 -31.59 72.09 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.355 -0.84 . . . . 0.0 111.243 177.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -82.68 11.07 6.27 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-O 116.738 -1.601 . . . . 0.0 113.559 175.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 93.5 t -123.05 138.54 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 122.391 2.36 . . . . 0.0 108.302 -179.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.7 m -149.66 170.44 18.68 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.876 1.27 . . . . 0.0 109.472 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -91.22 149.7 21.66 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 169.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -141.33 158.16 44.24 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 126.83 2.052 . . . . 0.0 106.713 -172.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -133.14 134.91 44.81 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 172.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 64.3 m -141.24 175.94 9.24 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.953 1.701 . . . . 0.0 109.68 -177.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -141.85 144.94 34.12 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.798 1.639 . . . . 0.0 107.836 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 64.6 p -67.82 130.29 42.53 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 175.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -69.36 -31.3 69.63 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 122.869 0.468 . . . . 0.0 111.785 -174.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 m -113.48 -5.48 13.48 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 114.587 1.328 . . . . 0.0 114.587 -169.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -123.77 -106.86 0.35 Allowed 'General case' 0 C--N 1.341 0.23 0 CA-C-N 119.892 1.223 . . . . 0.0 108.874 -176.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -169.61 3.74 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -169.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 5.3 mpp? -77.69 137.0 38.26 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 123.6 0.76 . . . . 0.0 110.9 -169.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -81.64 137.59 35.43 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 168.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 38.8 tp -133.16 138.75 46.72 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 174.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 35.9 mm -126.75 145.7 33.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 102.801 -3.037 . . . . 0.0 102.801 169.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -157.51 156.52 32.16 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.499 1.12 . . . . 0.0 109.952 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -126.67 107.12 9.89 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 178.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.0 m -148.21 171.44 2.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 O-C-N 124.656 1.222 . . . . 0.0 112.234 -168.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -59.79 141.06 56.0 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.612 1.565 . . . . 0.0 110.415 169.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.6 pp -117.08 1.08 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 125.982 1.713 . . . . 0.0 113.045 177.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -62.05 -22.54 65.83 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 120.48 1.491 . . . . 0.0 110.669 169.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 12.7 mt -53.62 -38.92 35.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 126.179 1.792 . . . . 0.0 109.857 169.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -68.42 129.02 92.98 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -172.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -72.28 -31.6 11.48 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.473 2.116 . . . . 0.0 111.402 178.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.7 m -145.79 154.96 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 126.124 1.77 . . . . 0.0 107.415 177.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -61.7 -25.09 67.19 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.349 0.66 . . . . 0.0 112.061 177.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.2 tp -57.79 -36.26 71.95 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.496 1.118 . . . . 0.0 112.261 -178.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 164.14 177.24 36.72 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-N 118.91 0.777 . . . . 0.0 112.851 178.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -156.99 169.44 24.82 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.487 1.515 . . . . 0.0 109.002 177.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -135.84 158.86 43.36 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.752 1.621 . . . . 0.0 107.974 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -142.47 169.85 16.8 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 123.921 0.888 . . . . 0.0 109.331 -169.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 -133.81 107.2 7.74 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 169.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 68.3 tp -93.98 132.74 38.15 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.0 p -153.6 155.91 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-O 121.943 0.877 . . . . 0.0 109.369 -170.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 tp -147.1 112.1 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 104.146 -2.538 . . . . 0.0 104.146 169.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -143.95 172.4 12.92 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.966 1.706 . . . . 0.0 109.229 -175.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.4 m -50.41 130.0 22.78 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.872 1.669 . . . . 0.0 112.536 -170.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.272 1.0 OUTLIER -79.17 -159.45 0.19 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.326 0.651 . . . . 0.0 111.46 177.757 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 56.93 30.92 18.85 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 -166.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 44.84 23.79 0.09 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 130.464 3.505 . . . . 0.0 115.067 -169.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -61.82 -18.65 60.78 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.408 1.003 . . . . 0.0 111.856 178.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.93 -24.87 17.83 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.689 1.996 . . . . 0.0 111.98 169.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.55 22.22 13.06 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 124.361 0.981 . . . . 0.0 110.766 -173.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.56 -23.6 67.32 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.34 1.456 . . . . 0.0 111.457 -172.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 91.8 mt -108.94 22.2 16.22 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.302 1.441 . . . . 0.0 110.574 175.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.8 t0 40.38 55.74 2.76 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 127.175 2.19 . . . . 0.0 112.485 -174.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.3 t70 54.21 22.98 3.92 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.352 1.861 . . . . 0.0 113.925 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 104.2 -5.51 45.6 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 125.42 1.486 . . . . 0.0 112.63 176.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -72.18 -22.36 61.3 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.942 1.371 . . . . 0.0 110.962 177.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -54.87 127.41 28.49 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.354 0.597 . . . . 0.0 109.825 174.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -148.8 164.68 20.36 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 126.553 1.941 . . . . 0.0 107.055 174.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_exo -49.84 -25.68 12.34 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 123.945 3.096 . . . . 0.0 117.66 -174.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 68.1 p -63.11 -22.44 66.86 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 121.109 1.777 . . . . 0.0 111.894 178.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -71.55 -17.1 62.33 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.796 0.839 . . . . 0.0 112.174 174.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -113.7 -17.42 12.12 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.225 1.41 . . . . 0.0 112.204 -175.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -52.16 133.43 41.13 Favored Pre-proline 0 N--CA 1.469 0.496 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 170.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . 0.254 0.4 OUTLIER 25.95 45.94 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.675 1 C-N-CA 126.673 4.915 . . . . 0.0 116.284 -169.466 . . . . . . . . 4 3 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.8 m -146.85 -171.89 3.86 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.526 2.331 . . . . 0.0 107.566 -178.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -138.42 151.54 47.55 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 173.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.75 -16.32 62.81 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -42.46 -29.47 0.28 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.184 2.194 . . . . 0.0 113.914 170.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -48.61 -43.19 36.02 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.416 1.087 . . . . 0.0 112.188 175.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -142.57 -0.61 1.2 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.43 0.692 . . . . 0.0 112.751 -170.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -140.05 31.84 1.97 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 119.301 0.955 . . . . 0.0 113.291 -168.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -78.41 59.88 2.47 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 120.614 1.552 . . . . 0.0 109.504 174.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.1 p -78.73 147.72 6.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 125.363 1.465 . . . . 0.0 108.414 178.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 3.2 ttm -158.68 174.3 15.26 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.243 1.017 . . . . 0.0 108.904 170.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -126.06 154.19 43.38 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 169.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -152.01 -162.24 10.7 Favored Glycine 0 C--N 1.333 0.369 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -173.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -140.83 112.54 7.57 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 172.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.8 p -69.17 149.91 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 C-N-CA 124.613 1.165 . . . . 0.0 109.347 168.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -139.44 122.65 16.95 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 102.296 -3.224 . . . . 0.0 102.296 172.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.04 142.38 31.55 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 120.065 1.302 . . . . 0.0 109.965 -168.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.9 pt -74.95 174.46 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 123.961 0.905 . . . . 0.0 110.917 -177.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -69.52 -2.99 12.81 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.292 1.437 . . . . 0.0 113.525 177.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 60.32 38.46 94.66 Favored Glycine 0 C--N 1.339 0.719 0 C-N-CA 124.748 1.166 . . . . 0.0 112.879 -176.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -145.97 130.34 17.69 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 168.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -134.76 12.22 3.69 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.425 1.09 . . . . 0.0 112.049 169.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 37.3 p -74.39 -63.24 1.28 Allowed 'General case' 0 N--CA 1.463 0.223 0 O-C-N 121.931 -0.481 . . . . 0.0 110.271 -178.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 32.9 m 144.68 38.56 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.822 1 C-N-CA 131.996 4.118 . . . . 0.0 108.558 -169.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . 0.257 1.3 m 84.98 8.12 0.43 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.788 1.635 . . . . 0.0 110.941 176.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -72.6 -17.78 61.66 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 168.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 76.55 88.31 0.08 Allowed 'General case' 0 C--N 1.349 0.544 0 C-N-CA 128.668 2.787 . . . . 0.0 108.136 169.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.85 151.26 6.66 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 113.935 -1.484 . . . . 0.0 111.969 -169.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.8 p -79.61 -4.88 53.57 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -174.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -126.07 141.29 52.01 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.627 1.171 . . . . 0.0 108.676 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.2 tp -102.81 152.09 21.66 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.122 1.769 . . . . 0.0 107.316 169.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.6 m -132.88 146.4 51.78 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 176.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -139.78 158.17 44.53 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 125.179 1.391 . . . . 0.0 108.872 -177.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -124.5 152.88 42.86 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 169.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.0 t -140.97 141.03 32.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 174.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 72.8 p -118.87 135.72 54.41 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 169.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -151.84 116.6 5.14 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -173.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 54.12 29.14 43.72 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 123.757 0.694 . . . . 0.0 113.97 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 85.48 -2.04 88.16 Favored Glycine 0 CA--C 1.535 1.316 0 CA-C-N 118.159 0.98 . . . . 0.0 113.879 -178.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 49.0 mt -95.22 168.21 10.88 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.281 1.432 . . . . 0.0 108.363 172.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 10.7 tp -139.12 158.1 44.78 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.868 -0.52 . . . . 0.0 111.062 -169.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 43.8 mtt -148.77 159.67 43.93 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.921 1.688 . . . . 0.0 109.408 169.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.7 ttp85 -140.17 131.0 25.93 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 168.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.7 tt -138.42 131.26 29.55 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 -169.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -136.6 144.63 44.2 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -178.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 177.63 -175.21 47.45 Favored Glycine 0 CA--C 1.518 0.245 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 177.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.01 141.93 32.17 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.04 0.92 . . . . 0.0 108.782 169.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -50.46 -53.3 30.77 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -175.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -61.77 -36.55 81.38 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.619 0.723 . . . . 0.0 112.112 179.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -65.64 -23.23 66.75 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 125.032 1.333 . . . . 0.0 111.871 176.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.52 -8.62 55.08 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 120.126 1.33 . . . . 0.0 110.524 172.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 77.2 m80 44.04 43.54 5.57 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 129.413 3.085 . . . . 0.0 111.088 -176.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 173.25 112.1 0.28 Allowed Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 107.267 -2.333 . . . . 0.0 107.267 179.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -65.79 -8.68 22.78 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-O 121.507 0.67 . . . . 0.0 110.93 167.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 50.83 152.13 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.179 1 C-N-CA 135.389 5.476 . . . . 0.0 121.128 168.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER 171.6 -27.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.555 1 C-N-CA 133.438 4.695 . . . . 0.0 107.63 169.41 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -167.24 40.44 0.04 OUTLIER 'General case' 0 C--N 1.349 0.569 0 CA-C-N 119.085 0.857 . . . . 0.0 113.11 -172.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 26.9 m -118.66 -38.41 3.12 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 123.353 0.661 . . . . 0.0 110.617 169.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -11.78 18.77 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.999 0.904 . . . . 0.0 113.084 174.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 18.6 m -77.7 -4.14 6.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 C-N-CA 126.216 1.806 . . . . 0.0 112.689 -174.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -122.19 118.38 28.47 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 104.036 -2.579 . . . . 0.0 104.036 170.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -149.56 147.1 27.76 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.846 0.748 . . . . 0.0 111.131 -172.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 15.7 tp -140.74 139.88 34.74 Favored 'General case' 0 CA--C 1.523 -0.094 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -177.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 16.7 tmm? -125.39 144.28 50.59 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 173.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -149.98 172.55 15.03 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.328 1.451 . . . . 0.0 109.426 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -62.64 157.11 21.57 Favored 'General case' 0 C--O 1.235 0.297 0 O-C-N 122.1 -0.375 . . . . 0.0 110.438 172.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.2 pp -67.61 161.42 25.77 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.121 0.486 . . . . 0.0 110.671 169.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -146.88 129.83 16.32 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 173.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 . . . . . 0 C--O 1.248 1.019 0 C-N-CA 126.466 1.906 . . . . 0.0 106.995 174.04 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 110.867 -0.049 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -57.81 -44.37 86.33 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.656 0.782 . . . . 0.0 111.026 175.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 159.47 -173.26 36.23 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 124.517 1.056 . . . . 0.0 110.549 176.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 30.2 pt -136.59 150.15 27.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 125.78 1.632 . . . . 0.0 107.211 169.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.4 tt -156.28 -57.43 0.09 Allowed 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -177.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -149.36 136.3 19.69 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 173.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -148.87 144.79 27.13 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.339 1.456 . . . . 0.0 108.262 -172.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -157.68 159.91 37.43 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 122.879 0.472 . . . . 0.0 110.585 169.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.1 mp -79.8 153.29 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 105.45 -2.056 . . . . 0.0 105.45 169.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -135.15 138.47 43.74 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.909 1.284 . . . . 0.0 107.644 178.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -105.57 122.96 47.1 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.073 1.349 . . . . 0.0 108.245 -178.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 44.8 t -71.09 116.92 13.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.6 mmmt -80.62 -40.99 24.69 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.729 0.811 . . . . 0.0 109.417 173.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -156.98 169.22 25.3 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 118.518 0.599 . . . . 0.0 111.458 -175.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.6 mp -135.18 144.96 32.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 127.245 2.218 . . . . 0.0 106.503 -178.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -141.91 89.12 9.05 Favored Pre-proline 0 CA--C 1.539 0.558 0 C-N-CA 126.552 1.941 . . . . 0.0 108.737 -176.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -81.21 100.88 1.2 Allowed 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 123.542 2.828 . . . . 0.0 107.674 169.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -61.77 -35.5 78.31 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.486 1.114 . . . . 0.0 112.705 -169.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 141.52 47.04 0.05 OUTLIER Glycine 0 CA--C 1.527 0.808 0 N-CA-C 103.595 -3.802 . . . . 0.0 103.595 -169.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.6 mmmt -61.49 115.97 4.33 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.542 1.537 . . . . 0.0 110.445 -167.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -55.47 -33.29 63.53 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.994 0.918 . . . . 0.0 110.884 170.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -127.22 96.61 4.64 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 176.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.98 -15.03 58.36 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.954 0.902 . . . . 0.0 113.411 -172.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -68.61 -0.2 4.91 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 118.789 -0.624 . . . . 0.0 112.546 169.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.8 t -120.62 138.52 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 104.929 -2.249 . . . . 0.0 104.929 169.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 61.0 m -155.34 160.67 40.9 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.634 1.107 . . . . 0.0 110.061 173.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 41.7 ttm105 -83.35 144.09 29.9 Favored 'General case' 0 C--N 1.342 0.272 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 173.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.1 mp -129.3 157.22 42.49 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 128.075 2.55 . . . . 0.0 105.958 177.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -130.47 130.68 44.54 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 170.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 22.1 m -141.79 168.48 19.67 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.716 1.206 . . . . 0.0 110.998 -171.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -134.3 155.97 49.27 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.447 1.099 . . . . 0.0 108.589 169.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.6 p -69.34 143.82 53.65 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.165 0.586 . . . . 0.0 110.375 176.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -71.77 -36.92 70.53 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.426 0.69 . . . . 0.0 111.247 175.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.1 m -110.92 -10.86 14.39 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -168.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -125.99 -105.97 0.33 Allowed 'General case' 0 C--N 1.343 0.303 0 CA-C-N 120.733 1.606 . . . . 0.0 111.3 -169.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -169.16 14.48 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.749 1.22 . . . . 0.0 114.16 -169.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -65.92 150.52 48.48 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 121.571 -0.706 . . . . 0.0 110.329 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -124.87 113.93 18.52 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 104.18 -2.526 . . . . 0.0 104.18 169.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.1 tp -124.66 145.28 49.74 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.237 1.015 . . . . 0.0 111.243 -168.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 33.2 mm -131.29 142.28 43.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 128.536 2.734 . . . . 0.0 103.741 169.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 123' ' ' MET . 2.1 pt? -156.62 133.05 10.0 Favored 'General case' 0 C--O 1.224 -0.265 0 C-N-CA 124.543 1.137 . . . . 0.0 111.133 175.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -97.02 103.92 15.89 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 102.815 -3.032 . . . . 0.0 102.815 168.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.9 p -128.51 154.34 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 124.344 1.058 . . . . 0.0 111.309 -167.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -68.66 96.05 0.7 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.779 2.032 . . . . 0.0 108.404 169.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.0 pp -75.58 0.35 2.27 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.362 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -169.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -68.15 -4.65 14.49 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 121.425 1.92 . . . . 0.0 112.045 178.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.5 mt -62.16 -34.11 62.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 168.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -77.86 127.54 81.69 Favored Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 174.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.1 -51.23 0.28 Allowed 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.031 1.82 . . . . 0.0 113.052 -169.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.6 m -144.84 -12.94 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -169.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -155.12 152.48 29.54 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.133 0.973 . . . . 0.0 108.785 -175.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.3 mt -111.05 -3.18 15.61 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.437 1.095 . . . . 0.0 112.727 -170.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.09 51.1 4.23 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 176.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -144.4 166.61 24.61 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.676 1.59 . . . . 0.0 108.615 -172.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -93.4 165.39 12.79 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.139 0.976 . . . . 0.0 109.573 -177.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -139.74 -179.17 5.77 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 124.256 1.022 . . . . 0.0 108.767 174.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -136.46 142.25 43.59 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -173.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.3 tt -138.98 144.04 38.78 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.374 1.069 . . . . 0.0 108.605 -169.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.1 t -140.79 152.91 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 126.46 1.904 . . . . 0.0 106.937 -177.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.0 pt -128.85 25.15 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.381 1.073 . . . . 0.0 111.433 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.06 149.82 49.67 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.38 0.672 . . . . 0.0 110.922 179.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.4 m -56.84 150.46 16.31 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.766 1.227 . . . . 0.0 111.63 178.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 25.0 m -139.37 156.35 47.05 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 178.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 43.0 tp -64.83 -20.0 66.16 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.535 0.734 . . . . 0.0 112.28 175.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 13.5 m-30 -57.03 150.95 15.95 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.006 1.322 . . . . 0.0 113.221 -173.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -142.0 -178.59 5.77 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 127.766 2.426 . . . . 0.0 106.815 168.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -59.16 -26.22 64.58 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -169.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -100.27 -9.13 48.67 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-O 118.598 -1.112 . . . . 0.0 113.423 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.6 m -69.19 -27.02 65.13 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 120.088 1.944 . . . . 0.0 109.767 170.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 90.0 mt -115.32 57.16 0.74 Allowed 'General case' 0 C--O 1.233 0.197 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 169.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -47.56 119.39 2.7 Favored 'General case' 0 CA--C 1.522 -0.112 0 C-N-CA 124.356 1.063 . . . . 0.0 108.926 178.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -65.93 66.56 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.092 1.757 . . . . 0.0 112.32 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 178.35 -50.34 0.1 OUTLIER Glycine 0 CA--C 1.527 0.807 0 C-N-CA 127.18 2.324 . . . . 0.0 108.501 178.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -71.91 -40.42 68.84 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.414 0.685 . . . . 0.0 110.693 171.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -55.79 120.32 7.16 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.553 1.141 . . . . 0.0 110.519 -177.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -151.97 140.8 13.8 Favored Pre-proline 0 N--CA 1.446 -0.637 0 C-N-CA 126.376 1.87 . . . . 0.0 106.999 169.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -82.29 1.83 8.92 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.19 2.593 . . . . 0.0 113.53 -177.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.0 p -123.0 39.31 3.98 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.211 1.804 . . . . 0.0 110.118 -169.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -82.82 -3.09 56.28 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.659 1.584 . . . . 0.0 113.715 -169.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -133.35 -72.52 0.5 Allowed 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 170.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 57.3 mmm-85 -126.48 -135.34 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.779 1 N-CA-C 99.455 -4.276 . . . . 0.0 99.455 167.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -77.04 62.8 7.55 Favored 'Trans proline' 0 CA--C 1.547 1.129 0 CA-C-N 126.274 3.276 . . . . 0.0 106.604 167.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 79.3 p -49.4 -40.54 36.6 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.667 2.387 . . . . 0.0 113.934 -168.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 52.0 ttm-85 -79.53 -11.67 59.88 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 118.883 -0.579 . . . . 0.0 112.148 -177.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -114.55 171.35 7.68 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 120.15 1.341 . . . . 0.0 110.771 -174.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.1 t70 64.67 -33.33 0.15 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 128.364 2.666 . . . . 0.0 114.996 -175.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . 0.322 2.8 pp0? -73.55 33.29 0.08 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.907 1.683 . . . . 0.0 114.32 179.1 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.5 p90 44.81 30.63 0.56 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 128.054 2.541 . . . . 0.0 115.074 176.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -159.63 59.61 0.38 Allowed 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.494 -0.754 . . . . 0.0 109.633 -176.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -74.65 72.42 1.96 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 169.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.3 p -85.3 145.87 7.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 124.569 1.148 . . . . 0.0 109.002 -176.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.76 166.99 31.7 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.903 1.681 . . . . 0.0 109.74 -169.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -137.99 142.32 40.45 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.959 1.304 . . . . 0.0 108.911 -177.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -152.73 -157.27 7.93 Favored Glycine 0 C--N 1.336 0.582 0 CA-C-N 118.672 0.669 . . . . 0.0 113.225 -175.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -134.49 130.01 36.02 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 172.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 44.4 t -95.7 150.49 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -132.81 162.34 31.77 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 127.184 2.194 . . . . 0.0 106.883 174.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.93 169.66 19.34 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.12 -0.987 . . . . 0.0 110.67 177.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.64 171.31 18.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 125.121 1.368 . . . . 0.0 107.313 168.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -65.78 -6.99 13.52 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.0 1.72 . . . . 0.0 115.022 -170.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 48.26 40.26 21.86 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.975 1.274 . . . . 0.0 112.868 -175.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -140.65 72.12 1.38 Allowed 'General case' 0 C--O 1.232 0.146 0 C-N-CA 124.877 1.271 . . . . 0.0 107.67 -177.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -139.93 81.16 1.81 Allowed 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 -171.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.84 153.54 24.34 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.722 169.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.6 m 97.74 -5.82 0.05 Allowed 'General case' 0 C--O 1.233 0.216 0 C-N-CA 128.255 2.622 . . . . 0.0 109.068 169.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.3 p -135.0 24.96 3.6 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.079 0.952 . . . . 0.0 110.203 168.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 47.37 43.45 15.32 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.277 1.831 . . . . 0.0 111.587 -179.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -118.3 35.28 4.81 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -100.99 -0.47 36.49 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -169.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.7 p -136.66 165.75 25.16 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 128.823 2.849 . . . . 0.0 108.768 -177.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? 61.75 163.0 0.08 Allowed 'General case' 0 C--N 1.345 0.378 0 C-N-CA 126.593 1.957 . . . . 0.0 110.885 -169.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 52.9 tp -101.04 135.91 41.74 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 103.448 -2.797 . . . . 0.0 103.448 168.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 16.1 m -128.18 134.17 49.01 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -171.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -137.67 162.36 34.05 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.65 1.58 . . . . 0.0 109.405 -169.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -130.3 156.6 44.39 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 172.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.6 t -138.5 139.78 40.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.7 m -125.71 121.42 33.4 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 105.069 -2.196 . . . . 0.0 105.069 174.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -142.38 103.61 4.29 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.333 0.653 . . . . 0.0 109.848 -169.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 59.59 26.5 62.38 Favored Glycine 0 CA--C 1.534 1.269 0 O-C-N 121.68 -0.638 . . . . 0.0 113.628 178.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 93.23 -12.93 68.8 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.409 1.004 . . . . 0.0 113.128 -177.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 84.3 mt -80.91 162.78 23.77 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 118.553 1.176 . . . . 0.0 107.885 169.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 10.7 tp -140.16 153.94 46.8 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 121.808 -0.558 . . . . 0.0 110.3 -170.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' MET . . . . . 0.401 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 29.4 mtm -144.88 156.56 44.07 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.098 1.359 . . . . 0.0 108.494 169.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -136.71 133.44 36.12 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 104.126 -2.546 . . . . 0.0 104.126 169.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 32.5 tp -148.37 145.59 28.14 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.194 0.598 . . . . 0.0 110.374 -168.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -136.01 153.49 51.35 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 167.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -170.25 172.86 44.14 Favored Glycine 0 CA--C 1.521 0.424 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 172.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -55.22 139.61 41.63 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.007 1.404 . . . . 0.0 108.869 173.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -41.06 -54.93 2.71 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -63.4 -37.71 88.34 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 122.564 1.173 . . . . 0.0 111.716 -176.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -69.22 -20.24 63.96 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 113.337 -1.756 . . . . 0.0 111.798 178.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 24.6 tp -69.67 -22.79 63.41 Favored 'General case' 0 C--N 1.346 0.439 0 CA-C-N 120.158 1.344 . . . . 0.0 110.092 174.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 45.71 34.22 1.72 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.675 1.99 . . . . 0.0 114.13 171.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -159.21 57.07 0.33 Allowed Glycine 0 C--N 1.335 0.496 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 -171.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -65.65 -10.0 32.28 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -169.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.412 ' C ' ' H ' ' A' ' 138' ' ' ASP . 38.7 mt-10 -107.27 145.51 32.63 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 125.153 1.381 . . . . 0.0 109.93 179.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 7.7 m -60.69 -7.94 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.233 168.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.412 ' H ' ' C ' ' A' ' 136' ' ' GLU . 32.8 t70 -124.16 14.8 9.1 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 127.58 2.352 . . . . 0.0 112.035 -179.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 70.2 m -81.6 -71.08 0.49 Allowed 'General case' 0 CA--C 1.529 0.151 0 O-C-N 121.589 -0.695 . . . . 0.0 109.491 168.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.299 13.1 ptm180 -85.27 18.26 2.71 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -169.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 18.7 m -62.12 -35.26 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 167.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -79.69 122.8 27.01 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 174.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 56.3 tp -142.82 140.7 31.41 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -169.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.8 tt -145.53 137.43 25.4 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -178.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 58.6 mtt -131.01 157.44 42.98 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.989 0.916 . . . . 0.0 109.457 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 39.8 pttt -164.7 169.95 16.22 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.146 1.378 . . . . 0.0 109.26 178.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.89 162.47 11.1 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.224 0.61 . . . . 0.0 111.363 172.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.44 164.71 2.43 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.57 1.148 . . . . 0.0 113.699 -177.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.72 60.3 5.21 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.063 1.345 . . . . 0.0 111.174 178.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 22.0 t80 . . . . . 0 C--O 1.25 1.105 0 C-N-CA 124.356 1.062 . . . . 0.0 108.371 176.107 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.4 mtp . . . . . 0 N--CA 1.483 1.191 0 CA-C-O 119.281 -0.39 . . . . 0.0 110.304 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 45.92 49.18 12.01 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 124.316 1.046 . . . . 0.0 113.73 173.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -169.37 -170.67 34.19 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 107.838 -2.105 . . . . 0.0 107.838 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.1 pp -69.94 168.85 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-O 121.636 0.731 . . . . 0.0 110.985 177.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 65.7 tp -153.31 -44.06 0.09 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.509 1.524 . . . . 0.0 108.336 174.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -143.3 144.52 32.15 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 169.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -147.46 140.57 25.12 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 -171.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -147.78 144.25 28.09 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 124.262 1.025 . . . . 0.0 109.42 -178.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.77 141.13 25.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -138.08 158.84 43.51 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 122.786 0.435 . . . . 0.0 110.651 174.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -135.08 148.26 49.79 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.802 1.241 . . . . 0.0 109.386 -172.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.1 t -59.86 141.4 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 125.54 1.536 . . . . 0.0 109.847 -178.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -123.35 -29.75 3.78 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 126.377 1.871 . . . . 0.0 108.912 169.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -158.99 169.79 23.52 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.886 0.874 . . . . 0.0 109.669 169.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.6 mp -131.67 141.21 46.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -140.26 76.07 27.05 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 124.319 1.048 . . . . 0.0 108.286 -178.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -81.59 10.27 3.54 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.015 2.477 . . . . 0.0 113.92 -169.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -79.45 54.99 1.84 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.682 1.593 . . . . 0.0 110.199 176.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -150.19 38.4 0.9 Allowed Glycine 0 CA--C 1.528 0.851 0 C-N-CA 126.14 1.829 . . . . 0.0 110.002 -175.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.47 ' HE2' ' HA ' ' A' ' 20' ' ' LYS . 5.3 mmpt? -68.89 65.09 0.13 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.41 1.884 . . . . 0.0 114.083 -169.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -60.43 -38.74 85.04 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 168.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -144.05 162.79 35.33 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 129.161 2.984 . . . . 0.0 104.268 169.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -60.29 -33.68 72.7 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.328 -0.857 . . . . 0.0 111.764 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -75.77 -6.9 52.85 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 117.096 -1.431 . . . . 0.0 114.133 178.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 72.9 t -101.41 123.85 54.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 120.886 1.676 . . . . 0.0 107.162 -174.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.3 m -147.19 152.56 38.59 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.911 0.884 . . . . 0.0 109.561 -176.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 64.9 mtm-85 -83.36 150.61 25.99 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 169.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -129.69 155.16 46.33 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 127.092 2.157 . . . . 0.0 105.8 175.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -127.69 128.62 45.74 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 103.485 -2.783 . . . . 0.0 103.485 170.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 71.3 m -142.61 169.09 18.23 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.396 1.078 . . . . 0.0 111.481 -169.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -135.49 134.86 39.96 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.716 1.606 . . . . 0.0 106.957 176.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.0 m -75.05 142.38 43.75 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 121.392 0.615 . . . . 0.0 110.767 176.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -93.97 -34.93 12.87 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.634 1.174 . . . . 0.0 110.694 -175.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -69.89 -41.98 74.01 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.607 0.763 . . . . 0.0 112.949 -169.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -136.49 -95.22 0.23 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.596 0.758 . . . . 0.0 109.17 -175.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -165.91 110.96 0.85 Allowed 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.06 1.344 . . . . 0.0 108.379 -175.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.8 mtt -158.58 142.01 15.04 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 174.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -112.89 129.31 56.51 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 104.802 -2.296 . . . . 0.0 104.802 169.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.3 tp -136.63 139.46 42.09 Favored 'General case' 0 C--O 1.227 -0.112 0 C-N-CA 123.52 0.728 . . . . 0.0 111.987 -168.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 35.3 mm -121.72 140.96 44.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 102.261 -3.237 . . . . 0.0 102.261 168.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 123' ' ' MET . 2.3 pt? -154.66 158.25 39.37 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 123.704 0.802 . . . . 0.0 110.586 177.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -127.09 111.53 14.13 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.6 m -145.6 166.89 9.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 O-C-N 124.224 0.953 . . . . 0.0 113.195 -168.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -72.65 126.87 30.92 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.945 1.298 . . . . 0.0 107.659 169.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 pp -105.6 -1.05 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -67.23 -16.92 64.58 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 120.775 1.625 . . . . 0.0 111.644 177.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.3 mt -58.57 -27.44 33.89 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 124.23 1.012 . . . . 0.0 109.187 169.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -122.42 158.68 55.4 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 125.093 1.357 . . . . 0.0 113.49 -168.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -75.01 75.13 3.8 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 124.012 3.142 . . . . 0.0 109.55 171.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.5 p -53.98 -23.81 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 124.972 1.309 . . . . 0.0 113.328 -174.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -59.25 -22.43 61.11 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.438 1.095 . . . . 0.0 113.024 174.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 59.1 tp -129.79 -30.19 2.07 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.192 1.397 . . . . 0.0 111.713 -177.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.82 164.95 36.37 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 -169.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -159.2 166.2 31.94 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.71 1.204 . . . . 0.0 108.525 -178.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -74.63 163.97 27.11 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 172.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -128.25 164.92 21.51 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.754 1.622 . . . . 0.0 107.159 177.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.8 ttm180 -127.1 141.14 51.84 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 125.914 1.686 . . . . 0.0 106.581 170.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 39.9 tp -123.72 141.44 52.02 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 127.057 2.143 . . . . 0.0 106.653 178.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.1 t -134.83 142.06 41.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 172.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.7 pt -128.96 19.51 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.329 1.052 . . . . 0.0 110.759 -173.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.4 159.12 27.63 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.24 1.016 . . . . 0.0 110.57 175.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.8 p -58.69 -21.76 55.43 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.333 1.453 . . . . 0.0 112.953 172.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.45 HG22 ' H ' ' A' ' 65' ' ' TYR . 2.7 t 50.58 -169.05 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.75 2.42 . . . . 0.0 114.422 169.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.2 mp -54.87 -26.3 34.61 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.752 1.621 . . . . 0.0 111.272 -177.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.45 ' H ' HG22 ' A' ' 63' ' ' THR . 12.8 m-30 -61.48 -28.03 69.0 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.591 1.156 . . . . 0.0 112.313 -179.134 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -73.99 -16.2 61.08 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.187 0.903 . . . . 0.0 112.002 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -123.29 -17.59 6.54 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.284 1.433 . . . . 0.0 112.116 -169.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.08 35.1 82.98 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 -175.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.2 m -57.81 -22.64 48.5 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.923 1.289 . . . . 0.0 113.542 -169.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.3 pp -131.33 -29.96 1.75 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.569 0.748 . . . . 0.0 111.446 169.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -66.04 -22.99 66.46 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.354 0.662 . . . . 0.0 112.399 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -136.69 35.36 2.66 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.282 1.833 . . . . 0.0 108.167 172.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -140.88 34.67 1.92 Allowed Glycine 0 CA--C 1.527 0.82 0 C-N-CA 125.376 1.465 . . . . 0.0 111.11 -170.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 51.18 55.03 10.12 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.026 1.731 . . . . 0.0 112.653 174.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -56.72 145.11 30.04 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 168.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -137.62 123.46 12.92 Favored Pre-proline 0 CA--C 1.532 0.262 0 CA-C-O 118.541 -0.743 . . . . 0.0 109.693 -170.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -52.04 148.27 24.26 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.12 2.547 . . . . 0.0 111.917 173.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.4 m 66.83 4.71 3.6 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.234 1.413 . . . . 0.0 112.514 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -66.39 -33.11 74.99 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 119.989 -1.695 . . . . 0.0 110.0 169.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -89.5 21.64 3.31 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.534 1.534 . . . . 0.0 111.755 178.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 25.8 ptt-85 -45.72 129.56 6.71 Favored Pre-proline 0 N--CA 1.467 0.378 0 C-N-CA 124.552 1.141 . . . . 0.0 110.862 -178.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo 22.65 49.01 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.757 1 C-N-CA 127.181 5.254 . . . . 0.0 117.102 -169.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.1 m -124.11 -3.31 8.06 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.638 1.175 . . . . 0.0 112.513 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 15.4 ttp180 41.59 41.58 1.72 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.744 2.018 . . . . 0.0 113.679 174.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 46.99 32.07 1.75 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.162 1.785 . . . . 0.0 113.838 -176.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -47.63 -30.88 4.03 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.644 1.578 . . . . 0.0 112.979 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -47.48 -61.38 1.95 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.749 2.019 . . . . 0.0 110.954 171.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -148.57 88.15 1.61 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 -178.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -61.08 -31.26 70.93 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 114.09 1.145 . . . . 0.0 114.09 -168.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -144.01 142.23 30.58 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 118.799 0.727 . . . . 0.0 109.154 172.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.2 m -143.06 139.15 27.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 C-N-CA 126.143 1.777 . . . . 0.0 106.707 177.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 37.5 tpp -161.02 166.04 28.84 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.325 1.05 . . . . 0.0 109.078 -177.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -124.54 145.31 49.65 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 170.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -153.15 -170.16 19.08 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-N 118.768 0.713 . . . . 0.0 111.766 -172.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -117.84 134.79 54.58 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.0 t -112.21 134.79 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 175.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -151.23 148.21 27.94 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.739 1.216 . . . . 0.0 108.233 -174.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.15 175.46 1.52 Allowed 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.427 1.491 . . . . 0.0 109.476 170.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 33.8 pt -70.06 -175.44 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 123.861 0.864 . . . . 0.0 110.304 169.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -63.81 -6.38 5.7 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.5 1.92 . . . . 0.0 115.687 -171.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.3 -15.97 62.06 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-O 118.851 -0.972 . . . . 0.0 112.812 178.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -80.0 75.42 6.74 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 169.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -116.33 75.05 0.93 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.107 1.363 . . . . 0.0 107.768 -168.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.7 t -151.14 -148.24 0.26 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.4 1.08 . . . . 0.0 108.938 -179.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.8 m -142.11 -7.03 0.93 Allowed 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 127.628 2.371 . . . . 0.0 108.9 -176.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 35.7 p -91.65 -0.53 57.58 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 123.697 0.799 . . . . 0.0 110.424 171.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 52.9 30.92 9.91 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.602 1.561 . . . . 0.0 109.621 -168.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -150.07 57.1 0.96 Allowed 'General case' 0 C--N 1.348 0.542 0 O-C-N 122.012 -0.43 . . . . 0.0 110.919 -175.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.66 164.8 13.68 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.854 -0.529 . . . . 0.0 110.679 178.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.6 p -128.17 1.08 5.82 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -178.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.4 mpt_? -132.72 128.69 37.46 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 126.077 1.751 . . . . 0.0 106.497 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.5 tp -73.91 139.0 44.65 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 174.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 7.8 p -90.75 154.95 19.16 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 122.045 -0.409 . . . . 0.0 110.34 176.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -147.77 137.78 22.8 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.132 0.973 . . . . 0.0 108.641 170.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 10.6 m-30 -114.96 146.53 41.09 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 103.45 -2.796 . . . . 0.0 103.45 168.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.2 t -135.33 143.56 36.6 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -173.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.3 t -134.85 123.94 24.29 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 105.496 -2.038 . . . . 0.0 105.496 169.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -146.98 107.94 4.19 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.408 0.683 . . . . 0.0 109.359 -169.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 57.17 24.15 50.03 Favored Glycine 0 CA--C 1.536 1.389 0 O-C-N 121.595 -0.691 . . . . 0.0 113.855 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 93.96 -11.33 71.03 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 124.629 1.109 . . . . 0.0 113.435 -178.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.5 mp -82.34 160.67 22.79 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 170.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 7.0 tp -139.5 159.71 41.53 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.817 -0.552 . . . . 0.0 111.036 -169.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' MET . . . . . 0.401 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 26.1 mtt -149.25 156.38 42.03 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 125.295 1.438 . . . . 0.0 109.092 169.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 39.0 mtm105 -143.47 126.31 16.17 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 105.019 -2.215 . . . . 0.0 105.019 169.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -155.81 166.4 33.61 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 119.667 1.122 . . . . 0.0 112.902 -169.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -134.82 141.33 46.37 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 168.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -156.53 168.85 33.82 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.32 132.19 33.91 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 170.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -45.82 -43.33 13.24 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 175.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.6 -22.86 65.34 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 120.989 -1.069 . . . . 0.0 113.601 177.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -75.65 -19.61 59.05 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 125.527 1.531 . . . . 0.0 110.808 172.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -85.84 3.6 40.9 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 119.467 1.03 . . . . 0.0 109.365 168.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 1.5 t60 38.33 30.04 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.513 1 C-N-CA 131.789 4.036 . . . . 0.0 118.107 169.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 163.27 28.69 0.02 OUTLIER Glycine 0 CA--C 1.525 0.698 0 CA-C-O 119.243 -0.754 . . . . 0.0 111.947 178.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 45.79 40.05 5.99 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.82 1.648 . . . . 0.0 111.95 -169.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . 0.369 2.7 pp20? 43.57 -148.53 0.05 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.932 2.093 . . . . 0.0 114.623 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.7 t 67.9 -34.49 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 127.6 2.36 . . . . 0.0 111.879 -168.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -154.37 18.05 0.48 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.416 1.087 . . . . 0.0 112.433 -170.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 48.8 m -87.04 -77.02 0.34 Allowed 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 169.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.277 9.8 ptm180 -79.35 14.53 1.51 Allowed 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.482 1.113 . . . . 0.0 113.186 -172.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 20.8 m -63.72 -38.67 82.91 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 167.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -82.67 129.22 34.92 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 169.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 7.4 tt -142.12 127.25 18.52 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 118.637 0.653 . . . . 0.0 109.306 -174.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 7.3 tt -132.94 134.06 44.03 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 178.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 60.2 ttm -137.78 140.07 40.39 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -176.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -158.94 -176.28 5.77 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.152 0.981 . . . . 0.0 109.786 178.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -52.93 158.63 1.35 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.992 1.317 . . . . 0.0 112.283 169.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.34 169.68 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.69 2.396 . . . . 0.0 114.205 174.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -125.85 0.43 7.35 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 179.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 14.2 p90 . . . . . 0 C--O 1.249 1.033 0 C-N-CA 127.955 2.502 . . . . 0.0 106.826 -179.482 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 mmt . . . . . 0 N--CA 1.484 1.275 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.51 7.86 2.83 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.388 1.075 . . . . 0.0 112.389 -178.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 170.49 177.41 40.57 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 55.9 mt -138.85 140.07 39.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 174.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tt -73.59 93.83 2.08 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -178.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -151.69 148.12 27.54 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.101 1.36 . . . . 0.0 108.184 171.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -148.64 143.15 26.33 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 126.431 1.892 . . . . 0.0 107.529 -173.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -151.81 124.9 8.66 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.224 1.009 . . . . 0.0 108.785 172.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.6 mp -79.44 142.14 14.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 104.385 -2.45 . . . . 0.0 104.385 169.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -130.44 158.4 39.99 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.391 0.615 . . . . 0.0 109.807 171.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -119.1 132.98 56.05 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.477 1.511 . . . . 0.0 107.194 178.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.4 p -69.99 135.04 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.9 mmmm -113.06 -25.17 9.07 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.303 1.441 . . . . 0.0 109.977 -177.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -156.07 163.34 39.79 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.098 0.863 . . . . 0.0 110.672 169.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.9 mp -139.09 137.27 42.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 127.264 2.225 . . . . 0.0 105.414 179.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -142.89 97.24 5.87 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 124.589 1.156 . . . . 0.0 108.985 -173.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -61.02 1.28 0.62 Allowed 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 124.326 3.351 . . . . 0.0 117.541 -175.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -77.28 46.73 0.52 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.726 2.01 . . . . 0.0 110.973 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -153.74 35.72 0.74 Allowed Glycine 0 CA--C 1.528 0.859 0 C-N-CA 126.995 2.236 . . . . 0.0 108.928 178.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.423 ' HA ' ' CE ' ' A' ' 20' ' ' LYS . 0.1 OUTLIER -71.68 55.41 0.26 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.567 1.947 . . . . 0.0 113.648 -169.812 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -54.44 -39.76 67.71 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 121.35 -0.843 . . . . 0.0 109.647 170.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -142.64 163.97 31.37 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 128.037 2.535 . . . . 0.0 104.569 169.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -57.48 -34.63 69.23 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.55 -0.719 . . . . 0.0 111.485 176.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 -79.03 4.23 15.03 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-O 117.101 -1.428 . . . . 0.0 114.535 178.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 81.3 t -118.04 132.17 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 121.736 2.062 . . . . 0.0 107.519 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 65.1 m -145.79 159.84 42.61 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.637 0.775 . . . . 0.0 109.709 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -76.69 148.91 36.52 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 169.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -142.56 153.99 44.05 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.712 1.605 . . . . 0.0 107.521 -169.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -134.3 136.58 43.61 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 171.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 67.7 m -145.35 165.38 28.63 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.277 1.031 . . . . 0.0 110.945 -171.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -139.54 136.01 34.03 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.273 1.429 . . . . 0.0 108.496 178.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.2 m -60.67 139.87 57.69 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.842 0.857 . . . . 0.0 112.185 173.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -94.41 -44.44 7.9 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 168.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.0 m -73.13 -38.16 66.39 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 118.643 -0.694 . . . . 0.0 112.029 -172.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -121.14 -106.84 0.37 Allowed 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -166.3 8.96 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 -169.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.8 mpp? -69.04 148.55 49.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.75 0.786 . . . . 0.0 109.145 -174.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -103.93 138.69 40.13 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 169.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.8 mt -135.86 144.71 45.75 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.287 0.635 . . . . 0.0 110.17 -169.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.8 mm -130.19 143.19 41.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 103.157 -2.905 . . . . 0.0 103.157 169.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.8 mp -144.61 159.84 42.15 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.622 1.569 . . . . 0.0 108.166 -177.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -136.04 95.1 3.14 Favored 'General case' 0 C--N 1.32 -0.693 1 N-CA-C 99.758 -4.164 . . . . 0.0 99.758 169.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.1 p -147.11 167.45 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 121.285 0.564 . . . . 0.0 112.392 -167.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -58.27 140.31 53.49 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.883 1.273 . . . . 0.0 109.31 169.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 pp -119.55 -1.38 8.56 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.669 0 CA-C-O 116.972 -1.49 . . . . 0.0 113.263 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -63.64 -15.57 58.65 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 121.773 2.079 . . . . 0.0 114.212 -169.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.519 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.6 OUTLIER -65.69 -28.39 44.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 127.388 2.275 . . . . 0.0 111.093 173.803 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -52.57 155.17 3.99 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 124.534 1.134 . . . . 0.0 111.979 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -73.87 50.57 2.15 Favored 'Trans proline' 0 CA--C 1.547 1.162 0 C-N-CA 124.698 3.599 . . . . 0.0 112.959 175.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . 0.27 20.3 m 52.65 -9.94 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 131.13 3.772 . . . . 0.0 119.229 169.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -143.2 -12.5 0.72 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 120.358 1.435 . . . . 0.0 112.625 -173.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -156.36 169.16 25.23 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 126.239 1.815 . . . . 0.0 108.259 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.16 175.22 54.71 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 176.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -152.18 171.08 18.48 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.732 1.213 . . . . 0.0 109.142 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -79.17 155.39 28.68 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.51 1.124 . . . . 0.0 109.698 175.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -129.74 162.25 28.83 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.975 1.31 . . . . 0.0 108.808 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 42.0 ttt180 -115.07 134.14 55.43 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 173.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 57.7 tp -127.78 132.86 49.47 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 177.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.6 m -137.99 163.99 28.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 124.551 1.14 . . . . 0.0 108.093 177.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.0 pt -127.41 13.07 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 123.514 0.726 . . . . 0.0 110.53 177.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.24 -8.76 57.19 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.548 1.139 . . . . 0.0 113.574 -175.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.9 m -148.52 168.25 23.23 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.653 1.181 . . . . 0.0 109.453 -175.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.5 t -152.86 173.35 15.44 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.902 1.281 . . . . 0.0 107.937 172.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -79.55 164.42 23.89 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 174.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -132.19 175.21 9.45 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -178.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -74.39 161.08 30.19 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 169.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -62.4 -38.24 88.88 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 121.557 -0.714 . . . . 0.0 110.428 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.42 -28.29 69.24 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 123.918 0.77 . . . . 0.0 112.929 178.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.1 m -65.4 -23.93 67.08 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.512 1.156 . . . . 0.0 111.532 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 92.9 mt -119.06 -28.11 5.57 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.444 0.697 . . . . 0.0 111.602 -176.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -61.62 -15.54 40.39 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.262 0.937 . . . . 0.0 112.161 174.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -61.22 -14.49 26.06 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.8 1.64 . . . . 0.0 114.614 175.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -177.3 0.68 0.03 OUTLIER Glycine 0 CA--C 1.53 0.99 0 N-CA-C 117.028 1.571 . . . . 0.0 117.028 175.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 48.46 58.8 4.83 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 119.535 1.667 . . . . 0.0 109.737 -169.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -52.91 133.72 37.74 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 176.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -141.68 113.01 6.49 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-O 118.657 -0.687 . . . . 0.0 109.747 -177.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo -60.93 -4.92 4.07 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.846 3.03 . . . . 0.0 116.096 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . 0.25 95.1 m 68.13 -33.94 0.24 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 127.913 2.485 . . . . 0.0 114.313 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -67.37 -23.05 65.55 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.549 1.068 . . . . 0.0 110.463 169.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -59.08 -43.14 91.76 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.949 1.7 . . . . 0.0 112.589 172.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 88.3 mtm-85 -66.14 -44.04 58.08 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-O 117.003 -1.475 . . . . 0.0 113.696 -169.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -78.99 10.42 2.94 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.354 2.036 . . . . 0.0 113.562 174.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 24.6 m -119.72 -30.89 4.68 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.75 1.22 . . . . 0.0 111.526 -175.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 57.1 -175.0 0.07 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.352 1.861 . . . . 0.0 111.855 177.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.98 -12.26 48.15 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 120.887 -1.133 . . . . 0.0 113.186 -172.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -56.05 -17.59 7.35 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.457 1.503 . . . . 0.0 113.267 175.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -53.99 -25.32 20.34 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.487 1.115 . . . . 0.0 112.545 169.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -141.25 177.84 7.82 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.44 1.496 . . . . 0.0 109.588 -169.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -146.04 -40.85 0.21 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.175 0.59 . . . . 0.0 109.421 169.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -143.94 144.73 31.83 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 123.909 0.884 . . . . 0.0 108.698 175.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.1 p -142.58 142.29 26.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 5.2 tmm? -158.89 160.75 36.48 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.455 0.645 . . . . 0.0 111.28 -168.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -129.91 104.92 7.65 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 104.721 -2.326 . . . . 0.0 104.721 173.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -94.93 -173.11 37.62 Favored Glycine 0 C--N 1.332 0.361 0 CA-C-O 121.288 0.382 . . . . 0.0 112.585 -169.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -120.61 100.56 7.2 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 169.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -70.42 142.13 16.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 170.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -136.37 127.22 27.48 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 103.075 -2.935 . . . . 0.0 103.075 169.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -146.29 169.18 19.33 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 120.028 1.285 . . . . 0.0 112.881 -169.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.1 pt -134.63 165.77 30.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 C-N-CA 126.533 1.933 . . . . 0.0 108.325 -169.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -66.53 -3.96 7.46 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.964 1.706 . . . . 0.0 112.77 175.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 144.11 173.33 15.45 Favored Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 104.855 -3.298 . . . . 0.0 104.855 -169.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -56.2 -23.18 33.72 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 118.129 0.965 . . . . 0.0 112.305 178.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -173.35 -126.95 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.791 1 C-N-CA 132.036 4.135 . . . . 0.0 101.809 169.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 21.4 p -135.76 167.0 21.96 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 125.789 1.636 . . . . 0.0 113.402 -174.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 75.6 m -132.06 -38.08 1.11 Allowed 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 129.249 3.02 . . . . 0.0 105.788 177.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 17.3 p -132.58 -60.44 0.88 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.618 1.167 . . . . 0.0 109.054 169.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -154.28 23.42 0.48 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.966 1.707 . . . . 0.0 110.223 -178.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 177.89 148.75 0.17 Allowed 'General case' 0 C--O 1.242 0.66 0 C-N-CA 130.742 3.617 . . . . 0.0 102.373 -169.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -77.56 166.1 23.47 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.841 1.201 . . . . 0.0 108.514 170.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.78 -3.73 13.43 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -178.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -138.27 140.14 39.49 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 103.948 -2.612 . . . . 0.0 103.948 169.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 22.3 tp -75.96 157.77 32.74 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 169.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 2.2 m -139.96 146.09 38.7 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -177.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -147.84 160.17 43.05 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.019 0.928 . . . . 0.0 109.157 178.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -124.76 149.78 46.97 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 173.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.9 t -141.24 116.07 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 17.2 m -86.34 124.56 32.84 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 105.469 -2.048 . . . . 0.0 105.469 169.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.4 m-30 -86.89 163.43 17.17 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 169.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -56.96 67.02 0.01 OUTLIER Glycine 0 CA--C 1.539 1.538 0 C-N-CA 126.521 2.01 . . . . 0.0 114.512 170.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 119.24 -7.24 12.72 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 127.137 2.303 . . . . 0.0 113.407 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -139.24 -179.81 6.09 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 119.885 1.842 . . . . 0.0 108.369 -169.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.7 tt -154.77 160.46 41.32 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 121.346 1.885 . . . . 0.0 112.3 -177.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -149.74 161.52 42.06 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.7 1.6 . . . . 0.0 109.426 169.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 92.0 mtt-85 -137.54 139.91 40.75 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 174.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 8.0 tt -143.89 147.93 34.71 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 123.13 0.572 . . . . 0.0 110.441 -169.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -129.07 151.47 49.72 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 168.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -173.55 173.07 45.65 Favored Glycine 0 C--N 1.329 0.146 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 170.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.93 139.98 38.75 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 169.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -39.94 -60.43 1.02 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -178.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -60.45 -37.52 81.22 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.874 0.845 . . . . 0.0 112.46 -178.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -66.9 -23.38 65.99 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 125.307 1.443 . . . . 0.0 111.249 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.7 tt -69.58 -26.78 64.63 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.481 1.037 . . . . 0.0 110.195 177.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 43.39 40.05 2.46 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 127.798 2.439 . . . . 0.0 113.472 175.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -165.62 42.71 0.28 Allowed Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 -169.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -76.17 9.41 2.55 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.546 1.138 . . . . 0.0 112.273 -173.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -130.15 135.95 48.75 Favored 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 125.212 1.405 . . . . 0.0 108.643 -172.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.6 m -57.1 -5.07 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 126.626 1.97 . . . . 0.0 112.31 169.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -134.38 16.83 3.7 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 173.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.7 m -102.78 -51.97 3.18 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 167.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 5.2 tpm_? -75.71 0.45 17.73 Favored 'General case' 0 C--N 1.342 0.271 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -172.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 35.7 m -62.55 -41.57 92.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 124.18 0.992 . . . . 0.0 110.83 169.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -71.28 130.95 42.69 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -170.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 7.7 tt -150.67 134.09 16.34 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 117.939 0.336 . . . . 0.0 110.292 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.8 tt -144.56 135.35 24.85 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 106.492 -1.669 . . . . 0.0 106.492 169.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 14.6 ptp -142.38 159.08 42.94 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 118.501 0.592 . . . . 0.0 111.663 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -157.01 -173.77 4.61 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 126.084 1.754 . . . . 0.0 108.756 171.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -60.95 169.69 1.85 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.889 0.768 . . . . 0.0 109.669 169.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -44.2 155.63 0.09 Allowed 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 179.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.86 63.5 7.0 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.776 1.23 . . . . 0.0 110.054 177.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 19.8 t80 . . . . . 0 C--O 1.249 1.042 0 C-N-CA 123.944 0.897 . . . . 0.0 108.81 178.495 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.29 144.92 49.35 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.505 0.722 . . . . 0.0 110.654 177.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 170.74 174.55 38.76 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 20.4 tt -154.41 154.34 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 169.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 22.1 tp -81.71 48.18 1.17 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.149 0.98 . . . . 0.0 109.909 174.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -150.69 125.61 9.82 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.416 1.086 . . . . 0.0 109.095 -177.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -155.87 140.59 17.05 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 178.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -148.41 148.59 30.5 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.13 0.877 . . . . 0.0 110.368 169.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 mp -77.54 154.46 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 173.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -145.76 160.45 41.72 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.971 0.909 . . . . 0.0 110.241 171.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -135.13 129.58 34.11 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.194 1.798 . . . . 0.0 108.194 -169.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.8 p -68.36 123.51 21.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 121.825 0.822 . . . . 0.0 109.058 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -82.14 -42.06 19.6 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 124.537 1.135 . . . . 0.0 109.294 170.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -159.76 167.98 26.98 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 118.831 0.742 . . . . 0.0 111.638 -175.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.3 mp -138.82 138.27 42.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 127.769 2.428 . . . . 0.0 105.55 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -146.0 97.76 4.48 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 118.787 0.721 . . . . 0.0 110.966 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -58.07 59.82 0.05 OUTLIER 'Trans proline' 0 CA--C 1.548 1.214 1 C-N-CA 126.921 5.081 . . . . 0.0 116.595 174.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -123.91 43.67 2.92 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.688 1.595 . . . . 0.0 109.789 178.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -168.1 44.45 0.24 Allowed Glycine 0 C--N 1.336 0.554 0 C-N-CA 124.182 0.896 . . . . 0.0 110.994 -175.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.9 mmmm -76.0 68.07 2.43 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.13 0.965 . . . . 0.0 111.149 -169.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.21 -36.61 68.63 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 169.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -139.68 167.44 22.09 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 128.651 2.78 . . . . 0.0 104.551 169.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -68.72 -25.34 64.71 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.079 -1.013 . . . . 0.0 111.351 -173.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -82.0 -6.35 59.07 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-O 116.536 -1.697 . . . . 0.0 113.553 175.016 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 70.0 t -101.35 128.75 53.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 121.664 2.029 . . . . 0.0 107.728 -175.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.2 m -148.19 167.97 23.7 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.787 1.235 . . . . 0.0 109.304 -177.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.0 tpp85 -70.58 153.98 42.33 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 170.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.8 mt -138.19 156.13 48.01 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.296 1.838 . . . . 0.0 106.904 170.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -133.39 133.68 42.72 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 170.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 65.0 m -143.0 163.65 32.2 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.719 1.208 . . . . 0.0 110.352 -171.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -134.7 137.73 43.79 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.861 1.664 . . . . 0.0 107.051 177.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.8 m -93.65 142.62 27.15 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.058 0.456 . . . . 0.0 110.169 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -69.75 -54.93 11.42 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.788 1.635 . . . . 0.0 113.122 -168.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.6 m -89.35 -35.47 16.07 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 123.114 0.566 . . . . 0.0 111.747 -169.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -108.03 6.56 27.16 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -169.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.287 0.0 OUTLIER 45.99 28.58 0.64 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.179 1.792 . . . . 0.0 114.467 178.678 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 78.8 mtm -61.52 152.48 30.11 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 169.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -123.73 124.12 42.01 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.6 tt -130.67 150.63 51.77 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.864 0.84 . . . . 0.0 111.818 -168.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 16.8 mm -129.15 147.46 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 128.75 2.82 . . . . 0.0 103.729 169.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -147.5 155.42 41.87 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 127.626 2.37 . . . . 0.0 105.89 -171.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -142.49 103.01 4.18 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 104.701 -2.333 . . . . 0.0 104.701 170.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.9 p -163.43 179.59 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 124.044 0.938 . . . . 0.0 109.765 -169.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -52.53 130.49 31.99 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.84 1.656 . . . . 0.0 111.646 172.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.6 pp -110.33 -1.98 10.07 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 C-N-CA 124.946 1.299 . . . . 0.0 113.134 177.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -70.24 -9.54 56.22 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 120.028 1.285 . . . . 0.0 111.395 177.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.2 mt -61.65 -36.53 74.05 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 168.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -91.05 156.14 44.32 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 125.36 1.464 . . . . 0.0 110.526 -177.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.28 169.63 17.87 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.567 2.178 . . . . 0.0 109.921 169.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.0 m -63.71 -23.9 34.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 -169.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -153.23 -35.34 0.11 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.248 0.931 . . . . 0.0 113.497 -175.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 54.6 tp -62.65 -27.69 69.4 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -172.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.98 177.65 36.6 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 -169.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -158.35 175.2 14.02 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.134 0.974 . . . . 0.0 108.768 -178.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -125.39 135.57 52.54 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.003 1.321 . . . . 0.0 107.695 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -131.53 -173.39 3.11 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -129.85 151.48 50.37 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.846 1.258 . . . . 0.0 108.246 177.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 62.1 tp -124.39 138.87 54.32 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 127.005 2.122 . . . . 0.0 107.328 -174.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 41.0 t -144.77 152.64 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 126.626 1.97 . . . . 0.0 106.048 -175.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.5 pt -133.0 55.24 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.477 1.111 . . . . 0.0 108.925 176.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -54.88 122.31 10.53 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 124.752 1.221 . . . . 0.0 110.662 -176.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.9 m -57.78 116.37 3.4 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.915 0.886 . . . . 0.0 108.944 176.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.4 m -143.19 132.0 22.7 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -172.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 41.7 tp -149.94 56.26 0.95 Allowed 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 172.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -64.77 158.52 24.63 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.979 -172.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -136.62 177.91 7.48 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.915 2.086 . . . . 0.0 107.609 175.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -60.06 -37.1 78.85 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.514 0.726 . . . . 0.0 111.237 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -71.5 -20.28 78.28 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-O 119.268 -0.74 . . . . 0.0 113.203 178.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.1 m -70.81 -27.31 63.79 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.901 1.351 . . . . 0.0 111.047 -177.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 pp -148.58 -46.51 0.15 Allowed 'General case' 0 C--N 1.342 0.279 0 CA-C-O 117.654 -1.165 . . . . 0.0 113.714 -174.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -70.45 -30.3 67.09 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 120.592 1.542 . . . . 0.0 111.033 -173.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -118.19 35.7 4.64 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.881 1.673 . . . . 0.0 108.311 169.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -137.47 54.37 0.71 Allowed Glycine 0 CA--C 1.526 0.766 0 C-N-CA 126.755 2.121 . . . . 0.0 108.981 -173.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.413 ' C ' ' H ' ' A' ' 76' ' ' ASN . 22.3 tt0 63.08 49.67 3.33 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.517 1.527 . . . . 0.0 111.715 178.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -72.57 21.65 0.06 Allowed 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.335 -0.853 . . . . 0.0 112.52 169.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.413 ' H ' ' C ' ' A' ' 74' ' ' GLU . 5.3 t30 -51.67 -43.06 86.86 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 125.834 1.653 . . . . 0.0 114.213 -177.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -80.07 5.37 6.04 Favored 'Trans proline' 0 C--N 1.352 0.745 0 CA-C-N 122.084 1.78 . . . . 0.0 112.77 178.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.8 m 55.88 22.67 5.85 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.018 1.727 . . . . 0.0 111.346 -169.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.7 t70 8.54 -69.11 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 130.847 3.659 . . . . 0.0 117.66 -169.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -77.92 1.41 20.72 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.45 1.1 . . . . 0.0 112.982 -172.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.17 127.98 2.74 Favored Pre-proline 0 C--N 1.342 0.263 0 C-N-CA 126.039 1.735 . . . . 0.0 111.494 -176.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo 24.66 43.62 0.0 OUTLIER 'Trans proline' 0 CA--C 1.539 0.755 1 C-N-CA 126.742 4.961 . . . . 0.0 116.956 -169.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.7 m -126.24 -31.62 2.79 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.235 1.414 . . . . 0.0 110.012 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? 46.06 53.61 9.01 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.788 1.235 . . . . 0.0 112.727 169.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 58.27 14.16 2.71 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.883 2.073 . . . . 0.0 115.063 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -60.44 -14.37 18.8 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 120.02 1.282 . . . . 0.0 112.075 169.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -53.13 -21.42 4.9 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.373 1.869 . . . . 0.0 112.01 169.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -132.6 158.64 41.7 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.01 2.124 . . . . 0.0 107.419 -174.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -78.11 -33.62 50.5 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.691 -0.631 . . . . 0.0 109.485 174.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -160.19 158.67 30.49 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.492 0.717 . . . . 0.0 109.791 169.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.2 m -139.53 145.07 27.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 C-N-CA 125.25 1.42 . . . . 0.0 107.177 172.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 15.8 ttt -151.83 143.39 23.53 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.915 0.886 . . . . 0.0 109.073 -169.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -135.74 75.67 1.57 Allowed 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 175.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -93.57 -163.94 36.8 Favored Glycine 0 C--N 1.337 0.589 0 N-CA-C 115.26 0.864 . . . . 0.0 115.26 -167.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -131.31 128.84 40.58 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 170.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -74.55 148.84 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 124.946 1.299 . . . . 0.0 108.642 169.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -142.09 64.83 1.38 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.653 1.581 . . . . 0.0 109.131 178.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -156.3 178.96 9.71 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 120.772 -1.205 . . . . 0.0 110.913 -178.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.53 -179.69 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 126.643 1.977 . . . . 0.0 109.5 -173.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -59.99 -6.69 1.42 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.849 2.06 . . . . 0.0 116.481 -169.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 163.48 -64.23 0.25 Allowed Glycine 0 C--N 1.334 0.47 0 N-CA-C 108.236 -1.946 . . . . 0.0 108.236 171.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -143.42 -66.68 0.36 Allowed 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 124.786 1.235 . . . . 0.0 108.222 169.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -168.68 61.94 0.06 Allowed 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 125.675 1.59 . . . . 0.0 108.086 171.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.6 151.88 4.02 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 123.004 1.383 . . . . 0.0 113.957 -176.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.1 p -152.52 -44.47 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 127.741 2.417 . . . . 0.0 106.823 -178.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.6 p -142.95 -53.34 0.39 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.517 1.527 . . . . 0.0 107.325 169.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -162.83 46.76 0.14 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.166 1.386 . . . . 0.0 109.341 -173.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -70.16 -37.34 75.19 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 169.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -132.17 159.98 37.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 111.863 -2.426 . . . . 0.0 109.015 167.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.9 p -136.29 6.75 3.07 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.145 0.978 . . . . 0.0 112.916 -177.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -135.34 145.42 47.39 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 171.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 40.6 tp -76.49 150.11 36.68 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 105.453 -2.055 . . . . 0.0 105.453 168.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 14.9 m -128.24 150.19 50.14 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -174.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -143.67 149.13 36.8 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.286 1.034 . . . . 0.0 108.365 176.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -134.54 135.2 42.15 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 101.412 -3.551 . . . . 0.0 101.412 169.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.4 t -142.35 144.23 25.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -170.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.4 m -134.46 143.2 47.38 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -159.92 134.15 7.48 Favored 'General case' 0 C--O 1.226 -0.151 0 C-N-CA 123.524 0.73 . . . . 0.0 109.957 171.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 54.61 27.41 42.17 Favored Glycine 0 CA--C 1.537 1.461 0 N-CA-C 114.935 0.734 . . . . 0.0 114.935 169.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 85.73 1.13 87.49 Favored Glycine 0 CA--C 1.535 1.312 0 CA-C-N 118.488 1.144 . . . . 0.0 113.866 -177.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.12 153.19 17.77 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.821 1.648 . . . . 0.0 107.995 173.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 22.8 tp -133.38 156.57 47.43 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.109 0.964 . . . . 0.0 109.477 -176.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 60.6 mtt -144.04 156.48 44.4 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.789 1.636 . . . . 0.0 108.44 171.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.6 129.96 23.84 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 104.377 -2.453 . . . . 0.0 104.377 169.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 18.8 tp -144.7 147.61 33.22 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 119.511 1.05 . . . . 0.0 109.72 -168.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -139.19 153.78 47.95 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.989 0.916 . . . . 0.0 108.753 169.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -172.78 171.13 44.18 Favored Glycine 0 CA--C 1.519 0.333 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 169.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -54.71 141.18 33.22 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 118.804 1.302 . . . . 0.0 107.52 169.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -40.47 -59.44 1.33 Allowed 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -178.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.15 -13.71 62.32 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.345 -0.847 . . . . 0.0 113.134 -174.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -89.31 -27.23 20.67 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 126.175 1.79 . . . . 0.0 109.808 177.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 5.8 tt -78.02 -26.48 48.5 Favored 'General case' 0 C--N 1.344 0.33 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 169.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 3.1 t60 51.95 32.24 9.73 Favored 'General case' 0 C--N 1.344 0.355 0 C-N-CA 126.885 2.074 . . . . 0.0 113.155 168.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -154.97 86.66 0.13 Allowed Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 -169.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -50.66 125.78 13.96 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 169.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.49 175.37 2.3 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -168.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.4 t 70.12 -25.18 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 127.602 2.361 . . . . 0.0 111.768 -170.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -163.53 59.26 0.17 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 120.351 1.432 . . . . 0.0 112.285 -170.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 36.3 m -145.79 -53.9 0.27 Allowed 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 113.64 -1.618 . . . . 0.0 108.841 168.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -75.35 4.59 6.93 Favored 'General case' 0 C--N 1.343 0.299 0 O-C-N 121.867 -0.521 . . . . 0.0 112.285 177.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 11.1 m -81.93 -3.63 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 C-N-CA 123.872 0.869 . . . . 0.0 111.696 178.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -136.57 116.12 12.87 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 169.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 10.4 tt -143.28 142.97 31.53 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.154 0.582 . . . . 0.0 109.527 -169.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 15.6 tp -140.53 141.75 35.26 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 125.815 1.646 . . . . 0.0 107.477 -172.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 38.6 ttm -131.35 132.37 44.4 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -148.35 147.72 29.57 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -178.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -54.55 155.96 3.73 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.663 1.12 . . . . 0.0 111.597 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.6 pp -67.38 158.92 30.52 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 169.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -149.38 96.89 2.57 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.298 0.639 . . . . 0.0 110.058 -177.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 24.3 p90 . . . . . 0 C--O 1.252 1.185 0 C-N-CA 126.096 1.758 . . . . 0.0 107.471 169.675 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.4 mmt . . . . . 0 N--CA 1.476 0.849 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.74 158.43 36.31 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.549 0.74 . . . . 0.0 110.671 173.427 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 60.41 22.84 59.45 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.096 0.855 . . . . 0.0 115.012 169.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 35.0 pt -71.91 174.91 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 124.849 1.26 . . . . 0.0 110.103 173.126 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 60.9 tp -149.88 124.71 9.86 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.629 -0.669 . . . . 0.0 110.599 174.924 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -157.97 145.36 18.25 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 104.096 -2.557 . . . . 0.0 104.096 169.244 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -147.72 144.8 28.56 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.443 1.497 . . . . 0.0 107.786 -175.01 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -154.27 167.64 29.26 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.233 1.813 . . . . 0.0 108.548 178.464 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.2 mp -124.72 114.34 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 103.646 -2.724 . . . . 0.0 103.646 169.828 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -94.23 152.2 18.88 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.486 0.66 . . . . 0.0 109.705 -179.863 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -135.1 133.85 39.68 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 126.408 1.883 . . . . 0.0 108.257 -173.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 40.3 t -68.71 143.88 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 123.997 0.919 . . . . 0.0 109.392 -178.057 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -124.24 -28.22 3.71 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 126.785 2.034 . . . . 0.0 109.341 177.542 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -159.06 168.23 27.21 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.481 1.037 . . . . 0.0 111.136 171.066 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.4 mp -135.2 139.05 47.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 127.443 2.297 . . . . 0.0 105.927 179.603 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -147.06 91.98 5.04 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 123.301 0.64 . . . . 0.0 112.27 -173.519 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -68.5 97.12 0.51 Allowed 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 123.059 2.506 . . . . 0.0 108.477 168.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -59.37 -36.32 75.53 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.966 0.906 . . . . 0.0 112.84 -169.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.35 44.65 0.03 OUTLIER Glycine 0 CA--C 1.525 0.703 0 N-CA-C 103.749 -3.741 . . . . 0.0 103.749 -170.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.4 mmmt -65.47 132.37 48.77 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.37 1.068 . . . . 0.0 111.811 -167.394 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -60.47 -33.59 72.81 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 113.798 -1.546 . . . . 0.0 110.087 169.3 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -132.47 102.4 5.71 Favored 'General case' 0 N--CA 1.458 -0.068 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 178.212 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -55.04 -33.09 62.39 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.468 1.107 . . . . 0.0 113.514 -169.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -65.54 -5.69 8.75 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 117.446 -1.264 . . . . 0.0 113.586 178.475 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.5 t -121.52 111.82 32.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 174.677 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 74.0 m -140.11 169.2 18.13 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 124.383 1.073 . . . . 0.0 111.013 -173.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -74.59 150.48 39.67 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 175.083 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 71.5 mt -134.12 158.16 44.34 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 127.051 2.14 . . . . 0.0 106.81 173.816 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -128.67 134.57 48.55 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 169.478 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 72.2 m -142.95 169.04 18.32 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.451 1.5 . . . . 0.0 110.352 -171.516 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -136.41 144.5 44.54 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.802 2.041 . . . . 0.0 107.863 -177.707 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.2 p -74.98 158.65 32.91 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.431 1.093 . . . . 0.0 110.992 174.203 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -72.59 -41.55 65.51 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.558 -0.714 . . . . 0.0 110.748 177.656 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.4 m -136.45 6.64 3.02 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -169.052 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -121.32 14.97 11.31 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -169.174 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.264 0.0 OUTLIER 41.45 31.66 0.19 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.95 2.1 . . . . 0.0 114.739 178.295 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 57.3 mtt -74.38 153.95 39.04 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.452 1.101 . . . . 0.0 110.381 -179.104 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -114.34 104.31 11.94 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 169.459 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 62.3 tp -112.18 144.26 41.88 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -171.707 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 31.2 mm -134.0 147.05 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 104.088 -2.56 . . . . 0.0 104.088 174.131 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 123' ' ' MET . 3.2 mp -144.13 158.11 43.91 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 126.155 1.782 . . . . 0.0 107.961 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -133.35 100.86 4.96 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 101.971 -3.344 . . . . 0.0 101.971 168.239 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.8 m -146.23 175.57 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 124.867 1.267 . . . . 0.0 111.126 -167.552 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -58.54 128.5 37.48 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.823 0.849 . . . . 0.0 109.254 169.654 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 pp -115.44 6.0 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 125.101 1.361 . . . . 0.0 112.875 -179.005 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -66.81 -15.0 63.3 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 120.693 1.588 . . . . 0.0 112.069 -176.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.6 mt -65.14 -24.52 35.45 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 C-N-CA 125.293 1.437 . . . . 0.0 109.581 169.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -123.22 71.88 45.92 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 126.931 2.092 . . . . 0.0 109.275 -172.682 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -68.32 -12.34 34.67 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.651 2.234 . . . . 0.0 111.933 173.323 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.5 p -147.32 175.2 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 128.728 2.811 . . . . 0.0 104.917 173.351 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -69.78 69.98 0.31 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.967 0.907 . . . . 0.0 110.123 169.849 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 50.3 tp -64.96 -25.85 68.05 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.729 1.612 . . . . 0.0 111.96 -175.084 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 67.35 26.54 73.52 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-O 119.659 -0.523 . . . . 0.0 112.108 -177.279 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -70.75 157.66 37.66 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 118.024 0.912 . . . . 0.0 108.736 169.853 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -135.97 152.83 51.36 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.188 0.995 . . . . 0.0 109.819 -169.323 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -132.9 127.24 33.93 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -174.456 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -71.45 134.79 46.84 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 169.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 tt -134.79 139.69 45.31 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 -179.67 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 t -139.19 158.04 28.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 -178.176 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 36.0 pt -121.62 14.87 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 123.389 0.675 . . . . 0.0 111.11 176.652 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.48 -4.38 45.26 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.453 1.101 . . . . 0.0 113.444 -175.521 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.8 p -64.15 173.29 2.01 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.657 0.783 . . . . 0.0 110.505 169.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 99.5 m -153.21 156.76 39.14 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 106.457 -1.682 . . . . 0.0 106.457 169.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 62.2 tp -71.78 80.84 0.87 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 169.524 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -52.1 -34.78 45.64 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -169.295 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -64.27 -15.0 59.28 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.2 1.0 . . . . 0.0 112.879 -178.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -63.87 -25.07 67.99 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.721 0.691 . . . . 0.0 111.738 173.538 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 135.78 6.78 1.95 Allowed Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.47 1.033 . . . . 0.0 113.013 178.449 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -60.14 -42.55 95.07 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.27 1.535 . . . . 0.0 107.857 174.141 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 35.0 mt -89.43 124.52 34.55 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 103.62 -2.733 . . . . 0.0 103.62 167.773 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -55.92 131.09 46.24 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 169.924 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -71.32 51.75 0.17 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.598 1.559 . . . . 0.0 111.968 179.479 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -169.82 -56.44 0.04 OUTLIER Glycine 0 CA--C 1.521 0.429 0 N-CA-C 108.122 -1.991 . . . . 0.0 108.122 177.214 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -82.56 47.3 1.16 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.943 1.297 . . . . 0.0 108.904 169.793 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -79.6 41.09 0.47 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.819 1.648 . . . . 0.0 110.747 -171.6 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.05 149.41 98.52 Favored Pre-proline 0 CA--C 1.539 0.522 0 O-C-N 121.073 -1.017 . . . . 0.0 110.725 -174.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.38 -29.85 85.8 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 122.669 2.246 . . . . 0.0 113.644 174.241 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.2 p -73.44 66.47 0.97 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.581 2.352 . . . . 0.0 110.765 -178.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -55.4 -25.98 38.92 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.843 1.257 . . . . 0.0 113.275 -176.337 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.4 ' H ' ' HB2' ' A' ' 83' ' ' SER . 26.4 t70 -145.0 -63.76 0.35 Allowed 'General case' 0 C--N 1.34 0.16 0 CA-C-N 118.298 0.499 . . . . 0.0 111.516 169.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.506 ' C ' ' H ' ' A' ' 83' ' ' SER . 9.0 mmm180 -118.41 -142.28 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.761 0 N-CA-C 102.794 -3.039 . . . . 0.0 102.794 169.312 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -61.61 32.1 0.06 OUTLIER 'Trans proline' 0 CA--C 1.553 1.436 0 C-N-CA 123.726 2.951 . . . . 0.0 114.2 167.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.506 ' H ' ' C ' ' A' ' 81' ' ' ARG . 23.5 m -68.01 38.11 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.659 1 C-N-CA 132.628 4.371 . . . . 0.0 113.049 -174.578 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 33.9 mtp180 -70.93 -7.66 47.46 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.909 1.684 . . . . 0.0 113.212 -176.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 61.64 -18.16 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 128.143 2.577 . . . . 0.0 114.468 -169.602 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -58.35 -14.61 7.89 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.007 1.723 . . . . 0.0 112.819 169.908 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -58.68 -18.05 27.75 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.418 1.487 . . . . 0.0 111.849 169.609 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -122.22 158.18 30.02 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.76 2.024 . . . . 0.0 108.207 -178.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -78.86 -24.83 44.05 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 122.954 0.502 . . . . 0.0 111.741 -171.067 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -147.67 148.22 30.82 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.683 0.793 . . . . 0.0 109.686 -175.53 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.4 p -146.14 143.64 21.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 175.365 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 31.4 tpp -157.81 170.47 22.27 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.592 0.757 . . . . 0.0 110.424 -175.288 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -136.07 154.47 51.01 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.486 2.315 . . . . 0.0 106.116 -175.252 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -161.89 -153.0 6.91 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-N 119.365 0.984 . . . . 0.0 113.838 -169.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -147.57 124.61 11.38 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.339 1.456 . . . . 0.0 108.243 176.823 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 46.1 t -77.61 133.72 29.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 168.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -141.24 70.72 1.35 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.99 0.916 . . . . 0.0 110.524 -169.093 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -155.5 173.01 17.29 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.873 -1.142 . . . . 0.0 111.556 175.079 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 19.7 pt -74.02 -177.63 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 126.128 1.771 . . . . 0.0 112.255 -172.575 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -65.81 -13.59 59.78 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.256 1.822 . . . . 0.0 114.893 -173.621 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 111.53 -36.06 4.39 Favored Glycine 0 C--N 1.338 0.68 0 C-N-CA 124.514 1.054 . . . . 0.0 111.483 178.663 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -66.94 113.83 5.27 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 169.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -128.68 4.35 5.51 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 123.388 0.43 . . . . 0.0 111.386 -169.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 34.1 p -140.45 -72.84 0.36 Allowed 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.191 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.3 m 177.26 -38.86 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 131.402 3.881 . . . . 0.0 107.107 179.096 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.3 p -165.05 -49.49 0.03 OUTLIER 'General case' 0 C--N 1.343 0.307 0 C-N-CA 125.22 1.408 . . . . 0.0 108.506 -169.924 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -55.57 -26.72 45.07 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 -168.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -142.37 14.12 2.0 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 118.617 0.644 . . . . 0.0 111.327 169.733 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.11 -7.7 48.37 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 178.343 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.3 p -81.39 -3.43 52.77 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 127.853 2.461 . . . . 0.0 114.187 -169.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? -126.91 141.07 51.9 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 172.133 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.3 tp -73.13 144.48 46.92 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 104.339 -2.467 . . . . 0.0 104.339 167.7 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 7.9 p -110.25 141.92 42.56 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 169.749 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -142.65 152.61 42.63 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 125.29 1.436 . . . . 0.0 107.207 -175.643 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -134.63 143.46 47.31 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 102.332 -3.21 . . . . 0.0 102.332 169.092 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 13.8 t -133.07 116.59 26.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 105.658 -1.979 . . . . 0.0 105.658 -179.155 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.5 p -96.76 129.96 44.09 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 170.042 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -152.05 123.62 7.86 Favored 'General case' 0 C--N 1.334 -0.103 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -171.051 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 52.9 27.66 29.82 Favored Glycine 0 CA--C 1.538 1.492 0 CA-C-O 119.455 -0.636 . . . . 0.0 114.234 -178.801 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 82.28 -0.39 88.95 Favored Glycine 0 CA--C 1.536 1.384 0 CA-C-N 118.448 1.124 . . . . 0.0 114.007 -177.815 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 63.5 mt -99.16 170.94 8.33 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.449 1.5 . . . . 0.0 108.3 171.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 45.4 tp -139.46 157.65 45.47 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 118.628 0.649 . . . . 0.0 111.301 -170.494 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' MET . . . . . 0.414 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 54.5 mtt -143.57 160.3 40.88 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 126.258 1.823 . . . . 0.0 109.055 169.389 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 41.5 ttt180 -135.04 137.28 42.78 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 102.972 -2.973 . . . . 0.0 102.972 168.532 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 25.4 tp -147.91 137.29 22.32 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -169.743 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -128.45 144.3 51.12 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 170.41 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -177.79 170.23 42.49 Favored Glycine 0 CA--C 1.519 0.288 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 175.341 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -52.59 134.55 35.45 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 118.5 1.15 . . . . 0.0 108.685 172.868 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -46.69 -58.74 3.57 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -172.767 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -57.97 -45.26 86.99 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 122.322 1.058 . . . . 0.0 111.277 -177.55 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -61.13 -27.29 68.28 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 126.438 1.895 . . . . 0.0 111.793 178.381 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 tt -81.05 -24.19 38.02 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.917 0.887 . . . . 0.0 109.236 -179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 54.27 30.25 12.11 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.212 1.005 . . . . 0.0 111.234 -170.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -104.25 9.74 50.16 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.662 1.125 . . . . 0.0 112.544 -176.447 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -72.13 7.95 1.48 Allowed 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.555 1.542 . . . . 0.0 112.643 178.233 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -145.18 106.55 4.21 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 127.76 2.424 . . . . 0.0 105.21 -178.221 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 14.6 m -63.02 -7.99 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 113.973 -1.467 . . . . 0.0 112.478 -177.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -122.05 18.89 10.85 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.364 1.065 . . . . 0.0 113.761 175.291 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 3.7 m -88.97 -70.26 0.66 Allowed 'General case' 0 N--CA 1.453 -0.296 0 O-C-N 121.639 -0.663 . . . . 0.0 110.683 168.516 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.28 2.0 ptp180 -75.64 11.48 1.31 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -173.006 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.3 m -65.61 -37.09 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 167.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -78.08 130.47 36.47 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 177.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.2 tt -141.2 141.96 34.03 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -172.492 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 49.2 tp -146.14 127.76 15.17 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 -174.564 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 48.9 ttp -143.8 146.06 32.81 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 119.829 1.195 . . . . 0.0 111.955 -169.443 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -151.57 166.05 32.37 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.904 2.081 . . . . 0.0 107.543 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -54.48 169.0 0.21 Allowed 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.464 1.029 . . . . 0.0 111.038 169.15 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.95 158.82 0.3 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 122.231 1.015 . . . . 0.0 113.333 173.938 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -143.61 130.15 20.11 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 174.112 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 54.3 p90 . . . . . 0 C--O 1.252 1.19 0 C-N-CA 126.169 1.787 . . . . 0.0 108.13 177.269 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 13.3 tp . . . . . 0 CA--C 1.545 0.765 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -148.14 147.47 29.52 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.868 1.213 . . . . 0.0 112.152 -177.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -159.43 137.79 10.56 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 128.174 2.59 . . . . 0.0 107.177 -175.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -158.46 154.86 27.5 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 119.336 0.971 . . . . 0.0 110.638 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.1 mp -99.16 159.6 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 126.392 1.877 . . . . 0.0 107.652 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -137.21 168.94 18.65 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.493 1.117 . . . . 0.0 110.549 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -134.1 128.76 34.85 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.641 1.576 . . . . 0.0 106.956 165.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 74.6 t -66.61 133.59 31.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 175.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -103.63 -34.32 8.67 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.616 1.167 . . . . 0.0 110.479 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -158.16 161.26 37.86 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.702 0.801 . . . . 0.0 110.146 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.8 mp -134.44 137.3 51.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 126.827 2.051 . . . . 0.0 105.728 -177.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -140.77 79.0 19.74 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 123.27 0.628 . . . . 0.0 111.453 -167.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -67.48 30.88 0.13 Allowed 'Trans proline' 0 CA--C 1.553 1.432 1 C-N-CA 126.089 4.526 . . . . 0.0 117.849 -172.076 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -50.13 -46.0 53.46 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 120.985 1.721 . . . . 0.0 115.449 -161.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -129.73 82.05 0.33 Allowed Glycine 0 C--N 1.336 0.572 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -160.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.456 ' HE2' ' HA ' ' A' ' 20' ' ' LYS . 9.5 mmpt? -74.44 62.91 1.02 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.26 1.424 . . . . 0.0 111.124 -176.087 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -55.92 -39.14 71.2 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.428 -0.795 . . . . 0.0 108.941 163.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -136.14 135.92 39.64 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 104.694 -2.336 . . . . 0.0 104.694 170.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -61.51 -33.29 73.54 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.271 0.487 . . . . 0.0 111.23 -177.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 -75.94 5.87 5.94 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.9 t -121.53 133.52 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 121.841 2.11 . . . . 0.0 107.858 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.7 m -148.38 158.97 44.43 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.352 1.061 . . . . 0.0 110.063 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 27.7 ttp180 -73.4 148.58 43.19 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 163.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 74.1 mt -134.18 162.66 31.52 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 126.153 1.781 . . . . 0.0 108.082 175.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -137.0 130.74 31.9 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 174.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 64.2 m -141.21 164.85 29.15 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.115 1.366 . . . . 0.0 109.525 -170.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -141.15 136.1 31.52 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.4 p -81.39 157.89 24.83 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.29 0.495 . . . . 0.0 111.194 -177.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -100.65 -50.78 3.77 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.581 0.752 . . . . 0.0 111.768 -168.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.0 m -73.57 -24.12 60.04 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 118.844 0.747 . . . . 0.0 111.292 -175.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -126.01 -134.08 0.25 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.921 1.289 . . . . 0.0 108.767 -177.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -143.61 13.54 1.74 Allowed 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.879 1.218 . . . . 0.0 113.689 -165.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 65.7 mtm -68.94 152.0 45.83 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 118.857 0.753 . . . . 0.0 110.685 -172.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -121.5 125.23 46.33 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 126.759 2.024 . . . . 0.0 106.516 176.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 67.9 tp -137.16 148.8 46.84 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.718 0.771 . . . . 0.0 110.264 -163.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.3 mm -130.88 144.9 36.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 128.704 2.801 . . . . 0.0 104.296 170.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.5 mp -134.79 162.51 32.15 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 173.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -132.39 109.16 9.65 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 104.692 -2.336 . . . . 0.0 104.692 158.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.4 p -153.42 158.66 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -154.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -62.16 125.2 23.06 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 169.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 pp -105.39 -1.13 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.253 1.021 . . . . 0.0 112.965 -177.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -66.75 -11.73 55.92 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 120.567 1.53 . . . . 0.0 112.357 177.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.9 mt -63.21 -40.2 88.14 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.75 1.22 . . . . 0.0 108.731 171.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -72.55 155.42 91.11 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 124.152 0.981 . . . . 0.0 109.155 174.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -63.37 -53.08 1.59 Allowed 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 121.766 1.644 . . . . 0.0 111.683 -174.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.8 m -152.67 -143.77 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 126.073 1.749 . . . . 0.0 107.604 -177.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -54.38 -30.42 51.84 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 127.805 2.442 . . . . 0.0 115.143 -173.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 27.9 tp -86.17 -18.92 30.93 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 -147.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.18 173.29 41.36 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -165.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -163.95 178.14 7.97 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.312 1.845 . . . . 0.0 107.912 -175.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -93.58 125.77 38.37 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 121.3 -0.875 . . . . 0.0 109.875 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -106.44 170.76 7.74 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.494 1.518 . . . . 0.0 109.544 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.3 ttp180 -127.54 104.52 7.93 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 126.172 1.789 . . . . 0.0 106.188 165.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.9 152.04 28.3 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 171.012 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 95.4 t -141.72 134.96 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 -175.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.0 pt -121.25 25.63 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 163.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.345 0.407 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 152.245 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.446 -0.644 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -39.03 -33.23 0.11 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 127.11 2.164 . . . . 0.0 114.591 -175.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -149.5 157.77 43.58 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 173.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.5 p -163.7 138.39 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 40.2 tpp -163.16 166.8 22.97 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.051 0.54 . . . . 0.0 110.387 -166.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -111.94 163.09 14.63 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.707 1.603 . . . . 0.0 109.589 172.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -165.16 -159.67 11.68 Favored Glycine 0 CA--C 1.521 0.419 0 O-C-N 121.648 -0.658 . . . . 0.0 113.022 -175.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 11.1 ttmm -141.73 126.84 18.43 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 177.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.2 t -89.94 143.29 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 171.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -127.41 111.85 14.32 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 177.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.25 144.9 16.15 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 -177.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.512 HG13 ' H ' ' A' ' 101' ' ' GLY . 3.2 pt -75.56 -171.82 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 127.587 2.355 . . . . 0.0 109.663 169.155 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -64.59 -6.38 7.52 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.462 1.505 . . . . 0.0 114.384 176.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.512 ' H ' HG13 ' A' ' 99' ' ' ILE . . . . . . . . 0 C--N 1.336 0.529 0 C-N-CA 126.698 2.094 . . . . 0.0 110.255 -177.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.8 p . . . . . 0 CA--C 1.536 0.429 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -108.48 115.3 29.85 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 165.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 34.5 tp -56.02 131.8 48.35 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 160.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 14.7 m -87.34 171.62 10.46 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 171.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -152.0 146.92 25.94 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 124.62 1.168 . . . . 0.0 108.237 161.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 2.9 m-30 -122.81 139.51 53.93 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 104.001 -2.592 . . . . 0.0 104.001 170.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.2 t -139.42 137.46 40.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 -174.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.1 m -116.92 132.09 56.79 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 166.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -149.43 109.77 4.19 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.089 0.859 . . . . 0.0 109.703 -170.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 58.19 22.94 51.47 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 123.797 0.713 . . . . 0.0 114.334 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.1 -14.11 65.0 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-N 118.42 1.11 . . . . 0.0 112.98 -176.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -83.05 171.87 13.33 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.643 1.177 . . . . 0.0 109.012 170.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 10.1 tp -140.07 153.74 46.85 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.242 1.017 . . . . 0.0 110.192 -173.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 42.6 mtt -138.75 158.31 44.47 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.684 1.194 . . . . 0.0 110.281 164.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.6 ttt-85 -143.97 122.34 12.35 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 104.357 -2.461 . . . . 0.0 104.357 176.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 33.8 tp -142.93 151.54 41.07 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.183 0.901 . . . . 0.0 109.342 -158.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -141.47 145.26 35.02 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.174 1.39 . . . . 0.0 109.817 167.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -172.76 166.81 39.54 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 125.989 1.757 . . . . 0.0 109.883 171.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -51.58 146.75 7.13 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.019 1.41 . . . . 0.0 111.09 176.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.77 -47.53 82.26 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -169.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -65.17 -43.71 90.85 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 122.678 0.391 . . . . 0.0 110.069 174.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.21 -40.73 94.54 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.416 1.086 . . . . 0.0 112.765 -172.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.2 tt -63.83 -22.17 66.79 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.522 1.129 . . . . 0.0 111.285 176.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 53.08 39.01 28.82 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.998 1.719 . . . . 0.0 112.556 170.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -157.5 50.8 0.42 Allowed Glycine 0 C--N 1.338 0.656 0 C-N-CA 124.067 0.842 . . . . 0.0 111.03 -169.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -58.36 -35.48 72.02 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.294 0.637 . . . . 0.0 110.406 170.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -83.63 155.0 23.43 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.535 1.534 . . . . 0.0 110.326 -170.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.1 m -73.28 -3.46 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 C-N-CA 123.68 0.792 . . . . 0.0 112.208 168.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -133.56 6.41 3.77 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.616 1.166 . . . . 0.0 112.877 -164.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 72.2 m -87.84 -69.3 0.7 Allowed 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.085 -1.01 . . . . 0.0 109.902 173.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.276 12.7 ptm180 -82.05 11.74 4.87 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 120.605 -1.309 . . . . 0.0 114.147 -170.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 24.6 m -62.87 -31.8 53.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 O-C-N 121.992 -0.442 . . . . 0.0 110.305 157.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -73.21 113.47 10.31 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 170.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.3 tt -145.95 137.57 24.97 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 118.342 0.519 . . . . 0.0 110.282 -167.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.3 tt -150.66 150.64 31.38 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.784 1.634 . . . . 0.0 107.088 -168.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 60.3 mtt -142.19 157.42 44.88 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 120.624 -1.298 . . . . 0.0 108.802 -176.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 15.5 ptmt -155.42 173.58 16.46 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 125.002 1.321 . . . . 0.0 109.718 163.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -57.93 163.5 2.69 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 164.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.09 159.82 5.46 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.281 163.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -132.17 106.59 8.06 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 175.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.252 1.196 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 -168.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.5 tm? . . . . . 0 C--O 1.232 0.157 0 CA-C-O 118.948 -0.549 . . . . 0.0 110.054 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -154.71 151.68 29.02 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -151.78 141.87 22.21 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 126.508 1.923 . . . . 0.0 107.642 -173.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -151.57 150.71 30.63 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 168.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 mp -72.42 148.52 9.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 172.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -135.94 156.82 48.17 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.325 1.85 . . . . 0.0 107.455 175.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -129.21 144.98 51.41 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.901 1.28 . . . . 0.0 108.355 176.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.8 p -73.83 146.22 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 C-N-CA 124.283 1.033 . . . . 0.0 108.767 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -125.59 -28.94 3.23 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 126.558 1.943 . . . . 0.0 109.479 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -157.68 166.62 32.34 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.028 0.831 . . . . 0.0 110.67 170.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.6 mp -143.57 138.15 25.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 127.26 2.224 . . . . 0.0 106.58 -174.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -151.66 101.25 2.91 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 123.202 0.601 . . . . 0.0 109.721 169.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -57.79 146.18 86.95 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.917 2.411 . . . . 0.0 111.292 172.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -127.66 13.64 6.96 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.227 0.611 . . . . 0.0 112.207 -172.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 174.72 79.86 0.05 OUTLIER Glycine 0 C--N 1.338 0.689 0 O-C-N 121.199 -0.938 . . . . 0.0 111.511 -170.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.9 mmtt -57.46 -18.4 18.15 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -72.47 -14.37 61.66 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.8 0.727 . . . . 0.0 111.111 175.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -136.32 52.33 1.97 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 127.149 2.18 . . . . 0.0 106.108 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -50.05 -28.06 6.52 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.806 1.643 . . . . 0.0 114.783 -169.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -68.64 2.17 2.66 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 117.668 -1.158 . . . . 0.0 113.707 173.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.3 t -125.52 121.89 61.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 121.138 1.79 . . . . 0.0 107.596 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.3 m -147.15 158.25 43.88 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.888 0.875 . . . . 0.0 110.759 -173.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.5 ttp-105 -83.02 148.28 27.65 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 170.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.0 mt -139.41 154.12 47.74 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.7 2.0 . . . . 0.0 107.273 177.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -126.69 132.52 51.15 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 103.926 -2.62 . . . . 0.0 103.926 171.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 64.0 m -145.21 167.24 23.28 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.956 1.302 . . . . 0.0 111.154 -169.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -140.71 142.5 34.84 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.463 1.905 . . . . 0.0 108.081 -176.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 31.9 p -72.72 151.78 42.0 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 118.125 0.421 . . . . 0.0 111.092 177.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -83.55 -37.32 23.14 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 118.757 -0.64 . . . . 0.0 111.495 176.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.6 m -101.76 -17.61 16.17 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 -168.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -124.2 -102.16 0.38 Allowed 'General case' 0 C--N 1.342 0.252 0 CA-C-N 120.545 1.52 . . . . 0.0 110.542 -170.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -168.19 10.8 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.204 1.002 . . . . 0.0 113.003 -169.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 59.6 mtm -70.56 146.7 49.96 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.342 0.591 . . . . 0.0 110.158 -173.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -118.58 128.78 54.87 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 172.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.4 tp -133.34 139.18 46.69 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 123.598 0.759 . . . . 0.0 110.46 -169.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 14.8 mm -125.6 148.25 30.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 103.776 -2.675 . . . . 0.0 103.776 169.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.5 mt -150.21 144.68 25.77 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 126.346 1.858 . . . . 0.0 107.057 -171.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -131.58 94.62 3.56 Favored 'General case' 0 C--N 1.32 -0.694 1 N-CA-C 99.754 -4.165 . . . . 0.0 99.754 168.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.7 p -136.24 161.65 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-O 122.07 0.938 . . . . 0.0 112.536 -166.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -68.48 90.71 0.38 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.039 2.135 . . . . 0.0 109.057 169.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.6 pp -69.65 3.88 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -169.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -65.98 -11.68 49.46 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 120.854 1.661 . . . . 0.0 111.957 176.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 55.7 mt -59.51 -34.08 53.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 169.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -92.32 155.04 42.88 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 124.923 1.289 . . . . 0.0 108.426 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.04 -23.82 33.64 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.196 1.931 . . . . 0.0 112.526 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.0 t -145.81 153.97 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 -178.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -53.93 -28.94 40.13 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.445 1.098 . . . . 0.0 112.306 169.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 39.5 tp -56.64 -17.0 7.24 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.456 1.502 . . . . 0.0 112.903 173.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.88 173.67 49.71 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 124.011 0.815 . . . . 0.0 111.359 177.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -164.11 175.07 10.56 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.901 2.08 . . . . 0.0 106.497 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -67.43 147.25 53.12 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 169.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -150.03 -173.44 4.43 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.063 1.345 . . . . 0.0 107.711 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -132.95 148.08 52.28 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 119.136 0.88 . . . . 0.0 109.338 170.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.1 tt -118.88 143.21 47.11 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.5 t -139.34 155.46 26.04 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 C-N-CA 124.666 1.187 . . . . 0.0 109.694 -168.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.1 tt -129.72 148.35 33.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 127.725 2.41 . . . . 0.0 106.24 170.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.397 0 C-N-CA 124.939 1.295 . . . . 0.0 109.155 -173.536 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 . . . . . 0 CA--C 1.535 0.376 0 N-CA-C 107.4 -1.334 . . . . 0.0 107.4 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -82.83 -31.29 28.15 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.703 0.683 . . . . 0.0 110.127 169.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -147.54 150.31 34.26 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.187 0.595 . . . . 0.0 109.663 177.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.2 t -143.62 138.88 25.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.08 169.56 23.24 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.894 0.855 . . . . 0.0 110.571 175.317 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -134.22 93.57 3.1 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 -171.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -92.62 -164.31 37.99 Favored Glycine 0 C--N 1.332 0.357 0 CA-C-O 121.682 0.601 . . . . 0.0 112.732 -169.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -134.04 111.93 10.78 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 169.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.7 t -69.84 149.0 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 169.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -143.34 58.59 1.39 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.556 0.742 . . . . 0.0 110.935 174.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -143.59 160.86 39.88 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.964 1.306 . . . . 0.0 109.878 174.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -83.5 -177.2 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 125.432 1.493 . . . . 0.0 109.723 169.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -64.08 -6.99 7.38 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.612 1.565 . . . . 0.0 114.847 -177.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.406 0 N-CA-C 107.0 -2.44 . . . . 0.0 107.0 -172.961 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 32.8 p . . . . . 0 N--CA 1.469 0.517 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -128.46 144.05 51.08 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 173.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 7.8 tt -92.83 149.08 21.51 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 168.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 10.7 p -116.0 146.0 42.5 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -139.42 100.18 3.92 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -95.66 128.19 42.32 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 101.65 -3.463 . . . . 0.0 101.65 169.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.7 t -140.02 137.7 38.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -169.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.7 t -117.45 137.82 52.26 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 170.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -150.15 105.63 3.39 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.609 0.764 . . . . 0.0 109.536 -171.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 61.27 22.44 60.94 Favored Glycine 0 CA--C 1.534 1.264 0 O-C-N 121.546 -0.721 . . . . 0.0 113.927 175.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.49 -13.58 65.34 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.499 1.047 . . . . 0.0 112.934 -177.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -85.59 164.13 17.93 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 169.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 7.8 tt -146.21 155.92 43.03 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 121.695 -0.628 . . . . 0.0 109.956 -171.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 23.4 ptm -150.42 161.01 43.34 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.394 1.077 . . . . 0.0 108.906 172.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 58.7 ttt-85 -135.96 127.44 28.65 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 104.978 -2.231 . . . . 0.0 104.978 172.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 25.5 tp -141.97 140.69 32.8 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -170.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -132.54 145.79 51.41 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 169.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -171.74 178.18 44.15 Favored Glycine 0 C--N 1.331 0.298 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 174.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.08 140.66 48.56 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 118.158 0.979 . . . . 0.0 109.221 172.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -52.27 -62.18 1.8 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.604 0.761 . . . . 0.0 112.613 -175.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.31 -24.08 66.48 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.117 0.871 . . . . 0.0 113.032 -174.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.37 -35.5 77.81 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 126.16 1.784 . . . . 0.0 109.774 174.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 16.9 tp -94.81 -19.2 20.53 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.713 0.805 . . . . 0.0 110.252 -175.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 42.58 42.2 2.7 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.669 1.988 . . . . 0.0 112.041 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -105.71 20.17 37.22 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.029 0.823 . . . . 0.0 112.458 -172.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -74.16 8.8 1.91 Allowed 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.25 1.025 . . . . 0.0 113.497 -178.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -131.79 131.11 42.64 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 169.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.9 p -57.65 -10.15 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 125.124 1.37 . . . . 0.0 110.857 169.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -123.56 12.71 9.33 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 126.002 1.721 . . . . 0.0 112.978 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 3.4 m -89.12 -58.98 2.35 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 167.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.6 tpm_? -75.55 2.07 12.66 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 115.466 -0.788 . . . . 0.0 113.031 -169.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 29.2 m -60.25 -37.98 75.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 124.422 1.089 . . . . 0.0 110.14 169.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -71.95 118.47 14.85 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 63.3 tp -138.88 120.65 15.32 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 -172.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.59 149.34 45.16 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -174.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 61.6 mtt -143.11 144.59 32.29 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -172.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -152.3 160.78 43.28 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -64.02 157.19 25.81 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 168.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.3 pp -67.21 165.36 16.27 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.242 0.544 . . . . 0.0 110.172 170.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -142.14 140.08 32.34 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 170.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 . . . . . 0 C--O 1.25 1.102 0 C-N-CA 126.392 1.877 . . . . 0.0 110.413 -176.312 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.3 tm? . . . . . 0 CA--C 1.532 0.278 0 CA-C-O 121.006 0.432 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -153.36 134.34 13.97 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 172.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -144.76 147.7 33.25 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.28 1.432 . . . . 0.0 108.08 -169.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -150.31 155.7 40.16 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.187 0.595 . . . . 0.0 109.434 169.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.3 mp -85.82 144.7 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 169.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -113.04 143.59 44.06 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.035 1.334 . . . . 0.0 107.68 171.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -117.06 122.83 45.29 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.878 1.671 . . . . 0.0 106.832 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.7 t -71.7 121.43 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -176.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.5 mmmt -96.61 -29.86 13.6 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.194 177.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -155.33 165.08 37.75 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.408 1.003 . . . . 0.0 111.459 175.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.4 mp -142.55 135.61 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 127.85 2.46 . . . . 0.0 105.756 -177.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -147.87 93.04 4.58 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 118.301 0.501 . . . . 0.0 111.155 178.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -61.16 144.77 99.18 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.911 2.407 . . . . 0.0 109.954 169.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -131.79 9.4 4.58 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -174.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.84 46.61 10.68 Favored Glycine 0 C--N 1.343 0.918 0 O-C-N 121.478 -0.764 . . . . 0.0 111.202 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.0 mmmm -73.03 25.97 0.06 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.289 1.436 . . . . 0.0 112.772 -171.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp 68.02 -59.84 0.42 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 128.497 2.719 . . . . 0.0 108.569 -168.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 4.8 m-30 -81.26 87.18 6.13 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 103.633 -2.729 . . . . 0.0 103.633 168.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -62.68 -17.58 60.85 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.285 -0.884 . . . . 0.0 112.656 -174.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 -66.54 -14.49 62.38 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 118.028 -0.987 . . . . 0.0 112.51 169.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 77.2 t -88.78 134.15 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 169.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.6 m -151.04 159.44 44.54 Favored 'General case' 0 C--O 1.239 0.542 0 O-C-N 120.928 -1.108 . . . . 0.0 109.981 -176.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.6 tpp85 -72.66 150.44 42.98 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 172.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.6 mt -138.14 157.19 46.81 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.923 1.689 . . . . 0.0 107.247 172.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -135.46 133.57 38.69 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 169.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 33.7 m -141.11 166.11 25.68 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.242 1.417 . . . . 0.0 110.087 -174.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -134.87 143.47 47.0 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 172.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.1 p -83.85 145.47 28.62 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 118.762 0.71 . . . . 0.0 110.255 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -80.57 -32.05 36.7 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -169.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.9 m -102.62 -34.21 9.16 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.138 0.881 . . . . 0.0 111.75 -171.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -121.71 10.28 10.29 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.669 1.187 . . . . 0.0 112.712 -170.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.315 0.0 OUTLIER 43.11 39.19 1.78 Allowed 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.915 2.086 . . . . 0.0 114.371 174.637 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 62.5 mtm -63.64 154.08 34.02 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 169.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -112.46 127.77 56.13 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 176.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 59.3 tp -137.81 144.9 41.74 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.78 0.8 . . . . 0.0 110.437 -169.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 35.6 mm -127.83 149.12 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 128.479 2.712 . . . . 0.0 103.737 169.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 123' ' ' MET . 2.0 mp -143.63 161.08 39.46 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 126.201 1.801 . . . . 0.0 108.254 176.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -138.48 94.59 2.87 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 102.312 -3.218 . . . . 0.0 102.312 168.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.7 m -144.15 168.74 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 124.36 1.064 . . . . 0.0 111.295 -168.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -60.03 134.2 56.81 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.041 0.936 . . . . 0.0 110.149 170.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 pp -116.51 2.14 7.88 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.445 0 C-N-CA 125.372 1.469 . . . . 0.0 112.966 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -64.77 -12.24 45.37 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 121.367 1.894 . . . . 0.0 113.248 -172.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 66.2 mt -58.95 -22.53 21.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 125.891 1.676 . . . . 0.0 108.816 169.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -127.38 167.05 19.19 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 128.531 2.733 . . . . 0.0 109.426 -178.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -52.17 157.27 6.59 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.664 2.242 . . . . 0.0 111.875 169.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.7 m -59.57 -10.77 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 N-CA-C 115.573 1.694 . . . . 0.0 115.573 -169.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -139.9 27.5 2.2 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.761 1.224 . . . . 0.0 110.55 -177.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 25.7 tp -140.89 163.16 33.7 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.235 -0.916 . . . . 0.0 110.753 -173.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -165.37 167.81 39.08 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 128.068 2.747 . . . . 0.0 106.405 171.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -141.77 -64.06 0.44 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 118.705 1.252 . . . . 0.0 111.788 -178.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -148.32 162.7 38.99 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.419 1.009 . . . . 0.0 111.159 178.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -145.27 171.34 14.71 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.54 1.936 . . . . 0.0 107.415 170.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -136.02 123.47 22.07 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.5 mp -125.15 146.44 49.49 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -169.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -157.01 128.25 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 121.839 0.828 . . . . 0.0 108.775 -169.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.0 tp -69.16 -32.46 54.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 123.508 0.723 . . . . 0.0 109.945 174.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.565 0 C-N-CA 126.845 2.058 . . . . 0.0 112.787 -172.002 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 . . . . . 0 CA--C 1.542 0.638 0 CA-C-O 120.304 0.097 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -164.29 124.93 2.12 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.494 1.117 . . . . 0.0 109.114 172.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -148.69 154.17 39.27 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 168.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.7 m -137.18 151.93 27.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 O-C-N 121.538 -0.726 . . . . 0.0 110.215 -171.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 37.5 ttm -152.84 161.92 41.94 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.597 1.559 . . . . 0.0 107.353 176.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -136.85 151.72 49.44 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -173.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.18 -157.51 8.58 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 120.908 -0.663 . . . . 0.0 114.366 -169.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -144.82 123.72 12.71 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.772 1.629 . . . . 0.0 107.146 176.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.9 t -77.89 141.89 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 169.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -140.09 64.89 1.43 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.857 1.263 . . . . 0.0 110.057 177.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.418 ' HB2' ' H ' ' A' ' 115' ' ' TYR . 1.0 OUTLIER -154.17 167.52 29.58 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.245 -1.535 . . . . 0.0 112.415 -179.578 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.9 pt -83.4 -177.12 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 127.249 2.22 . . . . 0.0 112.21 -170.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -74.5 -3.15 29.09 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.742 1.617 . . . . 0.0 114.115 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.23 0 C-N-CA 124.338 0.97 . . . . 0.0 112.537 -178.462 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 72.7 p . . . . . 0 C--O 1.235 0.332 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? 58.87 120.28 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 127.799 2.44 . . . . 0.0 111.652 -173.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 55.3 tp -57.98 144.28 40.11 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 170.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.6 p -123.65 149.03 45.91 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.473 1.109 . . . . 0.0 109.8 -173.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -148.38 108.15 4.01 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.575 1.15 . . . . 0.0 108.373 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.418 ' H ' ' HB2' ' A' ' 98' ' ' ARG . 7.6 m-30 -91.57 122.63 34.32 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 102.379 -3.193 . . . . 0.0 102.379 168.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.0 t -129.71 112.75 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -169.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.2 p -88.24 128.77 35.47 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 104.767 -2.308 . . . . 0.0 104.767 169.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.39 134.35 20.27 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 118.711 0.687 . . . . 0.0 109.631 -172.199 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 47.21 33.19 7.34 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 124.646 1.117 . . . . 0.0 115.188 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 76.51 17.07 80.23 Favored Glycine 0 CA--C 1.536 1.399 0 CA-C-N 118.716 1.258 . . . . 0.0 113.682 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 93.8 mt -129.2 178.65 6.28 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 128.284 2.633 . . . . 0.0 107.283 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 58.3 tp -139.13 154.15 48.08 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 120.837 -1.164 . . . . 0.0 111.539 -171.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.464 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 76.5 mtm -143.43 156.16 44.58 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.777 2.031 . . . . 0.0 107.901 169.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -137.54 117.93 13.73 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 169.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 51.3 tp -125.59 148.95 48.76 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 125.943 1.697 . . . . 0.0 109.789 -168.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -139.74 148.81 42.81 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.222 1.409 . . . . 0.0 108.448 169.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -165.59 165.17 37.77 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 173.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -71.87 86.7 0.98 Allowed 'General case' 0 N--CA 1.463 0.205 0 O-C-N 122.059 -0.671 . . . . 0.0 110.301 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . 22.85 -77.45 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 130.436 3.494 . . . . 0.0 115.242 -170.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -13.13 16.3 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 11.3 m-20 -85.74 -36.16 20.33 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.972 1.709 . . . . 0.0 109.323 176.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 9.2 tt -72.64 -29.97 63.91 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 170.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 1.8 t60 54.99 45.52 26.24 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.606 1.962 . . . . 0.0 112.069 169.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -152.04 68.49 0.32 Allowed Glycine 0 C--N 1.335 0.484 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 -175.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -73.4 3.55 5.83 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.233 1.013 . . . . 0.0 113.728 -174.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -129.13 145.35 51.32 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.366 1.866 . . . . 0.0 108.513 172.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 7.8 m -66.32 -1.04 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.098 168.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -123.16 15.36 9.84 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 127.746 2.419 . . . . 0.0 111.447 177.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 75.3 m -80.95 -70.5 0.53 Allowed 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.463 -0.773 . . . . 0.0 109.366 168.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.316 1.8 ptp180 -81.56 15.14 2.21 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -169.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 30.3 m -70.97 -12.24 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 167.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -109.27 120.77 43.52 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 103.232 -2.877 . . . . 0.0 103.232 168.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -136.75 130.5 32.07 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -172.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 7.5 tt -117.83 139.47 51.06 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 176.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 19.6 ptt? -144.83 162.11 37.61 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 121.327 -0.858 . . . . 0.0 109.733 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 78.8 mttt -152.86 166.64 31.66 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.759 1.623 . . . . 0.0 108.635 -169.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -71.17 167.69 18.82 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 167.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.34 157.26 8.84 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.173 0.511 . . . . 0.0 110.81 169.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -147.76 123.37 10.47 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 171.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 . . . . . 0 C--O 1.248 0.982 0 C-N-CA 125.995 1.718 . . . . 0.0 107.162 178.092 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.2 tm? . . . . . 0 C--O 1.232 0.15 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -142.87 163.58 32.41 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.006 1.322 . . . . 0.0 107.682 169.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -139.31 124.14 18.63 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 103.878 -2.638 . . . . 0.0 103.878 174.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -142.35 131.97 23.95 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.418 0.687 . . . . 0.0 109.357 -171.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.8 mp -81.79 129.15 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 177.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -96.69 153.03 18.1 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.651 1.581 . . . . 0.0 108.065 175.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -132.27 114.99 15.09 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 126.083 1.753 . . . . 0.0 106.999 172.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 68.9 t -71.47 122.19 23.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 177.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.0 mmmt -85.21 -41.35 15.7 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 173.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -158.6 166.56 31.79 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.305 0.502 . . . . 0.0 111.73 -173.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.4 mp -137.05 141.21 41.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 127.756 2.422 . . . . 0.0 106.481 -175.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -145.59 89.2 6.31 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 124.45 1.1 . . . . 0.0 110.485 -171.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -66.32 142.23 65.52 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.92 3.08 . . . . 0.0 111.352 170.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -78.37 -38.39 41.94 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.942 -0.474 . . . . 0.0 111.597 177.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 147.38 47.48 0.03 OUTLIER Glycine 0 CA--C 1.527 0.829 0 N-CA-C 104.932 -3.267 . . . . 0.0 104.932 -169.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -63.15 120.49 11.59 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.213 1.405 . . . . 0.0 113.468 -167.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.456 ' HA ' ' HE3' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -64.97 -46.93 79.44 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.164 168.955 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -80.63 -19.21 45.89 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.08 0.552 . . . . 0.0 112.351 -174.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.7 t70 47.12 39.08 7.52 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.99 2.116 . . . . 0.0 113.956 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -142.64 8.25 1.73 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 176.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.7 t -139.24 133.4 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 73.1 m -156.43 168.17 28.18 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 120.786 1.63 . . . . 0.0 110.48 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.1 ttm105 -72.19 149.3 44.76 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 169.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.88 158.09 45.25 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 125.786 1.634 . . . . 0.0 107.755 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -133.31 125.48 29.32 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 174.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 58.5 m -141.89 169.59 17.3 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.947 1.299 . . . . 0.0 111.004 -169.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.1 tt0 -143.78 145.0 32.05 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 125.267 1.427 . . . . 0.0 108.118 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.3 m -75.68 131.48 39.92 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 123.285 0.634 . . . . 0.0 109.939 169.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -80.28 -19.6 46.34 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.557 0.743 . . . . 0.0 111.011 170.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.23 -36.07 3.03 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -169.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -115.38 21.53 14.0 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.527 1.131 . . . . 0.0 112.243 -177.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt 42.96 18.03 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 118.685 2.846 . . . . 0.0 118.685 172.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 68.7 mtm -67.72 151.08 47.82 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.868 1.213 . . . . 0.0 108.534 174.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -112.35 127.69 56.08 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 104.613 -2.365 . . . . 0.0 104.613 171.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.5 mp -136.21 150.89 49.19 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 119.094 0.861 . . . . 0.0 112.614 -168.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 46.2 mm -123.1 144.5 32.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 102.812 -3.033 . . . . 0.0 102.812 168.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.8 mp -143.32 160.66 40.1 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 127.347 2.259 . . . . 0.0 107.455 -169.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -140.2 102.68 4.42 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 102.487 -3.153 . . . . 0.0 102.487 168.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.4 m -144.52 169.35 9.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 C-N-CA 124.203 1.001 . . . . 0.0 111.567 -168.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -65.43 136.06 56.01 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 169.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.8 pp -112.33 7.66 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 124.507 1.123 . . . . 0.0 112.686 -175.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -59.72 -23.14 62.93 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 121.541 -0.725 . . . . 0.0 110.675 169.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.1 mt -68.89 -26.83 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 126.127 1.771 . . . . 0.0 109.839 173.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -127.92 68.16 74.99 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 126.01 1.724 . . . . 0.0 109.02 -170.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -73.41 6.4 2.71 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.676 2.917 . . . . 0.0 114.464 -169.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.6 m -136.87 148.89 26.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 C-N-CA 124.934 1.293 . . . . 0.0 108.862 -174.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -60.57 -25.97 66.58 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.613 1.165 . . . . 0.0 112.349 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 52.7 tp -60.95 -23.92 65.68 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.652 1.181 . . . . 0.0 112.314 174.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.42 -168.08 46.22 Favored Glycine 0 CA--C 1.532 1.123 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -169.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -153.07 173.59 15.26 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.332 1.053 . . . . 0.0 108.281 176.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -94.46 152.46 18.57 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.566 0.746 . . . . 0.0 109.016 169.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -151.92 -177.0 5.88 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.246 1.418 . . . . 0.0 107.911 -173.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 10.7 ttp180 -136.65 146.29 45.81 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 120.929 -1.107 . . . . 0.0 108.661 177.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.0 tt -127.65 145.59 50.83 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.662 1.585 . . . . 0.0 107.883 176.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -145.59 166.91 9.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 127.342 2.257 . . . . 0.0 105.921 -174.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 46.4 pt -129.09 27.1 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 O-C-N 121.297 -0.877 . . . . 0.0 111.389 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.694 0 C-N-CA 124.882 1.273 . . . . 0.0 113.773 -174.471 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 52.8 p90 . . . . . 0 CA--C 1.532 0.268 0 CA-C-O 121.091 0.472 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -120.05 -33.57 3.91 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 169.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -144.75 144.87 31.41 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.198 1.799 . . . . 0.0 106.209 169.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.7 p -148.72 141.27 18.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -178.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 31.9 tpp -159.34 173.63 15.98 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.51 1.124 . . . . 0.0 110.457 -171.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -134.82 147.78 50.02 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 127.265 2.226 . . . . 0.0 106.924 -173.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -158.38 -157.2 8.35 Favored Glycine 0 C--N 1.338 0.692 0 CA-C-N 119.171 0.896 . . . . 0.0 113.857 -171.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -133.39 125.8 29.88 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 125.665 1.586 . . . . 0.0 106.767 173.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.405 ' HB ' ' HA ' ' A' ' 137' ' ' VAL . 84.3 t -93.19 150.64 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 175.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -134.94 154.46 51.69 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 126.625 1.97 . . . . 0.0 105.984 175.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.76 162.03 39.77 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.632 1.105 . . . . 0.0 111.423 171.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 24.5 pt -80.35 177.67 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 O-C-N 123.973 0.796 . . . . 0.0 108.937 169.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -76.95 -3.27 38.0 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.72 1.208 . . . . 0.0 113.683 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.725 0 CA-C-O 119.328 -0.707 . . . . 0.0 112.614 -176.972 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.4 p . . . . . 0 C--O 1.234 0.247 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -136.44 144.64 44.55 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.797 1.239 . . . . 0.0 108.773 169.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.1 tp -88.82 152.96 21.44 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 167.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 14.3 m -126.46 145.16 50.6 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 118.294 0.497 . . . . 0.0 109.822 177.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -146.46 160.04 42.61 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.748 1.219 . . . . 0.0 110.213 -172.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -130.38 158.56 39.51 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 169.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.0 p -149.27 136.2 13.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 169.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.9 t -123.75 129.16 50.64 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 178.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -150.42 122.67 8.36 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 123.859 0.863 . . . . 0.0 109.381 -169.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 54.28 21.64 19.83 Favored Glycine 0 CA--C 1.538 1.527 0 CA-C-O 119.158 -0.801 . . . . 0.0 114.899 178.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 92.7 -4.52 75.93 Favored Glycine 0 CA--C 1.536 1.347 0 CA-C-N 118.735 1.267 . . . . 0.0 113.797 -177.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -95.15 164.13 13.0 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 118.975 1.387 . . . . 0.0 108.229 171.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 39.9 tp -143.85 155.45 44.12 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 122.939 0.495 . . . . 0.0 110.693 -169.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 15.3 mtt -144.04 152.11 40.56 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.891 1.676 . . . . 0.0 106.649 168.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 74.5 mtm180 -137.91 135.26 35.93 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 104.948 -2.241 . . . . 0.0 104.948 169.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -155.49 167.37 30.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 119.335 0.971 . . . . 0.0 112.975 -169.025 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -134.42 159.72 40.2 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.118 1.367 . . . . 0.0 107.562 168.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -172.06 164.18 36.66 Favored Glycine 0 CA--C 1.516 0.148 0 N-CA-C 108.213 -1.955 . . . . 0.0 108.213 171.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.19 137.66 51.42 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 172.281 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -45.13 -60.26 2.19 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -169.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.18 -4.98 36.29 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -178.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -92.62 -21.46 20.03 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 125.386 1.475 . . . . 0.0 110.756 170.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.8 tt -68.13 -23.85 64.94 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 119.53 1.059 . . . . 0.0 109.204 171.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 1.4 t60 44.1 34.47 0.98 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 128.348 2.659 . . . . 0.0 114.54 168.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 179.97 42.55 0.08 OUTLIER Glycine 0 C--N 1.336 0.574 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 -171.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -65.76 -14.81 62.07 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 117.618 0.709 . . . . 0.0 112.535 172.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -61.68 103.81 0.37 Allowed 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 127.418 2.287 . . . . 0.0 108.24 169.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.405 ' HA ' ' HB ' ' A' ' 96' ' ' VAL . 13.8 m -53.98 -9.86 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 126.969 2.107 . . . . 0.0 113.307 173.401 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -133.35 23.15 4.07 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.344 1.058 . . . . 0.0 113.402 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 24.7 m -106.58 -58.15 1.96 Allowed 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 119.004 -0.522 . . . . 0.0 110.402 168.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.396 16.0 ptm180 -75.88 11.88 1.27 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.223 0.919 . . . . 0.0 113.24 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 16.9 m -63.0 -39.15 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 167.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -70.09 119.39 14.23 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 170.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.3 tt -136.37 134.6 38.01 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -177.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.412 HD23 ' N ' ' A' ' 145' ' ' MET . 5.6 tt -143.97 140.43 29.64 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 -173.218 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.412 ' N ' HD23 ' A' ' 144' ' ' LEU . 25.3 ptp -140.92 154.21 46.01 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 119.229 0.922 . . . . 0.0 110.619 173.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -159.24 160.63 35.53 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 126.352 1.861 . . . . 0.0 107.656 -176.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -54.49 159.0 2.22 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 118.847 0.749 . . . . 0.0 110.581 169.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.57 166.04 19.81 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.819 0.342 . . . . 0.0 110.58 169.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -142.73 36.31 1.44 Allowed 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.611 1.165 . . . . 0.0 110.299 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 43.1 t80 . . . . . 0 C--O 1.249 1.054 0 C-N-CA 124.62 1.168 . . . . 0.0 108.166 -174.335 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.9 tt . . . . . 0 N--CA 1.464 0.227 0 CA-C-O 120.823 0.344 . . . . 0.0 110.329 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -143.34 143.89 31.86 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 126.837 2.055 . . . . 0.0 106.002 169.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -150.6 134.82 17.0 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.195 1.398 . . . . 0.0 107.36 172.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -154.94 151.64 28.77 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.673 0.67 . . . . 0.0 109.943 169.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.1 mp -81.92 156.73 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 170.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -139.7 151.52 45.95 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.064 0.946 . . . . 0.0 108.745 169.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -117.2 126.33 52.6 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 125.518 1.527 . . . . 0.0 107.603 -176.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -70.64 128.22 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 176.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.6 mmmt -95.8 -35.71 11.41 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.476 1.111 . . . . 0.0 109.403 173.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -158.02 167.72 29.11 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 118.983 0.811 . . . . 0.0 111.307 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.9 mp -138.85 144.43 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 127.036 2.134 . . . . 0.0 107.244 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -145.29 92.58 5.6 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 126.814 2.046 . . . . 0.0 108.276 -176.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -55.26 156.05 18.02 Favored 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 124.081 3.187 . . . . 0.0 114.162 -178.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -77.81 45.78 0.53 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.425 1.49 . . . . 0.0 112.093 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.92 35.71 64.53 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 124.471 1.034 . . . . 0.0 113.54 169.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt 47.44 19.73 0.15 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.027 2.131 . . . . 0.0 114.167 -171.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.432 ' HA ' ' HE3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -77.17 -34.88 56.31 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 121.084 -1.01 . . . . 0.0 109.813 170.428 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -138.09 87.23 2.23 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 -177.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -55.06 -36.94 66.12 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.072 0.949 . . . . 0.0 113.341 -169.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -90.1 14.55 12.15 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 117.962 -1.018 . . . . 0.0 112.967 -178.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.7 t -127.34 140.93 47.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-N 120.821 1.646 . . . . 0.0 107.522 -176.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.6 m -151.87 151.67 31.6 Favored 'General case' 0 C--O 1.239 0.518 0 O-C-N 121.33 -0.856 . . . . 0.0 111.05 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 36.6 ttp180 -80.66 145.81 31.44 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 104.554 -2.387 . . . . 0.0 104.554 168.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.1 mp -134.09 158.44 43.6 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 125.923 1.689 . . . . 0.0 106.453 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -125.86 130.59 51.66 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 169.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 58.3 m -141.94 173.27 11.67 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.06 1.344 . . . . 0.0 109.796 -170.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -140.69 131.23 25.44 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 171.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.1 m -71.73 134.63 46.37 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 175.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -71.11 -35.23 71.7 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.62 1.168 . . . . 0.0 113.62 -169.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.72 -16.85 6.57 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -169.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -121.11 48.22 1.69 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.854 0.862 . . . . 0.0 112.168 -169.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt 30.34 64.37 0.16 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.582 1.953 . . . . 0.0 113.328 168.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 20.6 mtm -137.45 117.6 13.49 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 118.355 0.525 . . . . 0.0 110.474 -176.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -82.95 133.23 35.12 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 168.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -134.67 148.1 50.27 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.989 0.899 . . . . 0.0 113.045 -168.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 38.3 mm -130.14 141.97 44.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 101.237 -3.616 . . . . 0.0 101.237 168.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 53.0 tp -146.91 152.72 39.14 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 126.799 2.04 . . . . 0.0 107.096 -168.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -146.43 109.64 4.72 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 173.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.8 m -150.01 169.79 2.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 122.032 0.92 . . . . 0.0 112.13 -169.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 43.1 t-20 -64.5 130.51 44.0 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.15 1.38 . . . . 0.0 107.966 169.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.3 pp -105.68 0.94 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 124.48 1.112 . . . . 0.0 112.982 -177.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -68.43 -16.37 63.88 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 120.249 1.386 . . . . 0.0 111.064 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.439 HG13 ' H ' ' A' ' 47' ' ' ILE . 3.7 mt -62.39 -34.16 62.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 125.275 1.43 . . . . 0.0 109.337 171.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -91.32 159.11 39.97 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 124.754 1.222 . . . . 0.0 110.868 -169.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.71 179.25 3.25 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.462 2.774 . . . . 0.0 111.537 175.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.4 m -59.75 -16.52 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.84 1.256 . . . . 0.0 113.742 -177.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -67.69 -7.35 26.27 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.752 0.821 . . . . 0.0 112.476 170.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.5 tp 72.36 7.5 5.67 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 128.232 2.613 . . . . 0.0 113.389 174.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -167.23 164.47 37.91 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 108.289 -1.925 . . . . 0.0 108.289 174.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -161.34 168.61 23.61 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.769 1.627 . . . . 0.0 107.132 174.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -64.71 138.25 58.28 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 169.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -140.9 176.31 8.91 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -177.21 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.7 ttp180 -135.56 142.51 45.36 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -173.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 tt -121.09 140.43 51.97 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 126.149 1.78 . . . . 0.0 107.02 -176.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.0 t -143.05 166.81 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 126.995 2.118 . . . . 0.0 106.051 -178.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 30.0 pt -119.59 13.45 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 123.568 0.747 . . . . 0.0 112.27 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.733 0 C-N-CA 125.081 1.353 . . . . 0.0 113.182 -175.765 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 47.2 p90 . . . . . 0 N--CA 1.451 -0.384 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -122.36 -23.46 5.25 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.105 0.562 . . . . 0.0 110.729 172.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -145.66 149.45 34.49 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.804 1.242 . . . . 0.0 107.701 169.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.2 m -143.4 148.2 19.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 C-N-CA 125.621 1.568 . . . . 0.0 107.365 172.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 23.1 tpp -159.45 168.05 27.21 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.872 0.869 . . . . 0.0 109.207 176.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 84.7 t80 -128.5 150.52 50.13 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.809 1.643 . . . . 0.0 106.806 172.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -152.92 -160.06 9.43 Favored Glycine 0 C--N 1.336 0.569 0 CA-C-N 118.636 0.653 . . . . 0.0 113.672 -171.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -145.69 132.43 20.01 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.995 1.318 . . . . 0.0 108.771 172.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 42.2 t -77.14 145.57 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 168.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -144.87 74.94 1.43 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.057 1.743 . . . . 0.0 108.894 175.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -152.72 157.77 41.35 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.223 -0.923 . . . . 0.0 109.588 176.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 25.2 pt -76.99 -170.27 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 125.804 1.642 . . . . 0.0 111.356 177.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.63 -9.79 1.31 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 127.406 2.282 . . . . 0.0 115.47 -178.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.569 0 N-CA-C 107.525 -2.23 . . . . 0.0 107.525 -174.762 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.467 0.415 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -137.43 139.81 40.89 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 169.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 46.2 tp -75.96 159.5 30.81 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 168.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 16.6 m -134.98 150.65 50.39 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 175.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -142.13 128.79 20.36 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -112.52 129.76 56.24 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 168.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.6 p -146.72 144.91 19.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -169.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.3 t -134.53 144.01 47.75 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -136.9 82.62 1.95 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.282 1.833 . . . . 0.0 107.676 -170.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 58.57 19.67 42.79 Favored Glycine 0 CA--C 1.538 1.494 0 CA-C-O 118.977 -0.902 . . . . 0.0 114.629 174.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 124.32 -26.99 5.66 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.953 1.264 . . . . 0.0 112.723 -177.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 9.9 mp -75.31 150.06 38.59 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 169.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 7.0 tt -145.52 157.28 44.02 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.493 1.042 . . . . 0.0 110.689 -175.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 56.6 mtt -147.61 159.08 44.17 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.016 1.326 . . . . 0.0 108.861 170.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 85.4 mtp180 -141.25 130.22 23.2 Favored 'General case' 0 C--N 1.334 -0.1 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 169.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -152.59 160.09 43.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 119.059 0.845 . . . . 0.0 111.079 -170.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -137.17 149.65 47.4 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 124.315 1.046 . . . . 0.0 108.575 169.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -178.08 168.44 39.76 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -177.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -57.93 132.79 54.48 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -178.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -43.81 -73.7 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 -168.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -67.11 -26.18 66.58 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 122.404 1.097 . . . . 0.0 111.93 -172.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.95 -31.36 72.56 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 128.164 2.586 . . . . 0.0 111.203 175.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 5.4 tt -76.38 -13.47 60.13 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.28 1.032 . . . . 0.0 111.307 -176.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 32.3 t-80 52.81 40.51 30.75 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.721 1.208 . . . . 0.0 111.937 177.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -123.86 33.04 4.03 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 125.247 1.403 . . . . 0.0 110.642 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -76.48 -3.95 40.01 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.07 0.948 . . . . 0.0 113.34 -175.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -129.43 143.02 50.67 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 127.534 2.334 . . . . 0.0 106.142 169.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 8.2 p -59.21 -11.85 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.994 169.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -124.06 21.72 8.88 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 126.001 1.72 . . . . 0.0 113.492 176.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 57.9 m -72.83 -78.36 0.09 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.962 0.887 . . . . 0.0 109.779 168.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -82.58 12.62 4.41 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -169.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 33.9 m -67.27 -28.42 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-O 118.816 -0.612 . . . . 0.0 110.016 170.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -77.86 107.6 10.5 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 177.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 45.3 tp -112.66 131.38 55.67 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.459 1.104 . . . . 0.0 108.283 -176.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.5 tt -138.33 135.85 35.82 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 104.418 -2.438 . . . . 0.0 104.418 169.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -142.14 152.72 43.49 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 118.817 0.735 . . . . 0.0 111.484 176.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 39.6 pttt -165.01 172.97 12.05 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 126.224 1.81 . . . . 0.0 109.171 -174.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -55.1 156.69 3.82 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.422 0.689 . . . . 0.0 111.732 171.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.41 169.04 9.65 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.399 169.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -134.79 122.92 22.78 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 173.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 9.9 t80 . . . . . 0 C--O 1.246 0.902 0 C-N-CA 124.484 1.113 . . . . 0.0 108.276 176.66 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.2 tm? . . . . . 0 CA--C 1.532 0.273 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -151.47 158.16 43.28 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.902 1.281 . . . . 0.0 108.668 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -145.81 140.96 27.48 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.798 1.639 . . . . 0.0 108.371 -176.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -152.67 146.49 25.19 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.346 1.459 . . . . 0.0 110.54 -170.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.6 mp -112.59 137.74 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 105.847 -1.908 . . . . 0.0 105.847 171.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -145.64 161.89 38.78 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.758 1.223 . . . . 0.0 110.489 -174.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -140.86 144.79 35.51 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.598 0.759 . . . . 0.0 110.049 -174.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 39.0 t -70.08 122.56 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 125.078 1.351 . . . . 0.0 107.834 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -96.03 -32.0 12.77 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 124.508 1.123 . . . . 0.0 110.126 176.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -157.14 167.66 29.74 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.284 0.947 . . . . 0.0 110.718 175.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.7 mp -133.05 140.88 46.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 127.138 2.175 . . . . 0.0 106.296 -175.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -143.78 89.82 7.21 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 124.069 0.947 . . . . 0.0 110.011 -171.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -65.09 9.4 0.17 Allowed 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 124.121 3.214 . . . . 0.0 116.774 -178.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -78.82 55.88 1.8 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.079 1.351 . . . . 0.0 109.914 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -170.08 35.66 0.18 Allowed Glycine 0 CA--C 1.527 0.803 0 C-N-CA 124.89 1.233 . . . . 0.0 111.454 -172.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.404 ' HE2' ' HA ' ' A' ' 20' ' ' LYS . 11.2 mmpt? -65.97 64.58 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.61 1.564 . . . . 0.0 113.392 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -60.49 -38.4 84.16 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 168.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -144.37 165.5 27.75 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 129.468 3.107 . . . . 0.0 104.218 169.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.29 -40.86 83.05 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.28 -0.887 . . . . 0.0 110.737 175.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 49.0 ptt85 -70.4 7.72 0.98 Allowed 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 126.508 1.923 . . . . 0.0 114.806 175.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 77.7 t -120.48 132.09 70.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 121.497 1.953 . . . . 0.0 107.487 178.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 37.0 m -149.06 163.65 36.92 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.93 0.892 . . . . 0.0 109.789 176.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.1 ttm105 -85.45 154.28 21.92 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 169.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.0 mt -143.16 156.75 44.85 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 127.114 2.166 . . . . 0.0 107.199 -177.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -131.56 131.65 43.51 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 105.335 -2.098 . . . . 0.0 105.335 174.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 55.1 m -143.77 164.71 29.72 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.771 1.228 . . . . 0.0 110.201 -170.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -140.79 140.06 34.68 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 38.2 p -70.45 136.29 49.39 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 173.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -75.75 -35.68 60.11 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 168.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.6 m -69.56 -38.19 77.31 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -170.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -135.11 -102.26 0.22 Allowed 'General case' 0 C--N 1.345 0.38 0 CA-C-N 119.818 1.19 . . . . 0.0 110.34 -171.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -166.51 19.02 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.332 1.453 . . . . 0.0 112.559 -169.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 85.4 mtp -62.94 122.68 16.61 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.995 0.918 . . . . 0.0 108.68 176.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -98.08 112.45 24.4 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 169.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 49.0 tp -122.62 138.41 54.6 Favored 'General case' 0 N--CA 1.461 0.089 0 C-N-CA 123.455 0.702 . . . . 0.0 110.528 -169.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 33.1 mm -124.71 146.34 30.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 103.634 -2.728 . . . . 0.0 103.634 169.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 123' ' ' MET . 2.3 pt? -154.17 154.85 34.25 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.723 1.209 . . . . 0.0 109.547 176.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -121.59 120.68 35.52 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 102.992 -2.966 . . . . 0.0 102.992 170.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.2 p -151.09 163.18 2.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 121.707 0.765 . . . . 0.0 110.876 -168.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -69.02 90.23 0.44 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.907 1.683 . . . . 0.0 109.208 169.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.0 pp -65.84 -7.26 4.73 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -170.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -64.14 -18.61 64.6 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 120.161 1.346 . . . . 0.0 111.115 173.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.422 HD13 HG21 ' A' ' 47' ' ' ILE . 6.3 tt -55.34 -41.95 64.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.728 1.211 . . . . 0.0 110.629 169.099 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -88.02 139.37 30.74 Favored Pre-proline 0 CA--C 1.538 0.508 0 C-N-CA 125.88 1.672 . . . . 0.0 109.636 -173.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.45 132.74 30.11 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.272 1.981 . . . . 0.0 111.101 -177.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.8 t 50.34 31.06 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 126.567 1.947 . . . . 0.0 112.588 171.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.1 t70 62.42 -35.54 0.12 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 128.168 2.587 . . . . 0.0 115.203 -175.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 60.1 tp -59.36 -34.19 72.09 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.369 1.468 . . . . 0.0 111.405 177.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.37 -178.83 52.71 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-O 121.904 0.725 . . . . 0.0 112.262 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -157.96 174.16 15.67 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 126.662 1.985 . . . . 0.0 106.983 -174.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -58.92 134.22 56.74 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 173.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -128.91 168.66 15.65 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 125.908 1.683 . . . . 0.0 107.626 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -132.38 147.69 52.39 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.6 tt -137.88 144.0 41.16 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 -169.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.5 m -135.31 154.43 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 169.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 35.2 pt -121.15 147.84 24.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 104.287 -2.486 . . . . 0.0 104.287 168.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.442 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.198 -168.26 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 40.7 p90 . . . . . 0 N--CA 1.451 -0.393 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -123.58 -23.06 4.84 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.446 1.498 . . . . 0.0 109.476 169.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -142.81 155.03 44.74 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.378 1.471 . . . . 0.0 108.214 172.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.0 t -141.78 144.62 25.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 124.89 1.276 . . . . 0.0 107.83 -169.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 16.3 mtm -147.8 152.35 37.54 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.551 1.541 . . . . 0.0 110.308 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -138.46 144.49 40.12 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 127.587 2.355 . . . . 0.0 105.158 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.44 -151.3 6.73 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-N 120.641 1.564 . . . . 0.0 115.396 -169.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -144.71 133.39 22.25 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 126.098 1.759 . . . . 0.0 107.186 172.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.9 p -101.54 133.85 43.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 169.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -142.09 88.52 2.11 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.528 1.131 . . . . 0.0 108.874 -170.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -156.98 162.98 39.6 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.654 -1.279 . . . . 0.0 110.713 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.27 178.07 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 124.327 1.051 . . . . 0.0 110.543 178.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -64.42 4.85 0.33 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.9 2.08 . . . . 0.0 114.467 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.356 0 C-N-CA 125.49 1.519 . . . . 0.0 109.5 175.566 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.8 p . . . . . 0 C--O 1.235 0.308 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? -115.09 141.64 47.73 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.019 0.927 . . . . 0.0 108.95 176.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.0 tp -88.78 154.97 19.85 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 167.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 10.8 m -130.57 149.76 52.09 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 -174.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -144.12 143.76 31.27 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -127.05 125.8 41.98 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 101.052 -3.684 . . . . 0.0 101.052 169.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.2 t -135.13 130.1 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -170.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 50.1 m -115.99 136.02 53.43 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 176.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -136.35 158.99 43.11 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.427 1.091 . . . . 0.0 109.961 -169.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -71.87 65.88 1.15 Allowed Glycine 0 CA--C 1.531 1.056 0 N-CA-C 108.204 -1.958 . . . . 0.0 108.204 168.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 171.16 -17.22 0.06 OUTLIER Glycine 0 CA--C 1.534 1.268 0 CA-C-O 117.194 -1.892 . . . . 0.0 112.194 -169.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . 0.435 43.4 mt 133.17 -136.14 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 130.514 3.526 . . . . 0.0 111.453 168.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 5.2 tt -139.48 157.74 45.33 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 121.661 2.028 . . . . 0.0 113.516 -168.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.467 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 35.7 mtt -145.25 157.89 43.96 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.135 1.774 . . . . 0.0 109.961 177.286 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 62.9 mtt180 -136.11 137.73 41.34 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 104.651 -2.351 . . . . 0.0 104.651 169.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 27.6 tp -148.71 146.38 28.08 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 119.054 0.843 . . . . 0.0 110.463 -168.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -137.3 153.05 50.37 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.661 1.184 . . . . 0.0 108.314 168.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 176.17 -177.1 47.81 Favored Glycine 0 CA--C 1.519 0.336 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 170.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -53.1 139.86 27.27 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 118.291 1.046 . . . . 0.0 109.681 175.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -53.04 -56.25 17.57 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 123.593 0.558 . . . . 0.0 112.167 -174.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -54.81 -40.55 69.64 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-O 121.437 0.637 . . . . 0.0 111.471 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.5 -30.98 71.82 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 127.193 2.197 . . . . 0.0 110.39 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.37 -25.28 65.9 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 118.475 -0.774 . . . . 0.0 109.447 -178.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 72.2 m80 40.94 44.46 1.98 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.48 1.512 . . . . 0.0 111.76 -177.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -137.22 64.01 0.57 Allowed Glycine 0 C--N 1.338 0.648 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 -169.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -103.37 12.88 34.82 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.729 0.812 . . . . 0.0 112.055 -173.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.452 ' C ' ' H ' ' A' ' 138' ' ' ASP . 7.4 tp10 -140.61 146.3 37.79 Favored 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 126.122 1.769 . . . . 0.0 108.002 173.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.5 m -56.51 -9.06 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 124.512 1.125 . . . . 0.0 111.346 169.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.452 ' H ' ' C ' ' A' ' 136' ' ' GLU . 31.9 t70 -134.35 15.03 3.78 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 127.548 2.339 . . . . 0.0 112.245 -172.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 68.6 m -73.37 -81.8 0.06 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 122.309 1.052 . . . . 0.0 109.642 168.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -80.0 14.34 1.87 Allowed 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -169.14 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 20.1 m -68.18 -29.73 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 169.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -82.56 106.18 14.21 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 175.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 24.7 tp -129.79 137.18 50.36 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 124.617 1.167 . . . . 0.0 108.133 -173.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.9 mp -139.63 151.43 45.97 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 172.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 60.4 mtm -138.85 154.18 48.4 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.616 0.767 . . . . 0.0 109.581 -176.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 34.0 pttt -165.0 175.18 9.71 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.205 1.402 . . . . 0.0 110.964 -169.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 23.0 ptmt -63.31 157.17 23.57 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 122.406 0.283 . . . . 0.0 110.239 169.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.33 154.6 31.26 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.691 0.758 . . . . 0.0 111.512 172.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -135.86 112.72 10.24 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 169.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 . . . . . 0 C--O 1.247 0.939 0 CA-C-O 118.546 -0.74 . . . . 0.0 109.962 -177.247 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 44.3 tp . . . . . 0 C--O 1.232 0.137 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -161.04 166.65 27.83 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.485 1.114 . . . . 0.0 109.559 173.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -140.63 132.89 28.2 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.925 2.09 . . . . 0.0 106.313 176.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -149.86 153.75 37.24 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 171.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.0 mp -75.52 146.0 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 173.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -129.65 153.9 47.66 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.478 1.511 . . . . 0.0 107.389 170.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -131.74 129.59 40.82 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.664 1.586 . . . . 0.0 108.278 -174.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 51.8 t -72.51 118.03 16.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 124.448 1.099 . . . . 0.0 108.197 -177.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.2 mmpt? -78.25 -43.33 28.51 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 124.489 1.116 . . . . 0.0 109.59 169.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -159.11 170.65 21.54 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 118.824 0.738 . . . . 0.0 111.038 -175.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.2 mp -138.6 142.56 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 127.104 2.162 . . . . 0.0 106.825 -173.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -147.39 93.99 4.56 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 124.195 0.998 . . . . 0.0 111.205 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -73.14 90.84 0.85 Allowed 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 123.306 2.671 . . . . 0.0 107.765 168.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -57.87 -33.56 68.83 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -169.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 155.81 42.5 0.02 OUTLIER Glycine 0 CA--C 1.527 0.79 0 N-CA-C 106.248 -2.741 . . . . 0.0 106.248 -169.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 22.1 mmtt -72.42 95.96 1.84 Allowed 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.443 1.497 . . . . 0.0 109.66 -168.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -47.7 -43.31 26.56 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.232 1.013 . . . . 0.0 112.025 175.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.5 m-30 -81.08 -18.58 46.11 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 122.741 0.416 . . . . 0.0 112.071 -174.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.7 t70 62.75 -36.13 0.13 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 130.064 3.345 . . . . 0.0 115.688 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -72.64 11.0 0.71 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.316 1.446 . . . . 0.0 113.124 170.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 53.7 t -126.53 140.46 48.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 104.029 -2.582 . . . . 0.0 104.029 174.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 55.7 m -156.21 160.82 40.17 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 119.637 1.108 . . . . 0.0 110.417 174.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.461 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 15.1 ttm180 -83.81 150.38 25.8 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 170.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 66.0 mt -137.76 155.17 49.34 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.744 2.018 . . . . 0.0 106.141 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -121.58 127.35 50.82 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 102.804 -3.036 . . . . 0.0 102.804 169.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 74.5 m -141.27 162.63 35.01 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.182 0.993 . . . . 0.0 110.864 -169.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -138.75 134.2 33.2 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.556 1.542 . . . . 0.0 107.607 -176.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.5 p -67.18 148.3 51.97 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.014 0.926 . . . . 0.0 110.697 173.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -77.78 -30.41 51.34 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 118.756 -0.64 . . . . 0.0 111.013 172.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -132.49 -31.45 1.39 Allowed 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 115.234 1.568 . . . . 0.0 115.234 -169.031 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 23.3 m-30 -108.35 30.9 6.01 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -168.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 49.5 pttt 40.11 53.73 2.75 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.564 1.546 . . . . 0.0 114.282 169.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 47.6 mtt -114.52 110.82 20.42 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.388 1.875 . . . . 0.0 107.972 177.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -82.74 125.06 30.83 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 169.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 51.9 tp -132.85 142.09 48.77 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 118.733 0.697 . . . . 0.0 112.305 -168.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 40.8 mm -120.03 136.98 55.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 101.635 -3.468 . . . . 0.0 101.635 169.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 22.3 tp -152.7 105.21 2.95 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.062 0.945 . . . . 0.0 109.316 -168.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.461 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 16.1 t70 -100.87 105.54 16.82 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 126.212 1.805 . . . . 0.0 107.246 173.189 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.7 m -150.51 172.03 1.34 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-O 121.662 0.744 . . . . 0.0 110.515 -169.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -59.9 128.14 35.41 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.175 1.39 . . . . 0.0 109.264 169.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.1 pp -114.67 0.88 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 124.597 1.159 . . . . 0.0 113.812 -174.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.68 -4.92 25.97 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 120.42 1.463 . . . . 0.0 111.255 177.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.8 mt -62.83 -38.79 82.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 168.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -78.21 148.15 74.03 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 123.505 0.722 . . . . 0.0 110.138 -171.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.93 -25.33 19.92 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 122.592 2.195 . . . . 0.0 112.669 -177.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.8 m -145.42 160.82 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 125.611 1.564 . . . . 0.0 108.352 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -60.25 -27.82 67.53 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.313 1.045 . . . . 0.0 112.463 178.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 42.7 tp -62.65 -15.17 50.71 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.761 1.224 . . . . 0.0 112.456 174.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.1 -176.46 51.48 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -172.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -155.71 166.1 34.53 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.436 1.494 . . . . 0.0 107.344 177.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -66.95 131.69 46.39 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 173.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -139.69 146.16 39.28 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -172.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 61.5 mtm180 -79.67 134.08 36.41 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 170.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -106.04 134.44 49.17 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 104.355 -2.461 . . . . 0.0 104.355 169.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 80.1 t -134.29 138.65 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 -176.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.1 mm -106.78 135.18 46.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 104.832 -2.285 . . . . 0.0 104.832 169.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.515 0 C-N-CA 124.708 1.203 . . . . 0.0 110.127 -169.469 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.7 p90 . . . . . 0 C--O 1.236 0.357 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -116.15 -23.31 8.51 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.669 0.787 . . . . 0.0 110.353 175.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -149.86 150.32 31.77 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.247 1.019 . . . . 0.0 109.218 171.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.4 p -148.42 142.99 19.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 174.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 10.3 tpt -159.94 166.93 29.15 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.938 0.895 . . . . 0.0 109.596 176.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -121.06 146.8 46.34 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.107 1.363 . . . . 0.0 108.138 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -141.65 -160.43 8.32 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-N 118.637 0.653 . . . . 0.0 112.328 -175.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -142.02 128.84 20.54 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.862 1.265 . . . . 0.0 107.824 169.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 39.3 t -79.68 144.03 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 171.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -143.46 75.47 1.48 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.931 1.293 . . . . 0.0 109.529 177.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -157.09 163.58 38.82 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 120.764 -1.21 . . . . 0.0 110.954 170.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.53 -172.49 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 125.691 1.596 . . . . 0.0 110.935 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.22 -13.93 3.67 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.91 2.084 . . . . 0.0 115.437 -178.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.441 ' HA2' ' H ' ' A' ' 113' ' ' SER . . . . . . . . 0 C--N 1.334 0.435 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.4 p . . . . . 0 CA--C 1.533 0.3 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? 60.32 131.98 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 127.804 2.442 . . . . 0.0 111.611 -168.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 9.1 tt -79.55 135.87 36.73 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 103.15 -2.907 . . . . 0.0 103.15 167.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.441 ' H ' ' HA2' ' A' ' 101' ' ' GLY . 41.8 m -109.47 136.77 48.34 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 105.477 -2.046 . . . . 0.0 105.477 173.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -128.22 152.02 48.57 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.121 1.369 . . . . 0.0 108.091 -174.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -132.56 137.71 47.21 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 102.834 -3.025 . . . . 0.0 102.834 169.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.8 t -132.38 147.13 32.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 177.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.0 m -127.31 157.68 39.23 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 102.513 -3.143 . . . . 0.0 102.513 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . 0.333 98.4 m-85 58.76 -148.79 0.47 Allowed 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -167.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 61.15 13.57 35.74 Favored Glycine 0 CA--C 1.535 1.325 0 CA-C-N 120.186 1.357 . . . . 0.0 113.17 -176.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 138.21 -50.31 0.81 Allowed Glycine 0 CA--C 1.528 0.848 0 C-N-CA 126.066 1.793 . . . . 0.0 109.601 -171.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.65 -68.63 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.458 1.503 . . . . 0.0 109.0 169.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 11.3 tp -157.79 148.21 20.71 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 124.561 1.144 . . . . 0.0 109.065 -178.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.58 156.34 41.77 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 170.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 70.2 ttt-85 -127.61 142.57 51.32 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 169.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 15.3 tp -149.74 148.89 29.77 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -169.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -144.39 143.42 30.93 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 168.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -175.93 178.05 47.49 Favored Glycine 0 CA--C 1.52 0.361 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -52.42 137.24 29.98 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 118.305 1.053 . . . . 0.0 110.622 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -56.91 -55.98 27.53 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -169.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -57.03 -43.95 82.39 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 122.349 1.071 . . . . 0.0 111.403 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 27.0 t30 -60.99 -28.09 68.77 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 126.292 1.837 . . . . 0.0 111.935 177.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.11 -29.38 54.81 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 123.911 0.884 . . . . 0.0 110.145 178.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 49.21 21.56 0.54 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.925 1.69 . . . . 0.0 113.191 -169.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.02 -10.86 84.17 Favored Glycine 0 CA--C 1.528 0.865 0 O-C-N 121.059 -1.026 . . . . 0.0 113.955 -169.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -59.12 -30.64 68.27 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 118.476 1.138 . . . . 0.0 111.693 172.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -87.35 87.82 7.52 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 126.743 2.017 . . . . 0.0 106.212 169.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.5 m -59.59 -7.12 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 124.49 1.116 . . . . 0.0 113.407 176.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -123.4 18.74 9.75 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 126.11 1.764 . . . . 0.0 113.17 176.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.9 m -83.84 -68.93 0.67 Allowed 'General case' 0 C--O 1.232 0.147 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 167.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.292 10.6 ptm85 -78.31 11.67 2.29 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 -169.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 29.7 m -67.58 -34.86 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-O 118.645 -0.693 . . . . 0.0 109.337 168.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -82.82 104.35 12.99 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 10.3 tt -117.2 134.72 54.44 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -170.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -140.51 135.92 32.39 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 -171.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 78.4 mtm -137.85 149.4 46.26 Favored 'General case' 0 C--O 1.237 0.426 0 O-C-N 121.267 -0.896 . . . . 0.0 109.944 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -154.62 172.51 17.75 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.305 1.042 . . . . 0.0 109.761 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -53.51 160.46 1.23 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.298 0.639 . . . . 0.0 111.857 175.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.25 166.3 0.86 Allowed 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.394 0.616 . . . . 0.0 111.981 169.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -87.09 86.59 7.31 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 175.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 19.2 t80 . . . . . 0 C--O 1.248 0.995 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 172.632 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 23.1 tp . . . . . 0 CA--C 1.538 0.509 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -147.33 134.04 19.99 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -148.5 138.4 22.29 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 169.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -151.17 150.62 30.85 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.026 0.83 . . . . 0.0 110.869 172.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.6 mp -75.16 152.65 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 169.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -132.59 146.66 52.07 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.651 1.58 . . . . 0.0 107.788 174.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -123.75 119.74 30.63 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 127.225 2.21 . . . . 0.0 106.641 -175.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.7 t -78.39 123.92 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -177.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.5 mmmt -88.7 -40.0 13.58 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.952 0.901 . . . . 0.0 109.687 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -157.93 170.91 21.27 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 118.386 0.539 . . . . 0.0 112.318 -169.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.1 mp -141.9 147.54 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 127.881 2.472 . . . . 0.0 106.786 -175.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -143.86 110.58 5.2 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 169.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -64.62 7.35 0.25 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.605 2.87 . . . . 0.0 117.454 -177.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 46.14 39.93 6.62 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.731 2.012 . . . . 0.0 112.294 -174.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.29 37.71 41.26 Favored Glycine 0 CA--C 1.531 1.065 0 O-C-N 121.528 -0.732 . . . . 0.0 111.447 -177.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? 45.55 57.64 4.81 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 126.661 1.984 . . . . 0.0 109.642 -169.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -54.63 -36.76 64.86 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.921 0.888 . . . . 0.0 110.645 -178.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -140.17 160.99 38.73 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 169.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -64.64 -25.55 68.01 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -177.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -136.57 16.47 3.13 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 117.639 -1.172 . . . . 0.0 113.579 -173.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.8 t -131.61 129.14 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 121.005 1.73 . . . . 0.0 107.364 -178.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 39.6 m -148.34 159.55 43.89 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 124.387 1.075 . . . . 0.0 110.396 -170.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 -69.01 146.46 52.7 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 169.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.2 mp -127.86 158.09 38.72 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 127.018 2.127 . . . . 0.0 106.521 170.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -136.08 132.01 35.59 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 171.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.3 m -142.85 173.02 11.92 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.318 1.447 . . . . 0.0 110.609 -169.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -140.99 143.66 34.59 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.59 1.956 . . . . 0.0 106.858 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.3 p -88.09 147.68 24.83 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.109 0.868 . . . . 0.0 110.033 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -77.58 -41.79 37.48 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.497 1.119 . . . . 0.0 112.811 -169.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.28 -26.74 9.0 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.831 0.852 . . . . 0.0 112.775 -169.131 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -121.35 23.78 10.26 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.957 1.303 . . . . 0.0 112.188 -170.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.9 pttt 43.6 27.37 0.15 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 127.097 2.159 . . . . 0.0 116.247 168.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 53.8 mtt -70.53 149.29 47.3 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 119.813 1.188 . . . . 0.0 108.366 175.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -112.29 131.07 55.71 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 173.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 48.7 tp -133.56 141.88 47.9 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.667 0.746 . . . . 0.0 111.154 -169.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 42.6 mm -123.05 142.4 39.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 101.161 -3.644 . . . . 0.0 101.161 168.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 51.3 tp -148.92 154.73 39.84 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 126.221 1.808 . . . . 0.0 106.929 -168.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -137.18 114.14 10.59 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 103.478 -2.786 . . . . 0.0 103.478 169.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.0 p -151.46 167.29 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 O-C-N 124.373 1.046 . . . . 0.0 111.026 -168.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -60.61 137.08 58.22 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.943 1.297 . . . . 0.0 109.413 169.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.6 pp -119.14 8.0 6.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 124.935 1.294 . . . . 0.0 113.417 -177.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -65.41 -19.57 66.0 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 120.367 1.44 . . . . 0.0 110.96 173.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.4 mt -63.65 -33.92 64.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 126.238 1.815 . . . . 0.0 110.291 172.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -65.75 138.73 96.68 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 123.757 0.823 . . . . 0.0 112.916 -167.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -72.91 177.43 7.7 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.418 2.745 . . . . 0.0 110.974 172.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.6 m -70.87 -22.93 23.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 O-C-N 121.766 -0.583 . . . . 0.0 111.62 171.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -69.16 153.19 44.11 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.755 0.822 . . . . 0.0 110.733 177.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 53.9 tp -63.8 -29.68 70.85 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.512 0.725 . . . . 0.0 112.625 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.21 160.51 13.78 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-N 119.091 0.859 . . . . 0.0 111.679 -175.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -157.69 164.81 36.77 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 126.097 1.759 . . . . 0.0 107.433 174.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -138.43 150.87 46.92 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.681 0.792 . . . . 0.0 109.339 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -151.59 -175.32 5.15 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 124.989 1.316 . . . . 0.0 107.598 173.295 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.7 ttp180 -136.12 147.85 47.97 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 125.233 1.413 . . . . 0.0 107.716 -177.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.1 tp -134.91 151.0 50.5 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.132 0.973 . . . . 0.0 109.755 -169.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 55.7 t -136.46 137.11 48.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 105.472 -2.048 . . . . 0.0 105.472 173.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 pp -137.45 3.5 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 123.808 0.843 . . . . 0.0 113.077 -176.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.295 0 O-C-N 121.446 -0.784 . . . . 0.0 112.462 -170.905 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 30.4 p90 . . . . . 0 CA--C 1.538 0.519 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -97.8 -49.71 4.72 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.212 0.914 . . . . 0.0 110.209 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -157.4 165.97 34.3 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.18 0.9 . . . . 0.0 110.994 172.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.7 p -141.47 142.87 28.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 170.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.8 tpt -152.91 162.06 41.77 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.779 1.232 . . . . 0.0 109.164 -175.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -114.6 116.59 29.01 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 170.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.75 -167.08 32.09 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 -174.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.42 111.04 10.42 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 169.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 87.2 t -72.22 155.97 7.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 174.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -128.39 106.81 9.25 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 104.632 -2.359 . . . . 0.0 104.632 169.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -75.48 138.69 41.76 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -174.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.4 pt -128.31 179.46 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.149 0.98 . . . . 0.0 108.808 169.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -74.18 -1.46 20.52 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.609 1.564 . . . . 0.0 114.607 -173.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.583 0 O-C-N 121.841 -0.537 . . . . 0.0 112.696 -176.92 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.1 p . . . . . 0 CA--C 1.533 0.317 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -124.04 131.94 53.62 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.294 1.838 . . . . 0.0 106.562 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 34.9 tp -70.8 153.63 42.57 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 170.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -126.88 161.46 28.21 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.206 1.002 . . . . 0.0 108.838 -172.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -147.97 161.22 41.78 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.752 1.221 . . . . 0.0 108.974 171.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -124.48 147.7 48.18 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 169.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.8 t -144.54 143.16 23.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 29.6 m -120.48 136.4 54.77 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 169.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -146.58 114.99 6.71 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -178.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 57.19 23.33 46.95 Favored Glycine 0 CA--C 1.539 1.588 0 CA-C-O 119.311 -0.716 . . . . 0.0 114.456 174.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.57 -8.42 64.04 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 124.763 1.173 . . . . 0.0 113.633 -178.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -95.26 170.2 9.55 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.777 1.631 . . . . 0.0 108.814 175.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.0 tp -139.19 160.63 39.36 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 118.741 0.7 . . . . 0.0 111.587 -169.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 71.4 mtm -153.97 161.56 41.88 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.56 1.544 . . . . 0.0 110.253 169.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -141.49 133.61 27.77 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 103.825 -2.657 . . . . 0.0 103.825 167.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.8 tt -140.92 151.1 43.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 119.259 0.936 . . . . 0.0 108.866 -171.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -132.93 153.42 51.42 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.644 1.177 . . . . 0.0 109.409 170.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -168.66 169.26 41.59 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 170.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -51.13 136.98 22.88 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.224 1.012 . . . . 0.0 109.005 172.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -42.73 -53.65 4.44 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -172.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -60.83 -41.35 95.62 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 123.174 1.464 . . . . 0.0 111.511 -177.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -71.63 -18.92 62.17 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 127.099 2.16 . . . . 0.0 111.386 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -67.87 -25.2 65.4 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 119.168 0.895 . . . . 0.0 109.184 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 25.2 t-80 53.28 40.42 31.26 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.88 1.272 . . . . 0.0 111.064 171.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -165.92 50.65 0.27 Allowed Glycine 0 C--N 1.338 0.655 0 O-C-N 121.366 -0.834 . . . . 0.0 112.609 -169.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -74.7 8.35 2.45 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.085 0.954 . . . . 0.0 112.18 171.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -135.17 130.24 35.05 Favored 'General case' 0 CA--C 1.508 -0.649 0 C-N-CA 126.005 1.722 . . . . 0.0 106.909 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.9 p -59.01 -4.68 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 126.14 1.776 . . . . 0.0 111.348 170.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -131.93 15.2 4.76 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.288 1.435 . . . . 0.0 113.075 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 6.8 m -87.14 -66.52 0.9 Allowed 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 167.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.32 0.0 OUTLIER -81.41 14.92 2.23 Favored 'General case' 0 C--N 1.345 0.38 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -169.521 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 16.3 m -64.23 -32.28 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 167.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -65.23 127.41 31.6 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 175.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 63.4 tp -143.07 130.95 21.57 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -177.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.3 tt -139.93 144.47 37.12 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 172.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 57.4 ttm -131.36 144.71 51.43 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 174.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 50.4 pttt -153.55 174.36 14.53 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.18 1.392 . . . . 0.0 109.524 178.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -64.26 157.95 24.57 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 122.533 0.333 . . . . 0.0 111.012 172.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.88 166.55 15.35 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.767 0.427 . . . . 0.0 110.961 169.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -141.61 134.29 28.55 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 172.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 . . . . . 0 C--O 1.25 1.094 0 C-N-CA 127.009 2.124 . . . . 0.0 110.937 -177.586 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 56.1 tp . . . . . 0 C--O 1.233 0.211 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -147.84 151.04 35.27 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 126.527 1.931 . . . . 0.0 106.744 169.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -149.54 138.09 20.86 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.239 1.415 . . . . 0.0 107.581 -175.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -153.79 140.91 19.41 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.823 1.249 . . . . 0.0 109.251 -178.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.4 mp -107.46 139.16 30.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -134.99 158.07 45.3 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.438 1.095 . . . . 0.0 110.363 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -125.21 135.13 52.27 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 126.055 1.742 . . . . 0.0 107.514 -177.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.5 p -69.01 146.51 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 122.203 1.002 . . . . 0.0 109.358 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -125.11 -28.78 3.38 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 126.837 2.055 . . . . 0.0 109.116 -176.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -157.61 164.29 37.4 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 118.946 0.794 . . . . 0.0 110.913 170.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.8 mp -141.64 138.03 31.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 127.423 2.289 . . . . 0.0 106.032 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -146.61 97.8 4.26 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 125.351 1.46 . . . . 0.0 108.773 -176.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -60.67 26.1 0.04 OUTLIER 'Trans proline' 0 CA--C 1.543 0.952 1 C-N-CA 125.831 4.354 . . . . 0.0 118.554 -175.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -63.2 -9.05 9.61 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.214 -1.554 . . . . 0.0 113.628 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.72 10.63 12.48 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.442 1.496 . . . . 0.0 112.695 172.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.8 tppt? -44.15 -12.89 0.01 OUTLIER 'General case' 0 C--N 1.345 0.373 0 C-N-CA 129.536 3.134 . . . . 0.0 116.749 -176.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.2 tppt? -55.38 -31.35 61.73 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.224 0.92 . . . . 0.0 110.054 169.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -136.84 110.17 7.88 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 104.125 -2.546 . . . . 0.0 104.125 169.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -56.99 -28.3 62.27 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -169.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.2 ptt180 -72.02 4.7 3.22 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 117.453 -1.26 . . . . 0.0 113.759 174.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.0 t -120.85 134.95 62.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 121.363 1.892 . . . . 0.0 107.311 -178.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.8 m -145.78 151.73 38.41 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.694 0.797 . . . . 0.0 110.145 -177.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.5 ttp180 -73.25 143.12 47.2 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 168.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -136.46 155.61 49.76 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 125.547 1.539 . . . . 0.0 107.289 -174.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -131.92 135.06 46.34 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 105.218 -2.141 . . . . 0.0 105.218 169.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 65.7 m -141.18 167.02 23.17 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.536 1.534 . . . . 0.0 109.305 -176.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -135.94 130.47 33.77 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 178.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.3 m -76.62 131.01 38.64 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.218 0.607 . . . . 0.0 110.16 178.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -80.21 -36.5 34.76 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.91 0.884 . . . . 0.0 110.844 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.07 -29.5 69.3 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.506 0.722 . . . . 0.0 112.918 -169.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -132.92 -99.1 0.28 Allowed 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -167.08 13.82 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.449 1.1 . . . . 0.0 112.959 -172.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 72.2 mtm -71.18 141.14 50.69 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.174 0.512 . . . . 0.0 111.234 -169.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -88.73 135.97 33.24 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 169.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 64.1 tp -136.96 141.5 42.61 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 119.212 0.914 . . . . 0.0 109.426 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 36.3 mm -128.85 147.76 33.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 104.057 -2.571 . . . . 0.0 104.057 169.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 123' ' ' MET . 2.5 mp -144.17 166.28 25.48 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 125.639 1.575 . . . . 0.0 108.995 177.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -136.84 96.21 3.27 Favored 'General case' 0 C--N 1.324 -0.539 1 N-CA-C 99.038 -4.43 . . . . 0.0 99.038 167.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.7 p -139.45 161.18 27.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-O 121.353 0.596 . . . . 0.0 112.013 -167.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 62.5 t-20 -62.46 128.12 34.54 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.854 1.262 . . . . 0.0 109.273 170.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.5 pp -105.54 0.71 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 124.998 1.319 . . . . 0.0 112.93 -178.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -68.27 -17.51 64.31 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 120.347 1.431 . . . . 0.0 110.977 -177.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.4 mt -67.05 -34.97 73.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 124.501 1.12 . . . . 0.0 109.1 174.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -69.02 149.73 97.73 Favored Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -77.76 30.75 0.43 Allowed 'Trans proline' 0 CA--C 1.546 1.109 0 C-N-CA 124.445 3.43 . . . . 0.0 113.384 -172.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . 0.268 29.9 m 42.9 51.2 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 126.7 2.0 . . . . 0.0 111.937 -176.09 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -139.4 172.87 12.19 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.137 1.775 . . . . 0.0 108.343 -177.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 53.1 tp -52.14 -33.7 41.3 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.534 1.533 . . . . 0.0 113.417 -171.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -174.92 170.54 43.67 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 118.554 0.615 . . . . 0.0 111.611 172.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -158.84 172.34 18.4 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 126.431 1.892 . . . . 0.0 107.41 174.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -112.5 148.95 33.36 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.316 1.046 . . . . 0.0 109.916 -178.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -141.48 173.62 11.32 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.76 1.224 . . . . 0.0 108.367 -178.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -130.24 129.24 43.08 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 124.669 1.188 . . . . 0.0 107.911 -170.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.9 tp -91.53 141.12 29.07 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 169.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 55.1 t -134.7 146.72 30.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 172.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.4 mt -135.05 127.74 48.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 104.391 -2.448 . . . . 0.0 104.391 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.379 0 N-CA-C 105.083 -2.191 . . . . 0.0 105.083 175.161 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -75.39 -19.62 59.44 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.945 0.498 . . . . 0.0 111.889 -169.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -140.92 143.39 34.57 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.167 0.987 . . . . 0.0 108.968 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.7 p -145.5 140.77 22.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 174.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 40.7 tpp -154.96 163.02 40.9 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.591 1.156 . . . . 0.0 108.779 -177.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -121.63 152.28 39.49 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 175.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -152.24 -143.0 3.6 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.119 -169.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -151.52 142.91 23.45 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 127.69 2.396 . . . . 0.0 105.001 169.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.3 p -116.05 140.48 37.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 172.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -132.96 54.69 1.94 Allowed 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.04 163.34 22.58 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.074 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 15.8 pt -103.17 175.25 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 123.238 0.615 . . . . 0.0 110.161 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -72.77 -5.26 36.73 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.017 1.327 . . . . 0.0 113.253 178.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.758 0 C-N-CA 124.417 1.008 . . . . 0.0 112.585 -179.196 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.47 0.572 0 CA-C-O 121.295 0.569 . . . . 0.0 111.428 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -132.49 144.04 50.18 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 169.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 45.1 tp -80.35 143.62 33.4 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 168.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 13.4 m -135.75 143.4 45.27 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -169.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -138.89 156.27 47.42 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.881 0.873 . . . . 0.0 111.182 -169.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -133.74 139.42 46.35 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 171.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.3 t -137.8 144.05 32.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -177.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 65.6 m -126.31 121.75 33.5 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 174.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -145.47 116.11 7.67 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 119.396 0.998 . . . . 0.0 109.354 -170.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 56.92 21.3 36.98 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-O 119.377 -0.679 . . . . 0.0 114.513 -178.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 91.06 -8.49 79.62 Favored Glycine 0 CA--C 1.535 1.335 0 CA-C-N 118.553 1.176 . . . . 0.0 113.296 -175.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -85.91 168.12 14.49 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 118.719 1.26 . . . . 0.0 107.992 169.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.8 tp -139.59 157.75 45.28 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.457 0.703 . . . . 0.0 110.09 -173.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.418 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 14.6 ptp -155.64 159.26 39.45 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.141 0.976 . . . . 0.0 109.578 168.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.426 HH11 ' HG2' ' A' ' 124' ' ' ARG . 29.7 ttp85 -135.63 141.05 45.0 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 169.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 5.8 tt -143.38 154.5 43.78 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 118.801 0.728 . . . . 0.0 109.829 -176.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -135.13 148.48 49.77 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 169.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -169.2 166.41 39.67 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 170.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -70.9 103.57 2.68 Favored 'General case' 0 N--CA 1.462 0.126 0 O-C-N 121.728 -0.866 . . . . 0.0 109.825 179.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . 10.7 -67.57 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 130.987 3.715 . . . . 0.0 117.786 -171.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -61.47 -13.5 21.27 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 120.76 1.618 . . . . 0.0 114.077 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -62.8 -43.77 97.93 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 126.608 1.963 . . . . 0.0 109.781 171.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.47 -38.3 77.3 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.737 1.215 . . . . 0.0 109.977 -176.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 42.79 35.72 0.75 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.431 2.693 . . . . 0.0 113.599 175.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 173.86 58.82 0.05 OUTLIER Glycine 0 C--N 1.333 0.412 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -170.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -95.38 -0.65 52.38 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.761 0.824 . . . . 0.0 112.469 -170.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.436 ' C ' ' H ' ' A' ' 138' ' ' ASP . 7.0 tp10 -72.22 146.09 47.55 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 170.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 1.8 p -62.15 0.48 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 124.734 1.214 . . . . 0.0 110.988 169.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.477 ' HA ' HG21 ' A' ' 141' ' ' VAL . 36.8 t70 -137.97 9.51 2.8 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.471 1.909 . . . . 0.0 113.28 179.223 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 58.5 m -68.4 -73.1 0.15 Allowed 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.46 -0.775 . . . . 0.0 111.081 169.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.341 10.3 ptm180 -89.03 25.96 1.69 Allowed 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 122.364 1.078 . . . . 0.0 112.755 -169.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.477 HG21 ' HA ' ' A' ' 138' ' ' ASP 0.255 60.9 t -83.01 -4.93 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 C-N-CA 127.446 2.299 . . . . 0.0 107.708 168.644 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -126.45 120.12 28.94 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 102.654 -3.091 . . . . 0.0 102.654 169.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 10.4 tt -141.68 141.76 33.35 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -168.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 mp -138.65 157.33 46.33 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.379 1.072 . . . . 0.0 108.463 -174.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 78.1 mtm -143.03 158.94 43.14 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.887 -0.508 . . . . 0.0 110.795 173.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -152.26 169.47 22.4 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.985 1.714 . . . . 0.0 108.567 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -61.55 168.83 2.64 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.233 -0.917 . . . . 0.0 110.952 169.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.41 168.35 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.966 1.706 . . . . 0.0 114.551 175.348 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -142.45 21.26 2.04 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.692 1.197 . . . . 0.0 112.597 171.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 . . . . . 0 C--O 1.247 0.963 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -178.561 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 42.0 tp . . . . . 0 CA--C 1.536 0.414 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -154.3 164.64 38.26 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.742 1.217 . . . . 0.0 109.225 174.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -148.69 151.45 34.93 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 126.621 1.969 . . . . 0.0 105.948 172.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -147.1 148.06 31.22 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 123.381 0.672 . . . . 0.0 110.633 176.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.8 mp -115.84 137.17 50.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 104.529 -2.397 . . . . 0.0 104.529 169.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -137.84 168.62 19.32 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.318 0.647 . . . . 0.0 110.933 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -131.17 121.33 24.67 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.964 2.106 . . . . 0.0 107.697 -175.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 96.3 t -63.81 127.51 24.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 176.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.2 mmmt -105.83 -30.52 9.34 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 124.204 1.001 . . . . 0.0 109.87 176.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -156.27 167.33 30.76 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.833 0.742 . . . . 0.0 111.45 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.4 mp -139.53 140.41 37.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 127.758 2.423 . . . . 0.0 105.845 -176.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -146.67 93.19 4.93 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 123.35 0.66 . . . . 0.0 110.025 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.73 149.16 51.3 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.196 2.597 . . . . 0.0 112.234 173.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -82.51 -3.05 55.24 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -176.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.09 52.1 0.39 Allowed Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.981 -1.247 . . . . 0.0 109.981 -174.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? 40.3 42.33 1.2 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.865 2.066 . . . . 0.0 112.434 -169.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -79.02 79.79 5.4 Favored 'General case' 0 C--N 1.338 0.108 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 170.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 65.62 114.88 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 128.733 2.813 . . . . 0.0 108.704 -169.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -56.74 -33.89 66.99 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -169.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 51.6 ptt85 -81.89 0.53 39.31 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-O 116.558 -1.687 . . . . 0.0 113.708 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.5 t -121.77 113.78 40.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 121.686 2.039 . . . . 0.0 107.521 -174.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.408 ' HB2' HG21 ' A' ' 45' ' ' ILE . 41.4 m -147.84 163.21 37.48 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 123.206 0.603 . . . . 0.0 110.565 -172.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.9 ttm-85 -73.52 154.2 39.97 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 172.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.3 mt -135.13 155.01 51.45 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 125.749 1.62 . . . . 0.0 107.315 170.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -131.0 130.11 42.94 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 169.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 30.2 m -140.65 153.71 46.12 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.047 1.339 . . . . 0.0 110.571 -169.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -112.07 124.69 52.96 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 177.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 69.8 m -77.67 140.88 39.64 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 174.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -94.43 -26.73 16.37 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.456 1.102 . . . . 0.0 111.411 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.5 m -62.87 -46.52 87.5 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -169.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -141.68 -95.58 0.13 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.596 0.634 . . . . 0.0 110.413 -172.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 43.5 mtmt -145.29 21.09 1.55 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.7 1.6 . . . . 0.0 110.868 -168.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 56.5 mtm -88.64 159.44 17.85 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.402 0.681 . . . . 0.0 111.62 -169.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -138.98 127.67 23.32 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 127.62 2.368 . . . . 0.0 106.635 -177.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 56.6 tp -129.48 138.68 51.54 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.623 1.101 . . . . 0.0 110.769 -169.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.7 mm -124.41 146.94 29.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 169.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.1 mp -140.88 163.95 31.56 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.995 1.718 . . . . 0.0 108.142 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -138.49 96.29 3.14 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 100.374 -3.936 . . . . 0.0 100.374 168.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.3 p -140.95 171.18 13.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 123.26 0.624 . . . . 0.0 111.389 -167.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -68.17 93.13 0.43 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.194 1.398 . . . . 0.0 109.624 170.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.408 HG21 ' HB2' ' A' ' 26' ' ' SER . 1.6 pp -74.14 -1.33 2.83 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -171.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 60.9 mm-40 -65.75 -13.87 60.21 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 120.357 1.435 . . . . 0.0 111.503 175.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 82.7 mt -58.25 -29.79 38.38 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 C-N-CA 124.314 1.046 . . . . 0.0 108.921 168.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -115.61 145.42 34.48 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 124.663 1.185 . . . . 0.0 113.002 -168.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -78.93 77.65 4.01 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.531 2.82 . . . . 0.0 107.152 169.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.7 m -57.53 -9.93 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -171.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -57.67 -31.42 66.32 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.732 0.813 . . . . 0.0 111.999 169.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -147.03 -7.42 0.48 Allowed 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.811 1.412 . . . . 0.0 114.811 178.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.82 174.88 45.51 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-N 119.349 0.977 . . . . 0.0 111.827 -178.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -155.52 174.27 15.5 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.882 1.273 . . . . 0.0 108.713 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -93.61 153.21 18.52 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.169 0.988 . . . . 0.0 109.772 174.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -148.66 173.6 13.04 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.622 1.169 . . . . 0.0 109.458 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 50.6 ttt180 -131.18 146.23 52.25 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 125.839 1.656 . . . . 0.0 107.569 -175.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.1 tt -141.25 138.17 33.06 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 125.5 1.52 . . . . 0.0 107.474 -171.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.4 t -147.75 154.35 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -173.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 tt -81.71 -52.12 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 168.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.483 0 C-N-CA 128.544 2.738 . . . . 0.0 114.168 -175.33 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 . . . . . 0 N--CA 1.454 -0.248 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -80.52 -30.78 37.22 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 122.022 -0.424 . . . . 0.0 109.965 178.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -153.85 147.69 25.41 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.111 0.964 . . . . 0.0 108.972 171.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.4 p -151.93 142.39 15.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 169.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.7 tpt -158.28 168.43 27.03 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.006 1.323 . . . . 0.0 109.144 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -119.5 146.13 45.71 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 172.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -150.14 -158.33 8.15 Favored Glycine 0 C--N 1.336 0.558 0 CA-C-N 118.775 0.716 . . . . 0.0 112.014 -171.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -125.91 136.22 52.79 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 174.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 47.1 t -98.03 150.09 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 176.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -135.21 157.96 45.57 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 169.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.07 153.47 29.45 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 120.754 -1.216 . . . . 0.0 109.234 172.034 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.56 -177.85 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 O-C-N 123.671 0.607 . . . . 0.0 109.618 176.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -68.48 -6.57 25.78 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.053 1.341 . . . . 0.0 114.054 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.682 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 -175.194 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.5 p . . . . . 0 C--O 1.233 0.198 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -127.69 132.23 49.69 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 126.707 2.003 . . . . 0.0 105.605 175.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 66.1 tp -65.9 147.05 53.98 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 169.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -115.77 133.01 56.47 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 169.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -122.36 157.23 32.26 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 173.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -126.68 149.32 49.61 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.9 t -134.43 132.62 55.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 18.5 m -124.22 119.58 29.77 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -144.22 117.37 8.94 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.282 1.033 . . . . 0.0 109.192 -169.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 56.79 27.21 55.52 Favored Glycine 0 CA--C 1.535 1.294 0 O-C-N 121.724 -0.61 . . . . 0.0 114.221 176.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 84.13 -3.1 86.82 Favored Glycine 0 CA--C 1.536 1.346 0 CA-C-N 118.25 1.025 . . . . 0.0 113.543 -177.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 78.8 mt -95.7 163.52 13.15 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.1 1.36 . . . . 0.0 107.483 169.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.8 tt -148.88 157.67 43.6 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 121.712 -0.618 . . . . 0.0 111.068 -169.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 24.6 ptp -151.63 162.44 40.98 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.655 1.182 . . . . 0.0 109.311 169.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 43.6 ttt-85 -132.03 127.24 35.78 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 171.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 54.6 tp -127.37 119.38 26.08 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 -178.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -94.38 149.42 21.25 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 168.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -169.09 171.03 42.84 Favored Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 171.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -53.66 133.05 41.74 Favored 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 169.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -43.24 -59.28 2.14 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -172.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -58.43 -43.66 88.84 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 122.288 1.042 . . . . 0.0 111.429 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -61.73 -26.25 67.94 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 113.58 -1.646 . . . . 0.0 111.31 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 32.8 tp -81.23 -22.74 38.54 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 118.765 -0.636 . . . . 0.0 110.668 -176.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 37.6 49.49 1.04 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.292 1.037 . . . . 0.0 111.997 -170.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -118.08 0.42 17.01 Favored Glycine 0 C--N 1.341 0.845 0 CA-C-O 118.536 -1.147 . . . . 0.0 113.425 -173.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -67.06 -32.09 73.04 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.477 1.638 . . . . 0.0 108.211 168.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -65.14 71.19 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.678 1 C-N-CA 131.8 4.04 . . . . 0.0 108.936 169.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.9 m -59.82 -4.21 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 125.351 1.46 . . . . 0.0 113.954 176.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -125.6 18.39 8.08 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 125.711 1.605 . . . . 0.0 112.128 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.2 m -103.03 -59.1 1.76 Allowed 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 168.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.379 9.9 ptm85 -75.44 11.65 1.2 Allowed 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -175.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 16.6 m -62.35 -40.11 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 167.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -81.19 129.49 34.61 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 176.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -141.65 122.82 14.72 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 -169.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.7 tt -137.44 138.32 39.67 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -172.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 90.5 mtp -139.8 142.64 36.66 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 123.769 0.828 . . . . 0.0 109.229 -177.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -155.92 168.43 27.24 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.226 1.411 . . . . 0.0 107.875 -175.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -60.14 159.03 10.21 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.54 -0.725 . . . . 0.0 109.217 169.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.6 pp -68.91 165.22 20.4 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 120.684 0.278 . . . . 0.0 110.788 169.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -130.75 63.17 1.59 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.285 1.034 . . . . 0.0 109.288 -173.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 . . . . . 0 C--O 1.251 1.159 0 C-N-CA 125.947 1.699 . . . . 0.0 107.646 178.295 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 CA--C 1.534 0.363 0 CA-C-O 121.015 0.435 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -161.7 148.87 14.39 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.645 1.978 . . . . 0.0 106.061 169.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -154.16 138.96 17.09 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.382 1.073 . . . . 0.0 109.035 -172.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -151.12 145.07 25.2 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 168.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.7 mp -85.78 145.1 8.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 106.233 -1.765 . . . . 0.0 106.233 178.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -132.97 148.08 52.27 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.634 1.174 . . . . 0.0 108.654 177.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -117.64 130.55 56.44 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.268 1.427 . . . . 0.0 108.349 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 84.0 t -70.08 113.22 5.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -84.48 -35.18 23.14 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.804 1.241 . . . . 0.0 110.157 175.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -155.99 170.18 22.75 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.316 0.962 . . . . 0.0 111.19 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.8 mp -137.76 132.37 44.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 126.873 2.069 . . . . 0.0 105.905 -178.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -129.25 103.63 18.19 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 124.607 1.163 . . . . 0.0 109.08 176.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -104.31 11.69 0.26 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.925 3.084 . . . . 0.0 113.63 175.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -76.33 74.99 3.12 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.828 1.251 . . . . 0.0 111.346 -169.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 144.0 -9.68 2.03 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.812 1.672 . . . . 0.0 111.76 -178.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -71.33 86.17 0.81 Allowed 'General case' 0 C--N 1.339 0.144 0 C-N-CA 125.195 1.398 . . . . 0.0 110.78 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -54.66 -42.9 71.86 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 169.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -78.25 82.13 4.57 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 169.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -56.95 -24.62 54.15 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.881 1.273 . . . . 0.0 114.419 -169.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -73.9 3.82 6.18 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 174.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.7 t -115.15 147.77 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 176.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.7 m -150.25 158.02 43.71 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 120.995 -1.066 . . . . 0.0 110.439 169.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 19.6 ttp180 -85.89 89.41 7.77 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 171.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 82.2 mt -66.03 152.26 45.02 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 169.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -126.32 133.29 51.42 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 104.306 -2.479 . . . . 0.0 104.306 172.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.9 m -144.13 165.75 26.95 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.103 0.865 . . . . 0.0 112.733 -169.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -135.76 138.21 42.42 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.445 1.498 . . . . 0.0 109.543 -176.136 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 29.5 t -60.11 135.23 57.65 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.005 1.722 . . . . 0.0 110.326 174.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -81.92 -41.99 20.11 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 119.157 -0.449 . . . . 0.0 110.326 171.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.2 m -92.04 -26.82 18.16 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 115.654 1.724 . . . . 0.0 115.654 -168.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -129.89 -107.84 0.28 Allowed 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 120.359 1.436 . . . . 0.0 109.933 -169.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -149.7 0.44 0.48 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.748 1.619 . . . . 0.0 112.931 -169.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 68.3 mtm -67.03 145.78 55.03 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.36 0.6 . . . . 0.0 109.54 -172.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -123.11 138.28 54.7 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 177.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.1 mt -136.31 152.59 50.85 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.729 0.776 . . . . 0.0 112.221 -169.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 31.6 mm -137.32 140.82 41.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 129.248 3.019 . . . . 0.0 102.97 169.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 8.2 mt -148.82 100.59 3.1 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 126.495 1.918 . . . . 0.0 106.575 -169.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -84.55 92.8 8.21 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 169.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.1 m -143.53 167.64 12.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 124.016 0.926 . . . . 0.0 111.995 -169.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -55.58 138.47 46.8 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.289 1.436 . . . . 0.0 110.889 170.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 pp -120.77 1.39 7.06 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 C-N-CA 124.8 1.24 . . . . 0.0 113.374 178.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -67.69 -9.52 44.25 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 121.209 1.822 . . . . 0.0 112.543 -175.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 28.8 mt -61.41 -24.02 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 C-N-CA 125.507 1.523 . . . . 0.0 108.315 169.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -127.22 169.32 12.47 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 127.785 2.434 . . . . 0.0 109.501 -169.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -53.17 156.3 10.47 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.422 2.081 . . . . 0.0 111.982 169.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.4 p -56.49 -21.74 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 125.543 1.537 . . . . 0.0 114.53 -169.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -133.29 29.49 3.98 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.535 1.134 . . . . 0.0 110.594 -173.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 21.6 tp -144.42 168.3 20.43 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.154 0.982 . . . . 0.0 110.18 -173.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -150.57 164.2 29.78 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 107.122 -2.391 . . . . 0.0 107.122 169.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -141.81 166.45 24.7 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.928 0.891 . . . . 0.0 109.66 -172.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -57.73 140.66 50.91 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.223 1.009 . . . . 0.0 110.615 -173.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -148.49 -179.68 7.14 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.595 1.558 . . . . 0.0 108.466 -178.158 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -129.34 150.26 50.78 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 121.38 -0.825 . . . . 0.0 109.142 173.174 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 61.4 tp -110.55 141.29 43.92 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.925 1.69 . . . . 0.0 107.026 174.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 55.6 t -141.91 157.76 20.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 128.248 2.619 . . . . 0.0 105.534 -177.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.2 pt -133.14 30.51 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 123.899 0.88 . . . . 0.0 110.772 -175.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.552 0 C-N-CA 124.899 1.279 . . . . 0.0 113.599 -169.958 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 7.8 p90 . . . . . 0 CA--C 1.537 0.465 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -124.66 -37.8 2.45 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.303 0.641 . . . . 0.0 110.619 172.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -152.2 158.53 43.0 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.386 0.994 . . . . 0.0 110.746 174.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.4 m -145.26 146.93 19.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 126.367 1.867 . . . . 0.0 107.877 174.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.31 175.63 10.69 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.835 0.826 . . . . 0.0 112.684 173.335 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -133.55 154.31 50.95 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 128.092 2.557 . . . . 0.0 106.883 172.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.88 -152.35 6.87 Favored Glycine 0 C--N 1.337 0.6 0 CA-C-N 119.602 1.092 . . . . 0.0 113.342 -171.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 43.9 tttp -141.46 139.03 33.27 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.215 1.406 . . . . 0.0 108.397 173.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 38.9 t -83.54 149.87 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.868 1.267 . . . . 0.0 108.932 169.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -133.31 48.3 2.4 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.196 1.798 . . . . 0.0 109.354 -177.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.5 mmt180 -149.45 163.18 38.5 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.595 1.158 . . . . 0.0 110.044 -177.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 25.5 pt -72.12 171.43 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 124.698 1.199 . . . . 0.0 111.207 174.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -74.42 4.77 5.42 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 127.114 2.166 . . . . 0.0 114.471 -177.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.674 0 C-N-CA 124.458 1.028 . . . . 0.0 113.769 -176.889 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 37.1 p . . . . . 0 C--O 1.236 0.362 0 CA-C-O 121.845 0.831 . . . . 0.0 111.718 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -62.62 138.13 58.42 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 168.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.4 125.32 26.68 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 103.162 -2.903 . . . . 0.0 103.162 167.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 13.6 m -105.1 144.05 32.43 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 173.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -135.49 85.33 2.16 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 125.592 1.557 . . . . 0.0 107.367 -169.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 5.9 m-30 -85.28 126.35 33.64 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 103.03 -2.952 . . . . 0.0 103.03 169.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.1 t -141.23 143.59 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 119.971 1.26 . . . . 0.0 108.306 -171.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.0 t -130.38 139.4 50.64 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 171.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -149.65 106.44 3.55 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.339 1.455 . . . . 0.0 108.525 -169.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 58.45 24.34 55.95 Favored Glycine 0 CA--C 1.535 1.313 0 CA-C-O 119.362 -0.688 . . . . 0.0 114.248 175.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.04 -8.95 65.41 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-N 118.295 1.048 . . . . 0.0 113.47 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 11.2 mp -95.21 158.08 15.62 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 106.924 -1.509 . . . . 0.0 106.924 169.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.3 tt -144.1 154.14 42.89 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.915 -0.491 . . . . 0.0 110.109 -170.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 23.3 ptt? -142.11 161.24 38.5 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 169.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 25.6 ttm180 -138.27 115.27 10.86 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 104.464 -2.421 . . . . 0.0 104.464 171.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 11.2 tp -126.15 149.15 49.18 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 126.389 1.876 . . . . 0.0 107.086 -169.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -140.95 150.97 43.8 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 168.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -173.58 177.03 46.1 Favored Glycine 0 C--N 1.331 0.279 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 169.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -57.04 139.53 51.98 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 118.51 1.155 . . . . 0.0 109.183 172.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -50.86 -55.16 18.34 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -176.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.69 -11.4 60.61 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 121.467 -0.771 . . . . 0.0 112.507 -177.046 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -81.4 -29.12 34.05 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.603 1.161 . . . . 0.0 110.366 172.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.9 mp -80.36 -29.52 37.9 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 169.093 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 2.1 t60 59.92 25.35 14.49 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.278 1.831 . . . . 0.0 114.44 171.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -168.84 95.06 0.11 Allowed Glycine 0 C--N 1.335 0.49 0 N-CA-C 107.142 -2.383 . . . . 0.0 107.142 177.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -96.0 9.94 39.08 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.388 1.075 . . . . 0.0 113.544 -175.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -74.75 146.56 42.07 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.593 0.711 . . . . 0.0 109.142 173.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.6 m -64.53 -5.19 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.273 168.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -122.09 17.34 10.81 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 127.368 2.267 . . . . 0.0 111.787 176.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 57.5 m -88.2 -57.16 3.03 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 121.272 -0.892 . . . . 0.0 109.096 167.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 4.9 mmm180 -74.58 -5.24 41.75 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -169.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 30.2 m -62.09 -40.9 89.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.408 177.136 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -74.68 117.4 16.47 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.2 tt -132.56 135.72 46.12 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 -174.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 10.2 tt -143.19 142.03 31.31 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 173.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 80.5 mtp -135.82 152.24 50.88 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 174.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 51.7 mttt -144.09 176.43 9.31 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.108 0.963 . . . . 0.0 109.315 177.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -57.3 165.98 1.3 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.212 0.605 . . . . 0.0 109.47 168.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.57 166.58 0.88 Allowed 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.662 -0.649 . . . . 0.0 111.831 169.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.8 77.72 4.81 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.672 0.789 . . . . 0.0 109.084 176.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 15.5 t80 . . . . . 0 C--O 1.25 1.123 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 175.527 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.53 0.211 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -151.98 140.81 20.98 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.293 0.637 . . . . 0.0 110.909 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -158.11 138.27 12.47 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.84 2.456 . . . . 0.0 106.756 171.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -159.55 157.47 29.95 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.955 0.798 . . . . 0.0 110.265 168.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.35 153.41 4.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 105.588 -2.004 . . . . 0.0 105.588 169.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -134.21 151.12 51.16 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.569 1.547 . . . . 0.0 107.857 175.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -120.07 122.43 41.07 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 126.598 1.959 . . . . 0.0 107.786 -176.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.8 t -71.63 116.43 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -90.88 -32.7 15.93 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 124.878 1.271 . . . . 0.0 110.245 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -157.02 167.37 30.68 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 119.308 0.958 . . . . 0.0 111.181 176.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.4 mp -141.54 146.53 23.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 127.212 2.205 . . . . 0.0 107.358 -175.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -136.31 109.31 9.62 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 125.819 1.648 . . . . 0.0 108.294 170.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -118.13 26.77 0.02 OUTLIER 'Trans proline' 0 CA--C 1.548 1.181 1 C-N-CA 125.744 4.296 . . . . 0.0 110.203 169.675 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -61.53 -19.75 62.47 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 116.161 1.912 . . . . 0.0 116.161 -167.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -178.63 35.15 0.08 OUTLIER Glycine 0 C--N 1.336 0.554 0 N-CA-C 107.827 -2.109 . . . . 0.0 107.827 177.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.47 117.99 9.47 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 -177.048 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -41.85 -38.17 1.45 Allowed 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.498 1.919 . . . . 0.0 112.98 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -117.79 104.1 10.63 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 104.386 -2.45 . . . . 0.0 104.386 170.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -63.5 -25.22 68.16 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -169.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -66.18 -16.89 64.36 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.611 171.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 20.6 t -98.1 137.3 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 173.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 40.5 m -138.28 149.91 46.14 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 21.8 ttp180 -79.18 143.67 35.18 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 104.797 -2.298 . . . . 0.0 104.797 168.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.0 mt -135.28 158.7 43.7 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -130.85 130.78 44.05 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 104.222 -2.51 . . . . 0.0 104.222 169.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 58.3 m -138.46 168.68 19.26 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.577 1.151 . . . . 0.0 109.866 -175.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -136.19 135.89 39.5 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 174.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.1 p -66.52 149.52 50.33 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 174.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -67.08 -34.46 77.7 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.893 -0.504 . . . . 0.0 111.008 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.3 m -136.7 -32.74 0.81 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -173.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -83.12 17.44 2.0 Allowed 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -171.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 31.6 pttt 43.75 26.55 0.13 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.554 1.942 . . . . 0.0 114.98 175.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 64.3 mtt -80.13 115.79 19.89 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 124.927 1.291 . . . . 0.0 108.208 176.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -78.99 127.51 32.07 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 104.02 -2.585 . . . . 0.0 104.02 168.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.5 tp -133.11 144.06 49.71 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 119.949 1.249 . . . . 0.0 110.745 -169.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 34.1 mm -130.13 146.51 33.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 128.209 2.604 . . . . 0.0 104.216 169.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 mp -143.09 162.54 35.25 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 126.398 1.879 . . . . 0.0 108.7 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -137.03 95.41 3.1 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 101.163 -3.643 . . . . 0.0 101.163 168.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.1 p -142.6 158.87 19.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 123.357 0.663 . . . . 0.0 111.297 -167.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 36.8 t30 -60.69 140.16 57.6 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.378 1.071 . . . . 0.0 109.969 171.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.6 pp -117.47 -2.7 10.06 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 C-N-CA 125.299 1.44 . . . . 0.0 112.698 176.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -67.67 -11.71 58.87 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 120.19 1.359 . . . . 0.0 111.177 171.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.5 mt -60.11 -39.48 80.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 C-N-CA 124.633 1.173 . . . . 0.0 107.867 168.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -76.38 130.24 77.77 Favored Pre-proline 0 CA--C 1.538 0.503 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.05 -25.13 12.08 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.488 2.125 . . . . 0.0 112.746 -175.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.8 m -143.59 162.22 16.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 C-N-CA 125.681 1.593 . . . . 0.0 108.277 -178.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.3 t70 50.24 -148.97 0.29 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.062 1.345 . . . . 0.0 110.597 -174.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 87.0 mt -123.44 -8.58 8.05 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.427 1.491 . . . . 0.0 110.983 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 179.45 164.05 31.3 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 174.201 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -156.01 -89.69 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 173.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 35.7 mtmt -140.64 151.75 44.85 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.589 1.156 . . . . 0.0 108.241 170.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -151.04 170.65 18.86 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.517 1.127 . . . . 0.0 110.477 -179.143 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 65.5 ttp85 -115.64 119.51 36.34 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.52 1.528 . . . . 0.0 107.131 -177.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -106.72 139.12 41.66 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 177.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.0 p -158.25 149.79 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-O 121.389 0.614 . . . . 0.0 110.458 -169.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.7 pt -129.77 -19.38 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.491 1.117 . . . . 0.0 109.609 169.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.345 0.389 0 C-N-CA 125.767 1.627 . . . . 0.0 113.583 179.366 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.305 0 CA-C-O 121.842 0.829 . . . . 0.0 111.854 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.8 pm0 -56.98 125.14 21.28 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 114.561 -1.2 . . . . 0.0 112.052 -176.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -68.32 160.21 29.88 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 169.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.6 p -132.06 144.63 36.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 124.254 1.021 . . . . 0.0 109.542 -169.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 34.1 tpp -145.07 168.09 21.14 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 125.608 1.563 . . . . 0.0 107.935 171.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -130.65 147.02 52.27 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.404 1.482 . . . . 0.0 107.027 -173.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -156.62 -162.7 11.67 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 118.729 0.695 . . . . 0.0 113.638 -171.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -133.32 123.35 25.29 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.578 1.551 . . . . 0.0 106.828 174.16 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.4 t -84.14 147.28 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 173.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -139.66 129.74 25.06 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 173.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.88 157.54 43.28 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 120.706 1.594 . . . . 0.0 111.369 -178.433 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.411 HG13 ' H ' ' A' ' 101' ' ' GLY . 17.2 pt -77.24 179.02 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 O-C-N 124.126 0.891 . . . . 0.0 110.42 -177.116 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -74.33 -3.52 30.76 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.918 1.287 . . . . 0.0 113.537 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.411 ' H ' HG13 ' A' ' 99' ' ' ILE . . . . . . . . 0 C--N 1.339 0.731 0 CA-C-O 119.251 -0.749 . . . . 0.0 113.045 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 23.1 p . . . . . 0 N--CA 1.468 0.448 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -136.45 141.16 43.53 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.374 1.069 . . . . 0.0 108.97 178.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 55.6 tp -83.28 155.61 23.53 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 167.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.1 m -130.8 135.61 47.91 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 177.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -143.26 160.75 39.91 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.393 1.077 . . . . 0.0 110.79 -169.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -136.56 156.56 48.41 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.473 1.909 . . . . 0.0 107.485 176.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.0 p -150.69 139.94 15.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 169.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.5 m -121.07 123.41 42.28 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 -178.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 26.7 p90 -140.96 119.32 12.18 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 124.532 1.133 . . . . 0.0 109.437 -169.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 53.59 28.12 36.52 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 123.677 0.656 . . . . 0.0 114.464 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 84.55 -3.43 86.58 Favored Glycine 0 CA--C 1.535 1.342 0 CA-C-N 118.479 1.139 . . . . 0.0 113.782 -177.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 84.7 mt -95.5 166.24 11.95 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 125.282 1.433 . . . . 0.0 107.352 169.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 7.4 tt -148.63 155.66 41.37 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 121.306 -0.871 . . . . 0.0 110.99 -169.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 14.2 ptt? -153.29 157.92 40.84 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.944 0.898 . . . . 0.0 109.087 169.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -140.63 139.41 34.86 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 126.006 1.722 . . . . 0.0 106.829 -175.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -153.6 160.12 42.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 118.584 0.629 . . . . 0.0 112.221 -170.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -133.46 157.48 45.5 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.799 0.84 . . . . 0.0 109.029 169.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 178.42 173.77 44.09 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 171.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -52.52 134.38 35.12 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.651 1.225 . . . . 0.0 109.157 174.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -43.86 -66.09 0.43 Allowed 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 -169.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -57.88 -43.82 86.28 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 122.36 1.076 . . . . 0.0 111.665 -177.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -60.89 -26.38 67.4 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 126.797 2.039 . . . . 0.0 111.656 179.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 16.4 tp -73.45 -18.73 61.1 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 119.153 0.888 . . . . 0.0 110.186 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 41.89 44.65 2.98 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.689 1.596 . . . . 0.0 112.038 -178.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -142.78 2.66 1.7 Allowed Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.042 0.829 . . . . 0.0 113.557 -172.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -62.76 -27.0 68.98 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.507 1.154 . . . . 0.0 111.043 169.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -70.35 91.6 0.75 Allowed 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 129.083 2.953 . . . . 0.0 108.735 169.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 63.0 t -48.59 -21.39 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 126.996 2.119 . . . . 0.0 112.021 172.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -133.35 21.91 4.03 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -172.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 14.3 m -94.87 -64.02 1.11 Allowed 'General case' 0 C--O 1.232 0.179 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 167.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.329 9.3 ptm85 -77.89 12.95 1.52 Allowed 'General case' 0 C--N 1.344 0.356 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -172.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 15.7 m -61.44 -39.63 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 167.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -76.6 124.28 27.38 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 104.759 -2.311 . . . . 0.0 104.759 169.247 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 10.0 tt -137.96 128.15 25.99 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 -174.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 mp -134.66 151.01 50.71 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -175.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -156.13 153.34 29.16 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 174.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -144.53 164.44 30.89 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 169.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -56.07 164.04 1.37 Allowed 'General case' 0 CA--C 1.538 0.505 0 O-C-N 120.644 -1.285 . . . . 0.0 109.521 168.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.17 163.1 21.01 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.634 -0.666 . . . . 0.0 110.873 172.394 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -141.11 39.07 1.77 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.611 1.165 . . . . 0.0 110.065 -178.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 . . . . . 0 C--O 1.248 0.98 0 C-N-CA 125.578 1.551 . . . . 0.0 108.012 -174.884 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 61.6 tp . . . . . 0 C--O 1.233 0.234 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -151.93 137.6 17.87 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 178.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -157.0 130.6 8.1 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 169.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -158.46 152.52 23.89 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 118.474 0.579 . . . . 0.0 110.539 169.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 mp -86.54 142.87 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 172.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -126.04 148.87 49.21 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 125.576 1.55 . . . . 0.0 107.866 178.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -126.42 123.24 37.45 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 126.251 1.82 . . . . 0.0 107.615 -169.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 66.1 t -68.93 127.89 31.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 -173.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.9 mmpt? -89.97 -39.42 12.99 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.768 1.227 . . . . 0.0 109.338 169.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -159.62 166.99 29.52 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.083 0.856 . . . . 0.0 111.793 -177.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.4 mp -137.11 139.47 44.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 127.426 2.29 . . . . 0.0 106.124 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -147.41 95.18 4.36 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 124.902 1.281 . . . . 0.0 109.282 -171.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -63.51 9.72 0.12 Allowed 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 123.778 2.985 . . . . 0.0 116.921 -177.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -78.26 58.18 2.02 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.151 1.38 . . . . 0.0 109.631 175.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -166.94 35.59 0.23 Allowed Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.901 1.239 . . . . 0.0 111.277 -173.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.0 mmpt? -68.13 66.16 0.1 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.779 1.232 . . . . 0.0 113.295 -177.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -59.9 -38.0 81.03 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 168.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -143.66 167.69 21.66 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 130.002 3.321 . . . . 0.0 104.25 169.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -56.66 -41.17 76.78 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.415 -0.803 . . . . 0.0 110.644 171.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -71.73 7.41 1.52 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.201 1.4 . . . . 0.0 114.594 178.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 74.8 t -122.33 137.33 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 122.057 2.208 . . . . 0.0 107.783 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 67.4 m -147.25 161.7 40.41 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.329 1.052 . . . . 0.0 109.799 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 -83.42 149.81 26.45 Favored 'General case' 0 C--N 1.342 0.246 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 170.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.6 mp -145.08 164.82 30.05 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.83 2.052 . . . . 0.0 107.495 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -134.89 133.15 39.35 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 172.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 43.8 m -140.0 171.79 13.68 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.144 1.378 . . . . 0.0 110.081 -176.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -142.47 145.26 33.55 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.163 1.785 . . . . 0.0 107.152 -176.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.8 p -64.52 134.28 54.11 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 118.792 0.723 . . . . 0.0 109.946 174.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.4 tp10 -71.64 -30.18 65.46 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 119.177 -0.44 . . . . 0.0 110.609 172.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.1 m -100.32 -17.46 17.26 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 -169.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -129.71 -105.31 0.29 Allowed 'General case' 0 C--N 1.344 0.336 0 CA-C-N 120.594 1.543 . . . . 0.0 110.754 -169.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -168.64 5.67 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.271 1.428 . . . . 0.0 113.713 -169.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 7.7 ptt? -82.85 152.52 25.58 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.686 0.755 . . . . 0.0 110.009 -173.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -121.56 128.14 51.68 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.401 1.881 . . . . 0.0 107.497 -169.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.86 136.36 52.99 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.444 1.097 . . . . 0.0 108.401 -169.683 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.1 mm -127.02 137.77 56.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 102.634 -3.098 . . . . 0.0 102.634 169.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 123' ' ' MET . 2.2 pt? -154.2 159.46 41.38 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.111 0.964 . . . . 0.0 111.302 -177.465 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -126.8 112.32 15.24 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 102.967 -2.975 . . . . 0.0 102.967 172.2 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.2 p -146.22 160.38 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 121.411 0.624 . . . . 0.0 111.339 -168.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -64.61 125.43 24.7 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.866 1.266 . . . . 0.0 109.226 170.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.3 pp -95.21 -4.07 10.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 123.962 0.905 . . . . 0.0 113.178 -177.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -68.72 -15.15 63.43 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 120.684 1.584 . . . . 0.0 111.299 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 26.1 mt -64.66 -35.79 75.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 124.876 1.27 . . . . 0.0 108.533 171.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -78.97 150.86 75.6 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 123.253 0.621 . . . . 0.0 109.412 -175.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.73 -22.87 23.34 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.501 2.134 . . . . 0.0 112.925 -177.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.4 p -156.07 154.27 6.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -177.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -60.55 -27.59 67.78 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.315 1.046 . . . . 0.0 112.528 178.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 38.1 tp -63.31 -14.64 51.92 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.718 1.207 . . . . 0.0 112.269 174.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.0 170.38 46.55 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.467 1.032 . . . . 0.0 111.812 178.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -162.76 170.65 18.0 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.221 2.208 . . . . 0.0 106.472 177.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 11.9 mttp -60.5 151.73 27.7 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 118.896 0.771 . . . . 0.0 109.708 171.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -146.07 177.27 9.09 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.174 0.989 . . . . 0.0 108.402 172.125 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -132.73 138.41 47.21 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -172.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.2 mp -108.13 144.69 35.18 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 169.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.4 p -150.01 150.31 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 123.941 0.897 . . . . 0.0 108.662 -178.249 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.2 mt -142.74 127.28 15.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 174.168 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.239 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 172.135 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 19.3 p90 . . . . . 0 N--CA 1.455 -0.182 0 CA-C-O 121.666 0.746 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -59.45 88.59 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.966 2.506 . . . . 0.0 112.468 -175.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -68.94 152.15 45.63 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 168.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.8 p -115.77 152.37 17.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 118.995 0.816 . . . . 0.0 111.327 -169.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 45.9 tpp -149.89 155.3 39.78 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 126.552 1.941 . . . . 0.0 108.369 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -136.35 142.96 43.84 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 126.185 1.794 . . . . 0.0 106.811 -172.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -156.52 -159.48 9.46 Favored Glycine 0 C--N 1.339 0.708 0 CA-C-N 119.452 1.023 . . . . 0.0 114.789 -170.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 3.8 tmtp? -142.86 116.67 9.3 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 172.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 62.1 t -84.54 148.59 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 176.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -136.47 151.44 49.47 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 128.556 2.742 . . . . 0.0 105.276 176.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.69 167.71 29.64 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 120.241 -1.537 . . . . 0.0 112.085 -175.432 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.5 pt -120.65 177.47 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 124.222 1.009 . . . . 0.0 108.579 169.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -67.61 -5.08 13.89 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.316 1.446 . . . . 0.0 114.139 -175.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.624 0 N-CA-C 107.446 -2.262 . . . . 0.0 107.446 -173.952 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.6 p . . . . . 0 C--O 1.234 0.271 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -87.2 152.95 21.88 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 169.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 54.6 tp -100.22 141.73 32.66 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 103.638 -2.726 . . . . 0.0 103.638 167.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 17.9 m -131.7 139.34 49.0 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -176.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -136.4 149.28 48.22 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 124.415 1.086 . . . . 0.0 108.646 -178.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -111.14 142.94 42.65 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 103.868 -2.642 . . . . 0.0 103.868 169.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.1 p -144.78 126.66 9.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 38.1 m -100.37 139.76 35.58 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -135.49 78.88 1.75 Allowed 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.629 1.172 . . . . 0.0 109.114 -169.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 61.16 21.33 59.3 Favored Glycine 0 CA--C 1.537 1.435 0 CA-C-O 119.269 -0.74 . . . . 0.0 114.244 171.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 119.41 -24.29 8.17 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 125.268 1.413 . . . . 0.0 112.111 -176.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -82.84 167.9 17.63 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 169.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 31.7 tp -148.45 155.23 40.93 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.398 -0.814 . . . . 0.0 110.167 -174.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.419 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 34.6 mtt -147.38 161.11 41.68 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.888 1.275 . . . . 0.0 108.561 169.246 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -137.17 123.04 20.08 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 103.721 -2.696 . . . . 0.0 103.721 169.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -132.28 131.39 41.98 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 -175.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -125.07 140.26 53.06 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 171.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -164.13 178.24 39.56 Favored Glycine 0 N--CA 1.452 -0.243 0 N-CA-C 108.616 -1.793 . . . . 0.0 108.616 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -55.91 141.47 39.18 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.257 1.028 . . . . 0.0 108.879 170.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -41.82 -62.35 0.92 Allowed 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.39 -11.57 61.0 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.179 -0.95 . . . . 0.0 113.507 -176.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -83.71 -28.45 28.28 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.771 1.228 . . . . 0.0 110.137 173.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.34 -38.2 60.28 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 170.155 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 49.81 11.98 0.07 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 127.33 2.252 . . . . 0.0 116.105 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -73.99 -56.36 5.35 Favored Glycine 0 CA--C 1.522 0.53 0 O-C-N 121.008 -1.058 . . . . 0.0 110.835 -169.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 44.06 24.42 0.08 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 128.58 2.752 . . . . 0.0 115.01 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -162.87 133.15 4.54 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 125.659 1.584 . . . . 0.0 107.813 -169.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.5 m -67.66 -13.34 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.91 169.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -135.39 16.68 3.41 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -169.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 11.6 m -89.28 -66.35 0.93 Allowed 'General case' 0 N--CA 1.462 0.166 0 O-C-N 121.609 -0.682 . . . . 0.0 109.253 168.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.318 13.2 ptm180 -80.23 14.04 2.09 Favored 'General case' 0 C--N 1.344 0.339 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -170.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 19.4 m -60.79 -34.61 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 167.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -79.27 119.83 22.88 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 170.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -140.42 140.23 35.41 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -178.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.0 mp -129.54 156.48 44.1 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 174.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 23.6 ptp -148.44 152.86 37.67 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 121.854 -0.529 . . . . 0.0 111.342 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -158.03 -177.66 6.72 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.355 1.462 . . . . 0.0 110.408 -178.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -53.06 161.41 0.82 Allowed 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.688 1.595 . . . . 0.0 112.591 170.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.53 166.77 0.59 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.022 0.929 . . . . 0.0 111.473 169.496 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -88.82 89.52 8.02 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 173.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 17.1 t80 . . . . . 0 C--O 1.249 1.07 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 171.872 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.0 tm? . . . . . 0 C--O 1.233 0.207 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -147.23 150.97 35.91 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 126.076 1.75 . . . . 0.0 106.641 172.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -152.96 142.4 21.71 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.149 0.98 . . . . 0.0 109.094 178.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -158.58 158.91 34.82 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.53 0.732 . . . . 0.0 110.174 169.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 mp -76.2 150.4 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 168.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -131.85 154.21 49.39 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.885 1.274 . . . . 0.0 107.959 175.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -128.9 122.95 31.4 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -173.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.8 t -75.81 105.77 5.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -72.8 -37.78 67.44 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.192 0.997 . . . . 0.0 109.89 177.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -159.58 167.65 28.01 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.326 0.967 . . . . 0.0 111.486 176.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.5 mp -133.17 140.24 47.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 127.333 2.253 . . . . 0.0 106.211 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -146.17 92.95 5.17 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 124.494 1.118 . . . . 0.0 109.908 -170.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -64.26 13.59 0.09 OUTLIER 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 124.129 3.219 . . . . 0.0 116.696 -178.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -79.07 53.13 1.38 Allowed 'General case' 0 CA--C 1.544 0.712 0 O-C-N 120.648 -1.283 . . . . 0.0 109.338 172.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -174.89 41.44 0.12 Allowed Glycine 0 CA--C 1.525 0.682 0 C-N-CA 124.677 1.132 . . . . 0.0 111.052 -170.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -74.71 69.37 1.78 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.123 0.961 . . . . 0.0 110.496 -177.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -55.16 -38.65 68.55 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 169.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -146.73 169.48 18.97 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 129.256 3.022 . . . . 0.0 104.677 169.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -62.07 -33.23 74.02 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 120.985 -1.072 . . . . 0.0 111.744 178.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -83.82 9.45 11.96 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-O 116.919 -1.515 . . . . 0.0 113.105 175.024 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.0 t -119.32 142.74 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 121.84 2.109 . . . . 0.0 107.809 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 57.3 m -148.59 174.41 12.15 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.018 0.927 . . . . 0.0 108.913 175.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.429 ' C ' HD22 ' A' ' 28' ' ' LEU . 45.5 ttp180 -84.5 149.33 26.01 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 106.754 -1.572 . . . . 0.0 106.754 168.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.464 HD23 HG12 ' A' ' 43' ' ' VAL . 4.2 mm? -139.44 153.57 47.6 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 126.806 2.042 . . . . 0.0 106.634 -172.355 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -130.93 126.66 36.68 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 173.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 85.0 m -142.96 166.77 23.71 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.202 1.401 . . . . 0.0 110.161 -170.276 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 55.8 tt0 -144.78 139.8 28.06 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.339 1.056 . . . . 0.0 108.636 177.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.21 137.31 46.77 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 174.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -68.13 -32.52 72.87 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.869 0.868 . . . . 0.0 111.424 -176.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 m -117.15 -30.6 5.59 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.108 0.963 . . . . 0.0 111.887 -171.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -113.22 13.33 19.18 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -171.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt 45.71 20.87 0.07 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 118.224 2.676 . . . . 0.0 118.224 169.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 52.3 mtm -64.74 125.85 26.07 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 120.858 1.663 . . . . 0.0 107.806 176.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -77.65 118.62 20.22 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 104.921 -2.252 . . . . 0.0 104.921 169.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 49.8 tp -129.05 130.32 46.41 Favored 'General case' 0 N--CA 1.457 -0.081 0 C-N-CA 123.183 0.593 . . . . 0.0 110.303 -169.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 49.6 mm -118.04 142.41 32.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 103.272 -2.862 . . . . 0.0 103.272 168.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 123' ' ' MET . 2.5 pt? -155.67 163.0 40.48 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.21 1.004 . . . . 0.0 110.761 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -124.96 105.73 9.44 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 102.642 -3.095 . . . . 0.0 102.642 178.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.464 HG12 HD23 ' A' ' 28' ' ' LEU . 7.3 p -150.5 166.11 2.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 O-C-N 124.267 0.979 . . . . 0.0 111.366 -168.459 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -55.82 133.22 51.01 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.731 1.612 . . . . 0.0 110.504 170.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.42 ' CG2' HD21 ' A' ' 28' ' ' LEU . 1.5 pp -108.28 0.03 9.78 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 C-N-CA 125.045 1.338 . . . . 0.0 114.183 -177.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -67.29 -14.24 62.73 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 120.913 1.688 . . . . 0.0 111.623 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.1 mt -62.66 -27.35 42.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 125.505 1.522 . . . . 0.0 109.643 169.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -116.57 158.48 43.27 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 124.681 1.192 . . . . 0.0 112.182 -168.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -78.49 -15.72 13.79 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.251 2.634 . . . . 0.0 112.766 174.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . 0.283 17.7 m 53.96 -19.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 130.694 3.597 . . . . 0.0 117.243 -175.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -66.7 -23.72 66.16 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.668 1.122 . . . . 0.0 111.872 173.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.0 tp -151.76 163.41 39.22 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.449 1.9 . . . . 0.0 107.513 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.19 163.62 20.87 Favored Glycine 0 CA--C 1.534 1.263 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 169.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -156.02 176.21 12.95 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.22 1.408 . . . . 0.0 108.417 -173.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -126.92 150.64 49.22 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.4 1.08 . . . . 0.0 109.618 -175.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -152.58 178.31 9.72 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 125.411 1.484 . . . . 0.0 108.17 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 -129.11 144.7 51.29 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.5 tt -134.24 139.42 45.76 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 -170.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.3 t -140.78 139.57 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 125.247 1.419 . . . . 0.0 107.6 -169.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 38.3 mm -88.12 66.87 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 170.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.625 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -169.673 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 31.2 p90 . . . . . 0 CA--C 1.538 0.483 0 CA-C-O 121.34 0.59 . . . . 0.0 111.872 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -125.24 -9.68 7.01 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.12 1.368 . . . . 0.0 110.816 169.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 36.9 t80 62.24 -149.55 0.37 Allowed 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 116.993 -1.48 . . . . 0.0 108.604 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . 0.456 20.7 t 154.92 -90.1 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 130.308 3.443 . . . . 0.0 110.405 169.186 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.45 -173.09 2.12 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 122.183 2.265 . . . . 0.0 115.83 -167.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -125.77 154.93 41.82 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 129.562 3.145 . . . . 0.0 105.692 169.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -157.46 -151.42 6.02 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-N 119.835 1.198 . . . . 0.0 113.147 -174.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -140.73 147.76 39.68 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.972 1.709 . . . . 0.0 107.007 169.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.9 p -125.42 135.12 64.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 124.392 1.077 . . . . 0.0 108.33 177.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -146.3 106.75 4.06 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.09 0.956 . . . . 0.0 111.235 -170.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -156.71 167.58 30.01 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.089 1.356 . . . . 0.0 109.821 169.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -62.67 168.95 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 125.466 1.506 . . . . 0.0 112.028 174.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -61.45 3.83 0.11 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 129.171 2.988 . . . . 0.0 116.026 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.937 0 CA-C-N 119.405 1.002 . . . . 0.0 111.988 -175.712 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 81.2 p . . . . . 0 N--CA 1.47 0.54 0 CA-C-O 122.069 0.938 . . . . 0.0 113.31 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -129.79 138.88 51.29 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 174.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.1 tp -84.87 152.45 23.57 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 169.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 11.8 m -122.55 150.79 42.11 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -176.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -148.14 140.43 24.27 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.685 0.794 . . . . 0.0 108.981 178.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 -120.76 134.27 55.29 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 103.11 -2.922 . . . . 0.0 103.11 169.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.3 t -125.11 142.6 41.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 -175.162 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 45.6 m -133.35 122.83 24.38 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 -178.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -147.79 105.21 3.66 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 122.809 0.444 . . . . 0.0 110.173 -169.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 58.48 27.85 61.47 Favored Glycine 0 CA--C 1.536 1.361 0 O-C-N 121.53 -0.731 . . . . 0.0 113.878 174.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 90.92 -2.87 80.38 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 118.312 1.056 . . . . 0.0 113.528 -178.212 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 88.0 mt -95.39 164.22 12.91 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 125.439 1.496 . . . . 0.0 107.878 171.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 7.9 tp -142.96 161.91 36.88 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -168.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.474 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 27.6 mtt -147.04 155.38 42.17 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 126.391 1.877 . . . . 0.0 108.671 169.231 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 36.9 mtp-105 -142.4 126.07 16.94 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 104.849 -2.278 . . . . 0.0 104.849 169.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -152.28 163.6 39.11 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 119.179 0.899 . . . . 0.0 112.339 -172.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -138.78 155.91 47.78 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.856 1.263 . . . . 0.0 108.78 169.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -169.63 175.8 43.71 Favored Glycine 0 CA--C 1.52 0.381 0 N-CA-C 108.52 -1.832 . . . . 0.0 108.52 169.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -56.77 142.16 41.58 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 118.467 1.134 . . . . 0.0 108.493 170.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -47.09 -48.73 22.62 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.131 0.878 . . . . 0.0 112.035 177.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -56.34 -36.63 68.98 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 122.214 1.007 . . . . 0.0 112.174 178.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -79.0 -19.32 51.89 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 113.58 -1.646 . . . . 0.0 111.004 -174.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 14.7 tp -70.39 -28.15 64.85 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 119.826 1.194 . . . . 0.0 109.309 169.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 1.9 t60 44.44 34.36 1.06 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.504 2.322 . . . . 0.0 114.623 171.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 167.38 73.37 0.03 OUTLIER Glycine 0 C--N 1.334 0.446 0 N-CA-C 108.482 -1.847 . . . . 0.0 108.482 -169.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -101.98 3.84 39.35 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -169.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.405 ' C ' ' H ' ' A' ' 138' ' ' ASP . 9.7 mm-40 -71.85 149.68 44.99 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 169.483 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 16.5 m -57.79 -7.43 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 124.713 1.205 . . . . 0.0 110.941 168.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 136' ' ' GLU . 34.1 t70 -135.85 15.6 3.33 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 126.825 2.05 . . . . 0.0 112.692 -178.174 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 58.6 m -80.77 -76.25 0.24 Allowed 'General case' 0 C--N 1.338 0.079 0 O-C-N 121.412 -0.805 . . . . 0.0 109.06 168.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 11.5 ptm85 -81.23 16.61 1.52 Allowed 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -169.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 30.2 m -68.19 -30.37 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 CA-C-O 118.732 -0.652 . . . . 0.0 109.348 168.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -72.36 124.13 24.49 Favored 'General case' 0 C--N 1.341 0.212 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 175.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 60.0 tp -138.17 103.44 4.94 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.511 0.725 . . . . 0.0 109.231 -173.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 15.9 tp -114.83 135.0 54.67 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 174.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 61.5 mtt -118.96 155.41 31.4 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.961 1.304 . . . . 0.0 107.51 171.037 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -146.85 161.84 39.86 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 126.36 1.864 . . . . 0.0 107.684 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -67.4 -176.07 0.55 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.351 0.596 . . . . 0.0 110.161 169.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 66.6 mt -57.19 119.8 7.01 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 121.773 0.797 . . . . 0.0 110.273 169.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -142.34 144.85 33.39 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 102.171 -3.27 . . . . 0.0 102.171 169.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 . . . . . 0 C--O 1.249 1.077 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -174.313 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 66.5 tp . . . . . 0 N--CA 1.468 0.438 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.406 ' CZ ' ' HA ' ' A' ' 131' ' ' ASN . 83.7 t80 -145.2 143.53 30.35 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 169.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -151.83 139.59 19.85 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.429 1.491 . . . . 0.0 107.871 -177.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -154.26 115.71 4.13 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.408 0.683 . . . . 0.0 109.897 -171.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 mp -71.32 143.89 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -143.61 158.94 43.29 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 123.503 0.721 . . . . 0.0 111.431 175.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -135.35 129.27 33.17 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 126.385 1.874 . . . . 0.0 108.286 -174.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.7 t -66.13 126.86 26.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 175.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.1 mmmt -108.01 -25.46 11.15 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 124.312 1.045 . . . . 0.0 110.663 178.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -154.36 166.58 32.76 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.556 1.071 . . . . 0.0 110.672 172.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.4 mp -144.42 141.62 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 126.947 2.099 . . . . 0.0 106.975 -170.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -147.92 100.91 3.67 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 124.213 1.005 . . . . 0.0 109.02 171.131 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -65.07 -2.1 5.21 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 122.578 2.185 . . . . 0.0 115.937 176.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 36.9 45.41 0.43 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 128.756 2.822 . . . . 0.0 113.76 -176.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.19 11.95 37.78 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.094 0.854 . . . . 0.0 113.077 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? 45.82 67.86 0.68 Allowed 'General case' 0 C--N 1.343 0.307 0 C-N-CA 126.736 2.014 . . . . 0.0 109.895 -170.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -48.93 -41.16 32.91 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.451 1.1 . . . . 0.0 111.435 -177.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -140.74 156.56 46.16 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 169.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -62.5 -4.45 1.93 Allowed 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -172.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -147.24 26.75 1.06 Allowed 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 125.132 1.373 . . . . 0.0 112.229 -176.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.5 t -133.21 126.45 52.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.4 m -148.12 155.64 41.67 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.916 0.886 . . . . 0.0 110.271 -171.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 54.5 ttm-85 -83.41 149.72 26.5 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 169.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 85.9 mt -140.33 159.72 41.56 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 125.788 1.635 . . . . 0.0 107.815 -178.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -133.92 136.87 44.54 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 169.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.9 m -140.82 166.17 25.49 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.384 1.073 . . . . 0.0 109.845 -173.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -129.73 149.39 51.5 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 171.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.6 m -117.46 117.6 29.89 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -169.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -65.84 -44.22 86.17 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.241 1.416 . . . . 0.0 111.437 -169.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.2 m -74.94 -41.32 59.87 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 119.229 -0.415 . . . . 0.0 111.733 -169.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -131.66 29.36 4.5 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -172.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.292 0.0 OUTLIER 44.94 35.14 1.41 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 127.138 2.175 . . . . 0.0 114.702 169.814 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 11.8 tmm? -87.34 114.35 23.87 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.365 1.066 . . . . 0.0 109.003 -175.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -71.87 132.08 43.91 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 171.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 45.8 tp -135.81 143.37 45.13 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.474 0.71 . . . . 0.0 110.739 -169.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 41.4 mm -127.58 147.87 32.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 103.187 -2.894 . . . . 0.0 103.187 169.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.2 mt -150.88 146.44 26.32 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 126.577 1.951 . . . . 0.0 107.557 -169.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -135.3 101.74 4.93 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 102.056 -3.313 . . . . 0.0 102.056 169.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.3 p -146.34 163.51 9.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 122.483 1.135 . . . . 0.0 113.202 -167.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -67.01 123.92 21.57 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 126.072 1.749 . . . . 0.0 106.43 168.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 pp -105.44 4.64 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -174.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -69.36 -10.51 58.23 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 120.069 1.304 . . . . 0.0 111.146 176.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.3 mt -59.75 -42.11 87.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 169.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -79.57 155.4 76.15 Favored Pre-proline 0 C--O 1.236 0.39 0 C-N-CA 123.639 0.775 . . . . 0.0 109.467 -175.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -67.14 -21.1 49.18 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.315 2.01 . . . . 0.0 112.357 176.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.9 p -158.15 155.37 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.782 1.633 . . . . 0.0 106.938 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -55.66 -25.84 41.55 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.376 1.471 . . . . 0.0 113.126 178.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 58.5 tp -57.97 -22.46 49.36 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.281 1.432 . . . . 0.0 112.58 173.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.92 178.58 47.6 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 123.741 0.686 . . . . 0.0 112.219 177.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -157.75 168.57 26.83 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.534 1.933 . . . . 0.0 107.625 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -73.73 136.09 43.66 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 174.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 7.3 m-30 -138.59 178.88 6.82 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.977 1.711 . . . . 0.0 107.012 176.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.93 141.15 49.24 Favored 'General case' 0 CA--C 1.515 -0.383 0 O-C-N 121.127 -0.983 . . . . 0.0 109.129 169.323 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 12.9 tp -96.24 152.05 18.93 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 177.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 53.7 t -140.01 142.26 32.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 177.008 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.9 pt -132.64 21.02 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 122.94 0.496 . . . . 0.0 112.104 -178.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.324 0 O-C-N 121.506 -0.746 . . . . 0.0 109.302 172.25 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.1 p90 . . . . . 0 N--CA 1.446 -0.667 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -88.96 -32.82 17.48 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 118.966 -0.54 . . . . 0.0 110.261 175.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -155.67 153.57 30.2 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 118.819 0.736 . . . . 0.0 110.054 177.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.4 m -143.6 145.89 21.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 125.462 1.505 . . . . 0.0 107.464 169.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 5.8 tpt -162.13 174.27 13.17 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.029 0.932 . . . . 0.0 109.452 174.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -137.84 155.8 48.6 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 126.613 1.965 . . . . 0.0 106.212 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -167.08 -157.92 10.98 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 118.689 0.677 . . . . 0.0 113.147 -169.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.4 tttm -141.78 130.18 22.44 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 117.848 0.824 . . . . 0.0 109.152 174.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.3 t -75.11 148.35 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 124.656 1.182 . . . . 0.0 108.779 169.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -144.31 70.67 1.29 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.916 0.887 . . . . 0.0 110.798 175.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -144.01 163.67 32.84 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.376 1.07 . . . . 0.0 110.635 174.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.41 HG13 ' H ' ' A' ' 101' ' ' GLY . 26.3 pt -76.47 -170.08 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 125.124 1.369 . . . . 0.0 110.269 174.047 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -60.64 -0.29 0.26 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.965 2.106 . . . . 0.0 115.186 178.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.41 ' H ' HG13 ' A' ' 99' ' ' ILE . . . . . . . . 0 C--N 1.335 0.48 0 C-N-CA 125.231 1.396 . . . . 0.0 111.511 174.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.8 p . . . . . 0 N--CA 1.466 0.363 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -118.77 151.9 37.17 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 172.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.18 139.98 33.16 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 169.397 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.6 p -101.73 147.26 26.68 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 174.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -146.33 144.0 29.5 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 176.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 15.3 m-30 -122.85 137.27 54.98 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 102.485 -3.154 . . . . 0.0 102.485 169.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.4 p -142.47 144.36 24.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 24.0 p -116.97 130.23 56.55 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 172.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -144.51 116.05 8.12 Favored 'General case' 0 N--CA 1.458 -0.073 0 C-N-CA 123.878 0.871 . . . . 0.0 109.581 -169.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 55.78 21.75 30.83 Favored Glycine 0 CA--C 1.537 1.423 0 CA-C-O 119.234 -0.759 . . . . 0.0 114.534 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 92.19 -5.04 78.15 Favored Glycine 0 CA--C 1.535 1.3 0 CA-C-N 118.648 1.224 . . . . 0.0 113.477 -176.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -95.09 170.92 9.07 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.956 1.302 . . . . 0.0 107.809 170.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.5 tt -149.3 151.45 34.19 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 121.522 -0.736 . . . . 0.0 110.545 -170.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 13.0 ptp -148.37 158.08 43.88 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 169.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 -140.51 138.53 34.65 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 178.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -154.2 162.12 41.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 118.855 0.752 . . . . 0.0 112.937 -169.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -134.44 118.43 17.38 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 104.109 -2.552 . . . . 0.0 104.109 168.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -151.05 175.56 29.94 Favored Glycine 0 N--CA 1.452 -0.256 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 -175.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -58.21 148.45 26.98 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 122.332 -0.511 . . . . 0.0 111.177 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -46.49 -42.15 15.13 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 175.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.77 -12.61 60.44 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.996 1.271 . . . . 0.0 113.191 178.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.406 ' HA ' ' CZ ' ' A' ' 6' ' ' PHE . 5.8 t-20 -66.57 -19.06 65.69 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 168.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -100.0 19.19 16.72 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 117.067 -1.444 . . . . 0.0 110.634 174.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -30.2 108.0 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 120.32 1.418 . . . . 0.0 112.021 169.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 122.84 -13.97 8.55 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 125.077 1.322 . . . . 0.0 112.134 -169.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . 0.26 30.9 m-85 44.11 56.6 4.7 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 129.527 3.131 . . . . 0.0 114.165 177.167 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 70.97 164.53 0.28 Allowed 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 129.499 3.12 . . . . 0.0 113.488 170.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 60.1 t 59.23 -9.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 127.091 2.156 . . . . 0.0 113.686 -172.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -154.02 -11.99 0.14 Allowed 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 119.84 1.2 . . . . 0.0 114.007 -172.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 16.0 m -54.68 -63.47 1.14 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.963 0.887 . . . . 0.0 112.652 169.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 8.6 mmm180 -88.67 11.19 18.18 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.43 -169.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 98.2 t -87.9 -5.73 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 C-N-CA 124.838 1.255 . . . . 0.0 108.861 -177.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -128.2 114.71 17.33 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 103.383 -2.821 . . . . 0.0 103.383 168.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.7 tt -133.69 126.23 30.32 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 -171.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.0 tt -134.68 147.97 50.23 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 106.768 -1.568 . . . . 0.0 106.768 178.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 56.5 ttm -139.56 138.32 36.14 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.221 -1.399 . . . . 0.0 107.221 -178.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -147.01 162.84 37.97 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -57.06 156.36 7.1 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 118.532 0.605 . . . . 0.0 109.7 169.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.0 pp -67.4 160.04 28.19 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 169.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -148.09 125.93 11.94 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 177.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 . . . . . 0 C--O 1.251 1.162 0 C-N-CA 126.289 1.836 . . . . 0.0 107.186 175.753 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.4 tt . . . . . 0 CA--C 1.53 0.193 0 CA-C-O 118.62 -0.705 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -161.48 150.69 16.26 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 119.17 0.895 . . . . 0.0 109.627 174.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -157.87 132.12 8.2 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.053 1.341 . . . . 0.0 108.434 169.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -161.06 155.01 22.5 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.471 0.708 . . . . 0.0 109.879 168.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 mp -74.5 151.33 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 169.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -129.13 150.71 50.41 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 172.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -133.97 129.21 35.88 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.054 1.342 . . . . 0.0 108.004 -169.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.6 p -63.82 147.97 11.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-O 122.078 0.942 . . . . 0.0 110.153 -177.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -125.09 -29.01 3.36 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 126.73 2.012 . . . . 0.0 109.373 178.122 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -160.25 166.6 29.27 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.348 0.977 . . . . 0.0 111.062 170.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.1 mp -133.01 135.06 57.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 127.292 2.237 . . . . 0.0 105.372 178.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -146.45 89.85 5.76 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 124.03 0.932 . . . . 0.0 110.301 -169.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -64.27 16.92 0.07 OUTLIER 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 124.26 3.307 . . . . 0.0 116.594 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -79.98 53.98 1.8 Allowed 'General case' 0 CA--C 1.542 0.66 0 O-C-N 120.256 -1.527 . . . . 0.0 109.778 176.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -172.88 38.67 0.15 Allowed Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.231 0.92 . . . . 0.0 111.577 -171.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.6 mmmt -74.31 66.71 1.34 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 118.152 0.976 . . . . 0.0 111.445 -175.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -57.09 -36.63 70.84 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 169.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -143.85 167.77 21.52 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 128.194 2.598 . . . . 0.0 105.027 169.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -62.13 -31.59 72.09 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.355 -0.84 . . . . 0.0 111.243 177.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -82.68 11.07 6.27 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-O 116.738 -1.601 . . . . 0.0 113.559 175.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 93.5 t -123.05 138.54 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 122.391 2.36 . . . . 0.0 108.302 -179.039 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.7 m -149.66 170.44 18.68 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.876 1.27 . . . . 0.0 109.472 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.443 ' C ' HD22 ' A' ' 28' ' ' LEU . 49.7 ttp180 -91.22 149.7 21.66 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 169.191 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.45 HD23 HG22 ' A' ' 43' ' ' VAL . 3.5 mm? -141.33 158.16 44.24 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 126.83 2.052 . . . . 0.0 106.713 -172.443 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -133.14 134.91 44.81 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 172.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 64.3 m -141.24 175.94 9.24 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.953 1.701 . . . . 0.0 109.68 -177.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -141.85 144.94 34.12 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.798 1.639 . . . . 0.0 107.836 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 64.6 p -67.82 130.29 42.53 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 175.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -69.36 -31.3 69.63 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 122.869 0.468 . . . . 0.0 111.785 -174.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 m -113.48 -5.48 13.48 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 114.587 1.328 . . . . 0.0 114.587 -169.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -123.77 -106.86 0.35 Allowed 'General case' 0 C--N 1.341 0.23 0 CA-C-N 119.892 1.223 . . . . 0.0 108.874 -176.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -169.61 3.74 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -169.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 5.3 mpp? -77.69 137.0 38.26 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 123.6 0.76 . . . . 0.0 110.9 -169.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -81.64 137.59 35.43 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 168.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 38.8 tp -133.16 138.75 46.72 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 174.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 35.9 mm -126.75 145.7 33.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 102.801 -3.037 . . . . 0.0 102.801 169.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 123' ' ' MET . 2.0 pt? -157.51 156.52 32.16 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.499 1.12 . . . . 0.0 109.952 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -126.67 107.12 9.89 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 178.082 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.45 HG22 HD23 ' A' ' 28' ' ' LEU . 27.0 m -148.21 171.44 2.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 O-C-N 124.656 1.222 . . . . 0.0 112.234 -168.402 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -59.79 141.06 56.0 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.612 1.565 . . . . 0.0 110.415 169.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.6 pp -117.08 1.08 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 125.982 1.713 . . . . 0.0 113.045 177.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -62.05 -22.54 65.83 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 120.48 1.491 . . . . 0.0 110.669 169.099 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 12.7 mt -53.62 -38.92 35.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 126.179 1.792 . . . . 0.0 109.857 169.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -68.42 129.02 92.98 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -172.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -72.28 -31.6 11.48 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.473 2.116 . . . . 0.0 111.402 178.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.7 m -145.79 154.96 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 126.124 1.77 . . . . 0.0 107.415 177.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -61.7 -25.09 67.19 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.349 0.66 . . . . 0.0 112.061 177.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.2 tp -57.79 -36.26 71.95 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.496 1.118 . . . . 0.0 112.261 -178.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 164.14 177.24 36.72 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-N 118.91 0.777 . . . . 0.0 112.851 178.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -156.99 169.44 24.82 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.487 1.515 . . . . 0.0 109.002 177.174 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -135.84 158.86 43.36 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.752 1.621 . . . . 0.0 107.974 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -142.47 169.85 16.8 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 123.921 0.888 . . . . 0.0 109.331 -169.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 -133.81 107.2 7.74 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 169.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 68.3 tp -93.98 132.74 38.15 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.0 p -153.6 155.91 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-O 121.943 0.877 . . . . 0.0 109.369 -170.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 tp -147.1 112.1 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 104.146 -2.538 . . . . 0.0 104.146 169.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.507 0 C-N-CA 125.966 1.706 . . . . 0.0 109.229 -175.05 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 . . . . . 0 N--CA 1.465 0.321 0 CA-C-O 118.709 -0.662 . . . . 0.0 112.751 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -140.05 31.84 1.97 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 119.301 0.955 . . . . 0.0 113.291 -168.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -78.41 59.88 2.47 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 120.614 1.552 . . . . 0.0 109.504 174.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.1 p -78.73 147.72 6.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 125.363 1.465 . . . . 0.0 108.414 178.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 3.2 ttm -158.68 174.3 15.26 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.243 1.017 . . . . 0.0 108.904 170.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -126.06 154.19 43.38 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 169.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -152.01 -162.24 10.7 Favored Glycine 0 C--N 1.333 0.369 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -173.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -140.83 112.54 7.57 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 172.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.8 p -69.17 149.91 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 C-N-CA 124.613 1.165 . . . . 0.0 109.347 168.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -139.44 122.65 16.95 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 102.296 -3.224 . . . . 0.0 102.296 172.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.04 142.38 31.55 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 120.065 1.302 . . . . 0.0 109.965 -168.612 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.9 pt -74.95 174.46 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 123.961 0.905 . . . . 0.0 110.917 -177.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -69.52 -2.99 12.81 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.292 1.437 . . . . 0.0 113.525 177.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.719 0 C-N-CA 124.748 1.166 . . . . 0.0 112.879 -176.313 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.8 p . . . . . 0 N--CA 1.465 0.284 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -126.07 141.29 52.01 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.627 1.171 . . . . 0.0 108.676 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.2 tp -102.81 152.09 21.66 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.122 1.769 . . . . 0.0 107.316 169.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.6 m -132.88 146.4 51.78 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 176.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -139.78 158.17 44.53 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 125.179 1.391 . . . . 0.0 108.872 -177.433 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -124.5 152.88 42.86 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 169.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.0 t -140.97 141.03 32.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 174.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 72.8 p -118.87 135.72 54.41 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 169.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -151.84 116.6 5.14 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -173.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 54.12 29.14 43.72 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 123.757 0.694 . . . . 0.0 113.97 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 85.48 -2.04 88.16 Favored Glycine 0 CA--C 1.535 1.316 0 CA-C-N 118.159 0.98 . . . . 0.0 113.879 -178.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 49.0 mt -95.22 168.21 10.88 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.281 1.432 . . . . 0.0 108.363 172.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 10.7 tp -139.12 158.1 44.78 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.868 -0.52 . . . . 0.0 111.062 -169.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.448 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 43.8 mtt -148.77 159.67 43.93 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.921 1.688 . . . . 0.0 109.408 169.534 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.7 ttp85 -140.17 131.0 25.93 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 168.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.7 tt -138.42 131.26 29.55 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 -169.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -136.6 144.63 44.2 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -178.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 177.63 -175.21 47.45 Favored Glycine 0 CA--C 1.518 0.245 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 177.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.01 141.93 32.17 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.04 0.92 . . . . 0.0 108.782 169.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -50.46 -53.3 30.77 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -175.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -61.77 -36.55 81.38 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.619 0.723 . . . . 0.0 112.112 179.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -65.64 -23.23 66.75 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 125.032 1.333 . . . . 0.0 111.871 176.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.52 -8.62 55.08 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 120.126 1.33 . . . . 0.0 110.524 172.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 77.2 m80 44.04 43.54 5.57 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 129.413 3.085 . . . . 0.0 111.088 -176.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 173.25 112.1 0.28 Allowed Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 107.267 -2.333 . . . . 0.0 107.267 179.3 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -65.79 -8.68 22.78 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-O 121.507 0.67 . . . . 0.0 110.93 167.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 50.83 152.13 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.179 1 C-N-CA 135.389 5.476 . . . . 0.0 121.128 168.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER 171.6 -27.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.555 1 C-N-CA 133.438 4.695 . . . . 0.0 107.63 169.41 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -167.24 40.44 0.04 OUTLIER 'General case' 0 C--N 1.349 0.569 0 CA-C-N 119.085 0.857 . . . . 0.0 113.11 -172.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 26.9 m -118.66 -38.41 3.12 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 123.353 0.661 . . . . 0.0 110.617 169.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -11.78 18.77 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.999 0.904 . . . . 0.0 113.084 174.407 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 18.6 m -77.7 -4.14 6.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 C-N-CA 126.216 1.806 . . . . 0.0 112.689 -174.044 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -122.19 118.38 28.47 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 104.036 -2.579 . . . . 0.0 104.036 170.128 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -149.56 147.1 27.76 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.846 0.748 . . . . 0.0 111.131 -172.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 15.7 tp -140.74 139.88 34.74 Favored 'General case' 0 CA--C 1.523 -0.094 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -177.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 16.7 tmm? -125.39 144.28 50.59 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 173.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -149.98 172.55 15.03 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.328 1.451 . . . . 0.0 109.426 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -62.64 157.11 21.57 Favored 'General case' 0 C--O 1.235 0.297 0 O-C-N 122.1 -0.375 . . . . 0.0 110.438 172.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.2 pp -67.61 161.42 25.77 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.121 0.486 . . . . 0.0 110.671 169.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -146.88 129.83 16.32 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 173.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 . . . . . 0 C--O 1.248 1.019 0 C-N-CA 126.466 1.906 . . . . 0.0 106.995 174.04 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.4 tt . . . . . 0 N--CA 1.468 0.437 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -149.36 136.3 19.69 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 173.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -148.87 144.79 27.13 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.339 1.456 . . . . 0.0 108.262 -172.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -157.68 159.91 37.43 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 122.879 0.472 . . . . 0.0 110.585 169.132 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.1 mp -79.8 153.29 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 105.45 -2.056 . . . . 0.0 105.45 169.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -135.15 138.47 43.74 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.909 1.284 . . . . 0.0 107.644 178.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -105.57 122.96 47.1 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.073 1.349 . . . . 0.0 108.245 -178.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 44.8 t -71.09 116.92 13.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.6 mmmt -80.62 -40.99 24.69 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.729 0.811 . . . . 0.0 109.417 173.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -156.98 169.22 25.3 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 118.518 0.599 . . . . 0.0 111.458 -175.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.6 mp -135.18 144.96 32.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 127.245 2.218 . . . . 0.0 106.503 -178.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -141.91 89.12 9.05 Favored Pre-proline 0 CA--C 1.539 0.558 0 C-N-CA 126.552 1.941 . . . . 0.0 108.737 -176.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -81.21 100.88 1.2 Allowed 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 123.542 2.828 . . . . 0.0 107.674 169.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -61.77 -35.5 78.31 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.486 1.114 . . . . 0.0 112.705 -169.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 141.52 47.04 0.05 OUTLIER Glycine 0 CA--C 1.527 0.808 0 N-CA-C 103.595 -3.802 . . . . 0.0 103.595 -169.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.6 mmmt -61.49 115.97 4.33 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.542 1.537 . . . . 0.0 110.445 -167.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -55.47 -33.29 63.53 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.994 0.918 . . . . 0.0 110.884 170.004 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -127.22 96.61 4.64 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 176.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.98 -15.03 58.36 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.954 0.902 . . . . 0.0 113.411 -172.085 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -68.61 -0.2 4.91 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 118.789 -0.624 . . . . 0.0 112.546 169.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.8 t -120.62 138.52 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 104.929 -2.249 . . . . 0.0 104.929 169.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 61.0 m -155.34 160.67 40.9 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.634 1.107 . . . . 0.0 110.061 173.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 41.7 ttm105 -83.35 144.09 29.9 Favored 'General case' 0 C--N 1.342 0.272 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 173.118 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.1 mp -129.3 157.22 42.49 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 128.075 2.55 . . . . 0.0 105.958 177.063 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -130.47 130.68 44.54 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 170.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 22.1 m -141.79 168.48 19.67 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.716 1.206 . . . . 0.0 110.998 -171.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -134.3 155.97 49.27 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.447 1.099 . . . . 0.0 108.589 169.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.6 p -69.34 143.82 53.65 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.165 0.586 . . . . 0.0 110.375 176.162 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -71.77 -36.92 70.53 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.426 0.69 . . . . 0.0 111.247 175.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.1 m -110.92 -10.86 14.39 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -168.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -125.99 -105.97 0.33 Allowed 'General case' 0 C--N 1.343 0.303 0 CA-C-N 120.733 1.606 . . . . 0.0 111.3 -169.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -169.16 14.48 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.749 1.22 . . . . 0.0 114.16 -169.494 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -65.92 150.52 48.48 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 121.571 -0.706 . . . . 0.0 110.329 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -124.87 113.93 18.52 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 104.18 -2.526 . . . . 0.0 104.18 169.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.1 tp -124.66 145.28 49.74 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.237 1.015 . . . . 0.0 111.243 -168.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 33.2 mm -131.29 142.28 43.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 128.536 2.734 . . . . 0.0 103.741 169.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 123' ' ' MET . 2.1 pt? -156.62 133.05 10.0 Favored 'General case' 0 C--O 1.224 -0.265 0 C-N-CA 124.543 1.137 . . . . 0.0 111.133 175.742 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -97.02 103.92 15.89 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 102.815 -3.032 . . . . 0.0 102.815 168.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.9 p -128.51 154.34 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 124.344 1.058 . . . . 0.0 111.309 -167.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -68.66 96.05 0.7 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.779 2.032 . . . . 0.0 108.404 169.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.0 pp -75.58 0.35 2.27 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.362 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -169.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -68.15 -4.65 14.49 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 121.425 1.92 . . . . 0.0 112.045 178.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.5 mt -62.16 -34.11 62.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 168.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -77.86 127.54 81.69 Favored Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 174.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.1 -51.23 0.28 Allowed 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.031 1.82 . . . . 0.0 113.052 -169.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.6 m -144.84 -12.94 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -169.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -155.12 152.48 29.54 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.133 0.973 . . . . 0.0 108.785 -175.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.3 mt -111.05 -3.18 15.61 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.437 1.095 . . . . 0.0 112.727 -170.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.09 51.1 4.23 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 176.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -144.4 166.61 24.61 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.676 1.59 . . . . 0.0 108.615 -172.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -93.4 165.39 12.79 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.139 0.976 . . . . 0.0 109.573 -177.262 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -139.74 -179.17 5.77 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 124.256 1.022 . . . . 0.0 108.767 174.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -136.46 142.25 43.59 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -173.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.3 tt -138.98 144.04 38.78 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.374 1.069 . . . . 0.0 108.605 -169.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.1 t -140.79 152.91 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 126.46 1.904 . . . . 0.0 106.937 -177.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.0 pt -128.85 25.15 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.381 1.073 . . . . 0.0 111.433 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.254 0 C-N-CA 123.38 0.672 . . . . 0.0 110.922 179.287 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.5 p90 . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -159.63 59.61 0.38 Allowed 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.494 -0.754 . . . . 0.0 109.633 -176.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -74.65 72.42 1.96 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 169.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.3 p -85.3 145.87 7.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 124.569 1.148 . . . . 0.0 109.002 -176.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.76 166.99 31.7 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.903 1.681 . . . . 0.0 109.74 -169.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -137.99 142.32 40.45 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.959 1.304 . . . . 0.0 108.911 -177.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -152.73 -157.27 7.93 Favored Glycine 0 C--N 1.336 0.582 0 CA-C-N 118.672 0.669 . . . . 0.0 113.225 -175.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -134.49 130.01 36.02 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 172.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 44.4 t -95.7 150.49 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -132.81 162.34 31.77 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 127.184 2.194 . . . . 0.0 106.883 174.083 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.93 169.66 19.34 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.12 -0.987 . . . . 0.0 110.67 177.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.64 171.31 18.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 125.121 1.368 . . . . 0.0 107.313 168.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -65.78 -6.99 13.52 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.0 1.72 . . . . 0.0 115.022 -170.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.225 0 C-N-CA 124.975 1.274 . . . . 0.0 112.868 -175.694 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.7 p . . . . . 0 C--O 1.238 0.448 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? 61.75 163.0 0.08 Allowed 'General case' 0 C--N 1.345 0.378 0 C-N-CA 126.593 1.957 . . . . 0.0 110.885 -169.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 52.9 tp -101.04 135.91 41.74 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 103.448 -2.797 . . . . 0.0 103.448 168.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 16.1 m -128.18 134.17 49.01 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -171.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -137.67 162.36 34.05 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.65 1.58 . . . . 0.0 109.405 -169.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -130.3 156.6 44.39 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 172.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.6 t -138.5 139.78 40.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.7 m -125.71 121.42 33.4 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 105.069 -2.196 . . . . 0.0 105.069 174.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -142.38 103.61 4.29 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.333 0.653 . . . . 0.0 109.848 -169.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 59.59 26.5 62.38 Favored Glycine 0 CA--C 1.534 1.269 0 O-C-N 121.68 -0.638 . . . . 0.0 113.628 178.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 93.23 -12.93 68.8 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.409 1.004 . . . . 0.0 113.128 -177.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 84.3 mt -80.91 162.78 23.77 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 118.553 1.176 . . . . 0.0 107.885 169.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 10.7 tp -140.16 153.94 46.8 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 121.808 -0.558 . . . . 0.0 110.3 -170.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.441 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 29.4 mtm -144.88 156.56 44.07 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.098 1.359 . . . . 0.0 108.494 169.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -136.71 133.44 36.12 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 104.126 -2.546 . . . . 0.0 104.126 169.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 32.5 tp -148.37 145.59 28.14 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.194 0.598 . . . . 0.0 110.374 -168.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -136.01 153.49 51.35 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 167.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -170.25 172.86 44.14 Favored Glycine 0 CA--C 1.521 0.424 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 172.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -55.22 139.61 41.63 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.007 1.404 . . . . 0.0 108.869 173.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -41.06 -54.93 2.71 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -63.4 -37.71 88.34 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 122.564 1.173 . . . . 0.0 111.716 -176.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -69.22 -20.24 63.96 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 113.337 -1.756 . . . . 0.0 111.798 178.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 24.6 tp -69.67 -22.79 63.41 Favored 'General case' 0 C--N 1.346 0.439 0 CA-C-N 120.158 1.344 . . . . 0.0 110.092 174.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 45.71 34.22 1.72 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.675 1.99 . . . . 0.0 114.13 171.229 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -159.21 57.07 0.33 Allowed Glycine 0 C--N 1.335 0.496 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 -171.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -65.65 -10.0 32.28 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -169.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -107.27 145.51 32.63 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 125.153 1.381 . . . . 0.0 109.93 179.18 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 7.7 m -60.69 -7.94 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.233 168.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -124.16 14.8 9.1 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 127.58 2.352 . . . . 0.0 112.035 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 70.2 m -81.6 -71.08 0.49 Allowed 'General case' 0 CA--C 1.529 0.151 0 O-C-N 121.589 -0.695 . . . . 0.0 109.491 168.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.299 13.1 ptm180 -85.27 18.26 2.71 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -169.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 18.7 m -62.12 -35.26 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 167.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -79.69 122.8 27.01 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 174.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 56.3 tp -142.82 140.7 31.41 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -169.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.8 tt -145.53 137.43 25.4 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -178.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 58.6 mtt -131.01 157.44 42.98 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.989 0.916 . . . . 0.0 109.457 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 39.8 pttt -164.7 169.95 16.22 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.146 1.378 . . . . 0.0 109.26 178.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.89 162.47 11.1 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.224 0.61 . . . . 0.0 111.363 172.348 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.44 164.71 2.43 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.57 1.148 . . . . 0.0 113.699 -177.292 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.72 60.3 5.21 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.063 1.345 . . . . 0.0 111.174 178.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 22.0 t80 . . . . . 0 C--O 1.25 1.105 0 C-N-CA 124.356 1.062 . . . . 0.0 108.371 176.107 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 65.7 tp . . . . . 0 N--CA 1.466 0.366 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -143.3 144.52 32.15 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 169.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -147.46 140.57 25.12 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 -171.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -147.78 144.25 28.09 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 124.262 1.025 . . . . 0.0 109.42 -178.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.77 141.13 25.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -138.08 158.84 43.51 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 122.786 0.435 . . . . 0.0 110.651 174.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -135.08 148.26 49.79 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.802 1.241 . . . . 0.0 109.386 -172.077 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.1 t -59.86 141.4 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 125.54 1.536 . . . . 0.0 109.847 -178.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -123.35 -29.75 3.78 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 126.377 1.871 . . . . 0.0 108.912 169.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -158.99 169.79 23.52 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.886 0.874 . . . . 0.0 109.669 169.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.6 mp -131.67 141.21 46.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -140.26 76.07 27.05 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 124.319 1.048 . . . . 0.0 108.286 -178.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -81.59 10.27 3.54 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.015 2.477 . . . . 0.0 113.92 -169.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -79.45 54.99 1.84 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.682 1.593 . . . . 0.0 110.199 176.162 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -150.19 38.4 0.9 Allowed Glycine 0 CA--C 1.528 0.851 0 C-N-CA 126.14 1.829 . . . . 0.0 110.002 -175.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.471 ' HE2' ' HA ' ' A' ' 20' ' ' LYS . 5.3 mmpt? -68.89 65.09 0.13 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.41 1.884 . . . . 0.0 114.083 -169.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -60.43 -38.74 85.04 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 168.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -144.05 162.79 35.33 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 129.161 2.984 . . . . 0.0 104.268 169.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -60.29 -33.68 72.7 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.328 -0.857 . . . . 0.0 111.764 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -75.77 -6.9 52.85 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 117.096 -1.431 . . . . 0.0 114.133 178.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 72.9 t -101.41 123.85 54.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 120.886 1.676 . . . . 0.0 107.162 -174.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.3 m -147.19 152.56 38.59 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.911 0.884 . . . . 0.0 109.561 -176.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 64.9 mtm-85 -83.36 150.61 25.99 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 169.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -129.69 155.16 46.33 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 127.092 2.157 . . . . 0.0 105.8 175.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -127.69 128.62 45.74 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 103.485 -2.783 . . . . 0.0 103.485 170.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 71.3 m -142.61 169.09 18.23 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.396 1.078 . . . . 0.0 111.481 -169.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -135.49 134.86 39.96 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.716 1.606 . . . . 0.0 106.957 176.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.0 m -75.05 142.38 43.75 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 121.392 0.615 . . . . 0.0 110.767 176.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -93.97 -34.93 12.87 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.634 1.174 . . . . 0.0 110.694 -175.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -69.89 -41.98 74.01 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.607 0.763 . . . . 0.0 112.949 -169.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -136.49 -95.22 0.23 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.596 0.758 . . . . 0.0 109.17 -175.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -165.91 110.96 0.85 Allowed 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.06 1.344 . . . . 0.0 108.379 -175.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.8 mtt -158.58 142.01 15.04 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 174.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -112.89 129.31 56.51 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 104.802 -2.296 . . . . 0.0 104.802 169.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.3 tp -136.63 139.46 42.09 Favored 'General case' 0 C--O 1.227 -0.112 0 C-N-CA 123.52 0.728 . . . . 0.0 111.987 -168.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 35.3 mm -121.72 140.96 44.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 102.261 -3.237 . . . . 0.0 102.261 168.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 123' ' ' MET . 2.3 pt? -154.66 158.25 39.37 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 123.704 0.802 . . . . 0.0 110.586 177.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -127.09 111.53 14.13 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.411 HG11 HD12 ' A' ' 41' ' ' LEU . 28.6 m -145.6 166.89 9.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 O-C-N 124.224 0.953 . . . . 0.0 113.195 -168.36 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -72.65 126.87 30.92 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.945 1.298 . . . . 0.0 107.659 169.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 pp -105.6 -1.05 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -67.23 -16.92 64.58 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 120.775 1.625 . . . . 0.0 111.644 177.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.3 mt -58.57 -27.44 33.89 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 124.23 1.012 . . . . 0.0 109.187 169.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -122.42 158.68 55.4 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 125.093 1.357 . . . . 0.0 113.49 -168.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -75.01 75.13 3.8 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 124.012 3.142 . . . . 0.0 109.55 171.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.5 p -53.98 -23.81 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 124.972 1.309 . . . . 0.0 113.328 -174.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -59.25 -22.43 61.11 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.438 1.095 . . . . 0.0 113.024 174.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 59.1 tp -129.79 -30.19 2.07 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.192 1.397 . . . . 0.0 111.713 -177.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.82 164.95 36.37 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 -169.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -159.2 166.2 31.94 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.71 1.204 . . . . 0.0 108.525 -178.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -74.63 163.97 27.11 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 172.202 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -128.25 164.92 21.51 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.754 1.622 . . . . 0.0 107.159 177.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.8 ttm180 -127.1 141.14 51.84 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 125.914 1.686 . . . . 0.0 106.581 170.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 39.9 tp -123.72 141.44 52.02 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 127.057 2.143 . . . . 0.0 106.653 178.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.1 t -134.83 142.06 41.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 172.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.7 pt -128.96 19.51 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.329 1.052 . . . . 0.0 110.759 -173.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.216 0 C-N-CA 124.24 1.016 . . . . 0.0 110.57 175.174 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 . . . . . 0 CA--C 1.536 0.426 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -61.08 -31.26 70.93 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 114.09 1.145 . . . . 0.0 114.09 -168.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -144.01 142.23 30.58 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 118.799 0.727 . . . . 0.0 109.154 172.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.2 m -143.06 139.15 27.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 C-N-CA 126.143 1.777 . . . . 0.0 106.707 177.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 37.5 tpp -161.02 166.04 28.84 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.325 1.05 . . . . 0.0 109.078 -177.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -124.54 145.31 49.65 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 170.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -153.15 -170.16 19.08 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-N 118.768 0.713 . . . . 0.0 111.766 -172.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -117.84 134.79 54.58 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.0 t -112.21 134.79 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 175.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -151.23 148.21 27.94 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.739 1.216 . . . . 0.0 108.233 -174.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.15 175.46 1.52 Allowed 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.427 1.491 . . . . 0.0 109.476 170.11 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 33.8 pt -70.06 -175.44 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 123.861 0.864 . . . . 0.0 110.304 169.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -63.81 -6.38 5.7 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.5 1.92 . . . . 0.0 115.687 -171.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.66 0 CA-C-O 118.851 -0.972 . . . . 0.0 112.812 178.003 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.6 p . . . . . 0 N--CA 1.47 0.546 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.4 mpt_? -132.72 128.69 37.46 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 126.077 1.751 . . . . 0.0 106.497 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.5 tp -73.91 139.0 44.65 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 174.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 7.8 p -90.75 154.95 19.16 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 122.045 -0.409 . . . . 0.0 110.34 176.122 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -147.77 137.78 22.8 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.132 0.973 . . . . 0.0 108.641 170.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 10.6 m-30 -114.96 146.53 41.09 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 103.45 -2.796 . . . . 0.0 103.45 168.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.2 t -135.33 143.56 36.6 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -173.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.3 t -134.85 123.94 24.29 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 105.496 -2.038 . . . . 0.0 105.496 169.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -146.98 107.94 4.19 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.408 0.683 . . . . 0.0 109.359 -169.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 57.17 24.15 50.03 Favored Glycine 0 CA--C 1.536 1.389 0 O-C-N 121.595 -0.691 . . . . 0.0 113.855 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 93.96 -11.33 71.03 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 124.629 1.109 . . . . 0.0 113.435 -178.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.5 mp -82.34 160.67 22.79 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 170.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 7.0 tp -139.5 159.71 41.53 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.817 -0.552 . . . . 0.0 111.036 -169.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.442 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 26.1 mtt -149.25 156.38 42.03 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 125.295 1.438 . . . . 0.0 109.092 169.341 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 39.0 mtm105 -143.47 126.31 16.17 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 105.019 -2.215 . . . . 0.0 105.019 169.037 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -155.81 166.4 33.61 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 119.667 1.122 . . . . 0.0 112.902 -169.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -134.82 141.33 46.37 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 168.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -156.53 168.85 33.82 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.32 132.19 33.91 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 170.23 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -45.82 -43.33 13.24 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 175.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.6 -22.86 65.34 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 120.989 -1.069 . . . . 0.0 113.601 177.569 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -75.65 -19.61 59.05 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 125.527 1.531 . . . . 0.0 110.808 172.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -85.84 3.6 40.9 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 119.467 1.03 . . . . 0.0 109.365 168.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 1.5 t60 38.33 30.04 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.513 1 C-N-CA 131.789 4.036 . . . . 0.0 118.107 169.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 163.27 28.69 0.02 OUTLIER Glycine 0 CA--C 1.525 0.698 0 CA-C-O 119.243 -0.754 . . . . 0.0 111.947 178.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 45.79 40.05 5.99 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.82 1.648 . . . . 0.0 111.95 -169.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . 0.369 2.7 pp20? 43.57 -148.53 0.05 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.932 2.093 . . . . 0.0 114.623 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.7 t 67.9 -34.49 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 127.6 2.36 . . . . 0.0 111.879 -168.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -154.37 18.05 0.48 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.416 1.087 . . . . 0.0 112.433 -170.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 48.8 m -87.04 -77.02 0.34 Allowed 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 169.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.277 9.8 ptm180 -79.35 14.53 1.51 Allowed 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.482 1.113 . . . . 0.0 113.186 -172.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 20.8 m -63.72 -38.67 82.91 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 167.016 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -82.67 129.22 34.92 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 169.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 7.4 tt -142.12 127.25 18.52 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 118.637 0.653 . . . . 0.0 109.306 -174.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 7.3 tt -132.94 134.06 44.03 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 178.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 60.2 ttm -137.78 140.07 40.39 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -176.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -158.94 -176.28 5.77 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.152 0.981 . . . . 0.0 109.786 178.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -52.93 158.63 1.35 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.992 1.317 . . . . 0.0 112.283 169.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.34 169.68 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.69 2.396 . . . . 0.0 114.205 174.225 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -125.85 0.43 7.35 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 179.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 14.2 p90 . . . . . 0 C--O 1.249 1.033 0 C-N-CA 127.955 2.502 . . . . 0.0 106.826 -179.482 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tt . . . . . 0 CA--C 1.536 0.441 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -151.69 148.12 27.54 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.101 1.36 . . . . 0.0 108.184 171.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -148.64 143.15 26.33 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 126.431 1.892 . . . . 0.0 107.529 -173.219 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -151.81 124.9 8.66 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.224 1.009 . . . . 0.0 108.785 172.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.6 mp -79.44 142.14 14.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 104.385 -2.45 . . . . 0.0 104.385 169.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -130.44 158.4 39.99 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.391 0.615 . . . . 0.0 109.807 171.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -119.1 132.98 56.05 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.477 1.511 . . . . 0.0 107.194 178.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.4 p -69.99 135.04 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.9 mmmm -113.06 -25.17 9.07 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.303 1.441 . . . . 0.0 109.977 -177.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -156.07 163.34 39.79 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.098 0.863 . . . . 0.0 110.672 169.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.9 mp -139.09 137.27 42.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 127.264 2.225 . . . . 0.0 105.414 179.118 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -142.89 97.24 5.87 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 124.589 1.156 . . . . 0.0 108.985 -173.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -61.02 1.28 0.62 Allowed 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 124.326 3.351 . . . . 0.0 117.541 -175.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -77.28 46.73 0.52 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.726 2.01 . . . . 0.0 110.973 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -153.74 35.72 0.74 Allowed Glycine 0 CA--C 1.528 0.859 0 C-N-CA 126.995 2.236 . . . . 0.0 108.928 178.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.68 55.41 0.26 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.567 1.947 . . . . 0.0 113.648 -169.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -54.44 -39.76 67.71 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 121.35 -0.843 . . . . 0.0 109.647 170.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -142.64 163.97 31.37 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 128.037 2.535 . . . . 0.0 104.569 169.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -57.48 -34.63 69.23 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.55 -0.719 . . . . 0.0 111.485 176.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 -79.03 4.23 15.03 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-O 117.101 -1.428 . . . . 0.0 114.535 178.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 81.3 t -118.04 132.17 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 121.736 2.062 . . . . 0.0 107.519 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 65.1 m -145.79 159.84 42.61 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.637 0.775 . . . . 0.0 109.709 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -76.69 148.91 36.52 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 169.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -142.56 153.99 44.05 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.712 1.605 . . . . 0.0 107.521 -169.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -134.3 136.58 43.61 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 171.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 67.7 m -145.35 165.38 28.63 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.277 1.031 . . . . 0.0 110.945 -171.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -139.54 136.01 34.03 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.273 1.429 . . . . 0.0 108.496 178.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.2 m -60.67 139.87 57.69 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.842 0.857 . . . . 0.0 112.185 173.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -94.41 -44.44 7.9 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 168.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.0 m -73.13 -38.16 66.39 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 118.643 -0.694 . . . . 0.0 112.029 -172.02 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -121.14 -106.84 0.37 Allowed 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -166.3 8.96 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 -169.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.8 mpp? -69.04 148.55 49.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.75 0.786 . . . . 0.0 109.145 -174.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -103.93 138.69 40.13 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 169.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.8 mt -135.86 144.71 45.75 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.287 0.635 . . . . 0.0 110.17 -169.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.8 mm -130.19 143.19 41.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 103.157 -2.905 . . . . 0.0 103.157 169.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 123' ' ' MET . 4.8 mp -144.61 159.84 42.15 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.622 1.569 . . . . 0.0 108.166 -177.224 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -136.04 95.1 3.14 Favored 'General case' 0 C--N 1.32 -0.693 1 N-CA-C 99.758 -4.164 . . . . 0.0 99.758 169.049 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.1 p -147.11 167.45 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 121.285 0.564 . . . . 0.0 112.392 -167.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -58.27 140.31 53.49 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.883 1.273 . . . . 0.0 109.31 169.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 pp -119.55 -1.38 8.56 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.669 0 CA-C-O 116.972 -1.49 . . . . 0.0 113.263 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -63.64 -15.57 58.65 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 121.773 2.079 . . . . 0.0 114.212 -169.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.665 HD12 ' H ' ' A' ' 47' ' ' ILE . 0.6 OUTLIER -65.69 -28.39 44.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 127.388 2.275 . . . . 0.0 111.093 173.803 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -52.57 155.17 3.99 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 124.534 1.134 . . . . 0.0 111.979 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -73.87 50.57 2.15 Favored 'Trans proline' 0 CA--C 1.547 1.162 0 C-N-CA 124.698 3.599 . . . . 0.0 112.959 175.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . 0.27 20.3 m 52.65 -9.94 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 131.13 3.772 . . . . 0.0 119.229 169.686 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -143.2 -12.5 0.72 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 120.358 1.435 . . . . 0.0 112.625 -173.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -156.36 169.16 25.23 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 126.239 1.815 . . . . 0.0 108.259 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.16 175.22 54.71 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 176.356 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -152.18 171.08 18.48 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.732 1.213 . . . . 0.0 109.142 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -79.17 155.39 28.68 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.51 1.124 . . . . 0.0 109.698 175.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -129.74 162.25 28.83 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.975 1.31 . . . . 0.0 108.808 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 42.0 ttt180 -115.07 134.14 55.43 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 173.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 57.7 tp -127.78 132.86 49.47 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 177.117 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.6 m -137.99 163.99 28.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 124.551 1.14 . . . . 0.0 108.093 177.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.0 pt -127.41 13.07 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 123.514 0.726 . . . . 0.0 110.53 177.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.436 0 C-N-CA 124.548 1.139 . . . . 0.0 113.574 -175.7 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 . . . . . 0 CA--C 1.538 0.518 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -146.04 -40.85 0.21 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.175 0.59 . . . . 0.0 109.421 169.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -143.94 144.73 31.83 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 123.909 0.884 . . . . 0.0 108.698 175.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.1 p -142.58 142.29 26.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 5.2 tmm? -158.89 160.75 36.48 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.455 0.645 . . . . 0.0 111.28 -168.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -129.91 104.92 7.65 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 104.721 -2.326 . . . . 0.0 104.721 173.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -94.93 -173.11 37.62 Favored Glycine 0 C--N 1.332 0.361 0 CA-C-O 121.288 0.382 . . . . 0.0 112.585 -169.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -120.61 100.56 7.2 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 169.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.411 HG13 ' HA ' ' A' ' 137' ' ' VAL . 0.1 OUTLIER -70.42 142.13 16.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 170.588 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -136.37 127.22 27.48 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 103.075 -2.935 . . . . 0.0 103.075 169.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -146.29 169.18 19.33 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 120.028 1.285 . . . . 0.0 112.881 -169.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.1 pt -134.63 165.77 30.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 C-N-CA 126.533 1.933 . . . . 0.0 108.325 -169.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -66.53 -3.96 7.46 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.964 1.706 . . . . 0.0 112.77 175.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.934 0 N-CA-C 104.855 -3.298 . . . . 0.0 104.855 -169.851 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.469 0.492 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -138.27 140.14 39.49 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 103.948 -2.612 . . . . 0.0 103.948 169.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 22.3 tp -75.96 157.77 32.74 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 169.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 2.2 m -139.96 146.09 38.7 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -177.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -147.84 160.17 43.05 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.019 0.928 . . . . 0.0 109.157 178.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -124.76 149.78 46.97 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 173.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.9 t -141.24 116.07 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 17.2 m -86.34 124.56 32.84 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 105.469 -2.048 . . . . 0.0 105.469 169.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.4 m-30 -86.89 163.43 17.17 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 169.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -56.96 67.02 0.01 OUTLIER Glycine 0 CA--C 1.539 1.538 0 C-N-CA 126.521 2.01 . . . . 0.0 114.512 170.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 119.24 -7.24 12.72 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 127.137 2.303 . . . . 0.0 113.407 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -139.24 -179.81 6.09 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 119.885 1.842 . . . . 0.0 108.369 -169.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.7 tt -154.77 160.46 41.32 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 121.346 1.885 . . . . 0.0 112.3 -177.095 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.419 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 26.0 ptt? -149.74 161.52 42.06 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.7 1.6 . . . . 0.0 109.426 169.116 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 92.0 mtt-85 -137.54 139.91 40.75 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 174.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 8.0 tt -143.89 147.93 34.71 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 123.13 0.572 . . . . 0.0 110.441 -169.136 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -129.07 151.47 49.72 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 168.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -173.55 173.07 45.65 Favored Glycine 0 C--N 1.329 0.146 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 170.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.93 139.98 38.75 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 169.501 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -39.94 -60.43 1.02 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -178.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -60.45 -37.52 81.22 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.874 0.845 . . . . 0.0 112.46 -178.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -66.9 -23.38 65.99 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 125.307 1.443 . . . . 0.0 111.249 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.7 tt -69.58 -26.78 64.63 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.481 1.037 . . . . 0.0 110.195 177.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 43.39 40.05 2.46 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 127.798 2.439 . . . . 0.0 113.472 175.727 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -165.62 42.71 0.28 Allowed Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 -169.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -76.17 9.41 2.55 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.546 1.138 . . . . 0.0 112.273 -173.352 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -130.15 135.95 48.75 Favored 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 125.212 1.405 . . . . 0.0 108.643 -172.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.411 ' HA ' HG13 ' A' ' 96' ' ' VAL . 15.6 m -57.1 -5.07 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 126.626 1.97 . . . . 0.0 112.31 169.634 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -134.38 16.83 3.7 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 173.092 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.7 m -102.78 -51.97 3.18 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 167.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 5.2 tpm_? -75.71 0.45 17.73 Favored 'General case' 0 C--N 1.342 0.271 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -172.036 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 35.7 m -62.55 -41.57 92.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 124.18 0.992 . . . . 0.0 110.83 169.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -71.28 130.95 42.69 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -170.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 7.7 tt -150.67 134.09 16.34 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 117.939 0.336 . . . . 0.0 110.292 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.8 tt -144.56 135.35 24.85 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 106.492 -1.669 . . . . 0.0 106.492 169.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 14.6 ptp -142.38 159.08 42.94 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 118.501 0.592 . . . . 0.0 111.663 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -157.01 -173.77 4.61 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 126.084 1.754 . . . . 0.0 108.756 171.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -60.95 169.69 1.85 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.889 0.768 . . . . 0.0 109.669 169.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -44.2 155.63 0.09 Allowed 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 179.319 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.86 63.5 7.0 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.776 1.23 . . . . 0.0 110.054 177.441 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 19.8 t80 . . . . . 0 C--O 1.249 1.042 0 C-N-CA 123.944 0.897 . . . . 0.0 108.81 178.495 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 22.1 tp . . . . . 0 CA--C 1.542 0.664 0 CA-C-O 120.95 0.405 . . . . 0.0 109.909 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -150.69 125.61 9.82 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.416 1.086 . . . . 0.0 109.095 -177.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -155.87 140.59 17.05 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 178.015 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -148.41 148.59 30.5 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.13 0.877 . . . . 0.0 110.368 169.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 mp -77.54 154.46 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 173.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -145.76 160.45 41.72 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.971 0.909 . . . . 0.0 110.241 171.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -135.13 129.58 34.11 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.194 1.798 . . . . 0.0 108.194 -169.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.8 p -68.36 123.51 21.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 121.825 0.822 . . . . 0.0 109.058 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -82.14 -42.06 19.6 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 124.537 1.135 . . . . 0.0 109.294 170.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -159.76 167.98 26.98 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 118.831 0.742 . . . . 0.0 111.638 -175.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.3 mp -138.82 138.27 42.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 127.769 2.428 . . . . 0.0 105.55 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -146.0 97.76 4.48 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 118.787 0.721 . . . . 0.0 110.966 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -58.07 59.82 0.05 OUTLIER 'Trans proline' 0 CA--C 1.548 1.214 1 C-N-CA 126.921 5.081 . . . . 0.0 116.595 174.205 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -123.91 43.67 2.92 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.688 1.595 . . . . 0.0 109.789 178.083 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -168.1 44.45 0.24 Allowed Glycine 0 C--N 1.336 0.554 0 C-N-CA 124.182 0.896 . . . . 0.0 110.994 -175.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.9 mmmm -76.0 68.07 2.43 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.13 0.965 . . . . 0.0 111.149 -169.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.21 -36.61 68.63 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 169.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -139.68 167.44 22.09 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 128.651 2.78 . . . . 0.0 104.551 169.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -68.72 -25.34 64.71 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.079 -1.013 . . . . 0.0 111.351 -173.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -82.0 -6.35 59.07 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-O 116.536 -1.697 . . . . 0.0 113.553 175.016 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 70.0 t -101.35 128.75 53.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 121.664 2.029 . . . . 0.0 107.728 -175.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.2 m -148.19 167.97 23.7 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.787 1.235 . . . . 0.0 109.304 -177.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.0 tpp85 -70.58 153.98 42.33 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 170.135 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.8 mt -138.19 156.13 48.01 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.296 1.838 . . . . 0.0 106.904 170.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -133.39 133.68 42.72 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 170.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 65.0 m -143.0 163.65 32.2 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.719 1.208 . . . . 0.0 110.352 -171.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -134.7 137.73 43.79 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.861 1.664 . . . . 0.0 107.051 177.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.8 m -93.65 142.62 27.15 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.058 0.456 . . . . 0.0 110.169 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -69.75 -54.93 11.42 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.788 1.635 . . . . 0.0 113.122 -168.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.6 m -89.35 -35.47 16.07 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 123.114 0.566 . . . . 0.0 111.747 -169.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -108.03 6.56 27.16 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -169.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.287 0.0 OUTLIER 45.99 28.58 0.64 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.179 1.792 . . . . 0.0 114.467 178.678 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 78.8 mtm -61.52 152.48 30.11 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 169.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -123.73 124.12 42.01 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.6 tt -130.67 150.63 51.77 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.864 0.84 . . . . 0.0 111.818 -168.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 16.8 mm -129.15 147.46 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 128.75 2.82 . . . . 0.0 103.729 169.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.406 HD22 ' CG1' ' A' ' 43' ' ' VAL . 0.5 OUTLIER -147.5 155.42 41.87 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 127.626 2.37 . . . . 0.0 105.89 -171.08 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -142.49 103.01 4.18 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 104.701 -2.333 . . . . 0.0 104.701 170.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.472 HG22 ' H ' ' A' ' 44' ' ' ASN . 9.9 p -163.43 179.59 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 124.044 0.938 . . . . 0.0 109.765 -169.452 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.472 ' H ' HG22 ' A' ' 43' ' ' VAL . 29.6 t30 -52.53 130.49 31.99 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.84 1.656 . . . . 0.0 111.646 172.571 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.6 pp -110.33 -1.98 10.07 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 C-N-CA 124.946 1.299 . . . . 0.0 113.134 177.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -70.24 -9.54 56.22 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 120.028 1.285 . . . . 0.0 111.395 177.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.2 mt -61.65 -36.53 74.05 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 168.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -91.05 156.14 44.32 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 125.36 1.464 . . . . 0.0 110.526 -177.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.28 169.63 17.87 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.567 2.178 . . . . 0.0 109.921 169.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.0 m -63.71 -23.9 34.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 -169.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -153.23 -35.34 0.11 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.248 0.931 . . . . 0.0 113.497 -175.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 54.6 tp -62.65 -27.69 69.4 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -172.002 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.98 177.65 36.6 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 -169.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -158.35 175.2 14.02 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.134 0.974 . . . . 0.0 108.768 -178.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -125.39 135.57 52.54 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.003 1.321 . . . . 0.0 107.695 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -131.53 -173.39 3.11 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -129.85 151.48 50.37 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.846 1.258 . . . . 0.0 108.246 177.625 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 62.1 tp -124.39 138.87 54.32 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 127.005 2.122 . . . . 0.0 107.328 -174.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 41.0 t -144.77 152.64 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 126.626 1.97 . . . . 0.0 106.048 -175.179 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.5 pt -133.0 55.24 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.477 1.111 . . . . 0.0 108.925 176.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.145 0 C-N-CA 124.752 1.221 . . . . 0.0 110.662 -176.485 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 . . . . . 0 CA--C 1.535 0.386 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -78.11 -33.62 50.5 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.691 -0.631 . . . . 0.0 109.485 174.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -160.19 158.67 30.49 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.492 0.717 . . . . 0.0 109.791 169.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.2 m -139.53 145.07 27.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 C-N-CA 125.25 1.42 . . . . 0.0 107.177 172.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 15.8 ttt -151.83 143.39 23.53 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.915 0.886 . . . . 0.0 109.073 -169.25 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -135.74 75.67 1.57 Allowed 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 175.183 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -93.57 -163.94 36.8 Favored Glycine 0 C--N 1.337 0.589 0 N-CA-C 115.26 0.864 . . . . 0.0 115.26 -167.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -131.31 128.84 40.58 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 170.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -74.55 148.84 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 124.946 1.299 . . . . 0.0 108.642 169.719 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -142.09 64.83 1.38 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.653 1.581 . . . . 0.0 109.131 178.163 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -156.3 178.96 9.71 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 120.772 -1.205 . . . . 0.0 110.913 -178.227 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.53 -179.69 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 126.643 1.977 . . . . 0.0 109.5 -173.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -59.99 -6.69 1.42 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.849 2.06 . . . . 0.0 116.481 -169.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.47 0 N-CA-C 108.236 -1.946 . . . . 0.0 108.236 171.126 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.9 p . . . . . 0 N--CA 1.468 0.431 0 CA-C-O 122.024 0.916 . . . . 0.0 112.916 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -135.34 145.42 47.39 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 171.055 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 40.6 tp -76.49 150.11 36.68 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 105.453 -2.055 . . . . 0.0 105.453 168.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 14.9 m -128.24 150.19 50.14 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -174.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -143.67 149.13 36.8 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.286 1.034 . . . . 0.0 108.365 176.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -134.54 135.2 42.15 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 101.412 -3.551 . . . . 0.0 101.412 169.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.4 t -142.35 144.23 25.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -170.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.4 m -134.46 143.2 47.38 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -159.92 134.15 7.48 Favored 'General case' 0 C--O 1.226 -0.151 0 C-N-CA 123.524 0.73 . . . . 0.0 109.957 171.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 54.61 27.41 42.17 Favored Glycine 0 CA--C 1.537 1.461 0 N-CA-C 114.935 0.734 . . . . 0.0 114.935 169.248 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 85.73 1.13 87.49 Favored Glycine 0 CA--C 1.535 1.312 0 CA-C-N 118.488 1.144 . . . . 0.0 113.866 -177.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.12 153.19 17.77 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.821 1.648 . . . . 0.0 107.995 173.305 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 22.8 tp -133.38 156.57 47.43 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.109 0.964 . . . . 0.0 109.477 -176.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 60.6 mtt -144.04 156.48 44.4 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.789 1.636 . . . . 0.0 108.44 171.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.6 129.96 23.84 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 104.377 -2.453 . . . . 0.0 104.377 169.483 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 18.8 tp -144.7 147.61 33.22 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 119.511 1.05 . . . . 0.0 109.72 -168.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -139.19 153.78 47.95 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.989 0.916 . . . . 0.0 108.753 169.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -172.78 171.13 44.18 Favored Glycine 0 CA--C 1.519 0.333 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 169.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -54.71 141.18 33.22 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 118.804 1.302 . . . . 0.0 107.52 169.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -40.47 -59.44 1.33 Allowed 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -178.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.15 -13.71 62.32 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.345 -0.847 . . . . 0.0 113.134 -174.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -89.31 -27.23 20.67 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 126.175 1.79 . . . . 0.0 109.808 177.122 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 5.8 tt -78.02 -26.48 48.5 Favored 'General case' 0 C--N 1.344 0.33 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 169.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 3.1 t60 51.95 32.24 9.73 Favored 'General case' 0 C--N 1.344 0.355 0 C-N-CA 126.885 2.074 . . . . 0.0 113.155 168.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -154.97 86.66 0.13 Allowed Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 -169.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -50.66 125.78 13.96 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 169.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.49 175.37 2.3 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -168.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.4 t 70.12 -25.18 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 127.602 2.361 . . . . 0.0 111.768 -170.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -163.53 59.26 0.17 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 120.351 1.432 . . . . 0.0 112.285 -170.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 36.3 m -145.79 -53.9 0.27 Allowed 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 113.64 -1.618 . . . . 0.0 108.841 168.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -75.35 4.59 6.93 Favored 'General case' 0 C--N 1.343 0.299 0 O-C-N 121.867 -0.521 . . . . 0.0 112.285 177.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 11.1 m -81.93 -3.63 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 C-N-CA 123.872 0.869 . . . . 0.0 111.696 178.252 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -136.57 116.12 12.87 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 169.466 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 10.4 tt -143.28 142.97 31.53 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.154 0.582 . . . . 0.0 109.527 -169.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 15.6 tp -140.53 141.75 35.26 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 125.815 1.646 . . . . 0.0 107.477 -172.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 38.6 ttm -131.35 132.37 44.4 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -148.35 147.72 29.57 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -178.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -54.55 155.96 3.73 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.663 1.12 . . . . 0.0 111.597 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.6 pp -67.38 158.92 30.52 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 169.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -149.38 96.89 2.57 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.298 0.639 . . . . 0.0 110.058 -177.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 24.3 p90 . . . . . 0 C--O 1.252 1.185 0 C-N-CA 126.096 1.758 . . . . 0.0 107.471 169.675 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 60.9 tp . . . . . 0 CA--C 1.531 0.22 0 CA-C-O 120.924 0.392 . . . . 0.0 110.599 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -157.97 145.36 18.25 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 104.096 -2.557 . . . . 0.0 104.096 169.244 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -147.72 144.8 28.56 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.443 1.497 . . . . 0.0 107.786 -175.01 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -154.27 167.64 29.26 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.233 1.813 . . . . 0.0 108.548 178.464 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.2 mp -124.72 114.34 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 103.646 -2.724 . . . . 0.0 103.646 169.828 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -94.23 152.2 18.88 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.486 0.66 . . . . 0.0 109.705 -179.863 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -135.1 133.85 39.68 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 126.408 1.883 . . . . 0.0 108.257 -173.832 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 40.3 t -68.71 143.88 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 123.997 0.919 . . . . 0.0 109.392 -178.057 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -124.24 -28.22 3.71 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 126.785 2.034 . . . . 0.0 109.341 177.542 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -159.06 168.23 27.21 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.481 1.037 . . . . 0.0 111.136 171.066 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.4 mp -135.2 139.05 47.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 127.443 2.297 . . . . 0.0 105.927 179.603 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -147.06 91.98 5.04 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 123.301 0.64 . . . . 0.0 112.27 -173.519 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -68.5 97.12 0.51 Allowed 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 123.059 2.506 . . . . 0.0 108.477 168.983 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -59.37 -36.32 75.53 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.966 0.906 . . . . 0.0 112.84 -169.954 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.35 44.65 0.03 OUTLIER Glycine 0 CA--C 1.525 0.703 0 N-CA-C 103.749 -3.741 . . . . 0.0 103.749 -170.986 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.4 mmmt -65.47 132.37 48.77 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.37 1.068 . . . . 0.0 111.811 -167.394 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -60.47 -33.59 72.81 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 113.798 -1.546 . . . . 0.0 110.087 169.3 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -132.47 102.4 5.71 Favored 'General case' 0 N--CA 1.458 -0.068 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 178.212 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -55.04 -33.09 62.39 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.468 1.107 . . . . 0.0 113.514 -169.991 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -65.54 -5.69 8.75 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 117.446 -1.264 . . . . 0.0 113.586 178.475 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.5 t -121.52 111.82 32.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 174.677 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 74.0 m -140.11 169.2 18.13 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 124.383 1.073 . . . . 0.0 111.013 -173.859 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -74.59 150.48 39.67 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 175.083 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 71.5 mt -134.12 158.16 44.34 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 127.051 2.14 . . . . 0.0 106.81 173.816 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -128.67 134.57 48.55 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 169.478 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 72.2 m -142.95 169.04 18.32 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.451 1.5 . . . . 0.0 110.352 -171.516 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -136.41 144.5 44.54 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.802 2.041 . . . . 0.0 107.863 -177.707 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.2 p -74.98 158.65 32.91 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.431 1.093 . . . . 0.0 110.992 174.203 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -72.59 -41.55 65.51 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.558 -0.714 . . . . 0.0 110.748 177.656 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.4 m -136.45 6.64 3.02 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -169.052 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -121.32 14.97 11.31 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -169.174 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.264 0.0 OUTLIER 41.45 31.66 0.19 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.95 2.1 . . . . 0.0 114.739 178.295 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 57.3 mtt -74.38 153.95 39.04 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.452 1.101 . . . . 0.0 110.381 -179.104 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -114.34 104.31 11.94 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 169.459 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 62.3 tp -112.18 144.26 41.88 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -171.707 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 31.2 mm -134.0 147.05 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 104.088 -2.56 . . . . 0.0 104.088 174.131 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 123' ' ' MET . 3.2 mp -144.13 158.11 43.91 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 126.155 1.782 . . . . 0.0 107.961 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -133.35 100.86 4.96 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 101.971 -3.344 . . . . 0.0 101.971 168.239 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.8 m -146.23 175.57 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 124.867 1.267 . . . . 0.0 111.126 -167.552 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -58.54 128.5 37.48 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.823 0.849 . . . . 0.0 109.254 169.654 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 pp -115.44 6.0 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 125.101 1.361 . . . . 0.0 112.875 -179.005 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -66.81 -15.0 63.3 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 120.693 1.588 . . . . 0.0 112.069 -176.895 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.6 mt -65.14 -24.52 35.45 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 C-N-CA 125.293 1.437 . . . . 0.0 109.581 169.764 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -123.22 71.88 45.92 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 126.931 2.092 . . . . 0.0 109.275 -172.682 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -68.32 -12.34 34.67 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.651 2.234 . . . . 0.0 111.933 173.323 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.5 p -147.32 175.2 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 128.728 2.811 . . . . 0.0 104.917 173.351 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -69.78 69.98 0.31 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.967 0.907 . . . . 0.0 110.123 169.849 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 50.3 tp -64.96 -25.85 68.05 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.729 1.612 . . . . 0.0 111.96 -175.084 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 67.35 26.54 73.52 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-O 119.659 -0.523 . . . . 0.0 112.108 -177.279 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -70.75 157.66 37.66 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 118.024 0.912 . . . . 0.0 108.736 169.853 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -135.97 152.83 51.36 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.188 0.995 . . . . 0.0 109.819 -169.323 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -132.9 127.24 33.93 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -174.456 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -71.45 134.79 46.84 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 169.901 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 tt -134.79 139.69 45.31 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 -179.67 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 t -139.19 158.04 28.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 -178.176 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 36.0 pt -121.62 14.87 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 123.389 0.675 . . . . 0.0 111.11 176.652 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.481 0 C-N-CA 124.453 1.101 . . . . 0.0 113.444 -175.521 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 . . . . . 0 CA--C 1.533 0.289 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -78.86 -24.83 44.05 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 122.954 0.502 . . . . 0.0 111.741 -171.067 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -147.67 148.22 30.82 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.683 0.793 . . . . 0.0 109.686 -175.53 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.4 p -146.14 143.64 21.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 175.365 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 31.4 tpp -157.81 170.47 22.27 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.592 0.757 . . . . 0.0 110.424 -175.288 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -136.07 154.47 51.01 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.486 2.315 . . . . 0.0 106.116 -175.252 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -161.89 -153.0 6.91 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-N 119.365 0.984 . . . . 0.0 113.838 -169.896 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -147.57 124.61 11.38 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.339 1.456 . . . . 0.0 108.243 176.823 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 46.1 t -77.61 133.72 29.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 168.775 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -141.24 70.72 1.35 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.99 0.916 . . . . 0.0 110.524 -169.093 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -155.5 173.01 17.29 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.873 -1.142 . . . . 0.0 111.556 175.079 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 19.7 pt -74.02 -177.63 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 126.128 1.771 . . . . 0.0 112.255 -172.575 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -65.81 -13.59 59.78 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.256 1.822 . . . . 0.0 114.893 -173.621 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.68 0 C-N-CA 124.514 1.054 . . . . 0.0 111.483 178.663 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.3 p . . . . . 0 C--O 1.233 0.212 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? -126.91 141.07 51.9 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 172.133 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.3 tp -73.13 144.48 46.92 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 104.339 -2.467 . . . . 0.0 104.339 167.7 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 7.9 p -110.25 141.92 42.56 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 169.749 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -142.65 152.61 42.63 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 125.29 1.436 . . . . 0.0 107.207 -175.643 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -134.63 143.46 47.31 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 102.332 -3.21 . . . . 0.0 102.332 169.092 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 13.8 t -133.07 116.59 26.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 105.658 -1.979 . . . . 0.0 105.658 -179.155 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.5 p -96.76 129.96 44.09 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 170.042 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -152.05 123.62 7.86 Favored 'General case' 0 C--N 1.334 -0.103 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -171.051 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 52.9 27.66 29.82 Favored Glycine 0 CA--C 1.538 1.492 0 CA-C-O 119.455 -0.636 . . . . 0.0 114.234 -178.801 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 82.28 -0.39 88.95 Favored Glycine 0 CA--C 1.536 1.384 0 CA-C-N 118.448 1.124 . . . . 0.0 114.007 -177.815 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 63.5 mt -99.16 170.94 8.33 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.449 1.5 . . . . 0.0 108.3 171.907 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 45.4 tp -139.46 157.65 45.47 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 118.628 0.649 . . . . 0.0 111.301 -170.494 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.478 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 54.5 mtt -143.57 160.3 40.88 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 126.258 1.823 . . . . 0.0 109.055 169.389 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 41.5 ttt180 -135.04 137.28 42.78 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 102.972 -2.973 . . . . 0.0 102.972 168.532 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 25.4 tp -147.91 137.29 22.32 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -169.743 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -128.45 144.3 51.12 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 170.41 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -177.79 170.23 42.49 Favored Glycine 0 CA--C 1.519 0.288 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 175.341 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -52.59 134.55 35.45 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 118.5 1.15 . . . . 0.0 108.685 172.868 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -46.69 -58.74 3.57 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -172.767 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -57.97 -45.26 86.99 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 122.322 1.058 . . . . 0.0 111.277 -177.55 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -61.13 -27.29 68.28 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 126.438 1.895 . . . . 0.0 111.793 178.381 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 tt -81.05 -24.19 38.02 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.917 0.887 . . . . 0.0 109.236 -179.937 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 54.27 30.25 12.11 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.212 1.005 . . . . 0.0 111.234 -170.62 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -104.25 9.74 50.16 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.662 1.125 . . . . 0.0 112.544 -176.447 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -72.13 7.95 1.48 Allowed 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.555 1.542 . . . . 0.0 112.643 178.233 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -145.18 106.55 4.21 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 127.76 2.424 . . . . 0.0 105.21 -178.221 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 14.6 m -63.02 -7.99 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 113.973 -1.467 . . . . 0.0 112.478 -177.837 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -122.05 18.89 10.85 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.364 1.065 . . . . 0.0 113.761 175.291 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 3.7 m -88.97 -70.26 0.66 Allowed 'General case' 0 N--CA 1.453 -0.296 0 O-C-N 121.639 -0.663 . . . . 0.0 110.683 168.516 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.28 2.0 ptp180 -75.64 11.48 1.31 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -173.006 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.3 m -65.61 -37.09 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 167.895 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -78.08 130.47 36.47 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 177.852 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.2 tt -141.2 141.96 34.03 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -172.492 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 49.2 tp -146.14 127.76 15.17 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 -174.564 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 48.9 ttp -143.8 146.06 32.81 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 119.829 1.195 . . . . 0.0 111.955 -169.443 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -151.57 166.05 32.37 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.904 2.081 . . . . 0.0 107.543 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -54.48 169.0 0.21 Allowed 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.464 1.029 . . . . 0.0 111.038 169.15 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.95 158.82 0.3 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 122.231 1.015 . . . . 0.0 113.333 173.938 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -143.61 130.15 20.11 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 174.112 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 54.3 p90 . . . . . 0 C--O 1.252 1.19 0 C-N-CA 126.169 1.787 . . . . 0.0 108.13 177.269 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 120.891 0.377 . . . . 0.0 110.712 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -124.7 38.31 4.22 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.468 2.307 . . . . 0.0 108.144 166.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -89.07 56.4 4.02 Favored Glycine 0 C--N 1.34 0.762 0 C-N-CA 125.508 1.528 . . . . 0.0 112.3 -161.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . 2.436 0.2 OUTLIER 67.46 -157.19 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 123.753 0.821 . . . . 0.0 108.871 -175.106 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 13.3 tp -149.33 15.59 0.9 Allowed 'General case' 0 CA--C 1.545 0.765 0 O-C-N 119.669 -1.895 . . . . 0.0 113.241 19.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -148.14 147.47 29.52 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.868 1.213 . . . . 0.0 112.152 -177.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -159.43 137.79 10.56 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 128.174 2.59 . . . . 0.0 107.177 -175.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -158.46 154.86 27.5 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 119.336 0.971 . . . . 0.0 110.638 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.1 mp -99.16 159.6 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 126.392 1.877 . . . . 0.0 107.652 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -137.21 168.94 18.65 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.493 1.117 . . . . 0.0 110.549 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -134.1 128.76 34.85 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.641 1.576 . . . . 0.0 106.956 165.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 74.6 t -66.61 133.59 31.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 175.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -103.63 -34.32 8.67 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.616 1.167 . . . . 0.0 110.479 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -158.16 161.26 37.86 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.702 0.801 . . . . 0.0 110.146 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.8 mp -134.44 137.3 51.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 126.827 2.051 . . . . 0.0 105.728 -177.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -140.77 79.0 19.74 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 123.27 0.628 . . . . 0.0 111.453 -167.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -67.48 30.88 0.13 Allowed 'Trans proline' 0 CA--C 1.553 1.432 1 C-N-CA 126.089 4.526 . . . . 0.0 117.849 -172.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -50.13 -46.0 53.46 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 120.985 1.721 . . . . 0.0 115.449 -161.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -129.73 82.05 0.33 Allowed Glycine 0 C--N 1.336 0.572 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -160.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.456 ' HE2' ' HA ' ' A' ' 20' ' ' LYS . 9.5 mmpt? -74.44 62.91 1.02 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.26 1.424 . . . . 0.0 111.124 -176.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -55.92 -39.14 71.2 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.428 -0.795 . . . . 0.0 108.941 163.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -136.14 135.92 39.64 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 104.694 -2.336 . . . . 0.0 104.694 170.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -61.51 -33.29 73.54 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.271 0.487 . . . . 0.0 111.23 -177.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 -75.94 5.87 5.94 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.9 t -121.53 133.52 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 121.841 2.11 . . . . 0.0 107.858 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.7 m -148.38 158.97 44.43 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.352 1.061 . . . . 0.0 110.063 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 27.7 ttp180 -73.4 148.58 43.19 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 163.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 74.1 mt -134.18 162.66 31.52 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 126.153 1.781 . . . . 0.0 108.082 175.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -137.0 130.74 31.9 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 174.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 64.2 m -141.21 164.85 29.15 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.115 1.366 . . . . 0.0 109.525 -170.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -141.15 136.1 31.52 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.4 p -81.39 157.89 24.83 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.29 0.495 . . . . 0.0 111.194 -177.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -100.65 -50.78 3.77 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.581 0.752 . . . . 0.0 111.768 -168.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.0 m -73.57 -24.12 60.04 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 118.844 0.747 . . . . 0.0 111.292 -175.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -126.01 -134.08 0.25 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.921 1.289 . . . . 0.0 108.767 -177.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -143.61 13.54 1.74 Allowed 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.879 1.218 . . . . 0.0 113.689 -165.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 65.7 mtm -68.94 152.0 45.83 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 118.857 0.753 . . . . 0.0 110.685 -172.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -121.5 125.23 46.33 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 126.759 2.024 . . . . 0.0 106.516 176.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 67.9 tp -137.16 148.8 46.84 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.718 0.771 . . . . 0.0 110.264 -163.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.3 mm -130.88 144.9 36.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 128.704 2.801 . . . . 0.0 104.296 170.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.5 mp -134.79 162.51 32.15 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 173.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -132.39 109.16 9.65 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 104.692 -2.336 . . . . 0.0 104.692 158.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.4 p -153.42 158.66 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -154.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -62.16 125.2 23.06 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 169.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 pp -105.39 -1.13 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.253 1.021 . . . . 0.0 112.965 -177.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -66.75 -11.73 55.92 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 120.567 1.53 . . . . 0.0 112.357 177.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.9 mt -63.21 -40.2 88.14 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.75 1.22 . . . . 0.0 108.731 171.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -72.55 155.42 91.11 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 124.152 0.981 . . . . 0.0 109.155 174.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -63.37 -53.08 1.59 Allowed 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 121.766 1.644 . . . . 0.0 111.683 -174.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.8 m -152.67 -143.77 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 126.073 1.749 . . . . 0.0 107.604 -177.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -54.38 -30.42 51.84 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 127.805 2.442 . . . . 0.0 115.143 -173.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 27.9 tp -86.17 -18.92 30.93 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 -147.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.18 173.29 41.36 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -165.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -163.95 178.14 7.97 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.312 1.845 . . . . 0.0 107.912 -175.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -93.58 125.77 38.37 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 121.3 -0.875 . . . . 0.0 109.875 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -106.44 170.76 7.74 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.494 1.518 . . . . 0.0 109.544 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.3 ttp180 -127.54 104.52 7.93 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 126.172 1.789 . . . . 0.0 106.188 165.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.9 152.04 28.3 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 171.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 95.4 t -141.72 134.96 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 -175.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.0 pt -121.25 25.63 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 163.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -48.89 114.8 1.07 Allowed 'General case' 0 C--N 1.345 0.407 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 152.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 72.3 m -63.2 155.55 27.93 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 123.744 0.653 . . . . 0.0 109.494 -171.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.282 6.6 t -94.47 -89.67 0.22 Allowed 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -151.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.4 tt -153.45 -37.87 0.1 Allowed 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 110.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . 0.268 0.3 OUTLIER -125.79 46.77 2.34 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 120.443 -1.411 . . . . 0.0 109.241 -71.995 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -69.07 -19.72 64.08 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.532 1.133 . . . . 0.0 112.796 170.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -120.2 -78.51 0.59 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -149.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 168.85 27.6 0.02 OUTLIER Glycine 0 CA--C 1.528 0.905 0 C-N-CA 120.104 -1.046 . . . . 0.0 114.731 -159.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 91.0 m -82.92 -17.27 44.25 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 118.935 1.368 . . . . 0.0 109.831 160.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.69 -42.54 0.92 Allowed 'General case' 0 C--N 1.344 0.361 0 C-N-CA 124.341 1.057 . . . . 0.0 111.159 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -60.37 -12.93 10.58 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 118.869 0.759 . . . . 0.0 112.236 174.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -44.54 -33.63 1.82 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.588 1.955 . . . . 0.0 113.287 163.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -5.51 0.35 Allowed Glycine 0 CA--C 1.531 1.067 0 CA-C-O 118.869 -0.962 . . . . 0.0 114.053 173.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -95.72 -143.87 0.27 Allowed 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 118.904 1.352 . . . . 0.0 108.294 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . 0.253 26.1 t80 62.84 -7.42 0.14 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 126.029 1.731 . . . . 0.0 114.912 -177.064 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -65.11 -25.76 1.55 Allowed Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 116.956 2.206 . . . . 0.0 116.956 158.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -87.29 -157.43 0.07 OUTLIER 'Trans proline' 0 C--N 1.358 1.032 0 CA-C-N 123.601 2.322 . . . . 0.0 109.893 -161.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.452 HG23 ' H ' ' A' ' 78' ' ' THR . 73.5 p -30.54 1.62 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.628 1 C-N-CA 135.588 5.555 . . . . 0.0 118.063 154.558 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -74.06 -17.46 60.96 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 119.399 -2.063 . . . . 0.0 110.155 154.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -143.89 -142.59 0.13 Allowed 'General case' 0 CA--C 1.553 1.083 1 C-N-CA 132.197 4.199 . . . . 0.0 105.926 176.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . 0.337 70.7 mtm-85 53.19 -109.42 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.901 0 CA-C-O 115.042 -2.409 . . . . 0.0 112.0 -169.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.26 -36.25 3.36 Favored 'Trans proline' 0 C--N 1.36 1.153 0 CA-C-N 124.835 2.762 . . . . 0.0 110.395 177.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.0 m -70.95 177.07 3.87 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.303 1.041 . . . . 0.0 108.863 164.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 13.2 mmt85 -154.51 -179.92 8.42 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 -171.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -55.88 80.01 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 131.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -154.69 -41.8 0.09 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 128.739 2.816 . . . . 0.0 108.141 175.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -56.44 -13.78 2.53 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.613 0.765 . . . . 0.0 110.917 154.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -167.39 73.22 0.12 Allowed 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 129.253 3.021 . . . . 0.0 105.879 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -39.03 -33.23 0.11 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 127.11 2.164 . . . . 0.0 114.591 -175.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -149.5 157.77 43.58 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 173.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.5 p -163.7 138.39 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 40.2 tpp -163.16 166.8 22.97 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.051 0.54 . . . . 0.0 110.387 -166.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -111.94 163.09 14.63 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.707 1.603 . . . . 0.0 109.589 172.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -165.16 -159.67 11.68 Favored Glycine 0 CA--C 1.521 0.419 0 O-C-N 121.648 -0.658 . . . . 0.0 113.022 -175.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 11.1 ttmm -141.73 126.84 18.43 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 177.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.2 t -89.94 143.29 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 171.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -127.41 111.85 14.32 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 177.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.25 144.9 16.15 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 -177.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.512 HG13 ' H ' ' A' ' 101' ' ' GLY . 3.2 pt -75.56 -171.82 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 127.587 2.355 . . . . 0.0 109.663 169.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -64.59 -6.38 7.52 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.462 1.505 . . . . 0.0 114.384 176.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.512 ' H ' HG13 ' A' ' 99' ' ' ILE . . . 107.36 -46.51 1.16 Allowed Glycine 0 C--N 1.336 0.529 0 C-N-CA 126.698 2.094 . . . . 0.0 110.255 -177.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -68.72 137.69 54.3 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 117.163 0.482 . . . . 0.0 111.549 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -143.43 15.25 1.82 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.424 1.09 . . . . 0.0 109.934 162.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 70.2 p -81.98 -39.34 23.78 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.252 -0.905 . . . . 0.0 110.825 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 74.7 m 117.77 -36.58 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.47 1 C-N-CA 132.162 4.185 . . . . 0.0 109.902 -176.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.1 p -151.1 -29.55 0.19 Allowed 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -159.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -74.31 -7.87 54.29 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 118.923 0.783 . . . . 0.0 110.289 174.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 50.92 51.25 17.42 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.72 2.008 . . . . 0.0 110.515 177.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -1.28 103.05 0.01 OUTLIER 'General case' 0 C--N 1.348 0.539 0 C-N-CA 129.363 3.065 . . . . 0.0 113.304 -163.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.8 p -56.24 -21.05 21.12 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.496 1.118 . . . . 0.0 112.704 -174.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -108.48 115.3 29.85 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 165.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 34.5 tp -56.02 131.8 48.35 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 160.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 14.7 m -87.34 171.62 10.46 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 171.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -152.0 146.92 25.94 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 124.62 1.168 . . . . 0.0 108.237 161.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 2.9 m-30 -122.81 139.51 53.93 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 104.001 -2.592 . . . . 0.0 104.001 170.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.2 t -139.42 137.46 40.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 -174.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.1 m -116.92 132.09 56.79 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 166.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -149.43 109.77 4.19 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.089 0.859 . . . . 0.0 109.703 -170.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 58.19 22.94 51.47 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 123.797 0.713 . . . . 0.0 114.334 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.1 -14.11 65.0 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-N 118.42 1.11 . . . . 0.0 112.98 -176.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -83.05 171.87 13.33 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.643 1.177 . . . . 0.0 109.012 170.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 10.1 tp -140.07 153.74 46.85 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.242 1.017 . . . . 0.0 110.192 -173.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 42.6 mtt -138.75 158.31 44.47 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.684 1.194 . . . . 0.0 110.281 164.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.6 ttt-85 -143.97 122.34 12.35 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 104.357 -2.461 . . . . 0.0 104.357 176.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 33.8 tp -142.93 151.54 41.07 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.183 0.901 . . . . 0.0 109.342 -158.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -141.47 145.26 35.02 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.174 1.39 . . . . 0.0 109.817 167.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -172.76 166.81 39.54 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 125.989 1.757 . . . . 0.0 109.883 171.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -51.58 146.75 7.13 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.019 1.41 . . . . 0.0 111.09 176.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.77 -47.53 82.26 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -169.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -65.17 -43.71 90.85 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 122.678 0.391 . . . . 0.0 110.069 174.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.21 -40.73 94.54 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.416 1.086 . . . . 0.0 112.765 -172.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.2 tt -63.83 -22.17 66.79 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.522 1.129 . . . . 0.0 111.285 176.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 53.08 39.01 28.82 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.998 1.719 . . . . 0.0 112.556 170.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -157.5 50.8 0.42 Allowed Glycine 0 C--N 1.338 0.656 0 C-N-CA 124.067 0.842 . . . . 0.0 111.03 -169.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -58.36 -35.48 72.02 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.294 0.637 . . . . 0.0 110.406 170.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -83.63 155.0 23.43 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.535 1.534 . . . . 0.0 110.326 -170.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.1 m -73.28 -3.46 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 C-N-CA 123.68 0.792 . . . . 0.0 112.208 168.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -133.56 6.41 3.77 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.616 1.166 . . . . 0.0 112.877 -164.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 72.2 m -87.84 -69.3 0.7 Allowed 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.085 -1.01 . . . . 0.0 109.902 173.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.276 12.7 ptm180 -82.05 11.74 4.87 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 120.605 -1.309 . . . . 0.0 114.147 -170.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 24.6 m -62.87 -31.8 53.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 O-C-N 121.992 -0.442 . . . . 0.0 110.305 157.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -73.21 113.47 10.31 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 170.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.3 tt -145.95 137.57 24.97 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 118.342 0.519 . . . . 0.0 110.282 -167.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.3 tt -150.66 150.64 31.38 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.784 1.634 . . . . 0.0 107.088 -168.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 60.3 mtt -142.19 157.42 44.88 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 120.624 -1.298 . . . . 0.0 108.802 -176.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 15.5 ptmt -155.42 173.58 16.46 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 125.002 1.321 . . . . 0.0 109.718 163.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -57.93 163.5 2.69 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 164.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.09 159.82 5.46 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.281 163.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -132.17 106.59 8.06 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 175.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.252 1.196 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 -168.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.0 ptt? . . . . . 0 N--CA 1.479 1.016 0 CA-C-O 119.587 -0.244 . . . . 0.0 110.591 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.26 -35.04 68.66 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 119.443 -0.313 . . . . 0.0 111.067 169.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 60.88 56.67 22.87 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.161 -1.175 . . . . 0.0 110.161 -176.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.5 tt -51.48 139.83 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 124.424 1.09 . . . . 0.0 110.206 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -120.38 -48.1 2.32 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.697 0.799 . . . . 0.0 110.054 -169.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -154.71 151.68 29.02 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -151.78 141.87 22.21 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 126.508 1.923 . . . . 0.0 107.642 -173.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -151.57 150.71 30.63 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 168.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 mp -72.42 148.52 9.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 172.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -135.94 156.82 48.17 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.325 1.85 . . . . 0.0 107.455 175.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -129.21 144.98 51.41 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.901 1.28 . . . . 0.0 108.355 176.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.8 p -73.83 146.22 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 C-N-CA 124.283 1.033 . . . . 0.0 108.767 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -125.59 -28.94 3.23 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 126.558 1.943 . . . . 0.0 109.479 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -157.68 166.62 32.34 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.028 0.831 . . . . 0.0 110.67 170.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.6 mp -143.57 138.15 25.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 127.26 2.224 . . . . 0.0 106.58 -174.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -151.66 101.25 2.91 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 123.202 0.601 . . . . 0.0 109.721 169.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -57.79 146.18 86.95 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.917 2.411 . . . . 0.0 111.292 172.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -127.66 13.64 6.96 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.227 0.611 . . . . 0.0 112.207 -172.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 174.72 79.86 0.05 OUTLIER Glycine 0 C--N 1.338 0.689 0 O-C-N 121.199 -0.938 . . . . 0.0 111.511 -170.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.9 mmtt -57.46 -18.4 18.15 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -72.47 -14.37 61.66 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.8 0.727 . . . . 0.0 111.111 175.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -136.32 52.33 1.97 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 127.149 2.18 . . . . 0.0 106.108 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -50.05 -28.06 6.52 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.806 1.643 . . . . 0.0 114.783 -169.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -68.64 2.17 2.66 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 117.668 -1.158 . . . . 0.0 113.707 173.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.3 t -125.52 121.89 61.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 121.138 1.79 . . . . 0.0 107.596 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.3 m -147.15 158.25 43.88 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.888 0.875 . . . . 0.0 110.759 -173.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.5 ttp-105 -83.02 148.28 27.65 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 170.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.0 mt -139.41 154.12 47.74 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.7 2.0 . . . . 0.0 107.273 177.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -126.69 132.52 51.15 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 103.926 -2.62 . . . . 0.0 103.926 171.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 64.0 m -145.21 167.24 23.28 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.956 1.302 . . . . 0.0 111.154 -169.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -140.71 142.5 34.84 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.463 1.905 . . . . 0.0 108.081 -176.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 31.9 p -72.72 151.78 42.0 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 118.125 0.421 . . . . 0.0 111.092 177.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -83.55 -37.32 23.14 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 118.757 -0.64 . . . . 0.0 111.495 176.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.6 m -101.76 -17.61 16.17 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 -168.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -124.2 -102.16 0.38 Allowed 'General case' 0 C--N 1.342 0.252 0 CA-C-N 120.545 1.52 . . . . 0.0 110.542 -170.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -168.19 10.8 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.204 1.002 . . . . 0.0 113.003 -169.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 59.6 mtm -70.56 146.7 49.96 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.342 0.591 . . . . 0.0 110.158 -173.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -118.58 128.78 54.87 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 172.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.4 tp -133.34 139.18 46.69 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 123.598 0.759 . . . . 0.0 110.46 -169.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 14.8 mm -125.6 148.25 30.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 103.776 -2.675 . . . . 0.0 103.776 169.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.5 mt -150.21 144.68 25.77 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 126.346 1.858 . . . . 0.0 107.057 -171.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -131.58 94.62 3.56 Favored 'General case' 0 C--N 1.32 -0.694 1 N-CA-C 99.754 -4.165 . . . . 0.0 99.754 168.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.7 p -136.24 161.65 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-O 122.07 0.938 . . . . 0.0 112.536 -166.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -68.48 90.71 0.38 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.039 2.135 . . . . 0.0 109.057 169.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.6 pp -69.65 3.88 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -169.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -65.98 -11.68 49.46 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 120.854 1.661 . . . . 0.0 111.957 176.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 55.7 mt -59.51 -34.08 53.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 169.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -92.32 155.04 42.88 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 124.923 1.289 . . . . 0.0 108.426 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.04 -23.82 33.64 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.196 1.931 . . . . 0.0 112.526 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.0 t -145.81 153.97 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 -178.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -53.93 -28.94 40.13 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.445 1.098 . . . . 0.0 112.306 169.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 39.5 tp -56.64 -17.0 7.24 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.456 1.502 . . . . 0.0 112.903 173.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.88 173.67 49.71 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 124.011 0.815 . . . . 0.0 111.359 177.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -164.11 175.07 10.56 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.901 2.08 . . . . 0.0 106.497 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -67.43 147.25 53.12 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 169.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -150.03 -173.44 4.43 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.063 1.345 . . . . 0.0 107.711 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -132.95 148.08 52.28 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 119.136 0.88 . . . . 0.0 109.338 170.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.1 tt -118.88 143.21 47.11 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.5 t -139.34 155.46 26.04 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 C-N-CA 124.666 1.187 . . . . 0.0 109.694 -168.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.1 tt -129.72 148.35 33.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 127.725 2.41 . . . . 0.0 106.24 170.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -149.04 -168.16 3.03 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.939 1.295 . . . . 0.0 109.155 -173.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 37.1 m -145.05 51.85 1.22 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.51 1.524 . . . . 0.0 108.275 -174.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.2 m -43.87 105.29 0.05 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.569 1.947 . . . . 0.0 114.349 -169.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 19.6 tp -77.6 -13.53 59.89 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.45 1.1 . . . . 0.0 111.017 174.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -57.86 -24.62 58.36 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.016 -1.053 . . . . 0.0 111.786 174.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -68.94 -34.65 75.71 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.035 0.834 . . . . 0.0 111.333 174.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -72.63 -32.79 66.17 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 118.216 0.462 . . . . 0.0 110.331 174.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 124.6 41.79 0.37 Allowed Glycine 0 C--N 1.34 0.754 0 CA-C-O 118.4 -1.222 . . . . 0.0 113.65 169.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.84 -35.62 69.05 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 120.126 1.963 . . . . 0.0 111.734 -176.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.3 pp -76.03 -13.27 60.23 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -91.07 -30.11 16.94 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.966 0.803 . . . . 0.0 109.369 169.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -70.18 -22.56 62.94 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.081 0.952 . . . . 0.0 113.443 176.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 154.27 -15.51 0.58 Allowed Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.515 1.055 . . . . 0.0 115.237 169.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -80.6 40.96 0.53 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 119.471 1.636 . . . . 0.0 111.423 -173.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -74.74 75.28 2.07 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 120.86 -1.15 . . . . 0.0 109.189 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -59.3 127.41 84.23 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-O 118.088 -0.958 . . . . 0.0 109.388 -174.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -52.54 -31.37 48.72 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.216 2.61 . . . . 0.0 114.678 -177.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.99 -12.19 60.3 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.726 1.21 . . . . 0.0 111.784 -178.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -64.53 -19.84 65.86 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 120.585 -1.322 . . . . 0.0 111.814 175.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -135.76 4.24 3.04 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.201 1.0 . . . . 0.0 112.763 -176.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 67.5 mtt85 -127.1 128.24 24.18 Favored Pre-proline 0 N--CA 1.468 0.434 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER 23.36 58.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.683 1 C-N-CA 125.702 4.268 . . . . 0.0 113.665 -169.218 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.2 p -65.77 22.49 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 128.719 2.808 . . . . 0.0 116.787 -168.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.61 147.15 46.67 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 168.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.43 160.93 6.23 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.519 0.676 . . . . 0.0 110.125 174.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -159.45 -32.55 0.06 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.82 1.248 . . . . 0.0 111.038 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -53.01 -49.41 66.27 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.584 1.954 . . . . 0.0 109.127 169.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -146.8 167.81 22.96 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 127.6 2.36 . . . . 0.0 107.4 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -82.83 -31.29 28.15 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.703 0.683 . . . . 0.0 110.127 169.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -147.54 150.31 34.26 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.187 0.595 . . . . 0.0 109.663 177.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.2 t -143.62 138.88 25.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.08 169.56 23.24 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.894 0.855 . . . . 0.0 110.571 175.317 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -134.22 93.57 3.1 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 -171.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -92.62 -164.31 37.99 Favored Glycine 0 C--N 1.332 0.357 0 CA-C-O 121.682 0.601 . . . . 0.0 112.732 -169.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -134.04 111.93 10.78 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 169.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.7 t -69.84 149.0 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 169.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -143.34 58.59 1.39 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.556 0.742 . . . . 0.0 110.935 174.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -143.59 160.86 39.88 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.964 1.306 . . . . 0.0 109.878 174.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -83.5 -177.2 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 125.432 1.493 . . . . 0.0 109.723 169.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -64.08 -6.99 7.38 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.612 1.565 . . . . 0.0 114.847 -177.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 138.3 -61.81 0.58 Allowed Glycine 0 CA--C 1.52 0.406 0 N-CA-C 107.0 -2.44 . . . . 0.0 107.0 -172.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -147.49 -97.77 0.09 Allowed 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 125.045 1.338 . . . . 0.0 107.734 169.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -167.85 74.6 0.12 Allowed 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 124.295 1.038 . . . . 0.0 109.566 -170.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.53 HG21 ' H ' ' A' ' 109' ' ' ALA . 10.2 t -150.15 -159.79 1.08 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 123.013 1.387 . . . . 0.0 111.756 -169.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.0 m -125.26 9.46 7.95 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 128.876 2.871 . . . . 0.0 109.481 169.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . 0.279 3.9 m 109.77 38.41 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 130.27 3.428 . . . . 0.0 108.232 170.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -139.91 -2.15 1.54 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.731 1.612 . . . . 0.0 112.278 -176.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.448 ' HB3' ' HB ' ' A' ' 104' ' ' THR . . . -109.58 -46.29 3.55 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 169.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.53 ' H ' HG21 ' A' ' 104' ' ' THR . . . -111.61 149.21 31.81 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 111.991 -2.368 . . . . 0.0 107.676 167.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 32.8 p -128.64 -3.78 5.33 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -177.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -128.46 144.05 51.08 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 173.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 7.8 tt -92.83 149.08 21.51 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 168.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 10.7 p -116.0 146.0 42.5 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -139.42 100.18 3.92 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -95.66 128.19 42.32 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 101.65 -3.463 . . . . 0.0 101.65 169.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.7 t -140.02 137.7 38.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -169.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.7 t -117.45 137.82 52.26 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 170.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -150.15 105.63 3.39 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.609 0.764 . . . . 0.0 109.536 -171.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 61.27 22.44 60.94 Favored Glycine 0 CA--C 1.534 1.264 0 O-C-N 121.546 -0.721 . . . . 0.0 113.927 175.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.49 -13.58 65.34 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.499 1.047 . . . . 0.0 112.934 -177.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -85.59 164.13 17.93 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 169.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 7.8 tt -146.21 155.92 43.03 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 121.695 -0.628 . . . . 0.0 109.956 -171.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 23.4 ptm -150.42 161.01 43.34 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.394 1.077 . . . . 0.0 108.906 172.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 58.7 ttt-85 -135.96 127.44 28.65 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 104.978 -2.231 . . . . 0.0 104.978 172.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 25.5 tp -141.97 140.69 32.8 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -170.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -132.54 145.79 51.41 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 169.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -171.74 178.18 44.15 Favored Glycine 0 C--N 1.331 0.298 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 174.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.08 140.66 48.56 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 118.158 0.979 . . . . 0.0 109.221 172.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -52.27 -62.18 1.8 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.604 0.761 . . . . 0.0 112.613 -175.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.31 -24.08 66.48 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.117 0.871 . . . . 0.0 113.032 -174.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.37 -35.5 77.81 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 126.16 1.784 . . . . 0.0 109.774 174.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 16.9 tp -94.81 -19.2 20.53 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.713 0.805 . . . . 0.0 110.252 -175.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 42.58 42.2 2.7 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.669 1.988 . . . . 0.0 112.041 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -105.71 20.17 37.22 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.029 0.823 . . . . 0.0 112.458 -172.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -74.16 8.8 1.91 Allowed 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.25 1.025 . . . . 0.0 113.497 -178.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -131.79 131.11 42.64 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 169.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.9 p -57.65 -10.15 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 125.124 1.37 . . . . 0.0 110.857 169.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -123.56 12.71 9.33 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 126.002 1.721 . . . . 0.0 112.978 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 3.4 m -89.12 -58.98 2.35 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 167.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.6 tpm_? -75.55 2.07 12.66 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 115.466 -0.788 . . . . 0.0 113.031 -169.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 29.2 m -60.25 -37.98 75.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 124.422 1.089 . . . . 0.0 110.14 169.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -71.95 118.47 14.85 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 63.3 tp -138.88 120.65 15.32 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 -172.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.59 149.34 45.16 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -174.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 61.6 mtt -143.11 144.59 32.29 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -172.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -152.3 160.78 43.28 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -64.02 157.19 25.81 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 168.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.3 pp -67.21 165.36 16.27 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.242 0.544 . . . . 0.0 110.172 170.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -142.14 140.08 32.34 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 170.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 . . . . . 0 C--O 1.25 1.102 0 C-N-CA 126.392 1.877 . . . . 0.0 110.413 -176.312 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.4 mmm . . . . . 0 N--CA 1.474 0.757 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -56.28 145.46 26.74 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.241 0.616 . . . . 0.0 111.386 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -88.97 -162.64 38.69 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.747 1.165 . . . . 0.0 111.124 175.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.7 mm -135.92 144.61 32.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 171.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -49.85 116.34 1.76 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.613 1.165 . . . . 0.0 111.003 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -153.36 134.34 13.97 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 172.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -144.76 147.7 33.25 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.28 1.432 . . . . 0.0 108.08 -169.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -150.31 155.7 40.16 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.187 0.595 . . . . 0.0 109.434 169.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.3 mp -85.82 144.7 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 169.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -113.04 143.59 44.06 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.035 1.334 . . . . 0.0 107.68 171.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -117.06 122.83 45.29 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.878 1.671 . . . . 0.0 106.832 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.7 t -71.7 121.43 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -176.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.5 mmmt -96.61 -29.86 13.6 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.194 177.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -155.33 165.08 37.75 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.408 1.003 . . . . 0.0 111.459 175.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.4 mp -142.55 135.61 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 127.85 2.46 . . . . 0.0 105.756 -177.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -147.87 93.04 4.58 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 118.301 0.501 . . . . 0.0 111.155 178.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -61.16 144.77 99.18 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.911 2.407 . . . . 0.0 109.954 169.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -131.79 9.4 4.58 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -174.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.84 46.61 10.68 Favored Glycine 0 C--N 1.343 0.918 0 O-C-N 121.478 -0.764 . . . . 0.0 111.202 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.0 mmmm -73.03 25.97 0.06 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.289 1.436 . . . . 0.0 112.772 -171.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp 68.02 -59.84 0.42 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 128.497 2.719 . . . . 0.0 108.569 -168.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 4.8 m-30 -81.26 87.18 6.13 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 103.633 -2.729 . . . . 0.0 103.633 168.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -62.68 -17.58 60.85 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.285 -0.884 . . . . 0.0 112.656 -174.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 -66.54 -14.49 62.38 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 118.028 -0.987 . . . . 0.0 112.51 169.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 77.2 t -88.78 134.15 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 169.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.6 m -151.04 159.44 44.54 Favored 'General case' 0 C--O 1.239 0.542 0 O-C-N 120.928 -1.108 . . . . 0.0 109.981 -176.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.6 tpp85 -72.66 150.44 42.98 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 172.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.6 mt -138.14 157.19 46.81 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.923 1.689 . . . . 0.0 107.247 172.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -135.46 133.57 38.69 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 169.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 33.7 m -141.11 166.11 25.68 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.242 1.417 . . . . 0.0 110.087 -174.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -134.87 143.47 47.0 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 172.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.1 p -83.85 145.47 28.62 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 118.762 0.71 . . . . 0.0 110.255 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -80.57 -32.05 36.7 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -169.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.9 m -102.62 -34.21 9.16 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.138 0.881 . . . . 0.0 111.75 -171.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -121.71 10.28 10.29 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.669 1.187 . . . . 0.0 112.712 -170.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.315 0.0 OUTLIER 43.11 39.19 1.78 Allowed 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.915 2.086 . . . . 0.0 114.371 174.637 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 62.5 mtm -63.64 154.08 34.02 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 169.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -112.46 127.77 56.13 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 176.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 59.3 tp -137.81 144.9 41.74 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.78 0.8 . . . . 0.0 110.437 -169.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 35.6 mm -127.83 149.12 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 128.479 2.712 . . . . 0.0 103.737 169.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 123' ' ' MET . 2.0 mp -143.63 161.08 39.46 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 126.201 1.801 . . . . 0.0 108.254 176.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -138.48 94.59 2.87 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 102.312 -3.218 . . . . 0.0 102.312 168.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.7 m -144.15 168.74 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 124.36 1.064 . . . . 0.0 111.295 -168.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -60.03 134.2 56.81 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.041 0.936 . . . . 0.0 110.149 170.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 pp -116.51 2.14 7.88 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.445 0 C-N-CA 125.372 1.469 . . . . 0.0 112.966 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -64.77 -12.24 45.37 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 121.367 1.894 . . . . 0.0 113.248 -172.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 66.2 mt -58.95 -22.53 21.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 125.891 1.676 . . . . 0.0 108.816 169.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -127.38 167.05 19.19 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 128.531 2.733 . . . . 0.0 109.426 -178.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -52.17 157.27 6.59 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.664 2.242 . . . . 0.0 111.875 169.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.7 m -59.57 -10.77 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 N-CA-C 115.573 1.694 . . . . 0.0 115.573 -169.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -139.9 27.5 2.2 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.761 1.224 . . . . 0.0 110.55 -177.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 25.7 tp -140.89 163.16 33.7 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.235 -0.916 . . . . 0.0 110.753 -173.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -165.37 167.81 39.08 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 128.068 2.747 . . . . 0.0 106.405 171.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -141.77 -64.06 0.44 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 118.705 1.252 . . . . 0.0 111.788 -178.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -148.32 162.7 38.99 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.419 1.009 . . . . 0.0 111.159 178.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -145.27 171.34 14.71 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.54 1.936 . . . . 0.0 107.415 170.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -136.02 123.47 22.07 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.5 mp -125.15 146.44 49.49 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -169.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -157.01 128.25 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 121.839 0.828 . . . . 0.0 108.775 -169.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.0 tp -69.16 -32.46 54.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 123.508 0.723 . . . . 0.0 109.945 174.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 57.55 175.43 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.845 2.058 . . . . 0.0 112.787 -172.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.6 m -81.67 5.66 17.62 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.654 -0.654 . . . . 0.0 112.231 172.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.526 HG22 ' H ' ' A' ' 64' ' ' LEU . 1.9 m 62.66 -179.18 0.14 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.45 1.5 . . . . 0.0 110.782 -177.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.526 ' H ' HG22 ' A' ' 63' ' ' THR . 1.9 pt? -126.83 11.15 7.15 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.514 1.126 . . . . 0.0 113.505 -170.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 42.5 56.21 3.87 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.284 1.834 . . . . 0.0 113.554 171.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -59.92 -20.7 58.85 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.022 0.929 . . . . 0.0 111.748 176.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -61.86 -25.61 67.64 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.301 1.04 . . . . 0.0 111.893 176.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 151.11 -28.24 1.0 Allowed Glycine 0 C--N 1.34 0.765 0 CA-C-O 119.121 -0.822 . . . . 0.0 113.623 169.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -58.78 -27.97 65.5 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.454 1.127 . . . . 0.0 113.923 -168.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 98.3 mt -121.5 -19.27 6.98 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.201 0.91 . . . . 0.0 112.421 171.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -60.46 -27.65 67.7 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 119.277 0.944 . . . . 0.0 111.043 172.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -64.83 -9.81 23.55 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.24 1.416 . . . . 0.0 114.612 177.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -136.76 -0.54 2.85 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 125.362 1.458 . . . . 0.0 113.193 178.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 45.33 41.51 6.39 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.067 1.747 . . . . 0.0 111.23 -173.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -63.24 118.03 7.4 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -156.04 103.91 2.09 Favored Pre-proline 0 N--CA 1.452 -0.346 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -173.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -54.3 -23.09 28.9 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.292 2.661 . . . . 0.0 114.633 177.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.5 m 50.26 36.63 13.1 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.9 1.68 . . . . 0.0 110.851 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -77.83 64.76 3.14 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.282 1.433 . . . . 0.0 111.452 -169.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -152.25 -49.05 0.11 Allowed 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 125.992 1.717 . . . . 0.0 109.002 174.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -66.09 -45.26 62.36 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-O 117.12 -1.419 . . . . 0.0 113.401 -177.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -89.34 18.34 1.45 Allowed 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.149 2.566 . . . . 0.0 111.71 176.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.7 m -135.69 -168.55 2.23 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.125 1.77 . . . . 0.0 108.656 -169.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -64.37 109.54 1.95 Allowed 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 169.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.05 24.11 0.1 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.887 1.275 . . . . 0.0 112.468 -176.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -82.32 35.26 0.44 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.362 1.465 . . . . 0.0 111.462 -174.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 41.94 53.55 4.14 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 129.38 3.072 . . . . 0.0 114.066 175.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -75.35 38.27 0.14 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.35 1.46 . . . . 0.0 110.846 169.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -164.29 124.93 2.12 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.494 1.117 . . . . 0.0 109.114 172.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -148.69 154.17 39.27 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 168.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.7 m -137.18 151.93 27.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 O-C-N 121.538 -0.726 . . . . 0.0 110.215 -171.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 37.5 ttm -152.84 161.92 41.94 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.597 1.559 . . . . 0.0 107.353 176.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -136.85 151.72 49.44 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -173.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.18 -157.51 8.58 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 120.908 -0.663 . . . . 0.0 114.366 -169.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -144.82 123.72 12.71 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.772 1.629 . . . . 0.0 107.146 176.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.9 t -77.89 141.89 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 169.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -140.09 64.89 1.43 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.857 1.263 . . . . 0.0 110.057 177.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.418 ' HB2' ' H ' ' A' ' 115' ' ' TYR . 1.0 OUTLIER -154.17 167.52 29.58 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.245 -1.535 . . . . 0.0 112.415 -179.578 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.9 pt -83.4 -177.12 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 127.249 2.22 . . . . 0.0 112.21 -170.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -74.5 -3.15 29.09 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.742 1.617 . . . . 0.0 114.115 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 56.44 42.2 89.21 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.338 0.97 . . . . 0.0 112.537 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -143.42 65.5 1.32 Allowed 'General case' 0 C--O 1.233 0.214 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 172.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -143.64 95.27 2.72 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.513 1.125 . . . . 0.0 108.768 -171.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -65.17 146.39 55.03 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 168.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 84.3 p 121.46 -15.41 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 130.99 3.716 . . . . 0.0 109.707 169.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.6 29.95 3.2 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.331 0.653 . . . . 0.0 109.684 169.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 47.27 43.84 15.32 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.103 1.761 . . . . 0.0 111.702 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -114.78 39.54 2.82 Favored 'General case' 0 C--N 1.342 0.261 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -102.85 -2.98 26.95 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -168.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 72.7 p -134.85 158.27 44.66 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 125.382 1.473 . . . . 0.0 108.537 169.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? 58.87 120.28 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 127.799 2.44 . . . . 0.0 111.652 -173.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 55.3 tp -57.98 144.28 40.11 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 170.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.6 p -123.65 149.03 45.91 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.473 1.109 . . . . 0.0 109.8 -173.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -148.38 108.15 4.01 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.575 1.15 . . . . 0.0 108.373 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.418 ' H ' ' HB2' ' A' ' 98' ' ' ARG . 7.6 m-30 -91.57 122.63 34.32 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 102.379 -3.193 . . . . 0.0 102.379 168.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.0 t -129.71 112.75 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -169.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.2 p -88.24 128.77 35.47 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 104.767 -2.308 . . . . 0.0 104.767 169.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.39 134.35 20.27 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 118.711 0.687 . . . . 0.0 109.631 -172.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 47.21 33.19 7.34 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 124.646 1.117 . . . . 0.0 115.188 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 76.51 17.07 80.23 Favored Glycine 0 CA--C 1.536 1.399 0 CA-C-N 118.716 1.258 . . . . 0.0 113.682 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 93.8 mt -129.2 178.65 6.28 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 128.284 2.633 . . . . 0.0 107.283 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 58.3 tp -139.13 154.15 48.08 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 120.837 -1.164 . . . . 0.0 111.539 -171.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.464 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 76.5 mtm -143.43 156.16 44.58 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.777 2.031 . . . . 0.0 107.901 169.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -137.54 117.93 13.73 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 169.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 51.3 tp -125.59 148.95 48.76 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 125.943 1.697 . . . . 0.0 109.789 -168.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -139.74 148.81 42.81 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.222 1.409 . . . . 0.0 108.448 169.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -165.59 165.17 37.77 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 173.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -71.87 86.7 0.98 Allowed 'General case' 0 N--CA 1.463 0.205 0 O-C-N 122.059 -0.671 . . . . 0.0 110.301 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . 22.85 -77.45 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 130.436 3.494 . . . . 0.0 115.242 -170.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -13.13 16.3 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 11.3 m-20 -85.74 -36.16 20.33 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.972 1.709 . . . . 0.0 109.323 176.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 9.2 tt -72.64 -29.97 63.91 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 170.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 1.8 t60 54.99 45.52 26.24 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.606 1.962 . . . . 0.0 112.069 169.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -152.04 68.49 0.32 Allowed Glycine 0 C--N 1.335 0.484 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 -175.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -73.4 3.55 5.83 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.233 1.013 . . . . 0.0 113.728 -174.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -129.13 145.35 51.32 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.366 1.866 . . . . 0.0 108.513 172.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 7.8 m -66.32 -1.04 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.098 168.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -123.16 15.36 9.84 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 127.746 2.419 . . . . 0.0 111.447 177.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 75.3 m -80.95 -70.5 0.53 Allowed 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.463 -0.773 . . . . 0.0 109.366 168.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.316 1.8 ptp180 -81.56 15.14 2.21 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -169.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 30.3 m -70.97 -12.24 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 167.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -109.27 120.77 43.52 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 103.232 -2.877 . . . . 0.0 103.232 168.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -136.75 130.5 32.07 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -172.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 7.5 tt -117.83 139.47 51.06 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 176.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 19.6 ptt? -144.83 162.11 37.61 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 121.327 -0.858 . . . . 0.0 109.733 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 78.8 mttt -152.86 166.64 31.66 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.759 1.623 . . . . 0.0 108.635 -169.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -71.17 167.69 18.82 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 167.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.34 157.26 8.84 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.173 0.511 . . . . 0.0 110.81 169.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -147.76 123.37 10.47 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 171.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 . . . . . 0 C--O 1.248 0.982 0 C-N-CA 125.995 1.718 . . . . 0.0 107.162 178.092 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 ttt . . . . . 0 N--CA 1.485 1.317 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -48.22 148.79 1.7 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.928 0.891 . . . . 0.0 111.195 170.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -63.63 -26.06 69.45 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 123.646 0.641 . . . . 0.0 113.461 -171.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.2 tp -143.08 169.02 12.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 125.772 1.629 . . . . 0.0 107.127 171.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -144.6 136.14 25.58 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -177.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -142.87 163.58 32.41 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.006 1.322 . . . . 0.0 107.682 169.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -139.31 124.14 18.63 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 103.878 -2.638 . . . . 0.0 103.878 174.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -142.35 131.97 23.95 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.418 0.687 . . . . 0.0 109.357 -171.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.8 mp -81.79 129.15 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 177.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -96.69 153.03 18.1 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.651 1.581 . . . . 0.0 108.065 175.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -132.27 114.99 15.09 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 126.083 1.753 . . . . 0.0 106.999 172.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 68.9 t -71.47 122.19 23.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 177.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.0 mmmt -85.21 -41.35 15.7 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 173.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -158.6 166.56 31.79 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.305 0.502 . . . . 0.0 111.73 -173.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.4 mp -137.05 141.21 41.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 127.756 2.422 . . . . 0.0 106.481 -175.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -145.59 89.2 6.31 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 124.45 1.1 . . . . 0.0 110.485 -171.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -66.32 142.23 65.52 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.92 3.08 . . . . 0.0 111.352 170.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -78.37 -38.39 41.94 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.942 -0.474 . . . . 0.0 111.597 177.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 147.38 47.48 0.03 OUTLIER Glycine 0 CA--C 1.527 0.829 0 N-CA-C 104.932 -3.267 . . . . 0.0 104.932 -169.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -63.15 120.49 11.59 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.213 1.405 . . . . 0.0 113.468 -167.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.456 ' HA ' ' HE3' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -64.97 -46.93 79.44 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.164 168.955 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -80.63 -19.21 45.89 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.08 0.552 . . . . 0.0 112.351 -174.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.7 t70 47.12 39.08 7.52 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.99 2.116 . . . . 0.0 113.956 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -142.64 8.25 1.73 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 176.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.7 t -139.24 133.4 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 73.1 m -156.43 168.17 28.18 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 120.786 1.63 . . . . 0.0 110.48 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.1 ttm105 -72.19 149.3 44.76 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 169.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.88 158.09 45.25 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 125.786 1.634 . . . . 0.0 107.755 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -133.31 125.48 29.32 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 174.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 58.5 m -141.89 169.59 17.3 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.947 1.299 . . . . 0.0 111.004 -169.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.1 tt0 -143.78 145.0 32.05 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 125.267 1.427 . . . . 0.0 108.118 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.3 m -75.68 131.48 39.92 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 123.285 0.634 . . . . 0.0 109.939 169.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -80.28 -19.6 46.34 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.557 0.743 . . . . 0.0 111.011 170.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.23 -36.07 3.03 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -169.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -115.38 21.53 14.0 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.527 1.131 . . . . 0.0 112.243 -177.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt 42.96 18.03 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 118.685 2.846 . . . . 0.0 118.685 172.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 68.7 mtm -67.72 151.08 47.82 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.868 1.213 . . . . 0.0 108.534 174.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -112.35 127.69 56.08 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 104.613 -2.365 . . . . 0.0 104.613 171.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.5 mp -136.21 150.89 49.19 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 119.094 0.861 . . . . 0.0 112.614 -168.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 46.2 mm -123.1 144.5 32.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 102.812 -3.033 . . . . 0.0 102.812 168.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.8 mp -143.32 160.66 40.1 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 127.347 2.259 . . . . 0.0 107.455 -169.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -140.2 102.68 4.42 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 102.487 -3.153 . . . . 0.0 102.487 168.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.4 m -144.52 169.35 9.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 C-N-CA 124.203 1.001 . . . . 0.0 111.567 -168.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -65.43 136.06 56.01 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 169.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.8 pp -112.33 7.66 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 124.507 1.123 . . . . 0.0 112.686 -175.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -59.72 -23.14 62.93 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 121.541 -0.725 . . . . 0.0 110.675 169.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.1 mt -68.89 -26.83 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 126.127 1.771 . . . . 0.0 109.839 173.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -127.92 68.16 74.99 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 126.01 1.724 . . . . 0.0 109.02 -170.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -73.41 6.4 2.71 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.676 2.917 . . . . 0.0 114.464 -169.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.6 m -136.87 148.89 26.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 C-N-CA 124.934 1.293 . . . . 0.0 108.862 -174.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -60.57 -25.97 66.58 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.613 1.165 . . . . 0.0 112.349 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 52.7 tp -60.95 -23.92 65.68 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.652 1.181 . . . . 0.0 112.314 174.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.42 -168.08 46.22 Favored Glycine 0 CA--C 1.532 1.123 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -169.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -153.07 173.59 15.26 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.332 1.053 . . . . 0.0 108.281 176.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -94.46 152.46 18.57 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.566 0.746 . . . . 0.0 109.016 169.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -151.92 -177.0 5.88 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.246 1.418 . . . . 0.0 107.911 -173.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 10.7 ttp180 -136.65 146.29 45.81 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 120.929 -1.107 . . . . 0.0 108.661 177.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.0 tt -127.65 145.59 50.83 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.662 1.585 . . . . 0.0 107.883 176.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -145.59 166.91 9.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 127.342 2.257 . . . . 0.0 105.921 -174.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 46.4 pt -129.09 27.1 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 O-C-N 121.297 -0.877 . . . . 0.0 111.389 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -83.58 13.18 4.78 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.882 1.273 . . . . 0.0 113.773 -174.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.1 m -64.06 6.8 0.16 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 116.589 2.07 . . . . 0.0 116.589 -169.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.37 35.07 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 56.1 tp -60.4 -24.42 65.12 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 120.82 -1.175 . . . . 0.0 108.635 168.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 39.2 t80 76.05 166.32 0.26 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 128.814 2.845 . . . . 0.0 111.837 169.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -75.65 41.69 0.21 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.245 1.818 . . . . 0.0 110.222 170.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -62.13 -22.35 65.77 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.812 1.645 . . . . 0.0 113.635 -169.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -66.33 -2.67 15.5 Favored Glycine 0 CA--C 1.532 1.128 0 CA-C-O 119.069 -0.85 . . . . 0.0 113.698 170.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 57.9 m -64.15 -30.19 71.27 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.158 1.479 . . . . 0.0 108.834 169.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 73.8 mt -71.44 131.7 43.72 Favored 'General case' 0 C--N 1.343 0.302 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 169.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -75.42 60.82 1.19 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.222 1.409 . . . . 0.0 113.575 -169.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -145.15 13.51 1.43 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.403 1.081 . . . . 0.0 111.006 169.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.17 -32.6 3.01 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 126.502 2.001 . . . . 0.0 111.593 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -168.57 155.97 7.73 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 128.98 2.912 . . . . 0.0 105.225 177.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -139.87 23.09 2.45 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.452 1.101 . . . . 0.0 110.608 -175.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -130.17 81.03 69.6 Favored Pre-proline 0 C--O 1.233 0.219 0 C-N-CA 125.331 1.452 . . . . 0.0 107.64 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -62.64 -17.11 56.98 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.194 1.929 . . . . 0.0 111.856 176.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.5 m -55.05 -21.91 14.02 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.723 1.609 . . . . 0.0 112.509 171.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -67.21 -16.68 64.44 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 119.575 1.08 . . . . 0.0 112.776 172.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -124.79 -30.78 3.25 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.044 1.337 . . . . 0.0 112.567 -175.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 -58.69 123.18 66.4 Favored Pre-proline 0 N--CA 1.467 0.408 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 171.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER 23.86 45.94 0.0 OUTLIER 'Trans proline' 0 CA--C 1.539 0.748 1 C-N-CA 126.711 4.941 . . . . 0.0 116.72 -168.904 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.6 m -149.79 160.32 43.65 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.138 1.775 . . . . 0.0 108.645 -175.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 85.4 mtt85 -145.92 172.52 13.24 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.632 1.173 . . . . 0.0 108.671 -177.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.88 -13.22 22.61 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 171.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -49.82 -16.66 0.28 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.033 2.133 . . . . 0.0 113.891 172.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -50.19 -27.67 6.26 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.318 1.047 . . . . 0.0 112.441 169.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -146.3 171.72 14.55 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.493 1.517 . . . . 0.0 110.893 -178.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -120.05 -33.57 3.91 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 169.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -144.75 144.87 31.41 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.198 1.799 . . . . 0.0 106.209 169.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.7 p -148.72 141.27 18.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -178.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 31.9 tpp -159.34 173.63 15.98 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.51 1.124 . . . . 0.0 110.457 -171.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -134.82 147.78 50.02 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 127.265 2.226 . . . . 0.0 106.924 -173.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -158.38 -157.2 8.35 Favored Glycine 0 C--N 1.338 0.692 0 CA-C-N 119.171 0.896 . . . . 0.0 113.857 -171.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -133.39 125.8 29.88 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 125.665 1.586 . . . . 0.0 106.767 173.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.405 ' HB ' ' HA ' ' A' ' 137' ' ' VAL . 84.3 t -93.19 150.64 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 175.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -134.94 154.46 51.69 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 126.625 1.97 . . . . 0.0 105.984 175.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.76 162.03 39.77 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.632 1.105 . . . . 0.0 111.423 171.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 24.5 pt -80.35 177.67 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 O-C-N 123.973 0.796 . . . . 0.0 108.937 169.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -76.95 -3.27 38.0 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.72 1.208 . . . . 0.0 113.683 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 89.4 3.84 74.63 Favored Glycine 0 C--N 1.339 0.725 0 CA-C-O 119.328 -0.707 . . . . 0.0 112.614 -176.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -123.78 125.44 44.71 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 118.651 1.225 . . . . 0.0 108.683 169.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -138.82 42.64 2.12 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 169.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -138.12 -46.01 0.52 Allowed 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.25 1.02 . . . . 0.0 109.624 -169.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.3 p -177.2 -58.17 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.082 1.353 . . . . 0.0 109.372 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 175.08 -22.39 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 130.659 3.583 . . . . 0.0 107.8 -169.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -63.25 -20.12 65.16 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.158 0.983 . . . . 0.0 113.536 -174.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 84.98 113.55 0.05 Allowed 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 129.731 3.212 . . . . 0.0 106.589 -178.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.87 162.17 19.58 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.753 -170.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.4 p -71.29 -6.21 38.11 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -177.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -136.44 144.64 44.55 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.797 1.239 . . . . 0.0 108.773 169.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.1 tp -88.82 152.96 21.44 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 167.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 14.3 m -126.46 145.16 50.6 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 118.294 0.497 . . . . 0.0 109.822 177.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -146.46 160.04 42.61 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.748 1.219 . . . . 0.0 110.213 -172.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -130.38 158.56 39.51 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 169.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.0 p -149.27 136.2 13.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 169.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.9 t -123.75 129.16 50.64 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 178.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -150.42 122.67 8.36 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 123.859 0.863 . . . . 0.0 109.381 -169.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 54.28 21.64 19.83 Favored Glycine 0 CA--C 1.538 1.527 0 CA-C-O 119.158 -0.801 . . . . 0.0 114.899 178.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 92.7 -4.52 75.93 Favored Glycine 0 CA--C 1.536 1.347 0 CA-C-N 118.735 1.267 . . . . 0.0 113.797 -177.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -95.15 164.13 13.0 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 118.975 1.387 . . . . 0.0 108.229 171.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 39.9 tp -143.85 155.45 44.12 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 122.939 0.495 . . . . 0.0 110.693 -169.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 15.3 mtt -144.04 152.11 40.56 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.891 1.676 . . . . 0.0 106.649 168.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 74.5 mtm180 -137.91 135.26 35.93 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 104.948 -2.241 . . . . 0.0 104.948 169.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -155.49 167.37 30.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 119.335 0.971 . . . . 0.0 112.975 -169.025 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -134.42 159.72 40.2 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.118 1.367 . . . . 0.0 107.562 168.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -172.06 164.18 36.66 Favored Glycine 0 CA--C 1.516 0.148 0 N-CA-C 108.213 -1.955 . . . . 0.0 108.213 171.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.19 137.66 51.42 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 172.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -45.13 -60.26 2.19 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -169.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.18 -4.98 36.29 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -178.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -92.62 -21.46 20.03 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 125.386 1.475 . . . . 0.0 110.756 170.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.8 tt -68.13 -23.85 64.94 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 119.53 1.059 . . . . 0.0 109.204 171.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 1.4 t60 44.1 34.47 0.98 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 128.348 2.659 . . . . 0.0 114.54 168.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 179.97 42.55 0.08 OUTLIER Glycine 0 C--N 1.336 0.574 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 -171.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -65.76 -14.81 62.07 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 117.618 0.709 . . . . 0.0 112.535 172.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -61.68 103.81 0.37 Allowed 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 127.418 2.287 . . . . 0.0 108.24 169.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.405 ' HA ' ' HB ' ' A' ' 96' ' ' VAL . 13.8 m -53.98 -9.86 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 126.969 2.107 . . . . 0.0 113.307 173.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -133.35 23.15 4.07 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.344 1.058 . . . . 0.0 113.402 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 24.7 m -106.58 -58.15 1.96 Allowed 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 119.004 -0.522 . . . . 0.0 110.402 168.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.396 16.0 ptm180 -75.88 11.88 1.27 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.223 0.919 . . . . 0.0 113.24 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 16.9 m -63.0 -39.15 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 167.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -70.09 119.39 14.23 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 170.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.3 tt -136.37 134.6 38.01 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -177.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.412 HD23 ' N ' ' A' ' 145' ' ' MET . 5.6 tt -143.97 140.43 29.64 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 -173.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.412 ' N ' HD23 ' A' ' 144' ' ' LEU . 25.3 ptp -140.92 154.21 46.01 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 119.229 0.922 . . . . 0.0 110.619 173.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -159.24 160.63 35.53 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 126.352 1.861 . . . . 0.0 107.656 -176.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -54.49 159.0 2.22 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 118.847 0.749 . . . . 0.0 110.581 169.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.57 166.04 19.81 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.819 0.342 . . . . 0.0 110.58 169.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -142.73 36.31 1.44 Allowed 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.611 1.165 . . . . 0.0 110.299 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 43.1 t80 . . . . . 0 C--O 1.249 1.054 0 C-N-CA 124.62 1.168 . . . . 0.0 108.166 -174.335 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 ttt . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.18 150.55 42.64 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.135 0.493 . . . . 0.0 111.29 177.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -154.58 8.45 0.37 Allowed Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.55 1.071 . . . . 0.0 112.967 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.02 170.13 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 126.899 2.08 . . . . 0.0 107.328 -178.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.9 tt -118.7 148.41 42.8 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 124.376 1.07 . . . . 0.0 110.329 -172.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -143.34 143.89 31.86 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 126.837 2.055 . . . . 0.0 106.002 169.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -150.6 134.82 17.0 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.195 1.398 . . . . 0.0 107.36 172.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -154.94 151.64 28.77 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.673 0.67 . . . . 0.0 109.943 169.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.1 mp -81.92 156.73 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 170.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -139.7 151.52 45.95 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.064 0.946 . . . . 0.0 108.745 169.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -117.2 126.33 52.6 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 125.518 1.527 . . . . 0.0 107.603 -176.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -70.64 128.22 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 176.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.6 mmmt -95.8 -35.71 11.41 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.476 1.111 . . . . 0.0 109.403 173.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -158.02 167.72 29.11 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 118.983 0.811 . . . . 0.0 111.307 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.9 mp -138.85 144.43 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 127.036 2.134 . . . . 0.0 107.244 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -145.29 92.58 5.6 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 126.814 2.046 . . . . 0.0 108.276 -176.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -55.26 156.05 18.02 Favored 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 124.081 3.187 . . . . 0.0 114.162 -178.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -77.81 45.78 0.53 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.425 1.49 . . . . 0.0 112.093 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.92 35.71 64.53 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 124.471 1.034 . . . . 0.0 113.54 169.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt 47.44 19.73 0.15 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.027 2.131 . . . . 0.0 114.167 -171.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.432 ' HA ' ' HE3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -77.17 -34.88 56.31 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 121.084 -1.01 . . . . 0.0 109.813 170.428 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -138.09 87.23 2.23 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 -177.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -55.06 -36.94 66.12 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.072 0.949 . . . . 0.0 113.341 -169.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -90.1 14.55 12.15 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 117.962 -1.018 . . . . 0.0 112.967 -178.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.7 t -127.34 140.93 47.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-N 120.821 1.646 . . . . 0.0 107.522 -176.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.6 m -151.87 151.67 31.6 Favored 'General case' 0 C--O 1.239 0.518 0 O-C-N 121.33 -0.856 . . . . 0.0 111.05 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 36.6 ttp180 -80.66 145.81 31.44 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 104.554 -2.387 . . . . 0.0 104.554 168.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.1 mp -134.09 158.44 43.6 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 125.923 1.689 . . . . 0.0 106.453 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -125.86 130.59 51.66 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 169.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 58.3 m -141.94 173.27 11.67 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.06 1.344 . . . . 0.0 109.796 -170.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -140.69 131.23 25.44 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 171.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.1 m -71.73 134.63 46.37 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 175.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -71.11 -35.23 71.7 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.62 1.168 . . . . 0.0 113.62 -169.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.72 -16.85 6.57 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -169.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -121.11 48.22 1.69 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.854 0.862 . . . . 0.0 112.168 -169.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt 30.34 64.37 0.16 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.582 1.953 . . . . 0.0 113.328 168.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 20.6 mtm -137.45 117.6 13.49 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 118.355 0.525 . . . . 0.0 110.474 -176.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -82.95 133.23 35.12 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 168.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -134.67 148.1 50.27 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.989 0.899 . . . . 0.0 113.045 -168.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 38.3 mm -130.14 141.97 44.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 101.237 -3.616 . . . . 0.0 101.237 168.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 53.0 tp -146.91 152.72 39.14 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 126.799 2.04 . . . . 0.0 107.096 -168.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -146.43 109.64 4.72 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 173.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.8 m -150.01 169.79 2.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 122.032 0.92 . . . . 0.0 112.13 -169.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 43.1 t-20 -64.5 130.51 44.0 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.15 1.38 . . . . 0.0 107.966 169.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.3 pp -105.68 0.94 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 124.48 1.112 . . . . 0.0 112.982 -177.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -68.43 -16.37 63.88 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 120.249 1.386 . . . . 0.0 111.064 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.439 HG13 ' H ' ' A' ' 47' ' ' ILE . 3.7 mt -62.39 -34.16 62.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 125.275 1.43 . . . . 0.0 109.337 171.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -91.32 159.11 39.97 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 124.754 1.222 . . . . 0.0 110.868 -169.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.71 179.25 3.25 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.462 2.774 . . . . 0.0 111.537 175.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.4 m -59.75 -16.52 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.84 1.256 . . . . 0.0 113.742 -177.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -67.69 -7.35 26.27 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.752 0.821 . . . . 0.0 112.476 170.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.5 tp 72.36 7.5 5.67 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 128.232 2.613 . . . . 0.0 113.389 174.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -167.23 164.47 37.91 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 108.289 -1.925 . . . . 0.0 108.289 174.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -161.34 168.61 23.61 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.769 1.627 . . . . 0.0 107.132 174.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -64.71 138.25 58.28 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 169.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -140.9 176.31 8.91 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -177.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.7 ttp180 -135.56 142.51 45.36 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -173.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 tt -121.09 140.43 51.97 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 126.149 1.78 . . . . 0.0 107.02 -176.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.0 t -143.05 166.81 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 126.995 2.118 . . . . 0.0 106.051 -178.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 30.0 pt -119.59 13.45 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 123.568 0.747 . . . . 0.0 112.27 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.24 25.36 0.13 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.081 1.353 . . . . 0.0 113.182 -175.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.2 m -67.57 -9.77 45.77 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.628 1.571 . . . . 0.0 113.808 -173.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.0 t -146.61 169.88 18.07 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.862 0.865 . . . . 0.0 109.353 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 29.6 tp -63.51 111.05 2.18 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.444 1.097 . . . . 0.0 108.213 171.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -59.1 137.69 57.85 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 169.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -69.06 -13.82 62.66 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 177.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -71.46 141.88 50.22 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.144 0.978 . . . . 0.0 110.857 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -49.83 -23.5 5.25 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.66 1.6 . . . . 0.0 114.945 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 32.4 m -56.01 -27.46 53.08 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.483 1.641 . . . . 0.0 111.452 177.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 88.9 mt -122.98 -36.3 2.89 Favored 'General case' 0 C--N 1.343 0.291 0 C-N-CA 123.548 0.739 . . . . 0.0 111.056 171.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -67.31 -19.73 65.51 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 118.862 0.756 . . . . 0.0 112.524 -177.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -128.95 31.53 4.9 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.115 1.766 . . . . 0.0 108.399 170.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.03 28.8 2.23 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 126.396 1.95 . . . . 0.0 110.702 -175.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 59.89 12.95 3.32 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.191 1.796 . . . . 0.0 113.671 169.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER 52.39 25.37 3.45 Favored 'General case' 0 CA--C 1.55 0.961 0 O-C-N 121.28 -0.888 . . . . 0.0 110.082 -168.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -156.09 78.27 4.31 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 125.122 1.369 . . . . 0.0 109.54 -169.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -79.49 54.68 5.3 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 124.02 3.147 . . . . 0.0 108.421 169.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . 0.251 33.1 p 64.82 11.61 7.05 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.476 2.31 . . . . 0.0 112.829 -169.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -63.05 -34.0 76.65 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 124.839 1.256 . . . . 0.0 112.358 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -135.16 5.98 3.31 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.457 1.103 . . . . 0.0 112.514 -169.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.15 139.09 65.39 Favored Pre-proline 0 N--CA 1.468 0.427 0 CA-C-O 117.592 -1.194 . . . . 0.0 108.357 176.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . 0.282 0.1 OUTLIER 3.19 69.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.555 1 C-N-CA 127.892 5.728 . . . . 0.0 117.291 -169.141 . . . . . . . . 4 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.5 m -145.52 154.15 41.89 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.313 1.845 . . . . 0.0 108.429 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -71.07 149.34 46.62 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 169.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.41 108.8 2.08 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -145.89 1.45 0.88 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.704 1.602 . . . . 0.0 111.519 -174.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -72.0 0.36 9.58 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.134 1.374 . . . . 0.0 113.22 -175.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -146.47 161.44 40.41 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 126.463 1.905 . . . . 0.0 108.541 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -122.36 -23.46 5.25 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.105 0.562 . . . . 0.0 110.729 172.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -145.66 149.45 34.49 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.804 1.242 . . . . 0.0 107.701 169.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.2 m -143.4 148.2 19.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 C-N-CA 125.621 1.568 . . . . 0.0 107.365 172.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 23.1 tpp -159.45 168.05 27.21 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.872 0.869 . . . . 0.0 109.207 176.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 84.7 t80 -128.5 150.52 50.13 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.809 1.643 . . . . 0.0 106.806 172.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -152.92 -160.06 9.43 Favored Glycine 0 C--N 1.336 0.569 0 CA-C-N 118.636 0.653 . . . . 0.0 113.672 -171.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -145.69 132.43 20.01 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.995 1.318 . . . . 0.0 108.771 172.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 42.2 t -77.14 145.57 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 168.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -144.87 74.94 1.43 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.057 1.743 . . . . 0.0 108.894 175.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -152.72 157.77 41.35 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.223 -0.923 . . . . 0.0 109.588 176.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 25.2 pt -76.99 -170.27 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 125.804 1.642 . . . . 0.0 111.356 177.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.63 -9.79 1.31 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 127.406 2.282 . . . . 0.0 115.47 -178.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 155.3 -91.7 0.12 Allowed Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 107.525 -2.23 . . . . 0.0 107.525 -174.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -149.68 28.59 0.78 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.454 1.101 . . . . 0.0 111.381 175.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 72.75 76.12 0.15 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 127.697 2.399 . . . . 0.0 111.447 176.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.288 0.0 OUTLIER 64.84 163.4 0.14 Allowed 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 117.996 2.591 . . . . 0.0 117.996 169.626 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.3 p -153.51 -43.49 0.09 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.805 2.442 . . . . 0.0 106.663 169.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 21.1 p -128.69 -55.24 1.23 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.917 1.287 . . . . 0.0 109.962 173.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -145.94 -16.27 0.46 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.371 1.068 . . . . 0.0 112.877 -174.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -159.29 156.99 29.7 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 131.481 3.912 . . . . 0.0 101.353 170.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.47 148.3 46.11 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 120.09 1.314 . . . . 0.0 108.644 174.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.21 -6.82 25.56 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -169.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -137.43 139.81 40.89 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 169.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 46.2 tp -75.96 159.5 30.81 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 168.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 16.6 m -134.98 150.65 50.39 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 175.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -142.13 128.79 20.36 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -112.52 129.76 56.24 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 168.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.6 p -146.72 144.91 19.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -169.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.3 t -134.53 144.01 47.75 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -136.9 82.62 1.95 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.282 1.833 . . . . 0.0 107.676 -170.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 58.57 19.67 42.79 Favored Glycine 0 CA--C 1.538 1.494 0 CA-C-O 118.977 -0.902 . . . . 0.0 114.629 174.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 124.32 -26.99 5.66 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.953 1.264 . . . . 0.0 112.723 -177.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 9.9 mp -75.31 150.06 38.59 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 169.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 7.0 tt -145.52 157.28 44.02 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.493 1.042 . . . . 0.0 110.689 -175.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 56.6 mtt -147.61 159.08 44.17 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.016 1.326 . . . . 0.0 108.861 170.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 85.4 mtp180 -141.25 130.22 23.2 Favored 'General case' 0 C--N 1.334 -0.1 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 169.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -152.59 160.09 43.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 119.059 0.845 . . . . 0.0 111.079 -170.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -137.17 149.65 47.4 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 124.315 1.046 . . . . 0.0 108.575 169.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -178.08 168.44 39.76 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -177.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -57.93 132.79 54.48 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -178.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -43.81 -73.7 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 -168.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -67.11 -26.18 66.58 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 122.404 1.097 . . . . 0.0 111.93 -172.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.95 -31.36 72.56 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 128.164 2.586 . . . . 0.0 111.203 175.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 5.4 tt -76.38 -13.47 60.13 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.28 1.032 . . . . 0.0 111.307 -176.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 32.3 t-80 52.81 40.51 30.75 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.721 1.208 . . . . 0.0 111.937 177.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -123.86 33.04 4.03 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 125.247 1.403 . . . . 0.0 110.642 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -76.48 -3.95 40.01 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.07 0.948 . . . . 0.0 113.34 -175.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -129.43 143.02 50.67 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 127.534 2.334 . . . . 0.0 106.142 169.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 8.2 p -59.21 -11.85 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.994 169.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -124.06 21.72 8.88 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 126.001 1.72 . . . . 0.0 113.492 176.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 57.9 m -72.83 -78.36 0.09 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.962 0.887 . . . . 0.0 109.779 168.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -82.58 12.62 4.41 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -169.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 33.9 m -67.27 -28.42 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-O 118.816 -0.612 . . . . 0.0 110.016 170.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -77.86 107.6 10.5 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 177.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 45.3 tp -112.66 131.38 55.67 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.459 1.104 . . . . 0.0 108.283 -176.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.5 tt -138.33 135.85 35.82 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 104.418 -2.438 . . . . 0.0 104.418 169.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -142.14 152.72 43.49 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 118.817 0.735 . . . . 0.0 111.484 176.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 39.6 pttt -165.01 172.97 12.05 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 126.224 1.81 . . . . 0.0 109.171 -174.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -55.1 156.69 3.82 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.422 0.689 . . . . 0.0 111.732 171.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.41 169.04 9.65 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.399 169.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -134.79 122.92 22.78 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 173.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 9.9 t80 . . . . . 0 C--O 1.246 0.902 0 C-N-CA 124.484 1.113 . . . . 0.0 108.276 176.66 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 mmt . . . . . 0 N--CA 1.486 1.34 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.79 163.18 0.1 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.492 2.317 . . . . 0.0 113.666 -175.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 69.28 178.39 19.44 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.373 0.987 . . . . 0.0 112.351 -175.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 40.0 pt -77.94 168.83 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 O-C-N 122.345 -0.503 . . . . 0.0 109.844 173.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -123.08 -36.08 2.9 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.24 1.416 . . . . 0.0 109.976 -176.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -151.47 158.16 43.28 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.902 1.281 . . . . 0.0 108.668 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -145.81 140.96 27.48 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.798 1.639 . . . . 0.0 108.371 -176.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -152.67 146.49 25.19 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.346 1.459 . . . . 0.0 110.54 -170.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.6 mp -112.59 137.74 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 105.847 -1.908 . . . . 0.0 105.847 171.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -145.64 161.89 38.78 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.758 1.223 . . . . 0.0 110.489 -174.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -140.86 144.79 35.51 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.598 0.759 . . . . 0.0 110.049 -174.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 39.0 t -70.08 122.56 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 125.078 1.351 . . . . 0.0 107.834 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -96.03 -32.0 12.77 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 124.508 1.123 . . . . 0.0 110.126 176.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -157.14 167.66 29.74 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.284 0.947 . . . . 0.0 110.718 175.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.7 mp -133.05 140.88 46.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 127.138 2.175 . . . . 0.0 106.296 -175.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -143.78 89.82 7.21 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 124.069 0.947 . . . . 0.0 110.011 -171.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -65.09 9.4 0.17 Allowed 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 124.121 3.214 . . . . 0.0 116.774 -178.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -78.82 55.88 1.8 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.079 1.351 . . . . 0.0 109.914 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -170.08 35.66 0.18 Allowed Glycine 0 CA--C 1.527 0.803 0 C-N-CA 124.89 1.233 . . . . 0.0 111.454 -172.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.404 ' HE2' ' HA ' ' A' ' 20' ' ' LYS . 11.2 mmpt? -65.97 64.58 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.61 1.564 . . . . 0.0 113.392 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -60.49 -38.4 84.16 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 168.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -144.37 165.5 27.75 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 129.468 3.107 . . . . 0.0 104.218 169.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.29 -40.86 83.05 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.28 -0.887 . . . . 0.0 110.737 175.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 49.0 ptt85 -70.4 7.72 0.98 Allowed 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 126.508 1.923 . . . . 0.0 114.806 175.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 77.7 t -120.48 132.09 70.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 121.497 1.953 . . . . 0.0 107.487 178.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 37.0 m -149.06 163.65 36.92 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.93 0.892 . . . . 0.0 109.789 176.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.1 ttm105 -85.45 154.28 21.92 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 169.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.0 mt -143.16 156.75 44.85 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 127.114 2.166 . . . . 0.0 107.199 -177.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -131.56 131.65 43.51 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 105.335 -2.098 . . . . 0.0 105.335 174.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 55.1 m -143.77 164.71 29.72 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.771 1.228 . . . . 0.0 110.201 -170.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -140.79 140.06 34.68 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 38.2 p -70.45 136.29 49.39 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 173.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -75.75 -35.68 60.11 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 168.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.6 m -69.56 -38.19 77.31 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -170.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -135.11 -102.26 0.22 Allowed 'General case' 0 C--N 1.345 0.38 0 CA-C-N 119.818 1.19 . . . . 0.0 110.34 -171.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -166.51 19.02 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.332 1.453 . . . . 0.0 112.559 -169.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 85.4 mtp -62.94 122.68 16.61 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.995 0.918 . . . . 0.0 108.68 176.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -98.08 112.45 24.4 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 169.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 49.0 tp -122.62 138.41 54.6 Favored 'General case' 0 N--CA 1.461 0.089 0 C-N-CA 123.455 0.702 . . . . 0.0 110.528 -169.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 33.1 mm -124.71 146.34 30.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 103.634 -2.728 . . . . 0.0 103.634 169.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 123' ' ' MET . 2.3 pt? -154.17 154.85 34.25 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.723 1.209 . . . . 0.0 109.547 176.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -121.59 120.68 35.52 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 102.992 -2.966 . . . . 0.0 102.992 170.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.2 p -151.09 163.18 2.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 121.707 0.765 . . . . 0.0 110.876 -168.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -69.02 90.23 0.44 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.907 1.683 . . . . 0.0 109.208 169.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.0 pp -65.84 -7.26 4.73 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -170.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -64.14 -18.61 64.6 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 120.161 1.346 . . . . 0.0 111.115 173.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.422 HD13 HG21 ' A' ' 47' ' ' ILE . 6.3 tt -55.34 -41.95 64.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.728 1.211 . . . . 0.0 110.629 169.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -88.02 139.37 30.74 Favored Pre-proline 0 CA--C 1.538 0.508 0 C-N-CA 125.88 1.672 . . . . 0.0 109.636 -173.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.45 132.74 30.11 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.272 1.981 . . . . 0.0 111.101 -177.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.8 t 50.34 31.06 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 126.567 1.947 . . . . 0.0 112.588 171.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.1 t70 62.42 -35.54 0.12 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 128.168 2.587 . . . . 0.0 115.203 -175.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 60.1 tp -59.36 -34.19 72.09 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.369 1.468 . . . . 0.0 111.405 177.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.37 -178.83 52.71 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-O 121.904 0.725 . . . . 0.0 112.262 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -157.96 174.16 15.67 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 126.662 1.985 . . . . 0.0 106.983 -174.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -58.92 134.22 56.74 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 173.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -128.91 168.66 15.65 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 125.908 1.683 . . . . 0.0 107.626 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -132.38 147.69 52.39 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.6 tt -137.88 144.0 41.16 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 -169.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.5 m -135.31 154.43 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 169.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 35.2 pt -121.15 147.84 24.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 104.287 -2.486 . . . . 0.0 104.287 168.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -138.55 54.2 1.77 Allowed 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.198 -168.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.9 m -42.9 116.51 0.9 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.563 1.545 . . . . 0.0 109.854 175.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.532 HG21 ' CD2' ' A' ' 65' ' ' TYR . 11.2 t -159.56 -170.52 2.96 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.34 0.656 . . . . 0.0 109.88 -169.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 25.8 tp -143.9 44.66 1.47 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.271 1.828 . . . . 0.0 108.086 173.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.532 ' CD2' HG21 ' A' ' 63' ' ' THR . 16.1 m-85 -58.11 151.32 19.15 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.41 0.624 . . . . 0.0 110.499 176.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -141.62 175.02 10.02 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 127.444 2.298 . . . . 0.0 108.708 173.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -62.6 -18.6 62.51 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.052 0.941 . . . . 0.0 113.491 -173.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -141.66 50.65 0.72 Allowed Glycine 0 CA--C 1.524 0.656 0 C-N-CA 125.45 1.5 . . . . 0.0 110.192 -178.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.4 m -62.61 159.0 16.85 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 117.651 0.725 . . . . 0.0 109.442 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 54.8 mt 45.43 26.81 0.32 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.592 1.957 . . . . 0.0 112.897 -169.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.9 t70 45.72 31.0 0.9 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 127.106 2.162 . . . . 0.0 113.658 -171.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -148.84 6.18 0.7 Allowed 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 177.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.48 38.28 90.64 Favored Glycine 0 CA--C 1.533 1.199 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -171.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 70.32 131.4 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 128.176 2.59 . . . . 0.0 111.928 -172.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -75.37 66.67 1.84 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.059 1.344 . . . . 0.0 109.472 175.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 57.4 t-20 -134.21 66.1 70.39 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 123.617 0.767 . . . . 0.0 112.189 -169.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -69.18 -18.76 39.59 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 122.373 2.048 . . . . 0.0 110.961 169.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -60.62 -5.11 1.1 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.814 2.446 . . . . 0.0 113.511 172.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.04 -23.53 1.21 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 120.038 1.29 . . . . 0.0 113.047 169.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -114.48 14.5 17.82 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 -169.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 19.2 ptt180 -77.0 -155.56 0.0 OUTLIER Pre-proline 0 CA--C 1.557 1.249 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 167.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -50.4 -11.53 0.37 Allowed 'Trans proline' 0 CA--C 1.543 0.957 0 CA-C-N 123.044 2.123 . . . . 0.0 116.215 169.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.3 m -52.17 -25.36 8.84 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 128.462 2.705 . . . . 0.0 114.459 168.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.5 tpm_? -30.78 -51.21 0.15 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.816 1.646 . . . . 0.0 113.626 -168.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -140.44 11.58 2.33 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.146 0.43 . . . . 0.0 112.118 168.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -73.96 -11.91 60.49 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.142 -0.973 . . . . 0.0 110.642 169.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -60.6 -59.53 5.25 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.634 0.773 . . . . 0.0 109.237 169.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -162.39 161.54 27.37 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 126.136 1.774 . . . . 0.0 110.218 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -123.58 -23.06 4.84 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.446 1.498 . . . . 0.0 109.476 169.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -142.81 155.03 44.74 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.378 1.471 . . . . 0.0 108.214 172.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.0 t -141.78 144.62 25.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 124.89 1.276 . . . . 0.0 107.83 -169.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 16.3 mtm -147.8 152.35 37.54 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.551 1.541 . . . . 0.0 110.308 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -138.46 144.49 40.12 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 127.587 2.355 . . . . 0.0 105.158 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.44 -151.3 6.73 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-N 120.641 1.564 . . . . 0.0 115.396 -169.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -144.71 133.39 22.25 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 126.098 1.759 . . . . 0.0 107.186 172.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.9 p -101.54 133.85 43.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 169.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -142.09 88.52 2.11 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.528 1.131 . . . . 0.0 108.874 -170.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -156.98 162.98 39.6 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.654 -1.279 . . . . 0.0 110.713 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.27 178.07 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 124.327 1.051 . . . . 0.0 110.543 178.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -64.42 4.85 0.33 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.9 2.08 . . . . 0.0 114.467 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.19 -52.93 1.6 Allowed Glycine 0 C--N 1.332 0.356 0 C-N-CA 125.49 1.519 . . . . 0.0 109.5 175.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.538 ' HA ' ' HB3' ' A' ' 109' ' ' ALA . 20.5 t70 -67.08 124.12 22.15 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.324 0.583 . . . . 0.0 109.704 169.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -132.68 16.64 4.33 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.023 1.329 . . . . 0.0 110.45 169.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 44.4 p -87.75 -161.95 0.76 Allowed 'General case' 0 C--O 1.236 0.353 0 CA-C-O 122.084 0.945 . . . . 0.0 109.984 178.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 21.8 m -157.22 16.82 0.28 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.5 2.32 . . . . 0.0 107.238 -176.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.0 p -151.91 -59.72 0.16 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.144 1.377 . . . . 0.0 109.142 -168.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -77.96 -35.87 49.78 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.095 0.558 . . . . 0.0 111.398 -170.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 56.29 74.66 0.38 Allowed 'General case' 0 C--N 1.343 0.322 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 -169.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.538 ' HB3' ' HA ' ' A' ' 102' ' ' ASP . . . -49.21 135.87 16.13 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 114.302 -1.317 . . . . 0.0 112.423 -167.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.8 p -92.92 4.21 54.34 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 -169.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? -115.09 141.64 47.73 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.019 0.927 . . . . 0.0 108.95 176.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.0 tp -88.78 154.97 19.85 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 167.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 10.8 m -130.57 149.76 52.09 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 -174.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -144.12 143.76 31.27 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -127.05 125.8 41.98 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 101.052 -3.684 . . . . 0.0 101.052 169.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.2 t -135.13 130.1 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -170.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 50.1 m -115.99 136.02 53.43 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 176.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -136.35 158.99 43.11 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.427 1.091 . . . . 0.0 109.961 -169.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -71.87 65.88 1.15 Allowed Glycine 0 CA--C 1.531 1.056 0 N-CA-C 108.204 -1.958 . . . . 0.0 108.204 168.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 171.16 -17.22 0.06 OUTLIER Glycine 0 CA--C 1.534 1.268 0 CA-C-O 117.194 -1.892 . . . . 0.0 112.194 -169.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . 0.435 43.4 mt 133.17 -136.14 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 130.514 3.526 . . . . 0.0 111.453 168.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 5.2 tt -139.48 157.74 45.33 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 121.661 2.028 . . . . 0.0 113.516 -168.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.467 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 35.7 mtt -145.25 157.89 43.96 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.135 1.774 . . . . 0.0 109.961 177.286 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 62.9 mtt180 -136.11 137.73 41.34 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 104.651 -2.351 . . . . 0.0 104.651 169.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 27.6 tp -148.71 146.38 28.08 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 119.054 0.843 . . . . 0.0 110.463 -168.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -137.3 153.05 50.37 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.661 1.184 . . . . 0.0 108.314 168.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 176.17 -177.1 47.81 Favored Glycine 0 CA--C 1.519 0.336 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 170.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -53.1 139.86 27.27 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 118.291 1.046 . . . . 0.0 109.681 175.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -53.04 -56.25 17.57 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 123.593 0.558 . . . . 0.0 112.167 -174.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -54.81 -40.55 69.64 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-O 121.437 0.637 . . . . 0.0 111.471 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.5 -30.98 71.82 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 127.193 2.197 . . . . 0.0 110.39 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.37 -25.28 65.9 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 118.475 -0.774 . . . . 0.0 109.447 -178.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 72.2 m80 40.94 44.46 1.98 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.48 1.512 . . . . 0.0 111.76 -177.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -137.22 64.01 0.57 Allowed Glycine 0 C--N 1.338 0.648 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 -169.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -103.37 12.88 34.82 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.729 0.812 . . . . 0.0 112.055 -173.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.452 ' C ' ' H ' ' A' ' 138' ' ' ASP . 7.4 tp10 -140.61 146.3 37.79 Favored 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 126.122 1.769 . . . . 0.0 108.002 173.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.5 m -56.51 -9.06 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 124.512 1.125 . . . . 0.0 111.346 169.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.452 ' H ' ' C ' ' A' ' 136' ' ' GLU . 31.9 t70 -134.35 15.03 3.78 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 127.548 2.339 . . . . 0.0 112.245 -172.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 68.6 m -73.37 -81.8 0.06 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 122.309 1.052 . . . . 0.0 109.642 168.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -80.0 14.34 1.87 Allowed 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -169.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 20.1 m -68.18 -29.73 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 169.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -82.56 106.18 14.21 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 175.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 24.7 tp -129.79 137.18 50.36 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 124.617 1.167 . . . . 0.0 108.133 -173.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.9 mp -139.63 151.43 45.97 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 172.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 60.4 mtm -138.85 154.18 48.4 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.616 0.767 . . . . 0.0 109.581 -176.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 34.0 pttt -165.0 175.18 9.71 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.205 1.402 . . . . 0.0 110.964 -169.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 23.0 ptmt -63.31 157.17 23.57 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 122.406 0.283 . . . . 0.0 110.239 169.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.33 154.6 31.26 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.691 0.758 . . . . 0.0 111.512 172.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -135.86 112.72 10.24 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 169.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 . . . . . 0 C--O 1.247 0.939 0 CA-C-O 118.546 -0.74 . . . . 0.0 109.962 -177.247 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 119.881 -0.104 . . . . 0.0 110.846 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.36 6.7 3.3 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.394 1.078 . . . . 0.0 112.852 -175.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -172.83 171.6 44.5 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.476 -1.049 . . . . 0.0 110.476 178.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.0 tt -138.9 145.32 27.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 125.318 1.447 . . . . 0.0 108.53 -174.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 44.3 tp -109.57 -48.93 3.16 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 124.408 1.083 . . . . 0.0 109.668 178.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -161.04 166.65 27.83 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.485 1.114 . . . . 0.0 109.559 173.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -140.63 132.89 28.2 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.925 2.09 . . . . 0.0 106.313 176.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -149.86 153.75 37.24 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 171.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.0 mp -75.52 146.0 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 173.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -129.65 153.9 47.66 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.478 1.511 . . . . 0.0 107.389 170.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -131.74 129.59 40.82 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.664 1.586 . . . . 0.0 108.278 -174.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 51.8 t -72.51 118.03 16.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 124.448 1.099 . . . . 0.0 108.197 -177.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.2 mmpt? -78.25 -43.33 28.51 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 124.489 1.116 . . . . 0.0 109.59 169.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -159.11 170.65 21.54 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 118.824 0.738 . . . . 0.0 111.038 -175.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.2 mp -138.6 142.56 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 127.104 2.162 . . . . 0.0 106.825 -173.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -147.39 93.99 4.56 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 124.195 0.998 . . . . 0.0 111.205 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -73.14 90.84 0.85 Allowed 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 123.306 2.671 . . . . 0.0 107.765 168.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -57.87 -33.56 68.83 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -169.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 155.81 42.5 0.02 OUTLIER Glycine 0 CA--C 1.527 0.79 0 N-CA-C 106.248 -2.741 . . . . 0.0 106.248 -169.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 22.1 mmtt -72.42 95.96 1.84 Allowed 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.443 1.497 . . . . 0.0 109.66 -168.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -47.7 -43.31 26.56 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.232 1.013 . . . . 0.0 112.025 175.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.5 m-30 -81.08 -18.58 46.11 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 122.741 0.416 . . . . 0.0 112.071 -174.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.7 t70 62.75 -36.13 0.13 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 130.064 3.345 . . . . 0.0 115.688 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -72.64 11.0 0.71 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.316 1.446 . . . . 0.0 113.124 170.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 53.7 t -126.53 140.46 48.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 104.029 -2.582 . . . . 0.0 104.029 174.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 55.7 m -156.21 160.82 40.17 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 119.637 1.108 . . . . 0.0 110.417 174.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.461 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 15.1 ttm180 -83.81 150.38 25.8 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 170.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 66.0 mt -137.76 155.17 49.34 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.744 2.018 . . . . 0.0 106.141 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -121.58 127.35 50.82 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 102.804 -3.036 . . . . 0.0 102.804 169.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 74.5 m -141.27 162.63 35.01 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.182 0.993 . . . . 0.0 110.864 -169.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -138.75 134.2 33.2 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.556 1.542 . . . . 0.0 107.607 -176.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.5 p -67.18 148.3 51.97 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.014 0.926 . . . . 0.0 110.697 173.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -77.78 -30.41 51.34 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 118.756 -0.64 . . . . 0.0 111.013 172.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -132.49 -31.45 1.39 Allowed 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 115.234 1.568 . . . . 0.0 115.234 -169.031 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 23.3 m-30 -108.35 30.9 6.01 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -168.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 49.5 pttt 40.11 53.73 2.75 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.564 1.546 . . . . 0.0 114.282 169.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 47.6 mtt -114.52 110.82 20.42 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.388 1.875 . . . . 0.0 107.972 177.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -82.74 125.06 30.83 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 169.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 51.9 tp -132.85 142.09 48.77 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 118.733 0.697 . . . . 0.0 112.305 -168.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 40.8 mm -120.03 136.98 55.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 101.635 -3.468 . . . . 0.0 101.635 169.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 22.3 tp -152.7 105.21 2.95 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.062 0.945 . . . . 0.0 109.316 -168.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.461 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 16.1 t70 -100.87 105.54 16.82 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 126.212 1.805 . . . . 0.0 107.246 173.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.7 m -150.51 172.03 1.34 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-O 121.662 0.744 . . . . 0.0 110.515 -169.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -59.9 128.14 35.41 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.175 1.39 . . . . 0.0 109.264 169.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.1 pp -114.67 0.88 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 124.597 1.159 . . . . 0.0 113.812 -174.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.68 -4.92 25.97 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 120.42 1.463 . . . . 0.0 111.255 177.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.8 mt -62.83 -38.79 82.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 168.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -78.21 148.15 74.03 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 123.505 0.722 . . . . 0.0 110.138 -171.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.93 -25.33 19.92 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 122.592 2.195 . . . . 0.0 112.669 -177.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.8 m -145.42 160.82 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 125.611 1.564 . . . . 0.0 108.352 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -60.25 -27.82 67.53 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.313 1.045 . . . . 0.0 112.463 178.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 42.7 tp -62.65 -15.17 50.71 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.761 1.224 . . . . 0.0 112.456 174.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.1 -176.46 51.48 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -172.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -155.71 166.1 34.53 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.436 1.494 . . . . 0.0 107.344 177.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -66.95 131.69 46.39 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 173.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -139.69 146.16 39.28 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -172.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 61.5 mtm180 -79.67 134.08 36.41 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 170.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -106.04 134.44 49.17 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 104.355 -2.461 . . . . 0.0 104.355 169.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 80.1 t -134.29 138.65 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 -176.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.1 mm -106.78 135.18 46.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 104.832 -2.285 . . . . 0.0 104.832 169.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -120.02 -167.87 1.51 Allowed 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.708 1.203 . . . . 0.0 110.127 -169.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 69.7 m -152.48 145.05 24.17 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 169.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 26.5 m -145.94 133.07 20.4 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 42.7 tp -80.01 61.83 4.01 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 169.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -61.27 -23.36 65.61 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.613 -0.679 . . . . 0.0 112.753 -169.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -58.93 -22.5 60.01 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.112 0.965 . . . . 0.0 112.294 175.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -68.85 -22.76 64.2 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.593 0.757 . . . . 0.0 112.238 175.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.31 34.54 90.19 Favored Glycine 0 CA--C 1.534 1.233 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -173.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.92 -25.26 66.63 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 118.624 1.212 . . . . 0.0 110.216 173.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 75.5 mt -128.78 46.48 2.61 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 127.31 2.244 . . . . 0.0 106.706 171.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -50.21 119.69 3.88 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 124.084 0.954 . . . . 0.0 109.002 -177.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -51.42 96.63 0.01 OUTLIER 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.157 1.783 . . . . 0.0 111.033 -175.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 146.67 -30.97 1.52 Allowed Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.619 1.104 . . . . 0.0 110.657 -169.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -140.14 48.22 1.78 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 128.963 2.905 . . . . 0.0 106.183 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -70.35 86.61 0.6 Allowed 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 176.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -56.63 147.45 51.05 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 125.208 1.403 . . . . 0.0 110.569 -174.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -55.33 -12.47 5.74 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.544 2.829 . . . . 0.0 115.869 176.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.6 m 55.95 35.61 25.82 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.953 1.701 . . . . 0.0 110.751 -173.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -128.64 28.23 5.42 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 127.319 2.248 . . . . 0.0 106.767 169.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -152.35 -62.72 0.16 Allowed 'General case' 0 C--O 1.231 0.13 0 C-N-CA 127.791 2.436 . . . . 0.0 104.771 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 84.9 mtt180 -74.65 144.15 79.94 Favored Pre-proline 0 N--CA 1.469 0.486 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 167.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER 10.85 64.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.833 1 C-N-CA 127.383 5.389 . . . . 0.0 115.828 -169.664 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.7 p -59.4 -18.7 41.19 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.951 1.7 . . . . 0.0 114.921 -169.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -58.72 -23.87 60.47 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 121.272 -0.893 . . . . 0.0 111.875 172.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -74.6 -3.12 29.23 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 118.125 -0.94 . . . . 0.0 112.994 177.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -73.0 60.15 0.53 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 120.552 1.524 . . . . 0.0 112.19 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -139.84 -13.74 1.08 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.634 1.974 . . . . 0.0 111.215 -176.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -79.85 162.43 25.06 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 118.505 0.593 . . . . 0.0 110.269 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -116.15 -23.31 8.51 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.669 0.787 . . . . 0.0 110.353 175.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -149.86 150.32 31.77 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.247 1.019 . . . . 0.0 109.218 171.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.4 p -148.42 142.99 19.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 174.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 10.3 tpt -159.94 166.93 29.15 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.938 0.895 . . . . 0.0 109.596 176.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -121.06 146.8 46.34 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.107 1.363 . . . . 0.0 108.138 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -141.65 -160.43 8.32 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-N 118.637 0.653 . . . . 0.0 112.328 -175.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -142.02 128.84 20.54 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.862 1.265 . . . . 0.0 107.824 169.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 39.3 t -79.68 144.03 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 171.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -143.46 75.47 1.48 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.931 1.293 . . . . 0.0 109.529 177.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -157.09 163.58 38.82 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 120.764 -1.21 . . . . 0.0 110.954 170.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.53 -172.49 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 125.691 1.596 . . . . 0.0 110.935 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.22 -13.93 3.67 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.91 2.084 . . . . 0.0 115.437 -178.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.441 ' HA2' ' H ' ' A' ' 113' ' ' SER . . . 152.55 -67.04 0.33 Allowed Glycine 0 C--N 1.334 0.435 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -146.68 12.08 1.13 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.373 1.069 . . . . 0.0 112.906 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 58.47 71.12 0.6 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.751 2.021 . . . . 0.0 111.719 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 32.1 p -56.3 -57.38 12.48 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.675 0.79 . . . . 0.0 109.35 169.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 17.4 m 157.34 -37.4 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.441 1 C-N-CA 132.006 4.123 . . . . 0.0 107.915 -176.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.89 -25.92 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.686 0.794 . . . . 0.0 111.376 -169.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -64.87 -28.55 69.62 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.324 0.65 . . . . 0.0 111.599 -174.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 75.32 115.4 0.06 Allowed 'General case' 0 C--O 1.237 0.401 0 C-N-CA 128.638 2.775 . . . . 0.0 107.181 -172.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.05 165.44 5.61 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.809 -169.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.4 p -56.87 116.46 3.2 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 173.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? 60.32 131.98 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 127.804 2.442 . . . . 0.0 111.611 -168.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 9.1 tt -79.55 135.87 36.73 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 103.15 -2.907 . . . . 0.0 103.15 167.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.441 ' H ' ' HA2' ' A' ' 101' ' ' GLY . 41.8 m -109.47 136.77 48.34 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 105.477 -2.046 . . . . 0.0 105.477 173.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -128.22 152.02 48.57 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.121 1.369 . . . . 0.0 108.091 -174.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -132.56 137.71 47.21 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 102.834 -3.025 . . . . 0.0 102.834 169.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.8 t -132.38 147.13 32.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 177.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.0 m -127.31 157.68 39.23 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 102.513 -3.143 . . . . 0.0 102.513 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . 0.333 98.4 m-85 58.76 -148.79 0.47 Allowed 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -167.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 61.15 13.57 35.74 Favored Glycine 0 CA--C 1.535 1.325 0 CA-C-N 120.186 1.357 . . . . 0.0 113.17 -176.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 138.21 -50.31 0.81 Allowed Glycine 0 CA--C 1.528 0.848 0 C-N-CA 126.066 1.793 . . . . 0.0 109.601 -171.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.65 -68.63 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.458 1.503 . . . . 0.0 109.0 169.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 11.3 tp -157.79 148.21 20.71 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 124.561 1.144 . . . . 0.0 109.065 -178.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.58 156.34 41.77 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 170.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 70.2 ttt-85 -127.61 142.57 51.32 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 169.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 15.3 tp -149.74 148.89 29.77 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -169.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -144.39 143.42 30.93 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 168.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -175.93 178.05 47.49 Favored Glycine 0 CA--C 1.52 0.361 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -52.42 137.24 29.98 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 118.305 1.053 . . . . 0.0 110.622 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -56.91 -55.98 27.53 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -169.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -57.03 -43.95 82.39 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 122.349 1.071 . . . . 0.0 111.403 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 27.0 t30 -60.99 -28.09 68.77 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 126.292 1.837 . . . . 0.0 111.935 177.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.11 -29.38 54.81 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 123.911 0.884 . . . . 0.0 110.145 178.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 49.21 21.56 0.54 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.925 1.69 . . . . 0.0 113.191 -169.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.02 -10.86 84.17 Favored Glycine 0 CA--C 1.528 0.865 0 O-C-N 121.059 -1.026 . . . . 0.0 113.955 -169.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -59.12 -30.64 68.27 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 118.476 1.138 . . . . 0.0 111.693 172.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -87.35 87.82 7.52 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 126.743 2.017 . . . . 0.0 106.212 169.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.5 m -59.59 -7.12 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 124.49 1.116 . . . . 0.0 113.407 176.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -123.4 18.74 9.75 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 126.11 1.764 . . . . 0.0 113.17 176.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.9 m -83.84 -68.93 0.67 Allowed 'General case' 0 C--O 1.232 0.147 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 167.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.292 10.6 ptm85 -78.31 11.67 2.29 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 -169.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 29.7 m -67.58 -34.86 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-O 118.645 -0.693 . . . . 0.0 109.337 168.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -82.82 104.35 12.99 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 10.3 tt -117.2 134.72 54.44 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -170.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -140.51 135.92 32.39 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 -171.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 78.4 mtm -137.85 149.4 46.26 Favored 'General case' 0 C--O 1.237 0.426 0 O-C-N 121.267 -0.896 . . . . 0.0 109.944 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -154.62 172.51 17.75 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.305 1.042 . . . . 0.0 109.761 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -53.51 160.46 1.23 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.298 0.639 . . . . 0.0 111.857 175.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.25 166.3 0.86 Allowed 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.394 0.616 . . . . 0.0 111.981 169.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -87.09 86.59 7.31 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 175.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 19.2 t80 . . . . . 0 C--O 1.248 0.995 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 172.632 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.3 mmt . . . . . 0 N--CA 1.483 1.217 0 N-CA-C 109.254 -0.646 . . . . 0.0 109.254 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.26 142.67 57.6 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 122.953 0.501 . . . . 0.0 110.528 -177.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 174.29 177.63 43.59 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 170.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.6 tp -150.96 138.6 13.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 169.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 23.1 tp -153.37 -13.79 0.15 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.055 0.942 . . . . 0.0 112.088 175.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -147.33 134.04 19.99 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -148.5 138.4 22.29 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 169.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -151.17 150.62 30.85 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.026 0.83 . . . . 0.0 110.869 172.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.6 mp -75.16 152.65 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 169.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -132.59 146.66 52.07 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.651 1.58 . . . . 0.0 107.788 174.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -123.75 119.74 30.63 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 127.225 2.21 . . . . 0.0 106.641 -175.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.7 t -78.39 123.92 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -177.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.5 mmmt -88.7 -40.0 13.58 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.952 0.901 . . . . 0.0 109.687 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -157.93 170.91 21.27 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 118.386 0.539 . . . . 0.0 112.318 -169.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.1 mp -141.9 147.54 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 127.881 2.472 . . . . 0.0 106.786 -175.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -143.86 110.58 5.2 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 169.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -64.62 7.35 0.25 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.605 2.87 . . . . 0.0 117.454 -177.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 46.14 39.93 6.62 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.731 2.012 . . . . 0.0 112.294 -174.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.29 37.71 41.26 Favored Glycine 0 CA--C 1.531 1.065 0 O-C-N 121.528 -0.732 . . . . 0.0 111.447 -177.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? 45.55 57.64 4.81 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 126.661 1.984 . . . . 0.0 109.642 -169.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -54.63 -36.76 64.86 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.921 0.888 . . . . 0.0 110.645 -178.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -140.17 160.99 38.73 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 169.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -64.64 -25.55 68.01 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -177.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -136.57 16.47 3.13 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 117.639 -1.172 . . . . 0.0 113.579 -173.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.8 t -131.61 129.14 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 121.005 1.73 . . . . 0.0 107.364 -178.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 39.6 m -148.34 159.55 43.89 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 124.387 1.075 . . . . 0.0 110.396 -170.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 -69.01 146.46 52.7 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 169.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.2 mp -127.86 158.09 38.72 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 127.018 2.127 . . . . 0.0 106.521 170.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -136.08 132.01 35.59 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 171.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.3 m -142.85 173.02 11.92 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.318 1.447 . . . . 0.0 110.609 -169.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -140.99 143.66 34.59 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.59 1.956 . . . . 0.0 106.858 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.3 p -88.09 147.68 24.83 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.109 0.868 . . . . 0.0 110.033 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -77.58 -41.79 37.48 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.497 1.119 . . . . 0.0 112.811 -169.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.28 -26.74 9.0 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.831 0.852 . . . . 0.0 112.775 -169.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -121.35 23.78 10.26 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.957 1.303 . . . . 0.0 112.188 -170.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.9 pttt 43.6 27.37 0.15 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 127.097 2.159 . . . . 0.0 116.247 168.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 53.8 mtt -70.53 149.29 47.3 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 119.813 1.188 . . . . 0.0 108.366 175.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -112.29 131.07 55.71 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 173.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 48.7 tp -133.56 141.88 47.9 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.667 0.746 . . . . 0.0 111.154 -169.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 42.6 mm -123.05 142.4 39.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 101.161 -3.644 . . . . 0.0 101.161 168.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 51.3 tp -148.92 154.73 39.84 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 126.221 1.808 . . . . 0.0 106.929 -168.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -137.18 114.14 10.59 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 103.478 -2.786 . . . . 0.0 103.478 169.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.0 p -151.46 167.29 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 O-C-N 124.373 1.046 . . . . 0.0 111.026 -168.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -60.61 137.08 58.22 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.943 1.297 . . . . 0.0 109.413 169.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.6 pp -119.14 8.0 6.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 124.935 1.294 . . . . 0.0 113.417 -177.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -65.41 -19.57 66.0 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 120.367 1.44 . . . . 0.0 110.96 173.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.4 mt -63.65 -33.92 64.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 126.238 1.815 . . . . 0.0 110.291 172.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -65.75 138.73 96.68 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 123.757 0.823 . . . . 0.0 112.916 -167.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -72.91 177.43 7.7 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.418 2.745 . . . . 0.0 110.974 172.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.6 m -70.87 -22.93 23.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 O-C-N 121.766 -0.583 . . . . 0.0 111.62 171.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -69.16 153.19 44.11 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.755 0.822 . . . . 0.0 110.733 177.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 53.9 tp -63.8 -29.68 70.85 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.512 0.725 . . . . 0.0 112.625 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.21 160.51 13.78 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-N 119.091 0.859 . . . . 0.0 111.679 -175.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -157.69 164.81 36.77 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 126.097 1.759 . . . . 0.0 107.433 174.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -138.43 150.87 46.92 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.681 0.792 . . . . 0.0 109.339 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -151.59 -175.32 5.15 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 124.989 1.316 . . . . 0.0 107.598 173.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.7 ttp180 -136.12 147.85 47.97 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 125.233 1.413 . . . . 0.0 107.716 -177.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.1 tp -134.91 151.0 50.5 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.132 0.973 . . . . 0.0 109.755 -169.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 55.7 t -136.46 137.11 48.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 105.472 -2.048 . . . . 0.0 105.472 173.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 pp -137.45 3.5 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 123.808 0.843 . . . . 0.0 113.077 -176.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.16 -46.66 17.51 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.446 -0.784 . . . . 0.0 112.462 -170.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.1 m -157.55 173.08 17.41 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.595 1.558 . . . . 0.0 108.306 -169.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.426 HG22 ' H ' ' A' ' 65' ' ' TYR . 1.8 m -66.94 151.82 46.88 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 168.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 24.0 tp -77.06 -17.18 58.94 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.309 -0.869 . . . . 0.0 111.329 170.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.426 ' H ' HG22 ' A' ' 63' ' ' THR . 12.4 m-85 -143.56 159.75 41.87 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.349 1.06 . . . . 0.0 112.032 -172.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -150.25 -174.09 4.64 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.76 2.024 . . . . 0.0 108.408 169.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -57.3 -21.37 34.42 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.494 1.518 . . . . 0.0 114.492 -171.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -109.4 -5.44 30.04 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-O 118.873 -0.96 . . . . 0.0 113.721 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.03 173.21 11.55 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.258 1.529 . . . . 0.0 108.667 170.058 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 52.6 mt 48.87 -121.2 1.47 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -177.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -136.27 120.51 17.87 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 104.3 -2.481 . . . . 0.0 104.3 168.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.2 t70 54.99 25.88 7.38 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.121 1.368 . . . . 0.0 112.917 -173.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 66.84 25.01 73.08 Favored Glycine 0 CA--C 1.527 0.825 0 O-C-N 121.344 -0.847 . . . . 0.0 112.714 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -132.0 149.58 52.39 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.735 1.214 . . . . 0.0 107.894 -175.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -72.46 16.44 0.14 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.754 1.221 . . . . 0.0 113.507 -176.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -69.76 -16.79 0.34 Allowed Pre-proline 0 CA--C 1.542 0.643 0 CA-C-O 115.261 -2.304 . . . . 0.0 116.198 -175.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -79.98 47.36 2.51 Favored 'Trans proline' 0 C--N 1.358 1.068 0 CA-C-N 124.544 2.658 . . . . 0.0 109.848 169.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . 0.25 23.6 p 44.06 38.38 2.25 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 128.276 2.63 . . . . 0.0 113.083 -172.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -78.33 -19.3 53.78 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 121.359 -0.838 . . . . 0.0 111.657 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -149.38 -39.79 0.15 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.272 1.829 . . . . 0.0 109.36 171.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -60.65 135.47 92.24 Favored Pre-proline 0 CA--C 1.533 0.289 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . 0.279 2.4 Cg_exo 32.03 44.71 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.715 1 C-N-CA 125.439 4.093 . . . . 0.0 116.541 -169.243 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.9 m -139.52 -179.4 5.88 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.657 1.983 . . . . 0.0 108.97 173.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 26.6 mmt85 -63.78 172.85 2.0 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.279 0.632 . . . . 0.0 110.201 171.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -129.39 28.11 5.24 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.479 1.512 . . . . 0.0 109.855 176.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -80.72 -21.23 41.38 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.455 1.502 . . . . 0.0 111.573 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.91 -45.13 91.05 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.41 1.884 . . . . 0.0 112.656 -169.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -146.85 158.93 44.04 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.571 1.548 . . . . 0.0 108.178 178.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -97.8 -49.71 4.72 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.212 0.914 . . . . 0.0 110.209 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -157.4 165.97 34.3 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.18 0.9 . . . . 0.0 110.994 172.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.7 p -141.47 142.87 28.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 170.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.8 tpt -152.91 162.06 41.77 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.779 1.232 . . . . 0.0 109.164 -175.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -114.6 116.59 29.01 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 170.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.75 -167.08 32.09 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 -174.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.42 111.04 10.42 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 169.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 87.2 t -72.22 155.97 7.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 174.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -128.39 106.81 9.25 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 104.632 -2.359 . . . . 0.0 104.632 169.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -75.48 138.69 41.76 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -174.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.4 pt -128.31 179.46 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.149 0.98 . . . . 0.0 108.808 169.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -74.18 -1.46 20.52 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.609 1.564 . . . . 0.0 114.607 -173.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.1 37.68 91.82 Favored Glycine 0 C--N 1.336 0.583 0 O-C-N 121.841 -0.537 . . . . 0.0 112.696 -176.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -145.67 127.15 15.03 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 168.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -131.81 16.42 4.76 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 123.971 0.794 . . . . 0.0 111.617 169.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 43.1 p -68.44 -63.14 1.12 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.7 m 152.36 -38.69 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 131.02 3.728 . . . . 0.0 108.402 -175.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.04 -19.22 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.113 0.565 . . . . 0.0 112.231 -169.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -66.03 -23.82 66.63 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.134 0.879 . . . . 0.0 110.489 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 68.45 86.03 0.13 Allowed 'General case' 0 C--N 1.344 0.352 0 C-N-CA 127.449 2.3 . . . . 0.0 107.388 175.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.56 144.49 7.83 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 114.004 -1.453 . . . . 0.0 112.774 -168.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.1 p -84.5 4.1 33.37 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.56 1.144 . . . . 0.0 114.055 -176.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -124.04 131.94 53.62 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.294 1.838 . . . . 0.0 106.562 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 34.9 tp -70.8 153.63 42.57 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 170.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -126.88 161.46 28.21 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.206 1.002 . . . . 0.0 108.838 -172.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -147.97 161.22 41.78 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.752 1.221 . . . . 0.0 108.974 171.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -124.48 147.7 48.18 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 169.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.8 t -144.54 143.16 23.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 29.6 m -120.48 136.4 54.77 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 169.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -146.58 114.99 6.71 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -178.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 57.19 23.33 46.95 Favored Glycine 0 CA--C 1.539 1.588 0 CA-C-O 119.311 -0.716 . . . . 0.0 114.456 174.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.57 -8.42 64.04 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 124.763 1.173 . . . . 0.0 113.633 -178.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -95.26 170.2 9.55 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.777 1.631 . . . . 0.0 108.814 175.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.0 tp -139.19 160.63 39.36 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 118.741 0.7 . . . . 0.0 111.587 -169.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 71.4 mtm -153.97 161.56 41.88 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.56 1.544 . . . . 0.0 110.253 169.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -141.49 133.61 27.77 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 103.825 -2.657 . . . . 0.0 103.825 167.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.8 tt -140.92 151.1 43.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 119.259 0.936 . . . . 0.0 108.866 -171.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -132.93 153.42 51.42 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.644 1.177 . . . . 0.0 109.409 170.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -168.66 169.26 41.59 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 170.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -51.13 136.98 22.88 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.224 1.012 . . . . 0.0 109.005 172.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -42.73 -53.65 4.44 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -172.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -60.83 -41.35 95.62 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 123.174 1.464 . . . . 0.0 111.511 -177.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -71.63 -18.92 62.17 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 127.099 2.16 . . . . 0.0 111.386 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -67.87 -25.2 65.4 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 119.168 0.895 . . . . 0.0 109.184 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 25.2 t-80 53.28 40.42 31.26 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.88 1.272 . . . . 0.0 111.064 171.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -165.92 50.65 0.27 Allowed Glycine 0 C--N 1.338 0.655 0 O-C-N 121.366 -0.834 . . . . 0.0 112.609 -169.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -74.7 8.35 2.45 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.085 0.954 . . . . 0.0 112.18 171.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -135.17 130.24 35.05 Favored 'General case' 0 CA--C 1.508 -0.649 0 C-N-CA 126.005 1.722 . . . . 0.0 106.909 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.9 p -59.01 -4.68 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 126.14 1.776 . . . . 0.0 111.348 170.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -131.93 15.2 4.76 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.288 1.435 . . . . 0.0 113.075 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 6.8 m -87.14 -66.52 0.9 Allowed 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 167.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.32 0.0 OUTLIER -81.41 14.92 2.23 Favored 'General case' 0 C--N 1.345 0.38 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -169.521 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 16.3 m -64.23 -32.28 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 167.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -65.23 127.41 31.6 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 175.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 63.4 tp -143.07 130.95 21.57 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -177.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.3 tt -139.93 144.47 37.12 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 172.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 57.4 ttm -131.36 144.71 51.43 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 174.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 50.4 pttt -153.55 174.36 14.53 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.18 1.392 . . . . 0.0 109.524 178.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -64.26 157.95 24.57 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 122.533 0.333 . . . . 0.0 111.012 172.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.88 166.55 15.35 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.767 0.427 . . . . 0.0 110.961 169.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -141.61 134.29 28.55 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 172.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 . . . . . 0 C--O 1.25 1.094 0 C-N-CA 127.009 2.124 . . . . 0.0 110.937 -177.586 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 mpp? . . . . . 0 N--CA 1.482 1.16 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.6 173.3 15.7 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.596 1.158 . . . . 0.0 109.275 174.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -147.58 162.22 28.64 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 169.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.1 mm 62.63 155.72 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 125.893 1.677 . . . . 0.0 110.444 -169.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 56.1 tp -153.45 142.64 21.43 Favored 'General case' 0 C--O 1.233 0.211 0 O-C-N 120.918 -1.114 . . . . 0.0 109.039 174.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -147.84 151.04 35.27 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 126.527 1.931 . . . . 0.0 106.744 169.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -149.54 138.09 20.86 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.239 1.415 . . . . 0.0 107.581 -175.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -153.79 140.91 19.41 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.823 1.249 . . . . 0.0 109.251 -178.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.4 mp -107.46 139.16 30.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -134.99 158.07 45.3 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.438 1.095 . . . . 0.0 110.363 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -125.21 135.13 52.27 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 126.055 1.742 . . . . 0.0 107.514 -177.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.5 p -69.01 146.51 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 122.203 1.002 . . . . 0.0 109.358 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -125.11 -28.78 3.38 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 126.837 2.055 . . . . 0.0 109.116 -176.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -157.61 164.29 37.4 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 118.946 0.794 . . . . 0.0 110.913 170.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.8 mp -141.64 138.03 31.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 127.423 2.289 . . . . 0.0 106.032 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -146.61 97.8 4.26 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 125.351 1.46 . . . . 0.0 108.773 -176.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -60.67 26.1 0.04 OUTLIER 'Trans proline' 0 CA--C 1.543 0.952 1 C-N-CA 125.831 4.354 . . . . 0.0 118.554 -175.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -63.2 -9.05 9.61 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.214 -1.554 . . . . 0.0 113.628 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.72 10.63 12.48 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.442 1.496 . . . . 0.0 112.695 172.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.8 tppt? -44.15 -12.89 0.01 OUTLIER 'General case' 0 C--N 1.345 0.373 0 C-N-CA 129.536 3.134 . . . . 0.0 116.749 -176.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.2 tppt? -55.38 -31.35 61.73 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.224 0.92 . . . . 0.0 110.054 169.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -136.84 110.17 7.88 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 104.125 -2.546 . . . . 0.0 104.125 169.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -56.99 -28.3 62.27 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -169.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.2 ptt180 -72.02 4.7 3.22 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 117.453 -1.26 . . . . 0.0 113.759 174.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.0 t -120.85 134.95 62.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 121.363 1.892 . . . . 0.0 107.311 -178.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.8 m -145.78 151.73 38.41 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.694 0.797 . . . . 0.0 110.145 -177.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.5 ttp180 -73.25 143.12 47.2 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 168.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -136.46 155.61 49.76 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 125.547 1.539 . . . . 0.0 107.289 -174.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -131.92 135.06 46.34 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 105.218 -2.141 . . . . 0.0 105.218 169.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 65.7 m -141.18 167.02 23.17 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.536 1.534 . . . . 0.0 109.305 -176.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -135.94 130.47 33.77 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 178.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.3 m -76.62 131.01 38.64 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.218 0.607 . . . . 0.0 110.16 178.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -80.21 -36.5 34.76 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.91 0.884 . . . . 0.0 110.844 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.07 -29.5 69.3 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.506 0.722 . . . . 0.0 112.918 -169.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -132.92 -99.1 0.28 Allowed 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -167.08 13.82 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.449 1.1 . . . . 0.0 112.959 -172.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 72.2 mtm -71.18 141.14 50.69 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.174 0.512 . . . . 0.0 111.234 -169.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -88.73 135.97 33.24 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 169.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 64.1 tp -136.96 141.5 42.61 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 119.212 0.914 . . . . 0.0 109.426 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 36.3 mm -128.85 147.76 33.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 104.057 -2.571 . . . . 0.0 104.057 169.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 123' ' ' MET . 2.5 mp -144.17 166.28 25.48 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 125.639 1.575 . . . . 0.0 108.995 177.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -136.84 96.21 3.27 Favored 'General case' 0 C--N 1.324 -0.539 1 N-CA-C 99.038 -4.43 . . . . 0.0 99.038 167.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.7 p -139.45 161.18 27.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-O 121.353 0.596 . . . . 0.0 112.013 -167.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 62.5 t-20 -62.46 128.12 34.54 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.854 1.262 . . . . 0.0 109.273 170.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.5 pp -105.54 0.71 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 124.998 1.319 . . . . 0.0 112.93 -178.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -68.27 -17.51 64.31 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 120.347 1.431 . . . . 0.0 110.977 -177.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.4 mt -67.05 -34.97 73.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 124.501 1.12 . . . . 0.0 109.1 174.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -69.02 149.73 97.73 Favored Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -77.76 30.75 0.43 Allowed 'Trans proline' 0 CA--C 1.546 1.109 0 C-N-CA 124.445 3.43 . . . . 0.0 113.384 -172.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . 0.268 29.9 m 42.9 51.2 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 126.7 2.0 . . . . 0.0 111.937 -176.09 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -139.4 172.87 12.19 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.137 1.775 . . . . 0.0 108.343 -177.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 53.1 tp -52.14 -33.7 41.3 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.534 1.533 . . . . 0.0 113.417 -171.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -174.92 170.54 43.67 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 118.554 0.615 . . . . 0.0 111.611 172.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -158.84 172.34 18.4 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 126.431 1.892 . . . . 0.0 107.41 174.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -112.5 148.95 33.36 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.316 1.046 . . . . 0.0 109.916 -178.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -141.48 173.62 11.32 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.76 1.224 . . . . 0.0 108.367 -178.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -130.24 129.24 43.08 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 124.669 1.188 . . . . 0.0 107.911 -170.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.9 tp -91.53 141.12 29.07 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 169.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 55.1 t -134.7 146.72 30.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 172.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.4 mt -135.05 127.74 48.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 104.391 -2.448 . . . . 0.0 104.391 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -153.3 131.31 11.78 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 105.083 -2.191 . . . . 0.0 105.083 175.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.1 m -77.32 90.27 3.77 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 -176.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.2 m -61.99 -28.56 69.65 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.691 0.797 . . . . 0.0 111.375 176.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 71.7 mt 52.7 26.21 4.3 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.331 1.452 . . . . 0.0 112.23 -175.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -75.85 156.19 34.63 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.826 0.85 . . . . 0.0 110.158 -175.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -140.55 159.44 42.18 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.416 1.486 . . . . 0.0 108.672 169.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -60.37 -24.23 64.93 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -173.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -106.38 26.85 18.86 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.181 1.372 . . . . 0.0 112.688 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 46.7 m -60.96 -26.99 67.93 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 119.126 1.463 . . . . 0.0 110.316 172.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 38.7 mt -132.58 160.75 35.68 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 126.545 1.938 . . . . 0.0 106.813 174.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -80.96 44.94 0.78 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.245 1.018 . . . . 0.0 111.314 -178.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -164.12 -50.24 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.185 1.394 . . . . 0.0 110.742 175.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 126.19 -37.58 2.42 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 127.163 2.316 . . . . 0.0 110.878 -175.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -144.5 42.61 1.37 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.403 1.481 . . . . 0.0 108.896 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -57.26 125.12 21.34 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 169.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -140.41 79.29 20.98 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -168.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.48 -15.29 30.96 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.225 2.617 . . . . 0.0 112.835 -174.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 47.2 m -153.51 152.85 31.43 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 104.055 -2.572 . . . . 0.0 104.055 172.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -47.8 -45.41 29.49 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -169.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.83 -3.93 57.01 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -174.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -78.1 132.01 68.1 Favored Pre-proline 0 C--O 1.234 0.242 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -176.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . 0.262 0.1 OUTLIER 17.55 51.63 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.638 1 C-N-CA 127.609 5.539 . . . . 0.0 116.381 -169.216 . . . . . . . . 4 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.8 p -83.44 -176.08 6.13 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.035 1.734 . . . . 0.0 111.44 -176.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -62.78 167.49 4.56 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.793 0.837 . . . . 0.0 109.313 169.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -53.75 -44.45 69.98 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 118.44 -0.79 . . . . 0.0 111.73 -176.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.7 t70 61.44 -34.99 0.1 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 129.711 3.204 . . . . 0.0 115.931 177.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -64.22 -18.24 64.33 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.586 2.355 . . . . 0.0 111.509 174.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -133.57 146.08 50.66 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 126.168 1.787 . . . . 0.0 106.485 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -75.39 -19.62 59.44 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.945 0.498 . . . . 0.0 111.889 -169.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -140.92 143.39 34.57 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.167 0.987 . . . . 0.0 108.968 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.7 p -145.5 140.77 22.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 174.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 40.7 tpp -154.96 163.02 40.9 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.591 1.156 . . . . 0.0 108.779 -177.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -121.63 152.28 39.49 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 175.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -152.24 -143.0 3.6 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.119 -169.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -151.52 142.91 23.45 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 127.69 2.396 . . . . 0.0 105.001 169.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.3 p -116.05 140.48 37.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 172.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -132.96 54.69 1.94 Allowed 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.04 163.34 22.58 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.074 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 15.8 pt -103.17 175.25 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 123.238 0.615 . . . . 0.0 110.161 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -72.77 -5.26 36.73 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.017 1.327 . . . . 0.0 113.253 178.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.67 17.22 57.16 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.417 1.008 . . . . 0.0 112.585 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -139.63 119.45 13.34 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 169.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -130.05 25.74 5.23 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.291 1.836 . . . . 0.0 108.054 175.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 33.3 p -127.54 -174.0 3.06 Favored 'General case' 0 C--O 1.237 0.413 0 O-C-N 120.921 -1.112 . . . . 0.0 111.884 -168.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 71.0 m -143.0 -27.71 0.57 Allowed 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.048 0.939 . . . . 0.0 110.378 -169.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -147.37 -27.46 0.37 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.967 0.507 . . . . 0.0 111.008 177.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -57.18 -41.55 79.49 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.017 1.727 . . . . 0.0 109.077 171.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 54.99 73.84 0.39 Allowed 'General case' 0 C--N 1.343 0.321 0 C-N-CA 127.575 2.35 . . . . 0.0 107.223 177.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.72 150.79 2.67 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 113.465 -1.698 . . . . 0.0 113.315 -168.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.1 m -128.52 22.49 5.96 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.523 0.729 . . . . 0.0 111.428 -170.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -132.49 144.04 50.18 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 169.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 45.1 tp -80.35 143.62 33.4 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 168.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 13.4 m -135.75 143.4 45.27 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -169.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -138.89 156.27 47.42 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.881 0.873 . . . . 0.0 111.182 -169.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -133.74 139.42 46.35 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 171.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.3 t -137.8 144.05 32.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -177.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 65.6 m -126.31 121.75 33.5 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 174.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -145.47 116.11 7.67 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 119.396 0.998 . . . . 0.0 109.354 -170.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 56.92 21.3 36.98 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-O 119.377 -0.679 . . . . 0.0 114.513 -178.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 91.06 -8.49 79.62 Favored Glycine 0 CA--C 1.535 1.335 0 CA-C-N 118.553 1.176 . . . . 0.0 113.296 -175.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -85.91 168.12 14.49 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 118.719 1.26 . . . . 0.0 107.992 169.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.8 tp -139.59 157.75 45.28 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.457 0.703 . . . . 0.0 110.09 -173.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.418 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 14.6 ptp -155.64 159.26 39.45 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.141 0.976 . . . . 0.0 109.578 168.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.426 HH11 ' HG2' ' A' ' 124' ' ' ARG . 29.7 ttp85 -135.63 141.05 45.0 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 169.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 5.8 tt -143.38 154.5 43.78 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 118.801 0.728 . . . . 0.0 109.829 -176.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -135.13 148.48 49.77 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 169.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -169.2 166.41 39.67 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 170.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -70.9 103.57 2.68 Favored 'General case' 0 N--CA 1.462 0.126 0 O-C-N 121.728 -0.866 . . . . 0.0 109.825 179.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . 10.7 -67.57 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 130.987 3.715 . . . . 0.0 117.786 -171.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -61.47 -13.5 21.27 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 120.76 1.618 . . . . 0.0 114.077 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -62.8 -43.77 97.93 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 126.608 1.963 . . . . 0.0 109.781 171.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.47 -38.3 77.3 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.737 1.215 . . . . 0.0 109.977 -176.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 42.79 35.72 0.75 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.431 2.693 . . . . 0.0 113.599 175.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 173.86 58.82 0.05 OUTLIER Glycine 0 C--N 1.333 0.412 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -170.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -95.38 -0.65 52.38 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.761 0.824 . . . . 0.0 112.469 -170.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.436 ' C ' ' H ' ' A' ' 138' ' ' ASP . 7.0 tp10 -72.22 146.09 47.55 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 170.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 1.8 p -62.15 0.48 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 124.734 1.214 . . . . 0.0 110.988 169.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.477 ' HA ' HG21 ' A' ' 141' ' ' VAL . 36.8 t70 -137.97 9.51 2.8 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.471 1.909 . . . . 0.0 113.28 179.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 58.5 m -68.4 -73.1 0.15 Allowed 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.46 -0.775 . . . . 0.0 111.081 169.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.341 10.3 ptm180 -89.03 25.96 1.69 Allowed 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 122.364 1.078 . . . . 0.0 112.755 -169.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.477 HG21 ' HA ' ' A' ' 138' ' ' ASP 0.255 60.9 t -83.01 -4.93 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 C-N-CA 127.446 2.299 . . . . 0.0 107.708 168.644 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -126.45 120.12 28.94 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 102.654 -3.091 . . . . 0.0 102.654 169.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 10.4 tt -141.68 141.76 33.35 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -168.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 mp -138.65 157.33 46.33 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.379 1.072 . . . . 0.0 108.463 -174.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 78.1 mtm -143.03 158.94 43.14 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.887 -0.508 . . . . 0.0 110.795 173.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -152.26 169.47 22.4 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.985 1.714 . . . . 0.0 108.567 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -61.55 168.83 2.64 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.233 -0.917 . . . . 0.0 110.952 169.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.41 168.35 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.966 1.706 . . . . 0.0 114.551 175.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -142.45 21.26 2.04 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.692 1.197 . . . . 0.0 112.597 171.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 . . . . . 0 C--O 1.247 0.963 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -178.561 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.6 tpt . . . . . 0 N--CA 1.478 0.935 0 CA-C-O 121.34 0.591 . . . . 0.0 109.727 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.38 166.17 23.7 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.941 1.296 . . . . 0.0 111.813 -176.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 155.01 173.98 24.4 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 110.461 -1.055 . . . . 0.0 110.461 169.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 35.7 pt -78.6 43.78 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 O-C-N 121.554 -0.968 . . . . 0.0 110.168 170.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 42.0 tp -63.62 -30.08 71.23 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.603 1.161 . . . . 0.0 112.347 -169.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -154.3 164.64 38.26 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.742 1.217 . . . . 0.0 109.225 174.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -148.69 151.45 34.93 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 126.621 1.969 . . . . 0.0 105.948 172.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -147.1 148.06 31.22 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 123.381 0.672 . . . . 0.0 110.633 176.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.8 mp -115.84 137.17 50.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 104.529 -2.397 . . . . 0.0 104.529 169.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -137.84 168.62 19.32 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.318 0.647 . . . . 0.0 110.933 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -131.17 121.33 24.67 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.964 2.106 . . . . 0.0 107.697 -175.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 96.3 t -63.81 127.51 24.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 176.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.2 mmmt -105.83 -30.52 9.34 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 124.204 1.001 . . . . 0.0 109.87 176.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -156.27 167.33 30.76 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.833 0.742 . . . . 0.0 111.45 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.4 mp -139.53 140.41 37.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 127.758 2.423 . . . . 0.0 105.845 -176.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -146.67 93.19 4.93 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 123.35 0.66 . . . . 0.0 110.025 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.73 149.16 51.3 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.196 2.597 . . . . 0.0 112.234 173.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -82.51 -3.05 55.24 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -176.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.09 52.1 0.39 Allowed Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.981 -1.247 . . . . 0.0 109.981 -174.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? 40.3 42.33 1.2 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.865 2.066 . . . . 0.0 112.434 -169.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -79.02 79.79 5.4 Favored 'General case' 0 C--N 1.338 0.108 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 170.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 65.62 114.88 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 128.733 2.813 . . . . 0.0 108.704 -169.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -56.74 -33.89 66.99 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -169.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 51.6 ptt85 -81.89 0.53 39.31 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-O 116.558 -1.687 . . . . 0.0 113.708 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.5 t -121.77 113.78 40.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 121.686 2.039 . . . . 0.0 107.521 -174.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.408 ' HB2' HG21 ' A' ' 45' ' ' ILE . 41.4 m -147.84 163.21 37.48 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 123.206 0.603 . . . . 0.0 110.565 -172.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.9 ttm-85 -73.52 154.2 39.97 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 172.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.3 mt -135.13 155.01 51.45 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 125.749 1.62 . . . . 0.0 107.315 170.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -131.0 130.11 42.94 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 169.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 30.2 m -140.65 153.71 46.12 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.047 1.339 . . . . 0.0 110.571 -169.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -112.07 124.69 52.96 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 177.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 69.8 m -77.67 140.88 39.64 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 174.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -94.43 -26.73 16.37 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.456 1.102 . . . . 0.0 111.411 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.5 m -62.87 -46.52 87.5 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -169.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -141.68 -95.58 0.13 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.596 0.634 . . . . 0.0 110.413 -172.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 43.5 mtmt -145.29 21.09 1.55 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.7 1.6 . . . . 0.0 110.868 -168.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 56.5 mtm -88.64 159.44 17.85 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.402 0.681 . . . . 0.0 111.62 -169.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -138.98 127.67 23.32 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 127.62 2.368 . . . . 0.0 106.635 -177.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 56.6 tp -129.48 138.68 51.54 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.623 1.101 . . . . 0.0 110.769 -169.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.7 mm -124.41 146.94 29.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 169.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.1 mp -140.88 163.95 31.56 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.995 1.718 . . . . 0.0 108.142 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -138.49 96.29 3.14 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 100.374 -3.936 . . . . 0.0 100.374 168.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.3 p -140.95 171.18 13.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 123.26 0.624 . . . . 0.0 111.389 -167.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -68.17 93.13 0.43 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.194 1.398 . . . . 0.0 109.624 170.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.408 HG21 ' HB2' ' A' ' 26' ' ' SER . 1.6 pp -74.14 -1.33 2.83 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -171.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 60.9 mm-40 -65.75 -13.87 60.21 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 120.357 1.435 . . . . 0.0 111.503 175.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 82.7 mt -58.25 -29.79 38.38 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 C-N-CA 124.314 1.046 . . . . 0.0 108.921 168.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -115.61 145.42 34.48 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 124.663 1.185 . . . . 0.0 113.002 -168.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -78.93 77.65 4.01 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.531 2.82 . . . . 0.0 107.152 169.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.7 m -57.53 -9.93 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -171.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -57.67 -31.42 66.32 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.732 0.813 . . . . 0.0 111.999 169.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -147.03 -7.42 0.48 Allowed 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.811 1.412 . . . . 0.0 114.811 178.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.82 174.88 45.51 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-N 119.349 0.977 . . . . 0.0 111.827 -178.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -155.52 174.27 15.5 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.882 1.273 . . . . 0.0 108.713 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -93.61 153.21 18.52 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.169 0.988 . . . . 0.0 109.772 174.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -148.66 173.6 13.04 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.622 1.169 . . . . 0.0 109.458 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 50.6 ttt180 -131.18 146.23 52.25 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 125.839 1.656 . . . . 0.0 107.569 -175.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.1 tt -141.25 138.17 33.06 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 125.5 1.52 . . . . 0.0 107.474 -171.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.4 t -147.75 154.35 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -173.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 tt -81.71 -52.12 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 168.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 61.06 161.32 0.06 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 128.544 2.738 . . . . 0.0 114.168 -175.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.5 m -62.4 151.57 36.62 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.966 173.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.0 m -159.25 89.96 0.94 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 -177.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.1 tt -58.38 -23.93 58.44 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.558 0.743 . . . . 0.0 111.221 173.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -55.16 -17.05 3.64 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.381 1.472 . . . . 0.0 113.547 176.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -62.3 -21.36 65.18 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.236 0.926 . . . . 0.0 112.51 173.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -130.62 -35.85 1.45 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.593 1.157 . . . . 0.0 111.54 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -90.48 44.94 2.92 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 169.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.53 173.68 0.9 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.092 1.357 . . . . 0.0 108.76 169.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.0 pp -55.4 -23.92 27.31 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.107 -0.996 . . . . 0.0 113.41 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -61.04 -20.65 62.8 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.442 1.097 . . . . 0.0 112.799 175.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -73.73 2.26 8.61 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.153 0.981 . . . . 0.0 113.375 175.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.14 30.47 31.05 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.584 1.088 . . . . 0.0 112.222 172.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -138.23 116.38 11.78 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 177.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -154.04 143.86 21.8 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.827 1.251 . . . . 0.0 107.997 178.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -141.84 147.21 44.15 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 126.106 1.762 . . . . 0.0 107.396 169.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.82 -27.23 14.91 Favored 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 122.233 1.955 . . . . 0.0 113.043 -170.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -39.11 93.4 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.498 1.119 . . . . 0.0 110.944 177.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.2 t70 55.5 -51.98 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 130.846 3.658 . . . . 0.0 115.591 -178.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -138.85 -24.89 0.9 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.691 1.997 . . . . 0.0 111.923 174.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -62.06 131.69 93.46 Favored Pre-proline 0 C--N 1.343 0.298 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -178.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . 0.259 0.9 OUTLIER 28.14 38.95 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.654 1 C-N-CA 126.17 4.58 . . . . 0.0 116.985 -169.203 . . . . . . . . 4 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.8 m -99.27 11.51 38.86 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.807 1.243 . . . . 0.0 111.354 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 56.45 28.11 13.18 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.182 1.793 . . . . 0.0 112.431 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -137.22 2.02 2.49 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.35 1.06 . . . . 0.0 112.799 176.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -81.56 55.23 2.58 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 169.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -78.53 22.13 0.36 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.263 1.425 . . . . 0.0 111.122 -175.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -133.75 159.83 39.4 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 126.93 2.092 . . . . 0.0 108.806 -168.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -80.52 -30.78 37.22 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 122.022 -0.424 . . . . 0.0 109.965 178.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -153.85 147.69 25.41 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.111 0.964 . . . . 0.0 108.972 171.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.4 p -151.93 142.39 15.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 169.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.7 tpt -158.28 168.43 27.03 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.006 1.323 . . . . 0.0 109.144 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -119.5 146.13 45.71 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 172.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -150.14 -158.33 8.15 Favored Glycine 0 C--N 1.336 0.558 0 CA-C-N 118.775 0.716 . . . . 0.0 112.014 -171.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -125.91 136.22 52.79 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 174.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 47.1 t -98.03 150.09 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 176.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -135.21 157.96 45.57 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 169.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.07 153.47 29.45 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 120.754 -1.216 . . . . 0.0 109.234 172.034 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.56 -177.85 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 O-C-N 123.671 0.607 . . . . 0.0 109.618 176.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -68.48 -6.57 25.78 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.053 1.341 . . . . 0.0 114.054 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 121.58 -60.45 0.55 Allowed Glycine 0 C--N 1.338 0.682 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 -175.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -66.96 125.48 26.08 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 175.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -127.79 15.5 6.94 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.65 0.78 . . . . 0.0 111.169 174.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.521 HG21 ' HB3' ' A' ' 108' ' ' ALA . 38.7 p -139.67 -60.71 0.55 Allowed 'General case' 0 C--O 1.233 0.203 0 O-C-N 120.862 -1.149 . . . . 0.0 112.438 -169.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.3 m 156.6 -41.65 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.422 1 C-N-CA 133.678 4.791 . . . . 0.0 106.184 -173.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -178.24 -39.45 0.01 OUTLIER 'General case' 0 C--N 1.346 0.445 0 C-N-CA 125.817 1.647 . . . . 0.0 108.891 -174.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -58.87 -22.23 58.77 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 -169.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.521 ' HB3' HG21 ' A' ' 104' ' ' THR . . . -139.17 15.89 2.61 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.927 1.239 . . . . 0.0 111.791 169.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.88 -9.39 20.6 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 177.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.5 p -75.39 -7.25 53.54 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 127.303 2.241 . . . . 0.0 113.59 -174.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -127.69 132.23 49.69 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 126.707 2.003 . . . . 0.0 105.605 175.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 66.1 tp -65.9 147.05 53.98 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 169.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -115.77 133.01 56.47 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 169.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -122.36 157.23 32.26 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 173.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -126.68 149.32 49.61 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.9 t -134.43 132.62 55.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 18.5 m -124.22 119.58 29.77 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -144.22 117.37 8.94 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.282 1.033 . . . . 0.0 109.192 -169.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 56.79 27.21 55.52 Favored Glycine 0 CA--C 1.535 1.294 0 O-C-N 121.724 -0.61 . . . . 0.0 114.221 176.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 84.13 -3.1 86.82 Favored Glycine 0 CA--C 1.536 1.346 0 CA-C-N 118.25 1.025 . . . . 0.0 113.543 -177.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 78.8 mt -95.7 163.52 13.15 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.1 1.36 . . . . 0.0 107.483 169.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.8 tt -148.88 157.67 43.6 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 121.712 -0.618 . . . . 0.0 111.068 -169.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 24.6 ptp -151.63 162.44 40.98 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.655 1.182 . . . . 0.0 109.311 169.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 43.6 ttt-85 -132.03 127.24 35.78 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 171.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 54.6 tp -127.37 119.38 26.08 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 -178.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -94.38 149.42 21.25 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 168.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -169.09 171.03 42.84 Favored Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 171.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -53.66 133.05 41.74 Favored 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 169.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -43.24 -59.28 2.14 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -172.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -58.43 -43.66 88.84 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 122.288 1.042 . . . . 0.0 111.429 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -61.73 -26.25 67.94 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 113.58 -1.646 . . . . 0.0 111.31 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 32.8 tp -81.23 -22.74 38.54 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 118.765 -0.636 . . . . 0.0 110.668 -176.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 37.6 49.49 1.04 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.292 1.037 . . . . 0.0 111.997 -170.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -118.08 0.42 17.01 Favored Glycine 0 C--N 1.341 0.845 0 CA-C-O 118.536 -1.147 . . . . 0.0 113.425 -173.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -67.06 -32.09 73.04 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.477 1.638 . . . . 0.0 108.211 168.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -65.14 71.19 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.678 1 C-N-CA 131.8 4.04 . . . . 0.0 108.936 169.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.9 m -59.82 -4.21 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 125.351 1.46 . . . . 0.0 113.954 176.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -125.6 18.39 8.08 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 125.711 1.605 . . . . 0.0 112.128 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.2 m -103.03 -59.1 1.76 Allowed 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 168.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.379 9.9 ptm85 -75.44 11.65 1.2 Allowed 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -175.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 16.6 m -62.35 -40.11 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 167.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -81.19 129.49 34.61 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 176.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -141.65 122.82 14.72 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 -169.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.7 tt -137.44 138.32 39.67 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -172.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 90.5 mtp -139.8 142.64 36.66 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 123.769 0.828 . . . . 0.0 109.229 -177.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -155.92 168.43 27.24 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.226 1.411 . . . . 0.0 107.875 -175.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -60.14 159.03 10.21 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.54 -0.725 . . . . 0.0 109.217 169.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.6 pp -68.91 165.22 20.4 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 120.684 0.278 . . . . 0.0 110.788 169.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -130.75 63.17 1.59 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.285 1.034 . . . . 0.0 109.288 -173.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 . . . . . 0 C--O 1.251 1.159 0 C-N-CA 125.947 1.699 . . . . 0.0 107.646 178.295 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 mmt . . . . . 0 N--CA 1.484 1.243 0 N-CA-C 110.035 -0.358 . . . . 0.0 110.035 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.25 170.91 18.87 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.129 1.372 . . . . 0.0 109.049 178.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -67.21 -178.39 10.86 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.624 1.107 . . . . 0.0 113.111 174.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 40.1 pt -134.36 153.39 35.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 125.39 1.476 . . . . 0.0 109.424 -175.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -71.21 113.57 8.39 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.015 0.435 . . . . 0.0 110.223 177.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -161.7 148.87 14.39 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.645 1.978 . . . . 0.0 106.061 169.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -154.16 138.96 17.09 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.382 1.073 . . . . 0.0 109.035 -172.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -151.12 145.07 25.2 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 168.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.7 mp -85.78 145.1 8.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 106.233 -1.765 . . . . 0.0 106.233 178.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -132.97 148.08 52.27 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.634 1.174 . . . . 0.0 108.654 177.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -117.64 130.55 56.44 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.268 1.427 . . . . 0.0 108.349 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 84.0 t -70.08 113.22 5.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -84.48 -35.18 23.14 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.804 1.241 . . . . 0.0 110.157 175.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -155.99 170.18 22.75 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.316 0.962 . . . . 0.0 111.19 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.8 mp -137.76 132.37 44.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 126.873 2.069 . . . . 0.0 105.905 -178.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -129.25 103.63 18.19 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 124.607 1.163 . . . . 0.0 109.08 176.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -104.31 11.69 0.26 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.925 3.084 . . . . 0.0 113.63 175.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -76.33 74.99 3.12 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.828 1.251 . . . . 0.0 111.346 -169.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 144.0 -9.68 2.03 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.812 1.672 . . . . 0.0 111.76 -178.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -71.33 86.17 0.81 Allowed 'General case' 0 C--N 1.339 0.144 0 C-N-CA 125.195 1.398 . . . . 0.0 110.78 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -54.66 -42.9 71.86 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 169.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -78.25 82.13 4.57 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 169.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -56.95 -24.62 54.15 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.881 1.273 . . . . 0.0 114.419 -169.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -73.9 3.82 6.18 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 174.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.7 t -115.15 147.77 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 176.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.7 m -150.25 158.02 43.71 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 120.995 -1.066 . . . . 0.0 110.439 169.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 19.6 ttp180 -85.89 89.41 7.77 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 171.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 82.2 mt -66.03 152.26 45.02 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 169.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -126.32 133.29 51.42 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 104.306 -2.479 . . . . 0.0 104.306 172.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.9 m -144.13 165.75 26.95 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.103 0.865 . . . . 0.0 112.733 -169.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -135.76 138.21 42.42 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.445 1.498 . . . . 0.0 109.543 -176.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 29.5 t -60.11 135.23 57.65 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.005 1.722 . . . . 0.0 110.326 174.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -81.92 -41.99 20.11 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 119.157 -0.449 . . . . 0.0 110.326 171.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.2 m -92.04 -26.82 18.16 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 115.654 1.724 . . . . 0.0 115.654 -168.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -129.89 -107.84 0.28 Allowed 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 120.359 1.436 . . . . 0.0 109.933 -169.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -149.7 0.44 0.48 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.748 1.619 . . . . 0.0 112.931 -169.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 68.3 mtm -67.03 145.78 55.03 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.36 0.6 . . . . 0.0 109.54 -172.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -123.11 138.28 54.7 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 177.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.1 mt -136.31 152.59 50.85 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.729 0.776 . . . . 0.0 112.221 -169.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 31.6 mm -137.32 140.82 41.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 129.248 3.019 . . . . 0.0 102.97 169.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 8.2 mt -148.82 100.59 3.1 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 126.495 1.918 . . . . 0.0 106.575 -169.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -84.55 92.8 8.21 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 169.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.1 m -143.53 167.64 12.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 124.016 0.926 . . . . 0.0 111.995 -169.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -55.58 138.47 46.8 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.289 1.436 . . . . 0.0 110.889 170.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 pp -120.77 1.39 7.06 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 C-N-CA 124.8 1.24 . . . . 0.0 113.374 178.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -67.69 -9.52 44.25 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 121.209 1.822 . . . . 0.0 112.543 -175.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 28.8 mt -61.41 -24.02 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 C-N-CA 125.507 1.523 . . . . 0.0 108.315 169.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -127.22 169.32 12.47 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 127.785 2.434 . . . . 0.0 109.501 -169.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -53.17 156.3 10.47 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.422 2.081 . . . . 0.0 111.982 169.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.4 p -56.49 -21.74 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 125.543 1.537 . . . . 0.0 114.53 -169.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -133.29 29.49 3.98 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.535 1.134 . . . . 0.0 110.594 -173.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 21.6 tp -144.42 168.3 20.43 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.154 0.982 . . . . 0.0 110.18 -173.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -150.57 164.2 29.78 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 107.122 -2.391 . . . . 0.0 107.122 169.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -141.81 166.45 24.7 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.928 0.891 . . . . 0.0 109.66 -172.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -57.73 140.66 50.91 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.223 1.009 . . . . 0.0 110.615 -173.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -148.49 -179.68 7.14 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.595 1.558 . . . . 0.0 108.466 -178.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -129.34 150.26 50.78 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 121.38 -0.825 . . . . 0.0 109.142 173.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 61.4 tp -110.55 141.29 43.92 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.925 1.69 . . . . 0.0 107.026 174.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 55.6 t -141.91 157.76 20.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 128.248 2.619 . . . . 0.0 105.534 -177.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.2 pt -133.14 30.51 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 123.899 0.88 . . . . 0.0 110.772 -175.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -100.73 -0.69 36.78 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.899 1.279 . . . . 0.0 113.599 -169.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.9 p -70.21 177.89 3.08 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.901 1.28 . . . . 0.0 111.987 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.9 m -137.06 167.66 21.1 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 170.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 65.6 tp -62.44 -34.32 76.55 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.342 -0.849 . . . . 0.0 110.941 171.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 64.72 165.22 0.15 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 127.752 2.421 . . . . 0.0 112.953 -175.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -138.09 -157.31 0.76 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 128.391 2.676 . . . . 0.0 107.669 170.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -59.76 -23.89 63.61 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 -169.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -154.39 25.9 0.68 Allowed Glycine 0 C--N 1.341 0.825 0 CA-C-O 118.898 -0.945 . . . . 0.0 114.832 -171.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.8 m -61.24 -27.5 68.49 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.352 1.576 . . . . 0.0 112.245 -177.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 90.2 mt -75.63 -11.41 60.0 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 118.64 -0.695 . . . . 0.0 111.958 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.6 t0 40.06 54.69 2.7 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.39 1.876 . . . . 0.0 111.268 -169.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -147.63 -61.53 0.27 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.084 -169.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 66.62 1.3 10.72 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 126.72 2.105 . . . . 0.0 114.919 175.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -83.45 -38.18 22.21 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.166 1.483 . . . . 0.0 108.554 173.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -57.64 117.99 4.78 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.433 1.093 . . . . 0.0 108.398 169.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -148.53 161.07 34.74 Favored Pre-proline 0 CA--C 1.534 0.333 0 C-N-CA 125.731 1.613 . . . . 0.0 107.445 -178.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -52.96 -26.51 31.94 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 123.345 2.696 . . . . 0.0 114.85 176.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.1 p -60.59 -11.35 6.93 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.055 1.742 . . . . 0.0 113.243 174.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -66.87 -19.77 65.79 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.845 0.858 . . . . 0.0 112.023 170.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -132.07 -33.66 1.32 Allowed 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 45.8 mtm180 -60.68 128.28 88.31 Favored Pre-proline 0 N--CA 1.468 0.474 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 169.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . 0.27 1.1 Cg_exo 32.94 41.09 0.0 OUTLIER 'Trans proline' 0 CA--C 1.541 0.872 1 C-N-CA 125.392 4.061 . . . . 0.0 116.056 -168.805 . . . . . . . . 3 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.8 m -152.08 -158.76 0.93 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 128.565 2.746 . . . . 0.0 106.407 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? -152.63 114.75 4.41 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 120.886 -1.134 . . . . 0.0 109.591 172.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.3 146.13 54.43 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 169.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -140.4 -29.55 0.69 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.471 1.108 . . . . 0.0 111.68 174.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.453 ' H ' ' CD ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER -57.21 -30.04 64.23 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.774 1.63 . . . . 0.0 111.291 173.914 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -148.67 174.1 12.51 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.664 2.385 . . . . 0.0 107.378 176.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -124.66 -37.8 2.45 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.303 0.641 . . . . 0.0 110.619 172.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -152.2 158.53 43.0 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.386 0.994 . . . . 0.0 110.746 174.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.4 m -145.26 146.93 19.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 126.367 1.867 . . . . 0.0 107.877 174.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.31 175.63 10.69 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.835 0.826 . . . . 0.0 112.684 173.335 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -133.55 154.31 50.95 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 128.092 2.557 . . . . 0.0 106.883 172.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.88 -152.35 6.87 Favored Glycine 0 C--N 1.337 0.6 0 CA-C-N 119.602 1.092 . . . . 0.0 113.342 -171.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 43.9 tttp -141.46 139.03 33.27 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.215 1.406 . . . . 0.0 108.397 173.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 38.9 t -83.54 149.87 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.868 1.267 . . . . 0.0 108.932 169.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -133.31 48.3 2.4 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.196 1.798 . . . . 0.0 109.354 -177.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.5 mmt180 -149.45 163.18 38.5 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.595 1.158 . . . . 0.0 110.044 -177.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 25.5 pt -72.12 171.43 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 124.698 1.199 . . . . 0.0 111.207 174.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -74.42 4.77 5.42 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 127.114 2.166 . . . . 0.0 114.471 -177.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.61 29.01 70.73 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 124.458 1.028 . . . . 0.0 113.769 -176.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -129.05 120.24 25.63 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 169.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.402 ' H ' ' HA ' ' A' ' 109' ' ' ALA . 8.6 tp10 -112.9 -21.18 11.27 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 124.006 0.816 . . . . 0.0 111.628 -178.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.263 0.0 OUTLIER 44.03 169.85 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 131.092 3.757 . . . . 0.0 117.55 177.681 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 34.7 m -176.35 -50.02 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 129.765 3.226 . . . . 0.0 104.834 175.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.0 p -147.56 -58.4 0.26 Allowed 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 169.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -146.93 64.65 1.17 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.176 2.19 . . . . 0.0 106.371 177.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -124.75 24.25 7.77 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.867 0.867 . . . . 0.0 110.573 -173.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.402 ' HA ' ' H ' ' A' ' 103' ' ' GLU . . . -61.02 165.94 3.85 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 123.174 0.59 . . . . 0.0 109.935 169.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 37.1 p -130.46 -172.66 2.86 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 121.319 -0.863 . . . . 0.0 111.718 -169.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -62.62 138.13 58.42 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 168.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.4 125.32 26.68 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 103.162 -2.903 . . . . 0.0 103.162 167.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 13.6 m -105.1 144.05 32.43 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 173.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -135.49 85.33 2.16 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 125.592 1.557 . . . . 0.0 107.367 -169.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 5.9 m-30 -85.28 126.35 33.64 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 103.03 -2.952 . . . . 0.0 103.03 169.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.1 t -141.23 143.59 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 119.971 1.26 . . . . 0.0 108.306 -171.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.0 t -130.38 139.4 50.64 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 171.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -149.65 106.44 3.55 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.339 1.455 . . . . 0.0 108.525 -169.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 58.45 24.34 55.95 Favored Glycine 0 CA--C 1.535 1.313 0 CA-C-O 119.362 -0.688 . . . . 0.0 114.248 175.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.04 -8.95 65.41 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-N 118.295 1.048 . . . . 0.0 113.47 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 11.2 mp -95.21 158.08 15.62 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 106.924 -1.509 . . . . 0.0 106.924 169.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.3 tt -144.1 154.14 42.89 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.915 -0.491 . . . . 0.0 110.109 -170.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 23.3 ptt? -142.11 161.24 38.5 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 169.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 25.6 ttm180 -138.27 115.27 10.86 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 104.464 -2.421 . . . . 0.0 104.464 171.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 11.2 tp -126.15 149.15 49.18 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 126.389 1.876 . . . . 0.0 107.086 -169.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -140.95 150.97 43.8 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 168.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -173.58 177.03 46.1 Favored Glycine 0 C--N 1.331 0.279 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 169.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -57.04 139.53 51.98 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 118.51 1.155 . . . . 0.0 109.183 172.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -50.86 -55.16 18.34 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -176.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.69 -11.4 60.61 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 121.467 -0.771 . . . . 0.0 112.507 -177.046 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -81.4 -29.12 34.05 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.603 1.161 . . . . 0.0 110.366 172.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.9 mp -80.36 -29.52 37.9 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 169.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 2.1 t60 59.92 25.35 14.49 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.278 1.831 . . . . 0.0 114.44 171.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -168.84 95.06 0.11 Allowed Glycine 0 C--N 1.335 0.49 0 N-CA-C 107.142 -2.383 . . . . 0.0 107.142 177.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -96.0 9.94 39.08 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.388 1.075 . . . . 0.0 113.544 -175.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -74.75 146.56 42.07 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.593 0.711 . . . . 0.0 109.142 173.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.6 m -64.53 -5.19 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.273 168.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -122.09 17.34 10.81 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 127.368 2.267 . . . . 0.0 111.787 176.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 57.5 m -88.2 -57.16 3.03 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 121.272 -0.892 . . . . 0.0 109.096 167.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 4.9 mmm180 -74.58 -5.24 41.75 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -169.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 30.2 m -62.09 -40.9 89.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.408 177.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -74.68 117.4 16.47 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.2 tt -132.56 135.72 46.12 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 -174.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 10.2 tt -143.19 142.03 31.31 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 173.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 80.5 mtp -135.82 152.24 50.88 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 174.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 51.7 mttt -144.09 176.43 9.31 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.108 0.963 . . . . 0.0 109.315 177.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -57.3 165.98 1.3 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.212 0.605 . . . . 0.0 109.47 168.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.57 166.58 0.88 Allowed 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.662 -0.649 . . . . 0.0 111.831 169.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.8 77.72 4.81 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.672 0.789 . . . . 0.0 109.084 176.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 15.5 t80 . . . . . 0 C--O 1.25 1.123 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 175.527 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ptp . . . . . 0 N--CA 1.482 1.143 0 CA-C-O 120.417 0.151 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.67 162.93 20.09 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 122.879 0.471 . . . . 0.0 109.802 169.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.14 -163.78 37.06 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 -177.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.0 tp -52.49 126.92 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 123.844 0.857 . . . . 0.0 109.261 175.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.56 -61.7 0.16 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.625 0.77 . . . . 0.0 109.182 -175.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -151.98 140.81 20.98 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.293 0.637 . . . . 0.0 110.909 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -158.11 138.27 12.47 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.84 2.456 . . . . 0.0 106.756 171.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -159.55 157.47 29.95 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.955 0.798 . . . . 0.0 110.265 168.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.35 153.41 4.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 105.588 -2.004 . . . . 0.0 105.588 169.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -134.21 151.12 51.16 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.569 1.547 . . . . 0.0 107.857 175.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -120.07 122.43 41.07 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 126.598 1.959 . . . . 0.0 107.786 -176.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.8 t -71.63 116.43 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -90.88 -32.7 15.93 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 124.878 1.271 . . . . 0.0 110.245 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -157.02 167.37 30.68 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 119.308 0.958 . . . . 0.0 111.181 176.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.4 mp -141.54 146.53 23.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 127.212 2.205 . . . . 0.0 107.358 -175.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -136.31 109.31 9.62 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 125.819 1.648 . . . . 0.0 108.294 170.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -118.13 26.77 0.02 OUTLIER 'Trans proline' 0 CA--C 1.548 1.181 1 C-N-CA 125.744 4.296 . . . . 0.0 110.203 169.675 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -61.53 -19.75 62.47 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 116.161 1.912 . . . . 0.0 116.161 -167.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -178.63 35.15 0.08 OUTLIER Glycine 0 C--N 1.336 0.554 0 N-CA-C 107.827 -2.109 . . . . 0.0 107.827 177.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.47 117.99 9.47 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 -177.048 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -41.85 -38.17 1.45 Allowed 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.498 1.919 . . . . 0.0 112.98 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -117.79 104.1 10.63 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 104.386 -2.45 . . . . 0.0 104.386 170.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -63.5 -25.22 68.16 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -169.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -66.18 -16.89 64.36 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.611 171.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 20.6 t -98.1 137.3 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 173.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 40.5 m -138.28 149.91 46.14 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 21.8 ttp180 -79.18 143.67 35.18 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 104.797 -2.298 . . . . 0.0 104.797 168.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.0 mt -135.28 158.7 43.7 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -130.85 130.78 44.05 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 104.222 -2.51 . . . . 0.0 104.222 169.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 58.3 m -138.46 168.68 19.26 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.577 1.151 . . . . 0.0 109.866 -175.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -136.19 135.89 39.5 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 174.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.1 p -66.52 149.52 50.33 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 174.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -67.08 -34.46 77.7 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.893 -0.504 . . . . 0.0 111.008 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.3 m -136.7 -32.74 0.81 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -173.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -83.12 17.44 2.0 Allowed 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -171.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 31.6 pttt 43.75 26.55 0.13 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.554 1.942 . . . . 0.0 114.98 175.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 64.3 mtt -80.13 115.79 19.89 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 124.927 1.291 . . . . 0.0 108.208 176.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -78.99 127.51 32.07 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 104.02 -2.585 . . . . 0.0 104.02 168.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.5 tp -133.11 144.06 49.71 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 119.949 1.249 . . . . 0.0 110.745 -169.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 34.1 mm -130.13 146.51 33.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 128.209 2.604 . . . . 0.0 104.216 169.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 mp -143.09 162.54 35.25 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 126.398 1.879 . . . . 0.0 108.7 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -137.03 95.41 3.1 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 101.163 -3.643 . . . . 0.0 101.163 168.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.1 p -142.6 158.87 19.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 123.357 0.663 . . . . 0.0 111.297 -167.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 36.8 t30 -60.69 140.16 57.6 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.378 1.071 . . . . 0.0 109.969 171.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.6 pp -117.47 -2.7 10.06 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 C-N-CA 125.299 1.44 . . . . 0.0 112.698 176.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -67.67 -11.71 58.87 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 120.19 1.359 . . . . 0.0 111.177 171.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.5 mt -60.11 -39.48 80.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 C-N-CA 124.633 1.173 . . . . 0.0 107.867 168.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -76.38 130.24 77.77 Favored Pre-proline 0 CA--C 1.538 0.503 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.05 -25.13 12.08 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.488 2.125 . . . . 0.0 112.746 -175.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.8 m -143.59 162.22 16.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 C-N-CA 125.681 1.593 . . . . 0.0 108.277 -178.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.3 t70 50.24 -148.97 0.29 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.062 1.345 . . . . 0.0 110.597 -174.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 87.0 mt -123.44 -8.58 8.05 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.427 1.491 . . . . 0.0 110.983 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 179.45 164.05 31.3 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 174.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -156.01 -89.69 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 173.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 35.7 mtmt -140.64 151.75 44.85 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.589 1.156 . . . . 0.0 108.241 170.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -151.04 170.65 18.86 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.517 1.127 . . . . 0.0 110.477 -179.143 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 65.5 ttp85 -115.64 119.51 36.34 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.52 1.528 . . . . 0.0 107.131 -177.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -106.72 139.12 41.66 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 177.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.0 p -158.25 149.79 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-O 121.389 0.614 . . . . 0.0 110.458 -169.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.7 pt -129.77 -19.38 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.491 1.117 . . . . 0.0 109.609 169.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -52.27 -33.78 43.43 Favored 'General case' 0 C--N 1.345 0.389 0 C-N-CA 125.767 1.627 . . . . 0.0 113.583 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.3 m -70.44 -9.24 55.92 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.046 0.938 . . . . 0.0 112.931 -178.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.3 m -67.06 130.57 43.54 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 119.281 0.946 . . . . 0.0 109.124 175.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 23.8 tp -151.03 48.64 0.85 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 169.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -55.68 -32.24 63.08 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.856 0.863 . . . . 0.0 112.746 -169.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.19 -13.91 61.66 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.148 0.979 . . . . 0.0 112.869 -178.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -68.98 -20.33 64.17 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.284 0.947 . . . . 0.0 110.98 169.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.98 33.36 65.57 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 -177.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.0 m -60.83 -21.46 63.2 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.039 1.336 . . . . 0.0 112.428 -174.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.6 20.31 6.65 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.077 1.751 . . . . 0.0 111.096 175.188 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.8 t70 37.67 34.47 0.05 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 129.822 3.249 . . . . 0.0 115.042 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.2 t70 44.88 31.03 0.62 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.405 1.882 . . . . 0.0 113.239 -174.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 169.67 -11.91 0.05 OUTLIER Glycine 0 CA--C 1.531 1.047 0 CA-C-O 118.631 -1.094 . . . . 0.0 115.49 -174.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -67.91 -25.97 65.75 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.695 1.748 . . . . 0.0 110.03 169.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -55.83 108.76 0.48 Allowed 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.441 1.096 . . . . 0.0 108.939 170.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -152.15 166.12 15.98 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 124.605 1.162 . . . . 0.0 108.801 -174.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -54.84 -13.98 7.1 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 124.001 3.134 . . . . 0.0 117.933 -171.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 34.7 p -59.91 -19.7 53.11 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 121.255 1.843 . . . . 0.0 112.452 174.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -99.29 -2.49 36.35 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.193 0.997 . . . . 0.0 111.96 178.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -126.77 -30.9 2.73 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.668 1.187 . . . . 0.0 113.08 -169.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -65.38 -48.04 68.27 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-O 117.534 -1.222 . . . . 0.0 110.503 171.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -84.13 5.2 6.46 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.274 1.982 . . . . 0.0 111.645 169.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . 0.288 8.9 p 37.56 43.5 0.44 Allowed 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 128.826 2.851 . . . . 0.0 114.516 -175.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -60.0 -20.63 58.78 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 118.729 -0.653 . . . . 0.0 111.351 172.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -53.81 -29.08 39.06 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.32 0.963 . . . . 0.0 112.349 171.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -60.81 -13.68 16.89 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.608 1.163 . . . . 0.0 113.175 -178.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -52.29 -32.33 37.02 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 121.355 -0.84 . . . . 0.0 112.435 171.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -148.96 -177.55 5.87 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.125 1.37 . . . . 0.0 111.854 -172.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.8 pm0 -56.98 125.14 21.28 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 114.561 -1.2 . . . . 0.0 112.052 -176.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -68.32 160.21 29.88 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 169.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.6 p -132.06 144.63 36.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 124.254 1.021 . . . . 0.0 109.542 -169.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 34.1 tpp -145.07 168.09 21.14 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 125.608 1.563 . . . . 0.0 107.935 171.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -130.65 147.02 52.27 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.404 1.482 . . . . 0.0 107.027 -173.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -156.62 -162.7 11.67 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 118.729 0.695 . . . . 0.0 113.638 -171.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -133.32 123.35 25.29 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.578 1.551 . . . . 0.0 106.828 174.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.4 t -84.14 147.28 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 173.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -139.66 129.74 25.06 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 173.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.88 157.54 43.28 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 120.706 1.594 . . . . 0.0 111.369 -178.433 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.411 HG13 ' H ' ' A' ' 101' ' ' GLY . 17.2 pt -77.24 179.02 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 O-C-N 124.126 0.891 . . . . 0.0 110.42 -177.116 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -74.33 -3.52 30.76 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.918 1.287 . . . . 0.0 113.537 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.411 ' H ' HG13 ' A' ' 99' ' ' ILE . . . 88.8 15.29 59.82 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-O 119.251 -0.749 . . . . 0.0 113.045 -177.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -140.07 127.28 21.13 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 168.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -133.89 36.56 3.28 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.175 170.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.52 -44.01 1.56 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.653 1.181 . . . . 0.0 109.885 -169.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.2 p -164.03 -66.15 0.04 OUTLIER 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.5 p -151.95 -41.83 0.11 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.64 1.176 . . . . 0.0 110.211 -178.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -161.9 22.69 0.11 Allowed 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -169.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -120.34 7.73 10.74 Favored 'General case' 0 C--O 1.234 0.259 0 O-C-N 121.71 -0.619 . . . . 0.0 112.17 -170.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.84 165.66 8.3 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 169.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 23.1 p -121.89 -3.79 9.14 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -136.45 141.16 43.53 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.374 1.069 . . . . 0.0 108.97 178.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 55.6 tp -83.28 155.61 23.53 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 167.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.1 m -130.8 135.61 47.91 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 177.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -143.26 160.75 39.91 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.393 1.077 . . . . 0.0 110.79 -169.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -136.56 156.56 48.41 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.473 1.909 . . . . 0.0 107.485 176.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.0 p -150.69 139.94 15.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 169.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.5 m -121.07 123.41 42.28 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 -178.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 26.7 p90 -140.96 119.32 12.18 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 124.532 1.133 . . . . 0.0 109.437 -169.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 53.59 28.12 36.52 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 123.677 0.656 . . . . 0.0 114.464 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 84.55 -3.43 86.58 Favored Glycine 0 CA--C 1.535 1.342 0 CA-C-N 118.479 1.139 . . . . 0.0 113.782 -177.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 84.7 mt -95.5 166.24 11.95 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 125.282 1.433 . . . . 0.0 107.352 169.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 7.4 tt -148.63 155.66 41.37 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 121.306 -0.871 . . . . 0.0 110.99 -169.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 14.2 ptt? -153.29 157.92 40.84 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.944 0.898 . . . . 0.0 109.087 169.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -140.63 139.41 34.86 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 126.006 1.722 . . . . 0.0 106.829 -175.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -153.6 160.12 42.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 118.584 0.629 . . . . 0.0 112.221 -170.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -133.46 157.48 45.5 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.799 0.84 . . . . 0.0 109.029 169.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 178.42 173.77 44.09 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 171.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -52.52 134.38 35.12 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.651 1.225 . . . . 0.0 109.157 174.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -43.86 -66.09 0.43 Allowed 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 -169.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -57.88 -43.82 86.28 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 122.36 1.076 . . . . 0.0 111.665 -177.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -60.89 -26.38 67.4 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 126.797 2.039 . . . . 0.0 111.656 179.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 16.4 tp -73.45 -18.73 61.1 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 119.153 0.888 . . . . 0.0 110.186 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 41.89 44.65 2.98 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.689 1.596 . . . . 0.0 112.038 -178.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -142.78 2.66 1.7 Allowed Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.042 0.829 . . . . 0.0 113.557 -172.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -62.76 -27.0 68.98 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.507 1.154 . . . . 0.0 111.043 169.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -70.35 91.6 0.75 Allowed 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 129.083 2.953 . . . . 0.0 108.735 169.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 63.0 t -48.59 -21.39 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 126.996 2.119 . . . . 0.0 112.021 172.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -133.35 21.91 4.03 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -172.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 14.3 m -94.87 -64.02 1.11 Allowed 'General case' 0 C--O 1.232 0.179 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 167.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.329 9.3 ptm85 -77.89 12.95 1.52 Allowed 'General case' 0 C--N 1.344 0.356 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -172.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 15.7 m -61.44 -39.63 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 167.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -76.6 124.28 27.38 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 104.759 -2.311 . . . . 0.0 104.759 169.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 10.0 tt -137.96 128.15 25.99 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 -174.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 mp -134.66 151.01 50.71 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -175.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -156.13 153.34 29.16 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 174.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -144.53 164.44 30.89 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 169.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -56.07 164.04 1.37 Allowed 'General case' 0 CA--C 1.538 0.505 0 O-C-N 120.644 -1.285 . . . . 0.0 109.521 168.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.17 163.1 21.01 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.634 -0.666 . . . . 0.0 110.873 172.394 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -141.11 39.07 1.77 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.611 1.165 . . . . 0.0 110.065 -178.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 . . . . . 0 C--O 1.248 0.98 0 C-N-CA 125.578 1.551 . . . . 0.0 108.012 -174.884 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.0 mtm . . . . . 0 N--CA 1.484 1.251 0 CA-C-O 120.766 0.317 . . . . 0.0 110.419 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.99 -22.07 56.25 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.106 0.963 . . . . 0.0 112.177 178.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -161.39 -167.6 22.08 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -177.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -62.49 148.37 10.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 175.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 61.6 tp -66.83 128.67 37.18 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 169.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -151.93 137.6 17.87 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 178.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -157.0 130.6 8.1 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 169.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -158.46 152.52 23.89 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 118.474 0.579 . . . . 0.0 110.539 169.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 mp -86.54 142.87 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 172.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -126.04 148.87 49.21 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 125.576 1.55 . . . . 0.0 107.866 178.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -126.42 123.24 37.45 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 126.251 1.82 . . . . 0.0 107.615 -169.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 66.1 t -68.93 127.89 31.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 -173.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.9 mmpt? -89.97 -39.42 12.99 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.768 1.227 . . . . 0.0 109.338 169.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -159.62 166.99 29.52 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.083 0.856 . . . . 0.0 111.793 -177.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.4 mp -137.11 139.47 44.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 127.426 2.29 . . . . 0.0 106.124 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -147.41 95.18 4.36 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 124.902 1.281 . . . . 0.0 109.282 -171.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -63.51 9.72 0.12 Allowed 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 123.778 2.985 . . . . 0.0 116.921 -177.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -78.26 58.18 2.02 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.151 1.38 . . . . 0.0 109.631 175.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -166.94 35.59 0.23 Allowed Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.901 1.239 . . . . 0.0 111.277 -173.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.0 mmpt? -68.13 66.16 0.1 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.779 1.232 . . . . 0.0 113.295 -177.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -59.9 -38.0 81.03 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 168.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -143.66 167.69 21.66 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 130.002 3.321 . . . . 0.0 104.25 169.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -56.66 -41.17 76.78 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.415 -0.803 . . . . 0.0 110.644 171.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -71.73 7.41 1.52 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.201 1.4 . . . . 0.0 114.594 178.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 74.8 t -122.33 137.33 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 122.057 2.208 . . . . 0.0 107.783 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 67.4 m -147.25 161.7 40.41 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.329 1.052 . . . . 0.0 109.799 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 -83.42 149.81 26.45 Favored 'General case' 0 C--N 1.342 0.246 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 170.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.6 mp -145.08 164.82 30.05 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.83 2.052 . . . . 0.0 107.495 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -134.89 133.15 39.35 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 172.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 43.8 m -140.0 171.79 13.68 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.144 1.378 . . . . 0.0 110.081 -176.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -142.47 145.26 33.55 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.163 1.785 . . . . 0.0 107.152 -176.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.8 p -64.52 134.28 54.11 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 118.792 0.723 . . . . 0.0 109.946 174.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.4 tp10 -71.64 -30.18 65.46 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 119.177 -0.44 . . . . 0.0 110.609 172.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.1 m -100.32 -17.46 17.26 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 -169.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -129.71 -105.31 0.29 Allowed 'General case' 0 C--N 1.344 0.336 0 CA-C-N 120.594 1.543 . . . . 0.0 110.754 -169.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -168.64 5.67 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.271 1.428 . . . . 0.0 113.713 -169.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 7.7 ptt? -82.85 152.52 25.58 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.686 0.755 . . . . 0.0 110.009 -173.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -121.56 128.14 51.68 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.401 1.881 . . . . 0.0 107.497 -169.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.86 136.36 52.99 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.444 1.097 . . . . 0.0 108.401 -169.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.1 mm -127.02 137.77 56.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 102.634 -3.098 . . . . 0.0 102.634 169.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 123' ' ' MET . 2.2 pt? -154.2 159.46 41.38 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.111 0.964 . . . . 0.0 111.302 -177.465 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -126.8 112.32 15.24 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 102.967 -2.975 . . . . 0.0 102.967 172.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.2 p -146.22 160.38 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 121.411 0.624 . . . . 0.0 111.339 -168.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -64.61 125.43 24.7 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.866 1.266 . . . . 0.0 109.226 170.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.3 pp -95.21 -4.07 10.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 123.962 0.905 . . . . 0.0 113.178 -177.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -68.72 -15.15 63.43 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 120.684 1.584 . . . . 0.0 111.299 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 26.1 mt -64.66 -35.79 75.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 124.876 1.27 . . . . 0.0 108.533 171.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -78.97 150.86 75.6 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 123.253 0.621 . . . . 0.0 109.412 -175.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.73 -22.87 23.34 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.501 2.134 . . . . 0.0 112.925 -177.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.4 p -156.07 154.27 6.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -177.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -60.55 -27.59 67.78 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.315 1.046 . . . . 0.0 112.528 178.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 38.1 tp -63.31 -14.64 51.92 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.718 1.207 . . . . 0.0 112.269 174.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.0 170.38 46.55 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.467 1.032 . . . . 0.0 111.812 178.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -162.76 170.65 18.0 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.221 2.208 . . . . 0.0 106.472 177.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 11.9 mttp -60.5 151.73 27.7 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 118.896 0.771 . . . . 0.0 109.708 171.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -146.07 177.27 9.09 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.174 0.989 . . . . 0.0 108.402 172.125 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -132.73 138.41 47.21 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -172.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.2 mp -108.13 144.69 35.18 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 169.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.4 p -150.01 150.31 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 123.941 0.897 . . . . 0.0 108.662 -178.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.2 mt -142.74 127.28 15.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 174.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -153.24 -69.98 0.15 Allowed 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 172.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 70.0 m -142.52 150.69 40.78 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.256 1.023 . . . . 0.0 108.663 177.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -66.92 142.26 57.34 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.089 1.356 . . . . 0.0 110.952 -177.147 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.0 tp -72.58 -29.81 63.85 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.258 0.623 . . . . 0.0 109.933 169.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 62.18 174.63 0.13 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.709 2.004 . . . . 0.0 111.144 -169.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -141.22 15.25 2.23 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.217 1.007 . . . . 0.0 111.739 -175.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -124.02 14.7 9.18 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.104 1.362 . . . . 0.0 111.768 -176.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.76 31.03 77.16 Favored Glycine 0 CA--C 1.531 1.04 0 O-C-N 121.071 -1.018 . . . . 0.0 111.671 -175.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.6 m -61.45 -36.3 80.02 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.749 0.82 . . . . 0.0 109.032 170.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 60.0 mt -86.46 148.25 25.63 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 168.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -70.59 10.95 0.41 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.938 1.295 . . . . 0.0 114.071 -169.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -164.99 -43.53 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 126.102 1.761 . . . . 0.0 109.902 174.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.25 21.59 75.84 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-N 113.447 -1.706 . . . . 0.0 114.516 169.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -140.64 -47.58 0.42 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.206 1.503 . . . . 0.0 109.794 178.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 49.73 32.25 5.06 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.156 1.782 . . . . 0.0 113.129 174.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -141.71 72.63 24.42 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 124.299 1.04 . . . . 0.0 110.134 -177.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -54.15 -30.73 62.19 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.6 2.2 . . . . 0.0 112.353 171.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.23 7.71 1.21 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 127.625 2.37 . . . . 0.0 113.776 177.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -44.49 -47.02 10.02 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.901 1.28 . . . . 0.0 111.91 173.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -67.64 -16.52 64.2 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.259 1.423 . . . . 0.0 114.126 -174.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 32.1 mtp-105 -65.48 -63.28 3.55 Favored Pre-proline 0 N--CA 1.471 0.598 0 CA-C-N 119.895 1.225 . . . . 0.0 110.307 -175.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -79.49 -8.64 14.92 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.332 1.355 . . . . 0.0 111.145 168.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.4 t 52.92 49.52 20.04 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.726 2.01 . . . . 0.0 109.027 -169.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 45.9 mtm-85 -149.37 153.18 37.01 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 126.327 1.851 . . . . 0.0 107.939 177.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -101.85 -2.17 30.56 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.244 0.617 . . . . 0.0 112.658 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -59.11 -11.97 4.39 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.796 1.239 . . . . 0.0 113.278 177.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -53.36 -26.9 20.98 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.336 1.454 . . . . 0.0 112.166 170.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -139.32 167.13 22.76 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.481 1.112 . . . . 0.0 110.378 -179.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -59.45 88.59 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.966 2.506 . . . . 0.0 112.468 -175.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -68.94 152.15 45.63 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 168.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.8 p -115.77 152.37 17.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 118.995 0.816 . . . . 0.0 111.327 -169.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 45.9 tpp -149.89 155.3 39.78 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 126.552 1.941 . . . . 0.0 108.369 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -136.35 142.96 43.84 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 126.185 1.794 . . . . 0.0 106.811 -172.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -156.52 -159.48 9.46 Favored Glycine 0 C--N 1.339 0.708 0 CA-C-N 119.452 1.023 . . . . 0.0 114.789 -170.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 3.8 tmtp? -142.86 116.67 9.3 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 172.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 62.1 t -84.54 148.59 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 176.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -136.47 151.44 49.47 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 128.556 2.742 . . . . 0.0 105.276 176.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.69 167.71 29.64 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 120.241 -1.537 . . . . 0.0 112.085 -175.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.5 pt -120.65 177.47 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 124.222 1.009 . . . . 0.0 108.579 169.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -67.61 -5.08 13.89 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.316 1.446 . . . . 0.0 114.139 -175.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -179.82 -129.94 1.41 Allowed Glycine 0 CA--C 1.524 0.624 0 N-CA-C 107.446 -2.262 . . . . 0.0 107.446 -173.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -122.0 -21.21 6.06 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.235 1.414 . . . . 0.0 113.045 169.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 46.38 60.37 3.31 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.126 2.17 . . . . 0.0 112.441 169.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 22.5 p -61.21 -56.47 20.25 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 168.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 65.1 m -166.77 -41.14 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.616 1 C-N-CA 134.23 5.012 . . . . 0.0 104.833 172.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -176.3 -45.49 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.505 2.322 . . . . 0.0 106.548 -171.071 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -49.25 -27.72 4.01 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 127.158 2.183 . . . . 0.0 116.505 -169.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -140.0 15.5 2.46 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.735 1.152 . . . . 0.0 112.297 171.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.06 -5.04 4.04 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 114.336 1.235 . . . . 0.0 114.336 176.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.6 p -67.71 -20.67 65.3 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 128.778 2.831 . . . . 0.0 114.056 171.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -87.2 152.95 21.88 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 169.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 54.6 tp -100.22 141.73 32.66 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 103.638 -2.726 . . . . 0.0 103.638 167.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 17.9 m -131.7 139.34 49.0 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -176.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -136.4 149.28 48.22 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 124.415 1.086 . . . . 0.0 108.646 -178.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -111.14 142.94 42.65 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 103.868 -2.642 . . . . 0.0 103.868 169.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.1 p -144.78 126.66 9.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 38.1 m -100.37 139.76 35.58 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -135.49 78.88 1.75 Allowed 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.629 1.172 . . . . 0.0 109.114 -169.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 61.16 21.33 59.3 Favored Glycine 0 CA--C 1.537 1.435 0 CA-C-O 119.269 -0.74 . . . . 0.0 114.244 171.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 119.41 -24.29 8.17 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 125.268 1.413 . . . . 0.0 112.111 -176.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -82.84 167.9 17.63 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 169.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 31.7 tp -148.45 155.23 40.93 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.398 -0.814 . . . . 0.0 110.167 -174.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.419 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 34.6 mtt -147.38 161.11 41.68 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.888 1.275 . . . . 0.0 108.561 169.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -137.17 123.04 20.08 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 103.721 -2.696 . . . . 0.0 103.721 169.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -132.28 131.39 41.98 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 -175.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -125.07 140.26 53.06 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 171.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -164.13 178.24 39.56 Favored Glycine 0 N--CA 1.452 -0.243 0 N-CA-C 108.616 -1.793 . . . . 0.0 108.616 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -55.91 141.47 39.18 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.257 1.028 . . . . 0.0 108.879 170.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -41.82 -62.35 0.92 Allowed 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.39 -11.57 61.0 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.179 -0.95 . . . . 0.0 113.507 -176.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -83.71 -28.45 28.28 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.771 1.228 . . . . 0.0 110.137 173.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.34 -38.2 60.28 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 170.155 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 49.81 11.98 0.07 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 127.33 2.252 . . . . 0.0 116.105 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -73.99 -56.36 5.35 Favored Glycine 0 CA--C 1.522 0.53 0 O-C-N 121.008 -1.058 . . . . 0.0 110.835 -169.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 44.06 24.42 0.08 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 128.58 2.752 . . . . 0.0 115.01 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -162.87 133.15 4.54 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 125.659 1.584 . . . . 0.0 107.813 -169.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.5 m -67.66 -13.34 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.91 169.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -135.39 16.68 3.41 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -169.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 11.6 m -89.28 -66.35 0.93 Allowed 'General case' 0 N--CA 1.462 0.166 0 O-C-N 121.609 -0.682 . . . . 0.0 109.253 168.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.318 13.2 ptm180 -80.23 14.04 2.09 Favored 'General case' 0 C--N 1.344 0.339 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -170.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 19.4 m -60.79 -34.61 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 167.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -79.27 119.83 22.88 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 170.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -140.42 140.23 35.41 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -178.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.0 mp -129.54 156.48 44.1 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 174.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 23.6 ptp -148.44 152.86 37.67 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 121.854 -0.529 . . . . 0.0 111.342 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -158.03 -177.66 6.72 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.355 1.462 . . . . 0.0 110.408 -178.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -53.06 161.41 0.82 Allowed 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.688 1.595 . . . . 0.0 112.591 170.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.53 166.77 0.59 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.022 0.929 . . . . 0.0 111.473 169.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -88.82 89.52 8.02 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 173.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 17.1 t80 . . . . . 0 C--O 1.249 1.07 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 171.872 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.484 1.253 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.1 39.85 0.32 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.704 1.201 . . . . 0.0 111.928 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 177.93 -175.81 47.7 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.828 1.68 . . . . 0.0 109.398 -175.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.9 tt -63.39 156.34 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 174.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -133.41 135.7 44.79 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -175.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -147.23 150.97 35.91 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 126.076 1.75 . . . . 0.0 106.641 172.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -152.96 142.4 21.71 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.149 0.98 . . . . 0.0 109.094 178.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -158.58 158.91 34.82 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.53 0.732 . . . . 0.0 110.174 169.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 mp -76.2 150.4 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 168.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -131.85 154.21 49.39 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.885 1.274 . . . . 0.0 107.959 175.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -128.9 122.95 31.4 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -173.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.8 t -75.81 105.77 5.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -72.8 -37.78 67.44 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.192 0.997 . . . . 0.0 109.89 177.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -159.58 167.65 28.01 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.326 0.967 . . . . 0.0 111.486 176.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.5 mp -133.17 140.24 47.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 127.333 2.253 . . . . 0.0 106.211 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -146.17 92.95 5.17 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 124.494 1.118 . . . . 0.0 109.908 -170.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -64.26 13.59 0.09 OUTLIER 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 124.129 3.219 . . . . 0.0 116.696 -178.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -79.07 53.13 1.38 Allowed 'General case' 0 CA--C 1.544 0.712 0 O-C-N 120.648 -1.283 . . . . 0.0 109.338 172.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -174.89 41.44 0.12 Allowed Glycine 0 CA--C 1.525 0.682 0 C-N-CA 124.677 1.132 . . . . 0.0 111.052 -170.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -74.71 69.37 1.78 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.123 0.961 . . . . 0.0 110.496 -177.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -55.16 -38.65 68.55 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 169.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -146.73 169.48 18.97 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 129.256 3.022 . . . . 0.0 104.677 169.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -62.07 -33.23 74.02 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 120.985 -1.072 . . . . 0.0 111.744 178.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -83.82 9.45 11.96 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-O 116.919 -1.515 . . . . 0.0 113.105 175.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.0 t -119.32 142.74 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 121.84 2.109 . . . . 0.0 107.809 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 57.3 m -148.59 174.41 12.15 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.018 0.927 . . . . 0.0 108.913 175.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.429 ' C ' HD22 ' A' ' 28' ' ' LEU . 45.5 ttp180 -84.5 149.33 26.01 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 106.754 -1.572 . . . . 0.0 106.754 168.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.464 HD23 HG12 ' A' ' 43' ' ' VAL . 4.2 mm? -139.44 153.57 47.6 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 126.806 2.042 . . . . 0.0 106.634 -172.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -130.93 126.66 36.68 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 173.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 85.0 m -142.96 166.77 23.71 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.202 1.401 . . . . 0.0 110.161 -170.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 55.8 tt0 -144.78 139.8 28.06 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.339 1.056 . . . . 0.0 108.636 177.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.21 137.31 46.77 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 174.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -68.13 -32.52 72.87 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.869 0.868 . . . . 0.0 111.424 -176.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 m -117.15 -30.6 5.59 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.108 0.963 . . . . 0.0 111.887 -171.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -113.22 13.33 19.18 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -171.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt 45.71 20.87 0.07 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 118.224 2.676 . . . . 0.0 118.224 169.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 52.3 mtm -64.74 125.85 26.07 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 120.858 1.663 . . . . 0.0 107.806 176.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -77.65 118.62 20.22 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 104.921 -2.252 . . . . 0.0 104.921 169.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 49.8 tp -129.05 130.32 46.41 Favored 'General case' 0 N--CA 1.457 -0.081 0 C-N-CA 123.183 0.593 . . . . 0.0 110.303 -169.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 49.6 mm -118.04 142.41 32.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 103.272 -2.862 . . . . 0.0 103.272 168.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 123' ' ' MET . 2.5 pt? -155.67 163.0 40.48 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.21 1.004 . . . . 0.0 110.761 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -124.96 105.73 9.44 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 102.642 -3.095 . . . . 0.0 102.642 178.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.464 HG12 HD23 ' A' ' 28' ' ' LEU . 7.3 p -150.5 166.11 2.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 O-C-N 124.267 0.979 . . . . 0.0 111.366 -168.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -55.82 133.22 51.01 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.731 1.612 . . . . 0.0 110.504 170.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.42 ' CG2' HD21 ' A' ' 28' ' ' LEU . 1.5 pp -108.28 0.03 9.78 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 C-N-CA 125.045 1.338 . . . . 0.0 114.183 -177.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -67.29 -14.24 62.73 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 120.913 1.688 . . . . 0.0 111.623 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.1 mt -62.66 -27.35 42.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 125.505 1.522 . . . . 0.0 109.643 169.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -116.57 158.48 43.27 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 124.681 1.192 . . . . 0.0 112.182 -168.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -78.49 -15.72 13.79 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.251 2.634 . . . . 0.0 112.766 174.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . 0.283 17.7 m 53.96 -19.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 130.694 3.597 . . . . 0.0 117.243 -175.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -66.7 -23.72 66.16 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.668 1.122 . . . . 0.0 111.872 173.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.0 tp -151.76 163.41 39.22 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.449 1.9 . . . . 0.0 107.513 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.19 163.62 20.87 Favored Glycine 0 CA--C 1.534 1.263 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 169.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -156.02 176.21 12.95 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.22 1.408 . . . . 0.0 108.417 -173.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -126.92 150.64 49.22 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.4 1.08 . . . . 0.0 109.618 -175.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -152.58 178.31 9.72 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 125.411 1.484 . . . . 0.0 108.17 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 -129.11 144.7 51.29 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.5 tt -134.24 139.42 45.76 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 -170.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.3 t -140.78 139.57 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 125.247 1.419 . . . . 0.0 107.6 -169.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 38.3 mm -88.12 66.87 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 170.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -155.77 30.79 0.36 Allowed 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -169.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.8 p -66.83 -7.14 19.45 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 120.003 1.274 . . . . 0.0 112.618 170.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -46.82 145.54 1.94 Allowed 'General case' 0 C--O 1.237 0.422 0 C-N-CA 127.4 2.28 . . . . 0.0 111.927 -179.111 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.6 tt -134.24 126.5 29.96 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 175.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -72.02 70.82 0.79 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.725 1.21 . . . . 0.0 109.207 177.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -62.17 -16.52 53.46 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.882 1.273 . . . . 0.0 112.719 -177.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -62.29 -20.52 64.39 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.24 1.416 . . . . 0.0 111.866 169.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.12 18.21 56.17 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 124.574 1.083 . . . . 0.0 111.732 -177.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -61.33 -31.57 71.43 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.334 1.067 . . . . 0.0 111.706 -170.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 92.6 mt -92.81 -37.15 12.47 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 123.384 0.673 . . . . 0.0 110.441 174.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -60.42 -21.55 62.39 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.888 0.875 . . . . 0.0 112.585 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -63.24 -7.86 7.04 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.375 1.47 . . . . 0.0 114.177 172.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -127.86 -77.49 0.23 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 107.751 -2.14 . . . . 0.0 107.751 169.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -156.55 144.34 19.35 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 126.026 1.73 . . . . 0.0 107.105 169.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -112.3 23.29 13.81 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.389 1.076 . . . . 0.0 108.801 169.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -143.63 28.92 0.08 OUTLIER Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 127.096 2.158 . . . . 0.0 113.757 -172.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -58.28 -53.49 4.09 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.267 1.978 . . . . 0.0 112.325 -169.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.6 p -135.96 -0.84 2.49 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.413 1.885 . . . . 0.0 110.779 -176.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -66.88 -27.56 67.62 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.075 0.95 . . . . 0.0 111.662 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -128.32 -32.58 2.21 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.393 1.077 . . . . 0.0 112.454 -174.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 78.4 mtt85 -61.4 130.35 91.75 Favored Pre-proline 0 N--CA 1.468 0.445 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 170.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . 0.263 0.1 OUTLIER 18.29 57.12 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.693 1 C-N-CA 127.163 5.242 . . . . 0.0 116.92 -169.551 . . . . . . . . 4 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.3 m -146.95 166.01 28.08 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.056 2.143 . . . . 0.0 108.138 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 95.5 mtm-85 -139.62 166.62 24.11 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.602 1.161 . . . . 0.0 108.729 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.27 -13.87 43.12 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -51.05 -20.85 1.55 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.923 1.689 . . . . 0.0 113.295 172.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -51.13 -31.03 18.2 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.705 1.202 . . . . 0.0 113.367 170.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -146.22 174.72 11.08 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.259 1.024 . . . . 0.0 111.872 -169.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -125.24 -9.68 7.01 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.12 1.368 . . . . 0.0 110.816 169.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 36.9 t80 62.24 -149.55 0.37 Allowed 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 116.993 -1.48 . . . . 0.0 108.604 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . 0.456 20.7 t 154.92 -90.1 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 130.308 3.443 . . . . 0.0 110.405 169.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.45 -173.09 2.12 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 122.183 2.265 . . . . 0.0 115.83 -167.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -125.77 154.93 41.82 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 129.562 3.145 . . . . 0.0 105.692 169.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -157.46 -151.42 6.02 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-N 119.835 1.198 . . . . 0.0 113.147 -174.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -140.73 147.76 39.68 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.972 1.709 . . . . 0.0 107.007 169.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.9 p -125.42 135.12 64.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 124.392 1.077 . . . . 0.0 108.33 177.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -146.3 106.75 4.06 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.09 0.956 . . . . 0.0 111.235 -170.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -156.71 167.58 30.01 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.089 1.356 . . . . 0.0 109.821 169.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -62.67 168.95 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 125.466 1.506 . . . . 0.0 112.028 174.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -61.45 3.83 0.11 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 129.171 2.988 . . . . 0.0 116.026 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 58.05 43.82 94.93 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-N 119.405 1.002 . . . . 0.0 111.988 -175.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -143.76 80.03 1.65 Allowed 'General case' 0 C--O 1.232 0.144 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 170.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -130.92 14.73 5.27 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.573 0.702 . . . . 0.0 112.108 -169.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.447 ' CG2' ' H ' ' A' ' 108' ' ' ALA . 3.0 t -170.67 -132.5 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 -174.142 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.1 m -144.05 -8.67 0.7 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.205 2.202 . . . . 0.0 108.923 -178.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 21.9 p -142.75 -90.12 0.13 Allowed 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 118.907 0.776 . . . . 0.0 110.276 -176.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -55.88 -17.57 6.74 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 116.933 2.197 . . . . 0.0 116.933 -168.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.447 ' H ' ' CG2' ' A' ' 104' ' ' THR . . . -145.53 27.49 1.23 Allowed 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 119.823 1.192 . . . . 0.0 108.403 175.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -126.42 -2.03 6.86 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.24 1.416 . . . . 0.0 114.565 169.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 81.2 p -124.64 -9.82 7.34 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.715 1.606 . . . . 0.0 113.31 176.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -129.79 138.88 51.29 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 174.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.1 tp -84.87 152.45 23.57 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 169.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 11.8 m -122.55 150.79 42.11 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -176.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -148.14 140.43 24.27 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.685 0.794 . . . . 0.0 108.981 178.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 -120.76 134.27 55.29 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 103.11 -2.922 . . . . 0.0 103.11 169.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.3 t -125.11 142.6 41.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 -175.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 45.6 m -133.35 122.83 24.38 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 -178.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -147.79 105.21 3.66 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 122.809 0.444 . . . . 0.0 110.173 -169.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 58.48 27.85 61.47 Favored Glycine 0 CA--C 1.536 1.361 0 O-C-N 121.53 -0.731 . . . . 0.0 113.878 174.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 90.92 -2.87 80.38 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 118.312 1.056 . . . . 0.0 113.528 -178.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 88.0 mt -95.39 164.22 12.91 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 125.439 1.496 . . . . 0.0 107.878 171.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 7.9 tp -142.96 161.91 36.88 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -168.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.474 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 27.6 mtt -147.04 155.38 42.17 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 126.391 1.877 . . . . 0.0 108.671 169.231 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 36.9 mtp-105 -142.4 126.07 16.94 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 104.849 -2.278 . . . . 0.0 104.849 169.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -152.28 163.6 39.11 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 119.179 0.899 . . . . 0.0 112.339 -172.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -138.78 155.91 47.78 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.856 1.263 . . . . 0.0 108.78 169.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -169.63 175.8 43.71 Favored Glycine 0 CA--C 1.52 0.381 0 N-CA-C 108.52 -1.832 . . . . 0.0 108.52 169.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -56.77 142.16 41.58 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 118.467 1.134 . . . . 0.0 108.493 170.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -47.09 -48.73 22.62 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.131 0.878 . . . . 0.0 112.035 177.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -56.34 -36.63 68.98 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 122.214 1.007 . . . . 0.0 112.174 178.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -79.0 -19.32 51.89 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 113.58 -1.646 . . . . 0.0 111.004 -174.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 14.7 tp -70.39 -28.15 64.85 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 119.826 1.194 . . . . 0.0 109.309 169.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 1.9 t60 44.44 34.36 1.06 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.504 2.322 . . . . 0.0 114.623 171.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 167.38 73.37 0.03 OUTLIER Glycine 0 C--N 1.334 0.446 0 N-CA-C 108.482 -1.847 . . . . 0.0 108.482 -169.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -101.98 3.84 39.35 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -169.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.405 ' C ' ' H ' ' A' ' 138' ' ' ASP . 9.7 mm-40 -71.85 149.68 44.99 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 169.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 16.5 m -57.79 -7.43 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 124.713 1.205 . . . . 0.0 110.941 168.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 136' ' ' GLU . 34.1 t70 -135.85 15.6 3.33 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 126.825 2.05 . . . . 0.0 112.692 -178.174 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 58.6 m -80.77 -76.25 0.24 Allowed 'General case' 0 C--N 1.338 0.079 0 O-C-N 121.412 -0.805 . . . . 0.0 109.06 168.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 11.5 ptm85 -81.23 16.61 1.52 Allowed 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -169.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 30.2 m -68.19 -30.37 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 CA-C-O 118.732 -0.652 . . . . 0.0 109.348 168.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -72.36 124.13 24.49 Favored 'General case' 0 C--N 1.341 0.212 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 175.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 60.0 tp -138.17 103.44 4.94 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.511 0.725 . . . . 0.0 109.231 -173.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 15.9 tp -114.83 135.0 54.67 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 174.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 61.5 mtt -118.96 155.41 31.4 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.961 1.304 . . . . 0.0 107.51 171.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -146.85 161.84 39.86 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 126.36 1.864 . . . . 0.0 107.684 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -67.4 -176.07 0.55 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.351 0.596 . . . . 0.0 110.161 169.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 66.6 mt -57.19 119.8 7.01 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 121.773 0.797 . . . . 0.0 110.273 169.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -142.34 144.85 33.39 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 102.171 -3.27 . . . . 0.0 102.171 169.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 . . . . . 0 C--O 1.249 1.077 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -174.313 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.0 ptt? . . . . . 0 N--CA 1.486 1.328 0 N-CA-C 110.664 -0.124 . . . . 0.0 110.664 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 51.89 -146.21 0.5 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.403 1.481 . . . . 0.0 111.296 -178.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 75.52 29.03 60.39 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-O 119.057 -0.857 . . . . 0.0 112.855 176.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 41.3 pt 36.68 57.53 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 127.036 2.134 . . . . 0.0 113.19 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 66.5 tp -48.79 -37.28 18.69 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.097 1.359 . . . . 0.0 111.917 176.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.406 ' CZ ' ' HA ' ' A' ' 131' ' ' ASN . 83.7 t80 -145.2 143.53 30.35 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 169.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -151.83 139.59 19.85 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.429 1.491 . . . . 0.0 107.871 -177.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -154.26 115.71 4.13 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.408 0.683 . . . . 0.0 109.897 -171.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 mp -71.32 143.89 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -143.61 158.94 43.29 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 123.503 0.721 . . . . 0.0 111.431 175.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -135.35 129.27 33.17 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 126.385 1.874 . . . . 0.0 108.286 -174.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.7 t -66.13 126.86 26.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 175.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.1 mmmt -108.01 -25.46 11.15 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 124.312 1.045 . . . . 0.0 110.663 178.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -154.36 166.58 32.76 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.556 1.071 . . . . 0.0 110.672 172.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.4 mp -144.42 141.62 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 126.947 2.099 . . . . 0.0 106.975 -170.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -147.92 100.91 3.67 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 124.213 1.005 . . . . 0.0 109.02 171.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -65.07 -2.1 5.21 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 122.578 2.185 . . . . 0.0 115.937 176.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 36.9 45.41 0.43 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 128.756 2.822 . . . . 0.0 113.76 -176.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.19 11.95 37.78 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.094 0.854 . . . . 0.0 113.077 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? 45.82 67.86 0.68 Allowed 'General case' 0 C--N 1.343 0.307 0 C-N-CA 126.736 2.014 . . . . 0.0 109.895 -170.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -48.93 -41.16 32.91 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.451 1.1 . . . . 0.0 111.435 -177.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -140.74 156.56 46.16 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 169.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -62.5 -4.45 1.93 Allowed 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -172.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -147.24 26.75 1.06 Allowed 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 125.132 1.373 . . . . 0.0 112.229 -176.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.5 t -133.21 126.45 52.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.4 m -148.12 155.64 41.67 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.916 0.886 . . . . 0.0 110.271 -171.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 54.5 ttm-85 -83.41 149.72 26.5 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 169.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 85.9 mt -140.33 159.72 41.56 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 125.788 1.635 . . . . 0.0 107.815 -178.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -133.92 136.87 44.54 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 169.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.9 m -140.82 166.17 25.49 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.384 1.073 . . . . 0.0 109.845 -173.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -129.73 149.39 51.5 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 171.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.6 m -117.46 117.6 29.89 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -169.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -65.84 -44.22 86.17 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.241 1.416 . . . . 0.0 111.437 -169.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.2 m -74.94 -41.32 59.87 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 119.229 -0.415 . . . . 0.0 111.733 -169.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -131.66 29.36 4.5 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -172.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.292 0.0 OUTLIER 44.94 35.14 1.41 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 127.138 2.175 . . . . 0.0 114.702 169.814 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 11.8 tmm? -87.34 114.35 23.87 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.365 1.066 . . . . 0.0 109.003 -175.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -71.87 132.08 43.91 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 171.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 45.8 tp -135.81 143.37 45.13 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.474 0.71 . . . . 0.0 110.739 -169.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 41.4 mm -127.58 147.87 32.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 103.187 -2.894 . . . . 0.0 103.187 169.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.2 mt -150.88 146.44 26.32 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 126.577 1.951 . . . . 0.0 107.557 -169.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -135.3 101.74 4.93 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 102.056 -3.313 . . . . 0.0 102.056 169.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.3 p -146.34 163.51 9.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 122.483 1.135 . . . . 0.0 113.202 -167.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -67.01 123.92 21.57 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 126.072 1.749 . . . . 0.0 106.43 168.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 pp -105.44 4.64 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -174.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -69.36 -10.51 58.23 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 120.069 1.304 . . . . 0.0 111.146 176.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.3 mt -59.75 -42.11 87.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 169.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -79.57 155.4 76.15 Favored Pre-proline 0 C--O 1.236 0.39 0 C-N-CA 123.639 0.775 . . . . 0.0 109.467 -175.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -67.14 -21.1 49.18 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.315 2.01 . . . . 0.0 112.357 176.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.9 p -158.15 155.37 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.782 1.633 . . . . 0.0 106.938 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -55.66 -25.84 41.55 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.376 1.471 . . . . 0.0 113.126 178.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 58.5 tp -57.97 -22.46 49.36 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.281 1.432 . . . . 0.0 112.58 173.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.92 178.58 47.6 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 123.741 0.686 . . . . 0.0 112.219 177.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -157.75 168.57 26.83 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.534 1.933 . . . . 0.0 107.625 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -73.73 136.09 43.66 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 174.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 7.3 m-30 -138.59 178.88 6.82 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.977 1.711 . . . . 0.0 107.012 176.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.93 141.15 49.24 Favored 'General case' 0 CA--C 1.515 -0.383 0 O-C-N 121.127 -0.983 . . . . 0.0 109.129 169.323 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 12.9 tp -96.24 152.05 18.93 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 177.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 53.7 t -140.01 142.26 32.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 177.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.9 pt -132.64 21.02 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 122.94 0.496 . . . . 0.0 112.104 -178.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.94 138.47 57.41 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 121.506 -0.746 . . . . 0.0 109.302 172.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.0 t -59.14 130.02 44.94 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 169.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.4 t -165.04 167.87 17.94 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.875 0.845 . . . . 0.0 110.846 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.3 tp -139.48 11.83 2.53 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.66 2.384 . . . . 0.0 108.159 168.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . 0.321 47.5 p90 42.83 24.75 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 129.673 3.189 . . . . 0.0 116.194 -173.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -63.56 -20.72 65.88 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.4 1.08 . . . . 0.0 111.106 169.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -67.1 -23.04 65.79 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.127 1.371 . . . . 0.0 112.805 -177.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -163.27 36.6 0.32 Allowed Glycine 0 C--N 1.338 0.69 0 CA-C-N 118.284 0.493 . . . . 0.0 112.366 -172.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.82 159.21 11.5 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.194 0.998 . . . . 0.0 110.261 -177.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 72.7 mt 43.94 46.93 7.0 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.962 1.705 . . . . 0.0 110.761 -177.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.3 t0 42.3 69.28 0.39 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.919 2.088 . . . . 0.0 112.398 -169.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.4 t0 48.5 37.75 9.62 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.884 1.674 . . . . 0.0 112.634 -174.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.32 3.5 70.79 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.122 1.344 . . . . 0.0 113.916 177.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -70.27 -27.54 64.5 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.43 1.615 . . . . 0.0 110.617 175.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 25.0 t80 44.75 59.51 3.35 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 126.285 1.834 . . . . 0.0 110.59 -170.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -58.15 137.59 84.38 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 113.919 -1.491 . . . . 0.0 111.409 -169.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -50.08 -29.61 22.52 Favored 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 123.937 3.091 . . . . 0.0 115.374 176.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.2 m -65.31 -21.74 66.75 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 120.079 1.308 . . . . 0.0 111.422 178.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -96.89 -44.77 6.9 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.543 1.137 . . . . 0.0 109.205 176.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -71.37 -40.06 70.86 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.282 1.433 . . . . 0.0 114.621 -176.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 71.6 mmt-85 -69.36 -43.19 22.99 Favored Pre-proline 0 N--CA 1.466 0.337 0 CA-C-N 120.444 1.475 . . . . 0.0 111.466 -172.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -82.58 2.41 8.52 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 121.628 1.552 . . . . 0.0 111.667 168.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . 0.294 9.3 p 31.0 55.9 0.22 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 129.973 3.309 . . . . 0.0 113.393 -173.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -151.06 158.22 43.8 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 125.49 1.516 . . . . 0.0 107.713 176.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -56.73 129.82 42.84 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 123.537 0.523 . . . . 0.0 111.063 -172.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -125.74 -21.12 4.49 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.5 1.92 . . . . 0.0 110.23 170.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -52.78 -38.37 61.0 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.954 1.301 . . . . 0.0 110.688 169.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -146.36 161.39 40.46 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 129.428 3.091 . . . . 0.0 106.136 176.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -88.96 -32.82 17.48 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 118.966 -0.54 . . . . 0.0 110.261 175.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -155.67 153.57 30.2 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 118.819 0.736 . . . . 0.0 110.054 177.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.4 m -143.6 145.89 21.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 125.462 1.505 . . . . 0.0 107.464 169.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 5.8 tpt -162.13 174.27 13.17 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.029 0.932 . . . . 0.0 109.452 174.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -137.84 155.8 48.6 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 126.613 1.965 . . . . 0.0 106.212 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -167.08 -157.92 10.98 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 118.689 0.677 . . . . 0.0 113.147 -169.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.4 tttm -141.78 130.18 22.44 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 117.848 0.824 . . . . 0.0 109.152 174.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.3 t -75.11 148.35 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 124.656 1.182 . . . . 0.0 108.779 169.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -144.31 70.67 1.29 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.916 0.887 . . . . 0.0 110.798 175.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -144.01 163.67 32.84 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.376 1.07 . . . . 0.0 110.635 174.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.41 HG13 ' H ' ' A' ' 101' ' ' GLY . 26.3 pt -76.47 -170.08 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 125.124 1.369 . . . . 0.0 110.269 174.047 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -60.64 -0.29 0.26 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.965 2.106 . . . . 0.0 115.186 178.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.41 ' H ' HG13 ' A' ' 99' ' ' ILE . . . 97.38 -47.7 1.58 Allowed Glycine 0 C--N 1.335 0.48 0 C-N-CA 125.231 1.396 . . . . 0.0 111.511 174.047 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -73.65 118.78 17.0 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -135.52 35.27 2.95 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.891 1.276 . . . . 0.0 109.197 -175.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.8 t -141.35 179.68 6.64 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.099 1.36 . . . . 0.0 109.085 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.7 m -151.22 7.2 0.51 Allowed 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 128.132 2.573 . . . . 0.0 108.91 -172.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.3 p -128.38 4.62 5.7 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.745 0.818 . . . . 0.0 111.481 -169.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -157.5 -31.73 0.08 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.371 1.468 . . . . 0.0 110.106 173.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 63.79 97.88 0.04 OUTLIER 'General case' 0 C--N 1.35 0.602 0 C-N-CA 126.923 2.089 . . . . 0.0 106.2 -169.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.84 136.42 51.36 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.984 -1.007 . . . . 0.0 112.499 -167.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.8 p -96.84 4.32 51.75 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.036 1.335 . . . . 0.0 113.482 -178.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -118.77 151.9 37.17 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 172.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.18 139.98 33.16 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 169.397 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.6 p -101.73 147.26 26.68 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 174.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -146.33 144.0 29.5 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 176.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 15.3 m-30 -122.85 137.27 54.98 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 102.485 -3.154 . . . . 0.0 102.485 169.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.4 p -142.47 144.36 24.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 24.0 p -116.97 130.23 56.55 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 172.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -144.51 116.05 8.12 Favored 'General case' 0 N--CA 1.458 -0.073 0 C-N-CA 123.878 0.871 . . . . 0.0 109.581 -169.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 55.78 21.75 30.83 Favored Glycine 0 CA--C 1.537 1.423 0 CA-C-O 119.234 -0.759 . . . . 0.0 114.534 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 92.19 -5.04 78.15 Favored Glycine 0 CA--C 1.535 1.3 0 CA-C-N 118.648 1.224 . . . . 0.0 113.477 -176.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -95.09 170.92 9.07 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.956 1.302 . . . . 0.0 107.809 170.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.5 tt -149.3 151.45 34.19 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 121.522 -0.736 . . . . 0.0 110.545 -170.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 13.0 ptp -148.37 158.08 43.88 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 169.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 -140.51 138.53 34.65 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 178.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -154.2 162.12 41.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 118.855 0.752 . . . . 0.0 112.937 -169.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -134.44 118.43 17.38 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 104.109 -2.552 . . . . 0.0 104.109 168.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -151.05 175.56 29.94 Favored Glycine 0 N--CA 1.452 -0.256 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 -175.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -58.21 148.45 26.98 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 122.332 -0.511 . . . . 0.0 111.177 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -46.49 -42.15 15.13 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 175.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.77 -12.61 60.44 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.996 1.271 . . . . 0.0 113.191 178.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.406 ' HA ' ' CZ ' ' A' ' 6' ' ' PHE . 5.8 t-20 -66.57 -19.06 65.69 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 168.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -100.0 19.19 16.72 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 117.067 -1.444 . . . . 0.0 110.634 174.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -30.2 108.0 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 120.32 1.418 . . . . 0.0 112.021 169.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 122.84 -13.97 8.55 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 125.077 1.322 . . . . 0.0 112.134 -169.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . 0.26 30.9 m-85 44.11 56.6 4.7 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 129.527 3.131 . . . . 0.0 114.165 177.167 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 70.97 164.53 0.28 Allowed 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 129.499 3.12 . . . . 0.0 113.488 170.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 60.1 t 59.23 -9.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 127.091 2.156 . . . . 0.0 113.686 -172.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -154.02 -11.99 0.14 Allowed 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 119.84 1.2 . . . . 0.0 114.007 -172.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 16.0 m -54.68 -63.47 1.14 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.963 0.887 . . . . 0.0 112.652 169.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 8.6 mmm180 -88.67 11.19 18.18 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.43 -169.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 98.2 t -87.9 -5.73 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 C-N-CA 124.838 1.255 . . . . 0.0 108.861 -177.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -128.2 114.71 17.33 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 103.383 -2.821 . . . . 0.0 103.383 168.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.7 tt -133.69 126.23 30.32 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 -171.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.0 tt -134.68 147.97 50.23 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 106.768 -1.568 . . . . 0.0 106.768 178.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 56.5 ttm -139.56 138.32 36.14 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.221 -1.399 . . . . 0.0 107.221 -178.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -147.01 162.84 37.97 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -57.06 156.36 7.1 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 118.532 0.605 . . . . 0.0 109.7 169.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.0 pp -67.4 160.04 28.19 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 169.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -148.09 125.93 11.94 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 177.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 . . . . . 0 C--O 1.251 1.162 0 C-N-CA 126.289 1.836 . . . . 0.0 107.186 175.753 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.8 mmm . . . . . 0 N--CA 1.484 1.27 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.32 173.84 5.37 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.314 0.646 . . . . 0.0 110.08 169.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -150.01 171.31 30.01 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 108.348 -1.901 . . . . 0.0 108.348 171.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.6 tp -59.87 119.75 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 118.029 0.915 . . . . 0.0 108.695 175.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.4 tt -137.75 -37.19 0.61 Allowed 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 118.62 -0.705 . . . . 0.0 110.95 -170.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -161.48 150.69 16.26 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 119.17 0.895 . . . . 0.0 109.627 174.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -157.87 132.12 8.2 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.053 1.341 . . . . 0.0 108.434 169.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -161.06 155.01 22.5 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.471 0.708 . . . . 0.0 109.879 168.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 mp -74.5 151.33 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 169.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -129.13 150.71 50.41 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 172.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -133.97 129.21 35.88 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.054 1.342 . . . . 0.0 108.004 -169.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.6 p -63.82 147.97 11.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-O 122.078 0.942 . . . . 0.0 110.153 -177.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -125.09 -29.01 3.36 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 126.73 2.012 . . . . 0.0 109.373 178.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -160.25 166.6 29.27 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.348 0.977 . . . . 0.0 111.062 170.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.1 mp -133.01 135.06 57.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 127.292 2.237 . . . . 0.0 105.372 178.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -146.45 89.85 5.76 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 124.03 0.932 . . . . 0.0 110.301 -169.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -64.27 16.92 0.07 OUTLIER 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 124.26 3.307 . . . . 0.0 116.594 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -79.98 53.98 1.8 Allowed 'General case' 0 CA--C 1.542 0.66 0 O-C-N 120.256 -1.527 . . . . 0.0 109.778 176.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -172.88 38.67 0.15 Allowed Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.231 0.92 . . . . 0.0 111.577 -171.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.6 mmmt -74.31 66.71 1.34 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 118.152 0.976 . . . . 0.0 111.445 -175.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -57.09 -36.63 70.84 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 169.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -143.85 167.77 21.52 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 128.194 2.598 . . . . 0.0 105.027 169.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -62.13 -31.59 72.09 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.355 -0.84 . . . . 0.0 111.243 177.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -82.68 11.07 6.27 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-O 116.738 -1.601 . . . . 0.0 113.559 175.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 93.5 t -123.05 138.54 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 122.391 2.36 . . . . 0.0 108.302 -179.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.7 m -149.66 170.44 18.68 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.876 1.27 . . . . 0.0 109.472 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.443 ' C ' HD22 ' A' ' 28' ' ' LEU . 49.7 ttp180 -91.22 149.7 21.66 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 169.191 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.45 HD23 HG22 ' A' ' 43' ' ' VAL . 3.5 mm? -141.33 158.16 44.24 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 126.83 2.052 . . . . 0.0 106.713 -172.443 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -133.14 134.91 44.81 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 172.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 64.3 m -141.24 175.94 9.24 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.953 1.701 . . . . 0.0 109.68 -177.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -141.85 144.94 34.12 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.798 1.639 . . . . 0.0 107.836 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 64.6 p -67.82 130.29 42.53 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 175.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -69.36 -31.3 69.63 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 122.869 0.468 . . . . 0.0 111.785 -174.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 m -113.48 -5.48 13.48 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 114.587 1.328 . . . . 0.0 114.587 -169.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -123.77 -106.86 0.35 Allowed 'General case' 0 C--N 1.341 0.23 0 CA-C-N 119.892 1.223 . . . . 0.0 108.874 -176.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -169.61 3.74 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -169.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 5.3 mpp? -77.69 137.0 38.26 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 123.6 0.76 . . . . 0.0 110.9 -169.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -81.64 137.59 35.43 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 168.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 38.8 tp -133.16 138.75 46.72 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 174.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 35.9 mm -126.75 145.7 33.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 102.801 -3.037 . . . . 0.0 102.801 169.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 123' ' ' MET . 2.0 pt? -157.51 156.52 32.16 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.499 1.12 . . . . 0.0 109.952 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -126.67 107.12 9.89 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 178.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.45 HG22 HD23 ' A' ' 28' ' ' LEU . 27.0 m -148.21 171.44 2.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 O-C-N 124.656 1.222 . . . . 0.0 112.234 -168.402 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -59.79 141.06 56.0 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.612 1.565 . . . . 0.0 110.415 169.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.6 pp -117.08 1.08 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 125.982 1.713 . . . . 0.0 113.045 177.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -62.05 -22.54 65.83 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 120.48 1.491 . . . . 0.0 110.669 169.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 12.7 mt -53.62 -38.92 35.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 126.179 1.792 . . . . 0.0 109.857 169.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -68.42 129.02 92.98 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -172.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -72.28 -31.6 11.48 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.473 2.116 . . . . 0.0 111.402 178.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.7 m -145.79 154.96 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 126.124 1.77 . . . . 0.0 107.415 177.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -61.7 -25.09 67.19 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.349 0.66 . . . . 0.0 112.061 177.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.2 tp -57.79 -36.26 71.95 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.496 1.118 . . . . 0.0 112.261 -178.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 164.14 177.24 36.72 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-N 118.91 0.777 . . . . 0.0 112.851 178.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -156.99 169.44 24.82 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.487 1.515 . . . . 0.0 109.002 177.174 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -135.84 158.86 43.36 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.752 1.621 . . . . 0.0 107.974 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -142.47 169.85 16.8 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 123.921 0.888 . . . . 0.0 109.331 -169.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 -133.81 107.2 7.74 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 169.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 68.3 tp -93.98 132.74 38.15 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.0 p -153.6 155.91 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-O 121.943 0.877 . . . . 0.0 109.369 -170.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 tp -147.1 112.1 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 104.146 -2.538 . . . . 0.0 104.146 169.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -143.95 172.4 12.92 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.966 1.706 . . . . 0.0 109.229 -175.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.4 m -50.41 130.0 22.78 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.872 1.669 . . . . 0.0 112.536 -170.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.272 1.0 OUTLIER -79.17 -159.45 0.19 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.326 0.651 . . . . 0.0 111.46 177.757 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 56.93 30.92 18.85 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 -166.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 44.84 23.79 0.09 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 130.464 3.505 . . . . 0.0 115.067 -169.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -61.82 -18.65 60.78 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.408 1.003 . . . . 0.0 111.856 178.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.93 -24.87 17.83 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.689 1.996 . . . . 0.0 111.98 169.295 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.55 22.22 13.06 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 124.361 0.981 . . . . 0.0 110.766 -173.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.56 -23.6 67.32 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.34 1.456 . . . . 0.0 111.457 -172.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 91.8 mt -108.94 22.2 16.22 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.302 1.441 . . . . 0.0 110.574 175.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.8 t0 40.38 55.74 2.76 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 127.175 2.19 . . . . 0.0 112.485 -174.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.3 t70 54.21 22.98 3.92 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.352 1.861 . . . . 0.0 113.925 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 104.2 -5.51 45.6 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 125.42 1.486 . . . . 0.0 112.63 176.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -72.18 -22.36 61.3 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.942 1.371 . . . . 0.0 110.962 177.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -54.87 127.41 28.49 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.354 0.597 . . . . 0.0 109.825 174.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -148.8 164.68 20.36 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 126.553 1.941 . . . . 0.0 107.055 174.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_exo -49.84 -25.68 12.34 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 123.945 3.096 . . . . 0.0 117.66 -174.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 68.1 p -63.11 -22.44 66.86 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 121.109 1.777 . . . . 0.0 111.894 178.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -71.55 -17.1 62.33 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.796 0.839 . . . . 0.0 112.174 174.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -113.7 -17.42 12.12 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.225 1.41 . . . . 0.0 112.204 -175.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -52.16 133.43 41.13 Favored Pre-proline 0 N--CA 1.469 0.496 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 170.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . 0.254 0.4 OUTLIER 25.95 45.94 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.675 1 C-N-CA 126.673 4.915 . . . . 0.0 116.284 -169.466 . . . . . . . . 4 3 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.8 m -146.85 -171.89 3.86 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.526 2.331 . . . . 0.0 107.566 -178.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -138.42 151.54 47.55 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 173.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.75 -16.32 62.81 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -42.46 -29.47 0.28 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.184 2.194 . . . . 0.0 113.914 170.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -48.61 -43.19 36.02 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.416 1.087 . . . . 0.0 112.188 175.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -142.57 -0.61 1.2 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.43 0.692 . . . . 0.0 112.751 -170.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -140.05 31.84 1.97 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 119.301 0.955 . . . . 0.0 113.291 -168.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -78.41 59.88 2.47 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 120.614 1.552 . . . . 0.0 109.504 174.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.1 p -78.73 147.72 6.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 125.363 1.465 . . . . 0.0 108.414 178.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 3.2 ttm -158.68 174.3 15.26 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.243 1.017 . . . . 0.0 108.904 170.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -126.06 154.19 43.38 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 169.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -152.01 -162.24 10.7 Favored Glycine 0 C--N 1.333 0.369 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -173.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -140.83 112.54 7.57 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 172.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.8 p -69.17 149.91 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 C-N-CA 124.613 1.165 . . . . 0.0 109.347 168.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -139.44 122.65 16.95 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 102.296 -3.224 . . . . 0.0 102.296 172.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.04 142.38 31.55 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 120.065 1.302 . . . . 0.0 109.965 -168.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.9 pt -74.95 174.46 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 123.961 0.905 . . . . 0.0 110.917 -177.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -69.52 -2.99 12.81 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.292 1.437 . . . . 0.0 113.525 177.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 60.32 38.46 94.66 Favored Glycine 0 C--N 1.339 0.719 0 C-N-CA 124.748 1.166 . . . . 0.0 112.879 -176.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -145.97 130.34 17.69 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 168.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -134.76 12.22 3.69 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.425 1.09 . . . . 0.0 112.049 169.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 37.3 p -74.39 -63.24 1.28 Allowed 'General case' 0 N--CA 1.463 0.223 0 O-C-N 121.931 -0.481 . . . . 0.0 110.271 -178.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 32.9 m 144.68 38.56 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.822 1 C-N-CA 131.996 4.118 . . . . 0.0 108.558 -169.413 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . 0.257 1.3 m 84.98 8.12 0.43 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.788 1.635 . . . . 0.0 110.941 176.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -72.6 -17.78 61.66 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 168.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 76.55 88.31 0.08 Allowed 'General case' 0 C--N 1.349 0.544 0 C-N-CA 128.668 2.787 . . . . 0.0 108.136 169.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.85 151.26 6.66 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 113.935 -1.484 . . . . 0.0 111.969 -169.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.8 p -79.61 -4.88 53.57 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -174.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -126.07 141.29 52.01 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.627 1.171 . . . . 0.0 108.676 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.2 tp -102.81 152.09 21.66 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.122 1.769 . . . . 0.0 107.316 169.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.6 m -132.88 146.4 51.78 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 176.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -139.78 158.17 44.53 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 125.179 1.391 . . . . 0.0 108.872 -177.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -124.5 152.88 42.86 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 169.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.0 t -140.97 141.03 32.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 174.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 72.8 p -118.87 135.72 54.41 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 169.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -151.84 116.6 5.14 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -173.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 54.12 29.14 43.72 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 123.757 0.694 . . . . 0.0 113.97 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 85.48 -2.04 88.16 Favored Glycine 0 CA--C 1.535 1.316 0 CA-C-N 118.159 0.98 . . . . 0.0 113.879 -178.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 49.0 mt -95.22 168.21 10.88 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.281 1.432 . . . . 0.0 108.363 172.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 10.7 tp -139.12 158.1 44.78 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.868 -0.52 . . . . 0.0 111.062 -169.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.448 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 43.8 mtt -148.77 159.67 43.93 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.921 1.688 . . . . 0.0 109.408 169.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.7 ttp85 -140.17 131.0 25.93 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 168.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.7 tt -138.42 131.26 29.55 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 -169.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -136.6 144.63 44.2 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -178.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 177.63 -175.21 47.45 Favored Glycine 0 CA--C 1.518 0.245 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 177.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.01 141.93 32.17 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.04 0.92 . . . . 0.0 108.782 169.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -50.46 -53.3 30.77 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -175.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -61.77 -36.55 81.38 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.619 0.723 . . . . 0.0 112.112 179.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -65.64 -23.23 66.75 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 125.032 1.333 . . . . 0.0 111.871 176.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.52 -8.62 55.08 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 120.126 1.33 . . . . 0.0 110.524 172.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 77.2 m80 44.04 43.54 5.57 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 129.413 3.085 . . . . 0.0 111.088 -176.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 173.25 112.1 0.28 Allowed Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 107.267 -2.333 . . . . 0.0 107.267 179.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -65.79 -8.68 22.78 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-O 121.507 0.67 . . . . 0.0 110.93 167.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 50.83 152.13 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.179 1 C-N-CA 135.389 5.476 . . . . 0.0 121.128 168.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER 171.6 -27.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.555 1 C-N-CA 133.438 4.695 . . . . 0.0 107.63 169.41 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -167.24 40.44 0.04 OUTLIER 'General case' 0 C--N 1.349 0.569 0 CA-C-N 119.085 0.857 . . . . 0.0 113.11 -172.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 26.9 m -118.66 -38.41 3.12 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 123.353 0.661 . . . . 0.0 110.617 169.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -11.78 18.77 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.999 0.904 . . . . 0.0 113.084 174.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 18.6 m -77.7 -4.14 6.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 C-N-CA 126.216 1.806 . . . . 0.0 112.689 -174.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -122.19 118.38 28.47 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 104.036 -2.579 . . . . 0.0 104.036 170.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -149.56 147.1 27.76 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.846 0.748 . . . . 0.0 111.131 -172.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 15.7 tp -140.74 139.88 34.74 Favored 'General case' 0 CA--C 1.523 -0.094 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -177.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 16.7 tmm? -125.39 144.28 50.59 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 173.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -149.98 172.55 15.03 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.328 1.451 . . . . 0.0 109.426 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -62.64 157.11 21.57 Favored 'General case' 0 C--O 1.235 0.297 0 O-C-N 122.1 -0.375 . . . . 0.0 110.438 172.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.2 pp -67.61 161.42 25.77 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.121 0.486 . . . . 0.0 110.671 169.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -146.88 129.83 16.32 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 173.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 . . . . . 0 C--O 1.248 1.019 0 C-N-CA 126.466 1.906 . . . . 0.0 106.995 174.04 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 110.867 -0.049 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -57.81 -44.37 86.33 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.656 0.782 . . . . 0.0 111.026 175.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 159.47 -173.26 36.23 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 124.517 1.056 . . . . 0.0 110.549 176.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 30.2 pt -136.59 150.15 27.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 125.78 1.632 . . . . 0.0 107.211 169.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.4 tt -156.28 -57.43 0.09 Allowed 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -177.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -149.36 136.3 19.69 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 173.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -148.87 144.79 27.13 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.339 1.456 . . . . 0.0 108.262 -172.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -157.68 159.91 37.43 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 122.879 0.472 . . . . 0.0 110.585 169.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.1 mp -79.8 153.29 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 105.45 -2.056 . . . . 0.0 105.45 169.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -135.15 138.47 43.74 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.909 1.284 . . . . 0.0 107.644 178.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -105.57 122.96 47.1 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.073 1.349 . . . . 0.0 108.245 -178.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 44.8 t -71.09 116.92 13.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.6 mmmt -80.62 -40.99 24.69 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.729 0.811 . . . . 0.0 109.417 173.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -156.98 169.22 25.3 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 118.518 0.599 . . . . 0.0 111.458 -175.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.6 mp -135.18 144.96 32.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 127.245 2.218 . . . . 0.0 106.503 -178.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -141.91 89.12 9.05 Favored Pre-proline 0 CA--C 1.539 0.558 0 C-N-CA 126.552 1.941 . . . . 0.0 108.737 -176.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -81.21 100.88 1.2 Allowed 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 123.542 2.828 . . . . 0.0 107.674 169.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -61.77 -35.5 78.31 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.486 1.114 . . . . 0.0 112.705 -169.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 141.52 47.04 0.05 OUTLIER Glycine 0 CA--C 1.527 0.808 0 N-CA-C 103.595 -3.802 . . . . 0.0 103.595 -169.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.6 mmmt -61.49 115.97 4.33 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.542 1.537 . . . . 0.0 110.445 -167.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -55.47 -33.29 63.53 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.994 0.918 . . . . 0.0 110.884 170.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -127.22 96.61 4.64 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 176.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.98 -15.03 58.36 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.954 0.902 . . . . 0.0 113.411 -172.085 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -68.61 -0.2 4.91 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 118.789 -0.624 . . . . 0.0 112.546 169.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.8 t -120.62 138.52 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 104.929 -2.249 . . . . 0.0 104.929 169.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 61.0 m -155.34 160.67 40.9 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.634 1.107 . . . . 0.0 110.061 173.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 41.7 ttm105 -83.35 144.09 29.9 Favored 'General case' 0 C--N 1.342 0.272 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 173.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.1 mp -129.3 157.22 42.49 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 128.075 2.55 . . . . 0.0 105.958 177.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -130.47 130.68 44.54 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 170.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 22.1 m -141.79 168.48 19.67 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.716 1.206 . . . . 0.0 110.998 -171.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -134.3 155.97 49.27 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.447 1.099 . . . . 0.0 108.589 169.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.6 p -69.34 143.82 53.65 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.165 0.586 . . . . 0.0 110.375 176.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -71.77 -36.92 70.53 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.426 0.69 . . . . 0.0 111.247 175.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.1 m -110.92 -10.86 14.39 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -168.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -125.99 -105.97 0.33 Allowed 'General case' 0 C--N 1.343 0.303 0 CA-C-N 120.733 1.606 . . . . 0.0 111.3 -169.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -169.16 14.48 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.749 1.22 . . . . 0.0 114.16 -169.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -65.92 150.52 48.48 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 121.571 -0.706 . . . . 0.0 110.329 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -124.87 113.93 18.52 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 104.18 -2.526 . . . . 0.0 104.18 169.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.1 tp -124.66 145.28 49.74 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.237 1.015 . . . . 0.0 111.243 -168.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 33.2 mm -131.29 142.28 43.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 128.536 2.734 . . . . 0.0 103.741 169.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 123' ' ' MET . 2.1 pt? -156.62 133.05 10.0 Favored 'General case' 0 C--O 1.224 -0.265 0 C-N-CA 124.543 1.137 . . . . 0.0 111.133 175.742 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -97.02 103.92 15.89 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 102.815 -3.032 . . . . 0.0 102.815 168.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.9 p -128.51 154.34 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 124.344 1.058 . . . . 0.0 111.309 -167.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -68.66 96.05 0.7 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.779 2.032 . . . . 0.0 108.404 169.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.0 pp -75.58 0.35 2.27 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.362 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -169.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -68.15 -4.65 14.49 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 121.425 1.92 . . . . 0.0 112.045 178.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.5 mt -62.16 -34.11 62.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 168.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -77.86 127.54 81.69 Favored Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 174.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.1 -51.23 0.28 Allowed 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.031 1.82 . . . . 0.0 113.052 -169.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.6 m -144.84 -12.94 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -169.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -155.12 152.48 29.54 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.133 0.973 . . . . 0.0 108.785 -175.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.3 mt -111.05 -3.18 15.61 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.437 1.095 . . . . 0.0 112.727 -170.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.09 51.1 4.23 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 176.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -144.4 166.61 24.61 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.676 1.59 . . . . 0.0 108.615 -172.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -93.4 165.39 12.79 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.139 0.976 . . . . 0.0 109.573 -177.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -139.74 -179.17 5.77 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 124.256 1.022 . . . . 0.0 108.767 174.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -136.46 142.25 43.59 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -173.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.3 tt -138.98 144.04 38.78 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.374 1.069 . . . . 0.0 108.605 -169.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.1 t -140.79 152.91 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 126.46 1.904 . . . . 0.0 106.937 -177.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.0 pt -128.85 25.15 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.381 1.073 . . . . 0.0 111.433 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.06 149.82 49.67 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.38 0.672 . . . . 0.0 110.922 179.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.4 m -56.84 150.46 16.31 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.766 1.227 . . . . 0.0 111.63 178.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 25.0 m -139.37 156.35 47.05 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 178.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 43.0 tp -64.83 -20.0 66.16 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.535 0.734 . . . . 0.0 112.28 175.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 13.5 m-30 -57.03 150.95 15.95 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.006 1.322 . . . . 0.0 113.221 -173.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -142.0 -178.59 5.77 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 127.766 2.426 . . . . 0.0 106.815 168.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -59.16 -26.22 64.58 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -169.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -100.27 -9.13 48.67 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-O 118.598 -1.112 . . . . 0.0 113.423 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.6 m -69.19 -27.02 65.13 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 120.088 1.944 . . . . 0.0 109.767 170.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 90.0 mt -115.32 57.16 0.74 Allowed 'General case' 0 C--O 1.233 0.197 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 169.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -47.56 119.39 2.7 Favored 'General case' 0 CA--C 1.522 -0.112 0 C-N-CA 124.356 1.063 . . . . 0.0 108.926 178.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -65.93 66.56 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.092 1.757 . . . . 0.0 112.32 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 178.35 -50.34 0.1 OUTLIER Glycine 0 CA--C 1.527 0.807 0 C-N-CA 127.18 2.324 . . . . 0.0 108.501 178.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -71.91 -40.42 68.84 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.414 0.685 . . . . 0.0 110.693 171.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -55.79 120.32 7.16 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.553 1.141 . . . . 0.0 110.519 -177.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -151.97 140.8 13.8 Favored Pre-proline 0 N--CA 1.446 -0.637 0 C-N-CA 126.376 1.87 . . . . 0.0 106.999 169.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -82.29 1.83 8.92 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.19 2.593 . . . . 0.0 113.53 -177.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.0 p -123.0 39.31 3.98 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.211 1.804 . . . . 0.0 110.118 -169.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -82.82 -3.09 56.28 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.659 1.584 . . . . 0.0 113.715 -169.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -133.35 -72.52 0.5 Allowed 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 170.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 57.3 mmm-85 -126.48 -135.34 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.779 1 N-CA-C 99.455 -4.276 . . . . 0.0 99.455 167.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -77.04 62.8 7.55 Favored 'Trans proline' 0 CA--C 1.547 1.129 0 CA-C-N 126.274 3.276 . . . . 0.0 106.604 167.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 79.3 p -49.4 -40.54 36.6 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.667 2.387 . . . . 0.0 113.934 -168.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 52.0 ttm-85 -79.53 -11.67 59.88 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 118.883 -0.579 . . . . 0.0 112.148 -177.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -114.55 171.35 7.68 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 120.15 1.341 . . . . 0.0 110.771 -174.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.1 t70 64.67 -33.33 0.15 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 128.364 2.666 . . . . 0.0 114.996 -175.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . 0.322 2.8 pp0? -73.55 33.29 0.08 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.907 1.683 . . . . 0.0 114.32 179.1 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.5 p90 44.81 30.63 0.56 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 128.054 2.541 . . . . 0.0 115.074 176.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -159.63 59.61 0.38 Allowed 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.494 -0.754 . . . . 0.0 109.633 -176.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -74.65 72.42 1.96 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 169.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.3 p -85.3 145.87 7.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 124.569 1.148 . . . . 0.0 109.002 -176.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.76 166.99 31.7 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.903 1.681 . . . . 0.0 109.74 -169.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -137.99 142.32 40.45 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.959 1.304 . . . . 0.0 108.911 -177.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -152.73 -157.27 7.93 Favored Glycine 0 C--N 1.336 0.582 0 CA-C-N 118.672 0.669 . . . . 0.0 113.225 -175.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -134.49 130.01 36.02 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 172.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 44.4 t -95.7 150.49 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -132.81 162.34 31.77 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 127.184 2.194 . . . . 0.0 106.883 174.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.93 169.66 19.34 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.12 -0.987 . . . . 0.0 110.67 177.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.64 171.31 18.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 125.121 1.368 . . . . 0.0 107.313 168.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -65.78 -6.99 13.52 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.0 1.72 . . . . 0.0 115.022 -170.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 48.26 40.26 21.86 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.975 1.274 . . . . 0.0 112.868 -175.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -140.65 72.12 1.38 Allowed 'General case' 0 C--O 1.232 0.146 0 C-N-CA 124.877 1.271 . . . . 0.0 107.67 -177.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -139.93 81.16 1.81 Allowed 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 -171.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.84 153.54 24.34 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.722 169.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.6 m 97.74 -5.82 0.05 Allowed 'General case' 0 C--O 1.233 0.216 0 C-N-CA 128.255 2.622 . . . . 0.0 109.068 169.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.3 p -135.0 24.96 3.6 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.079 0.952 . . . . 0.0 110.203 168.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 47.37 43.45 15.32 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.277 1.831 . . . . 0.0 111.587 -179.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -118.3 35.28 4.81 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -100.99 -0.47 36.49 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -169.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.7 p -136.66 165.75 25.16 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 128.823 2.849 . . . . 0.0 108.768 -177.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? 61.75 163.0 0.08 Allowed 'General case' 0 C--N 1.345 0.378 0 C-N-CA 126.593 1.957 . . . . 0.0 110.885 -169.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 52.9 tp -101.04 135.91 41.74 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 103.448 -2.797 . . . . 0.0 103.448 168.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 16.1 m -128.18 134.17 49.01 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -171.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -137.67 162.36 34.05 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.65 1.58 . . . . 0.0 109.405 -169.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -130.3 156.6 44.39 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 172.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.6 t -138.5 139.78 40.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.7 m -125.71 121.42 33.4 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 105.069 -2.196 . . . . 0.0 105.069 174.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -142.38 103.61 4.29 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.333 0.653 . . . . 0.0 109.848 -169.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 59.59 26.5 62.38 Favored Glycine 0 CA--C 1.534 1.269 0 O-C-N 121.68 -0.638 . . . . 0.0 113.628 178.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 93.23 -12.93 68.8 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.409 1.004 . . . . 0.0 113.128 -177.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 84.3 mt -80.91 162.78 23.77 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 118.553 1.176 . . . . 0.0 107.885 169.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 10.7 tp -140.16 153.94 46.8 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 121.808 -0.558 . . . . 0.0 110.3 -170.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.441 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 29.4 mtm -144.88 156.56 44.07 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.098 1.359 . . . . 0.0 108.494 169.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -136.71 133.44 36.12 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 104.126 -2.546 . . . . 0.0 104.126 169.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 32.5 tp -148.37 145.59 28.14 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.194 0.598 . . . . 0.0 110.374 -168.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -136.01 153.49 51.35 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 167.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -170.25 172.86 44.14 Favored Glycine 0 CA--C 1.521 0.424 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 172.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -55.22 139.61 41.63 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.007 1.404 . . . . 0.0 108.869 173.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -41.06 -54.93 2.71 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -63.4 -37.71 88.34 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 122.564 1.173 . . . . 0.0 111.716 -176.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -69.22 -20.24 63.96 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 113.337 -1.756 . . . . 0.0 111.798 178.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 24.6 tp -69.67 -22.79 63.41 Favored 'General case' 0 C--N 1.346 0.439 0 CA-C-N 120.158 1.344 . . . . 0.0 110.092 174.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 45.71 34.22 1.72 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.675 1.99 . . . . 0.0 114.13 171.229 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -159.21 57.07 0.33 Allowed Glycine 0 C--N 1.335 0.496 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 -171.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -65.65 -10.0 32.28 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -169.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -107.27 145.51 32.63 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 125.153 1.381 . . . . 0.0 109.93 179.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 7.7 m -60.69 -7.94 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.233 168.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -124.16 14.8 9.1 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 127.58 2.352 . . . . 0.0 112.035 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 70.2 m -81.6 -71.08 0.49 Allowed 'General case' 0 CA--C 1.529 0.151 0 O-C-N 121.589 -0.695 . . . . 0.0 109.491 168.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.299 13.1 ptm180 -85.27 18.26 2.71 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -169.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 18.7 m -62.12 -35.26 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 167.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -79.69 122.8 27.01 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 174.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 56.3 tp -142.82 140.7 31.41 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -169.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.8 tt -145.53 137.43 25.4 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -178.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 58.6 mtt -131.01 157.44 42.98 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.989 0.916 . . . . 0.0 109.457 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 39.8 pttt -164.7 169.95 16.22 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.146 1.378 . . . . 0.0 109.26 178.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.89 162.47 11.1 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.224 0.61 . . . . 0.0 111.363 172.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.44 164.71 2.43 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.57 1.148 . . . . 0.0 113.699 -177.292 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.72 60.3 5.21 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.063 1.345 . . . . 0.0 111.174 178.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 22.0 t80 . . . . . 0 C--O 1.25 1.105 0 C-N-CA 124.356 1.062 . . . . 0.0 108.371 176.107 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.4 mtp . . . . . 0 N--CA 1.483 1.191 0 CA-C-O 119.281 -0.39 . . . . 0.0 110.304 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 45.92 49.18 12.01 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 124.316 1.046 . . . . 0.0 113.73 173.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -169.37 -170.67 34.19 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 107.838 -2.105 . . . . 0.0 107.838 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.1 pp -69.94 168.85 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-O 121.636 0.731 . . . . 0.0 110.985 177.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 65.7 tp -153.31 -44.06 0.09 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.509 1.524 . . . . 0.0 108.336 174.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -143.3 144.52 32.15 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 169.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -147.46 140.57 25.12 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 -171.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -147.78 144.25 28.09 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 124.262 1.025 . . . . 0.0 109.42 -178.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.77 141.13 25.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -138.08 158.84 43.51 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 122.786 0.435 . . . . 0.0 110.651 174.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -135.08 148.26 49.79 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.802 1.241 . . . . 0.0 109.386 -172.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.1 t -59.86 141.4 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 125.54 1.536 . . . . 0.0 109.847 -178.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -123.35 -29.75 3.78 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 126.377 1.871 . . . . 0.0 108.912 169.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -158.99 169.79 23.52 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.886 0.874 . . . . 0.0 109.669 169.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.6 mp -131.67 141.21 46.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -140.26 76.07 27.05 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 124.319 1.048 . . . . 0.0 108.286 -178.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -81.59 10.27 3.54 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.015 2.477 . . . . 0.0 113.92 -169.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -79.45 54.99 1.84 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.682 1.593 . . . . 0.0 110.199 176.162 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -150.19 38.4 0.9 Allowed Glycine 0 CA--C 1.528 0.851 0 C-N-CA 126.14 1.829 . . . . 0.0 110.002 -175.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.471 ' HE2' ' HA ' ' A' ' 20' ' ' LYS . 5.3 mmpt? -68.89 65.09 0.13 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.41 1.884 . . . . 0.0 114.083 -169.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -60.43 -38.74 85.04 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 168.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -144.05 162.79 35.33 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 129.161 2.984 . . . . 0.0 104.268 169.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -60.29 -33.68 72.7 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.328 -0.857 . . . . 0.0 111.764 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -75.77 -6.9 52.85 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 117.096 -1.431 . . . . 0.0 114.133 178.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 72.9 t -101.41 123.85 54.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 120.886 1.676 . . . . 0.0 107.162 -174.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.3 m -147.19 152.56 38.59 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.911 0.884 . . . . 0.0 109.561 -176.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 64.9 mtm-85 -83.36 150.61 25.99 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 169.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -129.69 155.16 46.33 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 127.092 2.157 . . . . 0.0 105.8 175.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -127.69 128.62 45.74 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 103.485 -2.783 . . . . 0.0 103.485 170.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 71.3 m -142.61 169.09 18.23 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.396 1.078 . . . . 0.0 111.481 -169.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -135.49 134.86 39.96 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.716 1.606 . . . . 0.0 106.957 176.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.0 m -75.05 142.38 43.75 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 121.392 0.615 . . . . 0.0 110.767 176.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -93.97 -34.93 12.87 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.634 1.174 . . . . 0.0 110.694 -175.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -69.89 -41.98 74.01 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.607 0.763 . . . . 0.0 112.949 -169.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -136.49 -95.22 0.23 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.596 0.758 . . . . 0.0 109.17 -175.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -165.91 110.96 0.85 Allowed 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.06 1.344 . . . . 0.0 108.379 -175.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.8 mtt -158.58 142.01 15.04 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 174.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -112.89 129.31 56.51 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 104.802 -2.296 . . . . 0.0 104.802 169.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.3 tp -136.63 139.46 42.09 Favored 'General case' 0 C--O 1.227 -0.112 0 C-N-CA 123.52 0.728 . . . . 0.0 111.987 -168.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 35.3 mm -121.72 140.96 44.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 102.261 -3.237 . . . . 0.0 102.261 168.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 123' ' ' MET . 2.3 pt? -154.66 158.25 39.37 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 123.704 0.802 . . . . 0.0 110.586 177.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -127.09 111.53 14.13 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.411 HG11 HD12 ' A' ' 41' ' ' LEU . 28.6 m -145.6 166.89 9.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 O-C-N 124.224 0.953 . . . . 0.0 113.195 -168.36 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -72.65 126.87 30.92 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.945 1.298 . . . . 0.0 107.659 169.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 pp -105.6 -1.05 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -67.23 -16.92 64.58 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 120.775 1.625 . . . . 0.0 111.644 177.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.3 mt -58.57 -27.44 33.89 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 124.23 1.012 . . . . 0.0 109.187 169.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -122.42 158.68 55.4 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 125.093 1.357 . . . . 0.0 113.49 -168.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -75.01 75.13 3.8 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 124.012 3.142 . . . . 0.0 109.55 171.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.5 p -53.98 -23.81 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 124.972 1.309 . . . . 0.0 113.328 -174.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -59.25 -22.43 61.11 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.438 1.095 . . . . 0.0 113.024 174.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 59.1 tp -129.79 -30.19 2.07 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.192 1.397 . . . . 0.0 111.713 -177.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.82 164.95 36.37 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 -169.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -159.2 166.2 31.94 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.71 1.204 . . . . 0.0 108.525 -178.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -74.63 163.97 27.11 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 172.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -128.25 164.92 21.51 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.754 1.622 . . . . 0.0 107.159 177.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.8 ttm180 -127.1 141.14 51.84 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 125.914 1.686 . . . . 0.0 106.581 170.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 39.9 tp -123.72 141.44 52.02 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 127.057 2.143 . . . . 0.0 106.653 178.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.1 t -134.83 142.06 41.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 172.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.7 pt -128.96 19.51 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.329 1.052 . . . . 0.0 110.759 -173.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.4 159.12 27.63 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.24 1.016 . . . . 0.0 110.57 175.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.8 p -58.69 -21.76 55.43 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.333 1.453 . . . . 0.0 112.953 172.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.404 HG23 ' H ' ' A' ' 65' ' ' TYR . 2.7 t 50.58 -169.05 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.75 2.42 . . . . 0.0 114.422 169.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.2 mp -54.87 -26.3 34.61 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.752 1.621 . . . . 0.0 111.272 -177.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.404 ' H ' HG23 ' A' ' 63' ' ' THR . 12.8 m-30 -61.48 -28.03 69.0 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.591 1.156 . . . . 0.0 112.313 -179.134 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -73.99 -16.2 61.08 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.187 0.903 . . . . 0.0 112.002 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -123.29 -17.59 6.54 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.284 1.433 . . . . 0.0 112.116 -169.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.08 35.1 82.98 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 -175.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.2 m -57.81 -22.64 48.5 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.923 1.289 . . . . 0.0 113.542 -169.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.3 pp -131.33 -29.96 1.75 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.569 0.748 . . . . 0.0 111.446 169.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -66.04 -22.99 66.46 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.354 0.662 . . . . 0.0 112.399 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -136.69 35.36 2.66 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.282 1.833 . . . . 0.0 108.167 172.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -140.88 34.67 1.92 Allowed Glycine 0 CA--C 1.527 0.82 0 C-N-CA 125.376 1.465 . . . . 0.0 111.11 -170.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 51.18 55.03 10.12 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.026 1.731 . . . . 0.0 112.653 174.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -56.72 145.11 30.04 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 168.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -137.62 123.46 12.92 Favored Pre-proline 0 CA--C 1.532 0.262 0 CA-C-O 118.541 -0.743 . . . . 0.0 109.693 -170.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -52.04 148.27 24.26 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.12 2.547 . . . . 0.0 111.917 173.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.4 m 66.83 4.71 3.6 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.234 1.413 . . . . 0.0 112.514 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -66.39 -33.11 74.99 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 119.989 -1.695 . . . . 0.0 110.0 169.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -89.5 21.64 3.31 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.534 1.534 . . . . 0.0 111.755 178.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 25.8 ptt-85 -45.72 129.56 6.71 Favored Pre-proline 0 N--CA 1.467 0.378 0 C-N-CA 124.552 1.141 . . . . 0.0 110.862 -178.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo 22.65 49.01 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.757 1 C-N-CA 127.181 5.254 . . . . 0.0 117.102 -169.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.1 m -124.11 -3.31 8.06 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.638 1.175 . . . . 0.0 112.513 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 15.4 ttp180 41.59 41.58 1.72 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.744 2.018 . . . . 0.0 113.679 174.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 46.99 32.07 1.75 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.162 1.785 . . . . 0.0 113.838 -176.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -47.63 -30.88 4.03 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.644 1.578 . . . . 0.0 112.979 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.437 ' H ' ' CD ' ' A' ' 87' ' ' GLN . 0.7 OUTLIER -47.48 -61.38 1.95 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.749 2.019 . . . . 0.0 110.954 171.033 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -148.57 88.15 1.61 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 -178.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -61.08 -31.26 70.93 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 114.09 1.145 . . . . 0.0 114.09 -168.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -144.01 142.23 30.58 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 118.799 0.727 . . . . 0.0 109.154 172.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.2 m -143.06 139.15 27.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 C-N-CA 126.143 1.777 . . . . 0.0 106.707 177.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 37.5 tpp -161.02 166.04 28.84 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.325 1.05 . . . . 0.0 109.078 -177.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -124.54 145.31 49.65 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 170.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -153.15 -170.16 19.08 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-N 118.768 0.713 . . . . 0.0 111.766 -172.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -117.84 134.79 54.58 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.0 t -112.21 134.79 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 175.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -151.23 148.21 27.94 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.739 1.216 . . . . 0.0 108.233 -174.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.15 175.46 1.52 Allowed 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.427 1.491 . . . . 0.0 109.476 170.11 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 33.8 pt -70.06 -175.44 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 123.861 0.864 . . . . 0.0 110.304 169.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -63.81 -6.38 5.7 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.5 1.92 . . . . 0.0 115.687 -171.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.3 -15.97 62.06 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-O 118.851 -0.972 . . . . 0.0 112.812 178.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -80.0 75.42 6.74 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 169.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -116.33 75.05 0.93 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.107 1.363 . . . . 0.0 107.768 -168.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.7 t -151.14 -148.24 0.26 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.4 1.08 . . . . 0.0 108.938 -179.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.8 m -142.11 -7.03 0.93 Allowed 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 127.628 2.371 . . . . 0.0 108.9 -176.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 35.7 p -91.65 -0.53 57.58 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 123.697 0.799 . . . . 0.0 110.424 171.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 52.9 30.92 9.91 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.602 1.561 . . . . 0.0 109.621 -168.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -150.07 57.1 0.96 Allowed 'General case' 0 C--N 1.348 0.542 0 O-C-N 122.012 -0.43 . . . . 0.0 110.919 -175.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.66 164.8 13.68 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.854 -0.529 . . . . 0.0 110.679 178.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.6 p -128.17 1.08 5.82 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -178.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.4 mpt_? -132.72 128.69 37.46 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 126.077 1.751 . . . . 0.0 106.497 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.5 tp -73.91 139.0 44.65 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 174.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 7.8 p -90.75 154.95 19.16 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 122.045 -0.409 . . . . 0.0 110.34 176.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -147.77 137.78 22.8 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.132 0.973 . . . . 0.0 108.641 170.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 10.6 m-30 -114.96 146.53 41.09 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 103.45 -2.796 . . . . 0.0 103.45 168.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.2 t -135.33 143.56 36.6 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -173.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.3 t -134.85 123.94 24.29 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 105.496 -2.038 . . . . 0.0 105.496 169.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -146.98 107.94 4.19 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.408 0.683 . . . . 0.0 109.359 -169.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 57.17 24.15 50.03 Favored Glycine 0 CA--C 1.536 1.389 0 O-C-N 121.595 -0.691 . . . . 0.0 113.855 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 93.96 -11.33 71.03 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 124.629 1.109 . . . . 0.0 113.435 -178.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.5 mp -82.34 160.67 22.79 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 170.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 7.0 tp -139.5 159.71 41.53 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.817 -0.552 . . . . 0.0 111.036 -169.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.442 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 26.1 mtt -149.25 156.38 42.03 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 125.295 1.438 . . . . 0.0 109.092 169.341 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 39.0 mtm105 -143.47 126.31 16.17 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 105.019 -2.215 . . . . 0.0 105.019 169.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -155.81 166.4 33.61 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 119.667 1.122 . . . . 0.0 112.902 -169.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -134.82 141.33 46.37 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 168.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -156.53 168.85 33.82 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.32 132.19 33.91 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 170.23 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -45.82 -43.33 13.24 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 175.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.6 -22.86 65.34 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 120.989 -1.069 . . . . 0.0 113.601 177.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -75.65 -19.61 59.05 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 125.527 1.531 . . . . 0.0 110.808 172.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -85.84 3.6 40.9 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 119.467 1.03 . . . . 0.0 109.365 168.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 1.5 t60 38.33 30.04 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.513 1 C-N-CA 131.789 4.036 . . . . 0.0 118.107 169.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 163.27 28.69 0.02 OUTLIER Glycine 0 CA--C 1.525 0.698 0 CA-C-O 119.243 -0.754 . . . . 0.0 111.947 178.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 45.79 40.05 5.99 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.82 1.648 . . . . 0.0 111.95 -169.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . 0.369 2.7 pp20? 43.57 -148.53 0.05 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.932 2.093 . . . . 0.0 114.623 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.7 t 67.9 -34.49 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 127.6 2.36 . . . . 0.0 111.879 -168.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -154.37 18.05 0.48 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.416 1.087 . . . . 0.0 112.433 -170.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 48.8 m -87.04 -77.02 0.34 Allowed 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 169.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.277 9.8 ptm180 -79.35 14.53 1.51 Allowed 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.482 1.113 . . . . 0.0 113.186 -172.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 20.8 m -63.72 -38.67 82.91 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 167.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -82.67 129.22 34.92 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 169.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 7.4 tt -142.12 127.25 18.52 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 118.637 0.653 . . . . 0.0 109.306 -174.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 7.3 tt -132.94 134.06 44.03 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 178.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 60.2 ttm -137.78 140.07 40.39 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -176.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -158.94 -176.28 5.77 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.152 0.981 . . . . 0.0 109.786 178.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -52.93 158.63 1.35 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.992 1.317 . . . . 0.0 112.283 169.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.34 169.68 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.69 2.396 . . . . 0.0 114.205 174.225 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -125.85 0.43 7.35 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 179.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 14.2 p90 . . . . . 0 C--O 1.249 1.033 0 C-N-CA 127.955 2.502 . . . . 0.0 106.826 -179.482 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 mmt . . . . . 0 N--CA 1.484 1.275 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.51 7.86 2.83 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.388 1.075 . . . . 0.0 112.389 -178.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 170.49 177.41 40.57 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 55.9 mt -138.85 140.07 39.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 174.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tt -73.59 93.83 2.08 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -178.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -151.69 148.12 27.54 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.101 1.36 . . . . 0.0 108.184 171.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -148.64 143.15 26.33 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 126.431 1.892 . . . . 0.0 107.529 -173.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -151.81 124.9 8.66 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.224 1.009 . . . . 0.0 108.785 172.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.6 mp -79.44 142.14 14.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 104.385 -2.45 . . . . 0.0 104.385 169.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -130.44 158.4 39.99 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.391 0.615 . . . . 0.0 109.807 171.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -119.1 132.98 56.05 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.477 1.511 . . . . 0.0 107.194 178.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.4 p -69.99 135.04 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.9 mmmm -113.06 -25.17 9.07 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.303 1.441 . . . . 0.0 109.977 -177.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -156.07 163.34 39.79 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.098 0.863 . . . . 0.0 110.672 169.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.9 mp -139.09 137.27 42.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 127.264 2.225 . . . . 0.0 105.414 179.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -142.89 97.24 5.87 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 124.589 1.156 . . . . 0.0 108.985 -173.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -61.02 1.28 0.62 Allowed 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 124.326 3.351 . . . . 0.0 117.541 -175.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -77.28 46.73 0.52 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.726 2.01 . . . . 0.0 110.973 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -153.74 35.72 0.74 Allowed Glycine 0 CA--C 1.528 0.859 0 C-N-CA 126.995 2.236 . . . . 0.0 108.928 178.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.68 55.41 0.26 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.567 1.947 . . . . 0.0 113.648 -169.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -54.44 -39.76 67.71 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 121.35 -0.843 . . . . 0.0 109.647 170.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -142.64 163.97 31.37 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 128.037 2.535 . . . . 0.0 104.569 169.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -57.48 -34.63 69.23 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.55 -0.719 . . . . 0.0 111.485 176.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 -79.03 4.23 15.03 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-O 117.101 -1.428 . . . . 0.0 114.535 178.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 81.3 t -118.04 132.17 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 121.736 2.062 . . . . 0.0 107.519 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 65.1 m -145.79 159.84 42.61 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.637 0.775 . . . . 0.0 109.709 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -76.69 148.91 36.52 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 169.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -142.56 153.99 44.05 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.712 1.605 . . . . 0.0 107.521 -169.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -134.3 136.58 43.61 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 171.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 67.7 m -145.35 165.38 28.63 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.277 1.031 . . . . 0.0 110.945 -171.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -139.54 136.01 34.03 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.273 1.429 . . . . 0.0 108.496 178.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.2 m -60.67 139.87 57.69 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.842 0.857 . . . . 0.0 112.185 173.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -94.41 -44.44 7.9 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 168.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.0 m -73.13 -38.16 66.39 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 118.643 -0.694 . . . . 0.0 112.029 -172.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -121.14 -106.84 0.37 Allowed 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -166.3 8.96 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 -169.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.8 mpp? -69.04 148.55 49.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.75 0.786 . . . . 0.0 109.145 -174.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -103.93 138.69 40.13 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 169.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.8 mt -135.86 144.71 45.75 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.287 0.635 . . . . 0.0 110.17 -169.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.8 mm -130.19 143.19 41.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 103.157 -2.905 . . . . 0.0 103.157 169.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 123' ' ' MET . 4.8 mp -144.61 159.84 42.15 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.622 1.569 . . . . 0.0 108.166 -177.224 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -136.04 95.1 3.14 Favored 'General case' 0 C--N 1.32 -0.693 1 N-CA-C 99.758 -4.164 . . . . 0.0 99.758 169.049 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.1 p -147.11 167.45 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 121.285 0.564 . . . . 0.0 112.392 -167.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -58.27 140.31 53.49 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.883 1.273 . . . . 0.0 109.31 169.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 pp -119.55 -1.38 8.56 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.669 0 CA-C-O 116.972 -1.49 . . . . 0.0 113.263 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -63.64 -15.57 58.65 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 121.773 2.079 . . . . 0.0 114.212 -169.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.665 HD12 ' H ' ' A' ' 47' ' ' ILE . 0.6 OUTLIER -65.69 -28.39 44.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 127.388 2.275 . . . . 0.0 111.093 173.803 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -52.57 155.17 3.99 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 124.534 1.134 . . . . 0.0 111.979 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -73.87 50.57 2.15 Favored 'Trans proline' 0 CA--C 1.547 1.162 0 C-N-CA 124.698 3.599 . . . . 0.0 112.959 175.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . 0.27 20.3 m 52.65 -9.94 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 131.13 3.772 . . . . 0.0 119.229 169.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -143.2 -12.5 0.72 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 120.358 1.435 . . . . 0.0 112.625 -173.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -156.36 169.16 25.23 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 126.239 1.815 . . . . 0.0 108.259 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.16 175.22 54.71 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 176.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -152.18 171.08 18.48 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.732 1.213 . . . . 0.0 109.142 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -79.17 155.39 28.68 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.51 1.124 . . . . 0.0 109.698 175.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -129.74 162.25 28.83 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.975 1.31 . . . . 0.0 108.808 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 42.0 ttt180 -115.07 134.14 55.43 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 173.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 57.7 tp -127.78 132.86 49.47 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 177.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.6 m -137.99 163.99 28.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 124.551 1.14 . . . . 0.0 108.093 177.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.0 pt -127.41 13.07 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 123.514 0.726 . . . . 0.0 110.53 177.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.24 -8.76 57.19 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.548 1.139 . . . . 0.0 113.574 -175.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.9 m -148.52 168.25 23.23 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.653 1.181 . . . . 0.0 109.453 -175.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.5 t -152.86 173.35 15.44 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.902 1.281 . . . . 0.0 107.937 172.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -79.55 164.42 23.89 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 174.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -132.19 175.21 9.45 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -178.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -74.39 161.08 30.19 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 169.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -62.4 -38.24 88.88 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 121.557 -0.714 . . . . 0.0 110.428 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.42 -28.29 69.24 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 123.918 0.77 . . . . 0.0 112.929 178.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.1 m -65.4 -23.93 67.08 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.512 1.156 . . . . 0.0 111.532 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 92.9 mt -119.06 -28.11 5.57 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.444 0.697 . . . . 0.0 111.602 -176.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -61.62 -15.54 40.39 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.262 0.937 . . . . 0.0 112.161 174.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -61.22 -14.49 26.06 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.8 1.64 . . . . 0.0 114.614 175.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -177.3 0.68 0.03 OUTLIER Glycine 0 CA--C 1.53 0.99 0 N-CA-C 117.028 1.571 . . . . 0.0 117.028 175.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 48.46 58.8 4.83 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 119.535 1.667 . . . . 0.0 109.737 -169.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -52.91 133.72 37.74 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 176.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -141.68 113.01 6.49 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-O 118.657 -0.687 . . . . 0.0 109.747 -177.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo -60.93 -4.92 4.07 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.846 3.03 . . . . 0.0 116.096 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . 0.25 95.1 m 68.13 -33.94 0.24 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 127.913 2.485 . . . . 0.0 114.313 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -67.37 -23.05 65.55 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.549 1.068 . . . . 0.0 110.463 169.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -59.08 -43.14 91.76 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.949 1.7 . . . . 0.0 112.589 172.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 88.3 mtm-85 -66.14 -44.04 58.08 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-O 117.003 -1.475 . . . . 0.0 113.696 -169.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -78.99 10.42 2.94 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.354 2.036 . . . . 0.0 113.562 174.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 24.6 m -119.72 -30.89 4.68 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.75 1.22 . . . . 0.0 111.526 -175.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 57.1 -175.0 0.07 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.352 1.861 . . . . 0.0 111.855 177.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.98 -12.26 48.15 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 120.887 -1.133 . . . . 0.0 113.186 -172.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -56.05 -17.59 7.35 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.457 1.503 . . . . 0.0 113.267 175.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -53.99 -25.32 20.34 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.487 1.115 . . . . 0.0 112.545 169.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -141.25 177.84 7.82 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.44 1.496 . . . . 0.0 109.588 -169.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -146.04 -40.85 0.21 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.175 0.59 . . . . 0.0 109.421 169.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -143.94 144.73 31.83 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 123.909 0.884 . . . . 0.0 108.698 175.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.1 p -142.58 142.29 26.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 5.2 tmm? -158.89 160.75 36.48 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.455 0.645 . . . . 0.0 111.28 -168.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -129.91 104.92 7.65 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 104.721 -2.326 . . . . 0.0 104.721 173.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -94.93 -173.11 37.62 Favored Glycine 0 C--N 1.332 0.361 0 CA-C-O 121.288 0.382 . . . . 0.0 112.585 -169.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -120.61 100.56 7.2 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 169.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.411 HG13 ' HA ' ' A' ' 137' ' ' VAL . 0.1 OUTLIER -70.42 142.13 16.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 170.588 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -136.37 127.22 27.48 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 103.075 -2.935 . . . . 0.0 103.075 169.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -146.29 169.18 19.33 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 120.028 1.285 . . . . 0.0 112.881 -169.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.1 pt -134.63 165.77 30.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 C-N-CA 126.533 1.933 . . . . 0.0 108.325 -169.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -66.53 -3.96 7.46 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.964 1.706 . . . . 0.0 112.77 175.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 144.11 173.33 15.45 Favored Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 104.855 -3.298 . . . . 0.0 104.855 -169.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -56.2 -23.18 33.72 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 118.129 0.965 . . . . 0.0 112.305 178.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -173.35 -126.95 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.791 1 C-N-CA 132.036 4.135 . . . . 0.0 101.809 169.168 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.444 HG22 ' N ' ' A' ' 108' ' ' ALA . 21.4 p -135.76 167.0 21.96 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 125.789 1.636 . . . . 0.0 113.402 -174.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 75.6 m -132.06 -38.08 1.11 Allowed 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 129.249 3.02 . . . . 0.0 105.788 177.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 17.3 p -132.58 -60.44 0.88 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.618 1.167 . . . . 0.0 109.054 169.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -154.28 23.42 0.48 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.966 1.707 . . . . 0.0 110.223 -178.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.444 ' N ' HG22 ' A' ' 104' ' ' THR . . . 177.89 148.75 0.17 Allowed 'General case' 0 C--O 1.242 0.66 0 C-N-CA 130.742 3.617 . . . . 0.0 102.373 -169.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -77.56 166.1 23.47 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.841 1.201 . . . . 0.0 108.514 170.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.78 -3.73 13.43 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -178.361 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -138.27 140.14 39.49 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 103.948 -2.612 . . . . 0.0 103.948 169.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 22.3 tp -75.96 157.77 32.74 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 169.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 2.2 m -139.96 146.09 38.7 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -177.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -147.84 160.17 43.05 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.019 0.928 . . . . 0.0 109.157 178.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -124.76 149.78 46.97 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 173.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.9 t -141.24 116.07 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 17.2 m -86.34 124.56 32.84 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 105.469 -2.048 . . . . 0.0 105.469 169.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.4 m-30 -86.89 163.43 17.17 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 169.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -56.96 67.02 0.01 OUTLIER Glycine 0 CA--C 1.539 1.538 0 C-N-CA 126.521 2.01 . . . . 0.0 114.512 170.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 119.24 -7.24 12.72 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 127.137 2.303 . . . . 0.0 113.407 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -139.24 -179.81 6.09 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 119.885 1.842 . . . . 0.0 108.369 -169.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.7 tt -154.77 160.46 41.32 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 121.346 1.885 . . . . 0.0 112.3 -177.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.419 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 26.0 ptt? -149.74 161.52 42.06 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.7 1.6 . . . . 0.0 109.426 169.116 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 92.0 mtt-85 -137.54 139.91 40.75 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 174.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 8.0 tt -143.89 147.93 34.71 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 123.13 0.572 . . . . 0.0 110.441 -169.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -129.07 151.47 49.72 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 168.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -173.55 173.07 45.65 Favored Glycine 0 C--N 1.329 0.146 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 170.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.93 139.98 38.75 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 169.501 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -39.94 -60.43 1.02 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -178.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -60.45 -37.52 81.22 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.874 0.845 . . . . 0.0 112.46 -178.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -66.9 -23.38 65.99 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 125.307 1.443 . . . . 0.0 111.249 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.7 tt -69.58 -26.78 64.63 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.481 1.037 . . . . 0.0 110.195 177.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 43.39 40.05 2.46 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 127.798 2.439 . . . . 0.0 113.472 175.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -165.62 42.71 0.28 Allowed Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 -169.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -76.17 9.41 2.55 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.546 1.138 . . . . 0.0 112.273 -173.352 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -130.15 135.95 48.75 Favored 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 125.212 1.405 . . . . 0.0 108.643 -172.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.411 ' HA ' HG13 ' A' ' 96' ' ' VAL . 15.6 m -57.1 -5.07 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 126.626 1.97 . . . . 0.0 112.31 169.634 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -134.38 16.83 3.7 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 173.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.7 m -102.78 -51.97 3.18 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 167.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 5.2 tpm_? -75.71 0.45 17.73 Favored 'General case' 0 C--N 1.342 0.271 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -172.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 35.7 m -62.55 -41.57 92.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 124.18 0.992 . . . . 0.0 110.83 169.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -71.28 130.95 42.69 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -170.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 7.7 tt -150.67 134.09 16.34 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 117.939 0.336 . . . . 0.0 110.292 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.8 tt -144.56 135.35 24.85 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 106.492 -1.669 . . . . 0.0 106.492 169.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 14.6 ptp -142.38 159.08 42.94 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 118.501 0.592 . . . . 0.0 111.663 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -157.01 -173.77 4.61 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 126.084 1.754 . . . . 0.0 108.756 171.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -60.95 169.69 1.85 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.889 0.768 . . . . 0.0 109.669 169.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -44.2 155.63 0.09 Allowed 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 179.319 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.86 63.5 7.0 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.776 1.23 . . . . 0.0 110.054 177.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 19.8 t80 . . . . . 0 C--O 1.249 1.042 0 C-N-CA 123.944 0.897 . . . . 0.0 108.81 178.495 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.29 144.92 49.35 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.505 0.722 . . . . 0.0 110.654 177.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 170.74 174.55 38.76 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 20.4 tt -154.41 154.34 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 169.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 22.1 tp -81.71 48.18 1.17 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.149 0.98 . . . . 0.0 109.909 174.082 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -150.69 125.61 9.82 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.416 1.086 . . . . 0.0 109.095 -177.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -155.87 140.59 17.05 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 178.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -148.41 148.59 30.5 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.13 0.877 . . . . 0.0 110.368 169.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 mp -77.54 154.46 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 173.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -145.76 160.45 41.72 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.971 0.909 . . . . 0.0 110.241 171.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -135.13 129.58 34.11 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.194 1.798 . . . . 0.0 108.194 -169.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.8 p -68.36 123.51 21.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 121.825 0.822 . . . . 0.0 109.058 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -82.14 -42.06 19.6 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 124.537 1.135 . . . . 0.0 109.294 170.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -159.76 167.98 26.98 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 118.831 0.742 . . . . 0.0 111.638 -175.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.3 mp -138.82 138.27 42.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 127.769 2.428 . . . . 0.0 105.55 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -146.0 97.76 4.48 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 118.787 0.721 . . . . 0.0 110.966 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -58.07 59.82 0.05 OUTLIER 'Trans proline' 0 CA--C 1.548 1.214 1 C-N-CA 126.921 5.081 . . . . 0.0 116.595 174.205 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -123.91 43.67 2.92 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.688 1.595 . . . . 0.0 109.789 178.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -168.1 44.45 0.24 Allowed Glycine 0 C--N 1.336 0.554 0 C-N-CA 124.182 0.896 . . . . 0.0 110.994 -175.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.9 mmmm -76.0 68.07 2.43 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.13 0.965 . . . . 0.0 111.149 -169.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.21 -36.61 68.63 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 169.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -139.68 167.44 22.09 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 128.651 2.78 . . . . 0.0 104.551 169.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -68.72 -25.34 64.71 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.079 -1.013 . . . . 0.0 111.351 -173.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -82.0 -6.35 59.07 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-O 116.536 -1.697 . . . . 0.0 113.553 175.016 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 70.0 t -101.35 128.75 53.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 121.664 2.029 . . . . 0.0 107.728 -175.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.2 m -148.19 167.97 23.7 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.787 1.235 . . . . 0.0 109.304 -177.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.0 tpp85 -70.58 153.98 42.33 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 170.135 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.8 mt -138.19 156.13 48.01 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.296 1.838 . . . . 0.0 106.904 170.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -133.39 133.68 42.72 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 170.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 65.0 m -143.0 163.65 32.2 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.719 1.208 . . . . 0.0 110.352 -171.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -134.7 137.73 43.79 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.861 1.664 . . . . 0.0 107.051 177.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.8 m -93.65 142.62 27.15 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.058 0.456 . . . . 0.0 110.169 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -69.75 -54.93 11.42 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.788 1.635 . . . . 0.0 113.122 -168.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.6 m -89.35 -35.47 16.07 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 123.114 0.566 . . . . 0.0 111.747 -169.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -108.03 6.56 27.16 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -169.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.287 0.0 OUTLIER 45.99 28.58 0.64 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.179 1.792 . . . . 0.0 114.467 178.678 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 78.8 mtm -61.52 152.48 30.11 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 169.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -123.73 124.12 42.01 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.6 tt -130.67 150.63 51.77 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.864 0.84 . . . . 0.0 111.818 -168.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 16.8 mm -129.15 147.46 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 128.75 2.82 . . . . 0.0 103.729 169.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.406 HD22 ' CG1' ' A' ' 43' ' ' VAL . 0.5 OUTLIER -147.5 155.42 41.87 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 127.626 2.37 . . . . 0.0 105.89 -171.08 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -142.49 103.01 4.18 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 104.701 -2.333 . . . . 0.0 104.701 170.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.472 HG22 ' H ' ' A' ' 44' ' ' ASN . 9.9 p -163.43 179.59 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 124.044 0.938 . . . . 0.0 109.765 -169.452 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.472 ' H ' HG22 ' A' ' 43' ' ' VAL . 29.6 t30 -52.53 130.49 31.99 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.84 1.656 . . . . 0.0 111.646 172.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.6 pp -110.33 -1.98 10.07 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 C-N-CA 124.946 1.299 . . . . 0.0 113.134 177.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -70.24 -9.54 56.22 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 120.028 1.285 . . . . 0.0 111.395 177.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.2 mt -61.65 -36.53 74.05 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 168.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -91.05 156.14 44.32 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 125.36 1.464 . . . . 0.0 110.526 -177.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.28 169.63 17.87 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.567 2.178 . . . . 0.0 109.921 169.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.0 m -63.71 -23.9 34.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 -169.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -153.23 -35.34 0.11 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.248 0.931 . . . . 0.0 113.497 -175.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 54.6 tp -62.65 -27.69 69.4 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -172.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.98 177.65 36.6 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 -169.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -158.35 175.2 14.02 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.134 0.974 . . . . 0.0 108.768 -178.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -125.39 135.57 52.54 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.003 1.321 . . . . 0.0 107.695 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -131.53 -173.39 3.11 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -129.85 151.48 50.37 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.846 1.258 . . . . 0.0 108.246 177.625 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 62.1 tp -124.39 138.87 54.32 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 127.005 2.122 . . . . 0.0 107.328 -174.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 41.0 t -144.77 152.64 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 126.626 1.97 . . . . 0.0 106.048 -175.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.5 pt -133.0 55.24 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.477 1.111 . . . . 0.0 108.925 176.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -54.88 122.31 10.53 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 124.752 1.221 . . . . 0.0 110.662 -176.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.9 m -57.78 116.37 3.4 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.915 0.886 . . . . 0.0 108.944 176.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.4 m -143.19 132.0 22.7 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -172.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 41.7 tp -149.94 56.26 0.95 Allowed 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 172.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -64.77 158.52 24.63 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.979 -172.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -136.62 177.91 7.48 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.915 2.086 . . . . 0.0 107.609 175.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -60.06 -37.1 78.85 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.514 0.726 . . . . 0.0 111.237 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -71.5 -20.28 78.28 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-O 119.268 -0.74 . . . . 0.0 113.203 178.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.1 m -70.81 -27.31 63.79 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.901 1.351 . . . . 0.0 111.047 -177.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 pp -148.58 -46.51 0.15 Allowed 'General case' 0 C--N 1.342 0.279 0 CA-C-O 117.654 -1.165 . . . . 0.0 113.714 -174.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -70.45 -30.3 67.09 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 120.592 1.542 . . . . 0.0 111.033 -173.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -118.19 35.7 4.64 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.881 1.673 . . . . 0.0 108.311 169.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -137.47 54.37 0.71 Allowed Glycine 0 CA--C 1.526 0.766 0 C-N-CA 126.755 2.121 . . . . 0.0 108.981 -173.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 63.08 49.67 3.33 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.517 1.527 . . . . 0.0 111.715 178.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -72.57 21.65 0.06 Allowed 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.335 -0.853 . . . . 0.0 112.52 169.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -51.67 -43.06 86.86 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 125.834 1.653 . . . . 0.0 114.213 -177.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -80.07 5.37 6.04 Favored 'Trans proline' 0 C--N 1.352 0.745 0 CA-C-N 122.084 1.78 . . . . 0.0 112.77 178.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.8 m 55.88 22.67 5.85 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.018 1.727 . . . . 0.0 111.346 -169.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.7 t70 8.54 -69.11 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 130.847 3.659 . . . . 0.0 117.66 -169.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -77.92 1.41 20.72 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.45 1.1 . . . . 0.0 112.982 -172.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.17 127.98 2.74 Favored Pre-proline 0 C--N 1.342 0.263 0 C-N-CA 126.039 1.735 . . . . 0.0 111.494 -176.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo 24.66 43.62 0.0 OUTLIER 'Trans proline' 0 CA--C 1.539 0.755 1 C-N-CA 126.742 4.961 . . . . 0.0 116.956 -169.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.7 m -126.24 -31.62 2.79 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.235 1.414 . . . . 0.0 110.012 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? 46.06 53.61 9.01 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.788 1.235 . . . . 0.0 112.727 169.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 58.27 14.16 2.71 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.883 2.073 . . . . 0.0 115.063 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -60.44 -14.37 18.8 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 120.02 1.282 . . . . 0.0 112.075 169.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -53.13 -21.42 4.9 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.373 1.869 . . . . 0.0 112.01 169.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -132.6 158.64 41.7 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.01 2.124 . . . . 0.0 107.419 -174.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -78.11 -33.62 50.5 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.691 -0.631 . . . . 0.0 109.485 174.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -160.19 158.67 30.49 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.492 0.717 . . . . 0.0 109.791 169.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.2 m -139.53 145.07 27.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 C-N-CA 125.25 1.42 . . . . 0.0 107.177 172.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 15.8 ttt -151.83 143.39 23.53 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.915 0.886 . . . . 0.0 109.073 -169.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -135.74 75.67 1.57 Allowed 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 175.183 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -93.57 -163.94 36.8 Favored Glycine 0 C--N 1.337 0.589 0 N-CA-C 115.26 0.864 . . . . 0.0 115.26 -167.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -131.31 128.84 40.58 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 170.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -74.55 148.84 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 124.946 1.299 . . . . 0.0 108.642 169.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -142.09 64.83 1.38 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.653 1.581 . . . . 0.0 109.131 178.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -156.3 178.96 9.71 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 120.772 -1.205 . . . . 0.0 110.913 -178.227 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.53 -179.69 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 126.643 1.977 . . . . 0.0 109.5 -173.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -59.99 -6.69 1.42 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.849 2.06 . . . . 0.0 116.481 -169.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 163.48 -64.23 0.25 Allowed Glycine 0 C--N 1.334 0.47 0 N-CA-C 108.236 -1.946 . . . . 0.0 108.236 171.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -143.42 -66.68 0.36 Allowed 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 124.786 1.235 . . . . 0.0 108.222 169.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -168.68 61.94 0.06 Allowed 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 125.675 1.59 . . . . 0.0 108.086 171.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.6 151.88 4.02 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 123.004 1.383 . . . . 0.0 113.957 -176.169 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.1 p -152.52 -44.47 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 127.741 2.417 . . . . 0.0 106.823 -178.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.6 p -142.95 -53.34 0.39 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.517 1.527 . . . . 0.0 107.325 169.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -162.83 46.76 0.14 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.166 1.386 . . . . 0.0 109.341 -173.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -70.16 -37.34 75.19 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 169.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -132.17 159.98 37.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 111.863 -2.426 . . . . 0.0 109.015 167.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.9 p -136.29 6.75 3.07 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.145 0.978 . . . . 0.0 112.916 -177.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -135.34 145.42 47.39 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 171.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 40.6 tp -76.49 150.11 36.68 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 105.453 -2.055 . . . . 0.0 105.453 168.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 14.9 m -128.24 150.19 50.14 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -174.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -143.67 149.13 36.8 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.286 1.034 . . . . 0.0 108.365 176.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -134.54 135.2 42.15 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 101.412 -3.551 . . . . 0.0 101.412 169.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.4 t -142.35 144.23 25.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -170.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.4 m -134.46 143.2 47.38 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -159.92 134.15 7.48 Favored 'General case' 0 C--O 1.226 -0.151 0 C-N-CA 123.524 0.73 . . . . 0.0 109.957 171.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 54.61 27.41 42.17 Favored Glycine 0 CA--C 1.537 1.461 0 N-CA-C 114.935 0.734 . . . . 0.0 114.935 169.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 85.73 1.13 87.49 Favored Glycine 0 CA--C 1.535 1.312 0 CA-C-N 118.488 1.144 . . . . 0.0 113.866 -177.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.12 153.19 17.77 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.821 1.648 . . . . 0.0 107.995 173.305 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 22.8 tp -133.38 156.57 47.43 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.109 0.964 . . . . 0.0 109.477 -176.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 60.6 mtt -144.04 156.48 44.4 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.789 1.636 . . . . 0.0 108.44 171.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.6 129.96 23.84 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 104.377 -2.453 . . . . 0.0 104.377 169.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 18.8 tp -144.7 147.61 33.22 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 119.511 1.05 . . . . 0.0 109.72 -168.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -139.19 153.78 47.95 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.989 0.916 . . . . 0.0 108.753 169.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -172.78 171.13 44.18 Favored Glycine 0 CA--C 1.519 0.333 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 169.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -54.71 141.18 33.22 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 118.804 1.302 . . . . 0.0 107.52 169.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -40.47 -59.44 1.33 Allowed 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -178.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.15 -13.71 62.32 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.345 -0.847 . . . . 0.0 113.134 -174.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -89.31 -27.23 20.67 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 126.175 1.79 . . . . 0.0 109.808 177.122 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 5.8 tt -78.02 -26.48 48.5 Favored 'General case' 0 C--N 1.344 0.33 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 169.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 3.1 t60 51.95 32.24 9.73 Favored 'General case' 0 C--N 1.344 0.355 0 C-N-CA 126.885 2.074 . . . . 0.0 113.155 168.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -154.97 86.66 0.13 Allowed Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 -169.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -50.66 125.78 13.96 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 169.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.49 175.37 2.3 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -168.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.4 t 70.12 -25.18 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 127.602 2.361 . . . . 0.0 111.768 -170.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -163.53 59.26 0.17 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 120.351 1.432 . . . . 0.0 112.285 -170.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 36.3 m -145.79 -53.9 0.27 Allowed 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 113.64 -1.618 . . . . 0.0 108.841 168.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -75.35 4.59 6.93 Favored 'General case' 0 C--N 1.343 0.299 0 O-C-N 121.867 -0.521 . . . . 0.0 112.285 177.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 11.1 m -81.93 -3.63 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 C-N-CA 123.872 0.869 . . . . 0.0 111.696 178.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -136.57 116.12 12.87 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 169.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 10.4 tt -143.28 142.97 31.53 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.154 0.582 . . . . 0.0 109.527 -169.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 15.6 tp -140.53 141.75 35.26 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 125.815 1.646 . . . . 0.0 107.477 -172.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 38.6 ttm -131.35 132.37 44.4 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -148.35 147.72 29.57 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -178.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -54.55 155.96 3.73 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.663 1.12 . . . . 0.0 111.597 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.6 pp -67.38 158.92 30.52 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 169.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -149.38 96.89 2.57 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.298 0.639 . . . . 0.0 110.058 -177.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 24.3 p90 . . . . . 0 C--O 1.252 1.185 0 C-N-CA 126.096 1.758 . . . . 0.0 107.471 169.675 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.4 mmt . . . . . 0 N--CA 1.476 0.849 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.74 158.43 36.31 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.549 0.74 . . . . 0.0 110.671 173.427 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 60.41 22.84 59.45 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.096 0.855 . . . . 0.0 115.012 169.764 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 35.0 pt -71.91 174.91 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 124.849 1.26 . . . . 0.0 110.103 173.126 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 60.9 tp -149.88 124.71 9.86 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.629 -0.669 . . . . 0.0 110.599 174.924 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -157.97 145.36 18.25 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 104.096 -2.557 . . . . 0.0 104.096 169.244 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -147.72 144.8 28.56 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.443 1.497 . . . . 0.0 107.786 -175.01 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -154.27 167.64 29.26 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.233 1.813 . . . . 0.0 108.548 178.464 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.2 mp -124.72 114.34 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 103.646 -2.724 . . . . 0.0 103.646 169.828 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -94.23 152.2 18.88 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.486 0.66 . . . . 0.0 109.705 -179.863 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -135.1 133.85 39.68 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 126.408 1.883 . . . . 0.0 108.257 -173.832 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 40.3 t -68.71 143.88 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 123.997 0.919 . . . . 0.0 109.392 -178.057 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -124.24 -28.22 3.71 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 126.785 2.034 . . . . 0.0 109.341 177.542 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -159.06 168.23 27.21 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.481 1.037 . . . . 0.0 111.136 171.066 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.4 mp -135.2 139.05 47.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 127.443 2.297 . . . . 0.0 105.927 179.603 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -147.06 91.98 5.04 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 123.301 0.64 . . . . 0.0 112.27 -173.519 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -68.5 97.12 0.51 Allowed 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 123.059 2.506 . . . . 0.0 108.477 168.983 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -59.37 -36.32 75.53 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.966 0.906 . . . . 0.0 112.84 -169.954 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.35 44.65 0.03 OUTLIER Glycine 0 CA--C 1.525 0.703 0 N-CA-C 103.749 -3.741 . . . . 0.0 103.749 -170.986 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.4 mmmt -65.47 132.37 48.77 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.37 1.068 . . . . 0.0 111.811 -167.394 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -60.47 -33.59 72.81 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 113.798 -1.546 . . . . 0.0 110.087 169.3 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -132.47 102.4 5.71 Favored 'General case' 0 N--CA 1.458 -0.068 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 178.212 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -55.04 -33.09 62.39 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.468 1.107 . . . . 0.0 113.514 -169.991 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -65.54 -5.69 8.75 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 117.446 -1.264 . . . . 0.0 113.586 178.475 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.5 t -121.52 111.82 32.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 174.677 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 74.0 m -140.11 169.2 18.13 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 124.383 1.073 . . . . 0.0 111.013 -173.859 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -74.59 150.48 39.67 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 175.083 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 71.5 mt -134.12 158.16 44.34 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 127.051 2.14 . . . . 0.0 106.81 173.816 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -128.67 134.57 48.55 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 169.478 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 72.2 m -142.95 169.04 18.32 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.451 1.5 . . . . 0.0 110.352 -171.516 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -136.41 144.5 44.54 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.802 2.041 . . . . 0.0 107.863 -177.707 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.2 p -74.98 158.65 32.91 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.431 1.093 . . . . 0.0 110.992 174.203 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -72.59 -41.55 65.51 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.558 -0.714 . . . . 0.0 110.748 177.656 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.4 m -136.45 6.64 3.02 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -169.052 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -121.32 14.97 11.31 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -169.174 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.264 0.0 OUTLIER 41.45 31.66 0.19 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.95 2.1 . . . . 0.0 114.739 178.295 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 57.3 mtt -74.38 153.95 39.04 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.452 1.101 . . . . 0.0 110.381 -179.104 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -114.34 104.31 11.94 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 169.459 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 62.3 tp -112.18 144.26 41.88 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -171.707 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 31.2 mm -134.0 147.05 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 104.088 -2.56 . . . . 0.0 104.088 174.131 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 123' ' ' MET . 3.2 mp -144.13 158.11 43.91 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 126.155 1.782 . . . . 0.0 107.961 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -133.35 100.86 4.96 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 101.971 -3.344 . . . . 0.0 101.971 168.239 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.8 m -146.23 175.57 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 124.867 1.267 . . . . 0.0 111.126 -167.552 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -58.54 128.5 37.48 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.823 0.849 . . . . 0.0 109.254 169.654 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 pp -115.44 6.0 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 125.101 1.361 . . . . 0.0 112.875 -179.005 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -66.81 -15.0 63.3 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 120.693 1.588 . . . . 0.0 112.069 -176.895 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.6 mt -65.14 -24.52 35.45 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 C-N-CA 125.293 1.437 . . . . 0.0 109.581 169.764 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -123.22 71.88 45.92 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 126.931 2.092 . . . . 0.0 109.275 -172.682 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -68.32 -12.34 34.67 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.651 2.234 . . . . 0.0 111.933 173.323 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.5 p -147.32 175.2 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 128.728 2.811 . . . . 0.0 104.917 173.351 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -69.78 69.98 0.31 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.967 0.907 . . . . 0.0 110.123 169.849 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 50.3 tp -64.96 -25.85 68.05 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.729 1.612 . . . . 0.0 111.96 -175.084 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 67.35 26.54 73.52 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-O 119.659 -0.523 . . . . 0.0 112.108 -177.279 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -70.75 157.66 37.66 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 118.024 0.912 . . . . 0.0 108.736 169.853 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -135.97 152.83 51.36 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.188 0.995 . . . . 0.0 109.819 -169.323 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -132.9 127.24 33.93 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -174.456 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -71.45 134.79 46.84 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 169.901 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 tt -134.79 139.69 45.31 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 -179.67 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 t -139.19 158.04 28.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 -178.176 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 36.0 pt -121.62 14.87 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 123.389 0.675 . . . . 0.0 111.11 176.652 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.48 -4.38 45.26 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.453 1.101 . . . . 0.0 113.444 -175.521 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.8 p -64.15 173.29 2.01 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.657 0.783 . . . . 0.0 110.505 169.981 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 99.5 m -153.21 156.76 39.14 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 106.457 -1.682 . . . . 0.0 106.457 169.965 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 62.2 tp -71.78 80.84 0.87 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 169.524 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -52.1 -34.78 45.64 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -169.295 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -64.27 -15.0 59.28 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.2 1.0 . . . . 0.0 112.879 -178.982 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -63.87 -25.07 67.99 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.721 0.691 . . . . 0.0 111.738 173.538 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 135.78 6.78 1.95 Allowed Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.47 1.033 . . . . 0.0 113.013 178.449 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -60.14 -42.55 95.07 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.27 1.535 . . . . 0.0 107.857 174.141 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 35.0 mt -89.43 124.52 34.55 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 103.62 -2.733 . . . . 0.0 103.62 167.773 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -55.92 131.09 46.24 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 169.924 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -71.32 51.75 0.17 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.598 1.559 . . . . 0.0 111.968 179.479 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -169.82 -56.44 0.04 OUTLIER Glycine 0 CA--C 1.521 0.429 0 N-CA-C 108.122 -1.991 . . . . 0.0 108.122 177.214 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -82.56 47.3 1.16 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.943 1.297 . . . . 0.0 108.904 169.793 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -79.6 41.09 0.47 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.819 1.648 . . . . 0.0 110.747 -171.6 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.05 149.41 98.52 Favored Pre-proline 0 CA--C 1.539 0.522 0 O-C-N 121.073 -1.017 . . . . 0.0 110.725 -174.999 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.38 -29.85 85.8 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 122.669 2.246 . . . . 0.0 113.644 174.241 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.2 p -73.44 66.47 0.97 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.581 2.352 . . . . 0.0 110.765 -178.888 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -55.4 -25.98 38.92 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.843 1.257 . . . . 0.0 113.275 -176.337 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.514 ' H ' ' HB2' ' A' ' 83' ' ' SER . 26.4 t70 -145.0 -63.76 0.35 Allowed 'General case' 0 C--N 1.34 0.16 0 CA-C-N 118.298 0.499 . . . . 0.0 111.516 169.984 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.481 ' C ' ' H ' ' A' ' 83' ' ' SER . 9.0 mmm180 -118.41 -142.28 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.761 0 N-CA-C 102.794 -3.039 . . . . 0.0 102.794 169.312 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -61.61 32.1 0.06 OUTLIER 'Trans proline' 0 CA--C 1.553 1.436 0 C-N-CA 123.726 2.951 . . . . 0.0 114.2 167.93 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.514 ' HB2' ' H ' ' A' ' 80' ' ' ASP . 23.5 m -68.01 38.11 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.659 1 C-N-CA 132.628 4.371 . . . . 0.0 113.049 -174.578 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 33.9 mtp180 -70.93 -7.66 47.46 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.909 1.684 . . . . 0.0 113.212 -176.881 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 61.64 -18.16 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 128.143 2.577 . . . . 0.0 114.468 -169.602 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -58.35 -14.61 7.89 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.007 1.723 . . . . 0.0 112.819 169.908 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -58.68 -18.05 27.75 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.418 1.487 . . . . 0.0 111.849 169.609 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -122.22 158.18 30.02 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.76 2.024 . . . . 0.0 108.207 -178.997 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -78.86 -24.83 44.05 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 122.954 0.502 . . . . 0.0 111.741 -171.067 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -147.67 148.22 30.82 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.683 0.793 . . . . 0.0 109.686 -175.53 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.4 p -146.14 143.64 21.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 175.365 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 31.4 tpp -157.81 170.47 22.27 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.592 0.757 . . . . 0.0 110.424 -175.288 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -136.07 154.47 51.01 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.486 2.315 . . . . 0.0 106.116 -175.252 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -161.89 -153.0 6.91 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-N 119.365 0.984 . . . . 0.0 113.838 -169.896 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -147.57 124.61 11.38 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.339 1.456 . . . . 0.0 108.243 176.823 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 46.1 t -77.61 133.72 29.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 168.775 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -141.24 70.72 1.35 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.99 0.916 . . . . 0.0 110.524 -169.093 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -155.5 173.01 17.29 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.873 -1.142 . . . . 0.0 111.556 175.079 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 19.7 pt -74.02 -177.63 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 126.128 1.771 . . . . 0.0 112.255 -172.575 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -65.81 -13.59 59.78 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.256 1.822 . . . . 0.0 114.893 -173.621 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 111.53 -36.06 4.39 Favored Glycine 0 C--N 1.338 0.68 0 C-N-CA 124.514 1.054 . . . . 0.0 111.483 178.663 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -66.94 113.83 5.27 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 169.786 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -128.68 4.35 5.51 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 123.388 0.43 . . . . 0.0 111.386 -169.869 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 34.1 p -140.45 -72.84 0.36 Allowed 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.191 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.3 m 177.26 -38.86 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 131.402 3.881 . . . . 0.0 107.107 179.096 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.3 p -165.05 -49.49 0.03 OUTLIER 'General case' 0 C--N 1.343 0.307 0 C-N-CA 125.22 1.408 . . . . 0.0 108.506 -169.924 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -55.57 -26.72 45.07 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 -168.764 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -142.37 14.12 2.0 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 118.617 0.644 . . . . 0.0 111.327 169.733 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.11 -7.7 48.37 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 178.343 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.3 p -81.39 -3.43 52.77 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 127.853 2.461 . . . . 0.0 114.187 -169.872 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? -126.91 141.07 51.9 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 172.133 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.3 tp -73.13 144.48 46.92 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 104.339 -2.467 . . . . 0.0 104.339 167.7 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 7.9 p -110.25 141.92 42.56 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 169.749 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -142.65 152.61 42.63 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 125.29 1.436 . . . . 0.0 107.207 -175.643 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -134.63 143.46 47.31 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 102.332 -3.21 . . . . 0.0 102.332 169.092 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 13.8 t -133.07 116.59 26.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 105.658 -1.979 . . . . 0.0 105.658 -179.155 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.5 p -96.76 129.96 44.09 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 170.042 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -152.05 123.62 7.86 Favored 'General case' 0 C--N 1.334 -0.103 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -171.051 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 52.9 27.66 29.82 Favored Glycine 0 CA--C 1.538 1.492 0 CA-C-O 119.455 -0.636 . . . . 0.0 114.234 -178.801 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 82.28 -0.39 88.95 Favored Glycine 0 CA--C 1.536 1.384 0 CA-C-N 118.448 1.124 . . . . 0.0 114.007 -177.815 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 63.5 mt -99.16 170.94 8.33 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.449 1.5 . . . . 0.0 108.3 171.907 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 45.4 tp -139.46 157.65 45.47 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 118.628 0.649 . . . . 0.0 111.301 -170.494 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.478 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 54.5 mtt -143.57 160.3 40.88 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 126.258 1.823 . . . . 0.0 109.055 169.389 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 41.5 ttt180 -135.04 137.28 42.78 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 102.972 -2.973 . . . . 0.0 102.972 168.532 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 25.4 tp -147.91 137.29 22.32 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -169.743 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -128.45 144.3 51.12 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 170.41 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -177.79 170.23 42.49 Favored Glycine 0 CA--C 1.519 0.288 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 175.341 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -52.59 134.55 35.45 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 118.5 1.15 . . . . 0.0 108.685 172.868 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -46.69 -58.74 3.57 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -172.767 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -57.97 -45.26 86.99 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 122.322 1.058 . . . . 0.0 111.277 -177.55 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -61.13 -27.29 68.28 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 126.438 1.895 . . . . 0.0 111.793 178.381 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 tt -81.05 -24.19 38.02 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.917 0.887 . . . . 0.0 109.236 -179.937 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 54.27 30.25 12.11 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.212 1.005 . . . . 0.0 111.234 -170.62 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -104.25 9.74 50.16 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.662 1.125 . . . . 0.0 112.544 -176.447 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -72.13 7.95 1.48 Allowed 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.555 1.542 . . . . 0.0 112.643 178.233 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -145.18 106.55 4.21 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 127.76 2.424 . . . . 0.0 105.21 -178.221 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 14.6 m -63.02 -7.99 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 113.973 -1.467 . . . . 0.0 112.478 -177.837 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -122.05 18.89 10.85 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.364 1.065 . . . . 0.0 113.761 175.291 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 3.7 m -88.97 -70.26 0.66 Allowed 'General case' 0 N--CA 1.453 -0.296 0 O-C-N 121.639 -0.663 . . . . 0.0 110.683 168.516 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.28 2.0 ptp180 -75.64 11.48 1.31 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -173.006 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.3 m -65.61 -37.09 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 167.895 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -78.08 130.47 36.47 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 177.852 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.2 tt -141.2 141.96 34.03 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -172.492 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 49.2 tp -146.14 127.76 15.17 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 -174.564 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 48.9 ttp -143.8 146.06 32.81 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 119.829 1.195 . . . . 0.0 111.955 -169.443 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -151.57 166.05 32.37 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.904 2.081 . . . . 0.0 107.543 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -54.48 169.0 0.21 Allowed 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.464 1.029 . . . . 0.0 111.038 169.15 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.95 158.82 0.3 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 122.231 1.015 . . . . 0.0 113.333 173.938 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -143.61 130.15 20.11 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 174.112 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 54.3 p90 . . . . . 0 C--O 1.252 1.19 0 C-N-CA 126.169 1.787 . . . . 0.0 108.13 177.269 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 13.3 tp . . . . . 0 CA--C 1.545 0.765 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -148.14 147.47 29.52 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.868 1.213 . . . . 0.0 112.152 -177.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -159.43 137.79 10.56 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 128.174 2.59 . . . . 0.0 107.177 -175.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -158.46 154.86 27.5 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 119.336 0.971 . . . . 0.0 110.638 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.1 mp -99.16 159.6 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 126.392 1.877 . . . . 0.0 107.652 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -137.21 168.94 18.65 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.493 1.117 . . . . 0.0 110.549 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -134.1 128.76 34.85 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.641 1.576 . . . . 0.0 106.956 165.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 74.6 t -66.61 133.59 31.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 175.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -103.63 -34.32 8.67 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.616 1.167 . . . . 0.0 110.479 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -158.16 161.26 37.86 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.702 0.801 . . . . 0.0 110.146 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.8 mp -134.44 137.3 51.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 126.827 2.051 . . . . 0.0 105.728 -177.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -140.77 79.0 19.74 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 123.27 0.628 . . . . 0.0 111.453 -167.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -67.48 30.88 0.13 Allowed 'Trans proline' 0 CA--C 1.553 1.432 1 C-N-CA 126.089 4.526 . . . . 0.0 117.849 -172.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -50.13 -46.0 53.46 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 120.985 1.721 . . . . 0.0 115.449 -161.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -129.73 82.05 0.33 Allowed Glycine 0 C--N 1.336 0.572 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -160.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.456 ' HE2' ' HA ' ' A' ' 20' ' ' LYS . 9.5 mmpt? -74.44 62.91 1.02 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.26 1.424 . . . . 0.0 111.124 -176.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -55.92 -39.14 71.2 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.428 -0.795 . . . . 0.0 108.941 163.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -136.14 135.92 39.64 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 104.694 -2.336 . . . . 0.0 104.694 170.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -61.51 -33.29 73.54 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.271 0.487 . . . . 0.0 111.23 -177.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 -75.94 5.87 5.94 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.9 t -121.53 133.52 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 121.841 2.11 . . . . 0.0 107.858 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.7 m -148.38 158.97 44.43 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.352 1.061 . . . . 0.0 110.063 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 27.7 ttp180 -73.4 148.58 43.19 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 163.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 74.1 mt -134.18 162.66 31.52 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 126.153 1.781 . . . . 0.0 108.082 175.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -137.0 130.74 31.9 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 174.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 64.2 m -141.21 164.85 29.15 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.115 1.366 . . . . 0.0 109.525 -170.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -141.15 136.1 31.52 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.4 p -81.39 157.89 24.83 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.29 0.495 . . . . 0.0 111.194 -177.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -100.65 -50.78 3.77 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.581 0.752 . . . . 0.0 111.768 -168.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.0 m -73.57 -24.12 60.04 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 118.844 0.747 . . . . 0.0 111.292 -175.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.482 ' HB3' HD21 ' A' ' 131' ' ' ASN . 19.1 m-85 -126.01 -134.08 0.25 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.921 1.289 . . . . 0.0 108.767 -177.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -143.61 13.54 1.74 Allowed 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.879 1.218 . . . . 0.0 113.689 -165.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 65.7 mtm -68.94 152.0 45.83 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 118.857 0.753 . . . . 0.0 110.685 -172.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -121.5 125.23 46.33 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 126.759 2.024 . . . . 0.0 106.516 176.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 67.9 tp -137.16 148.8 46.84 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.718 0.771 . . . . 0.0 110.264 -163.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.3 mm -130.88 144.9 36.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 128.704 2.801 . . . . 0.0 104.296 170.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.5 mp -134.79 162.51 32.15 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 173.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -132.39 109.16 9.65 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 104.692 -2.336 . . . . 0.0 104.692 158.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.4 p -153.42 158.66 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -154.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -62.16 125.2 23.06 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 169.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 pp -105.39 -1.13 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.253 1.021 . . . . 0.0 112.965 -177.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -66.75 -11.73 55.92 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 120.567 1.53 . . . . 0.0 112.357 177.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.9 mt -63.21 -40.2 88.14 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.75 1.22 . . . . 0.0 108.731 171.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -72.55 155.42 91.11 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 124.152 0.981 . . . . 0.0 109.155 174.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -63.37 -53.08 1.59 Allowed 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 121.766 1.644 . . . . 0.0 111.683 -174.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.8 m -152.67 -143.77 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 126.073 1.749 . . . . 0.0 107.604 -177.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -54.38 -30.42 51.84 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 127.805 2.442 . . . . 0.0 115.143 -173.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 27.9 tp -86.17 -18.92 30.93 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 -147.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.18 173.29 41.36 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -165.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -163.95 178.14 7.97 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.312 1.845 . . . . 0.0 107.912 -175.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -93.58 125.77 38.37 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 121.3 -0.875 . . . . 0.0 109.875 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -106.44 170.76 7.74 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.494 1.518 . . . . 0.0 109.544 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.3 ttp180 -127.54 104.52 7.93 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 126.172 1.789 . . . . 0.0 106.188 165.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.9 152.04 28.3 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 171.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 95.4 t -141.72 134.96 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 -175.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.0 pt -121.25 25.63 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 163.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.345 0.407 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 152.245 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.446 -0.644 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -39.03 -33.23 0.11 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 127.11 2.164 . . . . 0.0 114.591 -175.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -149.5 157.77 43.58 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 173.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.5 p -163.7 138.39 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 40.2 tpp -163.16 166.8 22.97 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.051 0.54 . . . . 0.0 110.387 -166.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -111.94 163.09 14.63 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.707 1.603 . . . . 0.0 109.589 172.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -165.16 -159.67 11.68 Favored Glycine 0 CA--C 1.521 0.419 0 O-C-N 121.648 -0.658 . . . . 0.0 113.022 -175.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 11.1 ttmm -141.73 126.84 18.43 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 177.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.2 t -89.94 143.29 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 171.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -127.41 111.85 14.32 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 177.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.25 144.9 16.15 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 -177.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.512 HG13 ' H ' ' A' ' 101' ' ' GLY . 3.2 pt -75.56 -171.82 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 127.587 2.355 . . . . 0.0 109.663 169.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -64.59 -6.38 7.52 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.462 1.505 . . . . 0.0 114.384 176.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.512 ' H ' HG13 ' A' ' 99' ' ' ILE . . . . . . . . 0 C--N 1.336 0.529 0 C-N-CA 126.698 2.094 . . . . 0.0 110.255 -177.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.8 p . . . . . 0 CA--C 1.536 0.429 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -108.48 115.3 29.85 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 165.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 34.5 tp -56.02 131.8 48.35 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 160.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 14.7 m -87.34 171.62 10.46 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 171.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -152.0 146.92 25.94 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 124.62 1.168 . . . . 0.0 108.237 161.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 2.9 m-30 -122.81 139.51 53.93 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 104.001 -2.592 . . . . 0.0 104.001 170.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.2 t -139.42 137.46 40.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 -174.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.1 m -116.92 132.09 56.79 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 166.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -149.43 109.77 4.19 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.089 0.859 . . . . 0.0 109.703 -170.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 58.19 22.94 51.47 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 123.797 0.713 . . . . 0.0 114.334 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.1 -14.11 65.0 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-N 118.42 1.11 . . . . 0.0 112.98 -176.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -83.05 171.87 13.33 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.643 1.177 . . . . 0.0 109.012 170.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 10.1 tp -140.07 153.74 46.85 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.242 1.017 . . . . 0.0 110.192 -173.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 42.6 mtt -138.75 158.31 44.47 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.684 1.194 . . . . 0.0 110.281 164.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.6 ttt-85 -143.97 122.34 12.35 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 104.357 -2.461 . . . . 0.0 104.357 176.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 33.8 tp -142.93 151.54 41.07 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.183 0.901 . . . . 0.0 109.342 -158.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -141.47 145.26 35.02 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.174 1.39 . . . . 0.0 109.817 167.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -172.76 166.81 39.54 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 125.989 1.757 . . . . 0.0 109.883 171.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -51.58 146.75 7.13 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.019 1.41 . . . . 0.0 111.09 176.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.77 -47.53 82.26 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -169.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -65.17 -43.71 90.85 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 122.678 0.391 . . . . 0.0 110.069 174.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.482 HD21 ' HB3' ' A' ' 35' ' ' PHE . 49.8 t30 -65.21 -40.73 94.54 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.416 1.086 . . . . 0.0 112.765 -172.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.2 tt -63.83 -22.17 66.79 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.522 1.129 . . . . 0.0 111.285 176.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 53.08 39.01 28.82 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.998 1.719 . . . . 0.0 112.556 170.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -157.5 50.8 0.42 Allowed Glycine 0 C--N 1.338 0.656 0 C-N-CA 124.067 0.842 . . . . 0.0 111.03 -169.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -58.36 -35.48 72.02 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.294 0.637 . . . . 0.0 110.406 170.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -83.63 155.0 23.43 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.535 1.534 . . . . 0.0 110.326 -170.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.1 m -73.28 -3.46 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 C-N-CA 123.68 0.792 . . . . 0.0 112.208 168.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -133.56 6.41 3.77 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.616 1.166 . . . . 0.0 112.877 -164.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 72.2 m -87.84 -69.3 0.7 Allowed 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.085 -1.01 . . . . 0.0 109.902 173.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.276 12.7 ptm180 -82.05 11.74 4.87 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 120.605 -1.309 . . . . 0.0 114.147 -170.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 24.6 m -62.87 -31.8 53.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 O-C-N 121.992 -0.442 . . . . 0.0 110.305 157.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -73.21 113.47 10.31 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 170.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.3 tt -145.95 137.57 24.97 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 118.342 0.519 . . . . 0.0 110.282 -167.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.3 tt -150.66 150.64 31.38 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.784 1.634 . . . . 0.0 107.088 -168.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 60.3 mtt -142.19 157.42 44.88 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 120.624 -1.298 . . . . 0.0 108.802 -176.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 15.5 ptmt -155.42 173.58 16.46 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 125.002 1.321 . . . . 0.0 109.718 163.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -57.93 163.5 2.69 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 164.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.09 159.82 5.46 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.281 163.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -132.17 106.59 8.06 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 175.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.252 1.196 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 -168.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.5 tm? . . . . . 0 C--O 1.232 0.157 0 CA-C-O 118.948 -0.549 . . . . 0.0 110.054 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -154.71 151.68 29.02 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -151.78 141.87 22.21 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 126.508 1.923 . . . . 0.0 107.642 -173.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -151.57 150.71 30.63 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 168.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 mp -72.42 148.52 9.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 172.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -135.94 156.82 48.17 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.325 1.85 . . . . 0.0 107.455 175.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -129.21 144.98 51.41 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.901 1.28 . . . . 0.0 108.355 176.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.8 p -73.83 146.22 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 C-N-CA 124.283 1.033 . . . . 0.0 108.767 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -125.59 -28.94 3.23 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 126.558 1.943 . . . . 0.0 109.479 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -157.68 166.62 32.34 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.028 0.831 . . . . 0.0 110.67 170.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.6 mp -143.57 138.15 25.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 127.26 2.224 . . . . 0.0 106.58 -174.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -151.66 101.25 2.91 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 123.202 0.601 . . . . 0.0 109.721 169.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -57.79 146.18 86.95 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.917 2.411 . . . . 0.0 111.292 172.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -127.66 13.64 6.96 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.227 0.611 . . . . 0.0 112.207 -172.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 174.72 79.86 0.05 OUTLIER Glycine 0 C--N 1.338 0.689 0 O-C-N 121.199 -0.938 . . . . 0.0 111.511 -170.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.9 mmtt -57.46 -18.4 18.15 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -72.47 -14.37 61.66 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.8 0.727 . . . . 0.0 111.111 175.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -136.32 52.33 1.97 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 127.149 2.18 . . . . 0.0 106.108 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -50.05 -28.06 6.52 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.806 1.643 . . . . 0.0 114.783 -169.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -68.64 2.17 2.66 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 117.668 -1.158 . . . . 0.0 113.707 173.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.3 t -125.52 121.89 61.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 121.138 1.79 . . . . 0.0 107.596 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.3 m -147.15 158.25 43.88 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.888 0.875 . . . . 0.0 110.759 -173.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.5 ttp-105 -83.02 148.28 27.65 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 170.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.0 mt -139.41 154.12 47.74 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.7 2.0 . . . . 0.0 107.273 177.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -126.69 132.52 51.15 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 103.926 -2.62 . . . . 0.0 103.926 171.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 64.0 m -145.21 167.24 23.28 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.956 1.302 . . . . 0.0 111.154 -169.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -140.71 142.5 34.84 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.463 1.905 . . . . 0.0 108.081 -176.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 31.9 p -72.72 151.78 42.0 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 118.125 0.421 . . . . 0.0 111.092 177.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -83.55 -37.32 23.14 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 118.757 -0.64 . . . . 0.0 111.495 176.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.6 m -101.76 -17.61 16.17 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 -168.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -124.2 -102.16 0.38 Allowed 'General case' 0 C--N 1.342 0.252 0 CA-C-N 120.545 1.52 . . . . 0.0 110.542 -170.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -168.19 10.8 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.204 1.002 . . . . 0.0 113.003 -169.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 59.6 mtm -70.56 146.7 49.96 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.342 0.591 . . . . 0.0 110.158 -173.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -118.58 128.78 54.87 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 172.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.4 tp -133.34 139.18 46.69 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 123.598 0.759 . . . . 0.0 110.46 -169.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 14.8 mm -125.6 148.25 30.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 103.776 -2.675 . . . . 0.0 103.776 169.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.5 mt -150.21 144.68 25.77 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 126.346 1.858 . . . . 0.0 107.057 -171.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -131.58 94.62 3.56 Favored 'General case' 0 C--N 1.32 -0.694 1 N-CA-C 99.754 -4.165 . . . . 0.0 99.754 168.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.7 p -136.24 161.65 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-O 122.07 0.938 . . . . 0.0 112.536 -166.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.412 HD21 ' NE2' ' A' ' 46' ' ' GLN . 22.2 t30 -68.48 90.71 0.38 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.039 2.135 . . . . 0.0 109.057 169.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.6 pp -69.65 3.88 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -169.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.412 ' NE2' HD21 ' A' ' 44' ' ' ASN . 12.1 pt20 -65.98 -11.68 49.46 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 120.854 1.661 . . . . 0.0 111.957 176.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 55.7 mt -59.51 -34.08 53.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 169.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -92.32 155.04 42.88 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 124.923 1.289 . . . . 0.0 108.426 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.04 -23.82 33.64 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.196 1.931 . . . . 0.0 112.526 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.0 t -145.81 153.97 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 -178.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -53.93 -28.94 40.13 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.445 1.098 . . . . 0.0 112.306 169.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 39.5 tp -56.64 -17.0 7.24 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.456 1.502 . . . . 0.0 112.903 173.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.88 173.67 49.71 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 124.011 0.815 . . . . 0.0 111.359 177.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -164.11 175.07 10.56 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.901 2.08 . . . . 0.0 106.497 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -67.43 147.25 53.12 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 169.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -150.03 -173.44 4.43 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.063 1.345 . . . . 0.0 107.711 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -132.95 148.08 52.28 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 119.136 0.88 . . . . 0.0 109.338 170.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.1 tt -118.88 143.21 47.11 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.5 t -139.34 155.46 26.04 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 C-N-CA 124.666 1.187 . . . . 0.0 109.694 -168.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.1 tt -129.72 148.35 33.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 127.725 2.41 . . . . 0.0 106.24 170.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.397 0 C-N-CA 124.939 1.295 . . . . 0.0 109.155 -173.536 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 . . . . . 0 CA--C 1.535 0.376 0 N-CA-C 107.4 -1.334 . . . . 0.0 107.4 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -82.83 -31.29 28.15 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.703 0.683 . . . . 0.0 110.127 169.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -147.54 150.31 34.26 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.187 0.595 . . . . 0.0 109.663 177.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.2 t -143.62 138.88 25.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.08 169.56 23.24 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.894 0.855 . . . . 0.0 110.571 175.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -134.22 93.57 3.1 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 -171.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -92.62 -164.31 37.99 Favored Glycine 0 C--N 1.332 0.357 0 CA-C-O 121.682 0.601 . . . . 0.0 112.732 -169.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -134.04 111.93 10.78 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 169.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.7 t -69.84 149.0 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 169.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -143.34 58.59 1.39 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.556 0.742 . . . . 0.0 110.935 174.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -143.59 160.86 39.88 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.964 1.306 . . . . 0.0 109.878 174.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -83.5 -177.2 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 125.432 1.493 . . . . 0.0 109.723 169.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -64.08 -6.99 7.38 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.612 1.565 . . . . 0.0 114.847 -177.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.406 0 N-CA-C 107.0 -2.44 . . . . 0.0 107.0 -172.961 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 32.8 p . . . . . 0 N--CA 1.469 0.517 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -128.46 144.05 51.08 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 173.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 7.8 tt -92.83 149.08 21.51 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 168.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 10.7 p -116.0 146.0 42.5 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -139.42 100.18 3.92 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -95.66 128.19 42.32 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 101.65 -3.463 . . . . 0.0 101.65 169.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.7 t -140.02 137.7 38.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -169.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.7 t -117.45 137.82 52.26 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 170.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -150.15 105.63 3.39 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.609 0.764 . . . . 0.0 109.536 -171.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 61.27 22.44 60.94 Favored Glycine 0 CA--C 1.534 1.264 0 O-C-N 121.546 -0.721 . . . . 0.0 113.927 175.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.49 -13.58 65.34 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.499 1.047 . . . . 0.0 112.934 -177.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -85.59 164.13 17.93 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 169.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 7.8 tt -146.21 155.92 43.03 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 121.695 -0.628 . . . . 0.0 109.956 -171.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 23.4 ptm -150.42 161.01 43.34 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.394 1.077 . . . . 0.0 108.906 172.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 58.7 ttt-85 -135.96 127.44 28.65 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 104.978 -2.231 . . . . 0.0 104.978 172.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 25.5 tp -141.97 140.69 32.8 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -170.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -132.54 145.79 51.41 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 169.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -171.74 178.18 44.15 Favored Glycine 0 C--N 1.331 0.298 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 174.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.08 140.66 48.56 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 118.158 0.979 . . . . 0.0 109.221 172.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -52.27 -62.18 1.8 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.604 0.761 . . . . 0.0 112.613 -175.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.31 -24.08 66.48 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.117 0.871 . . . . 0.0 113.032 -174.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.37 -35.5 77.81 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 126.16 1.784 . . . . 0.0 109.774 174.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 16.9 tp -94.81 -19.2 20.53 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.713 0.805 . . . . 0.0 110.252 -175.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 42.58 42.2 2.7 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.669 1.988 . . . . 0.0 112.041 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -105.71 20.17 37.22 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.029 0.823 . . . . 0.0 112.458 -172.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -74.16 8.8 1.91 Allowed 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.25 1.025 . . . . 0.0 113.497 -178.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -131.79 131.11 42.64 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 169.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.9 p -57.65 -10.15 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 125.124 1.37 . . . . 0.0 110.857 169.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -123.56 12.71 9.33 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 126.002 1.721 . . . . 0.0 112.978 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 3.4 m -89.12 -58.98 2.35 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 167.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.6 tpm_? -75.55 2.07 12.66 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 115.466 -0.788 . . . . 0.0 113.031 -169.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 29.2 m -60.25 -37.98 75.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 124.422 1.089 . . . . 0.0 110.14 169.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -71.95 118.47 14.85 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 63.3 tp -138.88 120.65 15.32 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 -172.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.59 149.34 45.16 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -174.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 61.6 mtt -143.11 144.59 32.29 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -172.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -152.3 160.78 43.28 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -64.02 157.19 25.81 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 168.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.3 pp -67.21 165.36 16.27 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.242 0.544 . . . . 0.0 110.172 170.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -142.14 140.08 32.34 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 170.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 . . . . . 0 C--O 1.25 1.102 0 C-N-CA 126.392 1.877 . . . . 0.0 110.413 -176.312 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.3 tm? . . . . . 0 CA--C 1.532 0.278 0 CA-C-O 121.006 0.432 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -153.36 134.34 13.97 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 172.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -144.76 147.7 33.25 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.28 1.432 . . . . 0.0 108.08 -169.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -150.31 155.7 40.16 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.187 0.595 . . . . 0.0 109.434 169.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.3 mp -85.82 144.7 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 169.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -113.04 143.59 44.06 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.035 1.334 . . . . 0.0 107.68 171.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -117.06 122.83 45.29 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.878 1.671 . . . . 0.0 106.832 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.7 t -71.7 121.43 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -176.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.5 mmmt -96.61 -29.86 13.6 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.194 177.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -155.33 165.08 37.75 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.408 1.003 . . . . 0.0 111.459 175.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.4 mp -142.55 135.61 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 127.85 2.46 . . . . 0.0 105.756 -177.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -147.87 93.04 4.58 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 118.301 0.501 . . . . 0.0 111.155 178.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -61.16 144.77 99.18 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.911 2.407 . . . . 0.0 109.954 169.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -131.79 9.4 4.58 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -174.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.84 46.61 10.68 Favored Glycine 0 C--N 1.343 0.918 0 O-C-N 121.478 -0.764 . . . . 0.0 111.202 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.0 mmmm -73.03 25.97 0.06 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.289 1.436 . . . . 0.0 112.772 -171.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp 68.02 -59.84 0.42 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 128.497 2.719 . . . . 0.0 108.569 -168.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 4.8 m-30 -81.26 87.18 6.13 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 103.633 -2.729 . . . . 0.0 103.633 168.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -62.68 -17.58 60.85 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.285 -0.884 . . . . 0.0 112.656 -174.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 -66.54 -14.49 62.38 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 118.028 -0.987 . . . . 0.0 112.51 169.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 77.2 t -88.78 134.15 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 169.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.6 m -151.04 159.44 44.54 Favored 'General case' 0 C--O 1.239 0.542 0 O-C-N 120.928 -1.108 . . . . 0.0 109.981 -176.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.6 tpp85 -72.66 150.44 42.98 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 172.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.6 mt -138.14 157.19 46.81 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.923 1.689 . . . . 0.0 107.247 172.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -135.46 133.57 38.69 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 169.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 33.7 m -141.11 166.11 25.68 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.242 1.417 . . . . 0.0 110.087 -174.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -134.87 143.47 47.0 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 172.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.1 p -83.85 145.47 28.62 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 118.762 0.71 . . . . 0.0 110.255 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -80.57 -32.05 36.7 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -169.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.9 m -102.62 -34.21 9.16 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.138 0.881 . . . . 0.0 111.75 -171.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -121.71 10.28 10.29 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.669 1.187 . . . . 0.0 112.712 -170.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.315 0.0 OUTLIER 43.11 39.19 1.78 Allowed 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.915 2.086 . . . . 0.0 114.371 174.637 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 62.5 mtm -63.64 154.08 34.02 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 169.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -112.46 127.77 56.13 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 176.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 59.3 tp -137.81 144.9 41.74 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.78 0.8 . . . . 0.0 110.437 -169.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 35.6 mm -127.83 149.12 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 128.479 2.712 . . . . 0.0 103.737 169.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 123' ' ' MET . 2.0 mp -143.63 161.08 39.46 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 126.201 1.801 . . . . 0.0 108.254 176.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -138.48 94.59 2.87 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 102.312 -3.218 . . . . 0.0 102.312 168.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.7 m -144.15 168.74 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 124.36 1.064 . . . . 0.0 111.295 -168.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -60.03 134.2 56.81 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.041 0.936 . . . . 0.0 110.149 170.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 pp -116.51 2.14 7.88 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.445 0 C-N-CA 125.372 1.469 . . . . 0.0 112.966 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -64.77 -12.24 45.37 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 121.367 1.894 . . . . 0.0 113.248 -172.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 66.2 mt -58.95 -22.53 21.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 125.891 1.676 . . . . 0.0 108.816 169.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -127.38 167.05 19.19 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 128.531 2.733 . . . . 0.0 109.426 -178.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -52.17 157.27 6.59 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.664 2.242 . . . . 0.0 111.875 169.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.7 m -59.57 -10.77 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 N-CA-C 115.573 1.694 . . . . 0.0 115.573 -169.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -139.9 27.5 2.2 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.761 1.224 . . . . 0.0 110.55 -177.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 25.7 tp -140.89 163.16 33.7 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.235 -0.916 . . . . 0.0 110.753 -173.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -165.37 167.81 39.08 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 128.068 2.747 . . . . 0.0 106.405 171.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -141.77 -64.06 0.44 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 118.705 1.252 . . . . 0.0 111.788 -178.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -148.32 162.7 38.99 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.419 1.009 . . . . 0.0 111.159 178.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -145.27 171.34 14.71 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.54 1.936 . . . . 0.0 107.415 170.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -136.02 123.47 22.07 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.5 mp -125.15 146.44 49.49 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -169.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -157.01 128.25 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 121.839 0.828 . . . . 0.0 108.775 -169.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.0 tp -69.16 -32.46 54.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 123.508 0.723 . . . . 0.0 109.945 174.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.565 0 C-N-CA 126.845 2.058 . . . . 0.0 112.787 -172.002 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 . . . . . 0 CA--C 1.542 0.638 0 CA-C-O 120.304 0.097 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -164.29 124.93 2.12 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.494 1.117 . . . . 0.0 109.114 172.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -148.69 154.17 39.27 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 168.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.7 m -137.18 151.93 27.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 O-C-N 121.538 -0.726 . . . . 0.0 110.215 -171.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 37.5 ttm -152.84 161.92 41.94 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.597 1.559 . . . . 0.0 107.353 176.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -136.85 151.72 49.44 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -173.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.18 -157.51 8.58 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 120.908 -0.663 . . . . 0.0 114.366 -169.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -144.82 123.72 12.71 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.772 1.629 . . . . 0.0 107.146 176.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.9 t -77.89 141.89 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 169.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -140.09 64.89 1.43 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.857 1.263 . . . . 0.0 110.057 177.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.418 ' HB2' ' H ' ' A' ' 115' ' ' TYR . 1.0 OUTLIER -154.17 167.52 29.58 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.245 -1.535 . . . . 0.0 112.415 -179.578 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.9 pt -83.4 -177.12 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 127.249 2.22 . . . . 0.0 112.21 -170.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -74.5 -3.15 29.09 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.742 1.617 . . . . 0.0 114.115 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.23 0 C-N-CA 124.338 0.97 . . . . 0.0 112.537 -178.462 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 72.7 p . . . . . 0 C--O 1.235 0.332 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? 58.87 120.28 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 127.799 2.44 . . . . 0.0 111.652 -173.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 55.3 tp -57.98 144.28 40.11 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 170.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.6 p -123.65 149.03 45.91 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.473 1.109 . . . . 0.0 109.8 -173.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -148.38 108.15 4.01 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.575 1.15 . . . . 0.0 108.373 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.418 ' H ' ' HB2' ' A' ' 98' ' ' ARG . 7.6 m-30 -91.57 122.63 34.32 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 102.379 -3.193 . . . . 0.0 102.379 168.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.0 t -129.71 112.75 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -169.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.2 p -88.24 128.77 35.47 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 104.767 -2.308 . . . . 0.0 104.767 169.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.39 134.35 20.27 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 118.711 0.687 . . . . 0.0 109.631 -172.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 47.21 33.19 7.34 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 124.646 1.117 . . . . 0.0 115.188 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 76.51 17.07 80.23 Favored Glycine 0 CA--C 1.536 1.399 0 CA-C-N 118.716 1.258 . . . . 0.0 113.682 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 93.8 mt -129.2 178.65 6.28 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 128.284 2.633 . . . . 0.0 107.283 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 58.3 tp -139.13 154.15 48.08 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 120.837 -1.164 . . . . 0.0 111.539 -171.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.464 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 76.5 mtm -143.43 156.16 44.58 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.777 2.031 . . . . 0.0 107.901 169.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -137.54 117.93 13.73 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 169.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 51.3 tp -125.59 148.95 48.76 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 125.943 1.697 . . . . 0.0 109.789 -168.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -139.74 148.81 42.81 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.222 1.409 . . . . 0.0 108.448 169.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -165.59 165.17 37.77 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 173.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -71.87 86.7 0.98 Allowed 'General case' 0 N--CA 1.463 0.205 0 O-C-N 122.059 -0.671 . . . . 0.0 110.301 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . 22.85 -77.45 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 130.436 3.494 . . . . 0.0 115.242 -170.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -13.13 16.3 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 11.3 m-20 -85.74 -36.16 20.33 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.972 1.709 . . . . 0.0 109.323 176.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 9.2 tt -72.64 -29.97 63.91 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 170.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 1.8 t60 54.99 45.52 26.24 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.606 1.962 . . . . 0.0 112.069 169.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -152.04 68.49 0.32 Allowed Glycine 0 C--N 1.335 0.484 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 -175.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -73.4 3.55 5.83 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.233 1.013 . . . . 0.0 113.728 -174.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -129.13 145.35 51.32 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.366 1.866 . . . . 0.0 108.513 172.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 7.8 m -66.32 -1.04 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.098 168.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -123.16 15.36 9.84 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 127.746 2.419 . . . . 0.0 111.447 177.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 75.3 m -80.95 -70.5 0.53 Allowed 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.463 -0.773 . . . . 0.0 109.366 168.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.316 1.8 ptp180 -81.56 15.14 2.21 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -169.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 30.3 m -70.97 -12.24 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 167.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -109.27 120.77 43.52 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 103.232 -2.877 . . . . 0.0 103.232 168.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -136.75 130.5 32.07 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -172.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 7.5 tt -117.83 139.47 51.06 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 176.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 19.6 ptt? -144.83 162.11 37.61 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 121.327 -0.858 . . . . 0.0 109.733 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 78.8 mttt -152.86 166.64 31.66 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.759 1.623 . . . . 0.0 108.635 -169.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -71.17 167.69 18.82 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 167.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.34 157.26 8.84 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.173 0.511 . . . . 0.0 110.81 169.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -147.76 123.37 10.47 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 171.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 . . . . . 0 C--O 1.248 0.982 0 C-N-CA 125.995 1.718 . . . . 0.0 107.162 178.092 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.2 tm? . . . . . 0 C--O 1.232 0.15 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -142.87 163.58 32.41 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.006 1.322 . . . . 0.0 107.682 169.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -139.31 124.14 18.63 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 103.878 -2.638 . . . . 0.0 103.878 174.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -142.35 131.97 23.95 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.418 0.687 . . . . 0.0 109.357 -171.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.8 mp -81.79 129.15 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 177.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -96.69 153.03 18.1 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.651 1.581 . . . . 0.0 108.065 175.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -132.27 114.99 15.09 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 126.083 1.753 . . . . 0.0 106.999 172.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 68.9 t -71.47 122.19 23.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 177.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.0 mmmt -85.21 -41.35 15.7 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 173.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -158.6 166.56 31.79 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.305 0.502 . . . . 0.0 111.73 -173.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.4 mp -137.05 141.21 41.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 127.756 2.422 . . . . 0.0 106.481 -175.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -145.59 89.2 6.31 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 124.45 1.1 . . . . 0.0 110.485 -171.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -66.32 142.23 65.52 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.92 3.08 . . . . 0.0 111.352 170.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -78.37 -38.39 41.94 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.942 -0.474 . . . . 0.0 111.597 177.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 147.38 47.48 0.03 OUTLIER Glycine 0 CA--C 1.527 0.829 0 N-CA-C 104.932 -3.267 . . . . 0.0 104.932 -169.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -63.15 120.49 11.59 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.213 1.405 . . . . 0.0 113.468 -167.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.456 ' HE3' ' HA ' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -64.97 -46.93 79.44 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.164 168.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -80.63 -19.21 45.89 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.08 0.552 . . . . 0.0 112.351 -174.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.7 t70 47.12 39.08 7.52 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.99 2.116 . . . . 0.0 113.956 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -142.64 8.25 1.73 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 176.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.7 t -139.24 133.4 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 73.1 m -156.43 168.17 28.18 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 120.786 1.63 . . . . 0.0 110.48 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.1 ttm105 -72.19 149.3 44.76 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 169.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.88 158.09 45.25 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 125.786 1.634 . . . . 0.0 107.755 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -133.31 125.48 29.32 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 174.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 58.5 m -141.89 169.59 17.3 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.947 1.299 . . . . 0.0 111.004 -169.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.1 tt0 -143.78 145.0 32.05 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 125.267 1.427 . . . . 0.0 108.118 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.3 m -75.68 131.48 39.92 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 123.285 0.634 . . . . 0.0 109.939 169.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -80.28 -19.6 46.34 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.557 0.743 . . . . 0.0 111.011 170.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.23 -36.07 3.03 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -169.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -115.38 21.53 14.0 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.527 1.131 . . . . 0.0 112.243 -177.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt 42.96 18.03 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 118.685 2.846 . . . . 0.0 118.685 172.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 68.7 mtm -67.72 151.08 47.82 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.868 1.213 . . . . 0.0 108.534 174.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -112.35 127.69 56.08 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 104.613 -2.365 . . . . 0.0 104.613 171.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.5 mp -136.21 150.89 49.19 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 119.094 0.861 . . . . 0.0 112.614 -168.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 46.2 mm -123.1 144.5 32.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 102.812 -3.033 . . . . 0.0 102.812 168.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.8 mp -143.32 160.66 40.1 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 127.347 2.259 . . . . 0.0 107.455 -169.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -140.2 102.68 4.42 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 102.487 -3.153 . . . . 0.0 102.487 168.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.4 m -144.52 169.35 9.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 C-N-CA 124.203 1.001 . . . . 0.0 111.567 -168.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -65.43 136.06 56.01 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 169.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.8 pp -112.33 7.66 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 124.507 1.123 . . . . 0.0 112.686 -175.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -59.72 -23.14 62.93 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 121.541 -0.725 . . . . 0.0 110.675 169.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.1 mt -68.89 -26.83 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 126.127 1.771 . . . . 0.0 109.839 173.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -127.92 68.16 74.99 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 126.01 1.724 . . . . 0.0 109.02 -170.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -73.41 6.4 2.71 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.676 2.917 . . . . 0.0 114.464 -169.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.6 m -136.87 148.89 26.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 C-N-CA 124.934 1.293 . . . . 0.0 108.862 -174.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -60.57 -25.97 66.58 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.613 1.165 . . . . 0.0 112.349 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 52.7 tp -60.95 -23.92 65.68 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.652 1.181 . . . . 0.0 112.314 174.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.42 -168.08 46.22 Favored Glycine 0 CA--C 1.532 1.123 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -169.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -153.07 173.59 15.26 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.332 1.053 . . . . 0.0 108.281 176.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -94.46 152.46 18.57 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.566 0.746 . . . . 0.0 109.016 169.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -151.92 -177.0 5.88 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.246 1.418 . . . . 0.0 107.911 -173.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 10.7 ttp180 -136.65 146.29 45.81 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 120.929 -1.107 . . . . 0.0 108.661 177.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.0 tt -127.65 145.59 50.83 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.662 1.585 . . . . 0.0 107.883 176.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -145.59 166.91 9.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 127.342 2.257 . . . . 0.0 105.921 -174.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 46.4 pt -129.09 27.1 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 O-C-N 121.297 -0.877 . . . . 0.0 111.389 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.694 0 C-N-CA 124.882 1.273 . . . . 0.0 113.773 -174.471 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 52.8 p90 . . . . . 0 CA--C 1.532 0.268 0 CA-C-O 121.091 0.472 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -120.05 -33.57 3.91 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 169.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -144.75 144.87 31.41 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.198 1.799 . . . . 0.0 106.209 169.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.7 p -148.72 141.27 18.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -178.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 31.9 tpp -159.34 173.63 15.98 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.51 1.124 . . . . 0.0 110.457 -171.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -134.82 147.78 50.02 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 127.265 2.226 . . . . 0.0 106.924 -173.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -158.38 -157.2 8.35 Favored Glycine 0 C--N 1.338 0.692 0 CA-C-N 119.171 0.896 . . . . 0.0 113.857 -171.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -133.39 125.8 29.88 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 125.665 1.586 . . . . 0.0 106.767 173.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.405 ' HB ' ' HA ' ' A' ' 137' ' ' VAL . 84.3 t -93.19 150.64 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 175.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -134.94 154.46 51.69 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 126.625 1.97 . . . . 0.0 105.984 175.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.76 162.03 39.77 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.632 1.105 . . . . 0.0 111.423 171.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 24.5 pt -80.35 177.67 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 O-C-N 123.973 0.796 . . . . 0.0 108.937 169.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -76.95 -3.27 38.0 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.72 1.208 . . . . 0.0 113.683 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.725 0 CA-C-O 119.328 -0.707 . . . . 0.0 112.614 -176.972 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.4 p . . . . . 0 C--O 1.234 0.247 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -136.44 144.64 44.55 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.797 1.239 . . . . 0.0 108.773 169.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.1 tp -88.82 152.96 21.44 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 167.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 14.3 m -126.46 145.16 50.6 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 118.294 0.497 . . . . 0.0 109.822 177.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -146.46 160.04 42.61 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.748 1.219 . . . . 0.0 110.213 -172.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -130.38 158.56 39.51 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 169.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.0 p -149.27 136.2 13.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 169.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.9 t -123.75 129.16 50.64 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 178.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -150.42 122.67 8.36 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 123.859 0.863 . . . . 0.0 109.381 -169.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 54.28 21.64 19.83 Favored Glycine 0 CA--C 1.538 1.527 0 CA-C-O 119.158 -0.801 . . . . 0.0 114.899 178.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 92.7 -4.52 75.93 Favored Glycine 0 CA--C 1.536 1.347 0 CA-C-N 118.735 1.267 . . . . 0.0 113.797 -177.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -95.15 164.13 13.0 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 118.975 1.387 . . . . 0.0 108.229 171.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 39.9 tp -143.85 155.45 44.12 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 122.939 0.495 . . . . 0.0 110.693 -169.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 15.3 mtt -144.04 152.11 40.56 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.891 1.676 . . . . 0.0 106.649 168.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 74.5 mtm180 -137.91 135.26 35.93 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 104.948 -2.241 . . . . 0.0 104.948 169.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -155.49 167.37 30.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 119.335 0.971 . . . . 0.0 112.975 -169.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -134.42 159.72 40.2 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.118 1.367 . . . . 0.0 107.562 168.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -172.06 164.18 36.66 Favored Glycine 0 CA--C 1.516 0.148 0 N-CA-C 108.213 -1.955 . . . . 0.0 108.213 171.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.19 137.66 51.42 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 172.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -45.13 -60.26 2.19 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -169.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.18 -4.98 36.29 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -178.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -92.62 -21.46 20.03 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 125.386 1.475 . . . . 0.0 110.756 170.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.8 tt -68.13 -23.85 64.94 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 119.53 1.059 . . . . 0.0 109.204 171.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 1.4 t60 44.1 34.47 0.98 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 128.348 2.659 . . . . 0.0 114.54 168.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 179.97 42.55 0.08 OUTLIER Glycine 0 C--N 1.336 0.574 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 -171.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -65.76 -14.81 62.07 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 117.618 0.709 . . . . 0.0 112.535 172.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -61.68 103.81 0.37 Allowed 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 127.418 2.287 . . . . 0.0 108.24 169.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.405 ' HA ' ' HB ' ' A' ' 96' ' ' VAL . 13.8 m -53.98 -9.86 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 126.969 2.107 . . . . 0.0 113.307 173.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -133.35 23.15 4.07 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.344 1.058 . . . . 0.0 113.402 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 24.7 m -106.58 -58.15 1.96 Allowed 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 119.004 -0.522 . . . . 0.0 110.402 168.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.396 16.0 ptm180 -75.88 11.88 1.27 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.223 0.919 . . . . 0.0 113.24 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 16.9 m -63.0 -39.15 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 167.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -70.09 119.39 14.23 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 170.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.3 tt -136.37 134.6 38.01 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -177.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.412 HD23 ' N ' ' A' ' 145' ' ' MET . 5.6 tt -143.97 140.43 29.64 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 -173.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.412 ' N ' HD23 ' A' ' 144' ' ' LEU . 25.3 ptp -140.92 154.21 46.01 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 119.229 0.922 . . . . 0.0 110.619 173.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -159.24 160.63 35.53 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 126.352 1.861 . . . . 0.0 107.656 -176.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -54.49 159.0 2.22 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 118.847 0.749 . . . . 0.0 110.581 169.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.57 166.04 19.81 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.819 0.342 . . . . 0.0 110.58 169.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -142.73 36.31 1.44 Allowed 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.611 1.165 . . . . 0.0 110.299 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 43.1 t80 . . . . . 0 C--O 1.249 1.054 0 C-N-CA 124.62 1.168 . . . . 0.0 108.166 -174.335 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.9 tt . . . . . 0 N--CA 1.464 0.227 0 CA-C-O 120.823 0.344 . . . . 0.0 110.329 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -143.34 143.89 31.86 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 126.837 2.055 . . . . 0.0 106.002 169.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -150.6 134.82 17.0 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.195 1.398 . . . . 0.0 107.36 172.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -154.94 151.64 28.77 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.673 0.67 . . . . 0.0 109.943 169.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.1 mp -81.92 156.73 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 170.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -139.7 151.52 45.95 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.064 0.946 . . . . 0.0 108.745 169.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -117.2 126.33 52.6 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 125.518 1.527 . . . . 0.0 107.603 -176.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -70.64 128.22 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 176.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.6 mmmt -95.8 -35.71 11.41 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.476 1.111 . . . . 0.0 109.403 173.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -158.02 167.72 29.11 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 118.983 0.811 . . . . 0.0 111.307 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.9 mp -138.85 144.43 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 127.036 2.134 . . . . 0.0 107.244 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -145.29 92.58 5.6 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 126.814 2.046 . . . . 0.0 108.276 -176.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -55.26 156.05 18.02 Favored 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 124.081 3.187 . . . . 0.0 114.162 -178.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -77.81 45.78 0.53 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.425 1.49 . . . . 0.0 112.093 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.92 35.71 64.53 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 124.471 1.034 . . . . 0.0 113.54 169.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt 47.44 19.73 0.15 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.027 2.131 . . . . 0.0 114.167 -171.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.432 ' HE3' ' HA ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -77.17 -34.88 56.31 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 121.084 -1.01 . . . . 0.0 109.813 170.428 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -138.09 87.23 2.23 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 -177.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -55.06 -36.94 66.12 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.072 0.949 . . . . 0.0 113.341 -169.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -90.1 14.55 12.15 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 117.962 -1.018 . . . . 0.0 112.967 -178.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.7 t -127.34 140.93 47.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-N 120.821 1.646 . . . . 0.0 107.522 -176.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.6 m -151.87 151.67 31.6 Favored 'General case' 0 C--O 1.239 0.518 0 O-C-N 121.33 -0.856 . . . . 0.0 111.05 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 36.6 ttp180 -80.66 145.81 31.44 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 104.554 -2.387 . . . . 0.0 104.554 168.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.1 mp -134.09 158.44 43.6 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 125.923 1.689 . . . . 0.0 106.453 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -125.86 130.59 51.66 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 169.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 58.3 m -141.94 173.27 11.67 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.06 1.344 . . . . 0.0 109.796 -170.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -140.69 131.23 25.44 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 171.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.1 m -71.73 134.63 46.37 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 175.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -71.11 -35.23 71.7 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.62 1.168 . . . . 0.0 113.62 -169.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.72 -16.85 6.57 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -169.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -121.11 48.22 1.69 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.854 0.862 . . . . 0.0 112.168 -169.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt 30.34 64.37 0.16 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.582 1.953 . . . . 0.0 113.328 168.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 20.6 mtm -137.45 117.6 13.49 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 118.355 0.525 . . . . 0.0 110.474 -176.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -82.95 133.23 35.12 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 168.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -134.67 148.1 50.27 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.989 0.899 . . . . 0.0 113.045 -168.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 38.3 mm -130.14 141.97 44.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 101.237 -3.616 . . . . 0.0 101.237 168.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 53.0 tp -146.91 152.72 39.14 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 126.799 2.04 . . . . 0.0 107.096 -168.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -146.43 109.64 4.72 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 173.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.8 m -150.01 169.79 2.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 122.032 0.92 . . . . 0.0 112.13 -169.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 43.1 t-20 -64.5 130.51 44.0 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.15 1.38 . . . . 0.0 107.966 169.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.3 pp -105.68 0.94 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 124.48 1.112 . . . . 0.0 112.982 -177.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -68.43 -16.37 63.88 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 120.249 1.386 . . . . 0.0 111.064 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.439 HG13 ' H ' ' A' ' 47' ' ' ILE . 3.7 mt -62.39 -34.16 62.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 125.275 1.43 . . . . 0.0 109.337 171.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -91.32 159.11 39.97 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 124.754 1.222 . . . . 0.0 110.868 -169.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.71 179.25 3.25 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.462 2.774 . . . . 0.0 111.537 175.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.4 m -59.75 -16.52 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.84 1.256 . . . . 0.0 113.742 -177.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -67.69 -7.35 26.27 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.752 0.821 . . . . 0.0 112.476 170.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.5 tp 72.36 7.5 5.67 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 128.232 2.613 . . . . 0.0 113.389 174.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -167.23 164.47 37.91 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 108.289 -1.925 . . . . 0.0 108.289 174.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -161.34 168.61 23.61 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.769 1.627 . . . . 0.0 107.132 174.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -64.71 138.25 58.28 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 169.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -140.9 176.31 8.91 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -177.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.7 ttp180 -135.56 142.51 45.36 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -173.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 tt -121.09 140.43 51.97 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 126.149 1.78 . . . . 0.0 107.02 -176.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.0 t -143.05 166.81 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 126.995 2.118 . . . . 0.0 106.051 -178.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 30.0 pt -119.59 13.45 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 123.568 0.747 . . . . 0.0 112.27 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.733 0 C-N-CA 125.081 1.353 . . . . 0.0 113.182 -175.765 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 47.2 p90 . . . . . 0 N--CA 1.451 -0.384 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -122.36 -23.46 5.25 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.105 0.562 . . . . 0.0 110.729 172.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -145.66 149.45 34.49 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.804 1.242 . . . . 0.0 107.701 169.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.2 m -143.4 148.2 19.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 C-N-CA 125.621 1.568 . . . . 0.0 107.365 172.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 23.1 tpp -159.45 168.05 27.21 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.872 0.869 . . . . 0.0 109.207 176.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 84.7 t80 -128.5 150.52 50.13 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.809 1.643 . . . . 0.0 106.806 172.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -152.92 -160.06 9.43 Favored Glycine 0 C--N 1.336 0.569 0 CA-C-N 118.636 0.653 . . . . 0.0 113.672 -171.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -145.69 132.43 20.01 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.995 1.318 . . . . 0.0 108.771 172.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 42.2 t -77.14 145.57 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 168.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -144.87 74.94 1.43 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.057 1.743 . . . . 0.0 108.894 175.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -152.72 157.77 41.35 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.223 -0.923 . . . . 0.0 109.588 176.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 25.2 pt -76.99 -170.27 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 125.804 1.642 . . . . 0.0 111.356 177.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.63 -9.79 1.31 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 127.406 2.282 . . . . 0.0 115.47 -178.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.569 0 N-CA-C 107.525 -2.23 . . . . 0.0 107.525 -174.762 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.467 0.415 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -137.43 139.81 40.89 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 169.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 46.2 tp -75.96 159.5 30.81 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 168.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 16.6 m -134.98 150.65 50.39 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 175.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -142.13 128.79 20.36 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -112.52 129.76 56.24 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 168.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.6 p -146.72 144.91 19.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -169.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.3 t -134.53 144.01 47.75 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -136.9 82.62 1.95 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.282 1.833 . . . . 0.0 107.676 -170.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 58.57 19.67 42.79 Favored Glycine 0 CA--C 1.538 1.494 0 CA-C-O 118.977 -0.902 . . . . 0.0 114.629 174.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 124.32 -26.99 5.66 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.953 1.264 . . . . 0.0 112.723 -177.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 9.9 mp -75.31 150.06 38.59 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 169.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 7.0 tt -145.52 157.28 44.02 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.493 1.042 . . . . 0.0 110.689 -175.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 56.6 mtt -147.61 159.08 44.17 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.016 1.326 . . . . 0.0 108.861 170.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 85.4 mtp180 -141.25 130.22 23.2 Favored 'General case' 0 C--N 1.334 -0.1 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 169.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -152.59 160.09 43.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 119.059 0.845 . . . . 0.0 111.079 -170.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -137.17 149.65 47.4 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 124.315 1.046 . . . . 0.0 108.575 169.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -178.08 168.44 39.76 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -177.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -57.93 132.79 54.48 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -178.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -43.81 -73.7 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 -168.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -67.11 -26.18 66.58 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 122.404 1.097 . . . . 0.0 111.93 -172.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.95 -31.36 72.56 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 128.164 2.586 . . . . 0.0 111.203 175.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 5.4 tt -76.38 -13.47 60.13 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.28 1.032 . . . . 0.0 111.307 -176.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 32.3 t-80 52.81 40.51 30.75 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.721 1.208 . . . . 0.0 111.937 177.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -123.86 33.04 4.03 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 125.247 1.403 . . . . 0.0 110.642 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -76.48 -3.95 40.01 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.07 0.948 . . . . 0.0 113.34 -175.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -129.43 143.02 50.67 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 127.534 2.334 . . . . 0.0 106.142 169.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 8.2 p -59.21 -11.85 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.994 169.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -124.06 21.72 8.88 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 126.001 1.72 . . . . 0.0 113.492 176.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 57.9 m -72.83 -78.36 0.09 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.962 0.887 . . . . 0.0 109.779 168.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -82.58 12.62 4.41 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -169.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 33.9 m -67.27 -28.42 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-O 118.816 -0.612 . . . . 0.0 110.016 170.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -77.86 107.6 10.5 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 177.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 45.3 tp -112.66 131.38 55.67 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.459 1.104 . . . . 0.0 108.283 -176.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.5 tt -138.33 135.85 35.82 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 104.418 -2.438 . . . . 0.0 104.418 169.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -142.14 152.72 43.49 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 118.817 0.735 . . . . 0.0 111.484 176.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 39.6 pttt -165.01 172.97 12.05 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 126.224 1.81 . . . . 0.0 109.171 -174.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -55.1 156.69 3.82 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.422 0.689 . . . . 0.0 111.732 171.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.41 169.04 9.65 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.399 169.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -134.79 122.92 22.78 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 173.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 9.9 t80 . . . . . 0 C--O 1.246 0.902 0 C-N-CA 124.484 1.113 . . . . 0.0 108.276 176.66 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.2 tm? . . . . . 0 CA--C 1.532 0.273 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -151.47 158.16 43.28 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.902 1.281 . . . . 0.0 108.668 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -145.81 140.96 27.48 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.798 1.639 . . . . 0.0 108.371 -176.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -152.67 146.49 25.19 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.346 1.459 . . . . 0.0 110.54 -170.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.6 mp -112.59 137.74 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 105.847 -1.908 . . . . 0.0 105.847 171.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -145.64 161.89 38.78 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.758 1.223 . . . . 0.0 110.489 -174.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -140.86 144.79 35.51 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.598 0.759 . . . . 0.0 110.049 -174.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 39.0 t -70.08 122.56 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 125.078 1.351 . . . . 0.0 107.834 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -96.03 -32.0 12.77 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 124.508 1.123 . . . . 0.0 110.126 176.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -157.14 167.66 29.74 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.284 0.947 . . . . 0.0 110.718 175.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.7 mp -133.05 140.88 46.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 127.138 2.175 . . . . 0.0 106.296 -175.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -143.78 89.82 7.21 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 124.069 0.947 . . . . 0.0 110.011 -171.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -65.09 9.4 0.17 Allowed 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 124.121 3.214 . . . . 0.0 116.774 -178.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -78.82 55.88 1.8 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.079 1.351 . . . . 0.0 109.914 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -170.08 35.66 0.18 Allowed Glycine 0 CA--C 1.527 0.803 0 C-N-CA 124.89 1.233 . . . . 0.0 111.454 -172.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.404 ' HE2' ' HA ' ' A' ' 20' ' ' LYS . 11.2 mmpt? -65.97 64.58 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.61 1.564 . . . . 0.0 113.392 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -60.49 -38.4 84.16 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 168.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -144.37 165.5 27.75 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 129.468 3.107 . . . . 0.0 104.218 169.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.29 -40.86 83.05 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.28 -0.887 . . . . 0.0 110.737 175.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 49.0 ptt85 -70.4 7.72 0.98 Allowed 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 126.508 1.923 . . . . 0.0 114.806 175.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 77.7 t -120.48 132.09 70.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 121.497 1.953 . . . . 0.0 107.487 178.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 37.0 m -149.06 163.65 36.92 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.93 0.892 . . . . 0.0 109.789 176.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.1 ttm105 -85.45 154.28 21.92 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 169.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.0 mt -143.16 156.75 44.85 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 127.114 2.166 . . . . 0.0 107.199 -177.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -131.56 131.65 43.51 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 105.335 -2.098 . . . . 0.0 105.335 174.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 55.1 m -143.77 164.71 29.72 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.771 1.228 . . . . 0.0 110.201 -170.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -140.79 140.06 34.68 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 38.2 p -70.45 136.29 49.39 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 173.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -75.75 -35.68 60.11 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 168.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.6 m -69.56 -38.19 77.31 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -170.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -135.11 -102.26 0.22 Allowed 'General case' 0 C--N 1.345 0.38 0 CA-C-N 119.818 1.19 . . . . 0.0 110.34 -171.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -166.51 19.02 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.332 1.453 . . . . 0.0 112.559 -169.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 85.4 mtp -62.94 122.68 16.61 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.995 0.918 . . . . 0.0 108.68 176.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -98.08 112.45 24.4 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 169.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 49.0 tp -122.62 138.41 54.6 Favored 'General case' 0 N--CA 1.461 0.089 0 C-N-CA 123.455 0.702 . . . . 0.0 110.528 -169.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 33.1 mm -124.71 146.34 30.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 103.634 -2.728 . . . . 0.0 103.634 169.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 123' ' ' MET . 2.3 pt? -154.17 154.85 34.25 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.723 1.209 . . . . 0.0 109.547 176.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -121.59 120.68 35.52 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 102.992 -2.966 . . . . 0.0 102.992 170.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.2 p -151.09 163.18 2.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 121.707 0.765 . . . . 0.0 110.876 -168.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -69.02 90.23 0.44 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.907 1.683 . . . . 0.0 109.208 169.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.0 pp -65.84 -7.26 4.73 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -170.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -64.14 -18.61 64.6 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 120.161 1.346 . . . . 0.0 111.115 173.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.422 HD13 HG21 ' A' ' 47' ' ' ILE . 6.3 tt -55.34 -41.95 64.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.728 1.211 . . . . 0.0 110.629 169.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -88.02 139.37 30.74 Favored Pre-proline 0 CA--C 1.538 0.508 0 C-N-CA 125.88 1.672 . . . . 0.0 109.636 -173.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.45 132.74 30.11 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.272 1.981 . . . . 0.0 111.101 -177.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.8 t 50.34 31.06 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 126.567 1.947 . . . . 0.0 112.588 171.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.1 t70 62.42 -35.54 0.12 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 128.168 2.587 . . . . 0.0 115.203 -175.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 60.1 tp -59.36 -34.19 72.09 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.369 1.468 . . . . 0.0 111.405 177.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.37 -178.83 52.71 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-O 121.904 0.725 . . . . 0.0 112.262 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -157.96 174.16 15.67 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 126.662 1.985 . . . . 0.0 106.983 -174.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -58.92 134.22 56.74 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 173.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -128.91 168.66 15.65 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 125.908 1.683 . . . . 0.0 107.626 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -132.38 147.69 52.39 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.6 tt -137.88 144.0 41.16 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 -169.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.5 m -135.31 154.43 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 169.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 35.2 pt -121.15 147.84 24.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 104.287 -2.486 . . . . 0.0 104.287 168.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.442 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.198 -168.26 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 40.7 p90 . . . . . 0 N--CA 1.451 -0.393 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -123.58 -23.06 4.84 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.446 1.498 . . . . 0.0 109.476 169.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -142.81 155.03 44.74 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.378 1.471 . . . . 0.0 108.214 172.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.0 t -141.78 144.62 25.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 124.89 1.276 . . . . 0.0 107.83 -169.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 16.3 mtm -147.8 152.35 37.54 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.551 1.541 . . . . 0.0 110.308 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -138.46 144.49 40.12 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 127.587 2.355 . . . . 0.0 105.158 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.44 -151.3 6.73 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-N 120.641 1.564 . . . . 0.0 115.396 -169.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -144.71 133.39 22.25 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 126.098 1.759 . . . . 0.0 107.186 172.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.9 p -101.54 133.85 43.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 169.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -142.09 88.52 2.11 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.528 1.131 . . . . 0.0 108.874 -170.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -156.98 162.98 39.6 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.654 -1.279 . . . . 0.0 110.713 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.27 178.07 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 124.327 1.051 . . . . 0.0 110.543 178.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -64.42 4.85 0.33 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.9 2.08 . . . . 0.0 114.467 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.356 0 C-N-CA 125.49 1.519 . . . . 0.0 109.5 175.566 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.8 p . . . . . 0 C--O 1.235 0.308 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? -115.09 141.64 47.73 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.019 0.927 . . . . 0.0 108.95 176.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.0 tp -88.78 154.97 19.85 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 167.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 10.8 m -130.57 149.76 52.09 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 -174.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -144.12 143.76 31.27 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -127.05 125.8 41.98 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 101.052 -3.684 . . . . 0.0 101.052 169.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.2 t -135.13 130.1 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -170.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 50.1 m -115.99 136.02 53.43 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 176.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -136.35 158.99 43.11 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.427 1.091 . . . . 0.0 109.961 -169.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -71.87 65.88 1.15 Allowed Glycine 0 CA--C 1.531 1.056 0 N-CA-C 108.204 -1.958 . . . . 0.0 108.204 168.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 171.16 -17.22 0.06 OUTLIER Glycine 0 CA--C 1.534 1.268 0 CA-C-O 117.194 -1.892 . . . . 0.0 112.194 -169.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . 0.435 43.4 mt 133.17 -136.14 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 130.514 3.526 . . . . 0.0 111.453 168.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 5.2 tt -139.48 157.74 45.33 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 121.661 2.028 . . . . 0.0 113.516 -168.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.467 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 35.7 mtt -145.25 157.89 43.96 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.135 1.774 . . . . 0.0 109.961 177.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 62.9 mtt180 -136.11 137.73 41.34 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 104.651 -2.351 . . . . 0.0 104.651 169.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 27.6 tp -148.71 146.38 28.08 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 119.054 0.843 . . . . 0.0 110.463 -168.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -137.3 153.05 50.37 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.661 1.184 . . . . 0.0 108.314 168.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 176.17 -177.1 47.81 Favored Glycine 0 CA--C 1.519 0.336 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 170.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -53.1 139.86 27.27 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 118.291 1.046 . . . . 0.0 109.681 175.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -53.04 -56.25 17.57 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 123.593 0.558 . . . . 0.0 112.167 -174.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -54.81 -40.55 69.64 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-O 121.437 0.637 . . . . 0.0 111.471 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.5 -30.98 71.82 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 127.193 2.197 . . . . 0.0 110.39 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.37 -25.28 65.9 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 118.475 -0.774 . . . . 0.0 109.447 -178.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 72.2 m80 40.94 44.46 1.98 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.48 1.512 . . . . 0.0 111.76 -177.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -137.22 64.01 0.57 Allowed Glycine 0 C--N 1.338 0.648 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 -169.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -103.37 12.88 34.82 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.729 0.812 . . . . 0.0 112.055 -173.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.452 ' C ' ' H ' ' A' ' 138' ' ' ASP . 7.4 tp10 -140.61 146.3 37.79 Favored 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 126.122 1.769 . . . . 0.0 108.002 173.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.5 m -56.51 -9.06 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 124.512 1.125 . . . . 0.0 111.346 169.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.452 ' H ' ' C ' ' A' ' 136' ' ' GLU . 31.9 t70 -134.35 15.03 3.78 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 127.548 2.339 . . . . 0.0 112.245 -172.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 68.6 m -73.37 -81.8 0.06 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 122.309 1.052 . . . . 0.0 109.642 168.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -80.0 14.34 1.87 Allowed 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -169.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 20.1 m -68.18 -29.73 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 169.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -82.56 106.18 14.21 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 175.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 24.7 tp -129.79 137.18 50.36 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 124.617 1.167 . . . . 0.0 108.133 -173.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.9 mp -139.63 151.43 45.97 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 172.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 60.4 mtm -138.85 154.18 48.4 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.616 0.767 . . . . 0.0 109.581 -176.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 34.0 pttt -165.0 175.18 9.71 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.205 1.402 . . . . 0.0 110.964 -169.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 23.0 ptmt -63.31 157.17 23.57 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 122.406 0.283 . . . . 0.0 110.239 169.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.33 154.6 31.26 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.691 0.758 . . . . 0.0 111.512 172.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -135.86 112.72 10.24 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 169.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 . . . . . 0 C--O 1.247 0.939 0 CA-C-O 118.546 -0.74 . . . . 0.0 109.962 -177.247 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 44.3 tp . . . . . 0 C--O 1.232 0.137 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -161.04 166.65 27.83 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.485 1.114 . . . . 0.0 109.559 173.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -140.63 132.89 28.2 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.925 2.09 . . . . 0.0 106.313 176.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -149.86 153.75 37.24 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 171.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.0 mp -75.52 146.0 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 173.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -129.65 153.9 47.66 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.478 1.511 . . . . 0.0 107.389 170.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -131.74 129.59 40.82 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.664 1.586 . . . . 0.0 108.278 -174.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 51.8 t -72.51 118.03 16.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 124.448 1.099 . . . . 0.0 108.197 -177.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.2 mmpt? -78.25 -43.33 28.51 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 124.489 1.116 . . . . 0.0 109.59 169.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -159.11 170.65 21.54 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 118.824 0.738 . . . . 0.0 111.038 -175.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.2 mp -138.6 142.56 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 127.104 2.162 . . . . 0.0 106.825 -173.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -147.39 93.99 4.56 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 124.195 0.998 . . . . 0.0 111.205 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -73.14 90.84 0.85 Allowed 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 123.306 2.671 . . . . 0.0 107.765 168.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -57.87 -33.56 68.83 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -169.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 155.81 42.5 0.02 OUTLIER Glycine 0 CA--C 1.527 0.79 0 N-CA-C 106.248 -2.741 . . . . 0.0 106.248 -169.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 22.1 mmtt -72.42 95.96 1.84 Allowed 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.443 1.497 . . . . 0.0 109.66 -168.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -47.7 -43.31 26.56 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.232 1.013 . . . . 0.0 112.025 175.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.5 m-30 -81.08 -18.58 46.11 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 122.741 0.416 . . . . 0.0 112.071 -174.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.7 t70 62.75 -36.13 0.13 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 130.064 3.345 . . . . 0.0 115.688 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -72.64 11.0 0.71 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.316 1.446 . . . . 0.0 113.124 170.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 53.7 t -126.53 140.46 48.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 104.029 -2.582 . . . . 0.0 104.029 174.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 55.7 m -156.21 160.82 40.17 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 119.637 1.108 . . . . 0.0 110.417 174.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.461 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 15.1 ttm180 -83.81 150.38 25.8 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 170.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 66.0 mt -137.76 155.17 49.34 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.744 2.018 . . . . 0.0 106.141 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -121.58 127.35 50.82 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 102.804 -3.036 . . . . 0.0 102.804 169.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 74.5 m -141.27 162.63 35.01 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.182 0.993 . . . . 0.0 110.864 -169.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -138.75 134.2 33.2 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.556 1.542 . . . . 0.0 107.607 -176.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.5 p -67.18 148.3 51.97 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.014 0.926 . . . . 0.0 110.697 173.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -77.78 -30.41 51.34 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 118.756 -0.64 . . . . 0.0 111.013 172.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -132.49 -31.45 1.39 Allowed 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 115.234 1.568 . . . . 0.0 115.234 -169.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 23.3 m-30 -108.35 30.9 6.01 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -168.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 49.5 pttt 40.11 53.73 2.75 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.564 1.546 . . . . 0.0 114.282 169.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 47.6 mtt -114.52 110.82 20.42 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.388 1.875 . . . . 0.0 107.972 177.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -82.74 125.06 30.83 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 169.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 51.9 tp -132.85 142.09 48.77 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 118.733 0.697 . . . . 0.0 112.305 -168.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 40.8 mm -120.03 136.98 55.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 101.635 -3.468 . . . . 0.0 101.635 169.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 22.3 tp -152.7 105.21 2.95 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.062 0.945 . . . . 0.0 109.316 -168.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.461 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 16.1 t70 -100.87 105.54 16.82 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 126.212 1.805 . . . . 0.0 107.246 173.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.7 m -150.51 172.03 1.34 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-O 121.662 0.744 . . . . 0.0 110.515 -169.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -59.9 128.14 35.41 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.175 1.39 . . . . 0.0 109.264 169.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.1 pp -114.67 0.88 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 124.597 1.159 . . . . 0.0 113.812 -174.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.68 -4.92 25.97 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 120.42 1.463 . . . . 0.0 111.255 177.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.8 mt -62.83 -38.79 82.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 168.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -78.21 148.15 74.03 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 123.505 0.722 . . . . 0.0 110.138 -171.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.93 -25.33 19.92 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 122.592 2.195 . . . . 0.0 112.669 -177.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.8 m -145.42 160.82 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 125.611 1.564 . . . . 0.0 108.352 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -60.25 -27.82 67.53 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.313 1.045 . . . . 0.0 112.463 178.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 42.7 tp -62.65 -15.17 50.71 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.761 1.224 . . . . 0.0 112.456 174.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.1 -176.46 51.48 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -172.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -155.71 166.1 34.53 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.436 1.494 . . . . 0.0 107.344 177.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -66.95 131.69 46.39 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 173.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -139.69 146.16 39.28 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -172.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 61.5 mtm180 -79.67 134.08 36.41 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 170.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -106.04 134.44 49.17 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 104.355 -2.461 . . . . 0.0 104.355 169.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 80.1 t -134.29 138.65 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 -176.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.1 mm -106.78 135.18 46.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 104.832 -2.285 . . . . 0.0 104.832 169.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.515 0 C-N-CA 124.708 1.203 . . . . 0.0 110.127 -169.469 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.7 p90 . . . . . 0 C--O 1.236 0.357 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -116.15 -23.31 8.51 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.669 0.787 . . . . 0.0 110.353 175.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -149.86 150.32 31.77 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.247 1.019 . . . . 0.0 109.218 171.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.4 p -148.42 142.99 19.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 174.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 10.3 tpt -159.94 166.93 29.15 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.938 0.895 . . . . 0.0 109.596 176.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -121.06 146.8 46.34 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.107 1.363 . . . . 0.0 108.138 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -141.65 -160.43 8.32 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-N 118.637 0.653 . . . . 0.0 112.328 -175.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -142.02 128.84 20.54 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.862 1.265 . . . . 0.0 107.824 169.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 39.3 t -79.68 144.03 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 171.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -143.46 75.47 1.48 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.931 1.293 . . . . 0.0 109.529 177.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -157.09 163.58 38.82 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 120.764 -1.21 . . . . 0.0 110.954 170.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.53 -172.49 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 125.691 1.596 . . . . 0.0 110.935 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.22 -13.93 3.67 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.91 2.084 . . . . 0.0 115.437 -178.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.441 ' HA2' ' H ' ' A' ' 113' ' ' SER . . . . . . . . 0 C--N 1.334 0.435 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.4 p . . . . . 0 CA--C 1.533 0.3 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? 60.32 131.98 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 127.804 2.442 . . . . 0.0 111.611 -168.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 9.1 tt -79.55 135.87 36.73 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 103.15 -2.907 . . . . 0.0 103.15 167.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.441 ' H ' ' HA2' ' A' ' 101' ' ' GLY . 41.8 m -109.47 136.77 48.34 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 105.477 -2.046 . . . . 0.0 105.477 173.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -128.22 152.02 48.57 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.121 1.369 . . . . 0.0 108.091 -174.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -132.56 137.71 47.21 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 102.834 -3.025 . . . . 0.0 102.834 169.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.8 t -132.38 147.13 32.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 177.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.0 m -127.31 157.68 39.23 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 102.513 -3.143 . . . . 0.0 102.513 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . 0.333 98.4 m-85 58.76 -148.79 0.47 Allowed 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -167.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 61.15 13.57 35.74 Favored Glycine 0 CA--C 1.535 1.325 0 CA-C-N 120.186 1.357 . . . . 0.0 113.17 -176.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 138.21 -50.31 0.81 Allowed Glycine 0 CA--C 1.528 0.848 0 C-N-CA 126.066 1.793 . . . . 0.0 109.601 -171.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.65 -68.63 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.458 1.503 . . . . 0.0 109.0 169.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 11.3 tp -157.79 148.21 20.71 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 124.561 1.144 . . . . 0.0 109.065 -178.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.58 156.34 41.77 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 170.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 70.2 ttt-85 -127.61 142.57 51.32 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 169.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 15.3 tp -149.74 148.89 29.77 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -169.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -144.39 143.42 30.93 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 168.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -175.93 178.05 47.49 Favored Glycine 0 CA--C 1.52 0.361 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -52.42 137.24 29.98 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 118.305 1.053 . . . . 0.0 110.622 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -56.91 -55.98 27.53 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -169.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -57.03 -43.95 82.39 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 122.349 1.071 . . . . 0.0 111.403 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 27.0 t30 -60.99 -28.09 68.77 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 126.292 1.837 . . . . 0.0 111.935 177.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.11 -29.38 54.81 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 123.911 0.884 . . . . 0.0 110.145 178.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 49.21 21.56 0.54 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.925 1.69 . . . . 0.0 113.191 -169.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.02 -10.86 84.17 Favored Glycine 0 CA--C 1.528 0.865 0 O-C-N 121.059 -1.026 . . . . 0.0 113.955 -169.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -59.12 -30.64 68.27 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 118.476 1.138 . . . . 0.0 111.693 172.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -87.35 87.82 7.52 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 126.743 2.017 . . . . 0.0 106.212 169.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.5 m -59.59 -7.12 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 124.49 1.116 . . . . 0.0 113.407 176.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -123.4 18.74 9.75 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 126.11 1.764 . . . . 0.0 113.17 176.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.9 m -83.84 -68.93 0.67 Allowed 'General case' 0 C--O 1.232 0.147 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 167.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.292 10.6 ptm85 -78.31 11.67 2.29 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 -169.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 29.7 m -67.58 -34.86 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-O 118.645 -0.693 . . . . 0.0 109.337 168.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -82.82 104.35 12.99 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 10.3 tt -117.2 134.72 54.44 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -170.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -140.51 135.92 32.39 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 -171.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 78.4 mtm -137.85 149.4 46.26 Favored 'General case' 0 C--O 1.237 0.426 0 O-C-N 121.267 -0.896 . . . . 0.0 109.944 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -154.62 172.51 17.75 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.305 1.042 . . . . 0.0 109.761 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -53.51 160.46 1.23 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.298 0.639 . . . . 0.0 111.857 175.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.25 166.3 0.86 Allowed 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.394 0.616 . . . . 0.0 111.981 169.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -87.09 86.59 7.31 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 175.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 19.2 t80 . . . . . 0 C--O 1.248 0.995 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 172.632 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 23.1 tp . . . . . 0 CA--C 1.538 0.509 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -147.33 134.04 19.99 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -148.5 138.4 22.29 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 169.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -151.17 150.62 30.85 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.026 0.83 . . . . 0.0 110.869 172.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.6 mp -75.16 152.65 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 169.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -132.59 146.66 52.07 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.651 1.58 . . . . 0.0 107.788 174.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -123.75 119.74 30.63 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 127.225 2.21 . . . . 0.0 106.641 -175.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.7 t -78.39 123.92 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -177.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.5 mmmt -88.7 -40.0 13.58 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.952 0.901 . . . . 0.0 109.687 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -157.93 170.91 21.27 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 118.386 0.539 . . . . 0.0 112.318 -169.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.1 mp -141.9 147.54 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 127.881 2.472 . . . . 0.0 106.786 -175.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -143.86 110.58 5.2 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 169.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -64.62 7.35 0.25 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.605 2.87 . . . . 0.0 117.454 -177.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 46.14 39.93 6.62 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.731 2.012 . . . . 0.0 112.294 -174.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.29 37.71 41.26 Favored Glycine 0 CA--C 1.531 1.065 0 O-C-N 121.528 -0.732 . . . . 0.0 111.447 -177.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? 45.55 57.64 4.81 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 126.661 1.984 . . . . 0.0 109.642 -169.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -54.63 -36.76 64.86 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.921 0.888 . . . . 0.0 110.645 -178.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -140.17 160.99 38.73 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 169.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -64.64 -25.55 68.01 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -177.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -136.57 16.47 3.13 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 117.639 -1.172 . . . . 0.0 113.579 -173.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.8 t -131.61 129.14 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 121.005 1.73 . . . . 0.0 107.364 -178.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 39.6 m -148.34 159.55 43.89 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 124.387 1.075 . . . . 0.0 110.396 -170.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 -69.01 146.46 52.7 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 169.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.2 mp -127.86 158.09 38.72 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 127.018 2.127 . . . . 0.0 106.521 170.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -136.08 132.01 35.59 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 171.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.3 m -142.85 173.02 11.92 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.318 1.447 . . . . 0.0 110.609 -169.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -140.99 143.66 34.59 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.59 1.956 . . . . 0.0 106.858 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.3 p -88.09 147.68 24.83 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.109 0.868 . . . . 0.0 110.033 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -77.58 -41.79 37.48 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.497 1.119 . . . . 0.0 112.811 -169.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.28 -26.74 9.0 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.831 0.852 . . . . 0.0 112.775 -169.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -121.35 23.78 10.26 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.957 1.303 . . . . 0.0 112.188 -170.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.9 pttt 43.6 27.37 0.15 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 127.097 2.159 . . . . 0.0 116.247 168.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 53.8 mtt -70.53 149.29 47.3 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 119.813 1.188 . . . . 0.0 108.366 175.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -112.29 131.07 55.71 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 173.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 48.7 tp -133.56 141.88 47.9 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.667 0.746 . . . . 0.0 111.154 -169.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 42.6 mm -123.05 142.4 39.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 101.161 -3.644 . . . . 0.0 101.161 168.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 51.3 tp -148.92 154.73 39.84 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 126.221 1.808 . . . . 0.0 106.929 -168.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -137.18 114.14 10.59 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 103.478 -2.786 . . . . 0.0 103.478 169.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.0 p -151.46 167.29 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 O-C-N 124.373 1.046 . . . . 0.0 111.026 -168.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -60.61 137.08 58.22 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.943 1.297 . . . . 0.0 109.413 169.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.6 pp -119.14 8.0 6.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 124.935 1.294 . . . . 0.0 113.417 -177.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -65.41 -19.57 66.0 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 120.367 1.44 . . . . 0.0 110.96 173.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.4 mt -63.65 -33.92 64.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 126.238 1.815 . . . . 0.0 110.291 172.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -65.75 138.73 96.68 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 123.757 0.823 . . . . 0.0 112.916 -167.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -72.91 177.43 7.7 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.418 2.745 . . . . 0.0 110.974 172.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.6 m -70.87 -22.93 23.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 O-C-N 121.766 -0.583 . . . . 0.0 111.62 171.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -69.16 153.19 44.11 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.755 0.822 . . . . 0.0 110.733 177.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 53.9 tp -63.8 -29.68 70.85 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.512 0.725 . . . . 0.0 112.625 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.21 160.51 13.78 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-N 119.091 0.859 . . . . 0.0 111.679 -175.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -157.69 164.81 36.77 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 126.097 1.759 . . . . 0.0 107.433 174.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -138.43 150.87 46.92 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.681 0.792 . . . . 0.0 109.339 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -151.59 -175.32 5.15 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 124.989 1.316 . . . . 0.0 107.598 173.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.7 ttp180 -136.12 147.85 47.97 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 125.233 1.413 . . . . 0.0 107.716 -177.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.1 tp -134.91 151.0 50.5 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.132 0.973 . . . . 0.0 109.755 -169.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 55.7 t -136.46 137.11 48.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 105.472 -2.048 . . . . 0.0 105.472 173.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 pp -137.45 3.5 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 123.808 0.843 . . . . 0.0 113.077 -176.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.295 0 O-C-N 121.446 -0.784 . . . . 0.0 112.462 -170.905 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 30.4 p90 . . . . . 0 CA--C 1.538 0.519 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -97.8 -49.71 4.72 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.212 0.914 . . . . 0.0 110.209 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -157.4 165.97 34.3 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.18 0.9 . . . . 0.0 110.994 172.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.7 p -141.47 142.87 28.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 170.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.8 tpt -152.91 162.06 41.77 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.779 1.232 . . . . 0.0 109.164 -175.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -114.6 116.59 29.01 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 170.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.75 -167.08 32.09 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 -174.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.42 111.04 10.42 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 169.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 87.2 t -72.22 155.97 7.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 174.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -128.39 106.81 9.25 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 104.632 -2.359 . . . . 0.0 104.632 169.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -75.48 138.69 41.76 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -174.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.4 pt -128.31 179.46 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.149 0.98 . . . . 0.0 108.808 169.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -74.18 -1.46 20.52 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.609 1.564 . . . . 0.0 114.607 -173.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.583 0 O-C-N 121.841 -0.537 . . . . 0.0 112.696 -176.92 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.1 p . . . . . 0 CA--C 1.533 0.317 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -124.04 131.94 53.62 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.294 1.838 . . . . 0.0 106.562 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 34.9 tp -70.8 153.63 42.57 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 170.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -126.88 161.46 28.21 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.206 1.002 . . . . 0.0 108.838 -172.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -147.97 161.22 41.78 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.752 1.221 . . . . 0.0 108.974 171.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -124.48 147.7 48.18 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 169.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.8 t -144.54 143.16 23.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 29.6 m -120.48 136.4 54.77 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 169.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -146.58 114.99 6.71 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -178.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 57.19 23.33 46.95 Favored Glycine 0 CA--C 1.539 1.588 0 CA-C-O 119.311 -0.716 . . . . 0.0 114.456 174.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.57 -8.42 64.04 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 124.763 1.173 . . . . 0.0 113.633 -178.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -95.26 170.2 9.55 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.777 1.631 . . . . 0.0 108.814 175.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.0 tp -139.19 160.63 39.36 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 118.741 0.7 . . . . 0.0 111.587 -169.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 71.4 mtm -153.97 161.56 41.88 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.56 1.544 . . . . 0.0 110.253 169.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -141.49 133.61 27.77 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 103.825 -2.657 . . . . 0.0 103.825 167.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.8 tt -140.92 151.1 43.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 119.259 0.936 . . . . 0.0 108.866 -171.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -132.93 153.42 51.42 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.644 1.177 . . . . 0.0 109.409 170.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -168.66 169.26 41.59 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 170.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -51.13 136.98 22.88 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.224 1.012 . . . . 0.0 109.005 172.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -42.73 -53.65 4.44 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -172.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -60.83 -41.35 95.62 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 123.174 1.464 . . . . 0.0 111.511 -177.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -71.63 -18.92 62.17 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 127.099 2.16 . . . . 0.0 111.386 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -67.87 -25.2 65.4 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 119.168 0.895 . . . . 0.0 109.184 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 25.2 t-80 53.28 40.42 31.26 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.88 1.272 . . . . 0.0 111.064 171.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -165.92 50.65 0.27 Allowed Glycine 0 C--N 1.338 0.655 0 O-C-N 121.366 -0.834 . . . . 0.0 112.609 -169.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -74.7 8.35 2.45 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.085 0.954 . . . . 0.0 112.18 171.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -135.17 130.24 35.05 Favored 'General case' 0 CA--C 1.508 -0.649 0 C-N-CA 126.005 1.722 . . . . 0.0 106.909 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.9 p -59.01 -4.68 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 126.14 1.776 . . . . 0.0 111.348 170.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -131.93 15.2 4.76 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.288 1.435 . . . . 0.0 113.075 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 6.8 m -87.14 -66.52 0.9 Allowed 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 167.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.32 0.0 OUTLIER -81.41 14.92 2.23 Favored 'General case' 0 C--N 1.345 0.38 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -169.521 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 16.3 m -64.23 -32.28 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 167.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -65.23 127.41 31.6 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 175.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 63.4 tp -143.07 130.95 21.57 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -177.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.3 tt -139.93 144.47 37.12 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 172.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 57.4 ttm -131.36 144.71 51.43 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 174.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 50.4 pttt -153.55 174.36 14.53 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.18 1.392 . . . . 0.0 109.524 178.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -64.26 157.95 24.57 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 122.533 0.333 . . . . 0.0 111.012 172.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.88 166.55 15.35 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.767 0.427 . . . . 0.0 110.961 169.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -141.61 134.29 28.55 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 172.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 . . . . . 0 C--O 1.25 1.094 0 C-N-CA 127.009 2.124 . . . . 0.0 110.937 -177.586 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 56.1 tp . . . . . 0 C--O 1.233 0.211 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -147.84 151.04 35.27 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 126.527 1.931 . . . . 0.0 106.744 169.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -149.54 138.09 20.86 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.239 1.415 . . . . 0.0 107.581 -175.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -153.79 140.91 19.41 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.823 1.249 . . . . 0.0 109.251 -178.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.4 mp -107.46 139.16 30.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -134.99 158.07 45.3 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.438 1.095 . . . . 0.0 110.363 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -125.21 135.13 52.27 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 126.055 1.742 . . . . 0.0 107.514 -177.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.5 p -69.01 146.51 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 122.203 1.002 . . . . 0.0 109.358 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -125.11 -28.78 3.38 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 126.837 2.055 . . . . 0.0 109.116 -176.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -157.61 164.29 37.4 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 118.946 0.794 . . . . 0.0 110.913 170.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.8 mp -141.64 138.03 31.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 127.423 2.289 . . . . 0.0 106.032 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -146.61 97.8 4.26 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 125.351 1.46 . . . . 0.0 108.773 -176.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -60.67 26.1 0.04 OUTLIER 'Trans proline' 0 CA--C 1.543 0.952 1 C-N-CA 125.831 4.354 . . . . 0.0 118.554 -175.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -63.2 -9.05 9.61 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.214 -1.554 . . . . 0.0 113.628 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.72 10.63 12.48 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.442 1.496 . . . . 0.0 112.695 172.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.8 tppt? -44.15 -12.89 0.01 OUTLIER 'General case' 0 C--N 1.345 0.373 0 C-N-CA 129.536 3.134 . . . . 0.0 116.749 -176.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.2 tppt? -55.38 -31.35 61.73 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.224 0.92 . . . . 0.0 110.054 169.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -136.84 110.17 7.88 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 104.125 -2.546 . . . . 0.0 104.125 169.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -56.99 -28.3 62.27 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -169.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.2 ptt180 -72.02 4.7 3.22 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 117.453 -1.26 . . . . 0.0 113.759 174.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.0 t -120.85 134.95 62.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 121.363 1.892 . . . . 0.0 107.311 -178.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.8 m -145.78 151.73 38.41 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.694 0.797 . . . . 0.0 110.145 -177.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.5 ttp180 -73.25 143.12 47.2 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 168.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -136.46 155.61 49.76 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 125.547 1.539 . . . . 0.0 107.289 -174.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -131.92 135.06 46.34 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 105.218 -2.141 . . . . 0.0 105.218 169.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 65.7 m -141.18 167.02 23.17 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.536 1.534 . . . . 0.0 109.305 -176.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -135.94 130.47 33.77 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 178.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.3 m -76.62 131.01 38.64 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.218 0.607 . . . . 0.0 110.16 178.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -80.21 -36.5 34.76 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.91 0.884 . . . . 0.0 110.844 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.07 -29.5 69.3 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.506 0.722 . . . . 0.0 112.918 -169.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -132.92 -99.1 0.28 Allowed 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -167.08 13.82 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.449 1.1 . . . . 0.0 112.959 -172.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 72.2 mtm -71.18 141.14 50.69 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.174 0.512 . . . . 0.0 111.234 -169.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -88.73 135.97 33.24 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 169.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 64.1 tp -136.96 141.5 42.61 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 119.212 0.914 . . . . 0.0 109.426 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 36.3 mm -128.85 147.76 33.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 104.057 -2.571 . . . . 0.0 104.057 169.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 123' ' ' MET . 2.5 mp -144.17 166.28 25.48 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 125.639 1.575 . . . . 0.0 108.995 177.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -136.84 96.21 3.27 Favored 'General case' 0 C--N 1.324 -0.539 1 N-CA-C 99.038 -4.43 . . . . 0.0 99.038 167.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.7 p -139.45 161.18 27.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-O 121.353 0.596 . . . . 0.0 112.013 -167.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 62.5 t-20 -62.46 128.12 34.54 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.854 1.262 . . . . 0.0 109.273 170.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.5 pp -105.54 0.71 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 124.998 1.319 . . . . 0.0 112.93 -178.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -68.27 -17.51 64.31 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 120.347 1.431 . . . . 0.0 110.977 -177.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.4 mt -67.05 -34.97 73.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 124.501 1.12 . . . . 0.0 109.1 174.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -69.02 149.73 97.73 Favored Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -77.76 30.75 0.43 Allowed 'Trans proline' 0 CA--C 1.546 1.109 0 C-N-CA 124.445 3.43 . . . . 0.0 113.384 -172.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . 0.268 29.9 m 42.9 51.2 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 126.7 2.0 . . . . 0.0 111.937 -176.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -139.4 172.87 12.19 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.137 1.775 . . . . 0.0 108.343 -177.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 53.1 tp -52.14 -33.7 41.3 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.534 1.533 . . . . 0.0 113.417 -171.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -174.92 170.54 43.67 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 118.554 0.615 . . . . 0.0 111.611 172.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -158.84 172.34 18.4 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 126.431 1.892 . . . . 0.0 107.41 174.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -112.5 148.95 33.36 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.316 1.046 . . . . 0.0 109.916 -178.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -141.48 173.62 11.32 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.76 1.224 . . . . 0.0 108.367 -178.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -130.24 129.24 43.08 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 124.669 1.188 . . . . 0.0 107.911 -170.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.9 tp -91.53 141.12 29.07 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 169.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 55.1 t -134.7 146.72 30.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 172.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.4 mt -135.05 127.74 48.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 104.391 -2.448 . . . . 0.0 104.391 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.379 0 N-CA-C 105.083 -2.191 . . . . 0.0 105.083 175.161 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -75.39 -19.62 59.44 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.945 0.498 . . . . 0.0 111.889 -169.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -140.92 143.39 34.57 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.167 0.987 . . . . 0.0 108.968 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.7 p -145.5 140.77 22.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 174.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 40.7 tpp -154.96 163.02 40.9 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.591 1.156 . . . . 0.0 108.779 -177.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -121.63 152.28 39.49 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 175.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -152.24 -143.0 3.6 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.119 -169.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -151.52 142.91 23.45 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 127.69 2.396 . . . . 0.0 105.001 169.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.3 p -116.05 140.48 37.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 172.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -132.96 54.69 1.94 Allowed 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.04 163.34 22.58 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.074 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 15.8 pt -103.17 175.25 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 123.238 0.615 . . . . 0.0 110.161 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -72.77 -5.26 36.73 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.017 1.327 . . . . 0.0 113.253 178.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.758 0 C-N-CA 124.417 1.008 . . . . 0.0 112.585 -179.196 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.47 0.572 0 CA-C-O 121.295 0.569 . . . . 0.0 111.428 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -132.49 144.04 50.18 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 169.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 45.1 tp -80.35 143.62 33.4 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 168.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 13.4 m -135.75 143.4 45.27 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -169.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -138.89 156.27 47.42 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.881 0.873 . . . . 0.0 111.182 -169.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -133.74 139.42 46.35 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 171.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.3 t -137.8 144.05 32.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -177.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 65.6 m -126.31 121.75 33.5 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 174.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -145.47 116.11 7.67 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 119.396 0.998 . . . . 0.0 109.354 -170.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 56.92 21.3 36.98 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-O 119.377 -0.679 . . . . 0.0 114.513 -178.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 91.06 -8.49 79.62 Favored Glycine 0 CA--C 1.535 1.335 0 CA-C-N 118.553 1.176 . . . . 0.0 113.296 -175.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -85.91 168.12 14.49 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 118.719 1.26 . . . . 0.0 107.992 169.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.8 tp -139.59 157.75 45.28 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.457 0.703 . . . . 0.0 110.09 -173.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.418 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 14.6 ptp -155.64 159.26 39.45 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.141 0.976 . . . . 0.0 109.578 168.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.426 HH11 ' HG2' ' A' ' 124' ' ' ARG . 29.7 ttp85 -135.63 141.05 45.0 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 169.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 5.8 tt -143.38 154.5 43.78 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 118.801 0.728 . . . . 0.0 109.829 -176.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -135.13 148.48 49.77 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 169.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -169.2 166.41 39.67 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 170.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -70.9 103.57 2.68 Favored 'General case' 0 N--CA 1.462 0.126 0 O-C-N 121.728 -0.866 . . . . 0.0 109.825 179.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . 10.7 -67.57 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 130.987 3.715 . . . . 0.0 117.786 -171.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -61.47 -13.5 21.27 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 120.76 1.618 . . . . 0.0 114.077 178.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -62.8 -43.77 97.93 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 126.608 1.963 . . . . 0.0 109.781 171.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.47 -38.3 77.3 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.737 1.215 . . . . 0.0 109.977 -176.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 42.79 35.72 0.75 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.431 2.693 . . . . 0.0 113.599 175.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 173.86 58.82 0.05 OUTLIER Glycine 0 C--N 1.333 0.412 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -170.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -95.38 -0.65 52.38 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.761 0.824 . . . . 0.0 112.469 -170.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.436 ' C ' ' H ' ' A' ' 138' ' ' ASP . 7.0 tp10 -72.22 146.09 47.55 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 170.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 1.8 p -62.15 0.48 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 124.734 1.214 . . . . 0.0 110.988 169.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.477 ' HA ' HG21 ' A' ' 141' ' ' VAL . 36.8 t70 -137.97 9.51 2.8 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.471 1.909 . . . . 0.0 113.28 179.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 58.5 m -68.4 -73.1 0.15 Allowed 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.46 -0.775 . . . . 0.0 111.081 169.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.341 10.3 ptm180 -89.03 25.96 1.69 Allowed 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 122.364 1.078 . . . . 0.0 112.755 -169.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.477 HG21 ' HA ' ' A' ' 138' ' ' ASP 0.255 60.9 t -83.01 -4.93 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 C-N-CA 127.446 2.299 . . . . 0.0 107.708 168.644 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -126.45 120.12 28.94 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 102.654 -3.091 . . . . 0.0 102.654 169.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 10.4 tt -141.68 141.76 33.35 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -168.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 mp -138.65 157.33 46.33 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.379 1.072 . . . . 0.0 108.463 -174.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 78.1 mtm -143.03 158.94 43.14 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.887 -0.508 . . . . 0.0 110.795 173.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -152.26 169.47 22.4 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.985 1.714 . . . . 0.0 108.567 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -61.55 168.83 2.64 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.233 -0.917 . . . . 0.0 110.952 169.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.41 168.35 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.966 1.706 . . . . 0.0 114.551 175.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -142.45 21.26 2.04 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.692 1.197 . . . . 0.0 112.597 171.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 . . . . . 0 C--O 1.247 0.963 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -178.561 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 42.0 tp . . . . . 0 CA--C 1.536 0.414 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -154.3 164.64 38.26 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.742 1.217 . . . . 0.0 109.225 174.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -148.69 151.45 34.93 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 126.621 1.969 . . . . 0.0 105.948 172.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -147.1 148.06 31.22 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 123.381 0.672 . . . . 0.0 110.633 176.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.8 mp -115.84 137.17 50.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 104.529 -2.397 . . . . 0.0 104.529 169.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -137.84 168.62 19.32 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.318 0.647 . . . . 0.0 110.933 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -131.17 121.33 24.67 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.964 2.106 . . . . 0.0 107.697 -175.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 96.3 t -63.81 127.51 24.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 176.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.2 mmmt -105.83 -30.52 9.34 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 124.204 1.001 . . . . 0.0 109.87 176.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -156.27 167.33 30.76 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.833 0.742 . . . . 0.0 111.45 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.4 mp -139.53 140.41 37.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 127.758 2.423 . . . . 0.0 105.845 -176.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -146.67 93.19 4.93 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 123.35 0.66 . . . . 0.0 110.025 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.73 149.16 51.3 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.196 2.597 . . . . 0.0 112.234 173.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -82.51 -3.05 55.24 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -176.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.09 52.1 0.39 Allowed Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.981 -1.247 . . . . 0.0 109.981 -174.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? 40.3 42.33 1.2 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.865 2.066 . . . . 0.0 112.434 -169.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -79.02 79.79 5.4 Favored 'General case' 0 C--N 1.338 0.108 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 170.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 65.62 114.88 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 128.733 2.813 . . . . 0.0 108.704 -169.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -56.74 -33.89 66.99 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -169.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 51.6 ptt85 -81.89 0.53 39.31 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-O 116.558 -1.687 . . . . 0.0 113.708 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.5 t -121.77 113.78 40.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 121.686 2.039 . . . . 0.0 107.521 -174.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.408 ' HB2' HG21 ' A' ' 45' ' ' ILE . 41.4 m -147.84 163.21 37.48 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 123.206 0.603 . . . . 0.0 110.565 -172.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.9 ttm-85 -73.52 154.2 39.97 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 172.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.3 mt -135.13 155.01 51.45 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 125.749 1.62 . . . . 0.0 107.315 170.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -131.0 130.11 42.94 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 169.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 30.2 m -140.65 153.71 46.12 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.047 1.339 . . . . 0.0 110.571 -169.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -112.07 124.69 52.96 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 177.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 69.8 m -77.67 140.88 39.64 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 174.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -94.43 -26.73 16.37 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.456 1.102 . . . . 0.0 111.411 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.5 m -62.87 -46.52 87.5 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -169.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -141.68 -95.58 0.13 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.596 0.634 . . . . 0.0 110.413 -172.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 43.5 mtmt -145.29 21.09 1.55 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.7 1.6 . . . . 0.0 110.868 -168.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 56.5 mtm -88.64 159.44 17.85 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.402 0.681 . . . . 0.0 111.62 -169.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -138.98 127.67 23.32 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 127.62 2.368 . . . . 0.0 106.635 -177.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 56.6 tp -129.48 138.68 51.54 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.623 1.101 . . . . 0.0 110.769 -169.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.7 mm -124.41 146.94 29.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 169.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.1 mp -140.88 163.95 31.56 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.995 1.718 . . . . 0.0 108.142 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -138.49 96.29 3.14 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 100.374 -3.936 . . . . 0.0 100.374 168.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.3 p -140.95 171.18 13.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 123.26 0.624 . . . . 0.0 111.389 -167.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -68.17 93.13 0.43 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.194 1.398 . . . . 0.0 109.624 170.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.408 HG21 ' HB2' ' A' ' 26' ' ' SER . 1.6 pp -74.14 -1.33 2.83 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -171.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 60.9 mm-40 -65.75 -13.87 60.21 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 120.357 1.435 . . . . 0.0 111.503 175.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 82.7 mt -58.25 -29.79 38.38 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 C-N-CA 124.314 1.046 . . . . 0.0 108.921 168.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -115.61 145.42 34.48 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 124.663 1.185 . . . . 0.0 113.002 -168.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -78.93 77.65 4.01 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.531 2.82 . . . . 0.0 107.152 169.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.7 m -57.53 -9.93 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -171.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -57.67 -31.42 66.32 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.732 0.813 . . . . 0.0 111.999 169.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -147.03 -7.42 0.48 Allowed 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.811 1.412 . . . . 0.0 114.811 178.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.82 174.88 45.51 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-N 119.349 0.977 . . . . 0.0 111.827 -178.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -155.52 174.27 15.5 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.882 1.273 . . . . 0.0 108.713 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -93.61 153.21 18.52 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.169 0.988 . . . . 0.0 109.772 174.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -148.66 173.6 13.04 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.622 1.169 . . . . 0.0 109.458 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 50.6 ttt180 -131.18 146.23 52.25 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 125.839 1.656 . . . . 0.0 107.569 -175.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.1 tt -141.25 138.17 33.06 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 125.5 1.52 . . . . 0.0 107.474 -171.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.4 t -147.75 154.35 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -173.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 tt -81.71 -52.12 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 168.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.483 0 C-N-CA 128.544 2.738 . . . . 0.0 114.168 -175.33 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 . . . . . 0 N--CA 1.454 -0.248 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -80.52 -30.78 37.22 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 122.022 -0.424 . . . . 0.0 109.965 178.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -153.85 147.69 25.41 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.111 0.964 . . . . 0.0 108.972 171.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.4 p -151.93 142.39 15.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 169.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.7 tpt -158.28 168.43 27.03 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.006 1.323 . . . . 0.0 109.144 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -119.5 146.13 45.71 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 172.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -150.14 -158.33 8.15 Favored Glycine 0 C--N 1.336 0.558 0 CA-C-N 118.775 0.716 . . . . 0.0 112.014 -171.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -125.91 136.22 52.79 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 174.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 47.1 t -98.03 150.09 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 176.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -135.21 157.96 45.57 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 169.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.07 153.47 29.45 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 120.754 -1.216 . . . . 0.0 109.234 172.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.56 -177.85 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 O-C-N 123.671 0.607 . . . . 0.0 109.618 176.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -68.48 -6.57 25.78 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.053 1.341 . . . . 0.0 114.054 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.682 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 -175.194 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.5 p . . . . . 0 C--O 1.233 0.198 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -127.69 132.23 49.69 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 126.707 2.003 . . . . 0.0 105.605 175.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 66.1 tp -65.9 147.05 53.98 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 169.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -115.77 133.01 56.47 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 169.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -122.36 157.23 32.26 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 173.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -126.68 149.32 49.61 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.9 t -134.43 132.62 55.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 18.5 m -124.22 119.58 29.77 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -144.22 117.37 8.94 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.282 1.033 . . . . 0.0 109.192 -169.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 56.79 27.21 55.52 Favored Glycine 0 CA--C 1.535 1.294 0 O-C-N 121.724 -0.61 . . . . 0.0 114.221 176.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 84.13 -3.1 86.82 Favored Glycine 0 CA--C 1.536 1.346 0 CA-C-N 118.25 1.025 . . . . 0.0 113.543 -177.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 78.8 mt -95.7 163.52 13.15 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.1 1.36 . . . . 0.0 107.483 169.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.8 tt -148.88 157.67 43.6 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 121.712 -0.618 . . . . 0.0 111.068 -169.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 24.6 ptp -151.63 162.44 40.98 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.655 1.182 . . . . 0.0 109.311 169.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 43.6 ttt-85 -132.03 127.24 35.78 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 171.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 54.6 tp -127.37 119.38 26.08 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 -178.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -94.38 149.42 21.25 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 168.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -169.09 171.03 42.84 Favored Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 171.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -53.66 133.05 41.74 Favored 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 169.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -43.24 -59.28 2.14 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -172.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -58.43 -43.66 88.84 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 122.288 1.042 . . . . 0.0 111.429 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -61.73 -26.25 67.94 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 113.58 -1.646 . . . . 0.0 111.31 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 32.8 tp -81.23 -22.74 38.54 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 118.765 -0.636 . . . . 0.0 110.668 -176.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 37.6 49.49 1.04 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.292 1.037 . . . . 0.0 111.997 -170.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -118.08 0.42 17.01 Favored Glycine 0 C--N 1.341 0.845 0 CA-C-O 118.536 -1.147 . . . . 0.0 113.425 -173.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -67.06 -32.09 73.04 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.477 1.638 . . . . 0.0 108.211 168.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -65.14 71.19 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.678 1 C-N-CA 131.8 4.04 . . . . 0.0 108.936 169.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.9 m -59.82 -4.21 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 125.351 1.46 . . . . 0.0 113.954 176.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -125.6 18.39 8.08 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 125.711 1.605 . . . . 0.0 112.128 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.2 m -103.03 -59.1 1.76 Allowed 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 168.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.379 9.9 ptm85 -75.44 11.65 1.2 Allowed 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -175.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 16.6 m -62.35 -40.11 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 167.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -81.19 129.49 34.61 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 176.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -141.65 122.82 14.72 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 -169.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.7 tt -137.44 138.32 39.67 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -172.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 90.5 mtp -139.8 142.64 36.66 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 123.769 0.828 . . . . 0.0 109.229 -177.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -155.92 168.43 27.24 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.226 1.411 . . . . 0.0 107.875 -175.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -60.14 159.03 10.21 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.54 -0.725 . . . . 0.0 109.217 169.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.6 pp -68.91 165.22 20.4 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 120.684 0.278 . . . . 0.0 110.788 169.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -130.75 63.17 1.59 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.285 1.034 . . . . 0.0 109.288 -173.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 . . . . . 0 C--O 1.251 1.159 0 C-N-CA 125.947 1.699 . . . . 0.0 107.646 178.295 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 CA--C 1.534 0.363 0 CA-C-O 121.015 0.435 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -161.7 148.87 14.39 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.645 1.978 . . . . 0.0 106.061 169.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -154.16 138.96 17.09 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.382 1.073 . . . . 0.0 109.035 -172.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -151.12 145.07 25.2 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 168.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.7 mp -85.78 145.1 8.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 106.233 -1.765 . . . . 0.0 106.233 178.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -132.97 148.08 52.27 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.634 1.174 . . . . 0.0 108.654 177.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -117.64 130.55 56.44 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.268 1.427 . . . . 0.0 108.349 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 84.0 t -70.08 113.22 5.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -84.48 -35.18 23.14 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.804 1.241 . . . . 0.0 110.157 175.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -155.99 170.18 22.75 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.316 0.962 . . . . 0.0 111.19 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.8 mp -137.76 132.37 44.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 126.873 2.069 . . . . 0.0 105.905 -178.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -129.25 103.63 18.19 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 124.607 1.163 . . . . 0.0 109.08 176.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -104.31 11.69 0.26 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.925 3.084 . . . . 0.0 113.63 175.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -76.33 74.99 3.12 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.828 1.251 . . . . 0.0 111.346 -169.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 144.0 -9.68 2.03 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.812 1.672 . . . . 0.0 111.76 -178.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -71.33 86.17 0.81 Allowed 'General case' 0 C--N 1.339 0.144 0 C-N-CA 125.195 1.398 . . . . 0.0 110.78 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -54.66 -42.9 71.86 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 169.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -78.25 82.13 4.57 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 169.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -56.95 -24.62 54.15 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.881 1.273 . . . . 0.0 114.419 -169.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -73.9 3.82 6.18 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 174.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.7 t -115.15 147.77 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 176.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.7 m -150.25 158.02 43.71 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 120.995 -1.066 . . . . 0.0 110.439 169.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 19.6 ttp180 -85.89 89.41 7.77 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 171.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 82.2 mt -66.03 152.26 45.02 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 169.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -126.32 133.29 51.42 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 104.306 -2.479 . . . . 0.0 104.306 172.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.9 m -144.13 165.75 26.95 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.103 0.865 . . . . 0.0 112.733 -169.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -135.76 138.21 42.42 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.445 1.498 . . . . 0.0 109.543 -176.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 29.5 t -60.11 135.23 57.65 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.005 1.722 . . . . 0.0 110.326 174.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -81.92 -41.99 20.11 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 119.157 -0.449 . . . . 0.0 110.326 171.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.2 m -92.04 -26.82 18.16 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 115.654 1.724 . . . . 0.0 115.654 -168.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -129.89 -107.84 0.28 Allowed 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 120.359 1.436 . . . . 0.0 109.933 -169.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -149.7 0.44 0.48 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.748 1.619 . . . . 0.0 112.931 -169.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 68.3 mtm -67.03 145.78 55.03 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.36 0.6 . . . . 0.0 109.54 -172.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -123.11 138.28 54.7 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 177.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.1 mt -136.31 152.59 50.85 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.729 0.776 . . . . 0.0 112.221 -169.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 31.6 mm -137.32 140.82 41.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 129.248 3.019 . . . . 0.0 102.97 169.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 8.2 mt -148.82 100.59 3.1 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 126.495 1.918 . . . . 0.0 106.575 -169.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -84.55 92.8 8.21 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 169.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.1 m -143.53 167.64 12.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 124.016 0.926 . . . . 0.0 111.995 -169.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -55.58 138.47 46.8 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.289 1.436 . . . . 0.0 110.889 170.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 pp -120.77 1.39 7.06 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 C-N-CA 124.8 1.24 . . . . 0.0 113.374 178.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -67.69 -9.52 44.25 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 121.209 1.822 . . . . 0.0 112.543 -175.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 28.8 mt -61.41 -24.02 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 C-N-CA 125.507 1.523 . . . . 0.0 108.315 169.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -127.22 169.32 12.47 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 127.785 2.434 . . . . 0.0 109.501 -169.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -53.17 156.3 10.47 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.422 2.081 . . . . 0.0 111.982 169.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.4 p -56.49 -21.74 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 125.543 1.537 . . . . 0.0 114.53 -169.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -133.29 29.49 3.98 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.535 1.134 . . . . 0.0 110.594 -173.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 21.6 tp -144.42 168.3 20.43 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.154 0.982 . . . . 0.0 110.18 -173.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -150.57 164.2 29.78 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 107.122 -2.391 . . . . 0.0 107.122 169.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -141.81 166.45 24.7 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.928 0.891 . . . . 0.0 109.66 -172.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -57.73 140.66 50.91 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.223 1.009 . . . . 0.0 110.615 -173.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -148.49 -179.68 7.14 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.595 1.558 . . . . 0.0 108.466 -178.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -129.34 150.26 50.78 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 121.38 -0.825 . . . . 0.0 109.142 173.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 61.4 tp -110.55 141.29 43.92 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.925 1.69 . . . . 0.0 107.026 174.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 55.6 t -141.91 157.76 20.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 128.248 2.619 . . . . 0.0 105.534 -177.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.2 pt -133.14 30.51 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 123.899 0.88 . . . . 0.0 110.772 -175.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.552 0 C-N-CA 124.899 1.279 . . . . 0.0 113.599 -169.958 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 7.8 p90 . . . . . 0 CA--C 1.537 0.465 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -124.66 -37.8 2.45 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.303 0.641 . . . . 0.0 110.619 172.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -152.2 158.53 43.0 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.386 0.994 . . . . 0.0 110.746 174.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.4 m -145.26 146.93 19.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 126.367 1.867 . . . . 0.0 107.877 174.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.31 175.63 10.69 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.835 0.826 . . . . 0.0 112.684 173.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -133.55 154.31 50.95 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 128.092 2.557 . . . . 0.0 106.883 172.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.88 -152.35 6.87 Favored Glycine 0 C--N 1.337 0.6 0 CA-C-N 119.602 1.092 . . . . 0.0 113.342 -171.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 43.9 tttp -141.46 139.03 33.27 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.215 1.406 . . . . 0.0 108.397 173.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 38.9 t -83.54 149.87 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.868 1.267 . . . . 0.0 108.932 169.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -133.31 48.3 2.4 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.196 1.798 . . . . 0.0 109.354 -177.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.5 mmt180 -149.45 163.18 38.5 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.595 1.158 . . . . 0.0 110.044 -177.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 25.5 pt -72.12 171.43 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 124.698 1.199 . . . . 0.0 111.207 174.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -74.42 4.77 5.42 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 127.114 2.166 . . . . 0.0 114.471 -177.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.674 0 C-N-CA 124.458 1.028 . . . . 0.0 113.769 -176.889 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 37.1 p . . . . . 0 C--O 1.236 0.362 0 CA-C-O 121.845 0.831 . . . . 0.0 111.718 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -62.62 138.13 58.42 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 168.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.4 125.32 26.68 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 103.162 -2.903 . . . . 0.0 103.162 167.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 13.6 m -105.1 144.05 32.43 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 173.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -135.49 85.33 2.16 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 125.592 1.557 . . . . 0.0 107.367 -169.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 5.9 m-30 -85.28 126.35 33.64 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 103.03 -2.952 . . . . 0.0 103.03 169.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.1 t -141.23 143.59 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 119.971 1.26 . . . . 0.0 108.306 -171.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.0 t -130.38 139.4 50.64 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 171.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -149.65 106.44 3.55 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.339 1.455 . . . . 0.0 108.525 -169.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 58.45 24.34 55.95 Favored Glycine 0 CA--C 1.535 1.313 0 CA-C-O 119.362 -0.688 . . . . 0.0 114.248 175.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.04 -8.95 65.41 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-N 118.295 1.048 . . . . 0.0 113.47 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 11.2 mp -95.21 158.08 15.62 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 106.924 -1.509 . . . . 0.0 106.924 169.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.3 tt -144.1 154.14 42.89 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.915 -0.491 . . . . 0.0 110.109 -170.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 23.3 ptt? -142.11 161.24 38.5 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 169.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 25.6 ttm180 -138.27 115.27 10.86 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 104.464 -2.421 . . . . 0.0 104.464 171.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 11.2 tp -126.15 149.15 49.18 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 126.389 1.876 . . . . 0.0 107.086 -169.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -140.95 150.97 43.8 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 168.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -173.58 177.03 46.1 Favored Glycine 0 C--N 1.331 0.279 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 169.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -57.04 139.53 51.98 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 118.51 1.155 . . . . 0.0 109.183 172.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -50.86 -55.16 18.34 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -176.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.69 -11.4 60.61 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 121.467 -0.771 . . . . 0.0 112.507 -177.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -81.4 -29.12 34.05 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.603 1.161 . . . . 0.0 110.366 172.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.9 mp -80.36 -29.52 37.9 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 169.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 2.1 t60 59.92 25.35 14.49 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.278 1.831 . . . . 0.0 114.44 171.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -168.84 95.06 0.11 Allowed Glycine 0 C--N 1.335 0.49 0 N-CA-C 107.142 -2.383 . . . . 0.0 107.142 177.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -96.0 9.94 39.08 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.388 1.075 . . . . 0.0 113.544 -175.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -74.75 146.56 42.07 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.593 0.711 . . . . 0.0 109.142 173.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.6 m -64.53 -5.19 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.273 168.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -122.09 17.34 10.81 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 127.368 2.267 . . . . 0.0 111.787 176.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 57.5 m -88.2 -57.16 3.03 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 121.272 -0.892 . . . . 0.0 109.096 167.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 4.9 mmm180 -74.58 -5.24 41.75 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -169.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 30.2 m -62.09 -40.9 89.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.408 177.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -74.68 117.4 16.47 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.2 tt -132.56 135.72 46.12 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 -174.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 10.2 tt -143.19 142.03 31.31 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 173.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 80.5 mtp -135.82 152.24 50.88 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 174.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 51.7 mttt -144.09 176.43 9.31 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.108 0.963 . . . . 0.0 109.315 177.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -57.3 165.98 1.3 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.212 0.605 . . . . 0.0 109.47 168.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.57 166.58 0.88 Allowed 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.662 -0.649 . . . . 0.0 111.831 169.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.8 77.72 4.81 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.672 0.789 . . . . 0.0 109.084 176.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 15.5 t80 . . . . . 0 C--O 1.25 1.123 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 175.527 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.53 0.211 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -151.98 140.81 20.98 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.293 0.637 . . . . 0.0 110.909 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -158.11 138.27 12.47 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.84 2.456 . . . . 0.0 106.756 171.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -159.55 157.47 29.95 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.955 0.798 . . . . 0.0 110.265 168.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.35 153.41 4.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 105.588 -2.004 . . . . 0.0 105.588 169.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -134.21 151.12 51.16 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.569 1.547 . . . . 0.0 107.857 175.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -120.07 122.43 41.07 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 126.598 1.959 . . . . 0.0 107.786 -176.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.8 t -71.63 116.43 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -90.88 -32.7 15.93 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 124.878 1.271 . . . . 0.0 110.245 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -157.02 167.37 30.68 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 119.308 0.958 . . . . 0.0 111.181 176.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.4 mp -141.54 146.53 23.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 127.212 2.205 . . . . 0.0 107.358 -175.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -136.31 109.31 9.62 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 125.819 1.648 . . . . 0.0 108.294 170.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -118.13 26.77 0.02 OUTLIER 'Trans proline' 0 CA--C 1.548 1.181 1 C-N-CA 125.744 4.296 . . . . 0.0 110.203 169.675 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -61.53 -19.75 62.47 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 116.161 1.912 . . . . 0.0 116.161 -167.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -178.63 35.15 0.08 OUTLIER Glycine 0 C--N 1.336 0.554 0 N-CA-C 107.827 -2.109 . . . . 0.0 107.827 177.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.47 117.99 9.47 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 -177.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -41.85 -38.17 1.45 Allowed 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.498 1.919 . . . . 0.0 112.98 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -117.79 104.1 10.63 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 104.386 -2.45 . . . . 0.0 104.386 170.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -63.5 -25.22 68.16 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -169.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -66.18 -16.89 64.36 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.611 171.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 20.6 t -98.1 137.3 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 173.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 40.5 m -138.28 149.91 46.14 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 21.8 ttp180 -79.18 143.67 35.18 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 104.797 -2.298 . . . . 0.0 104.797 168.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.0 mt -135.28 158.7 43.7 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -130.85 130.78 44.05 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 104.222 -2.51 . . . . 0.0 104.222 169.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 58.3 m -138.46 168.68 19.26 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.577 1.151 . . . . 0.0 109.866 -175.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -136.19 135.89 39.5 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 174.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.1 p -66.52 149.52 50.33 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 174.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -67.08 -34.46 77.7 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.893 -0.504 . . . . 0.0 111.008 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.3 m -136.7 -32.74 0.81 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -173.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -83.12 17.44 2.0 Allowed 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -171.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 31.6 pttt 43.75 26.55 0.13 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.554 1.942 . . . . 0.0 114.98 175.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 64.3 mtt -80.13 115.79 19.89 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 124.927 1.291 . . . . 0.0 108.208 176.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -78.99 127.51 32.07 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 104.02 -2.585 . . . . 0.0 104.02 168.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.5 tp -133.11 144.06 49.71 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 119.949 1.249 . . . . 0.0 110.745 -169.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 34.1 mm -130.13 146.51 33.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 128.209 2.604 . . . . 0.0 104.216 169.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 mp -143.09 162.54 35.25 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 126.398 1.879 . . . . 0.0 108.7 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -137.03 95.41 3.1 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 101.163 -3.643 . . . . 0.0 101.163 168.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.1 p -142.6 158.87 19.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 123.357 0.663 . . . . 0.0 111.297 -167.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 36.8 t30 -60.69 140.16 57.6 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.378 1.071 . . . . 0.0 109.969 171.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.6 pp -117.47 -2.7 10.06 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 C-N-CA 125.299 1.44 . . . . 0.0 112.698 176.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -67.67 -11.71 58.87 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 120.19 1.359 . . . . 0.0 111.177 171.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.5 mt -60.11 -39.48 80.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 C-N-CA 124.633 1.173 . . . . 0.0 107.867 168.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -76.38 130.24 77.77 Favored Pre-proline 0 CA--C 1.538 0.503 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.05 -25.13 12.08 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.488 2.125 . . . . 0.0 112.746 -175.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.8 m -143.59 162.22 16.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 C-N-CA 125.681 1.593 . . . . 0.0 108.277 -178.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.3 t70 50.24 -148.97 0.29 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.062 1.345 . . . . 0.0 110.597 -174.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 87.0 mt -123.44 -8.58 8.05 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.427 1.491 . . . . 0.0 110.983 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 179.45 164.05 31.3 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 174.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -156.01 -89.69 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 173.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 35.7 mtmt -140.64 151.75 44.85 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.589 1.156 . . . . 0.0 108.241 170.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -151.04 170.65 18.86 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.517 1.127 . . . . 0.0 110.477 -179.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 65.5 ttp85 -115.64 119.51 36.34 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.52 1.528 . . . . 0.0 107.131 -177.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -106.72 139.12 41.66 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 177.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.0 p -158.25 149.79 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-O 121.389 0.614 . . . . 0.0 110.458 -169.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.7 pt -129.77 -19.38 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.491 1.117 . . . . 0.0 109.609 169.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.345 0.389 0 C-N-CA 125.767 1.627 . . . . 0.0 113.583 179.366 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.305 0 CA-C-O 121.842 0.829 . . . . 0.0 111.854 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.8 pm0 -56.98 125.14 21.28 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 114.561 -1.2 . . . . 0.0 112.052 -176.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -68.32 160.21 29.88 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 169.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.6 p -132.06 144.63 36.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 124.254 1.021 . . . . 0.0 109.542 -169.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 34.1 tpp -145.07 168.09 21.14 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 125.608 1.563 . . . . 0.0 107.935 171.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -130.65 147.02 52.27 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.404 1.482 . . . . 0.0 107.027 -173.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -156.62 -162.7 11.67 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 118.729 0.695 . . . . 0.0 113.638 -171.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -133.32 123.35 25.29 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.578 1.551 . . . . 0.0 106.828 174.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.4 t -84.14 147.28 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 173.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -139.66 129.74 25.06 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 173.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.88 157.54 43.28 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 120.706 1.594 . . . . 0.0 111.369 -178.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.411 HG13 ' H ' ' A' ' 101' ' ' GLY . 17.2 pt -77.24 179.02 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 O-C-N 124.126 0.891 . . . . 0.0 110.42 -177.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -74.33 -3.52 30.76 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.918 1.287 . . . . 0.0 113.537 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.411 ' H ' HG13 ' A' ' 99' ' ' ILE . . . . . . . . 0 C--N 1.339 0.731 0 CA-C-O 119.251 -0.749 . . . . 0.0 113.045 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 23.1 p . . . . . 0 N--CA 1.468 0.448 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -136.45 141.16 43.53 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.374 1.069 . . . . 0.0 108.97 178.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 55.6 tp -83.28 155.61 23.53 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 167.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.1 m -130.8 135.61 47.91 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 177.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -143.26 160.75 39.91 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.393 1.077 . . . . 0.0 110.79 -169.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -136.56 156.56 48.41 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.473 1.909 . . . . 0.0 107.485 176.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.0 p -150.69 139.94 15.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 169.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.5 m -121.07 123.41 42.28 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 -178.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 26.7 p90 -140.96 119.32 12.18 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 124.532 1.133 . . . . 0.0 109.437 -169.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 53.59 28.12 36.52 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 123.677 0.656 . . . . 0.0 114.464 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 84.55 -3.43 86.58 Favored Glycine 0 CA--C 1.535 1.342 0 CA-C-N 118.479 1.139 . . . . 0.0 113.782 -177.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 84.7 mt -95.5 166.24 11.95 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 125.282 1.433 . . . . 0.0 107.352 169.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 7.4 tt -148.63 155.66 41.37 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 121.306 -0.871 . . . . 0.0 110.99 -169.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 14.2 ptt? -153.29 157.92 40.84 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.944 0.898 . . . . 0.0 109.087 169.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -140.63 139.41 34.86 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 126.006 1.722 . . . . 0.0 106.829 -175.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -153.6 160.12 42.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 118.584 0.629 . . . . 0.0 112.221 -170.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -133.46 157.48 45.5 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.799 0.84 . . . . 0.0 109.029 169.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 178.42 173.77 44.09 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 171.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -52.52 134.38 35.12 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.651 1.225 . . . . 0.0 109.157 174.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -43.86 -66.09 0.43 Allowed 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 -169.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -57.88 -43.82 86.28 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 122.36 1.076 . . . . 0.0 111.665 -177.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -60.89 -26.38 67.4 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 126.797 2.039 . . . . 0.0 111.656 179.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 16.4 tp -73.45 -18.73 61.1 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 119.153 0.888 . . . . 0.0 110.186 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 41.89 44.65 2.98 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.689 1.596 . . . . 0.0 112.038 -178.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -142.78 2.66 1.7 Allowed Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.042 0.829 . . . . 0.0 113.557 -172.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -62.76 -27.0 68.98 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.507 1.154 . . . . 0.0 111.043 169.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -70.35 91.6 0.75 Allowed 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 129.083 2.953 . . . . 0.0 108.735 169.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 63.0 t -48.59 -21.39 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 126.996 2.119 . . . . 0.0 112.021 172.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -133.35 21.91 4.03 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -172.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 14.3 m -94.87 -64.02 1.11 Allowed 'General case' 0 C--O 1.232 0.179 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 167.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.329 9.3 ptm85 -77.89 12.95 1.52 Allowed 'General case' 0 C--N 1.344 0.356 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -172.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 15.7 m -61.44 -39.63 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 167.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -76.6 124.28 27.38 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 104.759 -2.311 . . . . 0.0 104.759 169.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 10.0 tt -137.96 128.15 25.99 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 -174.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 mp -134.66 151.01 50.71 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -175.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -156.13 153.34 29.16 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 174.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -144.53 164.44 30.89 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 169.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -56.07 164.04 1.37 Allowed 'General case' 0 CA--C 1.538 0.505 0 O-C-N 120.644 -1.285 . . . . 0.0 109.521 168.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.17 163.1 21.01 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.634 -0.666 . . . . 0.0 110.873 172.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -141.11 39.07 1.77 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.611 1.165 . . . . 0.0 110.065 -178.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 . . . . . 0 C--O 1.248 0.98 0 C-N-CA 125.578 1.551 . . . . 0.0 108.012 -174.884 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 61.6 tp . . . . . 0 C--O 1.233 0.234 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -151.93 137.6 17.87 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 178.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -157.0 130.6 8.1 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 169.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -158.46 152.52 23.89 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 118.474 0.579 . . . . 0.0 110.539 169.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 mp -86.54 142.87 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 172.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -126.04 148.87 49.21 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 125.576 1.55 . . . . 0.0 107.866 178.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -126.42 123.24 37.45 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 126.251 1.82 . . . . 0.0 107.615 -169.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 66.1 t -68.93 127.89 31.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 -173.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.9 mmpt? -89.97 -39.42 12.99 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.768 1.227 . . . . 0.0 109.338 169.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -159.62 166.99 29.52 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.083 0.856 . . . . 0.0 111.793 -177.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.4 mp -137.11 139.47 44.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 127.426 2.29 . . . . 0.0 106.124 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -147.41 95.18 4.36 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 124.902 1.281 . . . . 0.0 109.282 -171.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -63.51 9.72 0.12 Allowed 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 123.778 2.985 . . . . 0.0 116.921 -177.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -78.26 58.18 2.02 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.151 1.38 . . . . 0.0 109.631 175.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -166.94 35.59 0.23 Allowed Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.901 1.239 . . . . 0.0 111.277 -173.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.0 mmpt? -68.13 66.16 0.1 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.779 1.232 . . . . 0.0 113.295 -177.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -59.9 -38.0 81.03 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 168.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -143.66 167.69 21.66 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 130.002 3.321 . . . . 0.0 104.25 169.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -56.66 -41.17 76.78 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.415 -0.803 . . . . 0.0 110.644 171.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -71.73 7.41 1.52 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.201 1.4 . . . . 0.0 114.594 178.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 74.8 t -122.33 137.33 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 122.057 2.208 . . . . 0.0 107.783 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 67.4 m -147.25 161.7 40.41 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.329 1.052 . . . . 0.0 109.799 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 -83.42 149.81 26.45 Favored 'General case' 0 C--N 1.342 0.246 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 170.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.6 mp -145.08 164.82 30.05 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.83 2.052 . . . . 0.0 107.495 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -134.89 133.15 39.35 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 172.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 43.8 m -140.0 171.79 13.68 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.144 1.378 . . . . 0.0 110.081 -176.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -142.47 145.26 33.55 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.163 1.785 . . . . 0.0 107.152 -176.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.8 p -64.52 134.28 54.11 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 118.792 0.723 . . . . 0.0 109.946 174.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.4 tp10 -71.64 -30.18 65.46 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 119.177 -0.44 . . . . 0.0 110.609 172.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.1 m -100.32 -17.46 17.26 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 -169.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -129.71 -105.31 0.29 Allowed 'General case' 0 C--N 1.344 0.336 0 CA-C-N 120.594 1.543 . . . . 0.0 110.754 -169.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -168.64 5.67 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.271 1.428 . . . . 0.0 113.713 -169.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 7.7 ptt? -82.85 152.52 25.58 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.686 0.755 . . . . 0.0 110.009 -173.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -121.56 128.14 51.68 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.401 1.881 . . . . 0.0 107.497 -169.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.86 136.36 52.99 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.444 1.097 . . . . 0.0 108.401 -169.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.1 mm -127.02 137.77 56.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 102.634 -3.098 . . . . 0.0 102.634 169.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 123' ' ' MET . 2.2 pt? -154.2 159.46 41.38 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.111 0.964 . . . . 0.0 111.302 -177.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -126.8 112.32 15.24 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 102.967 -2.975 . . . . 0.0 102.967 172.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.2 p -146.22 160.38 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 121.411 0.624 . . . . 0.0 111.339 -168.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -64.61 125.43 24.7 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.866 1.266 . . . . 0.0 109.226 170.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.3 pp -95.21 -4.07 10.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 123.962 0.905 . . . . 0.0 113.178 -177.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -68.72 -15.15 63.43 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 120.684 1.584 . . . . 0.0 111.299 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 26.1 mt -64.66 -35.79 75.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 124.876 1.27 . . . . 0.0 108.533 171.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -78.97 150.86 75.6 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 123.253 0.621 . . . . 0.0 109.412 -175.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.73 -22.87 23.34 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.501 2.134 . . . . 0.0 112.925 -177.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.4 p -156.07 154.27 6.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -177.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -60.55 -27.59 67.78 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.315 1.046 . . . . 0.0 112.528 178.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 38.1 tp -63.31 -14.64 51.92 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.718 1.207 . . . . 0.0 112.269 174.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.0 170.38 46.55 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.467 1.032 . . . . 0.0 111.812 178.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -162.76 170.65 18.0 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.221 2.208 . . . . 0.0 106.472 177.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 11.9 mttp -60.5 151.73 27.7 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 118.896 0.771 . . . . 0.0 109.708 171.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -146.07 177.27 9.09 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.174 0.989 . . . . 0.0 108.402 172.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -132.73 138.41 47.21 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -172.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.2 mp -108.13 144.69 35.18 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 169.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.4 p -150.01 150.31 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 123.941 0.897 . . . . 0.0 108.662 -178.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.2 mt -142.74 127.28 15.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 174.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.239 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 172.135 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 19.3 p90 . . . . . 0 N--CA 1.455 -0.182 0 CA-C-O 121.666 0.746 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -59.45 88.59 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.966 2.506 . . . . 0.0 112.468 -175.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -68.94 152.15 45.63 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 168.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.8 p -115.77 152.37 17.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 118.995 0.816 . . . . 0.0 111.327 -169.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 45.9 tpp -149.89 155.3 39.78 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 126.552 1.941 . . . . 0.0 108.369 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -136.35 142.96 43.84 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 126.185 1.794 . . . . 0.0 106.811 -172.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -156.52 -159.48 9.46 Favored Glycine 0 C--N 1.339 0.708 0 CA-C-N 119.452 1.023 . . . . 0.0 114.789 -170.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 3.8 tmtp? -142.86 116.67 9.3 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 172.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 62.1 t -84.54 148.59 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 176.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -136.47 151.44 49.47 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 128.556 2.742 . . . . 0.0 105.276 176.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.69 167.71 29.64 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 120.241 -1.537 . . . . 0.0 112.085 -175.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.5 pt -120.65 177.47 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 124.222 1.009 . . . . 0.0 108.579 169.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -67.61 -5.08 13.89 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.316 1.446 . . . . 0.0 114.139 -175.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.624 0 N-CA-C 107.446 -2.262 . . . . 0.0 107.446 -173.952 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.6 p . . . . . 0 C--O 1.234 0.271 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -87.2 152.95 21.88 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 169.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 54.6 tp -100.22 141.73 32.66 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 103.638 -2.726 . . . . 0.0 103.638 167.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 17.9 m -131.7 139.34 49.0 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -176.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -136.4 149.28 48.22 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 124.415 1.086 . . . . 0.0 108.646 -178.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -111.14 142.94 42.65 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 103.868 -2.642 . . . . 0.0 103.868 169.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.1 p -144.78 126.66 9.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 38.1 m -100.37 139.76 35.58 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -135.49 78.88 1.75 Allowed 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.629 1.172 . . . . 0.0 109.114 -169.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 61.16 21.33 59.3 Favored Glycine 0 CA--C 1.537 1.435 0 CA-C-O 119.269 -0.74 . . . . 0.0 114.244 171.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 119.41 -24.29 8.17 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 125.268 1.413 . . . . 0.0 112.111 -176.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -82.84 167.9 17.63 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 169.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 31.7 tp -148.45 155.23 40.93 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.398 -0.814 . . . . 0.0 110.167 -174.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.419 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 34.6 mtt -147.38 161.11 41.68 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.888 1.275 . . . . 0.0 108.561 169.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -137.17 123.04 20.08 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 103.721 -2.696 . . . . 0.0 103.721 169.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -132.28 131.39 41.98 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 -175.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -125.07 140.26 53.06 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 171.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -164.13 178.24 39.56 Favored Glycine 0 N--CA 1.452 -0.243 0 N-CA-C 108.616 -1.793 . . . . 0.0 108.616 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -55.91 141.47 39.18 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.257 1.028 . . . . 0.0 108.879 170.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -41.82 -62.35 0.92 Allowed 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.39 -11.57 61.0 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.179 -0.95 . . . . 0.0 113.507 -176.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -83.71 -28.45 28.28 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.771 1.228 . . . . 0.0 110.137 173.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.34 -38.2 60.28 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 170.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 49.81 11.98 0.07 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 127.33 2.252 . . . . 0.0 116.105 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -73.99 -56.36 5.35 Favored Glycine 0 CA--C 1.522 0.53 0 O-C-N 121.008 -1.058 . . . . 0.0 110.835 -169.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 44.06 24.42 0.08 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 128.58 2.752 . . . . 0.0 115.01 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -162.87 133.15 4.54 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 125.659 1.584 . . . . 0.0 107.813 -169.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.5 m -67.66 -13.34 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.91 169.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -135.39 16.68 3.41 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -169.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 11.6 m -89.28 -66.35 0.93 Allowed 'General case' 0 N--CA 1.462 0.166 0 O-C-N 121.609 -0.682 . . . . 0.0 109.253 168.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.318 13.2 ptm180 -80.23 14.04 2.09 Favored 'General case' 0 C--N 1.344 0.339 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -170.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 19.4 m -60.79 -34.61 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 167.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -79.27 119.83 22.88 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 170.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -140.42 140.23 35.41 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -178.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.0 mp -129.54 156.48 44.1 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 174.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 23.6 ptp -148.44 152.86 37.67 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 121.854 -0.529 . . . . 0.0 111.342 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -158.03 -177.66 6.72 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.355 1.462 . . . . 0.0 110.408 -178.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -53.06 161.41 0.82 Allowed 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.688 1.595 . . . . 0.0 112.591 170.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.53 166.77 0.59 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.022 0.929 . . . . 0.0 111.473 169.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -88.82 89.52 8.02 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 173.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 17.1 t80 . . . . . 0 C--O 1.249 1.07 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 171.872 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.0 tm? . . . . . 0 C--O 1.233 0.207 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -147.23 150.97 35.91 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 126.076 1.75 . . . . 0.0 106.641 172.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -152.96 142.4 21.71 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.149 0.98 . . . . 0.0 109.094 178.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -158.58 158.91 34.82 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.53 0.732 . . . . 0.0 110.174 169.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 mp -76.2 150.4 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 168.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -131.85 154.21 49.39 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.885 1.274 . . . . 0.0 107.959 175.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -128.9 122.95 31.4 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -173.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.8 t -75.81 105.77 5.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -72.8 -37.78 67.44 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.192 0.997 . . . . 0.0 109.89 177.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -159.58 167.65 28.01 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.326 0.967 . . . . 0.0 111.486 176.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.5 mp -133.17 140.24 47.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 127.333 2.253 . . . . 0.0 106.211 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -146.17 92.95 5.17 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 124.494 1.118 . . . . 0.0 109.908 -170.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -64.26 13.59 0.09 OUTLIER 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 124.129 3.219 . . . . 0.0 116.696 -178.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -79.07 53.13 1.38 Allowed 'General case' 0 CA--C 1.544 0.712 0 O-C-N 120.648 -1.283 . . . . 0.0 109.338 172.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -174.89 41.44 0.12 Allowed Glycine 0 CA--C 1.525 0.682 0 C-N-CA 124.677 1.132 . . . . 0.0 111.052 -170.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -74.71 69.37 1.78 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.123 0.961 . . . . 0.0 110.496 -177.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -55.16 -38.65 68.55 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 169.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -146.73 169.48 18.97 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 129.256 3.022 . . . . 0.0 104.677 169.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -62.07 -33.23 74.02 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 120.985 -1.072 . . . . 0.0 111.744 178.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -83.82 9.45 11.96 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-O 116.919 -1.515 . . . . 0.0 113.105 175.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.0 t -119.32 142.74 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 121.84 2.109 . . . . 0.0 107.809 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 57.3 m -148.59 174.41 12.15 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.018 0.927 . . . . 0.0 108.913 175.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.429 ' C ' HD22 ' A' ' 28' ' ' LEU . 45.5 ttp180 -84.5 149.33 26.01 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 106.754 -1.572 . . . . 0.0 106.754 168.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.464 HD23 HG12 ' A' ' 43' ' ' VAL . 4.2 mm? -139.44 153.57 47.6 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 126.806 2.042 . . . . 0.0 106.634 -172.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -130.93 126.66 36.68 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 173.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 85.0 m -142.96 166.77 23.71 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.202 1.401 . . . . 0.0 110.161 -170.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 55.8 tt0 -144.78 139.8 28.06 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.339 1.056 . . . . 0.0 108.636 177.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.21 137.31 46.77 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 174.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -68.13 -32.52 72.87 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.869 0.868 . . . . 0.0 111.424 -176.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 m -117.15 -30.6 5.59 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.108 0.963 . . . . 0.0 111.887 -171.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -113.22 13.33 19.18 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -171.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt 45.71 20.87 0.07 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 118.224 2.676 . . . . 0.0 118.224 169.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 52.3 mtm -64.74 125.85 26.07 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 120.858 1.663 . . . . 0.0 107.806 176.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -77.65 118.62 20.22 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 104.921 -2.252 . . . . 0.0 104.921 169.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 49.8 tp -129.05 130.32 46.41 Favored 'General case' 0 N--CA 1.457 -0.081 0 C-N-CA 123.183 0.593 . . . . 0.0 110.303 -169.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 49.6 mm -118.04 142.41 32.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 103.272 -2.862 . . . . 0.0 103.272 168.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 123' ' ' MET . 2.5 pt? -155.67 163.0 40.48 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.21 1.004 . . . . 0.0 110.761 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -124.96 105.73 9.44 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 102.642 -3.095 . . . . 0.0 102.642 178.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.464 HG12 HD23 ' A' ' 28' ' ' LEU . 7.3 p -150.5 166.11 2.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 O-C-N 124.267 0.979 . . . . 0.0 111.366 -168.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -55.82 133.22 51.01 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.731 1.612 . . . . 0.0 110.504 170.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.42 ' CG2' HD21 ' A' ' 28' ' ' LEU . 1.5 pp -108.28 0.03 9.78 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 C-N-CA 125.045 1.338 . . . . 0.0 114.183 -177.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -67.29 -14.24 62.73 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 120.913 1.688 . . . . 0.0 111.623 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.1 mt -62.66 -27.35 42.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 125.505 1.522 . . . . 0.0 109.643 169.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -116.57 158.48 43.27 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 124.681 1.192 . . . . 0.0 112.182 -168.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -78.49 -15.72 13.79 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.251 2.634 . . . . 0.0 112.766 174.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . 0.283 17.7 m 53.96 -19.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 130.694 3.597 . . . . 0.0 117.243 -175.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -66.7 -23.72 66.16 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.668 1.122 . . . . 0.0 111.872 173.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.0 tp -151.76 163.41 39.22 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.449 1.9 . . . . 0.0 107.513 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.19 163.62 20.87 Favored Glycine 0 CA--C 1.534 1.263 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 169.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -156.02 176.21 12.95 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.22 1.408 . . . . 0.0 108.417 -173.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -126.92 150.64 49.22 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.4 1.08 . . . . 0.0 109.618 -175.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -152.58 178.31 9.72 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 125.411 1.484 . . . . 0.0 108.17 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 -129.11 144.7 51.29 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.5 tt -134.24 139.42 45.76 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 -170.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.3 t -140.78 139.57 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 125.247 1.419 . . . . 0.0 107.6 -169.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 38.3 mm -88.12 66.87 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 170.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.625 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -169.673 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 31.2 p90 . . . . . 0 CA--C 1.538 0.483 0 CA-C-O 121.34 0.59 . . . . 0.0 111.872 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -125.24 -9.68 7.01 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.12 1.368 . . . . 0.0 110.816 169.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 36.9 t80 62.24 -149.55 0.37 Allowed 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 116.993 -1.48 . . . . 0.0 108.604 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . 0.456 20.7 t 154.92 -90.1 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 130.308 3.443 . . . . 0.0 110.405 169.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.45 -173.09 2.12 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 122.183 2.265 . . . . 0.0 115.83 -167.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -125.77 154.93 41.82 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 129.562 3.145 . . . . 0.0 105.692 169.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -157.46 -151.42 6.02 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-N 119.835 1.198 . . . . 0.0 113.147 -174.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -140.73 147.76 39.68 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.972 1.709 . . . . 0.0 107.007 169.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.9 p -125.42 135.12 64.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 124.392 1.077 . . . . 0.0 108.33 177.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -146.3 106.75 4.06 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.09 0.956 . . . . 0.0 111.235 -170.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -156.71 167.58 30.01 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.089 1.356 . . . . 0.0 109.821 169.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -62.67 168.95 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 125.466 1.506 . . . . 0.0 112.028 174.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -61.45 3.83 0.11 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 129.171 2.988 . . . . 0.0 116.026 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.937 0 CA-C-N 119.405 1.002 . . . . 0.0 111.988 -175.712 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 81.2 p . . . . . 0 N--CA 1.47 0.54 0 CA-C-O 122.069 0.938 . . . . 0.0 113.31 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -129.79 138.88 51.29 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 174.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.1 tp -84.87 152.45 23.57 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 169.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 11.8 m -122.55 150.79 42.11 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -176.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -148.14 140.43 24.27 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.685 0.794 . . . . 0.0 108.981 178.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 -120.76 134.27 55.29 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 103.11 -2.922 . . . . 0.0 103.11 169.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.3 t -125.11 142.6 41.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 -175.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 45.6 m -133.35 122.83 24.38 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 -178.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -147.79 105.21 3.66 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 122.809 0.444 . . . . 0.0 110.173 -169.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 58.48 27.85 61.47 Favored Glycine 0 CA--C 1.536 1.361 0 O-C-N 121.53 -0.731 . . . . 0.0 113.878 174.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 90.92 -2.87 80.38 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 118.312 1.056 . . . . 0.0 113.528 -178.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 88.0 mt -95.39 164.22 12.91 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 125.439 1.496 . . . . 0.0 107.878 171.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 7.9 tp -142.96 161.91 36.88 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -168.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.474 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 27.6 mtt -147.04 155.38 42.17 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 126.391 1.877 . . . . 0.0 108.671 169.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 36.9 mtp-105 -142.4 126.07 16.94 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 104.849 -2.278 . . . . 0.0 104.849 169.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -152.28 163.6 39.11 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 119.179 0.899 . . . . 0.0 112.339 -172.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -138.78 155.91 47.78 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.856 1.263 . . . . 0.0 108.78 169.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -169.63 175.8 43.71 Favored Glycine 0 CA--C 1.52 0.381 0 N-CA-C 108.52 -1.832 . . . . 0.0 108.52 169.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -56.77 142.16 41.58 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 118.467 1.134 . . . . 0.0 108.493 170.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -47.09 -48.73 22.62 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.131 0.878 . . . . 0.0 112.035 177.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -56.34 -36.63 68.98 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 122.214 1.007 . . . . 0.0 112.174 178.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -79.0 -19.32 51.89 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 113.58 -1.646 . . . . 0.0 111.004 -174.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 14.7 tp -70.39 -28.15 64.85 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 119.826 1.194 . . . . 0.0 109.309 169.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 1.9 t60 44.44 34.36 1.06 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.504 2.322 . . . . 0.0 114.623 171.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 167.38 73.37 0.03 OUTLIER Glycine 0 C--N 1.334 0.446 0 N-CA-C 108.482 -1.847 . . . . 0.0 108.482 -169.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -101.98 3.84 39.35 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -169.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.405 ' C ' ' H ' ' A' ' 138' ' ' ASP . 9.7 mm-40 -71.85 149.68 44.99 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 169.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 16.5 m -57.79 -7.43 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 124.713 1.205 . . . . 0.0 110.941 168.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 136' ' ' GLU . 34.1 t70 -135.85 15.6 3.33 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 126.825 2.05 . . . . 0.0 112.692 -178.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 58.6 m -80.77 -76.25 0.24 Allowed 'General case' 0 C--N 1.338 0.079 0 O-C-N 121.412 -0.805 . . . . 0.0 109.06 168.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 11.5 ptm85 -81.23 16.61 1.52 Allowed 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -169.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 30.2 m -68.19 -30.37 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 CA-C-O 118.732 -0.652 . . . . 0.0 109.348 168.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -72.36 124.13 24.49 Favored 'General case' 0 C--N 1.341 0.212 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 175.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 60.0 tp -138.17 103.44 4.94 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.511 0.725 . . . . 0.0 109.231 -173.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 15.9 tp -114.83 135.0 54.67 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 174.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 61.5 mtt -118.96 155.41 31.4 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.961 1.304 . . . . 0.0 107.51 171.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -146.85 161.84 39.86 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 126.36 1.864 . . . . 0.0 107.684 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -67.4 -176.07 0.55 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.351 0.596 . . . . 0.0 110.161 169.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 66.6 mt -57.19 119.8 7.01 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 121.773 0.797 . . . . 0.0 110.273 169.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -142.34 144.85 33.39 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 102.171 -3.27 . . . . 0.0 102.171 169.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 . . . . . 0 C--O 1.249 1.077 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -174.313 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 66.5 tp . . . . . 0 N--CA 1.468 0.438 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.406 ' CZ ' ' HA ' ' A' ' 131' ' ' ASN . 83.7 t80 -145.2 143.53 30.35 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 169.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -151.83 139.59 19.85 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.429 1.491 . . . . 0.0 107.871 -177.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -154.26 115.71 4.13 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.408 0.683 . . . . 0.0 109.897 -171.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 mp -71.32 143.89 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -143.61 158.94 43.29 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 123.503 0.721 . . . . 0.0 111.431 175.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -135.35 129.27 33.17 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 126.385 1.874 . . . . 0.0 108.286 -174.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.7 t -66.13 126.86 26.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 175.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.1 mmmt -108.01 -25.46 11.15 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 124.312 1.045 . . . . 0.0 110.663 178.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -154.36 166.58 32.76 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.556 1.071 . . . . 0.0 110.672 172.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.4 mp -144.42 141.62 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 126.947 2.099 . . . . 0.0 106.975 -170.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -147.92 100.91 3.67 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 124.213 1.005 . . . . 0.0 109.02 171.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -65.07 -2.1 5.21 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 122.578 2.185 . . . . 0.0 115.937 176.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 36.9 45.41 0.43 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 128.756 2.822 . . . . 0.0 113.76 -176.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.19 11.95 37.78 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.094 0.854 . . . . 0.0 113.077 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? 45.82 67.86 0.68 Allowed 'General case' 0 C--N 1.343 0.307 0 C-N-CA 126.736 2.014 . . . . 0.0 109.895 -170.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -48.93 -41.16 32.91 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.451 1.1 . . . . 0.0 111.435 -177.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -140.74 156.56 46.16 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 169.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -62.5 -4.45 1.93 Allowed 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -172.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -147.24 26.75 1.06 Allowed 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 125.132 1.373 . . . . 0.0 112.229 -176.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.5 t -133.21 126.45 52.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.4 m -148.12 155.64 41.67 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.916 0.886 . . . . 0.0 110.271 -171.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 54.5 ttm-85 -83.41 149.72 26.5 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 169.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 85.9 mt -140.33 159.72 41.56 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 125.788 1.635 . . . . 0.0 107.815 -178.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -133.92 136.87 44.54 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 169.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.9 m -140.82 166.17 25.49 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.384 1.073 . . . . 0.0 109.845 -173.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -129.73 149.39 51.5 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 171.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.6 m -117.46 117.6 29.89 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -169.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -65.84 -44.22 86.17 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.241 1.416 . . . . 0.0 111.437 -169.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.2 m -74.94 -41.32 59.87 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 119.229 -0.415 . . . . 0.0 111.733 -169.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -131.66 29.36 4.5 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -172.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.292 0.0 OUTLIER 44.94 35.14 1.41 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 127.138 2.175 . . . . 0.0 114.702 169.814 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 11.8 tmm? -87.34 114.35 23.87 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.365 1.066 . . . . 0.0 109.003 -175.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -71.87 132.08 43.91 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 171.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 45.8 tp -135.81 143.37 45.13 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.474 0.71 . . . . 0.0 110.739 -169.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 41.4 mm -127.58 147.87 32.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 103.187 -2.894 . . . . 0.0 103.187 169.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.2 mt -150.88 146.44 26.32 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 126.577 1.951 . . . . 0.0 107.557 -169.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -135.3 101.74 4.93 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 102.056 -3.313 . . . . 0.0 102.056 169.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.3 p -146.34 163.51 9.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 122.483 1.135 . . . . 0.0 113.202 -167.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -67.01 123.92 21.57 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 126.072 1.749 . . . . 0.0 106.43 168.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 pp -105.44 4.64 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -174.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -69.36 -10.51 58.23 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 120.069 1.304 . . . . 0.0 111.146 176.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.3 mt -59.75 -42.11 87.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 169.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -79.57 155.4 76.15 Favored Pre-proline 0 C--O 1.236 0.39 0 C-N-CA 123.639 0.775 . . . . 0.0 109.467 -175.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -67.14 -21.1 49.18 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.315 2.01 . . . . 0.0 112.357 176.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.9 p -158.15 155.37 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.782 1.633 . . . . 0.0 106.938 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -55.66 -25.84 41.55 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.376 1.471 . . . . 0.0 113.126 178.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 58.5 tp -57.97 -22.46 49.36 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.281 1.432 . . . . 0.0 112.58 173.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.92 178.58 47.6 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 123.741 0.686 . . . . 0.0 112.219 177.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -157.75 168.57 26.83 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.534 1.933 . . . . 0.0 107.625 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -73.73 136.09 43.66 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 174.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 7.3 m-30 -138.59 178.88 6.82 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.977 1.711 . . . . 0.0 107.012 176.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.93 141.15 49.24 Favored 'General case' 0 CA--C 1.515 -0.383 0 O-C-N 121.127 -0.983 . . . . 0.0 109.129 169.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 12.9 tp -96.24 152.05 18.93 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 177.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 53.7 t -140.01 142.26 32.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 177.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.9 pt -132.64 21.02 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 122.94 0.496 . . . . 0.0 112.104 -178.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.324 0 O-C-N 121.506 -0.746 . . . . 0.0 109.302 172.25 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.1 p90 . . . . . 0 N--CA 1.446 -0.667 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -88.96 -32.82 17.48 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 118.966 -0.54 . . . . 0.0 110.261 175.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -155.67 153.57 30.2 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 118.819 0.736 . . . . 0.0 110.054 177.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.4 m -143.6 145.89 21.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 125.462 1.505 . . . . 0.0 107.464 169.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 5.8 tpt -162.13 174.27 13.17 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.029 0.932 . . . . 0.0 109.452 174.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -137.84 155.8 48.6 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 126.613 1.965 . . . . 0.0 106.212 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -167.08 -157.92 10.98 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 118.689 0.677 . . . . 0.0 113.147 -169.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.4 tttm -141.78 130.18 22.44 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 117.848 0.824 . . . . 0.0 109.152 174.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.3 t -75.11 148.35 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 124.656 1.182 . . . . 0.0 108.779 169.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -144.31 70.67 1.29 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.916 0.887 . . . . 0.0 110.798 175.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -144.01 163.67 32.84 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.376 1.07 . . . . 0.0 110.635 174.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.41 HG13 ' H ' ' A' ' 101' ' ' GLY . 26.3 pt -76.47 -170.08 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 125.124 1.369 . . . . 0.0 110.269 174.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -60.64 -0.29 0.26 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.965 2.106 . . . . 0.0 115.186 178.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.41 ' H ' HG13 ' A' ' 99' ' ' ILE . . . . . . . . 0 C--N 1.335 0.48 0 C-N-CA 125.231 1.396 . . . . 0.0 111.511 174.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.8 p . . . . . 0 N--CA 1.466 0.363 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -118.77 151.9 37.17 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 172.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.18 139.98 33.16 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 169.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.6 p -101.73 147.26 26.68 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 174.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -146.33 144.0 29.5 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 176.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 15.3 m-30 -122.85 137.27 54.98 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 102.485 -3.154 . . . . 0.0 102.485 169.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.4 p -142.47 144.36 24.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 24.0 p -116.97 130.23 56.55 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 172.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -144.51 116.05 8.12 Favored 'General case' 0 N--CA 1.458 -0.073 0 C-N-CA 123.878 0.871 . . . . 0.0 109.581 -169.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 55.78 21.75 30.83 Favored Glycine 0 CA--C 1.537 1.423 0 CA-C-O 119.234 -0.759 . . . . 0.0 114.534 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 92.19 -5.04 78.15 Favored Glycine 0 CA--C 1.535 1.3 0 CA-C-N 118.648 1.224 . . . . 0.0 113.477 -176.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -95.09 170.92 9.07 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.956 1.302 . . . . 0.0 107.809 170.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.5 tt -149.3 151.45 34.19 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 121.522 -0.736 . . . . 0.0 110.545 -170.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 13.0 ptp -148.37 158.08 43.88 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 169.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 -140.51 138.53 34.65 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 178.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -154.2 162.12 41.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 118.855 0.752 . . . . 0.0 112.937 -169.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -134.44 118.43 17.38 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 104.109 -2.552 . . . . 0.0 104.109 168.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -151.05 175.56 29.94 Favored Glycine 0 N--CA 1.452 -0.256 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 -175.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -58.21 148.45 26.98 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 122.332 -0.511 . . . . 0.0 111.177 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -46.49 -42.15 15.13 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 175.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.77 -12.61 60.44 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.996 1.271 . . . . 0.0 113.191 178.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.406 ' HA ' ' CZ ' ' A' ' 6' ' ' PHE . 5.8 t-20 -66.57 -19.06 65.69 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 168.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -100.0 19.19 16.72 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 117.067 -1.444 . . . . 0.0 110.634 174.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -30.2 108.0 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 120.32 1.418 . . . . 0.0 112.021 169.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 122.84 -13.97 8.55 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 125.077 1.322 . . . . 0.0 112.134 -169.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . 0.26 30.9 m-85 44.11 56.6 4.7 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 129.527 3.131 . . . . 0.0 114.165 177.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 70.97 164.53 0.28 Allowed 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 129.499 3.12 . . . . 0.0 113.488 170.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 60.1 t 59.23 -9.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 127.091 2.156 . . . . 0.0 113.686 -172.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -154.02 -11.99 0.14 Allowed 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 119.84 1.2 . . . . 0.0 114.007 -172.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 16.0 m -54.68 -63.47 1.14 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.963 0.887 . . . . 0.0 112.652 169.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 8.6 mmm180 -88.67 11.19 18.18 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.43 -169.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 98.2 t -87.9 -5.73 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 C-N-CA 124.838 1.255 . . . . 0.0 108.861 -177.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -128.2 114.71 17.33 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 103.383 -2.821 . . . . 0.0 103.383 168.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.7 tt -133.69 126.23 30.32 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 -171.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.0 tt -134.68 147.97 50.23 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 106.768 -1.568 . . . . 0.0 106.768 178.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 56.5 ttm -139.56 138.32 36.14 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.221 -1.399 . . . . 0.0 107.221 -178.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -147.01 162.84 37.97 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -57.06 156.36 7.1 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 118.532 0.605 . . . . 0.0 109.7 169.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.0 pp -67.4 160.04 28.19 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 169.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -148.09 125.93 11.94 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 177.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 . . . . . 0 C--O 1.251 1.162 0 C-N-CA 126.289 1.836 . . . . 0.0 107.186 175.753 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.4 tt . . . . . 0 CA--C 1.53 0.193 0 CA-C-O 118.62 -0.705 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -161.48 150.69 16.26 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 119.17 0.895 . . . . 0.0 109.627 174.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -157.87 132.12 8.2 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.053 1.341 . . . . 0.0 108.434 169.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -161.06 155.01 22.5 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.471 0.708 . . . . 0.0 109.879 168.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 mp -74.5 151.33 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 169.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -129.13 150.71 50.41 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 172.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -133.97 129.21 35.88 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.054 1.342 . . . . 0.0 108.004 -169.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.6 p -63.82 147.97 11.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-O 122.078 0.942 . . . . 0.0 110.153 -177.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -125.09 -29.01 3.36 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 126.73 2.012 . . . . 0.0 109.373 178.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -160.25 166.6 29.27 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.348 0.977 . . . . 0.0 111.062 170.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.1 mp -133.01 135.06 57.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 127.292 2.237 . . . . 0.0 105.372 178.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -146.45 89.85 5.76 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 124.03 0.932 . . . . 0.0 110.301 -169.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -64.27 16.92 0.07 OUTLIER 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 124.26 3.307 . . . . 0.0 116.594 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -79.98 53.98 1.8 Allowed 'General case' 0 CA--C 1.542 0.66 0 O-C-N 120.256 -1.527 . . . . 0.0 109.778 176.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -172.88 38.67 0.15 Allowed Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.231 0.92 . . . . 0.0 111.577 -171.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.6 mmmt -74.31 66.71 1.34 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 118.152 0.976 . . . . 0.0 111.445 -175.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -57.09 -36.63 70.84 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 169.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -143.85 167.77 21.52 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 128.194 2.598 . . . . 0.0 105.027 169.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -62.13 -31.59 72.09 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.355 -0.84 . . . . 0.0 111.243 177.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -82.68 11.07 6.27 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-O 116.738 -1.601 . . . . 0.0 113.559 175.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 93.5 t -123.05 138.54 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 122.391 2.36 . . . . 0.0 108.302 -179.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.7 m -149.66 170.44 18.68 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.876 1.27 . . . . 0.0 109.472 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.443 ' C ' HD22 ' A' ' 28' ' ' LEU . 49.7 ttp180 -91.22 149.7 21.66 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 169.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.45 HD23 HG22 ' A' ' 43' ' ' VAL . 3.5 mm? -141.33 158.16 44.24 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 126.83 2.052 . . . . 0.0 106.713 -172.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -133.14 134.91 44.81 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 172.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 64.3 m -141.24 175.94 9.24 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.953 1.701 . . . . 0.0 109.68 -177.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -141.85 144.94 34.12 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.798 1.639 . . . . 0.0 107.836 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 64.6 p -67.82 130.29 42.53 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 175.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -69.36 -31.3 69.63 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 122.869 0.468 . . . . 0.0 111.785 -174.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 m -113.48 -5.48 13.48 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 114.587 1.328 . . . . 0.0 114.587 -169.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -123.77 -106.86 0.35 Allowed 'General case' 0 C--N 1.341 0.23 0 CA-C-N 119.892 1.223 . . . . 0.0 108.874 -176.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -169.61 3.74 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -169.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 5.3 mpp? -77.69 137.0 38.26 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 123.6 0.76 . . . . 0.0 110.9 -169.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -81.64 137.59 35.43 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 168.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 38.8 tp -133.16 138.75 46.72 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 174.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 35.9 mm -126.75 145.7 33.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 102.801 -3.037 . . . . 0.0 102.801 169.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 123' ' ' MET . 2.0 pt? -157.51 156.52 32.16 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.499 1.12 . . . . 0.0 109.952 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -126.67 107.12 9.89 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 178.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.45 HG22 HD23 ' A' ' 28' ' ' LEU . 27.0 m -148.21 171.44 2.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 O-C-N 124.656 1.222 . . . . 0.0 112.234 -168.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -59.79 141.06 56.0 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.612 1.565 . . . . 0.0 110.415 169.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.6 pp -117.08 1.08 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 125.982 1.713 . . . . 0.0 113.045 177.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -62.05 -22.54 65.83 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 120.48 1.491 . . . . 0.0 110.669 169.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 12.7 mt -53.62 -38.92 35.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 126.179 1.792 . . . . 0.0 109.857 169.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -68.42 129.02 92.98 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -172.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -72.28 -31.6 11.48 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.473 2.116 . . . . 0.0 111.402 178.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.7 m -145.79 154.96 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 126.124 1.77 . . . . 0.0 107.415 177.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -61.7 -25.09 67.19 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.349 0.66 . . . . 0.0 112.061 177.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.2 tp -57.79 -36.26 71.95 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.496 1.118 . . . . 0.0 112.261 -178.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 164.14 177.24 36.72 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-N 118.91 0.777 . . . . 0.0 112.851 178.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -156.99 169.44 24.82 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.487 1.515 . . . . 0.0 109.002 177.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -135.84 158.86 43.36 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.752 1.621 . . . . 0.0 107.974 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -142.47 169.85 16.8 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 123.921 0.888 . . . . 0.0 109.331 -169.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 -133.81 107.2 7.74 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 169.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 68.3 tp -93.98 132.74 38.15 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.0 p -153.6 155.91 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-O 121.943 0.877 . . . . 0.0 109.369 -170.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 tp -147.1 112.1 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 104.146 -2.538 . . . . 0.0 104.146 169.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.507 0 C-N-CA 125.966 1.706 . . . . 0.0 109.229 -175.05 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 . . . . . 0 N--CA 1.465 0.321 0 CA-C-O 118.709 -0.662 . . . . 0.0 112.751 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -140.05 31.84 1.97 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 119.301 0.955 . . . . 0.0 113.291 -168.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -78.41 59.88 2.47 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 120.614 1.552 . . . . 0.0 109.504 174.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.1 p -78.73 147.72 6.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 125.363 1.465 . . . . 0.0 108.414 178.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 3.2 ttm -158.68 174.3 15.26 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.243 1.017 . . . . 0.0 108.904 170.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -126.06 154.19 43.38 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 169.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -152.01 -162.24 10.7 Favored Glycine 0 C--N 1.333 0.369 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -173.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -140.83 112.54 7.57 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 172.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.8 p -69.17 149.91 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 C-N-CA 124.613 1.165 . . . . 0.0 109.347 168.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -139.44 122.65 16.95 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 102.296 -3.224 . . . . 0.0 102.296 172.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.04 142.38 31.55 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 120.065 1.302 . . . . 0.0 109.965 -168.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.9 pt -74.95 174.46 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 123.961 0.905 . . . . 0.0 110.917 -177.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -69.52 -2.99 12.81 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.292 1.437 . . . . 0.0 113.525 177.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.719 0 C-N-CA 124.748 1.166 . . . . 0.0 112.879 -176.313 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.8 p . . . . . 0 N--CA 1.465 0.284 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -126.07 141.29 52.01 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.627 1.171 . . . . 0.0 108.676 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.2 tp -102.81 152.09 21.66 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.122 1.769 . . . . 0.0 107.316 169.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.6 m -132.88 146.4 51.78 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 176.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -139.78 158.17 44.53 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 125.179 1.391 . . . . 0.0 108.872 -177.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -124.5 152.88 42.86 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 169.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.0 t -140.97 141.03 32.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 174.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 72.8 p -118.87 135.72 54.41 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 169.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -151.84 116.6 5.14 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -173.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 54.12 29.14 43.72 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 123.757 0.694 . . . . 0.0 113.97 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 85.48 -2.04 88.16 Favored Glycine 0 CA--C 1.535 1.316 0 CA-C-N 118.159 0.98 . . . . 0.0 113.879 -178.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 49.0 mt -95.22 168.21 10.88 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.281 1.432 . . . . 0.0 108.363 172.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 10.7 tp -139.12 158.1 44.78 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.868 -0.52 . . . . 0.0 111.062 -169.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.448 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 43.8 mtt -148.77 159.67 43.93 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.921 1.688 . . . . 0.0 109.408 169.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.7 ttp85 -140.17 131.0 25.93 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 168.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.7 tt -138.42 131.26 29.55 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 -169.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -136.6 144.63 44.2 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -178.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 177.63 -175.21 47.45 Favored Glycine 0 CA--C 1.518 0.245 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 177.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.01 141.93 32.17 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.04 0.92 . . . . 0.0 108.782 169.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -50.46 -53.3 30.77 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -175.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -61.77 -36.55 81.38 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.619 0.723 . . . . 0.0 112.112 179.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -65.64 -23.23 66.75 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 125.032 1.333 . . . . 0.0 111.871 176.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.52 -8.62 55.08 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 120.126 1.33 . . . . 0.0 110.524 172.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 77.2 m80 44.04 43.54 5.57 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 129.413 3.085 . . . . 0.0 111.088 -176.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 173.25 112.1 0.28 Allowed Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 107.267 -2.333 . . . . 0.0 107.267 179.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -65.79 -8.68 22.78 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-O 121.507 0.67 . . . . 0.0 110.93 167.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 50.83 152.13 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.179 1 C-N-CA 135.389 5.476 . . . . 0.0 121.128 168.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER 171.6 -27.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.555 1 C-N-CA 133.438 4.695 . . . . 0.0 107.63 169.41 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -167.24 40.44 0.04 OUTLIER 'General case' 0 C--N 1.349 0.569 0 CA-C-N 119.085 0.857 . . . . 0.0 113.11 -172.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 26.9 m -118.66 -38.41 3.12 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 123.353 0.661 . . . . 0.0 110.617 169.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -11.78 18.77 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.999 0.904 . . . . 0.0 113.084 174.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 18.6 m -77.7 -4.14 6.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 C-N-CA 126.216 1.806 . . . . 0.0 112.689 -174.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -122.19 118.38 28.47 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 104.036 -2.579 . . . . 0.0 104.036 170.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -149.56 147.1 27.76 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.846 0.748 . . . . 0.0 111.131 -172.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 15.7 tp -140.74 139.88 34.74 Favored 'General case' 0 CA--C 1.523 -0.094 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -177.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 16.7 tmm? -125.39 144.28 50.59 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 173.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -149.98 172.55 15.03 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.328 1.451 . . . . 0.0 109.426 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -62.64 157.11 21.57 Favored 'General case' 0 C--O 1.235 0.297 0 O-C-N 122.1 -0.375 . . . . 0.0 110.438 172.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.2 pp -67.61 161.42 25.77 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.121 0.486 . . . . 0.0 110.671 169.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -146.88 129.83 16.32 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 173.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 . . . . . 0 C--O 1.248 1.019 0 C-N-CA 126.466 1.906 . . . . 0.0 106.995 174.04 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.4 tt . . . . . 0 N--CA 1.468 0.437 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -149.36 136.3 19.69 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 173.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -148.87 144.79 27.13 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.339 1.456 . . . . 0.0 108.262 -172.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -157.68 159.91 37.43 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 122.879 0.472 . . . . 0.0 110.585 169.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.1 mp -79.8 153.29 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 105.45 -2.056 . . . . 0.0 105.45 169.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -135.15 138.47 43.74 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.909 1.284 . . . . 0.0 107.644 178.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -105.57 122.96 47.1 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.073 1.349 . . . . 0.0 108.245 -178.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 44.8 t -71.09 116.92 13.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.6 mmmt -80.62 -40.99 24.69 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.729 0.811 . . . . 0.0 109.417 173.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -156.98 169.22 25.3 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 118.518 0.599 . . . . 0.0 111.458 -175.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.6 mp -135.18 144.96 32.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 127.245 2.218 . . . . 0.0 106.503 -178.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -141.91 89.12 9.05 Favored Pre-proline 0 CA--C 1.539 0.558 0 C-N-CA 126.552 1.941 . . . . 0.0 108.737 -176.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -81.21 100.88 1.2 Allowed 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 123.542 2.828 . . . . 0.0 107.674 169.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -61.77 -35.5 78.31 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.486 1.114 . . . . 0.0 112.705 -169.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 141.52 47.04 0.05 OUTLIER Glycine 0 CA--C 1.527 0.808 0 N-CA-C 103.595 -3.802 . . . . 0.0 103.595 -169.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.6 mmmt -61.49 115.97 4.33 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.542 1.537 . . . . 0.0 110.445 -167.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -55.47 -33.29 63.53 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.994 0.918 . . . . 0.0 110.884 170.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -127.22 96.61 4.64 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 176.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.98 -15.03 58.36 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.954 0.902 . . . . 0.0 113.411 -172.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -68.61 -0.2 4.91 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 118.789 -0.624 . . . . 0.0 112.546 169.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.8 t -120.62 138.52 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 104.929 -2.249 . . . . 0.0 104.929 169.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 61.0 m -155.34 160.67 40.9 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.634 1.107 . . . . 0.0 110.061 173.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 41.7 ttm105 -83.35 144.09 29.9 Favored 'General case' 0 C--N 1.342 0.272 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 173.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.1 mp -129.3 157.22 42.49 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 128.075 2.55 . . . . 0.0 105.958 177.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -130.47 130.68 44.54 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 170.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 22.1 m -141.79 168.48 19.67 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.716 1.206 . . . . 0.0 110.998 -171.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -134.3 155.97 49.27 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.447 1.099 . . . . 0.0 108.589 169.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.6 p -69.34 143.82 53.65 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.165 0.586 . . . . 0.0 110.375 176.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -71.77 -36.92 70.53 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.426 0.69 . . . . 0.0 111.247 175.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.1 m -110.92 -10.86 14.39 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -168.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -125.99 -105.97 0.33 Allowed 'General case' 0 C--N 1.343 0.303 0 CA-C-N 120.733 1.606 . . . . 0.0 111.3 -169.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -169.16 14.48 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.749 1.22 . . . . 0.0 114.16 -169.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -65.92 150.52 48.48 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 121.571 -0.706 . . . . 0.0 110.329 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -124.87 113.93 18.52 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 104.18 -2.526 . . . . 0.0 104.18 169.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.1 tp -124.66 145.28 49.74 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.237 1.015 . . . . 0.0 111.243 -168.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 33.2 mm -131.29 142.28 43.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 128.536 2.734 . . . . 0.0 103.741 169.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 123' ' ' MET . 2.1 pt? -156.62 133.05 10.0 Favored 'General case' 0 C--O 1.224 -0.265 0 C-N-CA 124.543 1.137 . . . . 0.0 111.133 175.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -97.02 103.92 15.89 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 102.815 -3.032 . . . . 0.0 102.815 168.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.9 p -128.51 154.34 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 124.344 1.058 . . . . 0.0 111.309 -167.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -68.66 96.05 0.7 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.779 2.032 . . . . 0.0 108.404 169.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.0 pp -75.58 0.35 2.27 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.362 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -169.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -68.15 -4.65 14.49 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 121.425 1.92 . . . . 0.0 112.045 178.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.5 mt -62.16 -34.11 62.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 168.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -77.86 127.54 81.69 Favored Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 174.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.1 -51.23 0.28 Allowed 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.031 1.82 . . . . 0.0 113.052 -169.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.6 m -144.84 -12.94 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -169.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -155.12 152.48 29.54 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.133 0.973 . . . . 0.0 108.785 -175.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.3 mt -111.05 -3.18 15.61 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.437 1.095 . . . . 0.0 112.727 -170.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.09 51.1 4.23 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 176.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -144.4 166.61 24.61 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.676 1.59 . . . . 0.0 108.615 -172.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -93.4 165.39 12.79 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.139 0.976 . . . . 0.0 109.573 -177.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -139.74 -179.17 5.77 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 124.256 1.022 . . . . 0.0 108.767 174.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -136.46 142.25 43.59 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -173.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.3 tt -138.98 144.04 38.78 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.374 1.069 . . . . 0.0 108.605 -169.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.1 t -140.79 152.91 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 126.46 1.904 . . . . 0.0 106.937 -177.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.0 pt -128.85 25.15 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.381 1.073 . . . . 0.0 111.433 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.254 0 C-N-CA 123.38 0.672 . . . . 0.0 110.922 179.287 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.5 p90 . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -159.63 59.61 0.38 Allowed 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.494 -0.754 . . . . 0.0 109.633 -176.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -74.65 72.42 1.96 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 169.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.3 p -85.3 145.87 7.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 124.569 1.148 . . . . 0.0 109.002 -176.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.76 166.99 31.7 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.903 1.681 . . . . 0.0 109.74 -169.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -137.99 142.32 40.45 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.959 1.304 . . . . 0.0 108.911 -177.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -152.73 -157.27 7.93 Favored Glycine 0 C--N 1.336 0.582 0 CA-C-N 118.672 0.669 . . . . 0.0 113.225 -175.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -134.49 130.01 36.02 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 172.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 44.4 t -95.7 150.49 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -132.81 162.34 31.77 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 127.184 2.194 . . . . 0.0 106.883 174.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.93 169.66 19.34 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.12 -0.987 . . . . 0.0 110.67 177.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.64 171.31 18.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 125.121 1.368 . . . . 0.0 107.313 168.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -65.78 -6.99 13.52 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.0 1.72 . . . . 0.0 115.022 -170.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.225 0 C-N-CA 124.975 1.274 . . . . 0.0 112.868 -175.694 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.7 p . . . . . 0 C--O 1.238 0.448 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? 61.75 163.0 0.08 Allowed 'General case' 0 C--N 1.345 0.378 0 C-N-CA 126.593 1.957 . . . . 0.0 110.885 -169.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 52.9 tp -101.04 135.91 41.74 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 103.448 -2.797 . . . . 0.0 103.448 168.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 16.1 m -128.18 134.17 49.01 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -171.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -137.67 162.36 34.05 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.65 1.58 . . . . 0.0 109.405 -169.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -130.3 156.6 44.39 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 172.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.6 t -138.5 139.78 40.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.7 m -125.71 121.42 33.4 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 105.069 -2.196 . . . . 0.0 105.069 174.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -142.38 103.61 4.29 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.333 0.653 . . . . 0.0 109.848 -169.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 59.59 26.5 62.38 Favored Glycine 0 CA--C 1.534 1.269 0 O-C-N 121.68 -0.638 . . . . 0.0 113.628 178.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 93.23 -12.93 68.8 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.409 1.004 . . . . 0.0 113.128 -177.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 84.3 mt -80.91 162.78 23.77 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 118.553 1.176 . . . . 0.0 107.885 169.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 10.7 tp -140.16 153.94 46.8 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 121.808 -0.558 . . . . 0.0 110.3 -170.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.441 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 29.4 mtm -144.88 156.56 44.07 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.098 1.359 . . . . 0.0 108.494 169.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -136.71 133.44 36.12 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 104.126 -2.546 . . . . 0.0 104.126 169.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 32.5 tp -148.37 145.59 28.14 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.194 0.598 . . . . 0.0 110.374 -168.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -136.01 153.49 51.35 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 167.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -170.25 172.86 44.14 Favored Glycine 0 CA--C 1.521 0.424 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 172.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -55.22 139.61 41.63 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.007 1.404 . . . . 0.0 108.869 173.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -41.06 -54.93 2.71 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -63.4 -37.71 88.34 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 122.564 1.173 . . . . 0.0 111.716 -176.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -69.22 -20.24 63.96 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 113.337 -1.756 . . . . 0.0 111.798 178.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 24.6 tp -69.67 -22.79 63.41 Favored 'General case' 0 C--N 1.346 0.439 0 CA-C-N 120.158 1.344 . . . . 0.0 110.092 174.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 45.71 34.22 1.72 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.675 1.99 . . . . 0.0 114.13 171.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -159.21 57.07 0.33 Allowed Glycine 0 C--N 1.335 0.496 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 -171.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -65.65 -10.0 32.28 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -169.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -107.27 145.51 32.63 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 125.153 1.381 . . . . 0.0 109.93 179.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 7.7 m -60.69 -7.94 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.233 168.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -124.16 14.8 9.1 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 127.58 2.352 . . . . 0.0 112.035 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 70.2 m -81.6 -71.08 0.49 Allowed 'General case' 0 CA--C 1.529 0.151 0 O-C-N 121.589 -0.695 . . . . 0.0 109.491 168.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.299 13.1 ptm180 -85.27 18.26 2.71 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -169.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 18.7 m -62.12 -35.26 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 167.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -79.69 122.8 27.01 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 174.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 56.3 tp -142.82 140.7 31.41 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -169.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.8 tt -145.53 137.43 25.4 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -178.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 58.6 mtt -131.01 157.44 42.98 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.989 0.916 . . . . 0.0 109.457 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 39.8 pttt -164.7 169.95 16.22 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.146 1.378 . . . . 0.0 109.26 178.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.89 162.47 11.1 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.224 0.61 . . . . 0.0 111.363 172.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.44 164.71 2.43 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.57 1.148 . . . . 0.0 113.699 -177.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.72 60.3 5.21 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.063 1.345 . . . . 0.0 111.174 178.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 22.0 t80 . . . . . 0 C--O 1.25 1.105 0 C-N-CA 124.356 1.062 . . . . 0.0 108.371 176.107 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 65.7 tp . . . . . 0 N--CA 1.466 0.366 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -143.3 144.52 32.15 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 169.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -147.46 140.57 25.12 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 -171.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -147.78 144.25 28.09 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 124.262 1.025 . . . . 0.0 109.42 -178.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.77 141.13 25.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -138.08 158.84 43.51 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 122.786 0.435 . . . . 0.0 110.651 174.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -135.08 148.26 49.79 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.802 1.241 . . . . 0.0 109.386 -172.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.1 t -59.86 141.4 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 125.54 1.536 . . . . 0.0 109.847 -178.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -123.35 -29.75 3.78 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 126.377 1.871 . . . . 0.0 108.912 169.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -158.99 169.79 23.52 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.886 0.874 . . . . 0.0 109.669 169.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.6 mp -131.67 141.21 46.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -140.26 76.07 27.05 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 124.319 1.048 . . . . 0.0 108.286 -178.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -81.59 10.27 3.54 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.015 2.477 . . . . 0.0 113.92 -169.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -79.45 54.99 1.84 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.682 1.593 . . . . 0.0 110.199 176.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -150.19 38.4 0.9 Allowed Glycine 0 CA--C 1.528 0.851 0 C-N-CA 126.14 1.829 . . . . 0.0 110.002 -175.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.471 ' HE2' ' HA ' ' A' ' 20' ' ' LYS . 5.3 mmpt? -68.89 65.09 0.13 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.41 1.884 . . . . 0.0 114.083 -169.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -60.43 -38.74 85.04 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 168.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -144.05 162.79 35.33 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 129.161 2.984 . . . . 0.0 104.268 169.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -60.29 -33.68 72.7 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.328 -0.857 . . . . 0.0 111.764 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -75.77 -6.9 52.85 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 117.096 -1.431 . . . . 0.0 114.133 178.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 72.9 t -101.41 123.85 54.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 120.886 1.676 . . . . 0.0 107.162 -174.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.3 m -147.19 152.56 38.59 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.911 0.884 . . . . 0.0 109.561 -176.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 64.9 mtm-85 -83.36 150.61 25.99 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 169.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -129.69 155.16 46.33 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 127.092 2.157 . . . . 0.0 105.8 175.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -127.69 128.62 45.74 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 103.485 -2.783 . . . . 0.0 103.485 170.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 71.3 m -142.61 169.09 18.23 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.396 1.078 . . . . 0.0 111.481 -169.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -135.49 134.86 39.96 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.716 1.606 . . . . 0.0 106.957 176.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.0 m -75.05 142.38 43.75 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 121.392 0.615 . . . . 0.0 110.767 176.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -93.97 -34.93 12.87 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.634 1.174 . . . . 0.0 110.694 -175.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -69.89 -41.98 74.01 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.607 0.763 . . . . 0.0 112.949 -169.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -136.49 -95.22 0.23 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.596 0.758 . . . . 0.0 109.17 -175.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -165.91 110.96 0.85 Allowed 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.06 1.344 . . . . 0.0 108.379 -175.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.8 mtt -158.58 142.01 15.04 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 174.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -112.89 129.31 56.51 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 104.802 -2.296 . . . . 0.0 104.802 169.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.3 tp -136.63 139.46 42.09 Favored 'General case' 0 C--O 1.227 -0.112 0 C-N-CA 123.52 0.728 . . . . 0.0 111.987 -168.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 35.3 mm -121.72 140.96 44.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 102.261 -3.237 . . . . 0.0 102.261 168.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 123' ' ' MET . 2.3 pt? -154.66 158.25 39.37 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 123.704 0.802 . . . . 0.0 110.586 177.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -127.09 111.53 14.13 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.411 HG11 HD12 ' A' ' 41' ' ' LEU . 28.6 m -145.6 166.89 9.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 O-C-N 124.224 0.953 . . . . 0.0 113.195 -168.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -72.65 126.87 30.92 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.945 1.298 . . . . 0.0 107.659 169.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 pp -105.6 -1.05 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -67.23 -16.92 64.58 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 120.775 1.625 . . . . 0.0 111.644 177.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.3 mt -58.57 -27.44 33.89 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 124.23 1.012 . . . . 0.0 109.187 169.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -122.42 158.68 55.4 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 125.093 1.357 . . . . 0.0 113.49 -168.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -75.01 75.13 3.8 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 124.012 3.142 . . . . 0.0 109.55 171.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.5 p -53.98 -23.81 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 124.972 1.309 . . . . 0.0 113.328 -174.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -59.25 -22.43 61.11 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.438 1.095 . . . . 0.0 113.024 174.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 59.1 tp -129.79 -30.19 2.07 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.192 1.397 . . . . 0.0 111.713 -177.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.82 164.95 36.37 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 -169.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -159.2 166.2 31.94 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.71 1.204 . . . . 0.0 108.525 -178.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -74.63 163.97 27.11 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 172.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -128.25 164.92 21.51 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.754 1.622 . . . . 0.0 107.159 177.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.8 ttm180 -127.1 141.14 51.84 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 125.914 1.686 . . . . 0.0 106.581 170.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 39.9 tp -123.72 141.44 52.02 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 127.057 2.143 . . . . 0.0 106.653 178.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.1 t -134.83 142.06 41.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 172.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.7 pt -128.96 19.51 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.329 1.052 . . . . 0.0 110.759 -173.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.216 0 C-N-CA 124.24 1.016 . . . . 0.0 110.57 175.174 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 . . . . . 0 CA--C 1.536 0.426 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -61.08 -31.26 70.93 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 114.09 1.145 . . . . 0.0 114.09 -168.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -144.01 142.23 30.58 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 118.799 0.727 . . . . 0.0 109.154 172.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.2 m -143.06 139.15 27.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 C-N-CA 126.143 1.777 . . . . 0.0 106.707 177.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 37.5 tpp -161.02 166.04 28.84 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.325 1.05 . . . . 0.0 109.078 -177.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -124.54 145.31 49.65 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 170.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -153.15 -170.16 19.08 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-N 118.768 0.713 . . . . 0.0 111.766 -172.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -117.84 134.79 54.58 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.0 t -112.21 134.79 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 175.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -151.23 148.21 27.94 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.739 1.216 . . . . 0.0 108.233 -174.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.15 175.46 1.52 Allowed 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.427 1.491 . . . . 0.0 109.476 170.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 33.8 pt -70.06 -175.44 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 123.861 0.864 . . . . 0.0 110.304 169.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -63.81 -6.38 5.7 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.5 1.92 . . . . 0.0 115.687 -171.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.66 0 CA-C-O 118.851 -0.972 . . . . 0.0 112.812 178.003 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.6 p . . . . . 0 N--CA 1.47 0.546 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.4 mpt_? -132.72 128.69 37.46 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 126.077 1.751 . . . . 0.0 106.497 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.5 tp -73.91 139.0 44.65 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 174.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 7.8 p -90.75 154.95 19.16 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 122.045 -0.409 . . . . 0.0 110.34 176.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -147.77 137.78 22.8 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.132 0.973 . . . . 0.0 108.641 170.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 10.6 m-30 -114.96 146.53 41.09 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 103.45 -2.796 . . . . 0.0 103.45 168.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.2 t -135.33 143.56 36.6 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -173.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.3 t -134.85 123.94 24.29 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 105.496 -2.038 . . . . 0.0 105.496 169.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -146.98 107.94 4.19 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.408 0.683 . . . . 0.0 109.359 -169.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 57.17 24.15 50.03 Favored Glycine 0 CA--C 1.536 1.389 0 O-C-N 121.595 -0.691 . . . . 0.0 113.855 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 93.96 -11.33 71.03 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 124.629 1.109 . . . . 0.0 113.435 -178.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.5 mp -82.34 160.67 22.79 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 170.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 7.0 tp -139.5 159.71 41.53 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.817 -0.552 . . . . 0.0 111.036 -169.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.442 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 26.1 mtt -149.25 156.38 42.03 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 125.295 1.438 . . . . 0.0 109.092 169.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 39.0 mtm105 -143.47 126.31 16.17 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 105.019 -2.215 . . . . 0.0 105.019 169.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -155.81 166.4 33.61 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 119.667 1.122 . . . . 0.0 112.902 -169.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -134.82 141.33 46.37 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 168.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -156.53 168.85 33.82 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.32 132.19 33.91 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 170.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -45.82 -43.33 13.24 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 175.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.6 -22.86 65.34 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 120.989 -1.069 . . . . 0.0 113.601 177.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -75.65 -19.61 59.05 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 125.527 1.531 . . . . 0.0 110.808 172.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -85.84 3.6 40.9 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 119.467 1.03 . . . . 0.0 109.365 168.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 1.5 t60 38.33 30.04 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.513 1 C-N-CA 131.789 4.036 . . . . 0.0 118.107 169.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 163.27 28.69 0.02 OUTLIER Glycine 0 CA--C 1.525 0.698 0 CA-C-O 119.243 -0.754 . . . . 0.0 111.947 178.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 45.79 40.05 5.99 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.82 1.648 . . . . 0.0 111.95 -169.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . 0.369 2.7 pp20? 43.57 -148.53 0.05 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.932 2.093 . . . . 0.0 114.623 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.7 t 67.9 -34.49 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 127.6 2.36 . . . . 0.0 111.879 -168.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -154.37 18.05 0.48 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.416 1.087 . . . . 0.0 112.433 -170.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 48.8 m -87.04 -77.02 0.34 Allowed 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 169.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.277 9.8 ptm180 -79.35 14.53 1.51 Allowed 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.482 1.113 . . . . 0.0 113.186 -172.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 20.8 m -63.72 -38.67 82.91 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 167.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -82.67 129.22 34.92 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 169.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 7.4 tt -142.12 127.25 18.52 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 118.637 0.653 . . . . 0.0 109.306 -174.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 7.3 tt -132.94 134.06 44.03 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 178.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 60.2 ttm -137.78 140.07 40.39 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -176.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -158.94 -176.28 5.77 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.152 0.981 . . . . 0.0 109.786 178.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -52.93 158.63 1.35 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.992 1.317 . . . . 0.0 112.283 169.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.34 169.68 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.69 2.396 . . . . 0.0 114.205 174.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -125.85 0.43 7.35 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 179.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 14.2 p90 . . . . . 0 C--O 1.249 1.033 0 C-N-CA 127.955 2.502 . . . . 0.0 106.826 -179.482 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tt . . . . . 0 CA--C 1.536 0.441 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -151.69 148.12 27.54 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.101 1.36 . . . . 0.0 108.184 171.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -148.64 143.15 26.33 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 126.431 1.892 . . . . 0.0 107.529 -173.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -151.81 124.9 8.66 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.224 1.009 . . . . 0.0 108.785 172.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.6 mp -79.44 142.14 14.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 104.385 -2.45 . . . . 0.0 104.385 169.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -130.44 158.4 39.99 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.391 0.615 . . . . 0.0 109.807 171.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -119.1 132.98 56.05 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.477 1.511 . . . . 0.0 107.194 178.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.4 p -69.99 135.04 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.9 mmmm -113.06 -25.17 9.07 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.303 1.441 . . . . 0.0 109.977 -177.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -156.07 163.34 39.79 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.098 0.863 . . . . 0.0 110.672 169.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.9 mp -139.09 137.27 42.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 127.264 2.225 . . . . 0.0 105.414 179.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -142.89 97.24 5.87 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 124.589 1.156 . . . . 0.0 108.985 -173.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -61.02 1.28 0.62 Allowed 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 124.326 3.351 . . . . 0.0 117.541 -175.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -77.28 46.73 0.52 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.726 2.01 . . . . 0.0 110.973 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -153.74 35.72 0.74 Allowed Glycine 0 CA--C 1.528 0.859 0 C-N-CA 126.995 2.236 . . . . 0.0 108.928 178.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.68 55.41 0.26 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.567 1.947 . . . . 0.0 113.648 -169.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -54.44 -39.76 67.71 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 121.35 -0.843 . . . . 0.0 109.647 170.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -142.64 163.97 31.37 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 128.037 2.535 . . . . 0.0 104.569 169.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -57.48 -34.63 69.23 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.55 -0.719 . . . . 0.0 111.485 176.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 -79.03 4.23 15.03 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-O 117.101 -1.428 . . . . 0.0 114.535 178.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 81.3 t -118.04 132.17 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 121.736 2.062 . . . . 0.0 107.519 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 65.1 m -145.79 159.84 42.61 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.637 0.775 . . . . 0.0 109.709 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -76.69 148.91 36.52 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 169.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -142.56 153.99 44.05 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.712 1.605 . . . . 0.0 107.521 -169.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -134.3 136.58 43.61 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 171.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 67.7 m -145.35 165.38 28.63 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.277 1.031 . . . . 0.0 110.945 -171.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -139.54 136.01 34.03 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.273 1.429 . . . . 0.0 108.496 178.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.2 m -60.67 139.87 57.69 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.842 0.857 . . . . 0.0 112.185 173.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -94.41 -44.44 7.9 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 168.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.0 m -73.13 -38.16 66.39 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 118.643 -0.694 . . . . 0.0 112.029 -172.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -121.14 -106.84 0.37 Allowed 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -166.3 8.96 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 -169.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.8 mpp? -69.04 148.55 49.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.75 0.786 . . . . 0.0 109.145 -174.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -103.93 138.69 40.13 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 169.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.8 mt -135.86 144.71 45.75 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.287 0.635 . . . . 0.0 110.17 -169.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.8 mm -130.19 143.19 41.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 103.157 -2.905 . . . . 0.0 103.157 169.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 123' ' ' MET . 4.8 mp -144.61 159.84 42.15 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.622 1.569 . . . . 0.0 108.166 -177.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -136.04 95.1 3.14 Favored 'General case' 0 C--N 1.32 -0.693 1 N-CA-C 99.758 -4.164 . . . . 0.0 99.758 169.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.1 p -147.11 167.45 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 121.285 0.564 . . . . 0.0 112.392 -167.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -58.27 140.31 53.49 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.883 1.273 . . . . 0.0 109.31 169.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 pp -119.55 -1.38 8.56 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.669 0 CA-C-O 116.972 -1.49 . . . . 0.0 113.263 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -63.64 -15.57 58.65 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 121.773 2.079 . . . . 0.0 114.212 -169.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.665 ' H ' HD12 ' A' ' 47' ' ' ILE . 0.6 OUTLIER -65.69 -28.39 44.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 127.388 2.275 . . . . 0.0 111.093 173.803 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -52.57 155.17 3.99 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 124.534 1.134 . . . . 0.0 111.979 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -73.87 50.57 2.15 Favored 'Trans proline' 0 CA--C 1.547 1.162 0 C-N-CA 124.698 3.599 . . . . 0.0 112.959 175.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . 0.27 20.3 m 52.65 -9.94 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 131.13 3.772 . . . . 0.0 119.229 169.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -143.2 -12.5 0.72 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 120.358 1.435 . . . . 0.0 112.625 -173.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -156.36 169.16 25.23 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 126.239 1.815 . . . . 0.0 108.259 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.16 175.22 54.71 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 176.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -152.18 171.08 18.48 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.732 1.213 . . . . 0.0 109.142 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -79.17 155.39 28.68 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.51 1.124 . . . . 0.0 109.698 175.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -129.74 162.25 28.83 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.975 1.31 . . . . 0.0 108.808 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 42.0 ttt180 -115.07 134.14 55.43 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 173.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 57.7 tp -127.78 132.86 49.47 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 177.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.6 m -137.99 163.99 28.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 124.551 1.14 . . . . 0.0 108.093 177.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.0 pt -127.41 13.07 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 123.514 0.726 . . . . 0.0 110.53 177.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.436 0 C-N-CA 124.548 1.139 . . . . 0.0 113.574 -175.7 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 . . . . . 0 CA--C 1.538 0.518 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -146.04 -40.85 0.21 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.175 0.59 . . . . 0.0 109.421 169.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -143.94 144.73 31.83 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 123.909 0.884 . . . . 0.0 108.698 175.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.1 p -142.58 142.29 26.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 5.2 tmm? -158.89 160.75 36.48 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.455 0.645 . . . . 0.0 111.28 -168.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -129.91 104.92 7.65 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 104.721 -2.326 . . . . 0.0 104.721 173.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -94.93 -173.11 37.62 Favored Glycine 0 C--N 1.332 0.361 0 CA-C-O 121.288 0.382 . . . . 0.0 112.585 -169.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -120.61 100.56 7.2 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 169.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.411 HG13 ' HA ' ' A' ' 137' ' ' VAL . 0.1 OUTLIER -70.42 142.13 16.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 170.588 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -136.37 127.22 27.48 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 103.075 -2.935 . . . . 0.0 103.075 169.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -146.29 169.18 19.33 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 120.028 1.285 . . . . 0.0 112.881 -169.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.1 pt -134.63 165.77 30.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 C-N-CA 126.533 1.933 . . . . 0.0 108.325 -169.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -66.53 -3.96 7.46 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.964 1.706 . . . . 0.0 112.77 175.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.934 0 N-CA-C 104.855 -3.298 . . . . 0.0 104.855 -169.851 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.469 0.492 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -138.27 140.14 39.49 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 103.948 -2.612 . . . . 0.0 103.948 169.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 22.3 tp -75.96 157.77 32.74 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 169.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 2.2 m -139.96 146.09 38.7 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -177.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -147.84 160.17 43.05 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.019 0.928 . . . . 0.0 109.157 178.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -124.76 149.78 46.97 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 173.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.9 t -141.24 116.07 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 17.2 m -86.34 124.56 32.84 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 105.469 -2.048 . . . . 0.0 105.469 169.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.4 m-30 -86.89 163.43 17.17 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 169.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -56.96 67.02 0.01 OUTLIER Glycine 0 CA--C 1.539 1.538 0 C-N-CA 126.521 2.01 . . . . 0.0 114.512 170.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 119.24 -7.24 12.72 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 127.137 2.303 . . . . 0.0 113.407 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -139.24 -179.81 6.09 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 119.885 1.842 . . . . 0.0 108.369 -169.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.7 tt -154.77 160.46 41.32 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 121.346 1.885 . . . . 0.0 112.3 -177.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.419 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 26.0 ptt? -149.74 161.52 42.06 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.7 1.6 . . . . 0.0 109.426 169.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 92.0 mtt-85 -137.54 139.91 40.75 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 174.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 8.0 tt -143.89 147.93 34.71 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 123.13 0.572 . . . . 0.0 110.441 -169.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -129.07 151.47 49.72 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 168.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -173.55 173.07 45.65 Favored Glycine 0 C--N 1.329 0.146 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 170.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.93 139.98 38.75 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 169.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -39.94 -60.43 1.02 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -178.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -60.45 -37.52 81.22 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.874 0.845 . . . . 0.0 112.46 -178.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -66.9 -23.38 65.99 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 125.307 1.443 . . . . 0.0 111.249 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.7 tt -69.58 -26.78 64.63 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.481 1.037 . . . . 0.0 110.195 177.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 43.39 40.05 2.46 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 127.798 2.439 . . . . 0.0 113.472 175.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -165.62 42.71 0.28 Allowed Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 -169.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -76.17 9.41 2.55 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.546 1.138 . . . . 0.0 112.273 -173.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -130.15 135.95 48.75 Favored 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 125.212 1.405 . . . . 0.0 108.643 -172.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.411 ' HA ' HG13 ' A' ' 96' ' ' VAL . 15.6 m -57.1 -5.07 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 126.626 1.97 . . . . 0.0 112.31 169.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -134.38 16.83 3.7 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 173.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.7 m -102.78 -51.97 3.18 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 167.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 5.2 tpm_? -75.71 0.45 17.73 Favored 'General case' 0 C--N 1.342 0.271 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -172.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 35.7 m -62.55 -41.57 92.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 124.18 0.992 . . . . 0.0 110.83 169.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -71.28 130.95 42.69 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -170.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 7.7 tt -150.67 134.09 16.34 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 117.939 0.336 . . . . 0.0 110.292 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.8 tt -144.56 135.35 24.85 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 106.492 -1.669 . . . . 0.0 106.492 169.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 14.6 ptp -142.38 159.08 42.94 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 118.501 0.592 . . . . 0.0 111.663 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -157.01 -173.77 4.61 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 126.084 1.754 . . . . 0.0 108.756 171.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -60.95 169.69 1.85 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.889 0.768 . . . . 0.0 109.669 169.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -44.2 155.63 0.09 Allowed 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 179.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.86 63.5 7.0 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.776 1.23 . . . . 0.0 110.054 177.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 19.8 t80 . . . . . 0 C--O 1.249 1.042 0 C-N-CA 123.944 0.897 . . . . 0.0 108.81 178.495 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 22.1 tp . . . . . 0 CA--C 1.542 0.664 0 CA-C-O 120.95 0.405 . . . . 0.0 109.909 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -150.69 125.61 9.82 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.416 1.086 . . . . 0.0 109.095 -177.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -155.87 140.59 17.05 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 178.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -148.41 148.59 30.5 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.13 0.877 . . . . 0.0 110.368 169.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 mp -77.54 154.46 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 173.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -145.76 160.45 41.72 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.971 0.909 . . . . 0.0 110.241 171.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -135.13 129.58 34.11 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.194 1.798 . . . . 0.0 108.194 -169.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.8 p -68.36 123.51 21.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 121.825 0.822 . . . . 0.0 109.058 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -82.14 -42.06 19.6 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 124.537 1.135 . . . . 0.0 109.294 170.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -159.76 167.98 26.98 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 118.831 0.742 . . . . 0.0 111.638 -175.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.3 mp -138.82 138.27 42.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 127.769 2.428 . . . . 0.0 105.55 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -146.0 97.76 4.48 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 118.787 0.721 . . . . 0.0 110.966 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -58.07 59.82 0.05 OUTLIER 'Trans proline' 0 CA--C 1.548 1.214 1 C-N-CA 126.921 5.081 . . . . 0.0 116.595 174.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -123.91 43.67 2.92 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.688 1.595 . . . . 0.0 109.789 178.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -168.1 44.45 0.24 Allowed Glycine 0 C--N 1.336 0.554 0 C-N-CA 124.182 0.896 . . . . 0.0 110.994 -175.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.9 mmmm -76.0 68.07 2.43 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.13 0.965 . . . . 0.0 111.149 -169.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.21 -36.61 68.63 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 169.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -139.68 167.44 22.09 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 128.651 2.78 . . . . 0.0 104.551 169.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -68.72 -25.34 64.71 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.079 -1.013 . . . . 0.0 111.351 -173.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -82.0 -6.35 59.07 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-O 116.536 -1.697 . . . . 0.0 113.553 175.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 70.0 t -101.35 128.75 53.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 121.664 2.029 . . . . 0.0 107.728 -175.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.2 m -148.19 167.97 23.7 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.787 1.235 . . . . 0.0 109.304 -177.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.0 tpp85 -70.58 153.98 42.33 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 170.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.8 mt -138.19 156.13 48.01 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.296 1.838 . . . . 0.0 106.904 170.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -133.39 133.68 42.72 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 170.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 65.0 m -143.0 163.65 32.2 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.719 1.208 . . . . 0.0 110.352 -171.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -134.7 137.73 43.79 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.861 1.664 . . . . 0.0 107.051 177.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.8 m -93.65 142.62 27.15 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.058 0.456 . . . . 0.0 110.169 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -69.75 -54.93 11.42 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.788 1.635 . . . . 0.0 113.122 -168.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.6 m -89.35 -35.47 16.07 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 123.114 0.566 . . . . 0.0 111.747 -169.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -108.03 6.56 27.16 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -169.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.287 0.0 OUTLIER 45.99 28.58 0.64 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.179 1.792 . . . . 0.0 114.467 178.678 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 78.8 mtm -61.52 152.48 30.11 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 169.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -123.73 124.12 42.01 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.6 tt -130.67 150.63 51.77 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.864 0.84 . . . . 0.0 111.818 -168.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 16.8 mm -129.15 147.46 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 128.75 2.82 . . . . 0.0 103.729 169.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.406 HD22 ' CG1' ' A' ' 43' ' ' VAL . 0.5 OUTLIER -147.5 155.42 41.87 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 127.626 2.37 . . . . 0.0 105.89 -171.08 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -142.49 103.01 4.18 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 104.701 -2.333 . . . . 0.0 104.701 170.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.472 HG22 ' H ' ' A' ' 44' ' ' ASN . 9.9 p -163.43 179.59 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 124.044 0.938 . . . . 0.0 109.765 -169.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.472 ' H ' HG22 ' A' ' 43' ' ' VAL . 29.6 t30 -52.53 130.49 31.99 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.84 1.656 . . . . 0.0 111.646 172.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.6 pp -110.33 -1.98 10.07 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 C-N-CA 124.946 1.299 . . . . 0.0 113.134 177.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -70.24 -9.54 56.22 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 120.028 1.285 . . . . 0.0 111.395 177.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.2 mt -61.65 -36.53 74.05 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 168.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -91.05 156.14 44.32 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 125.36 1.464 . . . . 0.0 110.526 -177.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.28 169.63 17.87 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.567 2.178 . . . . 0.0 109.921 169.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.0 m -63.71 -23.9 34.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 -169.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -153.23 -35.34 0.11 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.248 0.931 . . . . 0.0 113.497 -175.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 54.6 tp -62.65 -27.69 69.4 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -172.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.98 177.65 36.6 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 -169.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -158.35 175.2 14.02 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.134 0.974 . . . . 0.0 108.768 -178.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -125.39 135.57 52.54 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.003 1.321 . . . . 0.0 107.695 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -131.53 -173.39 3.11 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -129.85 151.48 50.37 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.846 1.258 . . . . 0.0 108.246 177.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 62.1 tp -124.39 138.87 54.32 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 127.005 2.122 . . . . 0.0 107.328 -174.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 41.0 t -144.77 152.64 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 126.626 1.97 . . . . 0.0 106.048 -175.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.5 pt -133.0 55.24 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.477 1.111 . . . . 0.0 108.925 176.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.145 0 C-N-CA 124.752 1.221 . . . . 0.0 110.662 -176.485 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 . . . . . 0 CA--C 1.535 0.386 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -78.11 -33.62 50.5 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.691 -0.631 . . . . 0.0 109.485 174.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -160.19 158.67 30.49 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.492 0.717 . . . . 0.0 109.791 169.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.2 m -139.53 145.07 27.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 C-N-CA 125.25 1.42 . . . . 0.0 107.177 172.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 15.8 ttt -151.83 143.39 23.53 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.915 0.886 . . . . 0.0 109.073 -169.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -135.74 75.67 1.57 Allowed 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 175.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -93.57 -163.94 36.8 Favored Glycine 0 C--N 1.337 0.589 0 N-CA-C 115.26 0.864 . . . . 0.0 115.26 -167.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -131.31 128.84 40.58 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 170.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -74.55 148.84 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 124.946 1.299 . . . . 0.0 108.642 169.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -142.09 64.83 1.38 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.653 1.581 . . . . 0.0 109.131 178.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -156.3 178.96 9.71 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 120.772 -1.205 . . . . 0.0 110.913 -178.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.53 -179.69 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 126.643 1.977 . . . . 0.0 109.5 -173.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -59.99 -6.69 1.42 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.849 2.06 . . . . 0.0 116.481 -169.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.47 0 N-CA-C 108.236 -1.946 . . . . 0.0 108.236 171.126 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.9 p . . . . . 0 N--CA 1.468 0.431 0 CA-C-O 122.024 0.916 . . . . 0.0 112.916 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -135.34 145.42 47.39 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 171.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 40.6 tp -76.49 150.11 36.68 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 105.453 -2.055 . . . . 0.0 105.453 168.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 14.9 m -128.24 150.19 50.14 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -174.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -143.67 149.13 36.8 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.286 1.034 . . . . 0.0 108.365 176.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -134.54 135.2 42.15 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 101.412 -3.551 . . . . 0.0 101.412 169.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.4 t -142.35 144.23 25.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -170.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.4 m -134.46 143.2 47.38 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -159.92 134.15 7.48 Favored 'General case' 0 C--O 1.226 -0.151 0 C-N-CA 123.524 0.73 . . . . 0.0 109.957 171.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 54.61 27.41 42.17 Favored Glycine 0 CA--C 1.537 1.461 0 N-CA-C 114.935 0.734 . . . . 0.0 114.935 169.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 85.73 1.13 87.49 Favored Glycine 0 CA--C 1.535 1.312 0 CA-C-N 118.488 1.144 . . . . 0.0 113.866 -177.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.12 153.19 17.77 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.821 1.648 . . . . 0.0 107.995 173.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 22.8 tp -133.38 156.57 47.43 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.109 0.964 . . . . 0.0 109.477 -176.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 60.6 mtt -144.04 156.48 44.4 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.789 1.636 . . . . 0.0 108.44 171.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.6 129.96 23.84 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 104.377 -2.453 . . . . 0.0 104.377 169.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 18.8 tp -144.7 147.61 33.22 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 119.511 1.05 . . . . 0.0 109.72 -168.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -139.19 153.78 47.95 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.989 0.916 . . . . 0.0 108.753 169.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -172.78 171.13 44.18 Favored Glycine 0 CA--C 1.519 0.333 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 169.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -54.71 141.18 33.22 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 118.804 1.302 . . . . 0.0 107.52 169.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -40.47 -59.44 1.33 Allowed 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -178.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.15 -13.71 62.32 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.345 -0.847 . . . . 0.0 113.134 -174.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -89.31 -27.23 20.67 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 126.175 1.79 . . . . 0.0 109.808 177.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 5.8 tt -78.02 -26.48 48.5 Favored 'General case' 0 C--N 1.344 0.33 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 169.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 3.1 t60 51.95 32.24 9.73 Favored 'General case' 0 C--N 1.344 0.355 0 C-N-CA 126.885 2.074 . . . . 0.0 113.155 168.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -154.97 86.66 0.13 Allowed Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 -169.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -50.66 125.78 13.96 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 169.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.49 175.37 2.3 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -168.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.4 t 70.12 -25.18 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 127.602 2.361 . . . . 0.0 111.768 -170.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -163.53 59.26 0.17 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 120.351 1.432 . . . . 0.0 112.285 -170.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 36.3 m -145.79 -53.9 0.27 Allowed 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 113.64 -1.618 . . . . 0.0 108.841 168.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -75.35 4.59 6.93 Favored 'General case' 0 C--N 1.343 0.299 0 O-C-N 121.867 -0.521 . . . . 0.0 112.285 177.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 11.1 m -81.93 -3.63 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 C-N-CA 123.872 0.869 . . . . 0.0 111.696 178.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -136.57 116.12 12.87 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 169.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 10.4 tt -143.28 142.97 31.53 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.154 0.582 . . . . 0.0 109.527 -169.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 15.6 tp -140.53 141.75 35.26 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 125.815 1.646 . . . . 0.0 107.477 -172.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 38.6 ttm -131.35 132.37 44.4 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -148.35 147.72 29.57 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -178.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -54.55 155.96 3.73 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.663 1.12 . . . . 0.0 111.597 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.6 pp -67.38 158.92 30.52 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 169.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -149.38 96.89 2.57 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.298 0.639 . . . . 0.0 110.058 -177.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 24.3 p90 . . . . . 0 C--O 1.252 1.185 0 C-N-CA 126.096 1.758 . . . . 0.0 107.471 169.675 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 60.9 tp . . . . . 0 CA--C 1.531 0.22 0 CA-C-O 120.924 0.392 . . . . 0.0 110.599 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -157.97 145.36 18.25 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 104.096 -2.557 . . . . 0.0 104.096 169.244 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -147.72 144.8 28.56 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.443 1.497 . . . . 0.0 107.786 -175.01 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -154.27 167.64 29.26 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.233 1.813 . . . . 0.0 108.548 178.464 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.2 mp -124.72 114.34 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 103.646 -2.724 . . . . 0.0 103.646 169.828 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -94.23 152.2 18.88 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.486 0.66 . . . . 0.0 109.705 -179.863 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -135.1 133.85 39.68 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 126.408 1.883 . . . . 0.0 108.257 -173.832 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 40.3 t -68.71 143.88 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 123.997 0.919 . . . . 0.0 109.392 -178.057 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -124.24 -28.22 3.71 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 126.785 2.034 . . . . 0.0 109.341 177.542 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -159.06 168.23 27.21 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.481 1.037 . . . . 0.0 111.136 171.066 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.4 mp -135.2 139.05 47.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 127.443 2.297 . . . . 0.0 105.927 179.603 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -147.06 91.98 5.04 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 123.301 0.64 . . . . 0.0 112.27 -173.519 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -68.5 97.12 0.51 Allowed 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 123.059 2.506 . . . . 0.0 108.477 168.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -59.37 -36.32 75.53 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.966 0.906 . . . . 0.0 112.84 -169.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.35 44.65 0.03 OUTLIER Glycine 0 CA--C 1.525 0.703 0 N-CA-C 103.749 -3.741 . . . . 0.0 103.749 -170.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.4 mmmt -65.47 132.37 48.77 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.37 1.068 . . . . 0.0 111.811 -167.394 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -60.47 -33.59 72.81 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 113.798 -1.546 . . . . 0.0 110.087 169.3 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -132.47 102.4 5.71 Favored 'General case' 0 N--CA 1.458 -0.068 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 178.212 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -55.04 -33.09 62.39 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.468 1.107 . . . . 0.0 113.514 -169.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -65.54 -5.69 8.75 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 117.446 -1.264 . . . . 0.0 113.586 178.475 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.5 t -121.52 111.82 32.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 174.677 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 74.0 m -140.11 169.2 18.13 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 124.383 1.073 . . . . 0.0 111.013 -173.859 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -74.59 150.48 39.67 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 175.083 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 71.5 mt -134.12 158.16 44.34 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 127.051 2.14 . . . . 0.0 106.81 173.816 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -128.67 134.57 48.55 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 169.478 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 72.2 m -142.95 169.04 18.32 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.451 1.5 . . . . 0.0 110.352 -171.516 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -136.41 144.5 44.54 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.802 2.041 . . . . 0.0 107.863 -177.707 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.2 p -74.98 158.65 32.91 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.431 1.093 . . . . 0.0 110.992 174.203 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -72.59 -41.55 65.51 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.558 -0.714 . . . . 0.0 110.748 177.656 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.4 m -136.45 6.64 3.02 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -169.052 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -121.32 14.97 11.31 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -169.174 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.264 0.0 OUTLIER 41.45 31.66 0.19 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.95 2.1 . . . . 0.0 114.739 178.295 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 57.3 mtt -74.38 153.95 39.04 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.452 1.101 . . . . 0.0 110.381 -179.104 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -114.34 104.31 11.94 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 169.459 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 62.3 tp -112.18 144.26 41.88 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -171.707 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 31.2 mm -134.0 147.05 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 104.088 -2.56 . . . . 0.0 104.088 174.131 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 123' ' ' MET . 3.2 mp -144.13 158.11 43.91 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 126.155 1.782 . . . . 0.0 107.961 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -133.35 100.86 4.96 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 101.971 -3.344 . . . . 0.0 101.971 168.239 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.8 m -146.23 175.57 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 124.867 1.267 . . . . 0.0 111.126 -167.552 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -58.54 128.5 37.48 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.823 0.849 . . . . 0.0 109.254 169.654 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 pp -115.44 6.0 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 125.101 1.361 . . . . 0.0 112.875 -179.005 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -66.81 -15.0 63.3 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 120.693 1.588 . . . . 0.0 112.069 -176.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.6 mt -65.14 -24.52 35.45 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 C-N-CA 125.293 1.437 . . . . 0.0 109.581 169.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -123.22 71.88 45.92 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 126.931 2.092 . . . . 0.0 109.275 -172.682 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -68.32 -12.34 34.67 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.651 2.234 . . . . 0.0 111.933 173.323 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.5 p -147.32 175.2 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 128.728 2.811 . . . . 0.0 104.917 173.351 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -69.78 69.98 0.31 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.967 0.907 . . . . 0.0 110.123 169.849 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 50.3 tp -64.96 -25.85 68.05 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.729 1.612 . . . . 0.0 111.96 -175.084 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 67.35 26.54 73.52 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-O 119.659 -0.523 . . . . 0.0 112.108 -177.279 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -70.75 157.66 37.66 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 118.024 0.912 . . . . 0.0 108.736 169.853 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -135.97 152.83 51.36 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.188 0.995 . . . . 0.0 109.819 -169.323 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -132.9 127.24 33.93 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -174.456 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -71.45 134.79 46.84 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 169.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 tt -134.79 139.69 45.31 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 -179.67 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 t -139.19 158.04 28.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 -178.176 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 36.0 pt -121.62 14.87 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 123.389 0.675 . . . . 0.0 111.11 176.652 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.481 0 C-N-CA 124.453 1.101 . . . . 0.0 113.444 -175.521 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 . . . . . 0 CA--C 1.533 0.289 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -78.86 -24.83 44.05 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 122.954 0.502 . . . . 0.0 111.741 -171.067 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -147.67 148.22 30.82 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.683 0.793 . . . . 0.0 109.686 -175.53 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.4 p -146.14 143.64 21.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 175.365 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 31.4 tpp -157.81 170.47 22.27 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.592 0.757 . . . . 0.0 110.424 -175.288 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -136.07 154.47 51.01 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.486 2.315 . . . . 0.0 106.116 -175.252 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -161.89 -153.0 6.91 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-N 119.365 0.984 . . . . 0.0 113.838 -169.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -147.57 124.61 11.38 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.339 1.456 . . . . 0.0 108.243 176.823 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 46.1 t -77.61 133.72 29.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 168.775 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -141.24 70.72 1.35 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.99 0.916 . . . . 0.0 110.524 -169.093 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -155.5 173.01 17.29 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.873 -1.142 . . . . 0.0 111.556 175.079 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 19.7 pt -74.02 -177.63 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 126.128 1.771 . . . . 0.0 112.255 -172.575 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -65.81 -13.59 59.78 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.256 1.822 . . . . 0.0 114.893 -173.621 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.68 0 C-N-CA 124.514 1.054 . . . . 0.0 111.483 178.663 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.3 p . . . . . 0 C--O 1.233 0.212 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? -126.91 141.07 51.9 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 172.133 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.3 tp -73.13 144.48 46.92 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 104.339 -2.467 . . . . 0.0 104.339 167.7 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 7.9 p -110.25 141.92 42.56 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 169.749 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -142.65 152.61 42.63 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 125.29 1.436 . . . . 0.0 107.207 -175.643 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -134.63 143.46 47.31 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 102.332 -3.21 . . . . 0.0 102.332 169.092 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 13.8 t -133.07 116.59 26.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 105.658 -1.979 . . . . 0.0 105.658 -179.155 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.5 p -96.76 129.96 44.09 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 170.042 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -152.05 123.62 7.86 Favored 'General case' 0 C--N 1.334 -0.103 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -171.051 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 52.9 27.66 29.82 Favored Glycine 0 CA--C 1.538 1.492 0 CA-C-O 119.455 -0.636 . . . . 0.0 114.234 -178.801 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 82.28 -0.39 88.95 Favored Glycine 0 CA--C 1.536 1.384 0 CA-C-N 118.448 1.124 . . . . 0.0 114.007 -177.815 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 63.5 mt -99.16 170.94 8.33 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.449 1.5 . . . . 0.0 108.3 171.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 45.4 tp -139.46 157.65 45.47 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 118.628 0.649 . . . . 0.0 111.301 -170.494 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.478 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 54.5 mtt -143.57 160.3 40.88 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 126.258 1.823 . . . . 0.0 109.055 169.389 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 41.5 ttt180 -135.04 137.28 42.78 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 102.972 -2.973 . . . . 0.0 102.972 168.532 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 25.4 tp -147.91 137.29 22.32 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -169.743 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -128.45 144.3 51.12 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 170.41 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -177.79 170.23 42.49 Favored Glycine 0 CA--C 1.519 0.288 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 175.341 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -52.59 134.55 35.45 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 118.5 1.15 . . . . 0.0 108.685 172.868 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -46.69 -58.74 3.57 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -172.767 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -57.97 -45.26 86.99 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 122.322 1.058 . . . . 0.0 111.277 -177.55 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -61.13 -27.29 68.28 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 126.438 1.895 . . . . 0.0 111.793 178.381 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 tt -81.05 -24.19 38.02 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.917 0.887 . . . . 0.0 109.236 -179.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 54.27 30.25 12.11 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.212 1.005 . . . . 0.0 111.234 -170.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -104.25 9.74 50.16 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.662 1.125 . . . . 0.0 112.544 -176.447 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -72.13 7.95 1.48 Allowed 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.555 1.542 . . . . 0.0 112.643 178.233 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -145.18 106.55 4.21 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 127.76 2.424 . . . . 0.0 105.21 -178.221 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 14.6 m -63.02 -7.99 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 113.973 -1.467 . . . . 0.0 112.478 -177.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -122.05 18.89 10.85 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.364 1.065 . . . . 0.0 113.761 175.291 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 3.7 m -88.97 -70.26 0.66 Allowed 'General case' 0 N--CA 1.453 -0.296 0 O-C-N 121.639 -0.663 . . . . 0.0 110.683 168.516 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.28 2.0 ptp180 -75.64 11.48 1.31 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -173.006 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.3 m -65.61 -37.09 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 167.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -78.08 130.47 36.47 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 177.852 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.2 tt -141.2 141.96 34.03 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -172.492 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 49.2 tp -146.14 127.76 15.17 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 -174.564 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 48.9 ttp -143.8 146.06 32.81 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 119.829 1.195 . . . . 0.0 111.955 -169.443 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -151.57 166.05 32.37 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.904 2.081 . . . . 0.0 107.543 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -54.48 169.0 0.21 Allowed 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.464 1.029 . . . . 0.0 111.038 169.15 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.95 158.82 0.3 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 122.231 1.015 . . . . 0.0 113.333 173.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -143.61 130.15 20.11 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 174.112 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 54.3 p90 . . . . . 0 C--O 1.252 1.19 0 C-N-CA 126.169 1.787 . . . . 0.0 108.13 177.269 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 120.891 0.377 . . . . 0.0 110.712 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -124.7 38.31 4.22 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.468 2.307 . . . . 0.0 108.144 166.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -89.07 56.4 4.02 Favored Glycine 0 C--N 1.34 0.762 0 C-N-CA 125.508 1.528 . . . . 0.0 112.3 -161.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . 2.436 0.2 OUTLIER 67.46 -157.19 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 123.753 0.821 . . . . 0.0 108.871 -175.106 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 13.3 tp -149.33 15.59 0.9 Allowed 'General case' 0 CA--C 1.545 0.765 0 O-C-N 119.669 -1.895 . . . . 0.0 113.241 19.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -148.14 147.47 29.52 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.868 1.213 . . . . 0.0 112.152 -177.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -159.43 137.79 10.56 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 128.174 2.59 . . . . 0.0 107.177 -175.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -158.46 154.86 27.5 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 119.336 0.971 . . . . 0.0 110.638 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.1 mp -99.16 159.6 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 126.392 1.877 . . . . 0.0 107.652 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -137.21 168.94 18.65 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.493 1.117 . . . . 0.0 110.549 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -134.1 128.76 34.85 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.641 1.576 . . . . 0.0 106.956 165.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 74.6 t -66.61 133.59 31.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 175.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -103.63 -34.32 8.67 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.616 1.167 . . . . 0.0 110.479 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -158.16 161.26 37.86 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.702 0.801 . . . . 0.0 110.146 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.8 mp -134.44 137.3 51.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 126.827 2.051 . . . . 0.0 105.728 -177.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -140.77 79.0 19.74 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 123.27 0.628 . . . . 0.0 111.453 -167.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -67.48 30.88 0.13 Allowed 'Trans proline' 0 CA--C 1.553 1.432 1 C-N-CA 126.089 4.526 . . . . 0.0 117.849 -172.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -50.13 -46.0 53.46 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 120.985 1.721 . . . . 0.0 115.449 -161.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -129.73 82.05 0.33 Allowed Glycine 0 C--N 1.336 0.572 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -160.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.456 ' HE2' ' HA ' ' A' ' 20' ' ' LYS . 9.5 mmpt? -74.44 62.91 1.02 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.26 1.424 . . . . 0.0 111.124 -176.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -55.92 -39.14 71.2 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.428 -0.795 . . . . 0.0 108.941 163.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -136.14 135.92 39.64 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 104.694 -2.336 . . . . 0.0 104.694 170.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -61.51 -33.29 73.54 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.271 0.487 . . . . 0.0 111.23 -177.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 -75.94 5.87 5.94 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.9 t -121.53 133.52 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 121.841 2.11 . . . . 0.0 107.858 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.7 m -148.38 158.97 44.43 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.352 1.061 . . . . 0.0 110.063 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 27.7 ttp180 -73.4 148.58 43.19 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 163.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 74.1 mt -134.18 162.66 31.52 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 126.153 1.781 . . . . 0.0 108.082 175.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -137.0 130.74 31.9 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 174.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 64.2 m -141.21 164.85 29.15 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.115 1.366 . . . . 0.0 109.525 -170.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -141.15 136.1 31.52 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.4 p -81.39 157.89 24.83 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.29 0.495 . . . . 0.0 111.194 -177.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -100.65 -50.78 3.77 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.581 0.752 . . . . 0.0 111.768 -168.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.0 m -73.57 -24.12 60.04 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 118.844 0.747 . . . . 0.0 111.292 -175.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.482 ' HB3' HD21 ' A' ' 131' ' ' ASN . 19.1 m-85 -126.01 -134.08 0.25 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.921 1.289 . . . . 0.0 108.767 -177.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -143.61 13.54 1.74 Allowed 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.879 1.218 . . . . 0.0 113.689 -165.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 65.7 mtm -68.94 152.0 45.83 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 118.857 0.753 . . . . 0.0 110.685 -172.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -121.5 125.23 46.33 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 126.759 2.024 . . . . 0.0 106.516 176.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 67.9 tp -137.16 148.8 46.84 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.718 0.771 . . . . 0.0 110.264 -163.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.3 mm -130.88 144.9 36.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 128.704 2.801 . . . . 0.0 104.296 170.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.5 mp -134.79 162.51 32.15 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 173.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -132.39 109.16 9.65 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 104.692 -2.336 . . . . 0.0 104.692 158.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.4 p -153.42 158.66 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -154.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -62.16 125.2 23.06 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 169.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 pp -105.39 -1.13 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.253 1.021 . . . . 0.0 112.965 -177.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -66.75 -11.73 55.92 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 120.567 1.53 . . . . 0.0 112.357 177.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.9 mt -63.21 -40.2 88.14 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.75 1.22 . . . . 0.0 108.731 171.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -72.55 155.42 91.11 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 124.152 0.981 . . . . 0.0 109.155 174.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -63.37 -53.08 1.59 Allowed 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 121.766 1.644 . . . . 0.0 111.683 -174.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.8 m -152.67 -143.77 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 126.073 1.749 . . . . 0.0 107.604 -177.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -54.38 -30.42 51.84 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 127.805 2.442 . . . . 0.0 115.143 -173.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 27.9 tp -86.17 -18.92 30.93 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 -147.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.18 173.29 41.36 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -165.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -163.95 178.14 7.97 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.312 1.845 . . . . 0.0 107.912 -175.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -93.58 125.77 38.37 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 121.3 -0.875 . . . . 0.0 109.875 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -106.44 170.76 7.74 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.494 1.518 . . . . 0.0 109.544 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.3 ttp180 -127.54 104.52 7.93 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 126.172 1.789 . . . . 0.0 106.188 165.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.9 152.04 28.3 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 171.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 95.4 t -141.72 134.96 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 -175.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.0 pt -121.25 25.63 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 163.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -48.89 114.8 1.07 Allowed 'General case' 0 C--N 1.345 0.407 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 152.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 72.3 m -63.2 155.55 27.93 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 123.744 0.653 . . . . 0.0 109.494 -171.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.282 6.6 t -94.47 -89.67 0.22 Allowed 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -151.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.4 tt -153.45 -37.87 0.1 Allowed 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 110.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . 0.268 0.3 OUTLIER -125.79 46.77 2.34 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 120.443 -1.411 . . . . 0.0 109.241 -71.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -69.07 -19.72 64.08 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.532 1.133 . . . . 0.0 112.796 170.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -120.2 -78.51 0.59 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -149.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 168.85 27.6 0.02 OUTLIER Glycine 0 CA--C 1.528 0.905 0 C-N-CA 120.104 -1.046 . . . . 0.0 114.731 -159.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 91.0 m -82.92 -17.27 44.25 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 118.935 1.368 . . . . 0.0 109.831 160.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.69 -42.54 0.92 Allowed 'General case' 0 C--N 1.344 0.361 0 C-N-CA 124.341 1.057 . . . . 0.0 111.159 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -60.37 -12.93 10.58 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 118.869 0.759 . . . . 0.0 112.236 174.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -44.54 -33.63 1.82 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.588 1.955 . . . . 0.0 113.287 163.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -5.51 0.35 Allowed Glycine 0 CA--C 1.531 1.067 0 CA-C-O 118.869 -0.962 . . . . 0.0 114.053 173.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -95.72 -143.87 0.27 Allowed 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 118.904 1.352 . . . . 0.0 108.294 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . 0.253 26.1 t80 62.84 -7.42 0.14 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 126.029 1.731 . . . . 0.0 114.912 -177.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -65.11 -25.76 1.55 Allowed Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 116.956 2.206 . . . . 0.0 116.956 158.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -87.29 -157.43 0.07 OUTLIER 'Trans proline' 0 C--N 1.358 1.032 0 CA-C-N 123.601 2.322 . . . . 0.0 109.893 -161.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.452 HG23 ' H ' ' A' ' 78' ' ' THR . 73.5 p -30.54 1.62 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.628 1 C-N-CA 135.588 5.555 . . . . 0.0 118.063 154.558 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -74.06 -17.46 60.96 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 119.399 -2.063 . . . . 0.0 110.155 154.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -143.89 -142.59 0.13 Allowed 'General case' 0 CA--C 1.553 1.083 1 C-N-CA 132.197 4.199 . . . . 0.0 105.926 176.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . 0.337 70.7 mtm-85 53.19 -109.42 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.901 0 CA-C-O 115.042 -2.409 . . . . 0.0 112.0 -169.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.26 -36.25 3.36 Favored 'Trans proline' 0 C--N 1.36 1.153 0 CA-C-N 124.835 2.762 . . . . 0.0 110.395 177.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.0 m -70.95 177.07 3.87 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.303 1.041 . . . . 0.0 108.863 164.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 13.2 mmt85 -154.51 -179.92 8.42 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 -171.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -55.88 80.01 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 131.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -154.69 -41.8 0.09 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 128.739 2.816 . . . . 0.0 108.141 175.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -56.44 -13.78 2.53 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.613 0.765 . . . . 0.0 110.917 154.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -167.39 73.22 0.12 Allowed 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 129.253 3.021 . . . . 0.0 105.879 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -39.03 -33.23 0.11 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 127.11 2.164 . . . . 0.0 114.591 -175.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -149.5 157.77 43.58 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 173.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.5 p -163.7 138.39 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 40.2 tpp -163.16 166.8 22.97 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.051 0.54 . . . . 0.0 110.387 -166.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -111.94 163.09 14.63 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.707 1.603 . . . . 0.0 109.589 172.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -165.16 -159.67 11.68 Favored Glycine 0 CA--C 1.521 0.419 0 O-C-N 121.648 -0.658 . . . . 0.0 113.022 -175.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 11.1 ttmm -141.73 126.84 18.43 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 177.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.2 t -89.94 143.29 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 171.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -127.41 111.85 14.32 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 177.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.25 144.9 16.15 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 -177.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.512 HG13 ' H ' ' A' ' 101' ' ' GLY . 3.2 pt -75.56 -171.82 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 127.587 2.355 . . . . 0.0 109.663 169.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -64.59 -6.38 7.52 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.462 1.505 . . . . 0.0 114.384 176.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.512 ' H ' HG13 ' A' ' 99' ' ' ILE . . . 107.36 -46.51 1.16 Allowed Glycine 0 C--N 1.336 0.529 0 C-N-CA 126.698 2.094 . . . . 0.0 110.255 -177.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -68.72 137.69 54.3 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 117.163 0.482 . . . . 0.0 111.549 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -143.43 15.25 1.82 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.424 1.09 . . . . 0.0 109.934 162.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 70.2 p -81.98 -39.34 23.78 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.252 -0.905 . . . . 0.0 110.825 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 74.7 m 117.77 -36.58 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.47 1 C-N-CA 132.162 4.185 . . . . 0.0 109.902 -176.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.1 p -151.1 -29.55 0.19 Allowed 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -159.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -74.31 -7.87 54.29 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 118.923 0.783 . . . . 0.0 110.289 174.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 50.92 51.25 17.42 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.72 2.008 . . . . 0.0 110.515 177.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -1.28 103.05 0.01 OUTLIER 'General case' 0 C--N 1.348 0.539 0 C-N-CA 129.363 3.065 . . . . 0.0 113.304 -163.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.8 p -56.24 -21.05 21.12 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.496 1.118 . . . . 0.0 112.704 -174.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -108.48 115.3 29.85 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 165.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 34.5 tp -56.02 131.8 48.35 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 160.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 14.7 m -87.34 171.62 10.46 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 171.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -152.0 146.92 25.94 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 124.62 1.168 . . . . 0.0 108.237 161.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 2.9 m-30 -122.81 139.51 53.93 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 104.001 -2.592 . . . . 0.0 104.001 170.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.2 t -139.42 137.46 40.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 -174.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.1 m -116.92 132.09 56.79 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 166.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -149.43 109.77 4.19 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.089 0.859 . . . . 0.0 109.703 -170.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 58.19 22.94 51.47 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 123.797 0.713 . . . . 0.0 114.334 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.1 -14.11 65.0 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-N 118.42 1.11 . . . . 0.0 112.98 -176.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -83.05 171.87 13.33 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.643 1.177 . . . . 0.0 109.012 170.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 10.1 tp -140.07 153.74 46.85 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.242 1.017 . . . . 0.0 110.192 -173.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 42.6 mtt -138.75 158.31 44.47 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.684 1.194 . . . . 0.0 110.281 164.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.6 ttt-85 -143.97 122.34 12.35 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 104.357 -2.461 . . . . 0.0 104.357 176.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 33.8 tp -142.93 151.54 41.07 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.183 0.901 . . . . 0.0 109.342 -158.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -141.47 145.26 35.02 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.174 1.39 . . . . 0.0 109.817 167.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -172.76 166.81 39.54 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 125.989 1.757 . . . . 0.0 109.883 171.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -51.58 146.75 7.13 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.019 1.41 . . . . 0.0 111.09 176.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.77 -47.53 82.26 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -169.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -65.17 -43.71 90.85 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 122.678 0.391 . . . . 0.0 110.069 174.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.482 HD21 ' HB3' ' A' ' 35' ' ' PHE . 49.8 t30 -65.21 -40.73 94.54 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.416 1.086 . . . . 0.0 112.765 -172.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.2 tt -63.83 -22.17 66.79 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.522 1.129 . . . . 0.0 111.285 176.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 53.08 39.01 28.82 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.998 1.719 . . . . 0.0 112.556 170.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -157.5 50.8 0.42 Allowed Glycine 0 C--N 1.338 0.656 0 C-N-CA 124.067 0.842 . . . . 0.0 111.03 -169.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -58.36 -35.48 72.02 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.294 0.637 . . . . 0.0 110.406 170.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -83.63 155.0 23.43 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.535 1.534 . . . . 0.0 110.326 -170.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.1 m -73.28 -3.46 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 C-N-CA 123.68 0.792 . . . . 0.0 112.208 168.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -133.56 6.41 3.77 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.616 1.166 . . . . 0.0 112.877 -164.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 72.2 m -87.84 -69.3 0.7 Allowed 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.085 -1.01 . . . . 0.0 109.902 173.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.276 12.7 ptm180 -82.05 11.74 4.87 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 120.605 -1.309 . . . . 0.0 114.147 -170.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 24.6 m -62.87 -31.8 53.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 O-C-N 121.992 -0.442 . . . . 0.0 110.305 157.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -73.21 113.47 10.31 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 170.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.3 tt -145.95 137.57 24.97 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 118.342 0.519 . . . . 0.0 110.282 -167.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.3 tt -150.66 150.64 31.38 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.784 1.634 . . . . 0.0 107.088 -168.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 60.3 mtt -142.19 157.42 44.88 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 120.624 -1.298 . . . . 0.0 108.802 -176.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 15.5 ptmt -155.42 173.58 16.46 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 125.002 1.321 . . . . 0.0 109.718 163.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -57.93 163.5 2.69 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 164.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.09 159.82 5.46 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.281 163.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -132.17 106.59 8.06 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 175.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.252 1.196 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 -168.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.0 ptt? . . . . . 0 N--CA 1.479 1.016 0 CA-C-O 119.587 -0.244 . . . . 0.0 110.591 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.26 -35.04 68.66 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 119.443 -0.313 . . . . 0.0 111.067 169.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 60.88 56.67 22.87 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.161 -1.175 . . . . 0.0 110.161 -176.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.5 tt -51.48 139.83 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 124.424 1.09 . . . . 0.0 110.206 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -120.38 -48.1 2.32 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.697 0.799 . . . . 0.0 110.054 -169.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -154.71 151.68 29.02 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -151.78 141.87 22.21 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 126.508 1.923 . . . . 0.0 107.642 -173.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -151.57 150.71 30.63 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 168.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 mp -72.42 148.52 9.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 172.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -135.94 156.82 48.17 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.325 1.85 . . . . 0.0 107.455 175.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -129.21 144.98 51.41 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.901 1.28 . . . . 0.0 108.355 176.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.8 p -73.83 146.22 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 C-N-CA 124.283 1.033 . . . . 0.0 108.767 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -125.59 -28.94 3.23 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 126.558 1.943 . . . . 0.0 109.479 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -157.68 166.62 32.34 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.028 0.831 . . . . 0.0 110.67 170.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.6 mp -143.57 138.15 25.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 127.26 2.224 . . . . 0.0 106.58 -174.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -151.66 101.25 2.91 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 123.202 0.601 . . . . 0.0 109.721 169.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -57.79 146.18 86.95 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.917 2.411 . . . . 0.0 111.292 172.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -127.66 13.64 6.96 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.227 0.611 . . . . 0.0 112.207 -172.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 174.72 79.86 0.05 OUTLIER Glycine 0 C--N 1.338 0.689 0 O-C-N 121.199 -0.938 . . . . 0.0 111.511 -170.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.9 mmtt -57.46 -18.4 18.15 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -72.47 -14.37 61.66 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.8 0.727 . . . . 0.0 111.111 175.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -136.32 52.33 1.97 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 127.149 2.18 . . . . 0.0 106.108 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -50.05 -28.06 6.52 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.806 1.643 . . . . 0.0 114.783 -169.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -68.64 2.17 2.66 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 117.668 -1.158 . . . . 0.0 113.707 173.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.3 t -125.52 121.89 61.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 121.138 1.79 . . . . 0.0 107.596 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.3 m -147.15 158.25 43.88 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.888 0.875 . . . . 0.0 110.759 -173.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.5 ttp-105 -83.02 148.28 27.65 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 170.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.0 mt -139.41 154.12 47.74 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.7 2.0 . . . . 0.0 107.273 177.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -126.69 132.52 51.15 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 103.926 -2.62 . . . . 0.0 103.926 171.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 64.0 m -145.21 167.24 23.28 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.956 1.302 . . . . 0.0 111.154 -169.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -140.71 142.5 34.84 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.463 1.905 . . . . 0.0 108.081 -176.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 31.9 p -72.72 151.78 42.0 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 118.125 0.421 . . . . 0.0 111.092 177.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -83.55 -37.32 23.14 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 118.757 -0.64 . . . . 0.0 111.495 176.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.6 m -101.76 -17.61 16.17 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 -168.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -124.2 -102.16 0.38 Allowed 'General case' 0 C--N 1.342 0.252 0 CA-C-N 120.545 1.52 . . . . 0.0 110.542 -170.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -168.19 10.8 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.204 1.002 . . . . 0.0 113.003 -169.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 59.6 mtm -70.56 146.7 49.96 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.342 0.591 . . . . 0.0 110.158 -173.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -118.58 128.78 54.87 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 172.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.4 tp -133.34 139.18 46.69 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 123.598 0.759 . . . . 0.0 110.46 -169.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 14.8 mm -125.6 148.25 30.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 103.776 -2.675 . . . . 0.0 103.776 169.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.5 mt -150.21 144.68 25.77 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 126.346 1.858 . . . . 0.0 107.057 -171.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -131.58 94.62 3.56 Favored 'General case' 0 C--N 1.32 -0.694 1 N-CA-C 99.754 -4.165 . . . . 0.0 99.754 168.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.7 p -136.24 161.65 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-O 122.07 0.938 . . . . 0.0 112.536 -166.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.412 HD21 ' NE2' ' A' ' 46' ' ' GLN . 22.2 t30 -68.48 90.71 0.38 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.039 2.135 . . . . 0.0 109.057 169.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.6 pp -69.65 3.88 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -169.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.412 ' NE2' HD21 ' A' ' 44' ' ' ASN . 12.1 pt20 -65.98 -11.68 49.46 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 120.854 1.661 . . . . 0.0 111.957 176.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 55.7 mt -59.51 -34.08 53.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 169.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -92.32 155.04 42.88 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 124.923 1.289 . . . . 0.0 108.426 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.04 -23.82 33.64 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.196 1.931 . . . . 0.0 112.526 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.0 t -145.81 153.97 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 -178.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -53.93 -28.94 40.13 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.445 1.098 . . . . 0.0 112.306 169.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 39.5 tp -56.64 -17.0 7.24 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.456 1.502 . . . . 0.0 112.903 173.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.88 173.67 49.71 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 124.011 0.815 . . . . 0.0 111.359 177.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -164.11 175.07 10.56 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.901 2.08 . . . . 0.0 106.497 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -67.43 147.25 53.12 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 169.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -150.03 -173.44 4.43 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.063 1.345 . . . . 0.0 107.711 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -132.95 148.08 52.28 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 119.136 0.88 . . . . 0.0 109.338 170.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.1 tt -118.88 143.21 47.11 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.5 t -139.34 155.46 26.04 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 C-N-CA 124.666 1.187 . . . . 0.0 109.694 -168.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.1 tt -129.72 148.35 33.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 127.725 2.41 . . . . 0.0 106.24 170.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -149.04 -168.16 3.03 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.939 1.295 . . . . 0.0 109.155 -173.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 37.1 m -145.05 51.85 1.22 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.51 1.524 . . . . 0.0 108.275 -174.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.2 m -43.87 105.29 0.05 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.569 1.947 . . . . 0.0 114.349 -169.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 19.6 tp -77.6 -13.53 59.89 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.45 1.1 . . . . 0.0 111.017 174.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -57.86 -24.62 58.36 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.016 -1.053 . . . . 0.0 111.786 174.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -68.94 -34.65 75.71 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.035 0.834 . . . . 0.0 111.333 174.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -72.63 -32.79 66.17 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 118.216 0.462 . . . . 0.0 110.331 174.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 124.6 41.79 0.37 Allowed Glycine 0 C--N 1.34 0.754 0 CA-C-O 118.4 -1.222 . . . . 0.0 113.65 169.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.84 -35.62 69.05 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 120.126 1.963 . . . . 0.0 111.734 -176.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.3 pp -76.03 -13.27 60.23 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -91.07 -30.11 16.94 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.966 0.803 . . . . 0.0 109.369 169.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -70.18 -22.56 62.94 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.081 0.952 . . . . 0.0 113.443 176.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 154.27 -15.51 0.58 Allowed Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.515 1.055 . . . . 0.0 115.237 169.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -80.6 40.96 0.53 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 119.471 1.636 . . . . 0.0 111.423 -173.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -74.74 75.28 2.07 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 120.86 -1.15 . . . . 0.0 109.189 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -59.3 127.41 84.23 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-O 118.088 -0.958 . . . . 0.0 109.388 -174.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -52.54 -31.37 48.72 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.216 2.61 . . . . 0.0 114.678 -177.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.99 -12.19 60.3 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.726 1.21 . . . . 0.0 111.784 -178.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -64.53 -19.84 65.86 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 120.585 -1.322 . . . . 0.0 111.814 175.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -135.76 4.24 3.04 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.201 1.0 . . . . 0.0 112.763 -176.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 67.5 mtt85 -127.1 128.24 24.18 Favored Pre-proline 0 N--CA 1.468 0.434 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER 23.36 58.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.683 1 C-N-CA 125.702 4.268 . . . . 0.0 113.665 -169.218 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.2 p -65.77 22.49 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 128.719 2.808 . . . . 0.0 116.787 -168.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.61 147.15 46.67 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 168.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.43 160.93 6.23 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.519 0.676 . . . . 0.0 110.125 174.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -159.45 -32.55 0.06 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.82 1.248 . . . . 0.0 111.038 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -53.01 -49.41 66.27 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.584 1.954 . . . . 0.0 109.127 169.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -146.8 167.81 22.96 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 127.6 2.36 . . . . 0.0 107.4 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -82.83 -31.29 28.15 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.703 0.683 . . . . 0.0 110.127 169.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -147.54 150.31 34.26 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.187 0.595 . . . . 0.0 109.663 177.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.2 t -143.62 138.88 25.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.08 169.56 23.24 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.894 0.855 . . . . 0.0 110.571 175.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -134.22 93.57 3.1 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 -171.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -92.62 -164.31 37.99 Favored Glycine 0 C--N 1.332 0.357 0 CA-C-O 121.682 0.601 . . . . 0.0 112.732 -169.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -134.04 111.93 10.78 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 169.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.7 t -69.84 149.0 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 169.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -143.34 58.59 1.39 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.556 0.742 . . . . 0.0 110.935 174.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -143.59 160.86 39.88 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.964 1.306 . . . . 0.0 109.878 174.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -83.5 -177.2 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 125.432 1.493 . . . . 0.0 109.723 169.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -64.08 -6.99 7.38 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.612 1.565 . . . . 0.0 114.847 -177.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 138.3 -61.81 0.58 Allowed Glycine 0 CA--C 1.52 0.406 0 N-CA-C 107.0 -2.44 . . . . 0.0 107.0 -172.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -147.49 -97.77 0.09 Allowed 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 125.045 1.338 . . . . 0.0 107.734 169.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -167.85 74.6 0.12 Allowed 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 124.295 1.038 . . . . 0.0 109.566 -170.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.53 HG21 ' H ' ' A' ' 109' ' ' ALA . 10.2 t -150.15 -159.79 1.08 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 123.013 1.387 . . . . 0.0 111.756 -169.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.0 m -125.26 9.46 7.95 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 128.876 2.871 . . . . 0.0 109.481 169.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . 0.279 3.9 m 109.77 38.41 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 130.27 3.428 . . . . 0.0 108.232 170.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -139.91 -2.15 1.54 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.731 1.612 . . . . 0.0 112.278 -176.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.448 ' HB3' ' HB ' ' A' ' 104' ' ' THR . . . -109.58 -46.29 3.55 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 169.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.53 ' H ' HG21 ' A' ' 104' ' ' THR . . . -111.61 149.21 31.81 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 111.991 -2.368 . . . . 0.0 107.676 167.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 32.8 p -128.64 -3.78 5.33 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -177.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -128.46 144.05 51.08 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 173.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 7.8 tt -92.83 149.08 21.51 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 168.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 10.7 p -116.0 146.0 42.5 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -139.42 100.18 3.92 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -95.66 128.19 42.32 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 101.65 -3.463 . . . . 0.0 101.65 169.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.7 t -140.02 137.7 38.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -169.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.7 t -117.45 137.82 52.26 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 170.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -150.15 105.63 3.39 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.609 0.764 . . . . 0.0 109.536 -171.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 61.27 22.44 60.94 Favored Glycine 0 CA--C 1.534 1.264 0 O-C-N 121.546 -0.721 . . . . 0.0 113.927 175.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.49 -13.58 65.34 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.499 1.047 . . . . 0.0 112.934 -177.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -85.59 164.13 17.93 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 169.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 7.8 tt -146.21 155.92 43.03 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 121.695 -0.628 . . . . 0.0 109.956 -171.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 23.4 ptm -150.42 161.01 43.34 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.394 1.077 . . . . 0.0 108.906 172.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 58.7 ttt-85 -135.96 127.44 28.65 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 104.978 -2.231 . . . . 0.0 104.978 172.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 25.5 tp -141.97 140.69 32.8 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -170.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -132.54 145.79 51.41 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 169.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -171.74 178.18 44.15 Favored Glycine 0 C--N 1.331 0.298 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 174.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.08 140.66 48.56 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 118.158 0.979 . . . . 0.0 109.221 172.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -52.27 -62.18 1.8 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.604 0.761 . . . . 0.0 112.613 -175.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.31 -24.08 66.48 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.117 0.871 . . . . 0.0 113.032 -174.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.37 -35.5 77.81 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 126.16 1.784 . . . . 0.0 109.774 174.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 16.9 tp -94.81 -19.2 20.53 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.713 0.805 . . . . 0.0 110.252 -175.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 42.58 42.2 2.7 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.669 1.988 . . . . 0.0 112.041 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -105.71 20.17 37.22 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.029 0.823 . . . . 0.0 112.458 -172.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -74.16 8.8 1.91 Allowed 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.25 1.025 . . . . 0.0 113.497 -178.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -131.79 131.11 42.64 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 169.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.9 p -57.65 -10.15 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 125.124 1.37 . . . . 0.0 110.857 169.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -123.56 12.71 9.33 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 126.002 1.721 . . . . 0.0 112.978 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 3.4 m -89.12 -58.98 2.35 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 167.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.6 tpm_? -75.55 2.07 12.66 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 115.466 -0.788 . . . . 0.0 113.031 -169.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 29.2 m -60.25 -37.98 75.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 124.422 1.089 . . . . 0.0 110.14 169.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -71.95 118.47 14.85 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 63.3 tp -138.88 120.65 15.32 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 -172.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.59 149.34 45.16 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -174.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 61.6 mtt -143.11 144.59 32.29 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -172.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -152.3 160.78 43.28 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -64.02 157.19 25.81 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 168.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.3 pp -67.21 165.36 16.27 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.242 0.544 . . . . 0.0 110.172 170.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -142.14 140.08 32.34 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 170.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 . . . . . 0 C--O 1.25 1.102 0 C-N-CA 126.392 1.877 . . . . 0.0 110.413 -176.312 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.4 mmm . . . . . 0 N--CA 1.474 0.757 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -56.28 145.46 26.74 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.241 0.616 . . . . 0.0 111.386 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -88.97 -162.64 38.69 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.747 1.165 . . . . 0.0 111.124 175.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.7 mm -135.92 144.61 32.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 171.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -49.85 116.34 1.76 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.613 1.165 . . . . 0.0 111.003 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -153.36 134.34 13.97 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 172.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -144.76 147.7 33.25 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.28 1.432 . . . . 0.0 108.08 -169.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -150.31 155.7 40.16 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.187 0.595 . . . . 0.0 109.434 169.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.3 mp -85.82 144.7 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 169.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -113.04 143.59 44.06 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.035 1.334 . . . . 0.0 107.68 171.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -117.06 122.83 45.29 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.878 1.671 . . . . 0.0 106.832 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.7 t -71.7 121.43 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -176.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.5 mmmt -96.61 -29.86 13.6 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.194 177.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -155.33 165.08 37.75 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.408 1.003 . . . . 0.0 111.459 175.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.4 mp -142.55 135.61 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 127.85 2.46 . . . . 0.0 105.756 -177.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -147.87 93.04 4.58 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 118.301 0.501 . . . . 0.0 111.155 178.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -61.16 144.77 99.18 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.911 2.407 . . . . 0.0 109.954 169.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -131.79 9.4 4.58 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -174.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.84 46.61 10.68 Favored Glycine 0 C--N 1.343 0.918 0 O-C-N 121.478 -0.764 . . . . 0.0 111.202 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.0 mmmm -73.03 25.97 0.06 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.289 1.436 . . . . 0.0 112.772 -171.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp 68.02 -59.84 0.42 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 128.497 2.719 . . . . 0.0 108.569 -168.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 4.8 m-30 -81.26 87.18 6.13 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 103.633 -2.729 . . . . 0.0 103.633 168.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -62.68 -17.58 60.85 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.285 -0.884 . . . . 0.0 112.656 -174.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 -66.54 -14.49 62.38 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 118.028 -0.987 . . . . 0.0 112.51 169.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 77.2 t -88.78 134.15 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 169.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.6 m -151.04 159.44 44.54 Favored 'General case' 0 C--O 1.239 0.542 0 O-C-N 120.928 -1.108 . . . . 0.0 109.981 -176.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.6 tpp85 -72.66 150.44 42.98 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 172.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.6 mt -138.14 157.19 46.81 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.923 1.689 . . . . 0.0 107.247 172.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -135.46 133.57 38.69 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 169.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 33.7 m -141.11 166.11 25.68 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.242 1.417 . . . . 0.0 110.087 -174.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -134.87 143.47 47.0 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 172.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.1 p -83.85 145.47 28.62 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 118.762 0.71 . . . . 0.0 110.255 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -80.57 -32.05 36.7 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -169.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.9 m -102.62 -34.21 9.16 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.138 0.881 . . . . 0.0 111.75 -171.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -121.71 10.28 10.29 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.669 1.187 . . . . 0.0 112.712 -170.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.315 0.0 OUTLIER 43.11 39.19 1.78 Allowed 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.915 2.086 . . . . 0.0 114.371 174.637 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 62.5 mtm -63.64 154.08 34.02 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 169.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -112.46 127.77 56.13 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 176.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 59.3 tp -137.81 144.9 41.74 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.78 0.8 . . . . 0.0 110.437 -169.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 35.6 mm -127.83 149.12 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 128.479 2.712 . . . . 0.0 103.737 169.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 123' ' ' MET . 2.0 mp -143.63 161.08 39.46 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 126.201 1.801 . . . . 0.0 108.254 176.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -138.48 94.59 2.87 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 102.312 -3.218 . . . . 0.0 102.312 168.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.7 m -144.15 168.74 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 124.36 1.064 . . . . 0.0 111.295 -168.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -60.03 134.2 56.81 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.041 0.936 . . . . 0.0 110.149 170.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 pp -116.51 2.14 7.88 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.445 0 C-N-CA 125.372 1.469 . . . . 0.0 112.966 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -64.77 -12.24 45.37 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 121.367 1.894 . . . . 0.0 113.248 -172.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 66.2 mt -58.95 -22.53 21.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 125.891 1.676 . . . . 0.0 108.816 169.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -127.38 167.05 19.19 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 128.531 2.733 . . . . 0.0 109.426 -178.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -52.17 157.27 6.59 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.664 2.242 . . . . 0.0 111.875 169.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.7 m -59.57 -10.77 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 N-CA-C 115.573 1.694 . . . . 0.0 115.573 -169.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -139.9 27.5 2.2 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.761 1.224 . . . . 0.0 110.55 -177.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 25.7 tp -140.89 163.16 33.7 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.235 -0.916 . . . . 0.0 110.753 -173.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -165.37 167.81 39.08 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 128.068 2.747 . . . . 0.0 106.405 171.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -141.77 -64.06 0.44 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 118.705 1.252 . . . . 0.0 111.788 -178.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -148.32 162.7 38.99 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.419 1.009 . . . . 0.0 111.159 178.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -145.27 171.34 14.71 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.54 1.936 . . . . 0.0 107.415 170.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -136.02 123.47 22.07 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.5 mp -125.15 146.44 49.49 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -169.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -157.01 128.25 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 121.839 0.828 . . . . 0.0 108.775 -169.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.0 tp -69.16 -32.46 54.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 123.508 0.723 . . . . 0.0 109.945 174.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 57.55 175.43 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.845 2.058 . . . . 0.0 112.787 -172.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.6 m -81.67 5.66 17.62 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.654 -0.654 . . . . 0.0 112.231 172.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.526 HG22 ' H ' ' A' ' 64' ' ' LEU . 1.9 m 62.66 -179.18 0.14 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.45 1.5 . . . . 0.0 110.782 -177.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.526 ' H ' HG22 ' A' ' 63' ' ' THR . 1.9 pt? -126.83 11.15 7.15 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.514 1.126 . . . . 0.0 113.505 -170.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 42.5 56.21 3.87 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.284 1.834 . . . . 0.0 113.554 171.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -59.92 -20.7 58.85 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.022 0.929 . . . . 0.0 111.748 176.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -61.86 -25.61 67.64 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.301 1.04 . . . . 0.0 111.893 176.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 151.11 -28.24 1.0 Allowed Glycine 0 C--N 1.34 0.765 0 CA-C-O 119.121 -0.822 . . . . 0.0 113.623 169.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -58.78 -27.97 65.5 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.454 1.127 . . . . 0.0 113.923 -168.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 98.3 mt -121.5 -19.27 6.98 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.201 0.91 . . . . 0.0 112.421 171.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -60.46 -27.65 67.7 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 119.277 0.944 . . . . 0.0 111.043 172.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -64.83 -9.81 23.55 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.24 1.416 . . . . 0.0 114.612 177.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -136.76 -0.54 2.85 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 125.362 1.458 . . . . 0.0 113.193 178.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 45.33 41.51 6.39 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.067 1.747 . . . . 0.0 111.23 -173.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -63.24 118.03 7.4 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -156.04 103.91 2.09 Favored Pre-proline 0 N--CA 1.452 -0.346 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -173.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -54.3 -23.09 28.9 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.292 2.661 . . . . 0.0 114.633 177.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.5 m 50.26 36.63 13.1 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.9 1.68 . . . . 0.0 110.851 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -77.83 64.76 3.14 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.282 1.433 . . . . 0.0 111.452 -169.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -152.25 -49.05 0.11 Allowed 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 125.992 1.717 . . . . 0.0 109.002 174.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -66.09 -45.26 62.36 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-O 117.12 -1.419 . . . . 0.0 113.401 -177.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -89.34 18.34 1.45 Allowed 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.149 2.566 . . . . 0.0 111.71 176.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.7 m -135.69 -168.55 2.23 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.125 1.77 . . . . 0.0 108.656 -169.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -64.37 109.54 1.95 Allowed 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 169.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.05 24.11 0.1 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.887 1.275 . . . . 0.0 112.468 -176.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -82.32 35.26 0.44 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.362 1.465 . . . . 0.0 111.462 -174.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 41.94 53.55 4.14 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 129.38 3.072 . . . . 0.0 114.066 175.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -75.35 38.27 0.14 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.35 1.46 . . . . 0.0 110.846 169.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -164.29 124.93 2.12 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.494 1.117 . . . . 0.0 109.114 172.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -148.69 154.17 39.27 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 168.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.7 m -137.18 151.93 27.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 O-C-N 121.538 -0.726 . . . . 0.0 110.215 -171.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 37.5 ttm -152.84 161.92 41.94 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.597 1.559 . . . . 0.0 107.353 176.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -136.85 151.72 49.44 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -173.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.18 -157.51 8.58 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 120.908 -0.663 . . . . 0.0 114.366 -169.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -144.82 123.72 12.71 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.772 1.629 . . . . 0.0 107.146 176.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.9 t -77.89 141.89 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 169.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -140.09 64.89 1.43 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.857 1.263 . . . . 0.0 110.057 177.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.418 ' HB2' ' H ' ' A' ' 115' ' ' TYR . 1.0 OUTLIER -154.17 167.52 29.58 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.245 -1.535 . . . . 0.0 112.415 -179.578 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.9 pt -83.4 -177.12 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 127.249 2.22 . . . . 0.0 112.21 -170.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -74.5 -3.15 29.09 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.742 1.617 . . . . 0.0 114.115 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 56.44 42.2 89.21 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.338 0.97 . . . . 0.0 112.537 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -143.42 65.5 1.32 Allowed 'General case' 0 C--O 1.233 0.214 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 172.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -143.64 95.27 2.72 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.513 1.125 . . . . 0.0 108.768 -171.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -65.17 146.39 55.03 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 168.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 84.3 p 121.46 -15.41 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 130.99 3.716 . . . . 0.0 109.707 169.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.6 29.95 3.2 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.331 0.653 . . . . 0.0 109.684 169.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 47.27 43.84 15.32 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.103 1.761 . . . . 0.0 111.702 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -114.78 39.54 2.82 Favored 'General case' 0 C--N 1.342 0.261 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -102.85 -2.98 26.95 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -168.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 72.7 p -134.85 158.27 44.66 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 125.382 1.473 . . . . 0.0 108.537 169.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? 58.87 120.28 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 127.799 2.44 . . . . 0.0 111.652 -173.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 55.3 tp -57.98 144.28 40.11 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 170.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.6 p -123.65 149.03 45.91 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.473 1.109 . . . . 0.0 109.8 -173.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -148.38 108.15 4.01 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.575 1.15 . . . . 0.0 108.373 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.418 ' H ' ' HB2' ' A' ' 98' ' ' ARG . 7.6 m-30 -91.57 122.63 34.32 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 102.379 -3.193 . . . . 0.0 102.379 168.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.0 t -129.71 112.75 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -169.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.2 p -88.24 128.77 35.47 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 104.767 -2.308 . . . . 0.0 104.767 169.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.39 134.35 20.27 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 118.711 0.687 . . . . 0.0 109.631 -172.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 47.21 33.19 7.34 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 124.646 1.117 . . . . 0.0 115.188 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 76.51 17.07 80.23 Favored Glycine 0 CA--C 1.536 1.399 0 CA-C-N 118.716 1.258 . . . . 0.0 113.682 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 93.8 mt -129.2 178.65 6.28 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 128.284 2.633 . . . . 0.0 107.283 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 58.3 tp -139.13 154.15 48.08 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 120.837 -1.164 . . . . 0.0 111.539 -171.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.464 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 76.5 mtm -143.43 156.16 44.58 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.777 2.031 . . . . 0.0 107.901 169.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -137.54 117.93 13.73 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 169.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 51.3 tp -125.59 148.95 48.76 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 125.943 1.697 . . . . 0.0 109.789 -168.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -139.74 148.81 42.81 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.222 1.409 . . . . 0.0 108.448 169.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -165.59 165.17 37.77 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 173.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -71.87 86.7 0.98 Allowed 'General case' 0 N--CA 1.463 0.205 0 O-C-N 122.059 -0.671 . . . . 0.0 110.301 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . 22.85 -77.45 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 130.436 3.494 . . . . 0.0 115.242 -170.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -13.13 16.3 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 11.3 m-20 -85.74 -36.16 20.33 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.972 1.709 . . . . 0.0 109.323 176.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 9.2 tt -72.64 -29.97 63.91 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 170.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 1.8 t60 54.99 45.52 26.24 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.606 1.962 . . . . 0.0 112.069 169.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -152.04 68.49 0.32 Allowed Glycine 0 C--N 1.335 0.484 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 -175.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -73.4 3.55 5.83 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.233 1.013 . . . . 0.0 113.728 -174.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -129.13 145.35 51.32 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.366 1.866 . . . . 0.0 108.513 172.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 7.8 m -66.32 -1.04 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.098 168.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -123.16 15.36 9.84 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 127.746 2.419 . . . . 0.0 111.447 177.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 75.3 m -80.95 -70.5 0.53 Allowed 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.463 -0.773 . . . . 0.0 109.366 168.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.316 1.8 ptp180 -81.56 15.14 2.21 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -169.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 30.3 m -70.97 -12.24 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 167.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -109.27 120.77 43.52 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 103.232 -2.877 . . . . 0.0 103.232 168.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -136.75 130.5 32.07 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -172.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 7.5 tt -117.83 139.47 51.06 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 176.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 19.6 ptt? -144.83 162.11 37.61 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 121.327 -0.858 . . . . 0.0 109.733 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 78.8 mttt -152.86 166.64 31.66 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.759 1.623 . . . . 0.0 108.635 -169.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -71.17 167.69 18.82 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 167.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.34 157.26 8.84 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.173 0.511 . . . . 0.0 110.81 169.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -147.76 123.37 10.47 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 171.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 . . . . . 0 C--O 1.248 0.982 0 C-N-CA 125.995 1.718 . . . . 0.0 107.162 178.092 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 ttt . . . . . 0 N--CA 1.485 1.317 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -48.22 148.79 1.7 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.928 0.891 . . . . 0.0 111.195 170.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -63.63 -26.06 69.45 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 123.646 0.641 . . . . 0.0 113.461 -171.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.2 tp -143.08 169.02 12.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 125.772 1.629 . . . . 0.0 107.127 171.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -144.6 136.14 25.58 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -177.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -142.87 163.58 32.41 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.006 1.322 . . . . 0.0 107.682 169.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -139.31 124.14 18.63 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 103.878 -2.638 . . . . 0.0 103.878 174.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -142.35 131.97 23.95 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.418 0.687 . . . . 0.0 109.357 -171.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.8 mp -81.79 129.15 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 177.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -96.69 153.03 18.1 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.651 1.581 . . . . 0.0 108.065 175.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -132.27 114.99 15.09 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 126.083 1.753 . . . . 0.0 106.999 172.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 68.9 t -71.47 122.19 23.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 177.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.0 mmmt -85.21 -41.35 15.7 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 173.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -158.6 166.56 31.79 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.305 0.502 . . . . 0.0 111.73 -173.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.4 mp -137.05 141.21 41.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 127.756 2.422 . . . . 0.0 106.481 -175.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -145.59 89.2 6.31 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 124.45 1.1 . . . . 0.0 110.485 -171.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -66.32 142.23 65.52 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.92 3.08 . . . . 0.0 111.352 170.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -78.37 -38.39 41.94 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.942 -0.474 . . . . 0.0 111.597 177.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 147.38 47.48 0.03 OUTLIER Glycine 0 CA--C 1.527 0.829 0 N-CA-C 104.932 -3.267 . . . . 0.0 104.932 -169.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -63.15 120.49 11.59 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.213 1.405 . . . . 0.0 113.468 -167.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.456 ' HE3' ' HA ' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -64.97 -46.93 79.44 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.164 168.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -80.63 -19.21 45.89 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.08 0.552 . . . . 0.0 112.351 -174.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.7 t70 47.12 39.08 7.52 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.99 2.116 . . . . 0.0 113.956 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -142.64 8.25 1.73 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 176.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.7 t -139.24 133.4 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 73.1 m -156.43 168.17 28.18 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 120.786 1.63 . . . . 0.0 110.48 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.1 ttm105 -72.19 149.3 44.76 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 169.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.88 158.09 45.25 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 125.786 1.634 . . . . 0.0 107.755 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -133.31 125.48 29.32 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 174.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 58.5 m -141.89 169.59 17.3 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.947 1.299 . . . . 0.0 111.004 -169.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.1 tt0 -143.78 145.0 32.05 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 125.267 1.427 . . . . 0.0 108.118 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.3 m -75.68 131.48 39.92 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 123.285 0.634 . . . . 0.0 109.939 169.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -80.28 -19.6 46.34 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.557 0.743 . . . . 0.0 111.011 170.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.23 -36.07 3.03 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -169.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -115.38 21.53 14.0 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.527 1.131 . . . . 0.0 112.243 -177.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt 42.96 18.03 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 118.685 2.846 . . . . 0.0 118.685 172.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 68.7 mtm -67.72 151.08 47.82 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.868 1.213 . . . . 0.0 108.534 174.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -112.35 127.69 56.08 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 104.613 -2.365 . . . . 0.0 104.613 171.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.5 mp -136.21 150.89 49.19 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 119.094 0.861 . . . . 0.0 112.614 -168.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 46.2 mm -123.1 144.5 32.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 102.812 -3.033 . . . . 0.0 102.812 168.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.8 mp -143.32 160.66 40.1 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 127.347 2.259 . . . . 0.0 107.455 -169.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -140.2 102.68 4.42 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 102.487 -3.153 . . . . 0.0 102.487 168.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.4 m -144.52 169.35 9.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 C-N-CA 124.203 1.001 . . . . 0.0 111.567 -168.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -65.43 136.06 56.01 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 169.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.8 pp -112.33 7.66 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 124.507 1.123 . . . . 0.0 112.686 -175.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -59.72 -23.14 62.93 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 121.541 -0.725 . . . . 0.0 110.675 169.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.1 mt -68.89 -26.83 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 126.127 1.771 . . . . 0.0 109.839 173.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -127.92 68.16 74.99 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 126.01 1.724 . . . . 0.0 109.02 -170.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -73.41 6.4 2.71 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.676 2.917 . . . . 0.0 114.464 -169.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.6 m -136.87 148.89 26.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 C-N-CA 124.934 1.293 . . . . 0.0 108.862 -174.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -60.57 -25.97 66.58 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.613 1.165 . . . . 0.0 112.349 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 52.7 tp -60.95 -23.92 65.68 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.652 1.181 . . . . 0.0 112.314 174.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.42 -168.08 46.22 Favored Glycine 0 CA--C 1.532 1.123 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -169.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -153.07 173.59 15.26 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.332 1.053 . . . . 0.0 108.281 176.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -94.46 152.46 18.57 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.566 0.746 . . . . 0.0 109.016 169.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -151.92 -177.0 5.88 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.246 1.418 . . . . 0.0 107.911 -173.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 10.7 ttp180 -136.65 146.29 45.81 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 120.929 -1.107 . . . . 0.0 108.661 177.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.0 tt -127.65 145.59 50.83 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.662 1.585 . . . . 0.0 107.883 176.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -145.59 166.91 9.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 127.342 2.257 . . . . 0.0 105.921 -174.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 46.4 pt -129.09 27.1 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 O-C-N 121.297 -0.877 . . . . 0.0 111.389 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -83.58 13.18 4.78 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.882 1.273 . . . . 0.0 113.773 -174.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.1 m -64.06 6.8 0.16 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 116.589 2.07 . . . . 0.0 116.589 -169.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.37 35.07 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 56.1 tp -60.4 -24.42 65.12 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 120.82 -1.175 . . . . 0.0 108.635 168.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 39.2 t80 76.05 166.32 0.26 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 128.814 2.845 . . . . 0.0 111.837 169.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -75.65 41.69 0.21 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.245 1.818 . . . . 0.0 110.222 170.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -62.13 -22.35 65.77 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.812 1.645 . . . . 0.0 113.635 -169.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -66.33 -2.67 15.5 Favored Glycine 0 CA--C 1.532 1.128 0 CA-C-O 119.069 -0.85 . . . . 0.0 113.698 170.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 57.9 m -64.15 -30.19 71.27 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.158 1.479 . . . . 0.0 108.834 169.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 73.8 mt -71.44 131.7 43.72 Favored 'General case' 0 C--N 1.343 0.302 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 169.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -75.42 60.82 1.19 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.222 1.409 . . . . 0.0 113.575 -169.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -145.15 13.51 1.43 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.403 1.081 . . . . 0.0 111.006 169.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.17 -32.6 3.01 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 126.502 2.001 . . . . 0.0 111.593 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -168.57 155.97 7.73 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 128.98 2.912 . . . . 0.0 105.225 177.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -139.87 23.09 2.45 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.452 1.101 . . . . 0.0 110.608 -175.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -130.17 81.03 69.6 Favored Pre-proline 0 C--O 1.233 0.219 0 C-N-CA 125.331 1.452 . . . . 0.0 107.64 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -62.64 -17.11 56.98 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.194 1.929 . . . . 0.0 111.856 176.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.5 m -55.05 -21.91 14.02 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.723 1.609 . . . . 0.0 112.509 171.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -67.21 -16.68 64.44 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 119.575 1.08 . . . . 0.0 112.776 172.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -124.79 -30.78 3.25 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.044 1.337 . . . . 0.0 112.567 -175.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 -58.69 123.18 66.4 Favored Pre-proline 0 N--CA 1.467 0.408 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 171.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER 23.86 45.94 0.0 OUTLIER 'Trans proline' 0 CA--C 1.539 0.748 1 C-N-CA 126.711 4.941 . . . . 0.0 116.72 -168.904 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.6 m -149.79 160.32 43.65 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.138 1.775 . . . . 0.0 108.645 -175.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 85.4 mtt85 -145.92 172.52 13.24 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.632 1.173 . . . . 0.0 108.671 -177.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.88 -13.22 22.61 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 171.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -49.82 -16.66 0.28 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.033 2.133 . . . . 0.0 113.891 172.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -50.19 -27.67 6.26 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.318 1.047 . . . . 0.0 112.441 169.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -146.3 171.72 14.55 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.493 1.517 . . . . 0.0 110.893 -178.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -120.05 -33.57 3.91 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 169.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -144.75 144.87 31.41 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.198 1.799 . . . . 0.0 106.209 169.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.7 p -148.72 141.27 18.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -178.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 31.9 tpp -159.34 173.63 15.98 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.51 1.124 . . . . 0.0 110.457 -171.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -134.82 147.78 50.02 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 127.265 2.226 . . . . 0.0 106.924 -173.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -158.38 -157.2 8.35 Favored Glycine 0 C--N 1.338 0.692 0 CA-C-N 119.171 0.896 . . . . 0.0 113.857 -171.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -133.39 125.8 29.88 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 125.665 1.586 . . . . 0.0 106.767 173.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.405 ' HB ' ' HA ' ' A' ' 137' ' ' VAL . 84.3 t -93.19 150.64 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 175.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -134.94 154.46 51.69 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 126.625 1.97 . . . . 0.0 105.984 175.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.76 162.03 39.77 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.632 1.105 . . . . 0.0 111.423 171.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 24.5 pt -80.35 177.67 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 O-C-N 123.973 0.796 . . . . 0.0 108.937 169.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -76.95 -3.27 38.0 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.72 1.208 . . . . 0.0 113.683 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 89.4 3.84 74.63 Favored Glycine 0 C--N 1.339 0.725 0 CA-C-O 119.328 -0.707 . . . . 0.0 112.614 -176.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -123.78 125.44 44.71 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 118.651 1.225 . . . . 0.0 108.683 169.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -138.82 42.64 2.12 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 169.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -138.12 -46.01 0.52 Allowed 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.25 1.02 . . . . 0.0 109.624 -169.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.3 p -177.2 -58.17 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.082 1.353 . . . . 0.0 109.372 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 175.08 -22.39 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 130.659 3.583 . . . . 0.0 107.8 -169.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -63.25 -20.12 65.16 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.158 0.983 . . . . 0.0 113.536 -174.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 84.98 113.55 0.05 Allowed 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 129.731 3.212 . . . . 0.0 106.589 -178.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.87 162.17 19.58 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.753 -170.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.4 p -71.29 -6.21 38.11 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -177.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -136.44 144.64 44.55 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.797 1.239 . . . . 0.0 108.773 169.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.1 tp -88.82 152.96 21.44 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 167.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 14.3 m -126.46 145.16 50.6 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 118.294 0.497 . . . . 0.0 109.822 177.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -146.46 160.04 42.61 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.748 1.219 . . . . 0.0 110.213 -172.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -130.38 158.56 39.51 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 169.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.0 p -149.27 136.2 13.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 169.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.9 t -123.75 129.16 50.64 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 178.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -150.42 122.67 8.36 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 123.859 0.863 . . . . 0.0 109.381 -169.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 54.28 21.64 19.83 Favored Glycine 0 CA--C 1.538 1.527 0 CA-C-O 119.158 -0.801 . . . . 0.0 114.899 178.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 92.7 -4.52 75.93 Favored Glycine 0 CA--C 1.536 1.347 0 CA-C-N 118.735 1.267 . . . . 0.0 113.797 -177.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -95.15 164.13 13.0 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 118.975 1.387 . . . . 0.0 108.229 171.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 39.9 tp -143.85 155.45 44.12 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 122.939 0.495 . . . . 0.0 110.693 -169.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 15.3 mtt -144.04 152.11 40.56 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.891 1.676 . . . . 0.0 106.649 168.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 74.5 mtm180 -137.91 135.26 35.93 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 104.948 -2.241 . . . . 0.0 104.948 169.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -155.49 167.37 30.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 119.335 0.971 . . . . 0.0 112.975 -169.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -134.42 159.72 40.2 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.118 1.367 . . . . 0.0 107.562 168.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -172.06 164.18 36.66 Favored Glycine 0 CA--C 1.516 0.148 0 N-CA-C 108.213 -1.955 . . . . 0.0 108.213 171.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.19 137.66 51.42 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 172.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -45.13 -60.26 2.19 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -169.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.18 -4.98 36.29 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -178.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -92.62 -21.46 20.03 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 125.386 1.475 . . . . 0.0 110.756 170.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.8 tt -68.13 -23.85 64.94 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 119.53 1.059 . . . . 0.0 109.204 171.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 1.4 t60 44.1 34.47 0.98 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 128.348 2.659 . . . . 0.0 114.54 168.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 179.97 42.55 0.08 OUTLIER Glycine 0 C--N 1.336 0.574 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 -171.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -65.76 -14.81 62.07 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 117.618 0.709 . . . . 0.0 112.535 172.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -61.68 103.81 0.37 Allowed 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 127.418 2.287 . . . . 0.0 108.24 169.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.405 ' HA ' ' HB ' ' A' ' 96' ' ' VAL . 13.8 m -53.98 -9.86 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 126.969 2.107 . . . . 0.0 113.307 173.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -133.35 23.15 4.07 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.344 1.058 . . . . 0.0 113.402 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 24.7 m -106.58 -58.15 1.96 Allowed 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 119.004 -0.522 . . . . 0.0 110.402 168.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.396 16.0 ptm180 -75.88 11.88 1.27 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.223 0.919 . . . . 0.0 113.24 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 16.9 m -63.0 -39.15 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 167.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -70.09 119.39 14.23 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 170.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.3 tt -136.37 134.6 38.01 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -177.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.412 HD23 ' N ' ' A' ' 145' ' ' MET . 5.6 tt -143.97 140.43 29.64 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 -173.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.412 ' N ' HD23 ' A' ' 144' ' ' LEU . 25.3 ptp -140.92 154.21 46.01 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 119.229 0.922 . . . . 0.0 110.619 173.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -159.24 160.63 35.53 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 126.352 1.861 . . . . 0.0 107.656 -176.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -54.49 159.0 2.22 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 118.847 0.749 . . . . 0.0 110.581 169.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.57 166.04 19.81 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.819 0.342 . . . . 0.0 110.58 169.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -142.73 36.31 1.44 Allowed 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.611 1.165 . . . . 0.0 110.299 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 43.1 t80 . . . . . 0 C--O 1.249 1.054 0 C-N-CA 124.62 1.168 . . . . 0.0 108.166 -174.335 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 ttt . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.18 150.55 42.64 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.135 0.493 . . . . 0.0 111.29 177.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -154.58 8.45 0.37 Allowed Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.55 1.071 . . . . 0.0 112.967 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.02 170.13 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 126.899 2.08 . . . . 0.0 107.328 -178.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.9 tt -118.7 148.41 42.8 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 124.376 1.07 . . . . 0.0 110.329 -172.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -143.34 143.89 31.86 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 126.837 2.055 . . . . 0.0 106.002 169.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -150.6 134.82 17.0 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.195 1.398 . . . . 0.0 107.36 172.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -154.94 151.64 28.77 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.673 0.67 . . . . 0.0 109.943 169.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.1 mp -81.92 156.73 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 170.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -139.7 151.52 45.95 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.064 0.946 . . . . 0.0 108.745 169.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -117.2 126.33 52.6 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 125.518 1.527 . . . . 0.0 107.603 -176.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -70.64 128.22 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 176.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.6 mmmt -95.8 -35.71 11.41 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.476 1.111 . . . . 0.0 109.403 173.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -158.02 167.72 29.11 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 118.983 0.811 . . . . 0.0 111.307 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.9 mp -138.85 144.43 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 127.036 2.134 . . . . 0.0 107.244 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -145.29 92.58 5.6 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 126.814 2.046 . . . . 0.0 108.276 -176.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -55.26 156.05 18.02 Favored 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 124.081 3.187 . . . . 0.0 114.162 -178.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -77.81 45.78 0.53 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.425 1.49 . . . . 0.0 112.093 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.92 35.71 64.53 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 124.471 1.034 . . . . 0.0 113.54 169.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt 47.44 19.73 0.15 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.027 2.131 . . . . 0.0 114.167 -171.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.432 ' HE3' ' HA ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -77.17 -34.88 56.31 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 121.084 -1.01 . . . . 0.0 109.813 170.428 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -138.09 87.23 2.23 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 -177.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -55.06 -36.94 66.12 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.072 0.949 . . . . 0.0 113.341 -169.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -90.1 14.55 12.15 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 117.962 -1.018 . . . . 0.0 112.967 -178.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.7 t -127.34 140.93 47.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-N 120.821 1.646 . . . . 0.0 107.522 -176.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.6 m -151.87 151.67 31.6 Favored 'General case' 0 C--O 1.239 0.518 0 O-C-N 121.33 -0.856 . . . . 0.0 111.05 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 36.6 ttp180 -80.66 145.81 31.44 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 104.554 -2.387 . . . . 0.0 104.554 168.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.1 mp -134.09 158.44 43.6 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 125.923 1.689 . . . . 0.0 106.453 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -125.86 130.59 51.66 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 169.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 58.3 m -141.94 173.27 11.67 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.06 1.344 . . . . 0.0 109.796 -170.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -140.69 131.23 25.44 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 171.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.1 m -71.73 134.63 46.37 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 175.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -71.11 -35.23 71.7 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.62 1.168 . . . . 0.0 113.62 -169.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.72 -16.85 6.57 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -169.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -121.11 48.22 1.69 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.854 0.862 . . . . 0.0 112.168 -169.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt 30.34 64.37 0.16 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.582 1.953 . . . . 0.0 113.328 168.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 20.6 mtm -137.45 117.6 13.49 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 118.355 0.525 . . . . 0.0 110.474 -176.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -82.95 133.23 35.12 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 168.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -134.67 148.1 50.27 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.989 0.899 . . . . 0.0 113.045 -168.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 38.3 mm -130.14 141.97 44.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 101.237 -3.616 . . . . 0.0 101.237 168.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 53.0 tp -146.91 152.72 39.14 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 126.799 2.04 . . . . 0.0 107.096 -168.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -146.43 109.64 4.72 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 173.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.8 m -150.01 169.79 2.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 122.032 0.92 . . . . 0.0 112.13 -169.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 43.1 t-20 -64.5 130.51 44.0 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.15 1.38 . . . . 0.0 107.966 169.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.3 pp -105.68 0.94 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 124.48 1.112 . . . . 0.0 112.982 -177.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -68.43 -16.37 63.88 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 120.249 1.386 . . . . 0.0 111.064 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.439 HG13 ' H ' ' A' ' 47' ' ' ILE . 3.7 mt -62.39 -34.16 62.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 125.275 1.43 . . . . 0.0 109.337 171.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -91.32 159.11 39.97 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 124.754 1.222 . . . . 0.0 110.868 -169.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.71 179.25 3.25 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.462 2.774 . . . . 0.0 111.537 175.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.4 m -59.75 -16.52 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.84 1.256 . . . . 0.0 113.742 -177.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -67.69 -7.35 26.27 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.752 0.821 . . . . 0.0 112.476 170.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.5 tp 72.36 7.5 5.67 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 128.232 2.613 . . . . 0.0 113.389 174.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -167.23 164.47 37.91 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 108.289 -1.925 . . . . 0.0 108.289 174.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -161.34 168.61 23.61 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.769 1.627 . . . . 0.0 107.132 174.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -64.71 138.25 58.28 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 169.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -140.9 176.31 8.91 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -177.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.7 ttp180 -135.56 142.51 45.36 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -173.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 tt -121.09 140.43 51.97 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 126.149 1.78 . . . . 0.0 107.02 -176.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.0 t -143.05 166.81 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 126.995 2.118 . . . . 0.0 106.051 -178.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 30.0 pt -119.59 13.45 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 123.568 0.747 . . . . 0.0 112.27 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.24 25.36 0.13 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.081 1.353 . . . . 0.0 113.182 -175.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.2 m -67.57 -9.77 45.77 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.628 1.571 . . . . 0.0 113.808 -173.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.0 t -146.61 169.88 18.07 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.862 0.865 . . . . 0.0 109.353 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 29.6 tp -63.51 111.05 2.18 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.444 1.097 . . . . 0.0 108.213 171.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -59.1 137.69 57.85 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 169.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -69.06 -13.82 62.66 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 177.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -71.46 141.88 50.22 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.144 0.978 . . . . 0.0 110.857 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -49.83 -23.5 5.25 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.66 1.6 . . . . 0.0 114.945 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 32.4 m -56.01 -27.46 53.08 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.483 1.641 . . . . 0.0 111.452 177.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 88.9 mt -122.98 -36.3 2.89 Favored 'General case' 0 C--N 1.343 0.291 0 C-N-CA 123.548 0.739 . . . . 0.0 111.056 171.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -67.31 -19.73 65.51 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 118.862 0.756 . . . . 0.0 112.524 -177.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -128.95 31.53 4.9 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.115 1.766 . . . . 0.0 108.399 170.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.03 28.8 2.23 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 126.396 1.95 . . . . 0.0 110.702 -175.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 59.89 12.95 3.32 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.191 1.796 . . . . 0.0 113.671 169.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER 52.39 25.37 3.45 Favored 'General case' 0 CA--C 1.55 0.961 0 O-C-N 121.28 -0.888 . . . . 0.0 110.082 -168.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -156.09 78.27 4.31 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 125.122 1.369 . . . . 0.0 109.54 -169.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -79.49 54.68 5.3 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 124.02 3.147 . . . . 0.0 108.421 169.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . 0.251 33.1 p 64.82 11.61 7.05 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.476 2.31 . . . . 0.0 112.829 -169.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -63.05 -34.0 76.65 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 124.839 1.256 . . . . 0.0 112.358 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -135.16 5.98 3.31 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.457 1.103 . . . . 0.0 112.514 -169.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.15 139.09 65.39 Favored Pre-proline 0 N--CA 1.468 0.427 0 CA-C-O 117.592 -1.194 . . . . 0.0 108.357 176.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . 0.282 0.1 OUTLIER 3.19 69.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.555 1 C-N-CA 127.892 5.728 . . . . 0.0 117.291 -169.141 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.5 m -145.52 154.15 41.89 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.313 1.845 . . . . 0.0 108.429 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -71.07 149.34 46.62 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 169.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.41 108.8 2.08 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -145.89 1.45 0.88 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.704 1.602 . . . . 0.0 111.519 -174.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -72.0 0.36 9.58 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.134 1.374 . . . . 0.0 113.22 -175.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -146.47 161.44 40.41 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 126.463 1.905 . . . . 0.0 108.541 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -122.36 -23.46 5.25 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.105 0.562 . . . . 0.0 110.729 172.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -145.66 149.45 34.49 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.804 1.242 . . . . 0.0 107.701 169.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.2 m -143.4 148.2 19.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 C-N-CA 125.621 1.568 . . . . 0.0 107.365 172.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 23.1 tpp -159.45 168.05 27.21 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.872 0.869 . . . . 0.0 109.207 176.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 84.7 t80 -128.5 150.52 50.13 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.809 1.643 . . . . 0.0 106.806 172.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -152.92 -160.06 9.43 Favored Glycine 0 C--N 1.336 0.569 0 CA-C-N 118.636 0.653 . . . . 0.0 113.672 -171.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -145.69 132.43 20.01 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.995 1.318 . . . . 0.0 108.771 172.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 42.2 t -77.14 145.57 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 168.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -144.87 74.94 1.43 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.057 1.743 . . . . 0.0 108.894 175.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -152.72 157.77 41.35 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.223 -0.923 . . . . 0.0 109.588 176.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 25.2 pt -76.99 -170.27 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 125.804 1.642 . . . . 0.0 111.356 177.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.63 -9.79 1.31 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 127.406 2.282 . . . . 0.0 115.47 -178.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 155.3 -91.7 0.12 Allowed Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 107.525 -2.23 . . . . 0.0 107.525 -174.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -149.68 28.59 0.78 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.454 1.101 . . . . 0.0 111.381 175.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 72.75 76.12 0.15 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 127.697 2.399 . . . . 0.0 111.447 176.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.288 0.0 OUTLIER 64.84 163.4 0.14 Allowed 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 117.996 2.591 . . . . 0.0 117.996 169.626 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.3 p -153.51 -43.49 0.09 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.805 2.442 . . . . 0.0 106.663 169.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 21.1 p -128.69 -55.24 1.23 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.917 1.287 . . . . 0.0 109.962 173.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -145.94 -16.27 0.46 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.371 1.068 . . . . 0.0 112.877 -174.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -159.29 156.99 29.7 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 131.481 3.912 . . . . 0.0 101.353 170.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.47 148.3 46.11 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 120.09 1.314 . . . . 0.0 108.644 174.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.21 -6.82 25.56 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -169.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -137.43 139.81 40.89 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 169.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 46.2 tp -75.96 159.5 30.81 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 168.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 16.6 m -134.98 150.65 50.39 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 175.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -142.13 128.79 20.36 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -112.52 129.76 56.24 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 100.877 -3.749 . . . . 0.0 100.877 168.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.6 p -146.72 144.91 19.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -169.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.3 t -134.53 144.01 47.75 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -136.9 82.62 1.95 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.282 1.833 . . . . 0.0 107.676 -170.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 58.57 19.67 42.79 Favored Glycine 0 CA--C 1.538 1.494 0 CA-C-O 118.977 -0.902 . . . . 0.0 114.629 174.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 124.32 -26.99 5.66 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.953 1.264 . . . . 0.0 112.723 -177.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 9.9 mp -75.31 150.06 38.59 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 169.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 7.0 tt -145.52 157.28 44.02 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.493 1.042 . . . . 0.0 110.689 -175.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 56.6 mtt -147.61 159.08 44.17 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.016 1.326 . . . . 0.0 108.861 170.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 85.4 mtp180 -141.25 130.22 23.2 Favored 'General case' 0 C--N 1.334 -0.1 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 169.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -152.59 160.09 43.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 119.059 0.845 . . . . 0.0 111.079 -170.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -137.17 149.65 47.4 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 124.315 1.046 . . . . 0.0 108.575 169.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -178.08 168.44 39.76 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -177.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -57.93 132.79 54.48 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -178.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -43.81 -73.7 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 -168.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -67.11 -26.18 66.58 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 122.404 1.097 . . . . 0.0 111.93 -172.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.95 -31.36 72.56 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 128.164 2.586 . . . . 0.0 111.203 175.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 5.4 tt -76.38 -13.47 60.13 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.28 1.032 . . . . 0.0 111.307 -176.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 32.3 t-80 52.81 40.51 30.75 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.721 1.208 . . . . 0.0 111.937 177.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -123.86 33.04 4.03 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 125.247 1.403 . . . . 0.0 110.642 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -76.48 -3.95 40.01 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.07 0.948 . . . . 0.0 113.34 -175.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -129.43 143.02 50.67 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 127.534 2.334 . . . . 0.0 106.142 169.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 8.2 p -59.21 -11.85 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.994 169.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -124.06 21.72 8.88 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 126.001 1.72 . . . . 0.0 113.492 176.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 57.9 m -72.83 -78.36 0.09 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.962 0.887 . . . . 0.0 109.779 168.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -82.58 12.62 4.41 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -169.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 33.9 m -67.27 -28.42 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-O 118.816 -0.612 . . . . 0.0 110.016 170.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -77.86 107.6 10.5 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 177.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 45.3 tp -112.66 131.38 55.67 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.459 1.104 . . . . 0.0 108.283 -176.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.5 tt -138.33 135.85 35.82 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 104.418 -2.438 . . . . 0.0 104.418 169.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -142.14 152.72 43.49 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 118.817 0.735 . . . . 0.0 111.484 176.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 39.6 pttt -165.01 172.97 12.05 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 126.224 1.81 . . . . 0.0 109.171 -174.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -55.1 156.69 3.82 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.422 0.689 . . . . 0.0 111.732 171.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.41 169.04 9.65 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.399 169.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -134.79 122.92 22.78 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 173.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 9.9 t80 . . . . . 0 C--O 1.246 0.902 0 C-N-CA 124.484 1.113 . . . . 0.0 108.276 176.66 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 mmt . . . . . 0 N--CA 1.486 1.34 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.79 163.18 0.1 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.492 2.317 . . . . 0.0 113.666 -175.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 69.28 178.39 19.44 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.373 0.987 . . . . 0.0 112.351 -175.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 40.0 pt -77.94 168.83 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 O-C-N 122.345 -0.503 . . . . 0.0 109.844 173.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -123.08 -36.08 2.9 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.24 1.416 . . . . 0.0 109.976 -176.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -151.47 158.16 43.28 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.902 1.281 . . . . 0.0 108.668 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -145.81 140.96 27.48 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.798 1.639 . . . . 0.0 108.371 -176.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -152.67 146.49 25.19 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.346 1.459 . . . . 0.0 110.54 -170.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.6 mp -112.59 137.74 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 105.847 -1.908 . . . . 0.0 105.847 171.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -145.64 161.89 38.78 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.758 1.223 . . . . 0.0 110.489 -174.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -140.86 144.79 35.51 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.598 0.759 . . . . 0.0 110.049 -174.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 39.0 t -70.08 122.56 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 125.078 1.351 . . . . 0.0 107.834 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -96.03 -32.0 12.77 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 124.508 1.123 . . . . 0.0 110.126 176.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -157.14 167.66 29.74 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.284 0.947 . . . . 0.0 110.718 175.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.7 mp -133.05 140.88 46.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 127.138 2.175 . . . . 0.0 106.296 -175.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -143.78 89.82 7.21 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 124.069 0.947 . . . . 0.0 110.011 -171.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -65.09 9.4 0.17 Allowed 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 124.121 3.214 . . . . 0.0 116.774 -178.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -78.82 55.88 1.8 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.079 1.351 . . . . 0.0 109.914 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -170.08 35.66 0.18 Allowed Glycine 0 CA--C 1.527 0.803 0 C-N-CA 124.89 1.233 . . . . 0.0 111.454 -172.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.404 ' HE2' ' HA ' ' A' ' 20' ' ' LYS . 11.2 mmpt? -65.97 64.58 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.61 1.564 . . . . 0.0 113.392 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -60.49 -38.4 84.16 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 168.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -144.37 165.5 27.75 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 129.468 3.107 . . . . 0.0 104.218 169.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.29 -40.86 83.05 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.28 -0.887 . . . . 0.0 110.737 175.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 49.0 ptt85 -70.4 7.72 0.98 Allowed 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 126.508 1.923 . . . . 0.0 114.806 175.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 77.7 t -120.48 132.09 70.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 121.497 1.953 . . . . 0.0 107.487 178.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 37.0 m -149.06 163.65 36.92 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.93 0.892 . . . . 0.0 109.789 176.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.1 ttm105 -85.45 154.28 21.92 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 169.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.0 mt -143.16 156.75 44.85 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 127.114 2.166 . . . . 0.0 107.199 -177.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -131.56 131.65 43.51 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 105.335 -2.098 . . . . 0.0 105.335 174.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 55.1 m -143.77 164.71 29.72 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.771 1.228 . . . . 0.0 110.201 -170.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -140.79 140.06 34.68 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 38.2 p -70.45 136.29 49.39 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 173.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -75.75 -35.68 60.11 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 168.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.6 m -69.56 -38.19 77.31 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -170.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -135.11 -102.26 0.22 Allowed 'General case' 0 C--N 1.345 0.38 0 CA-C-N 119.818 1.19 . . . . 0.0 110.34 -171.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -166.51 19.02 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.332 1.453 . . . . 0.0 112.559 -169.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 85.4 mtp -62.94 122.68 16.61 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.995 0.918 . . . . 0.0 108.68 176.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -98.08 112.45 24.4 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 169.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 49.0 tp -122.62 138.41 54.6 Favored 'General case' 0 N--CA 1.461 0.089 0 C-N-CA 123.455 0.702 . . . . 0.0 110.528 -169.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 33.1 mm -124.71 146.34 30.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 103.634 -2.728 . . . . 0.0 103.634 169.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 123' ' ' MET . 2.3 pt? -154.17 154.85 34.25 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.723 1.209 . . . . 0.0 109.547 176.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -121.59 120.68 35.52 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 102.992 -2.966 . . . . 0.0 102.992 170.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.2 p -151.09 163.18 2.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 121.707 0.765 . . . . 0.0 110.876 -168.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -69.02 90.23 0.44 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.907 1.683 . . . . 0.0 109.208 169.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.0 pp -65.84 -7.26 4.73 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -170.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -64.14 -18.61 64.6 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 120.161 1.346 . . . . 0.0 111.115 173.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.422 HD13 HG21 ' A' ' 47' ' ' ILE . 6.3 tt -55.34 -41.95 64.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.728 1.211 . . . . 0.0 110.629 169.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -88.02 139.37 30.74 Favored Pre-proline 0 CA--C 1.538 0.508 0 C-N-CA 125.88 1.672 . . . . 0.0 109.636 -173.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.45 132.74 30.11 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.272 1.981 . . . . 0.0 111.101 -177.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.8 t 50.34 31.06 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 126.567 1.947 . . . . 0.0 112.588 171.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.1 t70 62.42 -35.54 0.12 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 128.168 2.587 . . . . 0.0 115.203 -175.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 60.1 tp -59.36 -34.19 72.09 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.369 1.468 . . . . 0.0 111.405 177.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.37 -178.83 52.71 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-O 121.904 0.725 . . . . 0.0 112.262 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -157.96 174.16 15.67 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 126.662 1.985 . . . . 0.0 106.983 -174.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -58.92 134.22 56.74 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 173.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -128.91 168.66 15.65 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 125.908 1.683 . . . . 0.0 107.626 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -132.38 147.69 52.39 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.6 tt -137.88 144.0 41.16 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 -169.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.5 m -135.31 154.43 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 169.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 35.2 pt -121.15 147.84 24.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 104.287 -2.486 . . . . 0.0 104.287 168.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -138.55 54.2 1.77 Allowed 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.198 -168.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.9 m -42.9 116.51 0.9 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.563 1.545 . . . . 0.0 109.854 175.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.532 HG21 ' CD2' ' A' ' 65' ' ' TYR . 11.2 t -159.56 -170.52 2.96 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.34 0.656 . . . . 0.0 109.88 -169.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 25.8 tp -143.9 44.66 1.47 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.271 1.828 . . . . 0.0 108.086 173.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.532 ' CD2' HG21 ' A' ' 63' ' ' THR . 16.1 m-85 -58.11 151.32 19.15 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.41 0.624 . . . . 0.0 110.499 176.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -141.62 175.02 10.02 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 127.444 2.298 . . . . 0.0 108.708 173.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -62.6 -18.6 62.51 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.052 0.941 . . . . 0.0 113.491 -173.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -141.66 50.65 0.72 Allowed Glycine 0 CA--C 1.524 0.656 0 C-N-CA 125.45 1.5 . . . . 0.0 110.192 -178.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.4 m -62.61 159.0 16.85 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 117.651 0.725 . . . . 0.0 109.442 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 54.8 mt 45.43 26.81 0.32 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.592 1.957 . . . . 0.0 112.897 -169.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.9 t70 45.72 31.0 0.9 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 127.106 2.162 . . . . 0.0 113.658 -171.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -148.84 6.18 0.7 Allowed 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 177.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.48 38.28 90.64 Favored Glycine 0 CA--C 1.533 1.199 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -171.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 70.32 131.4 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 128.176 2.59 . . . . 0.0 111.928 -172.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -75.37 66.67 1.84 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.059 1.344 . . . . 0.0 109.472 175.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 57.4 t-20 -134.21 66.1 70.39 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 123.617 0.767 . . . . 0.0 112.189 -169.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -69.18 -18.76 39.59 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 122.373 2.048 . . . . 0.0 110.961 169.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -60.62 -5.11 1.1 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.814 2.446 . . . . 0.0 113.511 172.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.04 -23.53 1.21 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 120.038 1.29 . . . . 0.0 113.047 169.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -114.48 14.5 17.82 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 -169.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 19.2 ptt180 -77.0 -155.56 0.0 OUTLIER Pre-proline 0 CA--C 1.557 1.249 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 167.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -50.4 -11.53 0.37 Allowed 'Trans proline' 0 CA--C 1.543 0.957 0 CA-C-N 123.044 2.123 . . . . 0.0 116.215 169.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.3 m -52.17 -25.36 8.84 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 128.462 2.705 . . . . 0.0 114.459 168.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.5 tpm_? -30.78 -51.21 0.15 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.816 1.646 . . . . 0.0 113.626 -168.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -140.44 11.58 2.33 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.146 0.43 . . . . 0.0 112.118 168.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -73.96 -11.91 60.49 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.142 -0.973 . . . . 0.0 110.642 169.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -60.6 -59.53 5.25 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.634 0.773 . . . . 0.0 109.237 169.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -162.39 161.54 27.37 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 126.136 1.774 . . . . 0.0 110.218 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -123.58 -23.06 4.84 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.446 1.498 . . . . 0.0 109.476 169.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -142.81 155.03 44.74 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.378 1.471 . . . . 0.0 108.214 172.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.0 t -141.78 144.62 25.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 124.89 1.276 . . . . 0.0 107.83 -169.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 16.3 mtm -147.8 152.35 37.54 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.551 1.541 . . . . 0.0 110.308 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -138.46 144.49 40.12 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 127.587 2.355 . . . . 0.0 105.158 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.44 -151.3 6.73 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-N 120.641 1.564 . . . . 0.0 115.396 -169.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -144.71 133.39 22.25 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 126.098 1.759 . . . . 0.0 107.186 172.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.9 p -101.54 133.85 43.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 169.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -142.09 88.52 2.11 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.528 1.131 . . . . 0.0 108.874 -170.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -156.98 162.98 39.6 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.654 -1.279 . . . . 0.0 110.713 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.27 178.07 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 124.327 1.051 . . . . 0.0 110.543 178.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -64.42 4.85 0.33 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.9 2.08 . . . . 0.0 114.467 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.19 -52.93 1.6 Allowed Glycine 0 C--N 1.332 0.356 0 C-N-CA 125.49 1.519 . . . . 0.0 109.5 175.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.538 ' HA ' ' HB3' ' A' ' 109' ' ' ALA . 20.5 t70 -67.08 124.12 22.15 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.324 0.583 . . . . 0.0 109.704 169.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -132.68 16.64 4.33 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.023 1.329 . . . . 0.0 110.45 169.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 44.4 p -87.75 -161.95 0.76 Allowed 'General case' 0 C--O 1.236 0.353 0 CA-C-O 122.084 0.945 . . . . 0.0 109.984 178.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 21.8 m -157.22 16.82 0.28 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.5 2.32 . . . . 0.0 107.238 -176.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.0 p -151.91 -59.72 0.16 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.144 1.377 . . . . 0.0 109.142 -168.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -77.96 -35.87 49.78 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.095 0.558 . . . . 0.0 111.398 -170.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 56.29 74.66 0.38 Allowed 'General case' 0 C--N 1.343 0.322 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 -169.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.538 ' HB3' ' HA ' ' A' ' 102' ' ' ASP . . . -49.21 135.87 16.13 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 114.302 -1.317 . . . . 0.0 112.423 -167.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.8 p -92.92 4.21 54.34 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 -169.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? -115.09 141.64 47.73 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.019 0.927 . . . . 0.0 108.95 176.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.0 tp -88.78 154.97 19.85 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 167.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 10.8 m -130.57 149.76 52.09 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 -174.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -144.12 143.76 31.27 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -127.05 125.8 41.98 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 101.052 -3.684 . . . . 0.0 101.052 169.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.2 t -135.13 130.1 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -170.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 50.1 m -115.99 136.02 53.43 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 176.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -136.35 158.99 43.11 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.427 1.091 . . . . 0.0 109.961 -169.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -71.87 65.88 1.15 Allowed Glycine 0 CA--C 1.531 1.056 0 N-CA-C 108.204 -1.958 . . . . 0.0 108.204 168.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 171.16 -17.22 0.06 OUTLIER Glycine 0 CA--C 1.534 1.268 0 CA-C-O 117.194 -1.892 . . . . 0.0 112.194 -169.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . 0.435 43.4 mt 133.17 -136.14 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 130.514 3.526 . . . . 0.0 111.453 168.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 5.2 tt -139.48 157.74 45.33 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 121.661 2.028 . . . . 0.0 113.516 -168.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.467 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 35.7 mtt -145.25 157.89 43.96 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.135 1.774 . . . . 0.0 109.961 177.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 62.9 mtt180 -136.11 137.73 41.34 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 104.651 -2.351 . . . . 0.0 104.651 169.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 27.6 tp -148.71 146.38 28.08 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 119.054 0.843 . . . . 0.0 110.463 -168.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -137.3 153.05 50.37 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.661 1.184 . . . . 0.0 108.314 168.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 176.17 -177.1 47.81 Favored Glycine 0 CA--C 1.519 0.336 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 170.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -53.1 139.86 27.27 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 118.291 1.046 . . . . 0.0 109.681 175.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -53.04 -56.25 17.57 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 123.593 0.558 . . . . 0.0 112.167 -174.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -54.81 -40.55 69.64 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-O 121.437 0.637 . . . . 0.0 111.471 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.5 -30.98 71.82 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 127.193 2.197 . . . . 0.0 110.39 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.37 -25.28 65.9 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 118.475 -0.774 . . . . 0.0 109.447 -178.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 72.2 m80 40.94 44.46 1.98 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.48 1.512 . . . . 0.0 111.76 -177.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -137.22 64.01 0.57 Allowed Glycine 0 C--N 1.338 0.648 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 -169.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -103.37 12.88 34.82 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.729 0.812 . . . . 0.0 112.055 -173.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.452 ' C ' ' H ' ' A' ' 138' ' ' ASP . 7.4 tp10 -140.61 146.3 37.79 Favored 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 126.122 1.769 . . . . 0.0 108.002 173.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.5 m -56.51 -9.06 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 124.512 1.125 . . . . 0.0 111.346 169.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.452 ' H ' ' C ' ' A' ' 136' ' ' GLU . 31.9 t70 -134.35 15.03 3.78 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 127.548 2.339 . . . . 0.0 112.245 -172.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 68.6 m -73.37 -81.8 0.06 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 122.309 1.052 . . . . 0.0 109.642 168.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -80.0 14.34 1.87 Allowed 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -169.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 20.1 m -68.18 -29.73 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 169.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -82.56 106.18 14.21 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 175.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 24.7 tp -129.79 137.18 50.36 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 124.617 1.167 . . . . 0.0 108.133 -173.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.9 mp -139.63 151.43 45.97 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 172.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 60.4 mtm -138.85 154.18 48.4 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.616 0.767 . . . . 0.0 109.581 -176.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 34.0 pttt -165.0 175.18 9.71 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.205 1.402 . . . . 0.0 110.964 -169.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 23.0 ptmt -63.31 157.17 23.57 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 122.406 0.283 . . . . 0.0 110.239 169.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.33 154.6 31.26 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.691 0.758 . . . . 0.0 111.512 172.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -135.86 112.72 10.24 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 169.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 . . . . . 0 C--O 1.247 0.939 0 CA-C-O 118.546 -0.74 . . . . 0.0 109.962 -177.247 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 119.881 -0.104 . . . . 0.0 110.846 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.36 6.7 3.3 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.394 1.078 . . . . 0.0 112.852 -175.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -172.83 171.6 44.5 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.476 -1.049 . . . . 0.0 110.476 178.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.0 tt -138.9 145.32 27.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 125.318 1.447 . . . . 0.0 108.53 -174.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 44.3 tp -109.57 -48.93 3.16 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 124.408 1.083 . . . . 0.0 109.668 178.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -161.04 166.65 27.83 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.485 1.114 . . . . 0.0 109.559 173.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -140.63 132.89 28.2 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.925 2.09 . . . . 0.0 106.313 176.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -149.86 153.75 37.24 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 171.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.0 mp -75.52 146.0 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 173.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -129.65 153.9 47.66 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.478 1.511 . . . . 0.0 107.389 170.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -131.74 129.59 40.82 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.664 1.586 . . . . 0.0 108.278 -174.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 51.8 t -72.51 118.03 16.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 124.448 1.099 . . . . 0.0 108.197 -177.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.2 mmpt? -78.25 -43.33 28.51 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 124.489 1.116 . . . . 0.0 109.59 169.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -159.11 170.65 21.54 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 118.824 0.738 . . . . 0.0 111.038 -175.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.2 mp -138.6 142.56 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 127.104 2.162 . . . . 0.0 106.825 -173.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -147.39 93.99 4.56 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 124.195 0.998 . . . . 0.0 111.205 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -73.14 90.84 0.85 Allowed 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 123.306 2.671 . . . . 0.0 107.765 168.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -57.87 -33.56 68.83 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -169.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 155.81 42.5 0.02 OUTLIER Glycine 0 CA--C 1.527 0.79 0 N-CA-C 106.248 -2.741 . . . . 0.0 106.248 -169.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 22.1 mmtt -72.42 95.96 1.84 Allowed 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.443 1.497 . . . . 0.0 109.66 -168.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -47.7 -43.31 26.56 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.232 1.013 . . . . 0.0 112.025 175.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.5 m-30 -81.08 -18.58 46.11 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 122.741 0.416 . . . . 0.0 112.071 -174.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.7 t70 62.75 -36.13 0.13 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 130.064 3.345 . . . . 0.0 115.688 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -72.64 11.0 0.71 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.316 1.446 . . . . 0.0 113.124 170.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 53.7 t -126.53 140.46 48.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 104.029 -2.582 . . . . 0.0 104.029 174.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 55.7 m -156.21 160.82 40.17 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 119.637 1.108 . . . . 0.0 110.417 174.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.461 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 15.1 ttm180 -83.81 150.38 25.8 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 170.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 66.0 mt -137.76 155.17 49.34 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.744 2.018 . . . . 0.0 106.141 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -121.58 127.35 50.82 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 102.804 -3.036 . . . . 0.0 102.804 169.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 74.5 m -141.27 162.63 35.01 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.182 0.993 . . . . 0.0 110.864 -169.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -138.75 134.2 33.2 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.556 1.542 . . . . 0.0 107.607 -176.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.5 p -67.18 148.3 51.97 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.014 0.926 . . . . 0.0 110.697 173.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -77.78 -30.41 51.34 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 118.756 -0.64 . . . . 0.0 111.013 172.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -132.49 -31.45 1.39 Allowed 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 115.234 1.568 . . . . 0.0 115.234 -169.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 23.3 m-30 -108.35 30.9 6.01 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -168.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 49.5 pttt 40.11 53.73 2.75 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.564 1.546 . . . . 0.0 114.282 169.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 47.6 mtt -114.52 110.82 20.42 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.388 1.875 . . . . 0.0 107.972 177.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -82.74 125.06 30.83 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 169.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 51.9 tp -132.85 142.09 48.77 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 118.733 0.697 . . . . 0.0 112.305 -168.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 40.8 mm -120.03 136.98 55.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 101.635 -3.468 . . . . 0.0 101.635 169.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 22.3 tp -152.7 105.21 2.95 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.062 0.945 . . . . 0.0 109.316 -168.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.461 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 16.1 t70 -100.87 105.54 16.82 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 126.212 1.805 . . . . 0.0 107.246 173.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.7 m -150.51 172.03 1.34 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-O 121.662 0.744 . . . . 0.0 110.515 -169.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -59.9 128.14 35.41 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.175 1.39 . . . . 0.0 109.264 169.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.1 pp -114.67 0.88 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 124.597 1.159 . . . . 0.0 113.812 -174.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.68 -4.92 25.97 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 120.42 1.463 . . . . 0.0 111.255 177.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.8 mt -62.83 -38.79 82.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 168.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -78.21 148.15 74.03 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 123.505 0.722 . . . . 0.0 110.138 -171.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.93 -25.33 19.92 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 122.592 2.195 . . . . 0.0 112.669 -177.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.8 m -145.42 160.82 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 125.611 1.564 . . . . 0.0 108.352 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -60.25 -27.82 67.53 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.313 1.045 . . . . 0.0 112.463 178.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 42.7 tp -62.65 -15.17 50.71 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.761 1.224 . . . . 0.0 112.456 174.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.1 -176.46 51.48 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -172.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -155.71 166.1 34.53 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.436 1.494 . . . . 0.0 107.344 177.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -66.95 131.69 46.39 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 173.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -139.69 146.16 39.28 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -172.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 61.5 mtm180 -79.67 134.08 36.41 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 170.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -106.04 134.44 49.17 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 104.355 -2.461 . . . . 0.0 104.355 169.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 80.1 t -134.29 138.65 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 -176.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.1 mm -106.78 135.18 46.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 104.832 -2.285 . . . . 0.0 104.832 169.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -120.02 -167.87 1.51 Allowed 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.708 1.203 . . . . 0.0 110.127 -169.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 69.7 m -152.48 145.05 24.17 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 169.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 26.5 m -145.94 133.07 20.4 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 42.7 tp -80.01 61.83 4.01 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 169.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -61.27 -23.36 65.61 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.613 -0.679 . . . . 0.0 112.753 -169.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -58.93 -22.5 60.01 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.112 0.965 . . . . 0.0 112.294 175.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -68.85 -22.76 64.2 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.593 0.757 . . . . 0.0 112.238 175.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.31 34.54 90.19 Favored Glycine 0 CA--C 1.534 1.233 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -173.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.92 -25.26 66.63 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 118.624 1.212 . . . . 0.0 110.216 173.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 75.5 mt -128.78 46.48 2.61 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 127.31 2.244 . . . . 0.0 106.706 171.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -50.21 119.69 3.88 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 124.084 0.954 . . . . 0.0 109.002 -177.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -51.42 96.63 0.01 OUTLIER 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.157 1.783 . . . . 0.0 111.033 -175.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 146.67 -30.97 1.52 Allowed Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.619 1.104 . . . . 0.0 110.657 -169.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -140.14 48.22 1.78 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 128.963 2.905 . . . . 0.0 106.183 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -70.35 86.61 0.6 Allowed 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 176.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -56.63 147.45 51.05 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 125.208 1.403 . . . . 0.0 110.569 -174.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -55.33 -12.47 5.74 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.544 2.829 . . . . 0.0 115.869 176.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.6 m 55.95 35.61 25.82 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.953 1.701 . . . . 0.0 110.751 -173.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -128.64 28.23 5.42 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 127.319 2.248 . . . . 0.0 106.767 169.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -152.35 -62.72 0.16 Allowed 'General case' 0 C--O 1.231 0.13 0 C-N-CA 127.791 2.436 . . . . 0.0 104.771 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 84.9 mtt180 -74.65 144.15 79.94 Favored Pre-proline 0 N--CA 1.469 0.486 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 167.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER 10.85 64.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.833 1 C-N-CA 127.383 5.389 . . . . 0.0 115.828 -169.664 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.7 p -59.4 -18.7 41.19 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.951 1.7 . . . . 0.0 114.921 -169.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -58.72 -23.87 60.47 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 121.272 -0.893 . . . . 0.0 111.875 172.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -74.6 -3.12 29.23 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 118.125 -0.94 . . . . 0.0 112.994 177.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -73.0 60.15 0.53 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 120.552 1.524 . . . . 0.0 112.19 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -139.84 -13.74 1.08 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.634 1.974 . . . . 0.0 111.215 -176.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -79.85 162.43 25.06 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 118.505 0.593 . . . . 0.0 110.269 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -116.15 -23.31 8.51 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.669 0.787 . . . . 0.0 110.353 175.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -149.86 150.32 31.77 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.247 1.019 . . . . 0.0 109.218 171.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.4 p -148.42 142.99 19.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 174.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 10.3 tpt -159.94 166.93 29.15 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.938 0.895 . . . . 0.0 109.596 176.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -121.06 146.8 46.34 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.107 1.363 . . . . 0.0 108.138 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -141.65 -160.43 8.32 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-N 118.637 0.653 . . . . 0.0 112.328 -175.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -142.02 128.84 20.54 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.862 1.265 . . . . 0.0 107.824 169.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 39.3 t -79.68 144.03 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 171.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -143.46 75.47 1.48 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.931 1.293 . . . . 0.0 109.529 177.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -157.09 163.58 38.82 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 120.764 -1.21 . . . . 0.0 110.954 170.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.53 -172.49 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 125.691 1.596 . . . . 0.0 110.935 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.22 -13.93 3.67 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.91 2.084 . . . . 0.0 115.437 -178.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.441 ' HA2' ' H ' ' A' ' 113' ' ' SER . . . 152.55 -67.04 0.33 Allowed Glycine 0 C--N 1.334 0.435 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -146.68 12.08 1.13 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.373 1.069 . . . . 0.0 112.906 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 58.47 71.12 0.6 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.751 2.021 . . . . 0.0 111.719 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 32.1 p -56.3 -57.38 12.48 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.675 0.79 . . . . 0.0 109.35 169.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 17.4 m 157.34 -37.4 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.441 1 C-N-CA 132.006 4.123 . . . . 0.0 107.915 -176.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.89 -25.92 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.686 0.794 . . . . 0.0 111.376 -169.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -64.87 -28.55 69.62 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.324 0.65 . . . . 0.0 111.599 -174.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 75.32 115.4 0.06 Allowed 'General case' 0 C--O 1.237 0.401 0 C-N-CA 128.638 2.775 . . . . 0.0 107.181 -172.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.05 165.44 5.61 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.809 -169.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.4 p -56.87 116.46 3.2 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 173.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? 60.32 131.98 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 127.804 2.442 . . . . 0.0 111.611 -168.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 9.1 tt -79.55 135.87 36.73 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 103.15 -2.907 . . . . 0.0 103.15 167.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.441 ' H ' ' HA2' ' A' ' 101' ' ' GLY . 41.8 m -109.47 136.77 48.34 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 105.477 -2.046 . . . . 0.0 105.477 173.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -128.22 152.02 48.57 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.121 1.369 . . . . 0.0 108.091 -174.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -132.56 137.71 47.21 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 102.834 -3.025 . . . . 0.0 102.834 169.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.8 t -132.38 147.13 32.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 177.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.0 m -127.31 157.68 39.23 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 102.513 -3.143 . . . . 0.0 102.513 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . 0.333 98.4 m-85 58.76 -148.79 0.47 Allowed 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -167.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 61.15 13.57 35.74 Favored Glycine 0 CA--C 1.535 1.325 0 CA-C-N 120.186 1.357 . . . . 0.0 113.17 -176.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 138.21 -50.31 0.81 Allowed Glycine 0 CA--C 1.528 0.848 0 C-N-CA 126.066 1.793 . . . . 0.0 109.601 -171.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.65 -68.63 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.458 1.503 . . . . 0.0 109.0 169.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 11.3 tp -157.79 148.21 20.71 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 124.561 1.144 . . . . 0.0 109.065 -178.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.58 156.34 41.77 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 170.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 70.2 ttt-85 -127.61 142.57 51.32 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 169.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 15.3 tp -149.74 148.89 29.77 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -169.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -144.39 143.42 30.93 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 168.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -175.93 178.05 47.49 Favored Glycine 0 CA--C 1.52 0.361 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -52.42 137.24 29.98 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 118.305 1.053 . . . . 0.0 110.622 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -56.91 -55.98 27.53 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -169.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -57.03 -43.95 82.39 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 122.349 1.071 . . . . 0.0 111.403 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 27.0 t30 -60.99 -28.09 68.77 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 126.292 1.837 . . . . 0.0 111.935 177.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.11 -29.38 54.81 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 123.911 0.884 . . . . 0.0 110.145 178.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 49.21 21.56 0.54 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.925 1.69 . . . . 0.0 113.191 -169.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.02 -10.86 84.17 Favored Glycine 0 CA--C 1.528 0.865 0 O-C-N 121.059 -1.026 . . . . 0.0 113.955 -169.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -59.12 -30.64 68.27 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 118.476 1.138 . . . . 0.0 111.693 172.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -87.35 87.82 7.52 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 126.743 2.017 . . . . 0.0 106.212 169.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.5 m -59.59 -7.12 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 124.49 1.116 . . . . 0.0 113.407 176.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -123.4 18.74 9.75 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 126.11 1.764 . . . . 0.0 113.17 176.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.9 m -83.84 -68.93 0.67 Allowed 'General case' 0 C--O 1.232 0.147 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 167.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.292 10.6 ptm85 -78.31 11.67 2.29 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 -169.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 29.7 m -67.58 -34.86 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-O 118.645 -0.693 . . . . 0.0 109.337 168.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -82.82 104.35 12.99 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 10.3 tt -117.2 134.72 54.44 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -170.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -140.51 135.92 32.39 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 -171.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 78.4 mtm -137.85 149.4 46.26 Favored 'General case' 0 C--O 1.237 0.426 0 O-C-N 121.267 -0.896 . . . . 0.0 109.944 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -154.62 172.51 17.75 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.305 1.042 . . . . 0.0 109.761 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -53.51 160.46 1.23 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.298 0.639 . . . . 0.0 111.857 175.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.25 166.3 0.86 Allowed 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.394 0.616 . . . . 0.0 111.981 169.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -87.09 86.59 7.31 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 175.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 19.2 t80 . . . . . 0 C--O 1.248 0.995 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 172.632 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.3 mmt . . . . . 0 N--CA 1.483 1.217 0 N-CA-C 109.254 -0.646 . . . . 0.0 109.254 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.26 142.67 57.6 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 122.953 0.501 . . . . 0.0 110.528 -177.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 174.29 177.63 43.59 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 170.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.6 tp -150.96 138.6 13.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 169.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 23.1 tp -153.37 -13.79 0.15 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.055 0.942 . . . . 0.0 112.088 175.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -147.33 134.04 19.99 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -148.5 138.4 22.29 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 169.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -151.17 150.62 30.85 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.026 0.83 . . . . 0.0 110.869 172.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.6 mp -75.16 152.65 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 169.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -132.59 146.66 52.07 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.651 1.58 . . . . 0.0 107.788 174.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -123.75 119.74 30.63 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 127.225 2.21 . . . . 0.0 106.641 -175.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.7 t -78.39 123.92 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -177.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.5 mmmt -88.7 -40.0 13.58 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.952 0.901 . . . . 0.0 109.687 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -157.93 170.91 21.27 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 118.386 0.539 . . . . 0.0 112.318 -169.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.1 mp -141.9 147.54 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 127.881 2.472 . . . . 0.0 106.786 -175.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -143.86 110.58 5.2 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 169.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -64.62 7.35 0.25 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.605 2.87 . . . . 0.0 117.454 -177.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 46.14 39.93 6.62 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.731 2.012 . . . . 0.0 112.294 -174.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.29 37.71 41.26 Favored Glycine 0 CA--C 1.531 1.065 0 O-C-N 121.528 -0.732 . . . . 0.0 111.447 -177.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? 45.55 57.64 4.81 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 126.661 1.984 . . . . 0.0 109.642 -169.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -54.63 -36.76 64.86 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.921 0.888 . . . . 0.0 110.645 -178.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -140.17 160.99 38.73 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 169.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -64.64 -25.55 68.01 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -177.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -136.57 16.47 3.13 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 117.639 -1.172 . . . . 0.0 113.579 -173.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.8 t -131.61 129.14 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 121.005 1.73 . . . . 0.0 107.364 -178.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 39.6 m -148.34 159.55 43.89 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 124.387 1.075 . . . . 0.0 110.396 -170.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 -69.01 146.46 52.7 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 169.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.2 mp -127.86 158.09 38.72 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 127.018 2.127 . . . . 0.0 106.521 170.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -136.08 132.01 35.59 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 171.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.3 m -142.85 173.02 11.92 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.318 1.447 . . . . 0.0 110.609 -169.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -140.99 143.66 34.59 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.59 1.956 . . . . 0.0 106.858 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.3 p -88.09 147.68 24.83 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.109 0.868 . . . . 0.0 110.033 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -77.58 -41.79 37.48 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.497 1.119 . . . . 0.0 112.811 -169.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.28 -26.74 9.0 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.831 0.852 . . . . 0.0 112.775 -169.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -121.35 23.78 10.26 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.957 1.303 . . . . 0.0 112.188 -170.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.9 pttt 43.6 27.37 0.15 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 127.097 2.159 . . . . 0.0 116.247 168.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 53.8 mtt -70.53 149.29 47.3 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 119.813 1.188 . . . . 0.0 108.366 175.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -112.29 131.07 55.71 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 173.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 48.7 tp -133.56 141.88 47.9 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.667 0.746 . . . . 0.0 111.154 -169.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 42.6 mm -123.05 142.4 39.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 101.161 -3.644 . . . . 0.0 101.161 168.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 51.3 tp -148.92 154.73 39.84 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 126.221 1.808 . . . . 0.0 106.929 -168.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -137.18 114.14 10.59 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 103.478 -2.786 . . . . 0.0 103.478 169.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.0 p -151.46 167.29 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 O-C-N 124.373 1.046 . . . . 0.0 111.026 -168.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -60.61 137.08 58.22 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.943 1.297 . . . . 0.0 109.413 169.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.6 pp -119.14 8.0 6.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 124.935 1.294 . . . . 0.0 113.417 -177.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -65.41 -19.57 66.0 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 120.367 1.44 . . . . 0.0 110.96 173.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.4 mt -63.65 -33.92 64.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 126.238 1.815 . . . . 0.0 110.291 172.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -65.75 138.73 96.68 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 123.757 0.823 . . . . 0.0 112.916 -167.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -72.91 177.43 7.7 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.418 2.745 . . . . 0.0 110.974 172.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.6 m -70.87 -22.93 23.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 O-C-N 121.766 -0.583 . . . . 0.0 111.62 171.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -69.16 153.19 44.11 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.755 0.822 . . . . 0.0 110.733 177.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 53.9 tp -63.8 -29.68 70.85 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.512 0.725 . . . . 0.0 112.625 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.21 160.51 13.78 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-N 119.091 0.859 . . . . 0.0 111.679 -175.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -157.69 164.81 36.77 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 126.097 1.759 . . . . 0.0 107.433 174.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -138.43 150.87 46.92 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.681 0.792 . . . . 0.0 109.339 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -151.59 -175.32 5.15 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 124.989 1.316 . . . . 0.0 107.598 173.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.7 ttp180 -136.12 147.85 47.97 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 125.233 1.413 . . . . 0.0 107.716 -177.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.1 tp -134.91 151.0 50.5 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.132 0.973 . . . . 0.0 109.755 -169.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 55.7 t -136.46 137.11 48.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 105.472 -2.048 . . . . 0.0 105.472 173.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 pp -137.45 3.5 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 123.808 0.843 . . . . 0.0 113.077 -176.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.16 -46.66 17.51 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.446 -0.784 . . . . 0.0 112.462 -170.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.1 m -157.55 173.08 17.41 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.595 1.558 . . . . 0.0 108.306 -169.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.426 HG22 ' H ' ' A' ' 65' ' ' TYR . 1.8 m -66.94 151.82 46.88 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 168.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 24.0 tp -77.06 -17.18 58.94 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.309 -0.869 . . . . 0.0 111.329 170.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.426 ' H ' HG22 ' A' ' 63' ' ' THR . 12.4 m-85 -143.56 159.75 41.87 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.349 1.06 . . . . 0.0 112.032 -172.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -150.25 -174.09 4.64 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.76 2.024 . . . . 0.0 108.408 169.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -57.3 -21.37 34.42 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.494 1.518 . . . . 0.0 114.492 -171.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -109.4 -5.44 30.04 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-O 118.873 -0.96 . . . . 0.0 113.721 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.03 173.21 11.55 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.258 1.529 . . . . 0.0 108.667 170.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 52.6 mt 48.87 -121.2 1.47 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -177.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -136.27 120.51 17.87 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 104.3 -2.481 . . . . 0.0 104.3 168.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.2 t70 54.99 25.88 7.38 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.121 1.368 . . . . 0.0 112.917 -173.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 66.84 25.01 73.08 Favored Glycine 0 CA--C 1.527 0.825 0 O-C-N 121.344 -0.847 . . . . 0.0 112.714 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -132.0 149.58 52.39 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.735 1.214 . . . . 0.0 107.894 -175.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -72.46 16.44 0.14 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.754 1.221 . . . . 0.0 113.507 -176.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -69.76 -16.79 0.34 Allowed Pre-proline 0 CA--C 1.542 0.643 0 CA-C-O 115.261 -2.304 . . . . 0.0 116.198 -175.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -79.98 47.36 2.51 Favored 'Trans proline' 0 C--N 1.358 1.068 0 CA-C-N 124.544 2.658 . . . . 0.0 109.848 169.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . 0.25 23.6 p 44.06 38.38 2.25 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 128.276 2.63 . . . . 0.0 113.083 -172.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -78.33 -19.3 53.78 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 121.359 -0.838 . . . . 0.0 111.657 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -149.38 -39.79 0.15 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.272 1.829 . . . . 0.0 109.36 171.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -60.65 135.47 92.24 Favored Pre-proline 0 CA--C 1.533 0.289 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . 0.279 2.4 Cg_exo 32.03 44.71 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.715 1 C-N-CA 125.439 4.093 . . . . 0.0 116.541 -169.243 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.9 m -139.52 -179.4 5.88 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.657 1.983 . . . . 0.0 108.97 173.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 26.6 mmt85 -63.78 172.85 2.0 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.279 0.632 . . . . 0.0 110.201 171.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -129.39 28.11 5.24 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.479 1.512 . . . . 0.0 109.855 176.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -80.72 -21.23 41.38 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.455 1.502 . . . . 0.0 111.573 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.91 -45.13 91.05 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.41 1.884 . . . . 0.0 112.656 -169.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -146.85 158.93 44.04 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.571 1.548 . . . . 0.0 108.178 178.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -97.8 -49.71 4.72 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.212 0.914 . . . . 0.0 110.209 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -157.4 165.97 34.3 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.18 0.9 . . . . 0.0 110.994 172.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.7 p -141.47 142.87 28.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 170.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.8 tpt -152.91 162.06 41.77 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.779 1.232 . . . . 0.0 109.164 -175.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -114.6 116.59 29.01 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 170.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.75 -167.08 32.09 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 -174.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.42 111.04 10.42 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 169.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 87.2 t -72.22 155.97 7.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 174.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -128.39 106.81 9.25 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 104.632 -2.359 . . . . 0.0 104.632 169.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -75.48 138.69 41.76 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -174.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.4 pt -128.31 179.46 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.149 0.98 . . . . 0.0 108.808 169.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -74.18 -1.46 20.52 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.609 1.564 . . . . 0.0 114.607 -173.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.1 37.68 91.82 Favored Glycine 0 C--N 1.336 0.583 0 O-C-N 121.841 -0.537 . . . . 0.0 112.696 -176.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -145.67 127.15 15.03 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 168.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -131.81 16.42 4.76 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 123.971 0.794 . . . . 0.0 111.617 169.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 43.1 p -68.44 -63.14 1.12 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.7 m 152.36 -38.69 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 131.02 3.728 . . . . 0.0 108.402 -175.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.04 -19.22 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.113 0.565 . . . . 0.0 112.231 -169.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -66.03 -23.82 66.63 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.134 0.879 . . . . 0.0 110.489 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 68.45 86.03 0.13 Allowed 'General case' 0 C--N 1.344 0.352 0 C-N-CA 127.449 2.3 . . . . 0.0 107.388 175.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.56 144.49 7.83 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 114.004 -1.453 . . . . 0.0 112.774 -168.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.1 p -84.5 4.1 33.37 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.56 1.144 . . . . 0.0 114.055 -176.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -124.04 131.94 53.62 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.294 1.838 . . . . 0.0 106.562 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 34.9 tp -70.8 153.63 42.57 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 170.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -126.88 161.46 28.21 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.206 1.002 . . . . 0.0 108.838 -172.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -147.97 161.22 41.78 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.752 1.221 . . . . 0.0 108.974 171.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -124.48 147.7 48.18 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 169.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.8 t -144.54 143.16 23.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 29.6 m -120.48 136.4 54.77 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 169.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -146.58 114.99 6.71 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -178.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 57.19 23.33 46.95 Favored Glycine 0 CA--C 1.539 1.588 0 CA-C-O 119.311 -0.716 . . . . 0.0 114.456 174.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.57 -8.42 64.04 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 124.763 1.173 . . . . 0.0 113.633 -178.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -95.26 170.2 9.55 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.777 1.631 . . . . 0.0 108.814 175.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.0 tp -139.19 160.63 39.36 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 118.741 0.7 . . . . 0.0 111.587 -169.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 71.4 mtm -153.97 161.56 41.88 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.56 1.544 . . . . 0.0 110.253 169.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -141.49 133.61 27.77 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 103.825 -2.657 . . . . 0.0 103.825 167.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.8 tt -140.92 151.1 43.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 119.259 0.936 . . . . 0.0 108.866 -171.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -132.93 153.42 51.42 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.644 1.177 . . . . 0.0 109.409 170.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -168.66 169.26 41.59 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 170.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -51.13 136.98 22.88 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.224 1.012 . . . . 0.0 109.005 172.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -42.73 -53.65 4.44 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -172.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -60.83 -41.35 95.62 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 123.174 1.464 . . . . 0.0 111.511 -177.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -71.63 -18.92 62.17 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 127.099 2.16 . . . . 0.0 111.386 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -67.87 -25.2 65.4 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 119.168 0.895 . . . . 0.0 109.184 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 25.2 t-80 53.28 40.42 31.26 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.88 1.272 . . . . 0.0 111.064 171.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -165.92 50.65 0.27 Allowed Glycine 0 C--N 1.338 0.655 0 O-C-N 121.366 -0.834 . . . . 0.0 112.609 -169.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -74.7 8.35 2.45 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.085 0.954 . . . . 0.0 112.18 171.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -135.17 130.24 35.05 Favored 'General case' 0 CA--C 1.508 -0.649 0 C-N-CA 126.005 1.722 . . . . 0.0 106.909 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.9 p -59.01 -4.68 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 126.14 1.776 . . . . 0.0 111.348 170.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -131.93 15.2 4.76 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.288 1.435 . . . . 0.0 113.075 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 6.8 m -87.14 -66.52 0.9 Allowed 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 167.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.32 0.0 OUTLIER -81.41 14.92 2.23 Favored 'General case' 0 C--N 1.345 0.38 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -169.521 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 16.3 m -64.23 -32.28 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 167.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -65.23 127.41 31.6 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 175.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 63.4 tp -143.07 130.95 21.57 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -177.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.3 tt -139.93 144.47 37.12 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 172.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 57.4 ttm -131.36 144.71 51.43 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 174.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 50.4 pttt -153.55 174.36 14.53 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.18 1.392 . . . . 0.0 109.524 178.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -64.26 157.95 24.57 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 122.533 0.333 . . . . 0.0 111.012 172.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.88 166.55 15.35 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.767 0.427 . . . . 0.0 110.961 169.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -141.61 134.29 28.55 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 172.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 . . . . . 0 C--O 1.25 1.094 0 C-N-CA 127.009 2.124 . . . . 0.0 110.937 -177.586 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 mpp? . . . . . 0 N--CA 1.482 1.16 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.6 173.3 15.7 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.596 1.158 . . . . 0.0 109.275 174.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -147.58 162.22 28.64 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 169.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.1 mm 62.63 155.72 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 125.893 1.677 . . . . 0.0 110.444 -169.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 56.1 tp -153.45 142.64 21.43 Favored 'General case' 0 C--O 1.233 0.211 0 O-C-N 120.918 -1.114 . . . . 0.0 109.039 174.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -147.84 151.04 35.27 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 126.527 1.931 . . . . 0.0 106.744 169.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -149.54 138.09 20.86 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.239 1.415 . . . . 0.0 107.581 -175.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -153.79 140.91 19.41 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.823 1.249 . . . . 0.0 109.251 -178.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.4 mp -107.46 139.16 30.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -134.99 158.07 45.3 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.438 1.095 . . . . 0.0 110.363 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -125.21 135.13 52.27 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 126.055 1.742 . . . . 0.0 107.514 -177.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.5 p -69.01 146.51 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 122.203 1.002 . . . . 0.0 109.358 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -125.11 -28.78 3.38 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 126.837 2.055 . . . . 0.0 109.116 -176.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -157.61 164.29 37.4 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 118.946 0.794 . . . . 0.0 110.913 170.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.8 mp -141.64 138.03 31.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 127.423 2.289 . . . . 0.0 106.032 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -146.61 97.8 4.26 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 125.351 1.46 . . . . 0.0 108.773 -176.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -60.67 26.1 0.04 OUTLIER 'Trans proline' 0 CA--C 1.543 0.952 1 C-N-CA 125.831 4.354 . . . . 0.0 118.554 -175.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -63.2 -9.05 9.61 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.214 -1.554 . . . . 0.0 113.628 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.72 10.63 12.48 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.442 1.496 . . . . 0.0 112.695 172.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.8 tppt? -44.15 -12.89 0.01 OUTLIER 'General case' 0 C--N 1.345 0.373 0 C-N-CA 129.536 3.134 . . . . 0.0 116.749 -176.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.2 tppt? -55.38 -31.35 61.73 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.224 0.92 . . . . 0.0 110.054 169.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -136.84 110.17 7.88 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 104.125 -2.546 . . . . 0.0 104.125 169.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -56.99 -28.3 62.27 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -169.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.2 ptt180 -72.02 4.7 3.22 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 117.453 -1.26 . . . . 0.0 113.759 174.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.0 t -120.85 134.95 62.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 121.363 1.892 . . . . 0.0 107.311 -178.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.8 m -145.78 151.73 38.41 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.694 0.797 . . . . 0.0 110.145 -177.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.5 ttp180 -73.25 143.12 47.2 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 168.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -136.46 155.61 49.76 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 125.547 1.539 . . . . 0.0 107.289 -174.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -131.92 135.06 46.34 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 105.218 -2.141 . . . . 0.0 105.218 169.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 65.7 m -141.18 167.02 23.17 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.536 1.534 . . . . 0.0 109.305 -176.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -135.94 130.47 33.77 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 178.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.3 m -76.62 131.01 38.64 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.218 0.607 . . . . 0.0 110.16 178.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -80.21 -36.5 34.76 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.91 0.884 . . . . 0.0 110.844 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.07 -29.5 69.3 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.506 0.722 . . . . 0.0 112.918 -169.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -132.92 -99.1 0.28 Allowed 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -167.08 13.82 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.449 1.1 . . . . 0.0 112.959 -172.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 72.2 mtm -71.18 141.14 50.69 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.174 0.512 . . . . 0.0 111.234 -169.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -88.73 135.97 33.24 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 169.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 64.1 tp -136.96 141.5 42.61 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 119.212 0.914 . . . . 0.0 109.426 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 36.3 mm -128.85 147.76 33.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 104.057 -2.571 . . . . 0.0 104.057 169.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 123' ' ' MET . 2.5 mp -144.17 166.28 25.48 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 125.639 1.575 . . . . 0.0 108.995 177.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -136.84 96.21 3.27 Favored 'General case' 0 C--N 1.324 -0.539 1 N-CA-C 99.038 -4.43 . . . . 0.0 99.038 167.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.7 p -139.45 161.18 27.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-O 121.353 0.596 . . . . 0.0 112.013 -167.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 62.5 t-20 -62.46 128.12 34.54 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.854 1.262 . . . . 0.0 109.273 170.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.5 pp -105.54 0.71 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 124.998 1.319 . . . . 0.0 112.93 -178.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -68.27 -17.51 64.31 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 120.347 1.431 . . . . 0.0 110.977 -177.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.4 mt -67.05 -34.97 73.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 124.501 1.12 . . . . 0.0 109.1 174.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -69.02 149.73 97.73 Favored Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -77.76 30.75 0.43 Allowed 'Trans proline' 0 CA--C 1.546 1.109 0 C-N-CA 124.445 3.43 . . . . 0.0 113.384 -172.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . 0.268 29.9 m 42.9 51.2 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 126.7 2.0 . . . . 0.0 111.937 -176.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -139.4 172.87 12.19 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.137 1.775 . . . . 0.0 108.343 -177.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 53.1 tp -52.14 -33.7 41.3 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.534 1.533 . . . . 0.0 113.417 -171.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -174.92 170.54 43.67 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 118.554 0.615 . . . . 0.0 111.611 172.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -158.84 172.34 18.4 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 126.431 1.892 . . . . 0.0 107.41 174.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -112.5 148.95 33.36 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.316 1.046 . . . . 0.0 109.916 -178.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -141.48 173.62 11.32 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.76 1.224 . . . . 0.0 108.367 -178.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -130.24 129.24 43.08 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 124.669 1.188 . . . . 0.0 107.911 -170.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.9 tp -91.53 141.12 29.07 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 169.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 55.1 t -134.7 146.72 30.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 172.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.4 mt -135.05 127.74 48.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 104.391 -2.448 . . . . 0.0 104.391 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -153.3 131.31 11.78 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 105.083 -2.191 . . . . 0.0 105.083 175.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.1 m -77.32 90.27 3.77 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 -176.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.2 m -61.99 -28.56 69.65 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.691 0.797 . . . . 0.0 111.375 176.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 71.7 mt 52.7 26.21 4.3 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.331 1.452 . . . . 0.0 112.23 -175.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -75.85 156.19 34.63 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.826 0.85 . . . . 0.0 110.158 -175.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -140.55 159.44 42.18 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.416 1.486 . . . . 0.0 108.672 169.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -60.37 -24.23 64.93 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -173.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -106.38 26.85 18.86 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.181 1.372 . . . . 0.0 112.688 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 46.7 m -60.96 -26.99 67.93 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 119.126 1.463 . . . . 0.0 110.316 172.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 38.7 mt -132.58 160.75 35.68 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 126.545 1.938 . . . . 0.0 106.813 174.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -80.96 44.94 0.78 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.245 1.018 . . . . 0.0 111.314 -178.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -164.12 -50.24 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.185 1.394 . . . . 0.0 110.742 175.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 126.19 -37.58 2.42 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 127.163 2.316 . . . . 0.0 110.878 -175.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -144.5 42.61 1.37 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.403 1.481 . . . . 0.0 108.896 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -57.26 125.12 21.34 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 169.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -140.41 79.29 20.98 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -168.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.48 -15.29 30.96 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.225 2.617 . . . . 0.0 112.835 -174.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 47.2 m -153.51 152.85 31.43 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 104.055 -2.572 . . . . 0.0 104.055 172.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -47.8 -45.41 29.49 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -169.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.83 -3.93 57.01 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -174.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -78.1 132.01 68.1 Favored Pre-proline 0 C--O 1.234 0.242 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -176.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . 0.262 0.1 OUTLIER 17.55 51.63 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.638 1 C-N-CA 127.609 5.539 . . . . 0.0 116.381 -169.216 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.8 p -83.44 -176.08 6.13 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.035 1.734 . . . . 0.0 111.44 -176.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -62.78 167.49 4.56 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.793 0.837 . . . . 0.0 109.313 169.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -53.75 -44.45 69.98 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 118.44 -0.79 . . . . 0.0 111.73 -176.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.7 t70 61.44 -34.99 0.1 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 129.711 3.204 . . . . 0.0 115.931 177.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -64.22 -18.24 64.33 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.586 2.355 . . . . 0.0 111.509 174.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -133.57 146.08 50.66 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 126.168 1.787 . . . . 0.0 106.485 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -75.39 -19.62 59.44 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.945 0.498 . . . . 0.0 111.889 -169.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -140.92 143.39 34.57 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.167 0.987 . . . . 0.0 108.968 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.7 p -145.5 140.77 22.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 174.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 40.7 tpp -154.96 163.02 40.9 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.591 1.156 . . . . 0.0 108.779 -177.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -121.63 152.28 39.49 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 175.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -152.24 -143.0 3.6 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.119 -169.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -151.52 142.91 23.45 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 127.69 2.396 . . . . 0.0 105.001 169.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.3 p -116.05 140.48 37.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 172.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -132.96 54.69 1.94 Allowed 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.04 163.34 22.58 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.074 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 15.8 pt -103.17 175.25 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 123.238 0.615 . . . . 0.0 110.161 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -72.77 -5.26 36.73 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.017 1.327 . . . . 0.0 113.253 178.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.67 17.22 57.16 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.417 1.008 . . . . 0.0 112.585 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -139.63 119.45 13.34 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 169.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -130.05 25.74 5.23 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.291 1.836 . . . . 0.0 108.054 175.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 33.3 p -127.54 -174.0 3.06 Favored 'General case' 0 C--O 1.237 0.413 0 O-C-N 120.921 -1.112 . . . . 0.0 111.884 -168.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 71.0 m -143.0 -27.71 0.57 Allowed 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.048 0.939 . . . . 0.0 110.378 -169.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -147.37 -27.46 0.37 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.967 0.507 . . . . 0.0 111.008 177.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -57.18 -41.55 79.49 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.017 1.727 . . . . 0.0 109.077 171.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 54.99 73.84 0.39 Allowed 'General case' 0 C--N 1.343 0.321 0 C-N-CA 127.575 2.35 . . . . 0.0 107.223 177.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.72 150.79 2.67 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 113.465 -1.698 . . . . 0.0 113.315 -168.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.1 m -128.52 22.49 5.96 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.523 0.729 . . . . 0.0 111.428 -170.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -132.49 144.04 50.18 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 169.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 45.1 tp -80.35 143.62 33.4 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 168.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 13.4 m -135.75 143.4 45.27 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -169.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -138.89 156.27 47.42 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.881 0.873 . . . . 0.0 111.182 -169.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -133.74 139.42 46.35 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 171.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.3 t -137.8 144.05 32.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -177.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 65.6 m -126.31 121.75 33.5 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 174.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -145.47 116.11 7.67 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 119.396 0.998 . . . . 0.0 109.354 -170.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 56.92 21.3 36.98 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-O 119.377 -0.679 . . . . 0.0 114.513 -178.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 91.06 -8.49 79.62 Favored Glycine 0 CA--C 1.535 1.335 0 CA-C-N 118.553 1.176 . . . . 0.0 113.296 -175.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -85.91 168.12 14.49 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 118.719 1.26 . . . . 0.0 107.992 169.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.8 tp -139.59 157.75 45.28 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.457 0.703 . . . . 0.0 110.09 -173.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.418 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 14.6 ptp -155.64 159.26 39.45 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.141 0.976 . . . . 0.0 109.578 168.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.426 HH11 ' HG2' ' A' ' 124' ' ' ARG . 29.7 ttp85 -135.63 141.05 45.0 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 169.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 5.8 tt -143.38 154.5 43.78 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 118.801 0.728 . . . . 0.0 109.829 -176.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -135.13 148.48 49.77 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 169.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -169.2 166.41 39.67 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 170.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -70.9 103.57 2.68 Favored 'General case' 0 N--CA 1.462 0.126 0 O-C-N 121.728 -0.866 . . . . 0.0 109.825 179.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . 10.7 -67.57 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 130.987 3.715 . . . . 0.0 117.786 -171.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -61.47 -13.5 21.27 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 120.76 1.618 . . . . 0.0 114.077 178.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -62.8 -43.77 97.93 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 126.608 1.963 . . . . 0.0 109.781 171.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.47 -38.3 77.3 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.737 1.215 . . . . 0.0 109.977 -176.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 42.79 35.72 0.75 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.431 2.693 . . . . 0.0 113.599 175.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 173.86 58.82 0.05 OUTLIER Glycine 0 C--N 1.333 0.412 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -170.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -95.38 -0.65 52.38 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.761 0.824 . . . . 0.0 112.469 -170.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.436 ' C ' ' H ' ' A' ' 138' ' ' ASP . 7.0 tp10 -72.22 146.09 47.55 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 170.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 1.8 p -62.15 0.48 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 124.734 1.214 . . . . 0.0 110.988 169.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.477 ' HA ' HG21 ' A' ' 141' ' ' VAL . 36.8 t70 -137.97 9.51 2.8 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.471 1.909 . . . . 0.0 113.28 179.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 58.5 m -68.4 -73.1 0.15 Allowed 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.46 -0.775 . . . . 0.0 111.081 169.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.341 10.3 ptm180 -89.03 25.96 1.69 Allowed 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 122.364 1.078 . . . . 0.0 112.755 -169.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.477 HG21 ' HA ' ' A' ' 138' ' ' ASP 0.255 60.9 t -83.01 -4.93 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 C-N-CA 127.446 2.299 . . . . 0.0 107.708 168.644 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -126.45 120.12 28.94 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 102.654 -3.091 . . . . 0.0 102.654 169.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 10.4 tt -141.68 141.76 33.35 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -168.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 mp -138.65 157.33 46.33 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.379 1.072 . . . . 0.0 108.463 -174.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 78.1 mtm -143.03 158.94 43.14 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.887 -0.508 . . . . 0.0 110.795 173.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -152.26 169.47 22.4 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.985 1.714 . . . . 0.0 108.567 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -61.55 168.83 2.64 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.233 -0.917 . . . . 0.0 110.952 169.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.41 168.35 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.966 1.706 . . . . 0.0 114.551 175.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -142.45 21.26 2.04 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.692 1.197 . . . . 0.0 112.597 171.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 . . . . . 0 C--O 1.247 0.963 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -178.561 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.6 tpt . . . . . 0 N--CA 1.478 0.935 0 CA-C-O 121.34 0.591 . . . . 0.0 109.727 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.38 166.17 23.7 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.941 1.296 . . . . 0.0 111.813 -176.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 155.01 173.98 24.4 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 110.461 -1.055 . . . . 0.0 110.461 169.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 35.7 pt -78.6 43.78 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 O-C-N 121.554 -0.968 . . . . 0.0 110.168 170.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 42.0 tp -63.62 -30.08 71.23 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.603 1.161 . . . . 0.0 112.347 -169.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -154.3 164.64 38.26 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.742 1.217 . . . . 0.0 109.225 174.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -148.69 151.45 34.93 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 126.621 1.969 . . . . 0.0 105.948 172.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -147.1 148.06 31.22 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 123.381 0.672 . . . . 0.0 110.633 176.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.8 mp -115.84 137.17 50.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 104.529 -2.397 . . . . 0.0 104.529 169.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -137.84 168.62 19.32 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.318 0.647 . . . . 0.0 110.933 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -131.17 121.33 24.67 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.964 2.106 . . . . 0.0 107.697 -175.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 96.3 t -63.81 127.51 24.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 176.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.2 mmmt -105.83 -30.52 9.34 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 124.204 1.001 . . . . 0.0 109.87 176.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -156.27 167.33 30.76 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.833 0.742 . . . . 0.0 111.45 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.4 mp -139.53 140.41 37.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 127.758 2.423 . . . . 0.0 105.845 -176.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -146.67 93.19 4.93 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 123.35 0.66 . . . . 0.0 110.025 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.73 149.16 51.3 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.196 2.597 . . . . 0.0 112.234 173.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -82.51 -3.05 55.24 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -176.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.09 52.1 0.39 Allowed Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.981 -1.247 . . . . 0.0 109.981 -174.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? 40.3 42.33 1.2 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.865 2.066 . . . . 0.0 112.434 -169.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -79.02 79.79 5.4 Favored 'General case' 0 C--N 1.338 0.108 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 170.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 65.62 114.88 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 128.733 2.813 . . . . 0.0 108.704 -169.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -56.74 -33.89 66.99 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -169.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 51.6 ptt85 -81.89 0.53 39.31 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-O 116.558 -1.687 . . . . 0.0 113.708 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.5 t -121.77 113.78 40.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 121.686 2.039 . . . . 0.0 107.521 -174.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.408 ' HB2' HG21 ' A' ' 45' ' ' ILE . 41.4 m -147.84 163.21 37.48 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 123.206 0.603 . . . . 0.0 110.565 -172.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.9 ttm-85 -73.52 154.2 39.97 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 172.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.3 mt -135.13 155.01 51.45 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 125.749 1.62 . . . . 0.0 107.315 170.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -131.0 130.11 42.94 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 169.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 30.2 m -140.65 153.71 46.12 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.047 1.339 . . . . 0.0 110.571 -169.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -112.07 124.69 52.96 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 177.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 69.8 m -77.67 140.88 39.64 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 174.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -94.43 -26.73 16.37 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.456 1.102 . . . . 0.0 111.411 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.5 m -62.87 -46.52 87.5 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -169.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -141.68 -95.58 0.13 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.596 0.634 . . . . 0.0 110.413 -172.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 43.5 mtmt -145.29 21.09 1.55 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.7 1.6 . . . . 0.0 110.868 -168.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 56.5 mtm -88.64 159.44 17.85 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.402 0.681 . . . . 0.0 111.62 -169.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -138.98 127.67 23.32 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 127.62 2.368 . . . . 0.0 106.635 -177.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 56.6 tp -129.48 138.68 51.54 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.623 1.101 . . . . 0.0 110.769 -169.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.7 mm -124.41 146.94 29.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 169.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.1 mp -140.88 163.95 31.56 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.995 1.718 . . . . 0.0 108.142 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -138.49 96.29 3.14 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 100.374 -3.936 . . . . 0.0 100.374 168.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.3 p -140.95 171.18 13.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 123.26 0.624 . . . . 0.0 111.389 -167.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -68.17 93.13 0.43 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.194 1.398 . . . . 0.0 109.624 170.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.408 HG21 ' HB2' ' A' ' 26' ' ' SER . 1.6 pp -74.14 -1.33 2.83 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -171.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 60.9 mm-40 -65.75 -13.87 60.21 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 120.357 1.435 . . . . 0.0 111.503 175.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 82.7 mt -58.25 -29.79 38.38 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 C-N-CA 124.314 1.046 . . . . 0.0 108.921 168.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -115.61 145.42 34.48 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 124.663 1.185 . . . . 0.0 113.002 -168.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -78.93 77.65 4.01 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.531 2.82 . . . . 0.0 107.152 169.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.7 m -57.53 -9.93 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -171.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -57.67 -31.42 66.32 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.732 0.813 . . . . 0.0 111.999 169.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -147.03 -7.42 0.48 Allowed 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.811 1.412 . . . . 0.0 114.811 178.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.82 174.88 45.51 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-N 119.349 0.977 . . . . 0.0 111.827 -178.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -155.52 174.27 15.5 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.882 1.273 . . . . 0.0 108.713 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -93.61 153.21 18.52 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.169 0.988 . . . . 0.0 109.772 174.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -148.66 173.6 13.04 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.622 1.169 . . . . 0.0 109.458 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 50.6 ttt180 -131.18 146.23 52.25 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 125.839 1.656 . . . . 0.0 107.569 -175.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.1 tt -141.25 138.17 33.06 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 125.5 1.52 . . . . 0.0 107.474 -171.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.4 t -147.75 154.35 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -173.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 tt -81.71 -52.12 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 168.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 61.06 161.32 0.06 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 128.544 2.738 . . . . 0.0 114.168 -175.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.5 m -62.4 151.57 36.62 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.966 173.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.0 m -159.25 89.96 0.94 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 -177.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.1 tt -58.38 -23.93 58.44 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.558 0.743 . . . . 0.0 111.221 173.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -55.16 -17.05 3.64 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.381 1.472 . . . . 0.0 113.547 176.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -62.3 -21.36 65.18 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.236 0.926 . . . . 0.0 112.51 173.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -130.62 -35.85 1.45 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.593 1.157 . . . . 0.0 111.54 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -90.48 44.94 2.92 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 169.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.53 173.68 0.9 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.092 1.357 . . . . 0.0 108.76 169.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.0 pp -55.4 -23.92 27.31 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.107 -0.996 . . . . 0.0 113.41 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -61.04 -20.65 62.8 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.442 1.097 . . . . 0.0 112.799 175.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -73.73 2.26 8.61 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.153 0.981 . . . . 0.0 113.375 175.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.14 30.47 31.05 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.584 1.088 . . . . 0.0 112.222 172.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -138.23 116.38 11.78 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 177.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -154.04 143.86 21.8 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.827 1.251 . . . . 0.0 107.997 178.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -141.84 147.21 44.15 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 126.106 1.762 . . . . 0.0 107.396 169.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.82 -27.23 14.91 Favored 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 122.233 1.955 . . . . 0.0 113.043 -170.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -39.11 93.4 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.498 1.119 . . . . 0.0 110.944 177.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.2 t70 55.5 -51.98 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 130.846 3.658 . . . . 0.0 115.591 -178.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -138.85 -24.89 0.9 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.691 1.997 . . . . 0.0 111.923 174.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -62.06 131.69 93.46 Favored Pre-proline 0 C--N 1.343 0.298 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -178.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . 0.259 0.9 OUTLIER 28.14 38.95 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.654 1 C-N-CA 126.17 4.58 . . . . 0.0 116.985 -169.203 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.8 m -99.27 11.51 38.86 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.807 1.243 . . . . 0.0 111.354 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 56.45 28.11 13.18 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.182 1.793 . . . . 0.0 112.431 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -137.22 2.02 2.49 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.35 1.06 . . . . 0.0 112.799 176.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -81.56 55.23 2.58 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 169.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -78.53 22.13 0.36 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.263 1.425 . . . . 0.0 111.122 -175.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -133.75 159.83 39.4 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 126.93 2.092 . . . . 0.0 108.806 -168.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -80.52 -30.78 37.22 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 122.022 -0.424 . . . . 0.0 109.965 178.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -153.85 147.69 25.41 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.111 0.964 . . . . 0.0 108.972 171.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.4 p -151.93 142.39 15.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 169.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.7 tpt -158.28 168.43 27.03 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.006 1.323 . . . . 0.0 109.144 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -119.5 146.13 45.71 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 172.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -150.14 -158.33 8.15 Favored Glycine 0 C--N 1.336 0.558 0 CA-C-N 118.775 0.716 . . . . 0.0 112.014 -171.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -125.91 136.22 52.79 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 174.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 47.1 t -98.03 150.09 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 176.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -135.21 157.96 45.57 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 169.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.07 153.47 29.45 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 120.754 -1.216 . . . . 0.0 109.234 172.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.56 -177.85 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 O-C-N 123.671 0.607 . . . . 0.0 109.618 176.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -68.48 -6.57 25.78 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.053 1.341 . . . . 0.0 114.054 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 121.58 -60.45 0.55 Allowed Glycine 0 C--N 1.338 0.682 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 -175.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -66.96 125.48 26.08 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 175.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -127.79 15.5 6.94 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.65 0.78 . . . . 0.0 111.169 174.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.521 HG21 ' HB3' ' A' ' 108' ' ' ALA . 38.7 p -139.67 -60.71 0.55 Allowed 'General case' 0 C--O 1.233 0.203 0 O-C-N 120.862 -1.149 . . . . 0.0 112.438 -169.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.3 m 156.6 -41.65 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.422 1 C-N-CA 133.678 4.791 . . . . 0.0 106.184 -173.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -178.24 -39.45 0.01 OUTLIER 'General case' 0 C--N 1.346 0.445 0 C-N-CA 125.817 1.647 . . . . 0.0 108.891 -174.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -58.87 -22.23 58.77 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 -169.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.521 ' HB3' HG21 ' A' ' 104' ' ' THR . . . -139.17 15.89 2.61 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.927 1.239 . . . . 0.0 111.791 169.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.88 -9.39 20.6 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 177.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.5 p -75.39 -7.25 53.54 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 127.303 2.241 . . . . 0.0 113.59 -174.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -127.69 132.23 49.69 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 126.707 2.003 . . . . 0.0 105.605 175.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 66.1 tp -65.9 147.05 53.98 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 169.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -115.77 133.01 56.47 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 169.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -122.36 157.23 32.26 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 173.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -126.68 149.32 49.61 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.9 t -134.43 132.62 55.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 18.5 m -124.22 119.58 29.77 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -144.22 117.37 8.94 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.282 1.033 . . . . 0.0 109.192 -169.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 56.79 27.21 55.52 Favored Glycine 0 CA--C 1.535 1.294 0 O-C-N 121.724 -0.61 . . . . 0.0 114.221 176.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 84.13 -3.1 86.82 Favored Glycine 0 CA--C 1.536 1.346 0 CA-C-N 118.25 1.025 . . . . 0.0 113.543 -177.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 78.8 mt -95.7 163.52 13.15 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.1 1.36 . . . . 0.0 107.483 169.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.8 tt -148.88 157.67 43.6 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 121.712 -0.618 . . . . 0.0 111.068 -169.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 24.6 ptp -151.63 162.44 40.98 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.655 1.182 . . . . 0.0 109.311 169.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 43.6 ttt-85 -132.03 127.24 35.78 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 171.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 54.6 tp -127.37 119.38 26.08 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 -178.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -94.38 149.42 21.25 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 168.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -169.09 171.03 42.84 Favored Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 171.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -53.66 133.05 41.74 Favored 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 169.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -43.24 -59.28 2.14 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -172.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -58.43 -43.66 88.84 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 122.288 1.042 . . . . 0.0 111.429 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -61.73 -26.25 67.94 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 113.58 -1.646 . . . . 0.0 111.31 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 32.8 tp -81.23 -22.74 38.54 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 118.765 -0.636 . . . . 0.0 110.668 -176.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 37.6 49.49 1.04 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.292 1.037 . . . . 0.0 111.997 -170.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -118.08 0.42 17.01 Favored Glycine 0 C--N 1.341 0.845 0 CA-C-O 118.536 -1.147 . . . . 0.0 113.425 -173.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -67.06 -32.09 73.04 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.477 1.638 . . . . 0.0 108.211 168.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -65.14 71.19 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.678 1 C-N-CA 131.8 4.04 . . . . 0.0 108.936 169.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.9 m -59.82 -4.21 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 125.351 1.46 . . . . 0.0 113.954 176.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -125.6 18.39 8.08 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 125.711 1.605 . . . . 0.0 112.128 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.2 m -103.03 -59.1 1.76 Allowed 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 168.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.379 9.9 ptm85 -75.44 11.65 1.2 Allowed 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -175.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 16.6 m -62.35 -40.11 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 167.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -81.19 129.49 34.61 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 176.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -141.65 122.82 14.72 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 -169.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.7 tt -137.44 138.32 39.67 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -172.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 90.5 mtp -139.8 142.64 36.66 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 123.769 0.828 . . . . 0.0 109.229 -177.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -155.92 168.43 27.24 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.226 1.411 . . . . 0.0 107.875 -175.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -60.14 159.03 10.21 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.54 -0.725 . . . . 0.0 109.217 169.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.6 pp -68.91 165.22 20.4 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 120.684 0.278 . . . . 0.0 110.788 169.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -130.75 63.17 1.59 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.285 1.034 . . . . 0.0 109.288 -173.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 . . . . . 0 C--O 1.251 1.159 0 C-N-CA 125.947 1.699 . . . . 0.0 107.646 178.295 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 mmt . . . . . 0 N--CA 1.484 1.243 0 N-CA-C 110.035 -0.358 . . . . 0.0 110.035 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.25 170.91 18.87 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.129 1.372 . . . . 0.0 109.049 178.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -67.21 -178.39 10.86 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.624 1.107 . . . . 0.0 113.111 174.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 40.1 pt -134.36 153.39 35.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 125.39 1.476 . . . . 0.0 109.424 -175.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -71.21 113.57 8.39 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.015 0.435 . . . . 0.0 110.223 177.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -161.7 148.87 14.39 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.645 1.978 . . . . 0.0 106.061 169.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -154.16 138.96 17.09 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.382 1.073 . . . . 0.0 109.035 -172.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -151.12 145.07 25.2 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 168.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.7 mp -85.78 145.1 8.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 106.233 -1.765 . . . . 0.0 106.233 178.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -132.97 148.08 52.27 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.634 1.174 . . . . 0.0 108.654 177.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -117.64 130.55 56.44 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.268 1.427 . . . . 0.0 108.349 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 84.0 t -70.08 113.22 5.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -84.48 -35.18 23.14 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.804 1.241 . . . . 0.0 110.157 175.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -155.99 170.18 22.75 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.316 0.962 . . . . 0.0 111.19 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.8 mp -137.76 132.37 44.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 126.873 2.069 . . . . 0.0 105.905 -178.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -129.25 103.63 18.19 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 124.607 1.163 . . . . 0.0 109.08 176.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -104.31 11.69 0.26 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.925 3.084 . . . . 0.0 113.63 175.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -76.33 74.99 3.12 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.828 1.251 . . . . 0.0 111.346 -169.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 144.0 -9.68 2.03 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.812 1.672 . . . . 0.0 111.76 -178.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -71.33 86.17 0.81 Allowed 'General case' 0 C--N 1.339 0.144 0 C-N-CA 125.195 1.398 . . . . 0.0 110.78 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -54.66 -42.9 71.86 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 169.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -78.25 82.13 4.57 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 169.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -56.95 -24.62 54.15 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.881 1.273 . . . . 0.0 114.419 -169.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -73.9 3.82 6.18 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 174.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.7 t -115.15 147.77 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 176.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.7 m -150.25 158.02 43.71 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 120.995 -1.066 . . . . 0.0 110.439 169.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 19.6 ttp180 -85.89 89.41 7.77 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 171.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 82.2 mt -66.03 152.26 45.02 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 169.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -126.32 133.29 51.42 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 104.306 -2.479 . . . . 0.0 104.306 172.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.9 m -144.13 165.75 26.95 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.103 0.865 . . . . 0.0 112.733 -169.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -135.76 138.21 42.42 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.445 1.498 . . . . 0.0 109.543 -176.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 29.5 t -60.11 135.23 57.65 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.005 1.722 . . . . 0.0 110.326 174.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -81.92 -41.99 20.11 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 119.157 -0.449 . . . . 0.0 110.326 171.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.2 m -92.04 -26.82 18.16 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 115.654 1.724 . . . . 0.0 115.654 -168.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -129.89 -107.84 0.28 Allowed 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 120.359 1.436 . . . . 0.0 109.933 -169.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -149.7 0.44 0.48 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.748 1.619 . . . . 0.0 112.931 -169.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 68.3 mtm -67.03 145.78 55.03 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.36 0.6 . . . . 0.0 109.54 -172.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -123.11 138.28 54.7 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 177.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.1 mt -136.31 152.59 50.85 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.729 0.776 . . . . 0.0 112.221 -169.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 31.6 mm -137.32 140.82 41.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 129.248 3.019 . . . . 0.0 102.97 169.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 8.2 mt -148.82 100.59 3.1 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 126.495 1.918 . . . . 0.0 106.575 -169.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -84.55 92.8 8.21 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 169.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.1 m -143.53 167.64 12.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 124.016 0.926 . . . . 0.0 111.995 -169.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -55.58 138.47 46.8 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.289 1.436 . . . . 0.0 110.889 170.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 pp -120.77 1.39 7.06 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 C-N-CA 124.8 1.24 . . . . 0.0 113.374 178.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -67.69 -9.52 44.25 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 121.209 1.822 . . . . 0.0 112.543 -175.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 28.8 mt -61.41 -24.02 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 C-N-CA 125.507 1.523 . . . . 0.0 108.315 169.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -127.22 169.32 12.47 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 127.785 2.434 . . . . 0.0 109.501 -169.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -53.17 156.3 10.47 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.422 2.081 . . . . 0.0 111.982 169.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.4 p -56.49 -21.74 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 125.543 1.537 . . . . 0.0 114.53 -169.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -133.29 29.49 3.98 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.535 1.134 . . . . 0.0 110.594 -173.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 21.6 tp -144.42 168.3 20.43 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.154 0.982 . . . . 0.0 110.18 -173.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -150.57 164.2 29.78 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 107.122 -2.391 . . . . 0.0 107.122 169.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -141.81 166.45 24.7 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.928 0.891 . . . . 0.0 109.66 -172.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -57.73 140.66 50.91 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.223 1.009 . . . . 0.0 110.615 -173.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -148.49 -179.68 7.14 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.595 1.558 . . . . 0.0 108.466 -178.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -129.34 150.26 50.78 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 121.38 -0.825 . . . . 0.0 109.142 173.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 61.4 tp -110.55 141.29 43.92 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.925 1.69 . . . . 0.0 107.026 174.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 55.6 t -141.91 157.76 20.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 128.248 2.619 . . . . 0.0 105.534 -177.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.2 pt -133.14 30.51 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 123.899 0.88 . . . . 0.0 110.772 -175.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -100.73 -0.69 36.78 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.899 1.279 . . . . 0.0 113.599 -169.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.9 p -70.21 177.89 3.08 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.901 1.28 . . . . 0.0 111.987 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.9 m -137.06 167.66 21.1 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 170.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 65.6 tp -62.44 -34.32 76.55 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.342 -0.849 . . . . 0.0 110.941 171.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 64.72 165.22 0.15 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 127.752 2.421 . . . . 0.0 112.953 -175.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -138.09 -157.31 0.76 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 128.391 2.676 . . . . 0.0 107.669 170.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -59.76 -23.89 63.61 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 -169.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -154.39 25.9 0.68 Allowed Glycine 0 C--N 1.341 0.825 0 CA-C-O 118.898 -0.945 . . . . 0.0 114.832 -171.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.8 m -61.24 -27.5 68.49 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.352 1.576 . . . . 0.0 112.245 -177.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 90.2 mt -75.63 -11.41 60.0 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 118.64 -0.695 . . . . 0.0 111.958 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.6 t0 40.06 54.69 2.7 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.39 1.876 . . . . 0.0 111.268 -169.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -147.63 -61.53 0.27 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.084 -169.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 66.62 1.3 10.72 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 126.72 2.105 . . . . 0.0 114.919 175.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -83.45 -38.18 22.21 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.166 1.483 . . . . 0.0 108.554 173.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -57.64 117.99 4.78 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.433 1.093 . . . . 0.0 108.398 169.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -148.53 161.07 34.74 Favored Pre-proline 0 CA--C 1.534 0.333 0 C-N-CA 125.731 1.613 . . . . 0.0 107.445 -178.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -52.96 -26.51 31.94 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 123.345 2.696 . . . . 0.0 114.85 176.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.1 p -60.59 -11.35 6.93 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.055 1.742 . . . . 0.0 113.243 174.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -66.87 -19.77 65.79 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.845 0.858 . . . . 0.0 112.023 170.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -132.07 -33.66 1.32 Allowed 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 45.8 mtm180 -60.68 128.28 88.31 Favored Pre-proline 0 N--CA 1.468 0.474 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 169.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . 0.27 1.1 Cg_exo 32.94 41.09 0.0 OUTLIER 'Trans proline' 0 CA--C 1.541 0.872 1 C-N-CA 125.392 4.061 . . . . 0.0 116.056 -168.805 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.8 m -152.08 -158.76 0.93 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 128.565 2.746 . . . . 0.0 106.407 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? -152.63 114.75 4.41 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 120.886 -1.134 . . . . 0.0 109.591 172.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.3 146.13 54.43 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 169.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -140.4 -29.55 0.69 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.471 1.108 . . . . 0.0 111.68 174.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.453 ' CD ' ' H ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER -57.21 -30.04 64.23 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.774 1.63 . . . . 0.0 111.291 173.914 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -148.67 174.1 12.51 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.664 2.385 . . . . 0.0 107.378 176.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -124.66 -37.8 2.45 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.303 0.641 . . . . 0.0 110.619 172.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -152.2 158.53 43.0 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.386 0.994 . . . . 0.0 110.746 174.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.4 m -145.26 146.93 19.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 126.367 1.867 . . . . 0.0 107.877 174.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.31 175.63 10.69 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.835 0.826 . . . . 0.0 112.684 173.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -133.55 154.31 50.95 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 128.092 2.557 . . . . 0.0 106.883 172.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.88 -152.35 6.87 Favored Glycine 0 C--N 1.337 0.6 0 CA-C-N 119.602 1.092 . . . . 0.0 113.342 -171.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 43.9 tttp -141.46 139.03 33.27 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.215 1.406 . . . . 0.0 108.397 173.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 38.9 t -83.54 149.87 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.868 1.267 . . . . 0.0 108.932 169.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -133.31 48.3 2.4 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.196 1.798 . . . . 0.0 109.354 -177.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.5 mmt180 -149.45 163.18 38.5 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.595 1.158 . . . . 0.0 110.044 -177.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 25.5 pt -72.12 171.43 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 124.698 1.199 . . . . 0.0 111.207 174.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -74.42 4.77 5.42 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 127.114 2.166 . . . . 0.0 114.471 -177.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.61 29.01 70.73 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 124.458 1.028 . . . . 0.0 113.769 -176.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -129.05 120.24 25.63 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 169.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.402 ' H ' ' HA ' ' A' ' 109' ' ' ALA . 8.6 tp10 -112.9 -21.18 11.27 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 124.006 0.816 . . . . 0.0 111.628 -178.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.263 0.0 OUTLIER 44.03 169.85 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 131.092 3.757 . . . . 0.0 117.55 177.681 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 34.7 m -176.35 -50.02 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 129.765 3.226 . . . . 0.0 104.834 175.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.0 p -147.56 -58.4 0.26 Allowed 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 169.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -146.93 64.65 1.17 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.176 2.19 . . . . 0.0 106.371 177.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -124.75 24.25 7.77 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.867 0.867 . . . . 0.0 110.573 -173.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.402 ' HA ' ' H ' ' A' ' 103' ' ' GLU . . . -61.02 165.94 3.85 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 123.174 0.59 . . . . 0.0 109.935 169.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 37.1 p -130.46 -172.66 2.86 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 121.319 -0.863 . . . . 0.0 111.718 -169.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -62.62 138.13 58.42 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 168.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.4 125.32 26.68 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 103.162 -2.903 . . . . 0.0 103.162 167.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 13.6 m -105.1 144.05 32.43 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 173.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -135.49 85.33 2.16 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 125.592 1.557 . . . . 0.0 107.367 -169.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 5.9 m-30 -85.28 126.35 33.64 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 103.03 -2.952 . . . . 0.0 103.03 169.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.1 t -141.23 143.59 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 119.971 1.26 . . . . 0.0 108.306 -171.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.0 t -130.38 139.4 50.64 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 171.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -149.65 106.44 3.55 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.339 1.455 . . . . 0.0 108.525 -169.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 58.45 24.34 55.95 Favored Glycine 0 CA--C 1.535 1.313 0 CA-C-O 119.362 -0.688 . . . . 0.0 114.248 175.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.04 -8.95 65.41 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-N 118.295 1.048 . . . . 0.0 113.47 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 11.2 mp -95.21 158.08 15.62 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 106.924 -1.509 . . . . 0.0 106.924 169.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.3 tt -144.1 154.14 42.89 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.915 -0.491 . . . . 0.0 110.109 -170.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 23.3 ptt? -142.11 161.24 38.5 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 169.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 25.6 ttm180 -138.27 115.27 10.86 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 104.464 -2.421 . . . . 0.0 104.464 171.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 11.2 tp -126.15 149.15 49.18 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 126.389 1.876 . . . . 0.0 107.086 -169.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -140.95 150.97 43.8 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 168.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -173.58 177.03 46.1 Favored Glycine 0 C--N 1.331 0.279 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 169.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -57.04 139.53 51.98 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 118.51 1.155 . . . . 0.0 109.183 172.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -50.86 -55.16 18.34 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -176.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.69 -11.4 60.61 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 121.467 -0.771 . . . . 0.0 112.507 -177.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -81.4 -29.12 34.05 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.603 1.161 . . . . 0.0 110.366 172.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.9 mp -80.36 -29.52 37.9 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 169.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 2.1 t60 59.92 25.35 14.49 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.278 1.831 . . . . 0.0 114.44 171.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -168.84 95.06 0.11 Allowed Glycine 0 C--N 1.335 0.49 0 N-CA-C 107.142 -2.383 . . . . 0.0 107.142 177.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -96.0 9.94 39.08 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.388 1.075 . . . . 0.0 113.544 -175.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -74.75 146.56 42.07 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.593 0.711 . . . . 0.0 109.142 173.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.6 m -64.53 -5.19 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.273 168.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -122.09 17.34 10.81 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 127.368 2.267 . . . . 0.0 111.787 176.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 57.5 m -88.2 -57.16 3.03 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 121.272 -0.892 . . . . 0.0 109.096 167.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 4.9 mmm180 -74.58 -5.24 41.75 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -169.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 30.2 m -62.09 -40.9 89.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.408 177.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -74.68 117.4 16.47 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.2 tt -132.56 135.72 46.12 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 -174.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 10.2 tt -143.19 142.03 31.31 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 173.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 80.5 mtp -135.82 152.24 50.88 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 174.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 51.7 mttt -144.09 176.43 9.31 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.108 0.963 . . . . 0.0 109.315 177.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -57.3 165.98 1.3 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.212 0.605 . . . . 0.0 109.47 168.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.57 166.58 0.88 Allowed 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.662 -0.649 . . . . 0.0 111.831 169.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.8 77.72 4.81 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.672 0.789 . . . . 0.0 109.084 176.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 15.5 t80 . . . . . 0 C--O 1.25 1.123 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 175.527 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ptp . . . . . 0 N--CA 1.482 1.143 0 CA-C-O 120.417 0.151 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.67 162.93 20.09 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 122.879 0.471 . . . . 0.0 109.802 169.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.14 -163.78 37.06 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 -177.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.0 tp -52.49 126.92 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 123.844 0.857 . . . . 0.0 109.261 175.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.56 -61.7 0.16 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.625 0.77 . . . . 0.0 109.182 -175.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -151.98 140.81 20.98 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.293 0.637 . . . . 0.0 110.909 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -158.11 138.27 12.47 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.84 2.456 . . . . 0.0 106.756 171.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -159.55 157.47 29.95 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.955 0.798 . . . . 0.0 110.265 168.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.35 153.41 4.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 105.588 -2.004 . . . . 0.0 105.588 169.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -134.21 151.12 51.16 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.569 1.547 . . . . 0.0 107.857 175.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -120.07 122.43 41.07 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 126.598 1.959 . . . . 0.0 107.786 -176.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.8 t -71.63 116.43 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -90.88 -32.7 15.93 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 124.878 1.271 . . . . 0.0 110.245 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -157.02 167.37 30.68 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 119.308 0.958 . . . . 0.0 111.181 176.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.4 mp -141.54 146.53 23.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 127.212 2.205 . . . . 0.0 107.358 -175.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -136.31 109.31 9.62 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 125.819 1.648 . . . . 0.0 108.294 170.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -118.13 26.77 0.02 OUTLIER 'Trans proline' 0 CA--C 1.548 1.181 1 C-N-CA 125.744 4.296 . . . . 0.0 110.203 169.675 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -61.53 -19.75 62.47 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 116.161 1.912 . . . . 0.0 116.161 -167.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -178.63 35.15 0.08 OUTLIER Glycine 0 C--N 1.336 0.554 0 N-CA-C 107.827 -2.109 . . . . 0.0 107.827 177.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.47 117.99 9.47 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 -177.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -41.85 -38.17 1.45 Allowed 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.498 1.919 . . . . 0.0 112.98 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -117.79 104.1 10.63 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 104.386 -2.45 . . . . 0.0 104.386 170.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -63.5 -25.22 68.16 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -169.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -66.18 -16.89 64.36 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.611 171.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 20.6 t -98.1 137.3 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 173.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 40.5 m -138.28 149.91 46.14 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 21.8 ttp180 -79.18 143.67 35.18 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 104.797 -2.298 . . . . 0.0 104.797 168.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.0 mt -135.28 158.7 43.7 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -130.85 130.78 44.05 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 104.222 -2.51 . . . . 0.0 104.222 169.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 58.3 m -138.46 168.68 19.26 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.577 1.151 . . . . 0.0 109.866 -175.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -136.19 135.89 39.5 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 174.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.1 p -66.52 149.52 50.33 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 174.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -67.08 -34.46 77.7 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.893 -0.504 . . . . 0.0 111.008 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.3 m -136.7 -32.74 0.81 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -173.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -83.12 17.44 2.0 Allowed 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -171.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 31.6 pttt 43.75 26.55 0.13 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.554 1.942 . . . . 0.0 114.98 175.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 64.3 mtt -80.13 115.79 19.89 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 124.927 1.291 . . . . 0.0 108.208 176.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -78.99 127.51 32.07 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 104.02 -2.585 . . . . 0.0 104.02 168.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.5 tp -133.11 144.06 49.71 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 119.949 1.249 . . . . 0.0 110.745 -169.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 34.1 mm -130.13 146.51 33.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 128.209 2.604 . . . . 0.0 104.216 169.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 mp -143.09 162.54 35.25 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 126.398 1.879 . . . . 0.0 108.7 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -137.03 95.41 3.1 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 101.163 -3.643 . . . . 0.0 101.163 168.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.1 p -142.6 158.87 19.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 123.357 0.663 . . . . 0.0 111.297 -167.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 36.8 t30 -60.69 140.16 57.6 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.378 1.071 . . . . 0.0 109.969 171.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.6 pp -117.47 -2.7 10.06 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 C-N-CA 125.299 1.44 . . . . 0.0 112.698 176.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -67.67 -11.71 58.87 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 120.19 1.359 . . . . 0.0 111.177 171.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.5 mt -60.11 -39.48 80.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 C-N-CA 124.633 1.173 . . . . 0.0 107.867 168.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -76.38 130.24 77.77 Favored Pre-proline 0 CA--C 1.538 0.503 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.05 -25.13 12.08 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.488 2.125 . . . . 0.0 112.746 -175.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.8 m -143.59 162.22 16.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 C-N-CA 125.681 1.593 . . . . 0.0 108.277 -178.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.3 t70 50.24 -148.97 0.29 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.062 1.345 . . . . 0.0 110.597 -174.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 87.0 mt -123.44 -8.58 8.05 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.427 1.491 . . . . 0.0 110.983 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 179.45 164.05 31.3 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 174.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -156.01 -89.69 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 173.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 35.7 mtmt -140.64 151.75 44.85 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.589 1.156 . . . . 0.0 108.241 170.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -151.04 170.65 18.86 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.517 1.127 . . . . 0.0 110.477 -179.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 65.5 ttp85 -115.64 119.51 36.34 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.52 1.528 . . . . 0.0 107.131 -177.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -106.72 139.12 41.66 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 177.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.0 p -158.25 149.79 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-O 121.389 0.614 . . . . 0.0 110.458 -169.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.7 pt -129.77 -19.38 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.491 1.117 . . . . 0.0 109.609 169.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -52.27 -33.78 43.43 Favored 'General case' 0 C--N 1.345 0.389 0 C-N-CA 125.767 1.627 . . . . 0.0 113.583 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.3 m -70.44 -9.24 55.92 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.046 0.938 . . . . 0.0 112.931 -178.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.3 m -67.06 130.57 43.54 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 119.281 0.946 . . . . 0.0 109.124 175.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 23.8 tp -151.03 48.64 0.85 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 169.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -55.68 -32.24 63.08 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.856 0.863 . . . . 0.0 112.746 -169.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.19 -13.91 61.66 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.148 0.979 . . . . 0.0 112.869 -178.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -68.98 -20.33 64.17 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.284 0.947 . . . . 0.0 110.98 169.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.98 33.36 65.57 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 -177.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.0 m -60.83 -21.46 63.2 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.039 1.336 . . . . 0.0 112.428 -174.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.6 20.31 6.65 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.077 1.751 . . . . 0.0 111.096 175.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.8 t70 37.67 34.47 0.05 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 129.822 3.249 . . . . 0.0 115.042 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.2 t70 44.88 31.03 0.62 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.405 1.882 . . . . 0.0 113.239 -174.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 169.67 -11.91 0.05 OUTLIER Glycine 0 CA--C 1.531 1.047 0 CA-C-O 118.631 -1.094 . . . . 0.0 115.49 -174.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -67.91 -25.97 65.75 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.695 1.748 . . . . 0.0 110.03 169.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -55.83 108.76 0.48 Allowed 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.441 1.096 . . . . 0.0 108.939 170.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -152.15 166.12 15.98 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 124.605 1.162 . . . . 0.0 108.801 -174.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -54.84 -13.98 7.1 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 124.001 3.134 . . . . 0.0 117.933 -171.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 34.7 p -59.91 -19.7 53.11 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 121.255 1.843 . . . . 0.0 112.452 174.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -99.29 -2.49 36.35 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.193 0.997 . . . . 0.0 111.96 178.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -126.77 -30.9 2.73 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.668 1.187 . . . . 0.0 113.08 -169.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -65.38 -48.04 68.27 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-O 117.534 -1.222 . . . . 0.0 110.503 171.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -84.13 5.2 6.46 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.274 1.982 . . . . 0.0 111.645 169.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . 0.288 8.9 p 37.56 43.5 0.44 Allowed 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 128.826 2.851 . . . . 0.0 114.516 -175.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -60.0 -20.63 58.78 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 118.729 -0.653 . . . . 0.0 111.351 172.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -53.81 -29.08 39.06 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.32 0.963 . . . . 0.0 112.349 171.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -60.81 -13.68 16.89 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.608 1.163 . . . . 0.0 113.175 -178.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -52.29 -32.33 37.02 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 121.355 -0.84 . . . . 0.0 112.435 171.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -148.96 -177.55 5.87 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.125 1.37 . . . . 0.0 111.854 -172.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.8 pm0 -56.98 125.14 21.28 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 114.561 -1.2 . . . . 0.0 112.052 -176.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -68.32 160.21 29.88 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 169.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.6 p -132.06 144.63 36.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 124.254 1.021 . . . . 0.0 109.542 -169.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 34.1 tpp -145.07 168.09 21.14 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 125.608 1.563 . . . . 0.0 107.935 171.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -130.65 147.02 52.27 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.404 1.482 . . . . 0.0 107.027 -173.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -156.62 -162.7 11.67 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 118.729 0.695 . . . . 0.0 113.638 -171.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -133.32 123.35 25.29 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.578 1.551 . . . . 0.0 106.828 174.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.4 t -84.14 147.28 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 173.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -139.66 129.74 25.06 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 173.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.88 157.54 43.28 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 120.706 1.594 . . . . 0.0 111.369 -178.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.411 HG13 ' H ' ' A' ' 101' ' ' GLY . 17.2 pt -77.24 179.02 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 O-C-N 124.126 0.891 . . . . 0.0 110.42 -177.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -74.33 -3.52 30.76 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.918 1.287 . . . . 0.0 113.537 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.411 ' H ' HG13 ' A' ' 99' ' ' ILE . . . 88.8 15.29 59.82 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-O 119.251 -0.749 . . . . 0.0 113.045 -177.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -140.07 127.28 21.13 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 168.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -133.89 36.56 3.28 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.175 170.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.52 -44.01 1.56 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.653 1.181 . . . . 0.0 109.885 -169.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.2 p -164.03 -66.15 0.04 OUTLIER 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.5 p -151.95 -41.83 0.11 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.64 1.176 . . . . 0.0 110.211 -178.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -161.9 22.69 0.11 Allowed 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -169.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -120.34 7.73 10.74 Favored 'General case' 0 C--O 1.234 0.259 0 O-C-N 121.71 -0.619 . . . . 0.0 112.17 -170.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.84 165.66 8.3 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 169.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 23.1 p -121.89 -3.79 9.14 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -136.45 141.16 43.53 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.374 1.069 . . . . 0.0 108.97 178.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 55.6 tp -83.28 155.61 23.53 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 167.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.1 m -130.8 135.61 47.91 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 177.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -143.26 160.75 39.91 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.393 1.077 . . . . 0.0 110.79 -169.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -136.56 156.56 48.41 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.473 1.909 . . . . 0.0 107.485 176.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.0 p -150.69 139.94 15.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 169.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.5 m -121.07 123.41 42.28 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 -178.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 26.7 p90 -140.96 119.32 12.18 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 124.532 1.133 . . . . 0.0 109.437 -169.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 53.59 28.12 36.52 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 123.677 0.656 . . . . 0.0 114.464 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 84.55 -3.43 86.58 Favored Glycine 0 CA--C 1.535 1.342 0 CA-C-N 118.479 1.139 . . . . 0.0 113.782 -177.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 84.7 mt -95.5 166.24 11.95 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 125.282 1.433 . . . . 0.0 107.352 169.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 7.4 tt -148.63 155.66 41.37 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 121.306 -0.871 . . . . 0.0 110.99 -169.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 14.2 ptt? -153.29 157.92 40.84 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.944 0.898 . . . . 0.0 109.087 169.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -140.63 139.41 34.86 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 126.006 1.722 . . . . 0.0 106.829 -175.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -153.6 160.12 42.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 118.584 0.629 . . . . 0.0 112.221 -170.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -133.46 157.48 45.5 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.799 0.84 . . . . 0.0 109.029 169.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 178.42 173.77 44.09 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 171.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -52.52 134.38 35.12 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.651 1.225 . . . . 0.0 109.157 174.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -43.86 -66.09 0.43 Allowed 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 -169.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -57.88 -43.82 86.28 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 122.36 1.076 . . . . 0.0 111.665 -177.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -60.89 -26.38 67.4 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 126.797 2.039 . . . . 0.0 111.656 179.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 16.4 tp -73.45 -18.73 61.1 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 119.153 0.888 . . . . 0.0 110.186 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 41.89 44.65 2.98 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.689 1.596 . . . . 0.0 112.038 -178.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -142.78 2.66 1.7 Allowed Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.042 0.829 . . . . 0.0 113.557 -172.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -62.76 -27.0 68.98 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.507 1.154 . . . . 0.0 111.043 169.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -70.35 91.6 0.75 Allowed 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 129.083 2.953 . . . . 0.0 108.735 169.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 63.0 t -48.59 -21.39 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 126.996 2.119 . . . . 0.0 112.021 172.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -133.35 21.91 4.03 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -172.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 14.3 m -94.87 -64.02 1.11 Allowed 'General case' 0 C--O 1.232 0.179 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 167.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.329 9.3 ptm85 -77.89 12.95 1.52 Allowed 'General case' 0 C--N 1.344 0.356 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -172.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 15.7 m -61.44 -39.63 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 167.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -76.6 124.28 27.38 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 104.759 -2.311 . . . . 0.0 104.759 169.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 10.0 tt -137.96 128.15 25.99 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 -174.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 mp -134.66 151.01 50.71 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -175.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -156.13 153.34 29.16 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 174.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -144.53 164.44 30.89 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 169.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -56.07 164.04 1.37 Allowed 'General case' 0 CA--C 1.538 0.505 0 O-C-N 120.644 -1.285 . . . . 0.0 109.521 168.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.17 163.1 21.01 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.634 -0.666 . . . . 0.0 110.873 172.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -141.11 39.07 1.77 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.611 1.165 . . . . 0.0 110.065 -178.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 . . . . . 0 C--O 1.248 0.98 0 C-N-CA 125.578 1.551 . . . . 0.0 108.012 -174.884 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.0 mtm . . . . . 0 N--CA 1.484 1.251 0 CA-C-O 120.766 0.317 . . . . 0.0 110.419 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.99 -22.07 56.25 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.106 0.963 . . . . 0.0 112.177 178.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -161.39 -167.6 22.08 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -177.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -62.49 148.37 10.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 175.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 61.6 tp -66.83 128.67 37.18 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 169.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -151.93 137.6 17.87 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 178.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -157.0 130.6 8.1 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 169.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -158.46 152.52 23.89 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 118.474 0.579 . . . . 0.0 110.539 169.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 mp -86.54 142.87 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 172.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -126.04 148.87 49.21 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 125.576 1.55 . . . . 0.0 107.866 178.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -126.42 123.24 37.45 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 126.251 1.82 . . . . 0.0 107.615 -169.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 66.1 t -68.93 127.89 31.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 -173.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.9 mmpt? -89.97 -39.42 12.99 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.768 1.227 . . . . 0.0 109.338 169.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -159.62 166.99 29.52 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.083 0.856 . . . . 0.0 111.793 -177.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.4 mp -137.11 139.47 44.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 127.426 2.29 . . . . 0.0 106.124 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -147.41 95.18 4.36 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 124.902 1.281 . . . . 0.0 109.282 -171.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -63.51 9.72 0.12 Allowed 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 123.778 2.985 . . . . 0.0 116.921 -177.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -78.26 58.18 2.02 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.151 1.38 . . . . 0.0 109.631 175.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -166.94 35.59 0.23 Allowed Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.901 1.239 . . . . 0.0 111.277 -173.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.0 mmpt? -68.13 66.16 0.1 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.779 1.232 . . . . 0.0 113.295 -177.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -59.9 -38.0 81.03 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 168.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -143.66 167.69 21.66 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 130.002 3.321 . . . . 0.0 104.25 169.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -56.66 -41.17 76.78 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.415 -0.803 . . . . 0.0 110.644 171.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -71.73 7.41 1.52 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.201 1.4 . . . . 0.0 114.594 178.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 74.8 t -122.33 137.33 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 122.057 2.208 . . . . 0.0 107.783 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 67.4 m -147.25 161.7 40.41 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.329 1.052 . . . . 0.0 109.799 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 -83.42 149.81 26.45 Favored 'General case' 0 C--N 1.342 0.246 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 170.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.6 mp -145.08 164.82 30.05 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.83 2.052 . . . . 0.0 107.495 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -134.89 133.15 39.35 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 172.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 43.8 m -140.0 171.79 13.68 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.144 1.378 . . . . 0.0 110.081 -176.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -142.47 145.26 33.55 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.163 1.785 . . . . 0.0 107.152 -176.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.8 p -64.52 134.28 54.11 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 118.792 0.723 . . . . 0.0 109.946 174.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.4 tp10 -71.64 -30.18 65.46 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 119.177 -0.44 . . . . 0.0 110.609 172.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.1 m -100.32 -17.46 17.26 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 -169.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -129.71 -105.31 0.29 Allowed 'General case' 0 C--N 1.344 0.336 0 CA-C-N 120.594 1.543 . . . . 0.0 110.754 -169.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -168.64 5.67 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.271 1.428 . . . . 0.0 113.713 -169.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 7.7 ptt? -82.85 152.52 25.58 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.686 0.755 . . . . 0.0 110.009 -173.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -121.56 128.14 51.68 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.401 1.881 . . . . 0.0 107.497 -169.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.86 136.36 52.99 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.444 1.097 . . . . 0.0 108.401 -169.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.1 mm -127.02 137.77 56.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 102.634 -3.098 . . . . 0.0 102.634 169.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 123' ' ' MET . 2.2 pt? -154.2 159.46 41.38 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.111 0.964 . . . . 0.0 111.302 -177.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -126.8 112.32 15.24 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 102.967 -2.975 . . . . 0.0 102.967 172.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.2 p -146.22 160.38 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 121.411 0.624 . . . . 0.0 111.339 -168.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -64.61 125.43 24.7 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.866 1.266 . . . . 0.0 109.226 170.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.3 pp -95.21 -4.07 10.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 123.962 0.905 . . . . 0.0 113.178 -177.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -68.72 -15.15 63.43 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 120.684 1.584 . . . . 0.0 111.299 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 26.1 mt -64.66 -35.79 75.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 124.876 1.27 . . . . 0.0 108.533 171.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -78.97 150.86 75.6 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 123.253 0.621 . . . . 0.0 109.412 -175.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.73 -22.87 23.34 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.501 2.134 . . . . 0.0 112.925 -177.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.4 p -156.07 154.27 6.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -177.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -60.55 -27.59 67.78 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.315 1.046 . . . . 0.0 112.528 178.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 38.1 tp -63.31 -14.64 51.92 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.718 1.207 . . . . 0.0 112.269 174.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.0 170.38 46.55 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.467 1.032 . . . . 0.0 111.812 178.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -162.76 170.65 18.0 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.221 2.208 . . . . 0.0 106.472 177.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 11.9 mttp -60.5 151.73 27.7 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 118.896 0.771 . . . . 0.0 109.708 171.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -146.07 177.27 9.09 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.174 0.989 . . . . 0.0 108.402 172.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -132.73 138.41 47.21 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -172.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.2 mp -108.13 144.69 35.18 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 169.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.4 p -150.01 150.31 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 123.941 0.897 . . . . 0.0 108.662 -178.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.2 mt -142.74 127.28 15.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 174.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -153.24 -69.98 0.15 Allowed 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 172.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 70.0 m -142.52 150.69 40.78 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.256 1.023 . . . . 0.0 108.663 177.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -66.92 142.26 57.34 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.089 1.356 . . . . 0.0 110.952 -177.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.0 tp -72.58 -29.81 63.85 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.258 0.623 . . . . 0.0 109.933 169.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 62.18 174.63 0.13 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.709 2.004 . . . . 0.0 111.144 -169.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -141.22 15.25 2.23 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.217 1.007 . . . . 0.0 111.739 -175.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -124.02 14.7 9.18 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.104 1.362 . . . . 0.0 111.768 -176.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.76 31.03 77.16 Favored Glycine 0 CA--C 1.531 1.04 0 O-C-N 121.071 -1.018 . . . . 0.0 111.671 -175.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.6 m -61.45 -36.3 80.02 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.749 0.82 . . . . 0.0 109.032 170.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 60.0 mt -86.46 148.25 25.63 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 168.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -70.59 10.95 0.41 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.938 1.295 . . . . 0.0 114.071 -169.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -164.99 -43.53 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 126.102 1.761 . . . . 0.0 109.902 174.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.25 21.59 75.84 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-N 113.447 -1.706 . . . . 0.0 114.516 169.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -140.64 -47.58 0.42 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.206 1.503 . . . . 0.0 109.794 178.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 49.73 32.25 5.06 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.156 1.782 . . . . 0.0 113.129 174.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.46 HD21 ' NE2' ' A' ' 87' ' ' GLN . 41.1 t30 -141.71 72.63 24.42 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 124.299 1.04 . . . . 0.0 110.134 -177.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -54.15 -30.73 62.19 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.6 2.2 . . . . 0.0 112.353 171.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.23 7.71 1.21 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 127.625 2.37 . . . . 0.0 113.776 177.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -44.49 -47.02 10.02 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.901 1.28 . . . . 0.0 111.91 173.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -67.64 -16.52 64.2 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.259 1.423 . . . . 0.0 114.126 -174.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 32.1 mtp-105 -65.48 -63.28 3.55 Favored Pre-proline 0 N--CA 1.471 0.598 0 CA-C-N 119.895 1.225 . . . . 0.0 110.307 -175.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -79.49 -8.64 14.92 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.332 1.355 . . . . 0.0 111.145 168.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.4 t 52.92 49.52 20.04 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.726 2.01 . . . . 0.0 109.027 -169.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 45.9 mtm-85 -149.37 153.18 37.01 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 126.327 1.851 . . . . 0.0 107.939 177.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -101.85 -2.17 30.56 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.244 0.617 . . . . 0.0 112.658 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -59.11 -11.97 4.39 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.796 1.239 . . . . 0.0 113.278 177.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.46 ' NE2' HD21 ' A' ' 76' ' ' ASN . 51.7 mt-30 -53.36 -26.9 20.98 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.336 1.454 . . . . 0.0 112.166 170.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -139.32 167.13 22.76 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.481 1.112 . . . . 0.0 110.378 -179.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -59.45 88.59 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.966 2.506 . . . . 0.0 112.468 -175.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -68.94 152.15 45.63 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 168.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.8 p -115.77 152.37 17.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 118.995 0.816 . . . . 0.0 111.327 -169.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 45.9 tpp -149.89 155.3 39.78 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 126.552 1.941 . . . . 0.0 108.369 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -136.35 142.96 43.84 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 126.185 1.794 . . . . 0.0 106.811 -172.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -156.52 -159.48 9.46 Favored Glycine 0 C--N 1.339 0.708 0 CA-C-N 119.452 1.023 . . . . 0.0 114.789 -170.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 3.8 tmtp? -142.86 116.67 9.3 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 172.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 62.1 t -84.54 148.59 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 176.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -136.47 151.44 49.47 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 128.556 2.742 . . . . 0.0 105.276 176.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.69 167.71 29.64 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 120.241 -1.537 . . . . 0.0 112.085 -175.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.5 pt -120.65 177.47 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 124.222 1.009 . . . . 0.0 108.579 169.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -67.61 -5.08 13.89 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.316 1.446 . . . . 0.0 114.139 -175.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -179.82 -129.94 1.41 Allowed Glycine 0 CA--C 1.524 0.624 0 N-CA-C 107.446 -2.262 . . . . 0.0 107.446 -173.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -122.0 -21.21 6.06 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.235 1.414 . . . . 0.0 113.045 169.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 46.38 60.37 3.31 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.126 2.17 . . . . 0.0 112.441 169.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 22.5 p -61.21 -56.47 20.25 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 168.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 65.1 m -166.77 -41.14 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.616 1 C-N-CA 134.23 5.012 . . . . 0.0 104.833 172.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -176.3 -45.49 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.505 2.322 . . . . 0.0 106.548 -171.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -49.25 -27.72 4.01 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 127.158 2.183 . . . . 0.0 116.505 -169.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -140.0 15.5 2.46 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.735 1.152 . . . . 0.0 112.297 171.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.06 -5.04 4.04 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 114.336 1.235 . . . . 0.0 114.336 176.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.6 p -67.71 -20.67 65.3 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 128.778 2.831 . . . . 0.0 114.056 171.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -87.2 152.95 21.88 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 169.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 54.6 tp -100.22 141.73 32.66 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 103.638 -2.726 . . . . 0.0 103.638 167.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 17.9 m -131.7 139.34 49.0 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -176.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -136.4 149.28 48.22 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 124.415 1.086 . . . . 0.0 108.646 -178.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -111.14 142.94 42.65 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 103.868 -2.642 . . . . 0.0 103.868 169.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.1 p -144.78 126.66 9.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 38.1 m -100.37 139.76 35.58 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -135.49 78.88 1.75 Allowed 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.629 1.172 . . . . 0.0 109.114 -169.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 61.16 21.33 59.3 Favored Glycine 0 CA--C 1.537 1.435 0 CA-C-O 119.269 -0.74 . . . . 0.0 114.244 171.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 119.41 -24.29 8.17 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 125.268 1.413 . . . . 0.0 112.111 -176.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -82.84 167.9 17.63 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 169.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 31.7 tp -148.45 155.23 40.93 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.398 -0.814 . . . . 0.0 110.167 -174.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.419 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 34.6 mtt -147.38 161.11 41.68 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.888 1.275 . . . . 0.0 108.561 169.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -137.17 123.04 20.08 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 103.721 -2.696 . . . . 0.0 103.721 169.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -132.28 131.39 41.98 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 -175.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -125.07 140.26 53.06 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 171.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -164.13 178.24 39.56 Favored Glycine 0 N--CA 1.452 -0.243 0 N-CA-C 108.616 -1.793 . . . . 0.0 108.616 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -55.91 141.47 39.18 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.257 1.028 . . . . 0.0 108.879 170.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -41.82 -62.35 0.92 Allowed 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.39 -11.57 61.0 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.179 -0.95 . . . . 0.0 113.507 -176.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -83.71 -28.45 28.28 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.771 1.228 . . . . 0.0 110.137 173.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.34 -38.2 60.28 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 170.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 49.81 11.98 0.07 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 127.33 2.252 . . . . 0.0 116.105 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -73.99 -56.36 5.35 Favored Glycine 0 CA--C 1.522 0.53 0 O-C-N 121.008 -1.058 . . . . 0.0 110.835 -169.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 44.06 24.42 0.08 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 128.58 2.752 . . . . 0.0 115.01 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -162.87 133.15 4.54 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 125.659 1.584 . . . . 0.0 107.813 -169.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.5 m -67.66 -13.34 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.91 169.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -135.39 16.68 3.41 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -169.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 11.6 m -89.28 -66.35 0.93 Allowed 'General case' 0 N--CA 1.462 0.166 0 O-C-N 121.609 -0.682 . . . . 0.0 109.253 168.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.318 13.2 ptm180 -80.23 14.04 2.09 Favored 'General case' 0 C--N 1.344 0.339 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -170.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 19.4 m -60.79 -34.61 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 167.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -79.27 119.83 22.88 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 170.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -140.42 140.23 35.41 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -178.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.0 mp -129.54 156.48 44.1 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 174.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 23.6 ptp -148.44 152.86 37.67 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 121.854 -0.529 . . . . 0.0 111.342 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -158.03 -177.66 6.72 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.355 1.462 . . . . 0.0 110.408 -178.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -53.06 161.41 0.82 Allowed 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.688 1.595 . . . . 0.0 112.591 170.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.53 166.77 0.59 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.022 0.929 . . . . 0.0 111.473 169.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -88.82 89.52 8.02 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 173.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 17.1 t80 . . . . . 0 C--O 1.249 1.07 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 171.872 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.484 1.253 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.1 39.85 0.32 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.704 1.201 . . . . 0.0 111.928 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 177.93 -175.81 47.7 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.828 1.68 . . . . 0.0 109.398 -175.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.9 tt -63.39 156.34 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 174.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -133.41 135.7 44.79 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -175.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -147.23 150.97 35.91 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 126.076 1.75 . . . . 0.0 106.641 172.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -152.96 142.4 21.71 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.149 0.98 . . . . 0.0 109.094 178.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -158.58 158.91 34.82 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.53 0.732 . . . . 0.0 110.174 169.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 mp -76.2 150.4 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 168.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -131.85 154.21 49.39 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.885 1.274 . . . . 0.0 107.959 175.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -128.9 122.95 31.4 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -173.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.8 t -75.81 105.77 5.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -72.8 -37.78 67.44 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.192 0.997 . . . . 0.0 109.89 177.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -159.58 167.65 28.01 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.326 0.967 . . . . 0.0 111.486 176.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.5 mp -133.17 140.24 47.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 127.333 2.253 . . . . 0.0 106.211 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -146.17 92.95 5.17 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 124.494 1.118 . . . . 0.0 109.908 -170.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -64.26 13.59 0.09 OUTLIER 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 124.129 3.219 . . . . 0.0 116.696 -178.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -79.07 53.13 1.38 Allowed 'General case' 0 CA--C 1.544 0.712 0 O-C-N 120.648 -1.283 . . . . 0.0 109.338 172.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -174.89 41.44 0.12 Allowed Glycine 0 CA--C 1.525 0.682 0 C-N-CA 124.677 1.132 . . . . 0.0 111.052 -170.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -74.71 69.37 1.78 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.123 0.961 . . . . 0.0 110.496 -177.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -55.16 -38.65 68.55 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 169.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -146.73 169.48 18.97 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 129.256 3.022 . . . . 0.0 104.677 169.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -62.07 -33.23 74.02 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 120.985 -1.072 . . . . 0.0 111.744 178.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -83.82 9.45 11.96 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-O 116.919 -1.515 . . . . 0.0 113.105 175.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.0 t -119.32 142.74 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 121.84 2.109 . . . . 0.0 107.809 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 57.3 m -148.59 174.41 12.15 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.018 0.927 . . . . 0.0 108.913 175.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.429 ' C ' HD22 ' A' ' 28' ' ' LEU . 45.5 ttp180 -84.5 149.33 26.01 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 106.754 -1.572 . . . . 0.0 106.754 168.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.464 HD23 HG12 ' A' ' 43' ' ' VAL . 4.2 mm? -139.44 153.57 47.6 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 126.806 2.042 . . . . 0.0 106.634 -172.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -130.93 126.66 36.68 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 173.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 85.0 m -142.96 166.77 23.71 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.202 1.401 . . . . 0.0 110.161 -170.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 55.8 tt0 -144.78 139.8 28.06 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.339 1.056 . . . . 0.0 108.636 177.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.21 137.31 46.77 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 174.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -68.13 -32.52 72.87 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.869 0.868 . . . . 0.0 111.424 -176.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 m -117.15 -30.6 5.59 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.108 0.963 . . . . 0.0 111.887 -171.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -113.22 13.33 19.18 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -171.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt 45.71 20.87 0.07 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 118.224 2.676 . . . . 0.0 118.224 169.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 52.3 mtm -64.74 125.85 26.07 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 120.858 1.663 . . . . 0.0 107.806 176.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -77.65 118.62 20.22 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 104.921 -2.252 . . . . 0.0 104.921 169.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 49.8 tp -129.05 130.32 46.41 Favored 'General case' 0 N--CA 1.457 -0.081 0 C-N-CA 123.183 0.593 . . . . 0.0 110.303 -169.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 49.6 mm -118.04 142.41 32.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 103.272 -2.862 . . . . 0.0 103.272 168.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 123' ' ' MET . 2.5 pt? -155.67 163.0 40.48 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.21 1.004 . . . . 0.0 110.761 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -124.96 105.73 9.44 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 102.642 -3.095 . . . . 0.0 102.642 178.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.464 HG12 HD23 ' A' ' 28' ' ' LEU . 7.3 p -150.5 166.11 2.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 O-C-N 124.267 0.979 . . . . 0.0 111.366 -168.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -55.82 133.22 51.01 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.731 1.612 . . . . 0.0 110.504 170.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.42 ' CG2' HD21 ' A' ' 28' ' ' LEU . 1.5 pp -108.28 0.03 9.78 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 C-N-CA 125.045 1.338 . . . . 0.0 114.183 -177.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -67.29 -14.24 62.73 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 120.913 1.688 . . . . 0.0 111.623 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.1 mt -62.66 -27.35 42.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 125.505 1.522 . . . . 0.0 109.643 169.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -116.57 158.48 43.27 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 124.681 1.192 . . . . 0.0 112.182 -168.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -78.49 -15.72 13.79 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.251 2.634 . . . . 0.0 112.766 174.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . 0.283 17.7 m 53.96 -19.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 130.694 3.597 . . . . 0.0 117.243 -175.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -66.7 -23.72 66.16 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.668 1.122 . . . . 0.0 111.872 173.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.0 tp -151.76 163.41 39.22 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.449 1.9 . . . . 0.0 107.513 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.19 163.62 20.87 Favored Glycine 0 CA--C 1.534 1.263 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 169.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -156.02 176.21 12.95 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.22 1.408 . . . . 0.0 108.417 -173.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -126.92 150.64 49.22 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.4 1.08 . . . . 0.0 109.618 -175.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -152.58 178.31 9.72 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 125.411 1.484 . . . . 0.0 108.17 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 -129.11 144.7 51.29 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.5 tt -134.24 139.42 45.76 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 -170.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.3 t -140.78 139.57 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 125.247 1.419 . . . . 0.0 107.6 -169.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 38.3 mm -88.12 66.87 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 170.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -155.77 30.79 0.36 Allowed 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -169.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.8 p -66.83 -7.14 19.45 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 120.003 1.274 . . . . 0.0 112.618 170.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -46.82 145.54 1.94 Allowed 'General case' 0 C--O 1.237 0.422 0 C-N-CA 127.4 2.28 . . . . 0.0 111.927 -179.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.6 tt -134.24 126.5 29.96 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 175.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -72.02 70.82 0.79 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.725 1.21 . . . . 0.0 109.207 177.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -62.17 -16.52 53.46 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.882 1.273 . . . . 0.0 112.719 -177.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -62.29 -20.52 64.39 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.24 1.416 . . . . 0.0 111.866 169.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.12 18.21 56.17 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 124.574 1.083 . . . . 0.0 111.732 -177.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -61.33 -31.57 71.43 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.334 1.067 . . . . 0.0 111.706 -170.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 92.6 mt -92.81 -37.15 12.47 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 123.384 0.673 . . . . 0.0 110.441 174.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -60.42 -21.55 62.39 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.888 0.875 . . . . 0.0 112.585 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -63.24 -7.86 7.04 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.375 1.47 . . . . 0.0 114.177 172.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -127.86 -77.49 0.23 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 107.751 -2.14 . . . . 0.0 107.751 169.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -156.55 144.34 19.35 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 126.026 1.73 . . . . 0.0 107.105 169.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -112.3 23.29 13.81 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.389 1.076 . . . . 0.0 108.801 169.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -143.63 28.92 0.08 OUTLIER Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 127.096 2.158 . . . . 0.0 113.757 -172.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -58.28 -53.49 4.09 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.267 1.978 . . . . 0.0 112.325 -169.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.6 p -135.96 -0.84 2.49 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.413 1.885 . . . . 0.0 110.779 -176.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -66.88 -27.56 67.62 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.075 0.95 . . . . 0.0 111.662 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -128.32 -32.58 2.21 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.393 1.077 . . . . 0.0 112.454 -174.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 78.4 mtt85 -61.4 130.35 91.75 Favored Pre-proline 0 N--CA 1.468 0.445 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 170.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . 0.263 0.1 OUTLIER 18.29 57.12 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.693 1 C-N-CA 127.163 5.242 . . . . 0.0 116.92 -169.551 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.3 m -146.95 166.01 28.08 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.056 2.143 . . . . 0.0 108.138 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 95.5 mtm-85 -139.62 166.62 24.11 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.602 1.161 . . . . 0.0 108.729 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.27 -13.87 43.12 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -51.05 -20.85 1.55 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.923 1.689 . . . . 0.0 113.295 172.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -51.13 -31.03 18.2 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.705 1.202 . . . . 0.0 113.367 170.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -146.22 174.72 11.08 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.259 1.024 . . . . 0.0 111.872 -169.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -125.24 -9.68 7.01 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.12 1.368 . . . . 0.0 110.816 169.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 36.9 t80 62.24 -149.55 0.37 Allowed 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 116.993 -1.48 . . . . 0.0 108.604 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . 0.456 20.7 t 154.92 -90.1 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 130.308 3.443 . . . . 0.0 110.405 169.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.45 -173.09 2.12 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 122.183 2.265 . . . . 0.0 115.83 -167.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -125.77 154.93 41.82 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 129.562 3.145 . . . . 0.0 105.692 169.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -157.46 -151.42 6.02 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-N 119.835 1.198 . . . . 0.0 113.147 -174.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -140.73 147.76 39.68 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.972 1.709 . . . . 0.0 107.007 169.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.9 p -125.42 135.12 64.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 124.392 1.077 . . . . 0.0 108.33 177.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -146.3 106.75 4.06 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.09 0.956 . . . . 0.0 111.235 -170.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -156.71 167.58 30.01 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.089 1.356 . . . . 0.0 109.821 169.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -62.67 168.95 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 125.466 1.506 . . . . 0.0 112.028 174.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -61.45 3.83 0.11 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 129.171 2.988 . . . . 0.0 116.026 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 58.05 43.82 94.93 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-N 119.405 1.002 . . . . 0.0 111.988 -175.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -143.76 80.03 1.65 Allowed 'General case' 0 C--O 1.232 0.144 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 170.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -130.92 14.73 5.27 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.573 0.702 . . . . 0.0 112.108 -169.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.447 ' CG2' ' H ' ' A' ' 108' ' ' ALA . 3.0 t -170.67 -132.5 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 -174.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.1 m -144.05 -8.67 0.7 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.205 2.202 . . . . 0.0 108.923 -178.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 21.9 p -142.75 -90.12 0.13 Allowed 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 118.907 0.776 . . . . 0.0 110.276 -176.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -55.88 -17.57 6.74 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 116.933 2.197 . . . . 0.0 116.933 -168.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.447 ' H ' ' CG2' ' A' ' 104' ' ' THR . . . -145.53 27.49 1.23 Allowed 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 119.823 1.192 . . . . 0.0 108.403 175.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -126.42 -2.03 6.86 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.24 1.416 . . . . 0.0 114.565 169.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 81.2 p -124.64 -9.82 7.34 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.715 1.606 . . . . 0.0 113.31 176.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -129.79 138.88 51.29 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 174.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.1 tp -84.87 152.45 23.57 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 169.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 11.8 m -122.55 150.79 42.11 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -176.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -148.14 140.43 24.27 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.685 0.794 . . . . 0.0 108.981 178.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 -120.76 134.27 55.29 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 103.11 -2.922 . . . . 0.0 103.11 169.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.3 t -125.11 142.6 41.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 -175.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 45.6 m -133.35 122.83 24.38 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 -178.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -147.79 105.21 3.66 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 122.809 0.444 . . . . 0.0 110.173 -169.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 58.48 27.85 61.47 Favored Glycine 0 CA--C 1.536 1.361 0 O-C-N 121.53 -0.731 . . . . 0.0 113.878 174.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 90.92 -2.87 80.38 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 118.312 1.056 . . . . 0.0 113.528 -178.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 88.0 mt -95.39 164.22 12.91 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 125.439 1.496 . . . . 0.0 107.878 171.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 7.9 tp -142.96 161.91 36.88 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -168.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.474 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 27.6 mtt -147.04 155.38 42.17 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 126.391 1.877 . . . . 0.0 108.671 169.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 36.9 mtp-105 -142.4 126.07 16.94 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 104.849 -2.278 . . . . 0.0 104.849 169.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -152.28 163.6 39.11 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 119.179 0.899 . . . . 0.0 112.339 -172.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -138.78 155.91 47.78 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.856 1.263 . . . . 0.0 108.78 169.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -169.63 175.8 43.71 Favored Glycine 0 CA--C 1.52 0.381 0 N-CA-C 108.52 -1.832 . . . . 0.0 108.52 169.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -56.77 142.16 41.58 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 118.467 1.134 . . . . 0.0 108.493 170.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -47.09 -48.73 22.62 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.131 0.878 . . . . 0.0 112.035 177.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -56.34 -36.63 68.98 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 122.214 1.007 . . . . 0.0 112.174 178.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -79.0 -19.32 51.89 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 113.58 -1.646 . . . . 0.0 111.004 -174.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 14.7 tp -70.39 -28.15 64.85 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 119.826 1.194 . . . . 0.0 109.309 169.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 1.9 t60 44.44 34.36 1.06 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.504 2.322 . . . . 0.0 114.623 171.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 167.38 73.37 0.03 OUTLIER Glycine 0 C--N 1.334 0.446 0 N-CA-C 108.482 -1.847 . . . . 0.0 108.482 -169.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -101.98 3.84 39.35 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -169.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.405 ' C ' ' H ' ' A' ' 138' ' ' ASP . 9.7 mm-40 -71.85 149.68 44.99 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 169.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 16.5 m -57.79 -7.43 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 124.713 1.205 . . . . 0.0 110.941 168.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 136' ' ' GLU . 34.1 t70 -135.85 15.6 3.33 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 126.825 2.05 . . . . 0.0 112.692 -178.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 58.6 m -80.77 -76.25 0.24 Allowed 'General case' 0 C--N 1.338 0.079 0 O-C-N 121.412 -0.805 . . . . 0.0 109.06 168.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 11.5 ptm85 -81.23 16.61 1.52 Allowed 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -169.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 30.2 m -68.19 -30.37 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 CA-C-O 118.732 -0.652 . . . . 0.0 109.348 168.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -72.36 124.13 24.49 Favored 'General case' 0 C--N 1.341 0.212 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 175.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 60.0 tp -138.17 103.44 4.94 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.511 0.725 . . . . 0.0 109.231 -173.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 15.9 tp -114.83 135.0 54.67 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 174.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 61.5 mtt -118.96 155.41 31.4 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.961 1.304 . . . . 0.0 107.51 171.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -146.85 161.84 39.86 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 126.36 1.864 . . . . 0.0 107.684 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -67.4 -176.07 0.55 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.351 0.596 . . . . 0.0 110.161 169.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 66.6 mt -57.19 119.8 7.01 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 121.773 0.797 . . . . 0.0 110.273 169.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -142.34 144.85 33.39 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 102.171 -3.27 . . . . 0.0 102.171 169.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 . . . . . 0 C--O 1.249 1.077 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -174.313 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.0 ptt? . . . . . 0 N--CA 1.486 1.328 0 N-CA-C 110.664 -0.124 . . . . 0.0 110.664 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 51.89 -146.21 0.5 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.403 1.481 . . . . 0.0 111.296 -178.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 75.52 29.03 60.39 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-O 119.057 -0.857 . . . . 0.0 112.855 176.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 41.3 pt 36.68 57.53 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 127.036 2.134 . . . . 0.0 113.19 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 66.5 tp -48.79 -37.28 18.69 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.097 1.359 . . . . 0.0 111.917 176.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.406 ' CZ ' ' HA ' ' A' ' 131' ' ' ASN . 83.7 t80 -145.2 143.53 30.35 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 169.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -151.83 139.59 19.85 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.429 1.491 . . . . 0.0 107.871 -177.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -154.26 115.71 4.13 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.408 0.683 . . . . 0.0 109.897 -171.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 mp -71.32 143.89 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -143.61 158.94 43.29 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 123.503 0.721 . . . . 0.0 111.431 175.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -135.35 129.27 33.17 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 126.385 1.874 . . . . 0.0 108.286 -174.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.7 t -66.13 126.86 26.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 175.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.1 mmmt -108.01 -25.46 11.15 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 124.312 1.045 . . . . 0.0 110.663 178.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -154.36 166.58 32.76 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.556 1.071 . . . . 0.0 110.672 172.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.4 mp -144.42 141.62 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 126.947 2.099 . . . . 0.0 106.975 -170.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -147.92 100.91 3.67 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 124.213 1.005 . . . . 0.0 109.02 171.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -65.07 -2.1 5.21 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 122.578 2.185 . . . . 0.0 115.937 176.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 36.9 45.41 0.43 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 128.756 2.822 . . . . 0.0 113.76 -176.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.19 11.95 37.78 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.094 0.854 . . . . 0.0 113.077 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? 45.82 67.86 0.68 Allowed 'General case' 0 C--N 1.343 0.307 0 C-N-CA 126.736 2.014 . . . . 0.0 109.895 -170.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -48.93 -41.16 32.91 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.451 1.1 . . . . 0.0 111.435 -177.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -140.74 156.56 46.16 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 169.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -62.5 -4.45 1.93 Allowed 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -172.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -147.24 26.75 1.06 Allowed 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 125.132 1.373 . . . . 0.0 112.229 -176.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.5 t -133.21 126.45 52.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.4 m -148.12 155.64 41.67 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.916 0.886 . . . . 0.0 110.271 -171.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 54.5 ttm-85 -83.41 149.72 26.5 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 169.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 85.9 mt -140.33 159.72 41.56 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 125.788 1.635 . . . . 0.0 107.815 -178.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -133.92 136.87 44.54 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 169.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.9 m -140.82 166.17 25.49 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.384 1.073 . . . . 0.0 109.845 -173.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -129.73 149.39 51.5 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 171.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.6 m -117.46 117.6 29.89 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -169.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -65.84 -44.22 86.17 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.241 1.416 . . . . 0.0 111.437 -169.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.2 m -74.94 -41.32 59.87 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 119.229 -0.415 . . . . 0.0 111.733 -169.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -131.66 29.36 4.5 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -172.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.292 0.0 OUTLIER 44.94 35.14 1.41 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 127.138 2.175 . . . . 0.0 114.702 169.814 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 11.8 tmm? -87.34 114.35 23.87 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.365 1.066 . . . . 0.0 109.003 -175.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -71.87 132.08 43.91 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 171.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 45.8 tp -135.81 143.37 45.13 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.474 0.71 . . . . 0.0 110.739 -169.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 41.4 mm -127.58 147.87 32.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 103.187 -2.894 . . . . 0.0 103.187 169.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.2 mt -150.88 146.44 26.32 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 126.577 1.951 . . . . 0.0 107.557 -169.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -135.3 101.74 4.93 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 102.056 -3.313 . . . . 0.0 102.056 169.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.3 p -146.34 163.51 9.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 122.483 1.135 . . . . 0.0 113.202 -167.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -67.01 123.92 21.57 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 126.072 1.749 . . . . 0.0 106.43 168.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 pp -105.44 4.64 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -174.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -69.36 -10.51 58.23 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 120.069 1.304 . . . . 0.0 111.146 176.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.3 mt -59.75 -42.11 87.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 169.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -79.57 155.4 76.15 Favored Pre-proline 0 C--O 1.236 0.39 0 C-N-CA 123.639 0.775 . . . . 0.0 109.467 -175.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -67.14 -21.1 49.18 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.315 2.01 . . . . 0.0 112.357 176.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.9 p -158.15 155.37 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.782 1.633 . . . . 0.0 106.938 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -55.66 -25.84 41.55 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.376 1.471 . . . . 0.0 113.126 178.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 58.5 tp -57.97 -22.46 49.36 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.281 1.432 . . . . 0.0 112.58 173.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.92 178.58 47.6 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 123.741 0.686 . . . . 0.0 112.219 177.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -157.75 168.57 26.83 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.534 1.933 . . . . 0.0 107.625 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -73.73 136.09 43.66 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 174.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 7.3 m-30 -138.59 178.88 6.82 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.977 1.711 . . . . 0.0 107.012 176.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.93 141.15 49.24 Favored 'General case' 0 CA--C 1.515 -0.383 0 O-C-N 121.127 -0.983 . . . . 0.0 109.129 169.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 12.9 tp -96.24 152.05 18.93 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 177.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 53.7 t -140.01 142.26 32.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 177.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.9 pt -132.64 21.02 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 122.94 0.496 . . . . 0.0 112.104 -178.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.94 138.47 57.41 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 121.506 -0.746 . . . . 0.0 109.302 172.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.0 t -59.14 130.02 44.94 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 169.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.4 t -165.04 167.87 17.94 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.875 0.845 . . . . 0.0 110.846 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.3 tp -139.48 11.83 2.53 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.66 2.384 . . . . 0.0 108.159 168.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . 0.321 47.5 p90 42.83 24.75 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 129.673 3.189 . . . . 0.0 116.194 -173.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -63.56 -20.72 65.88 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.4 1.08 . . . . 0.0 111.106 169.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -67.1 -23.04 65.79 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.127 1.371 . . . . 0.0 112.805 -177.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -163.27 36.6 0.32 Allowed Glycine 0 C--N 1.338 0.69 0 CA-C-N 118.284 0.493 . . . . 0.0 112.366 -172.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.82 159.21 11.5 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.194 0.998 . . . . 0.0 110.261 -177.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 72.7 mt 43.94 46.93 7.0 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.962 1.705 . . . . 0.0 110.761 -177.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.3 t0 42.3 69.28 0.39 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.919 2.088 . . . . 0.0 112.398 -169.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.4 t0 48.5 37.75 9.62 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.884 1.674 . . . . 0.0 112.634 -174.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.32 3.5 70.79 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.122 1.344 . . . . 0.0 113.916 177.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -70.27 -27.54 64.5 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.43 1.615 . . . . 0.0 110.617 175.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 25.0 t80 44.75 59.51 3.35 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 126.285 1.834 . . . . 0.0 110.59 -170.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -58.15 137.59 84.38 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 113.919 -1.491 . . . . 0.0 111.409 -169.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -50.08 -29.61 22.52 Favored 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 123.937 3.091 . . . . 0.0 115.374 176.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.2 m -65.31 -21.74 66.75 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 120.079 1.308 . . . . 0.0 111.422 178.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -96.89 -44.77 6.9 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.543 1.137 . . . . 0.0 109.205 176.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -71.37 -40.06 70.86 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.282 1.433 . . . . 0.0 114.621 -176.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 71.6 mmt-85 -69.36 -43.19 22.99 Favored Pre-proline 0 N--CA 1.466 0.337 0 CA-C-N 120.444 1.475 . . . . 0.0 111.466 -172.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -82.58 2.41 8.52 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 121.628 1.552 . . . . 0.0 111.667 168.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . 0.294 9.3 p 31.0 55.9 0.22 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 129.973 3.309 . . . . 0.0 113.393 -173.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -151.06 158.22 43.8 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 125.49 1.516 . . . . 0.0 107.713 176.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -56.73 129.82 42.84 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 123.537 0.523 . . . . 0.0 111.063 -172.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -125.74 -21.12 4.49 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.5 1.92 . . . . 0.0 110.23 170.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -52.78 -38.37 61.0 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.954 1.301 . . . . 0.0 110.688 169.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -146.36 161.39 40.46 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 129.428 3.091 . . . . 0.0 106.136 176.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -88.96 -32.82 17.48 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 118.966 -0.54 . . . . 0.0 110.261 175.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -155.67 153.57 30.2 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 118.819 0.736 . . . . 0.0 110.054 177.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.4 m -143.6 145.89 21.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 125.462 1.505 . . . . 0.0 107.464 169.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 5.8 tpt -162.13 174.27 13.17 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.029 0.932 . . . . 0.0 109.452 174.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -137.84 155.8 48.6 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 126.613 1.965 . . . . 0.0 106.212 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -167.08 -157.92 10.98 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 118.689 0.677 . . . . 0.0 113.147 -169.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.4 tttm -141.78 130.18 22.44 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 117.848 0.824 . . . . 0.0 109.152 174.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.3 t -75.11 148.35 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 124.656 1.182 . . . . 0.0 108.779 169.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -144.31 70.67 1.29 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.916 0.887 . . . . 0.0 110.798 175.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -144.01 163.67 32.84 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.376 1.07 . . . . 0.0 110.635 174.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.41 HG13 ' H ' ' A' ' 101' ' ' GLY . 26.3 pt -76.47 -170.08 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 125.124 1.369 . . . . 0.0 110.269 174.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -60.64 -0.29 0.26 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.965 2.106 . . . . 0.0 115.186 178.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.41 ' H ' HG13 ' A' ' 99' ' ' ILE . . . 97.38 -47.7 1.58 Allowed Glycine 0 C--N 1.335 0.48 0 C-N-CA 125.231 1.396 . . . . 0.0 111.511 174.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -73.65 118.78 17.0 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -135.52 35.27 2.95 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.891 1.276 . . . . 0.0 109.197 -175.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.8 t -141.35 179.68 6.64 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.099 1.36 . . . . 0.0 109.085 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.7 m -151.22 7.2 0.51 Allowed 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 128.132 2.573 . . . . 0.0 108.91 -172.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.3 p -128.38 4.62 5.7 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.745 0.818 . . . . 0.0 111.481 -169.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -157.5 -31.73 0.08 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.371 1.468 . . . . 0.0 110.106 173.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 63.79 97.88 0.04 OUTLIER 'General case' 0 C--N 1.35 0.602 0 C-N-CA 126.923 2.089 . . . . 0.0 106.2 -169.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.84 136.42 51.36 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.984 -1.007 . . . . 0.0 112.499 -167.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.8 p -96.84 4.32 51.75 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.036 1.335 . . . . 0.0 113.482 -178.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -118.77 151.9 37.17 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 172.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.18 139.98 33.16 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 169.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.6 p -101.73 147.26 26.68 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 174.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -146.33 144.0 29.5 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 176.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 15.3 m-30 -122.85 137.27 54.98 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 102.485 -3.154 . . . . 0.0 102.485 169.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.4 p -142.47 144.36 24.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 24.0 p -116.97 130.23 56.55 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 172.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -144.51 116.05 8.12 Favored 'General case' 0 N--CA 1.458 -0.073 0 C-N-CA 123.878 0.871 . . . . 0.0 109.581 -169.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 55.78 21.75 30.83 Favored Glycine 0 CA--C 1.537 1.423 0 CA-C-O 119.234 -0.759 . . . . 0.0 114.534 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 92.19 -5.04 78.15 Favored Glycine 0 CA--C 1.535 1.3 0 CA-C-N 118.648 1.224 . . . . 0.0 113.477 -176.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -95.09 170.92 9.07 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.956 1.302 . . . . 0.0 107.809 170.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.5 tt -149.3 151.45 34.19 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 121.522 -0.736 . . . . 0.0 110.545 -170.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 13.0 ptp -148.37 158.08 43.88 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 169.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 -140.51 138.53 34.65 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 178.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -154.2 162.12 41.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 118.855 0.752 . . . . 0.0 112.937 -169.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -134.44 118.43 17.38 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 104.109 -2.552 . . . . 0.0 104.109 168.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -151.05 175.56 29.94 Favored Glycine 0 N--CA 1.452 -0.256 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 -175.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -58.21 148.45 26.98 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 122.332 -0.511 . . . . 0.0 111.177 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -46.49 -42.15 15.13 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 175.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.77 -12.61 60.44 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.996 1.271 . . . . 0.0 113.191 178.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.406 ' HA ' ' CZ ' ' A' ' 6' ' ' PHE . 5.8 t-20 -66.57 -19.06 65.69 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 168.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -100.0 19.19 16.72 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 117.067 -1.444 . . . . 0.0 110.634 174.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -30.2 108.0 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 120.32 1.418 . . . . 0.0 112.021 169.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 122.84 -13.97 8.55 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 125.077 1.322 . . . . 0.0 112.134 -169.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . 0.26 30.9 m-85 44.11 56.6 4.7 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 129.527 3.131 . . . . 0.0 114.165 177.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 70.97 164.53 0.28 Allowed 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 129.499 3.12 . . . . 0.0 113.488 170.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 60.1 t 59.23 -9.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 127.091 2.156 . . . . 0.0 113.686 -172.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -154.02 -11.99 0.14 Allowed 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 119.84 1.2 . . . . 0.0 114.007 -172.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 16.0 m -54.68 -63.47 1.14 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.963 0.887 . . . . 0.0 112.652 169.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 8.6 mmm180 -88.67 11.19 18.18 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.43 -169.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 98.2 t -87.9 -5.73 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 C-N-CA 124.838 1.255 . . . . 0.0 108.861 -177.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -128.2 114.71 17.33 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 103.383 -2.821 . . . . 0.0 103.383 168.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.7 tt -133.69 126.23 30.32 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 -171.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.0 tt -134.68 147.97 50.23 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 106.768 -1.568 . . . . 0.0 106.768 178.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 56.5 ttm -139.56 138.32 36.14 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.221 -1.399 . . . . 0.0 107.221 -178.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -147.01 162.84 37.97 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -57.06 156.36 7.1 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 118.532 0.605 . . . . 0.0 109.7 169.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.0 pp -67.4 160.04 28.19 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 169.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -148.09 125.93 11.94 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 177.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 . . . . . 0 C--O 1.251 1.162 0 C-N-CA 126.289 1.836 . . . . 0.0 107.186 175.753 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.8 mmm . . . . . 0 N--CA 1.484 1.27 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.32 173.84 5.37 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.314 0.646 . . . . 0.0 110.08 169.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -150.01 171.31 30.01 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 108.348 -1.901 . . . . 0.0 108.348 171.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.6 tp -59.87 119.75 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 118.029 0.915 . . . . 0.0 108.695 175.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.4 tt -137.75 -37.19 0.61 Allowed 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 118.62 -0.705 . . . . 0.0 110.95 -170.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -161.48 150.69 16.26 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 119.17 0.895 . . . . 0.0 109.627 174.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -157.87 132.12 8.2 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.053 1.341 . . . . 0.0 108.434 169.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -161.06 155.01 22.5 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.471 0.708 . . . . 0.0 109.879 168.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 mp -74.5 151.33 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 169.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -129.13 150.71 50.41 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 172.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -133.97 129.21 35.88 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.054 1.342 . . . . 0.0 108.004 -169.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.6 p -63.82 147.97 11.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-O 122.078 0.942 . . . . 0.0 110.153 -177.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -125.09 -29.01 3.36 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 126.73 2.012 . . . . 0.0 109.373 178.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -160.25 166.6 29.27 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.348 0.977 . . . . 0.0 111.062 170.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.1 mp -133.01 135.06 57.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 127.292 2.237 . . . . 0.0 105.372 178.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -146.45 89.85 5.76 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 124.03 0.932 . . . . 0.0 110.301 -169.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -64.27 16.92 0.07 OUTLIER 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 124.26 3.307 . . . . 0.0 116.594 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -79.98 53.98 1.8 Allowed 'General case' 0 CA--C 1.542 0.66 0 O-C-N 120.256 -1.527 . . . . 0.0 109.778 176.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -172.88 38.67 0.15 Allowed Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.231 0.92 . . . . 0.0 111.577 -171.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.6 mmmt -74.31 66.71 1.34 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 118.152 0.976 . . . . 0.0 111.445 -175.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -57.09 -36.63 70.84 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 169.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -143.85 167.77 21.52 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 128.194 2.598 . . . . 0.0 105.027 169.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -62.13 -31.59 72.09 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.355 -0.84 . . . . 0.0 111.243 177.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -82.68 11.07 6.27 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-O 116.738 -1.601 . . . . 0.0 113.559 175.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 93.5 t -123.05 138.54 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 122.391 2.36 . . . . 0.0 108.302 -179.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.7 m -149.66 170.44 18.68 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.876 1.27 . . . . 0.0 109.472 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.443 ' C ' HD22 ' A' ' 28' ' ' LEU . 49.7 ttp180 -91.22 149.7 21.66 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 169.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.45 HD23 HG22 ' A' ' 43' ' ' VAL . 3.5 mm? -141.33 158.16 44.24 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 126.83 2.052 . . . . 0.0 106.713 -172.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -133.14 134.91 44.81 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 172.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 64.3 m -141.24 175.94 9.24 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.953 1.701 . . . . 0.0 109.68 -177.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -141.85 144.94 34.12 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.798 1.639 . . . . 0.0 107.836 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 64.6 p -67.82 130.29 42.53 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 175.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -69.36 -31.3 69.63 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 122.869 0.468 . . . . 0.0 111.785 -174.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 m -113.48 -5.48 13.48 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 114.587 1.328 . . . . 0.0 114.587 -169.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -123.77 -106.86 0.35 Allowed 'General case' 0 C--N 1.341 0.23 0 CA-C-N 119.892 1.223 . . . . 0.0 108.874 -176.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -169.61 3.74 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -169.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 5.3 mpp? -77.69 137.0 38.26 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 123.6 0.76 . . . . 0.0 110.9 -169.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -81.64 137.59 35.43 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 168.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 38.8 tp -133.16 138.75 46.72 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 174.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 35.9 mm -126.75 145.7 33.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 102.801 -3.037 . . . . 0.0 102.801 169.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 123' ' ' MET . 2.0 pt? -157.51 156.52 32.16 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.499 1.12 . . . . 0.0 109.952 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -126.67 107.12 9.89 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 178.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.45 HG22 HD23 ' A' ' 28' ' ' LEU . 27.0 m -148.21 171.44 2.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 O-C-N 124.656 1.222 . . . . 0.0 112.234 -168.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -59.79 141.06 56.0 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.612 1.565 . . . . 0.0 110.415 169.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.6 pp -117.08 1.08 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 125.982 1.713 . . . . 0.0 113.045 177.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -62.05 -22.54 65.83 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 120.48 1.491 . . . . 0.0 110.669 169.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 12.7 mt -53.62 -38.92 35.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 126.179 1.792 . . . . 0.0 109.857 169.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -68.42 129.02 92.98 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -172.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -72.28 -31.6 11.48 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.473 2.116 . . . . 0.0 111.402 178.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.7 m -145.79 154.96 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 126.124 1.77 . . . . 0.0 107.415 177.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -61.7 -25.09 67.19 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.349 0.66 . . . . 0.0 112.061 177.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.2 tp -57.79 -36.26 71.95 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.496 1.118 . . . . 0.0 112.261 -178.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 164.14 177.24 36.72 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-N 118.91 0.777 . . . . 0.0 112.851 178.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -156.99 169.44 24.82 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.487 1.515 . . . . 0.0 109.002 177.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -135.84 158.86 43.36 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.752 1.621 . . . . 0.0 107.974 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -142.47 169.85 16.8 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 123.921 0.888 . . . . 0.0 109.331 -169.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 -133.81 107.2 7.74 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 169.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 68.3 tp -93.98 132.74 38.15 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.0 p -153.6 155.91 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-O 121.943 0.877 . . . . 0.0 109.369 -170.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 tp -147.1 112.1 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 104.146 -2.538 . . . . 0.0 104.146 169.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -143.95 172.4 12.92 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.966 1.706 . . . . 0.0 109.229 -175.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.4 m -50.41 130.0 22.78 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.872 1.669 . . . . 0.0 112.536 -170.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.272 1.0 OUTLIER -79.17 -159.45 0.19 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.326 0.651 . . . . 0.0 111.46 177.757 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 56.93 30.92 18.85 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 -166.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 44.84 23.79 0.09 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 130.464 3.505 . . . . 0.0 115.067 -169.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -61.82 -18.65 60.78 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.408 1.003 . . . . 0.0 111.856 178.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.93 -24.87 17.83 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.689 1.996 . . . . 0.0 111.98 169.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.55 22.22 13.06 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 124.361 0.981 . . . . 0.0 110.766 -173.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.56 -23.6 67.32 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.34 1.456 . . . . 0.0 111.457 -172.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 91.8 mt -108.94 22.2 16.22 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.302 1.441 . . . . 0.0 110.574 175.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.8 t0 40.38 55.74 2.76 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 127.175 2.19 . . . . 0.0 112.485 -174.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.3 t70 54.21 22.98 3.92 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.352 1.861 . . . . 0.0 113.925 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 104.2 -5.51 45.6 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 125.42 1.486 . . . . 0.0 112.63 176.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -72.18 -22.36 61.3 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.942 1.371 . . . . 0.0 110.962 177.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -54.87 127.41 28.49 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.354 0.597 . . . . 0.0 109.825 174.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -148.8 164.68 20.36 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 126.553 1.941 . . . . 0.0 107.055 174.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_exo -49.84 -25.68 12.34 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 123.945 3.096 . . . . 0.0 117.66 -174.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 68.1 p -63.11 -22.44 66.86 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 121.109 1.777 . . . . 0.0 111.894 178.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -71.55 -17.1 62.33 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.796 0.839 . . . . 0.0 112.174 174.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -113.7 -17.42 12.12 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.225 1.41 . . . . 0.0 112.204 -175.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -52.16 133.43 41.13 Favored Pre-proline 0 N--CA 1.469 0.496 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 170.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . 0.254 0.4 OUTLIER 25.95 45.94 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.675 1 C-N-CA 126.673 4.915 . . . . 0.0 116.284 -169.466 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.8 m -146.85 -171.89 3.86 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.526 2.331 . . . . 0.0 107.566 -178.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -138.42 151.54 47.55 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 173.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.75 -16.32 62.81 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -42.46 -29.47 0.28 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.184 2.194 . . . . 0.0 113.914 170.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -48.61 -43.19 36.02 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.416 1.087 . . . . 0.0 112.188 175.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -142.57 -0.61 1.2 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.43 0.692 . . . . 0.0 112.751 -170.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -140.05 31.84 1.97 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 119.301 0.955 . . . . 0.0 113.291 -168.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -78.41 59.88 2.47 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 120.614 1.552 . . . . 0.0 109.504 174.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.1 p -78.73 147.72 6.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 125.363 1.465 . . . . 0.0 108.414 178.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 3.2 ttm -158.68 174.3 15.26 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.243 1.017 . . . . 0.0 108.904 170.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -126.06 154.19 43.38 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 169.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -152.01 -162.24 10.7 Favored Glycine 0 C--N 1.333 0.369 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -173.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -140.83 112.54 7.57 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 172.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.8 p -69.17 149.91 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 C-N-CA 124.613 1.165 . . . . 0.0 109.347 168.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -139.44 122.65 16.95 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 102.296 -3.224 . . . . 0.0 102.296 172.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.04 142.38 31.55 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 120.065 1.302 . . . . 0.0 109.965 -168.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.9 pt -74.95 174.46 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 123.961 0.905 . . . . 0.0 110.917 -177.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -69.52 -2.99 12.81 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.292 1.437 . . . . 0.0 113.525 177.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 60.32 38.46 94.66 Favored Glycine 0 C--N 1.339 0.719 0 C-N-CA 124.748 1.166 . . . . 0.0 112.879 -176.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -145.97 130.34 17.69 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 168.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -134.76 12.22 3.69 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.425 1.09 . . . . 0.0 112.049 169.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 37.3 p -74.39 -63.24 1.28 Allowed 'General case' 0 N--CA 1.463 0.223 0 O-C-N 121.931 -0.481 . . . . 0.0 110.271 -178.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 32.9 m 144.68 38.56 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.822 1 C-N-CA 131.996 4.118 . . . . 0.0 108.558 -169.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . 0.257 1.3 m 84.98 8.12 0.43 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.788 1.635 . . . . 0.0 110.941 176.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -72.6 -17.78 61.66 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 168.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 76.55 88.31 0.08 Allowed 'General case' 0 C--N 1.349 0.544 0 C-N-CA 128.668 2.787 . . . . 0.0 108.136 169.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.85 151.26 6.66 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 113.935 -1.484 . . . . 0.0 111.969 -169.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.8 p -79.61 -4.88 53.57 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -174.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -126.07 141.29 52.01 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.627 1.171 . . . . 0.0 108.676 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.2 tp -102.81 152.09 21.66 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.122 1.769 . . . . 0.0 107.316 169.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.6 m -132.88 146.4 51.78 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 176.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -139.78 158.17 44.53 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 125.179 1.391 . . . . 0.0 108.872 -177.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -124.5 152.88 42.86 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 169.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.0 t -140.97 141.03 32.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 174.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 72.8 p -118.87 135.72 54.41 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 169.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -151.84 116.6 5.14 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -173.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 54.12 29.14 43.72 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 123.757 0.694 . . . . 0.0 113.97 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 85.48 -2.04 88.16 Favored Glycine 0 CA--C 1.535 1.316 0 CA-C-N 118.159 0.98 . . . . 0.0 113.879 -178.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 49.0 mt -95.22 168.21 10.88 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.281 1.432 . . . . 0.0 108.363 172.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 10.7 tp -139.12 158.1 44.78 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.868 -0.52 . . . . 0.0 111.062 -169.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.448 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 43.8 mtt -148.77 159.67 43.93 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.921 1.688 . . . . 0.0 109.408 169.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.7 ttp85 -140.17 131.0 25.93 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 168.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.7 tt -138.42 131.26 29.55 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 -169.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -136.6 144.63 44.2 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -178.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 177.63 -175.21 47.45 Favored Glycine 0 CA--C 1.518 0.245 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 177.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.01 141.93 32.17 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.04 0.92 . . . . 0.0 108.782 169.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -50.46 -53.3 30.77 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -175.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -61.77 -36.55 81.38 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.619 0.723 . . . . 0.0 112.112 179.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -65.64 -23.23 66.75 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 125.032 1.333 . . . . 0.0 111.871 176.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.52 -8.62 55.08 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 120.126 1.33 . . . . 0.0 110.524 172.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 77.2 m80 44.04 43.54 5.57 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 129.413 3.085 . . . . 0.0 111.088 -176.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 173.25 112.1 0.28 Allowed Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 107.267 -2.333 . . . . 0.0 107.267 179.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -65.79 -8.68 22.78 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-O 121.507 0.67 . . . . 0.0 110.93 167.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 50.83 152.13 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.179 1 C-N-CA 135.389 5.476 . . . . 0.0 121.128 168.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER 171.6 -27.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.555 1 C-N-CA 133.438 4.695 . . . . 0.0 107.63 169.41 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -167.24 40.44 0.04 OUTLIER 'General case' 0 C--N 1.349 0.569 0 CA-C-N 119.085 0.857 . . . . 0.0 113.11 -172.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 26.9 m -118.66 -38.41 3.12 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 123.353 0.661 . . . . 0.0 110.617 169.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -11.78 18.77 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.999 0.904 . . . . 0.0 113.084 174.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 18.6 m -77.7 -4.14 6.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 C-N-CA 126.216 1.806 . . . . 0.0 112.689 -174.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -122.19 118.38 28.47 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 104.036 -2.579 . . . . 0.0 104.036 170.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -149.56 147.1 27.76 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.846 0.748 . . . . 0.0 111.131 -172.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 15.7 tp -140.74 139.88 34.74 Favored 'General case' 0 CA--C 1.523 -0.094 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -177.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 16.7 tmm? -125.39 144.28 50.59 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 173.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -149.98 172.55 15.03 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.328 1.451 . . . . 0.0 109.426 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -62.64 157.11 21.57 Favored 'General case' 0 C--O 1.235 0.297 0 O-C-N 122.1 -0.375 . . . . 0.0 110.438 172.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.2 pp -67.61 161.42 25.77 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.121 0.486 . . . . 0.0 110.671 169.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -146.88 129.83 16.32 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 173.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 . . . . . 0 C--O 1.248 1.019 0 C-N-CA 126.466 1.906 . . . . 0.0 106.995 174.04 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 110.867 -0.049 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -57.81 -44.37 86.33 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.656 0.782 . . . . 0.0 111.026 175.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 159.47 -173.26 36.23 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 124.517 1.056 . . . . 0.0 110.549 176.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 30.2 pt -136.59 150.15 27.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 125.78 1.632 . . . . 0.0 107.211 169.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.4 tt -156.28 -57.43 0.09 Allowed 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -177.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -149.36 136.3 19.69 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 173.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -148.87 144.79 27.13 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.339 1.456 . . . . 0.0 108.262 -172.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -157.68 159.91 37.43 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 122.879 0.472 . . . . 0.0 110.585 169.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.1 mp -79.8 153.29 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 105.45 -2.056 . . . . 0.0 105.45 169.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -135.15 138.47 43.74 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.909 1.284 . . . . 0.0 107.644 178.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -105.57 122.96 47.1 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.073 1.349 . . . . 0.0 108.245 -178.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 44.8 t -71.09 116.92 13.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.6 mmmt -80.62 -40.99 24.69 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.729 0.811 . . . . 0.0 109.417 173.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -156.98 169.22 25.3 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 118.518 0.599 . . . . 0.0 111.458 -175.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.6 mp -135.18 144.96 32.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 127.245 2.218 . . . . 0.0 106.503 -178.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -141.91 89.12 9.05 Favored Pre-proline 0 CA--C 1.539 0.558 0 C-N-CA 126.552 1.941 . . . . 0.0 108.737 -176.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -81.21 100.88 1.2 Allowed 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 123.542 2.828 . . . . 0.0 107.674 169.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -61.77 -35.5 78.31 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.486 1.114 . . . . 0.0 112.705 -169.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 141.52 47.04 0.05 OUTLIER Glycine 0 CA--C 1.527 0.808 0 N-CA-C 103.595 -3.802 . . . . 0.0 103.595 -169.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.6 mmmt -61.49 115.97 4.33 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.542 1.537 . . . . 0.0 110.445 -167.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -55.47 -33.29 63.53 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.994 0.918 . . . . 0.0 110.884 170.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -127.22 96.61 4.64 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 176.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.98 -15.03 58.36 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.954 0.902 . . . . 0.0 113.411 -172.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -68.61 -0.2 4.91 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 118.789 -0.624 . . . . 0.0 112.546 169.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.8 t -120.62 138.52 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 104.929 -2.249 . . . . 0.0 104.929 169.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 61.0 m -155.34 160.67 40.9 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.634 1.107 . . . . 0.0 110.061 173.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 41.7 ttm105 -83.35 144.09 29.9 Favored 'General case' 0 C--N 1.342 0.272 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 173.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.1 mp -129.3 157.22 42.49 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 128.075 2.55 . . . . 0.0 105.958 177.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -130.47 130.68 44.54 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 170.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 22.1 m -141.79 168.48 19.67 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.716 1.206 . . . . 0.0 110.998 -171.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -134.3 155.97 49.27 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.447 1.099 . . . . 0.0 108.589 169.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.6 p -69.34 143.82 53.65 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.165 0.586 . . . . 0.0 110.375 176.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -71.77 -36.92 70.53 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.426 0.69 . . . . 0.0 111.247 175.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.1 m -110.92 -10.86 14.39 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -168.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -125.99 -105.97 0.33 Allowed 'General case' 0 C--N 1.343 0.303 0 CA-C-N 120.733 1.606 . . . . 0.0 111.3 -169.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -169.16 14.48 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.749 1.22 . . . . 0.0 114.16 -169.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -65.92 150.52 48.48 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 121.571 -0.706 . . . . 0.0 110.329 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -124.87 113.93 18.52 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 104.18 -2.526 . . . . 0.0 104.18 169.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.1 tp -124.66 145.28 49.74 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.237 1.015 . . . . 0.0 111.243 -168.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 33.2 mm -131.29 142.28 43.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 128.536 2.734 . . . . 0.0 103.741 169.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 123' ' ' MET . 2.1 pt? -156.62 133.05 10.0 Favored 'General case' 0 C--O 1.224 -0.265 0 C-N-CA 124.543 1.137 . . . . 0.0 111.133 175.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -97.02 103.92 15.89 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 102.815 -3.032 . . . . 0.0 102.815 168.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.9 p -128.51 154.34 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 124.344 1.058 . . . . 0.0 111.309 -167.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -68.66 96.05 0.7 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.779 2.032 . . . . 0.0 108.404 169.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.0 pp -75.58 0.35 2.27 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.362 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -169.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -68.15 -4.65 14.49 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 121.425 1.92 . . . . 0.0 112.045 178.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.5 mt -62.16 -34.11 62.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 168.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -77.86 127.54 81.69 Favored Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 174.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.1 -51.23 0.28 Allowed 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.031 1.82 . . . . 0.0 113.052 -169.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.6 m -144.84 -12.94 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -169.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -155.12 152.48 29.54 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.133 0.973 . . . . 0.0 108.785 -175.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.3 mt -111.05 -3.18 15.61 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.437 1.095 . . . . 0.0 112.727 -170.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.09 51.1 4.23 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 176.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -144.4 166.61 24.61 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.676 1.59 . . . . 0.0 108.615 -172.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -93.4 165.39 12.79 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.139 0.976 . . . . 0.0 109.573 -177.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -139.74 -179.17 5.77 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 124.256 1.022 . . . . 0.0 108.767 174.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -136.46 142.25 43.59 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -173.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.3 tt -138.98 144.04 38.78 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.374 1.069 . . . . 0.0 108.605 -169.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.1 t -140.79 152.91 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 126.46 1.904 . . . . 0.0 106.937 -177.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.0 pt -128.85 25.15 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.381 1.073 . . . . 0.0 111.433 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.06 149.82 49.67 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.38 0.672 . . . . 0.0 110.922 179.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.4 m -56.84 150.46 16.31 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.766 1.227 . . . . 0.0 111.63 178.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 25.0 m -139.37 156.35 47.05 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 178.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 43.0 tp -64.83 -20.0 66.16 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.535 0.734 . . . . 0.0 112.28 175.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 13.5 m-30 -57.03 150.95 15.95 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.006 1.322 . . . . 0.0 113.221 -173.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -142.0 -178.59 5.77 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 127.766 2.426 . . . . 0.0 106.815 168.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -59.16 -26.22 64.58 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -169.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -100.27 -9.13 48.67 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-O 118.598 -1.112 . . . . 0.0 113.423 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.6 m -69.19 -27.02 65.13 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 120.088 1.944 . . . . 0.0 109.767 170.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 90.0 mt -115.32 57.16 0.74 Allowed 'General case' 0 C--O 1.233 0.197 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 169.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -47.56 119.39 2.7 Favored 'General case' 0 CA--C 1.522 -0.112 0 C-N-CA 124.356 1.063 . . . . 0.0 108.926 178.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -65.93 66.56 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.092 1.757 . . . . 0.0 112.32 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 178.35 -50.34 0.1 OUTLIER Glycine 0 CA--C 1.527 0.807 0 C-N-CA 127.18 2.324 . . . . 0.0 108.501 178.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -71.91 -40.42 68.84 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.414 0.685 . . . . 0.0 110.693 171.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -55.79 120.32 7.16 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.553 1.141 . . . . 0.0 110.519 -177.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -151.97 140.8 13.8 Favored Pre-proline 0 N--CA 1.446 -0.637 0 C-N-CA 126.376 1.87 . . . . 0.0 106.999 169.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -82.29 1.83 8.92 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.19 2.593 . . . . 0.0 113.53 -177.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.0 p -123.0 39.31 3.98 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.211 1.804 . . . . 0.0 110.118 -169.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -82.82 -3.09 56.28 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.659 1.584 . . . . 0.0 113.715 -169.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -133.35 -72.52 0.5 Allowed 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 170.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 57.3 mmm-85 -126.48 -135.34 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.779 1 N-CA-C 99.455 -4.276 . . . . 0.0 99.455 167.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -77.04 62.8 7.55 Favored 'Trans proline' 0 CA--C 1.547 1.129 0 CA-C-N 126.274 3.276 . . . . 0.0 106.604 167.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 79.3 p -49.4 -40.54 36.6 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.667 2.387 . . . . 0.0 113.934 -168.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 52.0 ttm-85 -79.53 -11.67 59.88 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 118.883 -0.579 . . . . 0.0 112.148 -177.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -114.55 171.35 7.68 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 120.15 1.341 . . . . 0.0 110.771 -174.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.1 t70 64.67 -33.33 0.15 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 128.364 2.666 . . . . 0.0 114.996 -175.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . 0.322 2.8 pp0? -73.55 33.29 0.08 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.907 1.683 . . . . 0.0 114.32 179.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.5 p90 44.81 30.63 0.56 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 128.054 2.541 . . . . 0.0 115.074 176.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -159.63 59.61 0.38 Allowed 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.494 -0.754 . . . . 0.0 109.633 -176.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -74.65 72.42 1.96 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 169.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.3 p -85.3 145.87 7.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 124.569 1.148 . . . . 0.0 109.002 -176.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.76 166.99 31.7 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.903 1.681 . . . . 0.0 109.74 -169.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -137.99 142.32 40.45 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.959 1.304 . . . . 0.0 108.911 -177.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -152.73 -157.27 7.93 Favored Glycine 0 C--N 1.336 0.582 0 CA-C-N 118.672 0.669 . . . . 0.0 113.225 -175.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -134.49 130.01 36.02 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 172.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 44.4 t -95.7 150.49 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -132.81 162.34 31.77 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 127.184 2.194 . . . . 0.0 106.883 174.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.93 169.66 19.34 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.12 -0.987 . . . . 0.0 110.67 177.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.64 171.31 18.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 125.121 1.368 . . . . 0.0 107.313 168.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -65.78 -6.99 13.52 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.0 1.72 . . . . 0.0 115.022 -170.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 48.26 40.26 21.86 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.975 1.274 . . . . 0.0 112.868 -175.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -140.65 72.12 1.38 Allowed 'General case' 0 C--O 1.232 0.146 0 C-N-CA 124.877 1.271 . . . . 0.0 107.67 -177.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -139.93 81.16 1.81 Allowed 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 -171.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.84 153.54 24.34 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.722 169.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.6 m 97.74 -5.82 0.05 Allowed 'General case' 0 C--O 1.233 0.216 0 C-N-CA 128.255 2.622 . . . . 0.0 109.068 169.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.3 p -135.0 24.96 3.6 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.079 0.952 . . . . 0.0 110.203 168.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 47.37 43.45 15.32 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.277 1.831 . . . . 0.0 111.587 -179.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -118.3 35.28 4.81 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -100.99 -0.47 36.49 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -169.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.7 p -136.66 165.75 25.16 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 128.823 2.849 . . . . 0.0 108.768 -177.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? 61.75 163.0 0.08 Allowed 'General case' 0 C--N 1.345 0.378 0 C-N-CA 126.593 1.957 . . . . 0.0 110.885 -169.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 52.9 tp -101.04 135.91 41.74 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 103.448 -2.797 . . . . 0.0 103.448 168.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 16.1 m -128.18 134.17 49.01 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -171.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -137.67 162.36 34.05 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.65 1.58 . . . . 0.0 109.405 -169.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -130.3 156.6 44.39 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 172.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.6 t -138.5 139.78 40.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.7 m -125.71 121.42 33.4 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 105.069 -2.196 . . . . 0.0 105.069 174.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -142.38 103.61 4.29 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.333 0.653 . . . . 0.0 109.848 -169.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 59.59 26.5 62.38 Favored Glycine 0 CA--C 1.534 1.269 0 O-C-N 121.68 -0.638 . . . . 0.0 113.628 178.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 93.23 -12.93 68.8 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.409 1.004 . . . . 0.0 113.128 -177.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 84.3 mt -80.91 162.78 23.77 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 118.553 1.176 . . . . 0.0 107.885 169.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 10.7 tp -140.16 153.94 46.8 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 121.808 -0.558 . . . . 0.0 110.3 -170.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.441 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 29.4 mtm -144.88 156.56 44.07 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.098 1.359 . . . . 0.0 108.494 169.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -136.71 133.44 36.12 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 104.126 -2.546 . . . . 0.0 104.126 169.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 32.5 tp -148.37 145.59 28.14 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.194 0.598 . . . . 0.0 110.374 -168.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -136.01 153.49 51.35 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 167.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -170.25 172.86 44.14 Favored Glycine 0 CA--C 1.521 0.424 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 172.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -55.22 139.61 41.63 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.007 1.404 . . . . 0.0 108.869 173.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -41.06 -54.93 2.71 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -63.4 -37.71 88.34 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 122.564 1.173 . . . . 0.0 111.716 -176.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -69.22 -20.24 63.96 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 113.337 -1.756 . . . . 0.0 111.798 178.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 24.6 tp -69.67 -22.79 63.41 Favored 'General case' 0 C--N 1.346 0.439 0 CA-C-N 120.158 1.344 . . . . 0.0 110.092 174.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 45.71 34.22 1.72 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.675 1.99 . . . . 0.0 114.13 171.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -159.21 57.07 0.33 Allowed Glycine 0 C--N 1.335 0.496 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 -171.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -65.65 -10.0 32.28 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -169.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -107.27 145.51 32.63 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 125.153 1.381 . . . . 0.0 109.93 179.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 7.7 m -60.69 -7.94 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.233 168.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -124.16 14.8 9.1 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 127.58 2.352 . . . . 0.0 112.035 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 70.2 m -81.6 -71.08 0.49 Allowed 'General case' 0 CA--C 1.529 0.151 0 O-C-N 121.589 -0.695 . . . . 0.0 109.491 168.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.299 13.1 ptm180 -85.27 18.26 2.71 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -169.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 18.7 m -62.12 -35.26 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 167.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -79.69 122.8 27.01 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 174.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 56.3 tp -142.82 140.7 31.41 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -169.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.8 tt -145.53 137.43 25.4 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -178.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 58.6 mtt -131.01 157.44 42.98 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.989 0.916 . . . . 0.0 109.457 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 39.8 pttt -164.7 169.95 16.22 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.146 1.378 . . . . 0.0 109.26 178.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.89 162.47 11.1 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.224 0.61 . . . . 0.0 111.363 172.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.44 164.71 2.43 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.57 1.148 . . . . 0.0 113.699 -177.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.72 60.3 5.21 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.063 1.345 . . . . 0.0 111.174 178.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 22.0 t80 . . . . . 0 C--O 1.25 1.105 0 C-N-CA 124.356 1.062 . . . . 0.0 108.371 176.107 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.4 mtp . . . . . 0 N--CA 1.483 1.191 0 CA-C-O 119.281 -0.39 . . . . 0.0 110.304 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 45.92 49.18 12.01 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 124.316 1.046 . . . . 0.0 113.73 173.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -169.37 -170.67 34.19 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 107.838 -2.105 . . . . 0.0 107.838 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.1 pp -69.94 168.85 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-O 121.636 0.731 . . . . 0.0 110.985 177.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 65.7 tp -153.31 -44.06 0.09 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.509 1.524 . . . . 0.0 108.336 174.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -143.3 144.52 32.15 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 169.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -147.46 140.57 25.12 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 -171.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -147.78 144.25 28.09 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 124.262 1.025 . . . . 0.0 109.42 -178.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.77 141.13 25.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -138.08 158.84 43.51 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 122.786 0.435 . . . . 0.0 110.651 174.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -135.08 148.26 49.79 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.802 1.241 . . . . 0.0 109.386 -172.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.1 t -59.86 141.4 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 125.54 1.536 . . . . 0.0 109.847 -178.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -123.35 -29.75 3.78 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 126.377 1.871 . . . . 0.0 108.912 169.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -158.99 169.79 23.52 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.886 0.874 . . . . 0.0 109.669 169.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.6 mp -131.67 141.21 46.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -140.26 76.07 27.05 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 124.319 1.048 . . . . 0.0 108.286 -178.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -81.59 10.27 3.54 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.015 2.477 . . . . 0.0 113.92 -169.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -79.45 54.99 1.84 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.682 1.593 . . . . 0.0 110.199 176.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -150.19 38.4 0.9 Allowed Glycine 0 CA--C 1.528 0.851 0 C-N-CA 126.14 1.829 . . . . 0.0 110.002 -175.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.471 ' HE2' ' HA ' ' A' ' 20' ' ' LYS . 5.3 mmpt? -68.89 65.09 0.13 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.41 1.884 . . . . 0.0 114.083 -169.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -60.43 -38.74 85.04 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 168.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -144.05 162.79 35.33 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 129.161 2.984 . . . . 0.0 104.268 169.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -60.29 -33.68 72.7 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.328 -0.857 . . . . 0.0 111.764 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -75.77 -6.9 52.85 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 117.096 -1.431 . . . . 0.0 114.133 178.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 72.9 t -101.41 123.85 54.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 120.886 1.676 . . . . 0.0 107.162 -174.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.3 m -147.19 152.56 38.59 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.911 0.884 . . . . 0.0 109.561 -176.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 64.9 mtm-85 -83.36 150.61 25.99 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 169.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -129.69 155.16 46.33 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 127.092 2.157 . . . . 0.0 105.8 175.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -127.69 128.62 45.74 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 103.485 -2.783 . . . . 0.0 103.485 170.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 71.3 m -142.61 169.09 18.23 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.396 1.078 . . . . 0.0 111.481 -169.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -135.49 134.86 39.96 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.716 1.606 . . . . 0.0 106.957 176.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.0 m -75.05 142.38 43.75 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 121.392 0.615 . . . . 0.0 110.767 176.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -93.97 -34.93 12.87 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.634 1.174 . . . . 0.0 110.694 -175.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -69.89 -41.98 74.01 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.607 0.763 . . . . 0.0 112.949 -169.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -136.49 -95.22 0.23 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.596 0.758 . . . . 0.0 109.17 -175.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -165.91 110.96 0.85 Allowed 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.06 1.344 . . . . 0.0 108.379 -175.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.8 mtt -158.58 142.01 15.04 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 174.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -112.89 129.31 56.51 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 104.802 -2.296 . . . . 0.0 104.802 169.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.3 tp -136.63 139.46 42.09 Favored 'General case' 0 C--O 1.227 -0.112 0 C-N-CA 123.52 0.728 . . . . 0.0 111.987 -168.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 35.3 mm -121.72 140.96 44.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 102.261 -3.237 . . . . 0.0 102.261 168.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 123' ' ' MET . 2.3 pt? -154.66 158.25 39.37 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 123.704 0.802 . . . . 0.0 110.586 177.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -127.09 111.53 14.13 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.411 HG11 HD12 ' A' ' 41' ' ' LEU . 28.6 m -145.6 166.89 9.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 O-C-N 124.224 0.953 . . . . 0.0 113.195 -168.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -72.65 126.87 30.92 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.945 1.298 . . . . 0.0 107.659 169.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 pp -105.6 -1.05 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -67.23 -16.92 64.58 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 120.775 1.625 . . . . 0.0 111.644 177.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.3 mt -58.57 -27.44 33.89 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 124.23 1.012 . . . . 0.0 109.187 169.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -122.42 158.68 55.4 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 125.093 1.357 . . . . 0.0 113.49 -168.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -75.01 75.13 3.8 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 124.012 3.142 . . . . 0.0 109.55 171.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.5 p -53.98 -23.81 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 124.972 1.309 . . . . 0.0 113.328 -174.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -59.25 -22.43 61.11 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.438 1.095 . . . . 0.0 113.024 174.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 59.1 tp -129.79 -30.19 2.07 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.192 1.397 . . . . 0.0 111.713 -177.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.82 164.95 36.37 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 -169.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -159.2 166.2 31.94 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.71 1.204 . . . . 0.0 108.525 -178.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -74.63 163.97 27.11 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 172.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -128.25 164.92 21.51 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.754 1.622 . . . . 0.0 107.159 177.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.8 ttm180 -127.1 141.14 51.84 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 125.914 1.686 . . . . 0.0 106.581 170.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 39.9 tp -123.72 141.44 52.02 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 127.057 2.143 . . . . 0.0 106.653 178.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.1 t -134.83 142.06 41.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 172.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.7 pt -128.96 19.51 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.329 1.052 . . . . 0.0 110.759 -173.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.4 159.12 27.63 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.24 1.016 . . . . 0.0 110.57 175.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.8 p -58.69 -21.76 55.43 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.333 1.453 . . . . 0.0 112.953 172.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.404 HG23 ' H ' ' A' ' 65' ' ' TYR . 2.7 t 50.58 -169.05 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.75 2.42 . . . . 0.0 114.422 169.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.2 mp -54.87 -26.3 34.61 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.752 1.621 . . . . 0.0 111.272 -177.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.404 ' H ' HG23 ' A' ' 63' ' ' THR . 12.8 m-30 -61.48 -28.03 69.0 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.591 1.156 . . . . 0.0 112.313 -179.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -73.99 -16.2 61.08 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.187 0.903 . . . . 0.0 112.002 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -123.29 -17.59 6.54 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.284 1.433 . . . . 0.0 112.116 -169.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.08 35.1 82.98 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 -175.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.2 m -57.81 -22.64 48.5 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.923 1.289 . . . . 0.0 113.542 -169.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.3 pp -131.33 -29.96 1.75 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.569 0.748 . . . . 0.0 111.446 169.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -66.04 -22.99 66.46 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.354 0.662 . . . . 0.0 112.399 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -136.69 35.36 2.66 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.282 1.833 . . . . 0.0 108.167 172.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -140.88 34.67 1.92 Allowed Glycine 0 CA--C 1.527 0.82 0 C-N-CA 125.376 1.465 . . . . 0.0 111.11 -170.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 51.18 55.03 10.12 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.026 1.731 . . . . 0.0 112.653 174.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -56.72 145.11 30.04 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 168.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -137.62 123.46 12.92 Favored Pre-proline 0 CA--C 1.532 0.262 0 CA-C-O 118.541 -0.743 . . . . 0.0 109.693 -170.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -52.04 148.27 24.26 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.12 2.547 . . . . 0.0 111.917 173.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.4 m 66.83 4.71 3.6 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.234 1.413 . . . . 0.0 112.514 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -66.39 -33.11 74.99 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 119.989 -1.695 . . . . 0.0 110.0 169.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -89.5 21.64 3.31 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.534 1.534 . . . . 0.0 111.755 178.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 25.8 ptt-85 -45.72 129.56 6.71 Favored Pre-proline 0 N--CA 1.467 0.378 0 C-N-CA 124.552 1.141 . . . . 0.0 110.862 -178.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo 22.65 49.01 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.757 1 C-N-CA 127.181 5.254 . . . . 0.0 117.102 -169.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.1 m -124.11 -3.31 8.06 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.638 1.175 . . . . 0.0 112.513 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 15.4 ttp180 41.59 41.58 1.72 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.744 2.018 . . . . 0.0 113.679 174.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 46.99 32.07 1.75 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.162 1.785 . . . . 0.0 113.838 -176.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -47.63 -30.88 4.03 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.644 1.578 . . . . 0.0 112.979 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.437 ' CD ' ' H ' ' A' ' 87' ' ' GLN . 0.7 OUTLIER -47.48 -61.38 1.95 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.749 2.019 . . . . 0.0 110.954 171.033 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -148.57 88.15 1.61 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 -178.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -61.08 -31.26 70.93 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 114.09 1.145 . . . . 0.0 114.09 -168.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -144.01 142.23 30.58 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 118.799 0.727 . . . . 0.0 109.154 172.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.2 m -143.06 139.15 27.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 C-N-CA 126.143 1.777 . . . . 0.0 106.707 177.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 37.5 tpp -161.02 166.04 28.84 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.325 1.05 . . . . 0.0 109.078 -177.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -124.54 145.31 49.65 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 170.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -153.15 -170.16 19.08 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-N 118.768 0.713 . . . . 0.0 111.766 -172.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -117.84 134.79 54.58 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.0 t -112.21 134.79 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 175.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -151.23 148.21 27.94 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.739 1.216 . . . . 0.0 108.233 -174.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.15 175.46 1.52 Allowed 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.427 1.491 . . . . 0.0 109.476 170.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 33.8 pt -70.06 -175.44 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 123.861 0.864 . . . . 0.0 110.304 169.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -63.81 -6.38 5.7 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.5 1.92 . . . . 0.0 115.687 -171.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.3 -15.97 62.06 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-O 118.851 -0.972 . . . . 0.0 112.812 178.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -80.0 75.42 6.74 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 169.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -116.33 75.05 0.93 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.107 1.363 . . . . 0.0 107.768 -168.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.7 t -151.14 -148.24 0.26 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.4 1.08 . . . . 0.0 108.938 -179.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.8 m -142.11 -7.03 0.93 Allowed 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 127.628 2.371 . . . . 0.0 108.9 -176.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 35.7 p -91.65 -0.53 57.58 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 123.697 0.799 . . . . 0.0 110.424 171.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 52.9 30.92 9.91 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.602 1.561 . . . . 0.0 109.621 -168.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -150.07 57.1 0.96 Allowed 'General case' 0 C--N 1.348 0.542 0 O-C-N 122.012 -0.43 . . . . 0.0 110.919 -175.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.66 164.8 13.68 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.854 -0.529 . . . . 0.0 110.679 178.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.6 p -128.17 1.08 5.82 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -178.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.4 mpt_? -132.72 128.69 37.46 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 126.077 1.751 . . . . 0.0 106.497 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.5 tp -73.91 139.0 44.65 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 174.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 7.8 p -90.75 154.95 19.16 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 122.045 -0.409 . . . . 0.0 110.34 176.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -147.77 137.78 22.8 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.132 0.973 . . . . 0.0 108.641 170.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 10.6 m-30 -114.96 146.53 41.09 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 103.45 -2.796 . . . . 0.0 103.45 168.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.2 t -135.33 143.56 36.6 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -173.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.3 t -134.85 123.94 24.29 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 105.496 -2.038 . . . . 0.0 105.496 169.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -146.98 107.94 4.19 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.408 0.683 . . . . 0.0 109.359 -169.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 57.17 24.15 50.03 Favored Glycine 0 CA--C 1.536 1.389 0 O-C-N 121.595 -0.691 . . . . 0.0 113.855 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 93.96 -11.33 71.03 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 124.629 1.109 . . . . 0.0 113.435 -178.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.5 mp -82.34 160.67 22.79 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 170.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 7.0 tp -139.5 159.71 41.53 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.817 -0.552 . . . . 0.0 111.036 -169.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.442 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 26.1 mtt -149.25 156.38 42.03 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 125.295 1.438 . . . . 0.0 109.092 169.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 39.0 mtm105 -143.47 126.31 16.17 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 105.019 -2.215 . . . . 0.0 105.019 169.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -155.81 166.4 33.61 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 119.667 1.122 . . . . 0.0 112.902 -169.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -134.82 141.33 46.37 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 168.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -156.53 168.85 33.82 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.32 132.19 33.91 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 170.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -45.82 -43.33 13.24 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 175.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.6 -22.86 65.34 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 120.989 -1.069 . . . . 0.0 113.601 177.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -75.65 -19.61 59.05 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 125.527 1.531 . . . . 0.0 110.808 172.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -85.84 3.6 40.9 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 119.467 1.03 . . . . 0.0 109.365 168.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 1.5 t60 38.33 30.04 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.513 1 C-N-CA 131.789 4.036 . . . . 0.0 118.107 169.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 163.27 28.69 0.02 OUTLIER Glycine 0 CA--C 1.525 0.698 0 CA-C-O 119.243 -0.754 . . . . 0.0 111.947 178.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 45.79 40.05 5.99 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.82 1.648 . . . . 0.0 111.95 -169.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . 0.369 2.7 pp20? 43.57 -148.53 0.05 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.932 2.093 . . . . 0.0 114.623 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.7 t 67.9 -34.49 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 127.6 2.36 . . . . 0.0 111.879 -168.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -154.37 18.05 0.48 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.416 1.087 . . . . 0.0 112.433 -170.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 48.8 m -87.04 -77.02 0.34 Allowed 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 169.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.277 9.8 ptm180 -79.35 14.53 1.51 Allowed 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.482 1.113 . . . . 0.0 113.186 -172.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 20.8 m -63.72 -38.67 82.91 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 167.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -82.67 129.22 34.92 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 169.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 7.4 tt -142.12 127.25 18.52 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 118.637 0.653 . . . . 0.0 109.306 -174.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 7.3 tt -132.94 134.06 44.03 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 178.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 60.2 ttm -137.78 140.07 40.39 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -176.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -158.94 -176.28 5.77 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.152 0.981 . . . . 0.0 109.786 178.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -52.93 158.63 1.35 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.992 1.317 . . . . 0.0 112.283 169.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.34 169.68 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.69 2.396 . . . . 0.0 114.205 174.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -125.85 0.43 7.35 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 179.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 14.2 p90 . . . . . 0 C--O 1.249 1.033 0 C-N-CA 127.955 2.502 . . . . 0.0 106.826 -179.482 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 mmt . . . . . 0 N--CA 1.484 1.275 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.51 7.86 2.83 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.388 1.075 . . . . 0.0 112.389 -178.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 170.49 177.41 40.57 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 55.9 mt -138.85 140.07 39.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 174.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tt -73.59 93.83 2.08 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -178.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -151.69 148.12 27.54 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.101 1.36 . . . . 0.0 108.184 171.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -148.64 143.15 26.33 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 126.431 1.892 . . . . 0.0 107.529 -173.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -151.81 124.9 8.66 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.224 1.009 . . . . 0.0 108.785 172.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.6 mp -79.44 142.14 14.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 104.385 -2.45 . . . . 0.0 104.385 169.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -130.44 158.4 39.99 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.391 0.615 . . . . 0.0 109.807 171.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -119.1 132.98 56.05 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.477 1.511 . . . . 0.0 107.194 178.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.4 p -69.99 135.04 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.9 mmmm -113.06 -25.17 9.07 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.303 1.441 . . . . 0.0 109.977 -177.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -156.07 163.34 39.79 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.098 0.863 . . . . 0.0 110.672 169.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.9 mp -139.09 137.27 42.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 127.264 2.225 . . . . 0.0 105.414 179.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -142.89 97.24 5.87 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 124.589 1.156 . . . . 0.0 108.985 -173.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -61.02 1.28 0.62 Allowed 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 124.326 3.351 . . . . 0.0 117.541 -175.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -77.28 46.73 0.52 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.726 2.01 . . . . 0.0 110.973 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -153.74 35.72 0.74 Allowed Glycine 0 CA--C 1.528 0.859 0 C-N-CA 126.995 2.236 . . . . 0.0 108.928 178.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.68 55.41 0.26 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.567 1.947 . . . . 0.0 113.648 -169.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -54.44 -39.76 67.71 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 121.35 -0.843 . . . . 0.0 109.647 170.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -142.64 163.97 31.37 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 128.037 2.535 . . . . 0.0 104.569 169.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -57.48 -34.63 69.23 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.55 -0.719 . . . . 0.0 111.485 176.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 -79.03 4.23 15.03 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-O 117.101 -1.428 . . . . 0.0 114.535 178.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 81.3 t -118.04 132.17 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 121.736 2.062 . . . . 0.0 107.519 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 65.1 m -145.79 159.84 42.61 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.637 0.775 . . . . 0.0 109.709 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -76.69 148.91 36.52 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 169.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -142.56 153.99 44.05 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.712 1.605 . . . . 0.0 107.521 -169.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -134.3 136.58 43.61 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 171.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 67.7 m -145.35 165.38 28.63 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.277 1.031 . . . . 0.0 110.945 -171.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -139.54 136.01 34.03 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.273 1.429 . . . . 0.0 108.496 178.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.2 m -60.67 139.87 57.69 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.842 0.857 . . . . 0.0 112.185 173.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -94.41 -44.44 7.9 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 168.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.0 m -73.13 -38.16 66.39 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 118.643 -0.694 . . . . 0.0 112.029 -172.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -121.14 -106.84 0.37 Allowed 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -166.3 8.96 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 -169.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.8 mpp? -69.04 148.55 49.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.75 0.786 . . . . 0.0 109.145 -174.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -103.93 138.69 40.13 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 169.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.8 mt -135.86 144.71 45.75 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.287 0.635 . . . . 0.0 110.17 -169.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.8 mm -130.19 143.19 41.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 103.157 -2.905 . . . . 0.0 103.157 169.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 123' ' ' MET . 4.8 mp -144.61 159.84 42.15 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.622 1.569 . . . . 0.0 108.166 -177.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -136.04 95.1 3.14 Favored 'General case' 0 C--N 1.32 -0.693 1 N-CA-C 99.758 -4.164 . . . . 0.0 99.758 169.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.1 p -147.11 167.45 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 121.285 0.564 . . . . 0.0 112.392 -167.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -58.27 140.31 53.49 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.883 1.273 . . . . 0.0 109.31 169.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 pp -119.55 -1.38 8.56 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.669 0 CA-C-O 116.972 -1.49 . . . . 0.0 113.263 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -63.64 -15.57 58.65 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 121.773 2.079 . . . . 0.0 114.212 -169.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.665 ' H ' HD12 ' A' ' 47' ' ' ILE . 0.6 OUTLIER -65.69 -28.39 44.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 127.388 2.275 . . . . 0.0 111.093 173.803 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -52.57 155.17 3.99 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 124.534 1.134 . . . . 0.0 111.979 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -73.87 50.57 2.15 Favored 'Trans proline' 0 CA--C 1.547 1.162 0 C-N-CA 124.698 3.599 . . . . 0.0 112.959 175.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . 0.27 20.3 m 52.65 -9.94 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 131.13 3.772 . . . . 0.0 119.229 169.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -143.2 -12.5 0.72 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 120.358 1.435 . . . . 0.0 112.625 -173.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -156.36 169.16 25.23 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 126.239 1.815 . . . . 0.0 108.259 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.16 175.22 54.71 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 176.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -152.18 171.08 18.48 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.732 1.213 . . . . 0.0 109.142 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -79.17 155.39 28.68 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.51 1.124 . . . . 0.0 109.698 175.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -129.74 162.25 28.83 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.975 1.31 . . . . 0.0 108.808 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 42.0 ttt180 -115.07 134.14 55.43 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 173.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 57.7 tp -127.78 132.86 49.47 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 177.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.6 m -137.99 163.99 28.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 124.551 1.14 . . . . 0.0 108.093 177.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.0 pt -127.41 13.07 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 123.514 0.726 . . . . 0.0 110.53 177.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.24 -8.76 57.19 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.548 1.139 . . . . 0.0 113.574 -175.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.9 m -148.52 168.25 23.23 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.653 1.181 . . . . 0.0 109.453 -175.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.5 t -152.86 173.35 15.44 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.902 1.281 . . . . 0.0 107.937 172.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -79.55 164.42 23.89 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 174.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -132.19 175.21 9.45 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -178.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -74.39 161.08 30.19 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 169.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -62.4 -38.24 88.88 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 121.557 -0.714 . . . . 0.0 110.428 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.42 -28.29 69.24 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 123.918 0.77 . . . . 0.0 112.929 178.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.1 m -65.4 -23.93 67.08 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.512 1.156 . . . . 0.0 111.532 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 92.9 mt -119.06 -28.11 5.57 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.444 0.697 . . . . 0.0 111.602 -176.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -61.62 -15.54 40.39 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.262 0.937 . . . . 0.0 112.161 174.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -61.22 -14.49 26.06 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.8 1.64 . . . . 0.0 114.614 175.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -177.3 0.68 0.03 OUTLIER Glycine 0 CA--C 1.53 0.99 0 N-CA-C 117.028 1.571 . . . . 0.0 117.028 175.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 48.46 58.8 4.83 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 119.535 1.667 . . . . 0.0 109.737 -169.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -52.91 133.72 37.74 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 176.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -141.68 113.01 6.49 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-O 118.657 -0.687 . . . . 0.0 109.747 -177.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo -60.93 -4.92 4.07 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.846 3.03 . . . . 0.0 116.096 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . 0.25 95.1 m 68.13 -33.94 0.24 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 127.913 2.485 . . . . 0.0 114.313 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -67.37 -23.05 65.55 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.549 1.068 . . . . 0.0 110.463 169.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -59.08 -43.14 91.76 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.949 1.7 . . . . 0.0 112.589 172.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 88.3 mtm-85 -66.14 -44.04 58.08 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-O 117.003 -1.475 . . . . 0.0 113.696 -169.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -78.99 10.42 2.94 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.354 2.036 . . . . 0.0 113.562 174.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 24.6 m -119.72 -30.89 4.68 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.75 1.22 . . . . 0.0 111.526 -175.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 57.1 -175.0 0.07 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.352 1.861 . . . . 0.0 111.855 177.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.98 -12.26 48.15 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 120.887 -1.133 . . . . 0.0 113.186 -172.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -56.05 -17.59 7.35 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.457 1.503 . . . . 0.0 113.267 175.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -53.99 -25.32 20.34 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.487 1.115 . . . . 0.0 112.545 169.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -141.25 177.84 7.82 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.44 1.496 . . . . 0.0 109.588 -169.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -146.04 -40.85 0.21 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.175 0.59 . . . . 0.0 109.421 169.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -143.94 144.73 31.83 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 123.909 0.884 . . . . 0.0 108.698 175.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.1 p -142.58 142.29 26.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 5.2 tmm? -158.89 160.75 36.48 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.455 0.645 . . . . 0.0 111.28 -168.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -129.91 104.92 7.65 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 104.721 -2.326 . . . . 0.0 104.721 173.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -94.93 -173.11 37.62 Favored Glycine 0 C--N 1.332 0.361 0 CA-C-O 121.288 0.382 . . . . 0.0 112.585 -169.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -120.61 100.56 7.2 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 169.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.411 HG13 ' HA ' ' A' ' 137' ' ' VAL . 0.1 OUTLIER -70.42 142.13 16.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 170.588 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -136.37 127.22 27.48 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 103.075 -2.935 . . . . 0.0 103.075 169.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -146.29 169.18 19.33 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 120.028 1.285 . . . . 0.0 112.881 -169.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.1 pt -134.63 165.77 30.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 C-N-CA 126.533 1.933 . . . . 0.0 108.325 -169.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -66.53 -3.96 7.46 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.964 1.706 . . . . 0.0 112.77 175.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 144.11 173.33 15.45 Favored Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 104.855 -3.298 . . . . 0.0 104.855 -169.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -56.2 -23.18 33.72 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 118.129 0.965 . . . . 0.0 112.305 178.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -173.35 -126.95 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.791 1 C-N-CA 132.036 4.135 . . . . 0.0 101.809 169.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.444 HG22 ' N ' ' A' ' 108' ' ' ALA . 21.4 p -135.76 167.0 21.96 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 125.789 1.636 . . . . 0.0 113.402 -174.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 75.6 m -132.06 -38.08 1.11 Allowed 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 129.249 3.02 . . . . 0.0 105.788 177.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 17.3 p -132.58 -60.44 0.88 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.618 1.167 . . . . 0.0 109.054 169.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -154.28 23.42 0.48 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.966 1.707 . . . . 0.0 110.223 -178.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.444 ' N ' HG22 ' A' ' 104' ' ' THR . . . 177.89 148.75 0.17 Allowed 'General case' 0 C--O 1.242 0.66 0 C-N-CA 130.742 3.617 . . . . 0.0 102.373 -169.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -77.56 166.1 23.47 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.841 1.201 . . . . 0.0 108.514 170.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.78 -3.73 13.43 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -178.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -138.27 140.14 39.49 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 103.948 -2.612 . . . . 0.0 103.948 169.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 22.3 tp -75.96 157.77 32.74 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 169.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 2.2 m -139.96 146.09 38.7 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -177.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -147.84 160.17 43.05 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.019 0.928 . . . . 0.0 109.157 178.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -124.76 149.78 46.97 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 173.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.9 t -141.24 116.07 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 17.2 m -86.34 124.56 32.84 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 105.469 -2.048 . . . . 0.0 105.469 169.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.4 m-30 -86.89 163.43 17.17 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 169.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -56.96 67.02 0.01 OUTLIER Glycine 0 CA--C 1.539 1.538 0 C-N-CA 126.521 2.01 . . . . 0.0 114.512 170.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 119.24 -7.24 12.72 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 127.137 2.303 . . . . 0.0 113.407 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -139.24 -179.81 6.09 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 119.885 1.842 . . . . 0.0 108.369 -169.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.7 tt -154.77 160.46 41.32 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 121.346 1.885 . . . . 0.0 112.3 -177.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.419 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 26.0 ptt? -149.74 161.52 42.06 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.7 1.6 . . . . 0.0 109.426 169.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 92.0 mtt-85 -137.54 139.91 40.75 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 174.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 8.0 tt -143.89 147.93 34.71 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 123.13 0.572 . . . . 0.0 110.441 -169.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -129.07 151.47 49.72 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 168.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -173.55 173.07 45.65 Favored Glycine 0 C--N 1.329 0.146 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 170.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.93 139.98 38.75 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 169.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -39.94 -60.43 1.02 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -178.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -60.45 -37.52 81.22 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.874 0.845 . . . . 0.0 112.46 -178.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -66.9 -23.38 65.99 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 125.307 1.443 . . . . 0.0 111.249 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.7 tt -69.58 -26.78 64.63 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.481 1.037 . . . . 0.0 110.195 177.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 43.39 40.05 2.46 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 127.798 2.439 . . . . 0.0 113.472 175.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -165.62 42.71 0.28 Allowed Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 -169.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -76.17 9.41 2.55 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.546 1.138 . . . . 0.0 112.273 -173.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -130.15 135.95 48.75 Favored 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 125.212 1.405 . . . . 0.0 108.643 -172.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.411 ' HA ' HG13 ' A' ' 96' ' ' VAL . 15.6 m -57.1 -5.07 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 126.626 1.97 . . . . 0.0 112.31 169.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -134.38 16.83 3.7 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 173.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.7 m -102.78 -51.97 3.18 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 167.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 5.2 tpm_? -75.71 0.45 17.73 Favored 'General case' 0 C--N 1.342 0.271 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -172.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 35.7 m -62.55 -41.57 92.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 124.18 0.992 . . . . 0.0 110.83 169.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -71.28 130.95 42.69 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -170.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 7.7 tt -150.67 134.09 16.34 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 117.939 0.336 . . . . 0.0 110.292 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.8 tt -144.56 135.35 24.85 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 106.492 -1.669 . . . . 0.0 106.492 169.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 14.6 ptp -142.38 159.08 42.94 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 118.501 0.592 . . . . 0.0 111.663 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -157.01 -173.77 4.61 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 126.084 1.754 . . . . 0.0 108.756 171.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -60.95 169.69 1.85 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.889 0.768 . . . . 0.0 109.669 169.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -44.2 155.63 0.09 Allowed 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 179.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.86 63.5 7.0 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.776 1.23 . . . . 0.0 110.054 177.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 19.8 t80 . . . . . 0 C--O 1.249 1.042 0 C-N-CA 123.944 0.897 . . . . 0.0 108.81 178.495 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.29 144.92 49.35 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.505 0.722 . . . . 0.0 110.654 177.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 170.74 174.55 38.76 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 20.4 tt -154.41 154.34 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 169.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 22.1 tp -81.71 48.18 1.17 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.149 0.98 . . . . 0.0 109.909 174.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -150.69 125.61 9.82 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.416 1.086 . . . . 0.0 109.095 -177.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -155.87 140.59 17.05 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 178.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -148.41 148.59 30.5 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.13 0.877 . . . . 0.0 110.368 169.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 mp -77.54 154.46 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 173.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -145.76 160.45 41.72 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.971 0.909 . . . . 0.0 110.241 171.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -135.13 129.58 34.11 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.194 1.798 . . . . 0.0 108.194 -169.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.8 p -68.36 123.51 21.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 121.825 0.822 . . . . 0.0 109.058 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -82.14 -42.06 19.6 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 124.537 1.135 . . . . 0.0 109.294 170.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -159.76 167.98 26.98 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 118.831 0.742 . . . . 0.0 111.638 -175.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.3 mp -138.82 138.27 42.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 127.769 2.428 . . . . 0.0 105.55 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -146.0 97.76 4.48 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 118.787 0.721 . . . . 0.0 110.966 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -58.07 59.82 0.05 OUTLIER 'Trans proline' 0 CA--C 1.548 1.214 1 C-N-CA 126.921 5.081 . . . . 0.0 116.595 174.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -123.91 43.67 2.92 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.688 1.595 . . . . 0.0 109.789 178.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -168.1 44.45 0.24 Allowed Glycine 0 C--N 1.336 0.554 0 C-N-CA 124.182 0.896 . . . . 0.0 110.994 -175.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.9 mmmm -76.0 68.07 2.43 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.13 0.965 . . . . 0.0 111.149 -169.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.21 -36.61 68.63 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 169.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -139.68 167.44 22.09 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 128.651 2.78 . . . . 0.0 104.551 169.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -68.72 -25.34 64.71 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.079 -1.013 . . . . 0.0 111.351 -173.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -82.0 -6.35 59.07 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-O 116.536 -1.697 . . . . 0.0 113.553 175.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 70.0 t -101.35 128.75 53.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 121.664 2.029 . . . . 0.0 107.728 -175.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.2 m -148.19 167.97 23.7 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.787 1.235 . . . . 0.0 109.304 -177.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.0 tpp85 -70.58 153.98 42.33 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 170.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.8 mt -138.19 156.13 48.01 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.296 1.838 . . . . 0.0 106.904 170.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -133.39 133.68 42.72 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 170.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 65.0 m -143.0 163.65 32.2 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.719 1.208 . . . . 0.0 110.352 -171.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -134.7 137.73 43.79 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.861 1.664 . . . . 0.0 107.051 177.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.8 m -93.65 142.62 27.15 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.058 0.456 . . . . 0.0 110.169 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -69.75 -54.93 11.42 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.788 1.635 . . . . 0.0 113.122 -168.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.6 m -89.35 -35.47 16.07 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 123.114 0.566 . . . . 0.0 111.747 -169.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -108.03 6.56 27.16 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -169.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.287 0.0 OUTLIER 45.99 28.58 0.64 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.179 1.792 . . . . 0.0 114.467 178.678 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 78.8 mtm -61.52 152.48 30.11 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 169.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -123.73 124.12 42.01 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.6 tt -130.67 150.63 51.77 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.864 0.84 . . . . 0.0 111.818 -168.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 16.8 mm -129.15 147.46 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 128.75 2.82 . . . . 0.0 103.729 169.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.406 HD22 ' CG1' ' A' ' 43' ' ' VAL . 0.5 OUTLIER -147.5 155.42 41.87 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 127.626 2.37 . . . . 0.0 105.89 -171.08 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -142.49 103.01 4.18 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 104.701 -2.333 . . . . 0.0 104.701 170.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.472 HG22 ' H ' ' A' ' 44' ' ' ASN . 9.9 p -163.43 179.59 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 124.044 0.938 . . . . 0.0 109.765 -169.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.472 ' H ' HG22 ' A' ' 43' ' ' VAL . 29.6 t30 -52.53 130.49 31.99 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.84 1.656 . . . . 0.0 111.646 172.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.6 pp -110.33 -1.98 10.07 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 C-N-CA 124.946 1.299 . . . . 0.0 113.134 177.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -70.24 -9.54 56.22 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 120.028 1.285 . . . . 0.0 111.395 177.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.2 mt -61.65 -36.53 74.05 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 168.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -91.05 156.14 44.32 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 125.36 1.464 . . . . 0.0 110.526 -177.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.28 169.63 17.87 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.567 2.178 . . . . 0.0 109.921 169.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.0 m -63.71 -23.9 34.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 -169.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -153.23 -35.34 0.11 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.248 0.931 . . . . 0.0 113.497 -175.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 54.6 tp -62.65 -27.69 69.4 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -172.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.98 177.65 36.6 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 -169.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -158.35 175.2 14.02 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.134 0.974 . . . . 0.0 108.768 -178.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -125.39 135.57 52.54 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.003 1.321 . . . . 0.0 107.695 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -131.53 -173.39 3.11 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -129.85 151.48 50.37 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.846 1.258 . . . . 0.0 108.246 177.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 62.1 tp -124.39 138.87 54.32 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 127.005 2.122 . . . . 0.0 107.328 -174.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 41.0 t -144.77 152.64 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 126.626 1.97 . . . . 0.0 106.048 -175.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.5 pt -133.0 55.24 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.477 1.111 . . . . 0.0 108.925 176.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -54.88 122.31 10.53 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 124.752 1.221 . . . . 0.0 110.662 -176.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.9 m -57.78 116.37 3.4 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.915 0.886 . . . . 0.0 108.944 176.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.4 m -143.19 132.0 22.7 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -172.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 41.7 tp -149.94 56.26 0.95 Allowed 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 172.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -64.77 158.52 24.63 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.979 -172.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -136.62 177.91 7.48 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.915 2.086 . . . . 0.0 107.609 175.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -60.06 -37.1 78.85 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.514 0.726 . . . . 0.0 111.237 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -71.5 -20.28 78.28 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-O 119.268 -0.74 . . . . 0.0 113.203 178.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.1 m -70.81 -27.31 63.79 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.901 1.351 . . . . 0.0 111.047 -177.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 pp -148.58 -46.51 0.15 Allowed 'General case' 0 C--N 1.342 0.279 0 CA-C-O 117.654 -1.165 . . . . 0.0 113.714 -174.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -70.45 -30.3 67.09 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 120.592 1.542 . . . . 0.0 111.033 -173.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -118.19 35.7 4.64 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.881 1.673 . . . . 0.0 108.311 169.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -137.47 54.37 0.71 Allowed Glycine 0 CA--C 1.526 0.766 0 C-N-CA 126.755 2.121 . . . . 0.0 108.981 -173.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 63.08 49.67 3.33 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.517 1.527 . . . . 0.0 111.715 178.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -72.57 21.65 0.06 Allowed 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.335 -0.853 . . . . 0.0 112.52 169.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -51.67 -43.06 86.86 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 125.834 1.653 . . . . 0.0 114.213 -177.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -80.07 5.37 6.04 Favored 'Trans proline' 0 C--N 1.352 0.745 0 CA-C-N 122.084 1.78 . . . . 0.0 112.77 178.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.8 m 55.88 22.67 5.85 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.018 1.727 . . . . 0.0 111.346 -169.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.7 t70 8.54 -69.11 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 130.847 3.659 . . . . 0.0 117.66 -169.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -77.92 1.41 20.72 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.45 1.1 . . . . 0.0 112.982 -172.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.17 127.98 2.74 Favored Pre-proline 0 C--N 1.342 0.263 0 C-N-CA 126.039 1.735 . . . . 0.0 111.494 -176.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo 24.66 43.62 0.0 OUTLIER 'Trans proline' 0 CA--C 1.539 0.755 1 C-N-CA 126.742 4.961 . . . . 0.0 116.956 -169.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.7 m -126.24 -31.62 2.79 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.235 1.414 . . . . 0.0 110.012 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? 46.06 53.61 9.01 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.788 1.235 . . . . 0.0 112.727 169.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 58.27 14.16 2.71 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.883 2.073 . . . . 0.0 115.063 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -60.44 -14.37 18.8 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 120.02 1.282 . . . . 0.0 112.075 169.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -53.13 -21.42 4.9 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.373 1.869 . . . . 0.0 112.01 169.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -132.6 158.64 41.7 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.01 2.124 . . . . 0.0 107.419 -174.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -78.11 -33.62 50.5 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.691 -0.631 . . . . 0.0 109.485 174.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -160.19 158.67 30.49 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.492 0.717 . . . . 0.0 109.791 169.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.2 m -139.53 145.07 27.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 C-N-CA 125.25 1.42 . . . . 0.0 107.177 172.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 15.8 ttt -151.83 143.39 23.53 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.915 0.886 . . . . 0.0 109.073 -169.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -135.74 75.67 1.57 Allowed 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 175.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -93.57 -163.94 36.8 Favored Glycine 0 C--N 1.337 0.589 0 N-CA-C 115.26 0.864 . . . . 0.0 115.26 -167.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -131.31 128.84 40.58 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 170.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -74.55 148.84 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 124.946 1.299 . . . . 0.0 108.642 169.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -142.09 64.83 1.38 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.653 1.581 . . . . 0.0 109.131 178.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -156.3 178.96 9.71 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 120.772 -1.205 . . . . 0.0 110.913 -178.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.53 -179.69 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 126.643 1.977 . . . . 0.0 109.5 -173.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -59.99 -6.69 1.42 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.849 2.06 . . . . 0.0 116.481 -169.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 163.48 -64.23 0.25 Allowed Glycine 0 C--N 1.334 0.47 0 N-CA-C 108.236 -1.946 . . . . 0.0 108.236 171.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -143.42 -66.68 0.36 Allowed 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 124.786 1.235 . . . . 0.0 108.222 169.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -168.68 61.94 0.06 Allowed 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 125.675 1.59 . . . . 0.0 108.086 171.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.6 151.88 4.02 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 123.004 1.383 . . . . 0.0 113.957 -176.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.1 p -152.52 -44.47 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 127.741 2.417 . . . . 0.0 106.823 -178.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.6 p -142.95 -53.34 0.39 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.517 1.527 . . . . 0.0 107.325 169.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -162.83 46.76 0.14 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.166 1.386 . . . . 0.0 109.341 -173.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -70.16 -37.34 75.19 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 169.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -132.17 159.98 37.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 111.863 -2.426 . . . . 0.0 109.015 167.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.9 p -136.29 6.75 3.07 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.145 0.978 . . . . 0.0 112.916 -177.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -135.34 145.42 47.39 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 171.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 40.6 tp -76.49 150.11 36.68 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 105.453 -2.055 . . . . 0.0 105.453 168.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 14.9 m -128.24 150.19 50.14 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -174.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -143.67 149.13 36.8 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.286 1.034 . . . . 0.0 108.365 176.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -134.54 135.2 42.15 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 101.412 -3.551 . . . . 0.0 101.412 169.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.4 t -142.35 144.23 25.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -170.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.4 m -134.46 143.2 47.38 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -159.92 134.15 7.48 Favored 'General case' 0 C--O 1.226 -0.151 0 C-N-CA 123.524 0.73 . . . . 0.0 109.957 171.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 54.61 27.41 42.17 Favored Glycine 0 CA--C 1.537 1.461 0 N-CA-C 114.935 0.734 . . . . 0.0 114.935 169.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 85.73 1.13 87.49 Favored Glycine 0 CA--C 1.535 1.312 0 CA-C-N 118.488 1.144 . . . . 0.0 113.866 -177.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.12 153.19 17.77 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.821 1.648 . . . . 0.0 107.995 173.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 22.8 tp -133.38 156.57 47.43 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.109 0.964 . . . . 0.0 109.477 -176.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 60.6 mtt -144.04 156.48 44.4 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.789 1.636 . . . . 0.0 108.44 171.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.6 129.96 23.84 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 104.377 -2.453 . . . . 0.0 104.377 169.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 18.8 tp -144.7 147.61 33.22 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 119.511 1.05 . . . . 0.0 109.72 -168.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -139.19 153.78 47.95 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.989 0.916 . . . . 0.0 108.753 169.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -172.78 171.13 44.18 Favored Glycine 0 CA--C 1.519 0.333 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 169.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -54.71 141.18 33.22 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 118.804 1.302 . . . . 0.0 107.52 169.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -40.47 -59.44 1.33 Allowed 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -178.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.15 -13.71 62.32 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.345 -0.847 . . . . 0.0 113.134 -174.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -89.31 -27.23 20.67 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 126.175 1.79 . . . . 0.0 109.808 177.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 5.8 tt -78.02 -26.48 48.5 Favored 'General case' 0 C--N 1.344 0.33 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 169.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 3.1 t60 51.95 32.24 9.73 Favored 'General case' 0 C--N 1.344 0.355 0 C-N-CA 126.885 2.074 . . . . 0.0 113.155 168.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -154.97 86.66 0.13 Allowed Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 -169.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -50.66 125.78 13.96 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 169.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.49 175.37 2.3 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -168.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.4 t 70.12 -25.18 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 127.602 2.361 . . . . 0.0 111.768 -170.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -163.53 59.26 0.17 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 120.351 1.432 . . . . 0.0 112.285 -170.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 36.3 m -145.79 -53.9 0.27 Allowed 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 113.64 -1.618 . . . . 0.0 108.841 168.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -75.35 4.59 6.93 Favored 'General case' 0 C--N 1.343 0.299 0 O-C-N 121.867 -0.521 . . . . 0.0 112.285 177.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 11.1 m -81.93 -3.63 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 C-N-CA 123.872 0.869 . . . . 0.0 111.696 178.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -136.57 116.12 12.87 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 169.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 10.4 tt -143.28 142.97 31.53 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.154 0.582 . . . . 0.0 109.527 -169.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 15.6 tp -140.53 141.75 35.26 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 125.815 1.646 . . . . 0.0 107.477 -172.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 38.6 ttm -131.35 132.37 44.4 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -148.35 147.72 29.57 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -178.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -54.55 155.96 3.73 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.663 1.12 . . . . 0.0 111.597 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.6 pp -67.38 158.92 30.52 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 169.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -149.38 96.89 2.57 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.298 0.639 . . . . 0.0 110.058 -177.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 24.3 p90 . . . . . 0 C--O 1.252 1.185 0 C-N-CA 126.096 1.758 . . . . 0.0 107.471 169.675 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.4 mmt . . . . . 0 N--CA 1.476 0.849 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.74 158.43 36.31 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.549 0.74 . . . . 0.0 110.671 173.427 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 60.41 22.84 59.45 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.096 0.855 . . . . 0.0 115.012 169.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 35.0 pt -71.91 174.91 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 124.849 1.26 . . . . 0.0 110.103 173.126 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 60.9 tp -149.88 124.71 9.86 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.629 -0.669 . . . . 0.0 110.599 174.924 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -157.97 145.36 18.25 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 104.096 -2.557 . . . . 0.0 104.096 169.244 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -147.72 144.8 28.56 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.443 1.497 . . . . 0.0 107.786 -175.01 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -154.27 167.64 29.26 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.233 1.813 . . . . 0.0 108.548 178.464 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.2 mp -124.72 114.34 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 103.646 -2.724 . . . . 0.0 103.646 169.828 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -94.23 152.2 18.88 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.486 0.66 . . . . 0.0 109.705 -179.863 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -135.1 133.85 39.68 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 126.408 1.883 . . . . 0.0 108.257 -173.832 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 40.3 t -68.71 143.88 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 123.997 0.919 . . . . 0.0 109.392 -178.057 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -124.24 -28.22 3.71 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 126.785 2.034 . . . . 0.0 109.341 177.542 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -159.06 168.23 27.21 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.481 1.037 . . . . 0.0 111.136 171.066 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.4 mp -135.2 139.05 47.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 127.443 2.297 . . . . 0.0 105.927 179.603 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -147.06 91.98 5.04 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 123.301 0.64 . . . . 0.0 112.27 -173.519 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -68.5 97.12 0.51 Allowed 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 123.059 2.506 . . . . 0.0 108.477 168.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -59.37 -36.32 75.53 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.966 0.906 . . . . 0.0 112.84 -169.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.35 44.65 0.03 OUTLIER Glycine 0 CA--C 1.525 0.703 0 N-CA-C 103.749 -3.741 . . . . 0.0 103.749 -170.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.4 mmmt -65.47 132.37 48.77 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.37 1.068 . . . . 0.0 111.811 -167.394 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -60.47 -33.59 72.81 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 113.798 -1.546 . . . . 0.0 110.087 169.3 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -132.47 102.4 5.71 Favored 'General case' 0 N--CA 1.458 -0.068 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 178.212 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -55.04 -33.09 62.39 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.468 1.107 . . . . 0.0 113.514 -169.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -65.54 -5.69 8.75 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 117.446 -1.264 . . . . 0.0 113.586 178.475 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.5 t -121.52 111.82 32.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 174.677 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 74.0 m -140.11 169.2 18.13 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 124.383 1.073 . . . . 0.0 111.013 -173.859 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -74.59 150.48 39.67 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 175.083 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 71.5 mt -134.12 158.16 44.34 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 127.051 2.14 . . . . 0.0 106.81 173.816 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -128.67 134.57 48.55 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 169.478 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 72.2 m -142.95 169.04 18.32 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.451 1.5 . . . . 0.0 110.352 -171.516 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -136.41 144.5 44.54 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.802 2.041 . . . . 0.0 107.863 -177.707 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.2 p -74.98 158.65 32.91 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.431 1.093 . . . . 0.0 110.992 174.203 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -72.59 -41.55 65.51 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.558 -0.714 . . . . 0.0 110.748 177.656 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.4 m -136.45 6.64 3.02 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -169.052 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -121.32 14.97 11.31 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -169.174 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.264 0.0 OUTLIER 41.45 31.66 0.19 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.95 2.1 . . . . 0.0 114.739 178.295 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 57.3 mtt -74.38 153.95 39.04 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.452 1.101 . . . . 0.0 110.381 -179.104 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -114.34 104.31 11.94 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 169.459 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 62.3 tp -112.18 144.26 41.88 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -171.707 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 31.2 mm -134.0 147.05 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 104.088 -2.56 . . . . 0.0 104.088 174.131 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 123' ' ' MET . 3.2 mp -144.13 158.11 43.91 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 126.155 1.782 . . . . 0.0 107.961 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -133.35 100.86 4.96 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 101.971 -3.344 . . . . 0.0 101.971 168.239 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.8 m -146.23 175.57 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 124.867 1.267 . . . . 0.0 111.126 -167.552 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -58.54 128.5 37.48 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.823 0.849 . . . . 0.0 109.254 169.654 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 pp -115.44 6.0 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 125.101 1.361 . . . . 0.0 112.875 -179.005 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -66.81 -15.0 63.3 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 120.693 1.588 . . . . 0.0 112.069 -176.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.6 mt -65.14 -24.52 35.45 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 C-N-CA 125.293 1.437 . . . . 0.0 109.581 169.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -123.22 71.88 45.92 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 126.931 2.092 . . . . 0.0 109.275 -172.682 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -68.32 -12.34 34.67 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.651 2.234 . . . . 0.0 111.933 173.323 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.5 p -147.32 175.2 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 128.728 2.811 . . . . 0.0 104.917 173.351 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -69.78 69.98 0.31 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.967 0.907 . . . . 0.0 110.123 169.849 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 50.3 tp -64.96 -25.85 68.05 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.729 1.612 . . . . 0.0 111.96 -175.084 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 67.35 26.54 73.52 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-O 119.659 -0.523 . . . . 0.0 112.108 -177.279 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -70.75 157.66 37.66 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 118.024 0.912 . . . . 0.0 108.736 169.853 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -135.97 152.83 51.36 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.188 0.995 . . . . 0.0 109.819 -169.323 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -132.9 127.24 33.93 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -174.456 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -71.45 134.79 46.84 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 169.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 tt -134.79 139.69 45.31 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 -179.67 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 t -139.19 158.04 28.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 -178.176 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 36.0 pt -121.62 14.87 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 123.389 0.675 . . . . 0.0 111.11 176.652 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.48 -4.38 45.26 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.453 1.101 . . . . 0.0 113.444 -175.521 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.8 p -64.15 173.29 2.01 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.657 0.783 . . . . 0.0 110.505 169.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 99.5 m -153.21 156.76 39.14 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 106.457 -1.682 . . . . 0.0 106.457 169.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 62.2 tp -71.78 80.84 0.87 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 169.524 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -52.1 -34.78 45.64 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -169.295 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -64.27 -15.0 59.28 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.2 1.0 . . . . 0.0 112.879 -178.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -63.87 -25.07 67.99 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.721 0.691 . . . . 0.0 111.738 173.538 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 135.78 6.78 1.95 Allowed Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.47 1.033 . . . . 0.0 113.013 178.449 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -60.14 -42.55 95.07 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.27 1.535 . . . . 0.0 107.857 174.141 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 35.0 mt -89.43 124.52 34.55 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 103.62 -2.733 . . . . 0.0 103.62 167.773 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -55.92 131.09 46.24 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 169.924 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -71.32 51.75 0.17 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.598 1.559 . . . . 0.0 111.968 179.479 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -169.82 -56.44 0.04 OUTLIER Glycine 0 CA--C 1.521 0.429 0 N-CA-C 108.122 -1.991 . . . . 0.0 108.122 177.214 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -82.56 47.3 1.16 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.943 1.297 . . . . 0.0 108.904 169.793 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -79.6 41.09 0.47 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.819 1.648 . . . . 0.0 110.747 -171.6 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.05 149.41 98.52 Favored Pre-proline 0 CA--C 1.539 0.522 0 O-C-N 121.073 -1.017 . . . . 0.0 110.725 -174.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.38 -29.85 85.8 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 122.669 2.246 . . . . 0.0 113.644 174.241 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.2 p -73.44 66.47 0.97 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.581 2.352 . . . . 0.0 110.765 -178.888 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -55.4 -25.98 38.92 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.843 1.257 . . . . 0.0 113.275 -176.337 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.514 ' H ' ' HB2' ' A' ' 83' ' ' SER . 26.4 t70 -145.0 -63.76 0.35 Allowed 'General case' 0 C--N 1.34 0.16 0 CA-C-N 118.298 0.499 . . . . 0.0 111.516 169.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.481 ' C ' ' H ' ' A' ' 83' ' ' SER . 9.0 mmm180 -118.41 -142.28 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.761 0 N-CA-C 102.794 -3.039 . . . . 0.0 102.794 169.312 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -61.61 32.1 0.06 OUTLIER 'Trans proline' 0 CA--C 1.553 1.436 0 C-N-CA 123.726 2.951 . . . . 0.0 114.2 167.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.514 ' HB2' ' H ' ' A' ' 80' ' ' ASP . 23.5 m -68.01 38.11 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.659 1 C-N-CA 132.628 4.371 . . . . 0.0 113.049 -174.578 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 33.9 mtp180 -70.93 -7.66 47.46 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.909 1.684 . . . . 0.0 113.212 -176.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 61.64 -18.16 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 128.143 2.577 . . . . 0.0 114.468 -169.602 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -58.35 -14.61 7.89 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.007 1.723 . . . . 0.0 112.819 169.908 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -58.68 -18.05 27.75 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.418 1.487 . . . . 0.0 111.849 169.609 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -122.22 158.18 30.02 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.76 2.024 . . . . 0.0 108.207 -178.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -78.86 -24.83 44.05 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 122.954 0.502 . . . . 0.0 111.741 -171.067 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -147.67 148.22 30.82 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.683 0.793 . . . . 0.0 109.686 -175.53 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.4 p -146.14 143.64 21.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 175.365 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 31.4 tpp -157.81 170.47 22.27 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.592 0.757 . . . . 0.0 110.424 -175.288 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -136.07 154.47 51.01 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.486 2.315 . . . . 0.0 106.116 -175.252 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -161.89 -153.0 6.91 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-N 119.365 0.984 . . . . 0.0 113.838 -169.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -147.57 124.61 11.38 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.339 1.456 . . . . 0.0 108.243 176.823 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 46.1 t -77.61 133.72 29.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 168.775 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -141.24 70.72 1.35 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.99 0.916 . . . . 0.0 110.524 -169.093 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -155.5 173.01 17.29 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.873 -1.142 . . . . 0.0 111.556 175.079 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 19.7 pt -74.02 -177.63 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 126.128 1.771 . . . . 0.0 112.255 -172.575 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -65.81 -13.59 59.78 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.256 1.822 . . . . 0.0 114.893 -173.621 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 111.53 -36.06 4.39 Favored Glycine 0 C--N 1.338 0.68 0 C-N-CA 124.514 1.054 . . . . 0.0 111.483 178.663 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -66.94 113.83 5.27 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 169.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -128.68 4.35 5.51 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 123.388 0.43 . . . . 0.0 111.386 -169.869 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 34.1 p -140.45 -72.84 0.36 Allowed 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.191 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.3 m 177.26 -38.86 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 131.402 3.881 . . . . 0.0 107.107 179.096 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.3 p -165.05 -49.49 0.03 OUTLIER 'General case' 0 C--N 1.343 0.307 0 C-N-CA 125.22 1.408 . . . . 0.0 108.506 -169.924 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -55.57 -26.72 45.07 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 -168.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -142.37 14.12 2.0 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 118.617 0.644 . . . . 0.0 111.327 169.733 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.11 -7.7 48.37 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 178.343 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.3 p -81.39 -3.43 52.77 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 127.853 2.461 . . . . 0.0 114.187 -169.872 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? -126.91 141.07 51.9 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 172.133 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.3 tp -73.13 144.48 46.92 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 104.339 -2.467 . . . . 0.0 104.339 167.7 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 7.9 p -110.25 141.92 42.56 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 169.749 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -142.65 152.61 42.63 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 125.29 1.436 . . . . 0.0 107.207 -175.643 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -134.63 143.46 47.31 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 102.332 -3.21 . . . . 0.0 102.332 169.092 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 13.8 t -133.07 116.59 26.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 105.658 -1.979 . . . . 0.0 105.658 -179.155 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.5 p -96.76 129.96 44.09 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 170.042 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -152.05 123.62 7.86 Favored 'General case' 0 C--N 1.334 -0.103 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -171.051 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 52.9 27.66 29.82 Favored Glycine 0 CA--C 1.538 1.492 0 CA-C-O 119.455 -0.636 . . . . 0.0 114.234 -178.801 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 82.28 -0.39 88.95 Favored Glycine 0 CA--C 1.536 1.384 0 CA-C-N 118.448 1.124 . . . . 0.0 114.007 -177.815 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 63.5 mt -99.16 170.94 8.33 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.449 1.5 . . . . 0.0 108.3 171.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 45.4 tp -139.46 157.65 45.47 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 118.628 0.649 . . . . 0.0 111.301 -170.494 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.478 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 54.5 mtt -143.57 160.3 40.88 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 126.258 1.823 . . . . 0.0 109.055 169.389 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 41.5 ttt180 -135.04 137.28 42.78 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 102.972 -2.973 . . . . 0.0 102.972 168.532 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 25.4 tp -147.91 137.29 22.32 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -169.743 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -128.45 144.3 51.12 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 170.41 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -177.79 170.23 42.49 Favored Glycine 0 CA--C 1.519 0.288 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 175.341 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -52.59 134.55 35.45 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 118.5 1.15 . . . . 0.0 108.685 172.868 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -46.69 -58.74 3.57 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -172.767 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -57.97 -45.26 86.99 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 122.322 1.058 . . . . 0.0 111.277 -177.55 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -61.13 -27.29 68.28 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 126.438 1.895 . . . . 0.0 111.793 178.381 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 tt -81.05 -24.19 38.02 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.917 0.887 . . . . 0.0 109.236 -179.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 54.27 30.25 12.11 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.212 1.005 . . . . 0.0 111.234 -170.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -104.25 9.74 50.16 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.662 1.125 . . . . 0.0 112.544 -176.447 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -72.13 7.95 1.48 Allowed 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.555 1.542 . . . . 0.0 112.643 178.233 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -145.18 106.55 4.21 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 127.76 2.424 . . . . 0.0 105.21 -178.221 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 14.6 m -63.02 -7.99 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 113.973 -1.467 . . . . 0.0 112.478 -177.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -122.05 18.89 10.85 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.364 1.065 . . . . 0.0 113.761 175.291 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 3.7 m -88.97 -70.26 0.66 Allowed 'General case' 0 N--CA 1.453 -0.296 0 O-C-N 121.639 -0.663 . . . . 0.0 110.683 168.516 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.28 2.0 ptp180 -75.64 11.48 1.31 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -173.006 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.3 m -65.61 -37.09 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 167.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -78.08 130.47 36.47 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 177.852 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.2 tt -141.2 141.96 34.03 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -172.492 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 49.2 tp -146.14 127.76 15.17 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 -174.564 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 48.9 ttp -143.8 146.06 32.81 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 119.829 1.195 . . . . 0.0 111.955 -169.443 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -151.57 166.05 32.37 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.904 2.081 . . . . 0.0 107.543 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -54.48 169.0 0.21 Allowed 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.464 1.029 . . . . 0.0 111.038 169.15 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.95 158.82 0.3 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 122.231 1.015 . . . . 0.0 113.333 173.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -143.61 130.15 20.11 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 174.112 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 54.3 p90 . . . . . 0 C--O 1.252 1.19 0 C-N-CA 126.169 1.787 . . . . 0.0 108.13 177.269 . . . . . . . . 0 0 . 1 stop_ save_